data_1axj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1axj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.87 159.9 47.22 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.545 2.163 . . . . 0.0 109.788 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.21 94.04 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -51.4 -39.01 56.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.941 1.696 . . . . 0.0 111.438 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.28 -57.84 7.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.593 1.088 . . . . 0.0 110.388 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -54.78 -48.43 72.7 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.522 1.129 . . . . 0.0 109.902 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.82 -35.96 73.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.5 t -69.4 -44.07 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.618 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -41.67 77.12 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.068 1.304 . . . . 0.0 112.433 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -51.77 -24.67 6.25 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.86 168.48 9.4 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 122.42 1.105 . . . . 0.0 111.669 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.5 138.69 45.23 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.83 172.36 44.61 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.04 150.93 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.1 t -128.97 163.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 127.585 2.354 . . . . 0.0 104.926 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.19 156.09 46.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.543 1.137 . . . . 0.0 108.315 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -138.54 110.88 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.87 108.51 19.57 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -93.89 108.79 20.54 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -74.4 137.24 42.56 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 121.034 1.743 . . . . 0.0 106.441 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.72 -81.94 0.22 Allowed Glycine 0 C--O 1.222 -0.607 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -164.16 -61.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.98 55.95 3.76 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.128 1.918 . . . . 0.0 109.49 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.59 140.69 4.92 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 127.238 2.351 . . . . 0.0 112.144 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.9 151.66 77.91 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 118.248 1.024 . . . . 0.0 109.619 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -121.12 101.82 7.91 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -87.43 88.55 7.71 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.33 173.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.006 2.123 . . . . 0.0 110.521 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -119.21 167.69 11.59 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.778 1.172 . . . . 0.0 113.128 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.7 t -168.34 173.16 7.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.1 2.16 . . . . 0.0 108.758 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -120.77 141.59 50.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.448 2.299 . . . . 0.0 109.984 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.56 -31.23 63.99 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.224 0.92 . . . . 0.0 111.013 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -60.09 -9.08 2.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.7 1.6 . . . . 0.0 113.612 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -118.1 -10.74 10.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.031 1.332 . . . . 0.0 109.361 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.7 mt -92.33 164.62 13.44 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.745 -1.222 . . . . 0.0 111.232 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.78 141.27 42.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.3 t -101.68 150.05 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.3 mt -122.14 178.86 4.74 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.37 2.668 . . . . 0.0 107.64 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -73.1 174.83 7.37 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.98 28.29 32.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.591 1.567 . . . . 0.0 110.942 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.301 0.1 OUTLIER 53.49 21.99 2.72 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.0 2.12 . . . . 0.0 114.69 -176.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -73.36 139.61 46.09 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -123.69 167.49 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 t -147.62 145.97 18.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 O-C-N 120.484 -1.385 . . . . 0.0 108.582 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.4 131.79 24.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.289 2.636 . . . . 0.0 105.959 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.91 108.75 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.485 2.123 . . . . 0.0 108.84 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.42 111.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.4 -21.08 5.63 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.852 1.691 . . . . 0.0 112.966 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.07 41.55 0.29 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.7 mtt -107.88 71.41 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.553 1.541 . . . . 0.0 107.862 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -66.29 -64.91 0.75 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 130.348 3.459 . . . . 0.0 113.732 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -51.69 -41.11 61.21 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.982 -1.074 . . . . 0.0 109.15 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -61.5 -38.94 89.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.69 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.78 -50.18 74.91 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 121.126 1.785 . . . . 0.0 110.532 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.31 -39.31 90.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 111.498 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -68.08 -41.96 81.09 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 116.279 -1.82 . . . . 0.0 110.471 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.15 -48.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.101 1.319 . . . . 0.0 108.966 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.19 51.06 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.295 -0.86 . . . . 0.0 112.694 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.86 -45.93 10.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.36 0.982 . . . . 0.0 113.081 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -141.59 133.14 26.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.931 0.893 . . . . 0.0 110.777 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -16.15 62.21 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.948 -1.095 . . . . 0.0 112.902 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -59.76 117.12 4.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.9 147.1 25.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 123.679 1.704 . . . . 0.0 112.444 173.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.25 148.9 31.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 11.7 ttt -139.38 126.62 21.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.3 p -108.74 127.96 54.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.79 164.92 13.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.994 1.725 . . . . 0.0 108.696 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.1 -175.77 38.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.9 t -146.99 161.92 39.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.024 1.329 . . . . 0.0 108.841 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -98.73 -8.1 26.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.854 1.662 . . . . 0.0 109.922 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -8.51 48.73 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.839 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.88 133.95 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.13 131.38 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.5 1.12 . . . . 0.0 111.419 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -140.92 6.14 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.89 -59.43 2.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.746 2.019 . . . . 0.0 108.324 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.27 102.94 8.87 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.2 -168.63 1.58 Allowed Glycine 0 CA--C 1.537 1.463 0 O-C-N 121.997 -0.439 . . . . 0.0 112.289 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -75.65 64.18 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.574 2.182 . . . . 0.0 109.954 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.11 121.13 1.1 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -118.16 169.61 9.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.008 0.904 . . . . 0.0 110.155 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.61 -171.84 43.56 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 124.271 0.939 . . . . 0.0 112.406 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -145.35 156.04 43.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 109.791 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 tt -101.38 131.36 47.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.33 162.07 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -133.32 150.75 51.85 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.399 1.479 . . . . 0.0 108.923 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.97 179.6 43.52 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.216 0.912 . . . . 0.0 111.745 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -101.21 128.98 47.08 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.02 161.78 14.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.609 1.095 . . . . 0.0 111.692 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 121.28 3.11 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.41 1.484 . . . . 0.0 109.351 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.91 137.54 43.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.538 HH11 ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -138.34 141.22 39.73 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.532 1.533 . . . . 0.0 109.334 176.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.26 37.39 4.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -159.2 159.12 33.91 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 129.072 2.949 . . . . 0.0 110.613 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.44 178.56 46.84 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 126.432 1.967 . . . . 0.0 115.694 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.57 -18.26 53.47 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.891 3.06 . . . . 0.0 111.724 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.83 -64.09 0.94 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.16 -31.27 71.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.633 0.773 . . . . 0.0 111.556 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -68.58 -60.3 2.51 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.75 -19.34 62.35 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.847 -1.158 . . . . 0.0 113.517 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.8 pp -92.6 -18.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.112 1.324 . . . . 0.0 110.854 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.58 -27.97 3.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.782 1.633 . . . . 0.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -50.67 -23.22 2.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.441 1.096 . . . . 0.0 113.567 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -80.3 178.73 8.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.733 1.151 . . . . 0.0 109.604 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 tttt -137.27 20.35 2.96 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.91 -1.744 . . . . 0.0 111.331 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -136.15 8.67 3.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.902 1.281 . . . . 0.0 111.137 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.93 131.1 35.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.529 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -20.9 16.53 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 109.669 173.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.85 161.76 11.08 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.377 1.871 . . . . 0.0 109.769 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 103.5 13.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.18 95.38 5.6 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.12 131.66 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.951 1.7 . . . . 0.0 106.961 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.2 mt -117.93 128.47 75.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -99.01 85.9 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.4 t -60.78 151.7 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.494 1.118 . . . . 0.0 109.461 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.5 -54.99 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m -148.34 141.22 24.74 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.258 . . -120.59 158.15 27.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 130.698 3.599 . . . . 0.0 114.732 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -145.93 135.77 23.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.218 2.207 . . . . 0.0 107.221 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.84 138.57 42.6 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -134.83 -81.04 0.44 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.518 0.327 . . . . 0.0 110.48 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 121.38 0.609 . . . . 0.0 109.938 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.2 mt . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 157.16 57.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.502 2.134 . . . . 0.0 110.956 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -38.84 93.63 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -49.16 -38.94 27.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.606 1.562 . . . . 0.0 112.121 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -51.5 -52.82 43.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.426 1.466 . . . . 0.0 111.245 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -56.11 -48.35 76.36 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.585 1.154 . . . . 0.0 108.996 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.98 -34.03 69.53 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.12 -45.35 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.349 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.08 -43.17 70.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.315 1.416 . . . . 0.0 112.839 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -51.84 -19.36 1.67 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -112.16 161.94 15.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.938 1.351 . . . . 0.0 111.472 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -73.6 131.59 41.86 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.774 1.23 . . . . 0.0 109.356 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.31 165.13 35.37 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 124.978 1.275 . . . . 0.0 111.251 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.78 150.6 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.4 t -135.15 161.44 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.59 43.01 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.032 0.933 . . . . 0.0 108.808 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.7 mt -138.71 118.83 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.9 108.38 19.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 m -89.43 116.66 27.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -73.26 141.18 47.23 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 120.916 1.689 . . . . 0.0 106.554 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.13 -81.28 0.25 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -161.42 -48.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 19.9 p-10 -78.44 40.63 0.37 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 129.61 3.164 . . . . 0.0 111.133 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.43 151.4 18.56 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.693 1.139 . . . . 0.0 110.851 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.8 149.27 72.69 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 CA-C-N 118.609 1.205 . . . . 0.0 109.51 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.635 ' CD2' ' HG1' ' A' ' 54' ' ' THR . 0.5 OUTLIER -110.91 98.12 7.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.68 2.392 . . . . 0.0 112.892 -172.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -82.14 89.21 6.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.674 0.79 . . . . 0.0 111.395 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.41 168.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.908 1.283 . . . . 0.0 110.491 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -122.23 166.07 15.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.1 t -168.42 176.57 5.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.224 2.209 . . . . 0.0 109.222 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.14 141.63 50.63 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.327 2.251 . . . . 0.0 109.848 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -55.61 -31.47 62.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.971 0.805 . . . . 0.0 111.193 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 t -60.48 -8.88 3.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.515 1.926 . . . . 0.0 114.043 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -118.72 -1.05 11.16 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.752 1.16 . . . . 0.0 111.399 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.65 163.38 12.25 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.29 0.95 . . . . 0.0 112.262 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -136.3 141.59 43.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.79 141.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.43 -178.02 3.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.839 1.655 . . . . 0.0 108.999 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.76 164.81 4.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.651 1.181 . . . . 0.0 111.298 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.82 28.21 30.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.388 1.947 . . . . 0.0 111.109 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.293 0.1 OUTLIER 53.44 22.15 2.74 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.532 1.933 . . . . 0.0 113.29 -175.151 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -73.83 131.89 41.99 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -114.11 161.09 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.63 138.54 35.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 108.669 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.15 133.14 24.34 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.742 2.017 . . . . 0.0 106.966 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.36 123.18 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.88 1.72 . . . . 0.0 107.739 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -85.08 112.16 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.65 -20.67 8.77 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 124.868 1.223 . . . . 0.0 113.458 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.62 39.99 0.19 Allowed Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.377 1.589 . . . . 0.0 112.175 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 30.9 mtt -99.12 71.06 1.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.035 0.917 . . . . 0.0 110.788 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -71.07 -67.41 0.51 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.368 1.867 . . . . 0.0 112.749 -173.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HZ3' ' CG ' ' A' ' 24' ' ' ASP 0.259 12.2 tmtt? -51.97 -38.89 58.25 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.172 0.989 . . . . 0.0 108.966 176.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.635 ' HG1' ' CD2' ' A' ' 27' ' ' HIS . 1.6 m -64.5 -38.81 92.32 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.909 173.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 26.5 tt0 -57.45 -43.63 84.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.478 1.944 . . . . 0.0 109.657 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.24 95.35 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.239 -0.288 . . . . 0.0 111.649 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.35 -41.76 76.66 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 116.968 -1.491 . . . . 0.0 113.567 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.08 -48.11 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.436 1.471 . . . . 0.0 109.089 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.7 -23.56 29.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -85.99 -46.07 10.87 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -151.42 129.43 11.8 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.759 1.224 . . . . 0.0 110.009 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -17.53 59.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.57 131.04 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.327 1.421 . . . . 0.0 110.739 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.3 m -141.4 155.96 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 123.379 1.562 . . . . 0.0 112.332 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -101.21 152.54 20.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.9 ttt -138.93 118.77 13.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -111.03 128.1 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -116.8 170.21 8.78 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 109.623 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.59 -177.02 39.3 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.442 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.5 t -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -98.63 -7.91 27.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.801 1.64 . . . . 0.0 108.936 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -11.26 38.55 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 119.371 -2.081 . . . . 0.0 113.338 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.42 138.87 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 120.627 1.558 . . . . 0.0 107.101 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.0 130.26 35.33 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.026 0.53 . . . . 0.0 110.75 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.67 -121.7 2.79 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 124.437 1.018 . . . . 0.0 112.927 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -91.81 -78.63 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.247 1.419 . . . . 0.0 110.529 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -73.61 104.95 4.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.166 0.984 . . . . 0.0 108.431 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.15 -168.59 10.59 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.704 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.74 63.7 5.76 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.851 2.368 . . . . 0.0 110.29 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.83 121.44 1.32 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -115.4 173.33 6.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.966 0.883 . . . . 0.0 110.726 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.3 -173.3 43.67 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 118.797 0.726 . . . . 0.0 113.133 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -151.34 157.32 42.33 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.409 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.5 130.9 47.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.62 155.14 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -126.86 143.87 51.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.626 1.57 . . . . 0.0 107.818 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.63 -165.11 32.65 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.3 m -121.39 142.87 49.58 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.313 0.645 . . . . 0.0 110.017 173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.92 161.78 15.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.623 1.169 . . . . 0.0 110.174 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.74 114.5 2.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.702 1.201 . . . . 0.0 107.775 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 50.1 m-85 -74.57 136.26 42.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.505 HH11 ' HG3' ' A' ' 92' ' ' ARG . 6.4 mmm-85 -139.13 137.3 35.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 109.866 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -120.78 38.06 4.14 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.81 158.96 34.55 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 129.394 3.078 . . . . 0.0 111.19 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.73 46.88 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.966 1.746 . . . . 0.0 114.72 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.03 -19.55 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.645 2.23 . . . . 0.0 109.523 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -63.62 -65.86 0.62 Allowed 'General case' 0 C--O 1.25 1.11 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.58 -31.85 71.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 116.607 -1.663 . . . . 0.0 112.515 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -68.25 -53.95 21.03 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.852 1.66 . . . . 0.0 110.823 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.67 70.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 116.96 -1.495 . . . . 0.0 111.309 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pp -85.1 -20.67 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 117.507 -1.677 . . . . 0.0 113.558 173.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.05 97.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.881 1.673 . . . . 0.0 112.915 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.504 ' H ' ' HD2' ' A' ' 103' ' ' ARG 0.52 0.0 OUTLIER -51.72 -18.06 1.1 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 173.784 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.02 -179.0 0.12 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -128.38 16.11 6.59 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 118.782 -2.449 . . . . 0.0 111.998 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -139.32 12.16 2.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.042 1.337 . . . . 0.0 110.891 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.12 140.46 37.8 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.372 -0.83 . . . . 0.0 111.28 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.81 -21.53 6.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.988 2.115 . . . . 0.0 111.706 174.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.24 161.99 1.9 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.69 1.996 . . . . 0.0 109.396 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.61 112.44 24.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 tp -84.1 93.56 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.11 120.8 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.93 128.8 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.2 m -98.61 78.91 2.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.5 t -61.09 153.84 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 125.745 1.618 . . . . 0.0 109.381 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.9 t -130.15 -54.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -151.4 141.59 22.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.717 0.689 . . . . 0.0 112.844 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.58 20.22 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 127.283 2.233 . . . . 0.0 111.22 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.38 154.21 42.75 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.308 2.643 . . . . 0.0 106.689 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -100.8 133.97 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.223 -1.548 . . . . 0.0 108.404 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.0 p -135.37 -81.91 0.42 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.196 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.808 0 C-N-CA 130.415 3.486 . . . . 0.0 114.871 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.86 158.51 52.74 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.109 1.873 . . . . 0.0 109.197 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.2 -40.44 95.79 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -54.18 -38.84 66.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 111.827 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -51.32 -52.31 46.53 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.51 1.05 . . . . 0.0 110.692 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -60.0 -48.28 82.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.764 0.826 . . . . 0.0 110.495 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -53.21 -38.66 63.1 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.505 1.048 . . . . 0.0 112.159 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.04 -42.35 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.858 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.2 mt -58.39 -42.67 87.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.261 1.392 . . . . 0.0 112.164 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -51.87 -25.34 7.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.105 0.962 . . . . 0.0 113.04 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -101.26 161.09 13.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.62 139.99 45.86 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.13 164.4 37.75 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.53 148.5 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.8 t -135.49 161.66 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.6 158.38 41.08 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.123 0.969 . . . . 0.0 108.875 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -138.81 114.42 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.66 108.87 19.69 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 173.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -92.89 116.19 28.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 116.939 -1.505 . . . . 0.0 107.607 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -73.3 137.42 44.84 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 120.859 1.663 . . . . 0.0 108.4 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.25 -81.51 0.22 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 106.8 -2.52 . . . . 0.0 106.8 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -168.98 -48.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -78.18 38.68 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 131.326 3.85 . . . . 0.0 110.069 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.92 151.17 5.7 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.62 148.56 72.51 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 CA-C-N 119.762 1.781 . . . . 0.0 107.725 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.563 ' CD2' ' HZ3' ' A' ' 53' ' ' LYS . 52.5 t60 -108.15 101.5 10.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.347 -173.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 tp -74.68 88.8 2.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.216 1.006 . . . . 0.0 111.441 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.08 170.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.489 1.516 . . . . 0.0 110.242 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.24 168.08 11.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.802 1.183 . . . . 0.0 113.571 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.1 t -168.61 174.1 6.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.254 2.622 . . . . 0.0 108.253 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -121.11 141.96 50.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.52 2.328 . . . . 0.0 110.726 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -52.92 -31.63 41.06 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.828 1.194 . . . . 0.0 111.776 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -58.48 -8.71 1.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.701 2.001 . . . . 0.0 113.653 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -118.06 -3.35 11.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.813 1.245 . . . . 0.0 110.479 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.9 mt -99.23 170.59 8.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 120.449 1.477 . . . . 0.0 114.36 -173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -136.33 141.32 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -100.92 148.81 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 mt -121.78 178.93 4.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.17 2.188 . . . . 0.0 110.463 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -67.13 167.65 11.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.577 1.551 . . . . 0.0 109.742 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.9 28.62 57.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.073 1.321 . . . . 0.0 111.307 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.25 0.1 OUTLIER 53.73 20.43 2.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.873 2.069 . . . . 0.0 114.236 -175.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -73.44 145.56 45.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -127.27 168.15 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.02 145.0 18.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 120.392 -1.443 . . . . 0.0 108.8 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.68 138.88 32.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 128.749 2.82 . . . . 0.0 107.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.24 109.12 2.28 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.8 3.0 . . . . 0.0 109.427 173.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.28 111.84 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 173.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.77 -21.63 4.94 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.771 1.177 . . . . 0.0 113.24 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.24 37.45 0.41 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 119.183 1.491 . . . . 0.0 111.44 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.4 mtt -103.39 71.5 1.1 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.433 ' CD2' HH22 ' A' ' 108' ' ' ARG . 34.0 m80 -67.28 -70.53 0.25 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.401 2.68 . . . . 0.0 114.573 -173.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.563 ' HZ3' ' CD2' ' A' ' 27' ' ' HIS . 4.4 ttpm? -51.68 -40.74 60.62 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 120.791 -1.193 . . . . 0.0 109.987 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 m -60.39 -39.14 86.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.868 0.867 . . . . 0.0 113.323 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.85 -48.13 82.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.291 1.405 . . . . 0.0 108.587 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.2 97.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.761 173.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -63.07 -41.93 99.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.57 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.49 -48.21 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.622 1.101 . . . . 0.0 108.664 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.87 -26.81 62.61 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.122 -0.942 . . . . 0.0 113.503 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -87.18 -46.99 9.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.977 1.262 . . . . 0.0 112.187 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -147.06 128.85 15.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.399 1.08 . . . . 0.0 111.848 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -17.67 59.3 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.66 130.97 48.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.225 0.921 . . . . 0.0 110.466 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -144.24 156.15 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 123.264 1.507 . . . . 0.0 112.879 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -104.88 152.74 22.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 172.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 ttt -138.99 128.27 24.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 p -129.72 128.6 42.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -116.46 164.07 15.1 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 119.431 1.014 . . . . 0.0 109.29 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.64 42.4 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.8 t -160.95 172.04 17.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.171 -1.194 . . . . 0.0 109.428 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -99.23 -8.29 25.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.212 2.205 . . . . 0.0 108.987 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -11.18 43.88 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 115.815 -2.041 . . . . 0.0 116.265 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.87 140.33 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.76 131.29 35.88 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.727 0.811 . . . . 0.0 110.868 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.4 -139.47 5.68 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 125.441 1.496 . . . . 0.0 112.099 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -79.23 -59.04 2.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.165 1.786 . . . . 0.0 107.662 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.7 103.09 15.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.27 -168.7 4.13 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.36 61.02 6.59 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.492 2.128 . . . . 0.0 109.969 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.33 121.56 1.2 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 108.559 -1.817 . . . . 0.0 108.559 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.19 169.85 8.96 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.479 1.14 . . . . 0.0 110.197 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 171.83 43.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.295 0.95 . . . . 0.0 113.1 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -131.83 147.78 52.51 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.417 1.487 . . . . 0.0 108.696 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -100.51 131.5 46.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.893 2.477 . . . . 0.0 105.409 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.4 mt -136.4 154.73 33.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 mtt-85 -127.74 143.12 51.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.285 1.434 . . . . 0.0 107.682 -174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.09 -171.84 40.27 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 119.094 0.861 . . . . 0.0 113.407 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -121.31 134.68 55.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.323 1.449 . . . . 0.0 110.514 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.76 160.53 17.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.747 1.619 . . . . 0.0 110.565 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.62 120.64 1.5 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.464 1.506 . . . . 0.0 109.13 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.99 149.37 29.34 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.19 -0.944 . . . . 0.0 112.747 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.18 141.4 34.1 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.557 1.943 . . . . 0.0 109.179 172.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.8 p -114.11 24.8 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.546 1.539 . . . . 0.0 107.321 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.72 167.32 29.81 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 126.317 1.847 . . . . 0.0 110.39 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.8 179.74 45.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.639 2.066 . . . . 0.0 113.295 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.7 -11.46 17.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.886 3.057 . . . . 0.0 112.459 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -64.04 0.98 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.328 1.851 . . . . 0.0 107.138 173.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.29 -31.12 70.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.127 0.892 . . . . 0.0 110.749 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -68.65 -56.86 6.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.001 0.819 . . . . 0.0 109.801 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.39 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.909 -1.119 . . . . 0.0 112.428 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.343 1.5 pp -92.3 -18.12 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.666 1.121 . . . . 0.0 111.463 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.28 -28.09 2.89 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.688 1.995 . . . . 0.0 112.334 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -51.49 -32.34 27.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.237 172.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -79.07 178.02 8.36 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 173.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.69 8.18 1.93 Allowed 'General case' 0 C--O 1.221 -0.427 0 O-C-N 118.473 -2.642 . . . . 0.0 111.704 173.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -102.0 8.38 40.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.628 1.171 . . . . 0.0 110.554 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.96 22.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.519 0.727 . . . . 0.0 109.992 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.433 HH22 ' CD2' ' A' ' 52' ' ' HIS . 23.1 ttm180 -120.65 -20.93 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.887 2.075 . . . . 0.0 111.355 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.35 161.83 12.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.666 1.586 . . . . 0.0 108.519 -173.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.5 105.41 15.43 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.599 2.36 . . . . 0.0 106.695 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 tp -79.22 95.86 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.285 1.834 . . . . 0.0 107.094 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.7 t -78.91 131.52 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.676 1.59 . . . . 0.0 106.718 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.78 128.36 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.5 m -98.91 85.9 3.37 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.76 150.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.46 -58.83 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -147.95 141.53 25.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.3 154.73 25.22 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.394 2.278 . . . . 0.0 110.347 173.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -140.41 139.14 35.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.447 2.299 . . . . 0.0 106.865 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -77.84 139.97 39.33 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -132.98 -58.82 0.9 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.243 0.717 0 CA-C-O 116.561 -1.685 . . . . 0.0 111.945 -173.362 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.15 155.48 56.61 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.576 2.184 . . . . 0.0 110.644 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.84 -42.06 97.96 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -49.48 -38.8 31.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.36 1.864 . . . . 0.0 112.327 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -51.1 -56.26 13.56 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.45 1.023 . . . . 0.0 110.145 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -58.62 -48.74 79.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.914 0.886 . . . . 0.0 109.36 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.59 -40.23 71.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.483 0.583 . . . . 0.0 112.269 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.52 -45.83 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.801 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.65 -37.25 73.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.81 1.186 . . . . 0.0 113.921 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -51.78 -29.51 19.26 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.748 1.158 . . . . 0.0 112.134 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -101.08 165.55 11.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.607 1.163 . . . . 0.0 109.83 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.21 139.05 45.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.33 167.56 40.31 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.13 144.12 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.068 1.747 . . . . 0.0 107.432 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.0 t -136.8 158.32 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.42 155.45 43.15 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.566 1.546 . . . . 0.0 108.115 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.5 mt -140.98 112.93 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.99 108.92 19.84 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -95.35 116.99 29.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -73.31 141.16 47.14 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 121.001 1.728 . . . . 0.0 106.542 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.12 -81.27 0.22 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.89 -60.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 15.8 p-10 -78.61 38.84 0.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 130.096 3.359 . . . . 0.0 111.445 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.0 151.29 17.03 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.13 0.871 . . . . 0.0 110.994 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.6 152.09 53.34 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 120.994 1.13 . . . . 0.0 111.529 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -110.5 101.6 10.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.4 tt -88.91 88.94 7.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -85.71 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.561 1.944 . . . . 0.0 110.785 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -119.23 166.72 12.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.367 0.985 . . . . 0.0 113.368 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 t -168.44 171.89 8.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.407 2.283 . . . . 0.0 108.212 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -121.34 141.71 50.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.084 1.754 . . . . 0.0 110.192 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.69 -31.25 15.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.795 0.838 . . . . 0.0 111.376 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -59.31 -8.66 1.79 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.095 1.758 . . . . 0.0 113.682 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -118.56 -13.21 9.69 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.722 1.209 . . . . 0.0 110.623 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.8 mt -91.1 168.62 11.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.64 -1.288 . . . . 0.0 111.901 -173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.91 37.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.46 134.05 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.28 179.07 4.53 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.897 1.679 . . . . 0.0 107.337 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 35.0 t0 -75.83 -179.21 4.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.274 0.629 . . . . 0.0 110.31 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.476 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 58.6 28.85 63.16 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.419 -1.425 . . . . 0.0 110.303 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 p30 53.82 13.23 0.5 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 130.106 3.362 . . . . 0.0 114.684 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -74.01 128.05 34.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.082 0.401 . . . . 0.0 110.301 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -119.07 158.83 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.5 142.72 25.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 O-C-N 120.397 -1.439 . . . . 0.0 107.732 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.38 126.15 25.53 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 128.623 2.769 . . . . 0.0 106.522 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -72.9 108.4 2.57 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.453 1.436 . . . . 0.0 108.934 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.87 111.59 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.7 -21.48 5.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.35 0.976 . . . . 0.0 112.097 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.58 41.3 0.47 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.044 -174.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.7 mtt -109.75 71.74 0.77 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.271 1.429 . . . . 0.0 108.203 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -67.04 -64.13 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 130.239 3.416 . . . . 0.0 112.794 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 50.0 tttm -51.66 -41.04 61.07 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.258 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.8 m -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.358 1.463 . . . . 0.0 111.509 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.95 -48.97 79.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.714 1.206 . . . . 0.0 108.838 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.83 94.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.0 -41.86 90.52 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.014 0.926 . . . . 0.0 109.316 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.34 -47.96 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.39 -28.3 28.69 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.505 -0.747 . . . . 0.0 112.322 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -79.95 -45.96 17.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 173.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -150.79 138.97 20.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.051 0.842 . . . . 0.0 110.174 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -74.62 -18.52 60.54 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.362 -0.836 . . . . 0.0 111.984 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.79 118.15 6.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.804 1.241 . . . . 0.0 113.935 -174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 m -139.31 152.72 23.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 123.084 1.421 . . . . 0.0 112.762 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.74 148.78 32.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 173.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.0 ttt -140.47 123.44 16.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.0 p -108.79 128.15 54.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.03 167.68 10.93 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 120.408 1.458 . . . . 0.0 109.208 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.91 178.82 46.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -151.89 155.18 37.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.6 mtt-85 -98.4 -8.4 26.99 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.284 0.634 . . . . 0.0 111.182 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -72.39 -7.66 50.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.535 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.98 135.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 174.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.01 130.36 35.44 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.24 -137.54 5.29 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -90.76 -58.39 2.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.575 0.75 . . . . 0.0 109.142 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.91 102.61 5.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 118.794 -1.162 . . . . 0.0 108.532 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.21 -168.27 0.12 Allowed Glycine 0 CA--C 1.54 1.642 0 O-C-N 120.647 -1.283 . . . . 0.0 111.086 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.37 90.78 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 106.462 -2.169 . . . . 0.0 106.462 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.41 0.71 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.748 -1.585 . . . . 0.0 109.599 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -105.99 168.87 8.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.399 1.099 . . . . 0.0 110.091 174.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.43 -166.14 35.31 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-O 121.266 0.37 . . . . 0.0 113.646 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.69 152.39 42.34 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.497 1.119 . . . . 0.0 110.009 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.22 131.12 47.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.3 mt -133.55 150.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -124.25 138.23 54.42 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.687 1.995 . . . . 0.0 106.268 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.45 -167.17 26.71 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -121.14 142.1 50.19 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.448 1.899 . . . . 0.0 108.682 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.06 160.99 16.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.913 1.233 . . . . 0.0 110.935 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.11 120.44 3.33 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.266 1.027 . . . . 0.0 109.448 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -74.13 128.7 36.21 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.56 141.12 50.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.782 2.433 . . . . 0.0 109.632 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -121.21 29.53 7.25 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.658 1.983 . . . . 0.0 107.262 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.77 165.98 33.03 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.646 2.378 . . . . 0.0 108.663 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.7 178.97 46.34 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.499 1.523 . . . . 0.0 113.643 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.73 -20.43 68.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.545 2.163 . . . . 0.0 111.11 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.32 -55.58 20.29 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.52 1.528 . . . . 0.0 108.595 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -61.34 -31.35 71.22 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 116.924 -1.512 . . . . 0.0 110.521 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.22 -48.39 65.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 121.515 1.962 . . . . 0.0 110.516 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.11 -35.99 60.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.854 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.25 1.3 pp -93.68 -20.95 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.66 93.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 121.544 1.974 . . . . 0.0 111.695 -173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.464 0.0 OUTLIER -51.35 -18.02 0.89 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.988 1.715 . . . . 0.0 114.744 173.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -174.74 0.21 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -129.22 10.59 5.82 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 119.022 -2.299 . . . . 0.0 113.003 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -139.66 8.82 2.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.495 0.718 . . . . 0.0 112.587 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.36 151.25 31.09 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.231 0.923 . . . . 0.0 111.356 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -120.65 -21.34 6.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.216 2.207 . . . . 0.0 111.657 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.78 161.63 11.16 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.659 1.584 . . . . 0.0 109.482 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.41 103.69 15.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.43 94.68 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.19 131.59 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.211 1.804 . . . . 0.0 106.59 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -118.99 138.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.7 m -114.64 101.39 9.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.15 153.77 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.639 0.733 . . . . 0.0 109.352 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.91 -40.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.6 m -151.03 128.06 11.1 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 120.857 -1.152 . . . . 0.0 110.924 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.4 138.81 49.54 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.589 2.356 . . . . 0.0 109.117 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -142.01 140.97 32.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.86 1.664 . . . . 0.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.56 133.8 47.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -152.84 -58.55 0.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.252 1.224 0 CA-C-O 115.216 -2.326 . . . . 0.0 115.687 -172.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.242 0.704 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.47 160.32 48.44 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.606 2.204 . . . . 0.0 111.329 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.65 -47.53 90.45 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.83 -42.11 62.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.22 1.408 . . . . 0.0 111.99 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -51.12 -56.62 11.79 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.555 0.616 . . . . 0.0 111.493 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -59.17 -48.52 81.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.316 0.646 . . . . 0.0 110.578 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.79 -40.5 72.76 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.935 0.789 . . . . 0.0 111.976 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.89 -44.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.021 0.828 . . . . 0.0 108.884 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.4 mt -56.71 -43.89 81.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.087 0.858 . . . . 0.0 112.437 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -51.69 -27.08 10.61 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -99.11 171.63 7.89 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.295 1.045 . . . . 0.0 111.205 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.45 131.67 42.08 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.1 168.57 41.67 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.2 t -101.01 149.88 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.95 152.44 42.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mt -138.79 116.31 11.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.91 109.23 20.06 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -89.35 114.88 26.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 -176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 118.54 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.71 -74.65 0.11 Allowed Glycine 0 C--N 1.333 0.403 0 CA-C-N 118.236 0.471 . . . . 0.0 112.91 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.23 -48.24 0.06 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -173.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.18 38.48 0.29 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.523 1.529 . . . . 0.0 110.792 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 152.47 6.59 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 105.851 -2.9 . . . . 0.0 105.851 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.19 147.76 19.91 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 122.233 3.016 . . . . 0.0 106.875 173.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.591 ' CD2' ' HZ3' ' A' ' 53' ' ' LYS . 66.5 t60 -119.71 101.26 7.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.533 -172.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.4 tp -78.13 88.57 4.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.302 1.041 . . . . 0.0 111.208 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -77.48 171.71 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.942 1.297 . . . . 0.0 110.401 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -122.12 166.32 14.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.628 1.104 . . . . 0.0 113.516 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -168.52 175.01 6.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.561 2.344 . . . . 0.0 108.473 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -120.67 141.68 50.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.327 2.251 . . . . 0.0 109.463 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -55.21 -31.42 61.43 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.77 0.714 . . . . 0.0 110.598 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -59.24 -8.81 1.79 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.99 2.116 . . . . 0.0 113.876 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -118.13 -7.05 10.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.594 1.158 . . . . 0.0 109.576 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 mt -97.18 171.41 8.47 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.747 -1.221 . . . . 0.0 112.01 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -133.64 123.15 24.54 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.7 139.5 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.66 178.52 4.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 40.7 t0 -76.55 -178.3 4.62 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.442 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 60.0 29.14 67.38 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 120.511 -1.368 . . . . 0.0 109.812 -176.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 53.79 13.0 0.47 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 130.337 3.455 . . . . 0.0 115.602 -174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -73.6 140.03 45.94 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.673 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -130.59 161.4 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.87 145.63 20.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -122.24 130.04 24.85 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 128.31 2.644 . . . . 0.0 106.548 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.49 108.69 2.74 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.223 2.615 . . . . 0.0 109.087 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.58 111.66 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.879 -0.513 . . . . 0.0 109.958 173.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.57 -21.31 5.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.954 1.74 . . . . 0.0 111.93 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.06 39.97 0.38 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.89 1.345 . . . . 0.0 110.353 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.2 mtt -109.23 50.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.472 1.509 . . . . 0.0 107.052 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.47 -50.06 35.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.445 -1.264 . . . . 0.0 113.484 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HZ3' ' CD2' ' A' ' 27' ' ' HIS . 3.7 ttpm? -52.27 -41.57 62.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.272 1.851 . . . . 0.0 108.611 173.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -58.77 -38.4 78.41 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.71 0.804 . . . . 0.0 110.811 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.1 -48.18 79.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.682 1.583 . . . . 0.0 110.065 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.1 98.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 119.788 -0.148 . . . . 0.0 111.122 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -61.22 -41.27 96.56 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 123.826 0.85 . . . . 0.0 110.052 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.9 -47.97 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.843 1.201 . . . . 0.0 109.361 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.92 -25.92 45.32 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.042 -1.036 . . . . 0.0 112.154 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -78.09 -45.03 24.55 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -151.25 140.82 21.64 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.234 1.014 . . . . 0.0 109.884 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -70.33 -19.41 63.07 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.873 -1.142 . . . . 0.0 111.94 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.8 120.77 10.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.18 1.392 . . . . 0.0 113.639 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.2 m -139.06 155.91 27.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 123.001 1.382 . . . . 0.0 112.185 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -111.11 151.95 27.53 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.02 132.79 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 p -128.47 128.07 43.68 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -116.98 167.2 11.35 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.81 1.186 . . . . 0.0 110.781 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 178.5 42.42 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -150.32 170.79 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.732 -0.864 . . . . 0.0 109.076 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -98.66 -8.79 25.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.362 1.865 . . . . 0.0 110.888 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -91.58 -10.74 39.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.4 137.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.86 131.45 36.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.214 1.005 . . . . 0.0 109.798 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.22 -140.99 6.81 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -83.99 -58.48 2.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.53 102.92 8.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.3 -168.72 2.27 Favored Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 112.6 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.5 59.53 6.76 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.867 2.378 . . . . 0.0 110.789 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.44 121.32 1.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -113.95 169.07 9.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.91 1.355 . . . . 0.0 110.181 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 176.57 44.35 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 123.463 0.554 . . . . 0.0 112.889 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -126.39 144.6 50.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.718 1.607 . . . . 0.0 110.197 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.54 128.39 46.61 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 128.253 2.621 . . . . 0.0 104.442 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt -138.41 153.83 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 -119.84 148.16 43.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.89 1.676 . . . . 0.0 107.52 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.77 -171.38 31.89 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.1 m -120.85 144.38 48.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.376 2.27 . . . . 0.0 107.179 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.93 161.05 16.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.778 1.172 . . . . 0.0 111.405 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.22 114.92 2.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.174 0.99 . . . . 0.0 109.966 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -73.94 129.45 37.91 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.67 141.57 51.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 129.119 2.967 . . . . 0.0 108.606 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 p -118.28 30.36 7.27 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.774 1.629 . . . . 0.0 107.552 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -158.81 163.82 36.34 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.209 1.804 . . . . 0.0 109.328 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.74 46.87 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.116 1.817 . . . . 0.0 113.782 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.88 -13.86 37.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.707 2.938 . . . . 0.0 112.653 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.59 -63.38 1.07 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -61.23 -31.31 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.967 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.62 -55.54 11.18 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.689 1.131 . . . . 0.0 109.42 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.53 -27.12 68.38 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.857 -1.152 . . . . 0.0 112.178 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.362 1.0 OUTLIER -86.25 -18.18 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.881 1.218 . . . . 0.0 111.567 173.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.33 -27.67 2.69 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.961 2.104 . . . . 0.0 111.675 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -49.26 -35.79 18.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.028 . . . . 0.0 111.764 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -77.94 178.05 7.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.89 -0.98 1.44 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 118.529 -2.607 . . . . 0.0 111.568 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -97.01 8.38 44.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.979 0.912 . . . . 0.0 110.682 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.72 149.41 22.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.821 0.737 . . . . 0.0 109.515 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -117.71 -11.22 10.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.244 1.818 . . . . 0.0 110.936 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.28 161.7 12.3 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 110.0 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.15 104.57 14.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.512 2.725 . . . . 0.0 106.174 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.32 96.96 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.08 131.65 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.378 1.871 . . . . 0.0 107.11 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.11 139.76 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.9 m -118.9 101.44 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.2 t -60.28 160.98 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.613 1.565 . . . . 0.0 109.472 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.22 -57.14 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -141.06 122.84 15.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.17 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 146.99 42.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 128.054 2.542 . . . . 0.0 111.337 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -143.91 152.13 40.72 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.0 108.894 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -81.05 137.31 36.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.6 p -138.69 -58.49 0.62 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -173.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--O 1.251 1.168 0 C-N-CA 123.594 0.757 . . . . 0.0 111.182 -173.52 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 118.47 -0.776 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.61 160.17 50.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.974 1.782 . . . . 0.0 111.756 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.26 96.86 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -52.85 -38.82 61.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.931 1.692 . . . . 0.0 112.072 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -51.14 -51.89 49.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.487 1.039 . . . . 0.0 110.962 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -60.1 -48.39 81.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.338 0.655 . . . . 0.0 110.73 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -54.97 -37.22 66.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.642 1.11 . . . . 0.0 112.638 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.09 -45.01 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.364 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.2 mt -57.21 -44.09 83.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.397 0.999 . . . . 0.0 112.018 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -51.85 -18.93 1.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -107.71 158.41 17.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.556 1.071 . . . . 0.0 110.788 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -77.0 147.69 36.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.47 168.54 31.57 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.18 149.05 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.24 161.98 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 127.343 2.257 . . . . 0.0 105.021 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.43 157.17 43.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.371 1.068 . . . . 0.0 109.139 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -139.39 120.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.91 108.77 19.73 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 173.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 m -90.6 113.45 25.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -73.2 131.71 42.32 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.93 -79.14 0.17 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 122.514 1.064 . . . . 0.0 111.131 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -158.32 -48.59 0.06 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.647 -1.277 . . . . 0.0 109.003 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.61 37.74 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.773 1.229 . . . . 0.0 112.053 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.28 152.12 5.76 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -59.23 148.02 88.02 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 121.043 2.421 . . . . 0.0 108.481 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.617 ' CD2' ' HZ3' ' A' ' 53' ' ' LYS . 70.2 t60 -117.04 101.45 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.622 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.2 tp -75.02 88.64 2.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.832 0.853 . . . . 0.0 111.531 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 m -78.1 169.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.395 1.078 . . . . 0.0 109.834 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -119.85 166.34 13.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 112.243 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -168.52 176.05 5.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.453 2.301 . . . . 0.0 107.879 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -121.28 141.62 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.517 1.527 . . . . 0.0 110.76 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -50.86 -29.96 13.26 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 119.077 0.853 . . . . 0.0 111.154 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -55.13 -19.89 8.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.669 2.388 . . . . 0.0 112.58 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -118.13 -4.23 11.01 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.144 1.378 . . . . 0.0 109.619 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 mt -98.88 167.15 10.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.94 -1.1 . . . . 0.0 111.016 -174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 140.49 42.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.9 149.51 6.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.8 mt -122.24 178.82 4.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.638 2.775 . . . . 0.0 106.244 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 37.3 t0 -76.03 -179.04 4.69 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.417 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 60.33 31.01 72.48 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 120.237 -1.539 . . . . 0.0 110.715 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 p30 54.08 13.06 0.53 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.765 3.226 . . . . 0.0 115.257 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -73.49 142.32 46.78 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 109.547 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.41 166.41 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 t -147.97 145.07 18.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 O-C-N 120.793 -1.192 . . . . 0.0 108.644 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.58 136.07 26.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 108.585 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.77 121.28 6.2 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 124.269 3.312 . . . . 0.0 110.582 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.48 111.94 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 119.52 1.055 . . . . 0.0 112.764 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.31 -20.81 5.76 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.774 1.654 . . . . 0.0 111.64 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.54 30.0 0.23 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.459 1.63 . . . . 0.0 112.292 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.2 mtt -99.4 61.96 1.21 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.103 1.452 . . . . 0.0 107.825 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -71.15 -60.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.029 0.932 . . . . 0.0 112.951 -174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HZ3' ' CD2' ' A' ' 27' ' ' HIS . 4.0 ttpm? -52.09 -41.77 62.68 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.138 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -61.62 -38.55 88.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.852 0.751 . . . . 0.0 111.641 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.456 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 36.9 tt0 -59.08 -44.74 91.93 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.927 1.239 . . . . 0.0 109.792 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.04 93.25 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.234 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -62.61 -41.39 98.96 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 124.175 0.99 . . . . 0.0 109.473 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.78 -48.17 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 108.708 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.93 29.82 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.377 -0.827 . . . . 0.0 112.616 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -45.39 19.06 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -151.04 138.95 19.92 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.747 1.219 . . . . 0.0 109.417 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.1 -19.79 61.08 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.03 -1.044 . . . . 0.0 112.009 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.1 mmp_? -60.88 119.97 9.25 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.268 1.427 . . . . 0.0 114.265 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.64 156.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 123.108 1.432 . . . . 0.0 112.8 173.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.4 tp -110.81 151.19 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.5 ttt -142.4 140.89 32.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 p -129.68 130.66 45.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -116.68 163.62 15.85 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.11 179.53 44.47 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.2 t -147.62 163.65 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -9.01 25.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.508 0.723 . . . . 0.0 109.221 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -81.1 -7.7 59.61 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.009 -0.996 . . . . 0.0 113.165 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.99 137.07 56.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.08 36.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.38 -141.48 6.15 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp-105 -81.57 -58.98 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.582 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.46 102.64 9.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.388 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 49.51 -168.71 0.2 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.236 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.3 87.52 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 107.557 -1.747 . . . . 0.0 107.557 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 121.25 0.7 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-O 117.734 -1.592 . . . . 0.0 109.16 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -115.52 -179.85 3.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.252 1.026 . . . . 0.0 108.963 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.32 -155.81 20.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 117.819 -1.545 . . . . 0.0 110.063 -173.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -151.2 157.49 42.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.306 1.442 . . . . 0.0 109.629 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.1 131.12 47.18 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 129.239 3.015 . . . . 0.0 104.811 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mt -136.95 152.31 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -119.61 140.77 50.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.4 1.88 . . . . 0.0 107.078 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.51 -171.15 30.4 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.415 0.531 . . . . 0.0 112.047 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -121.12 149.16 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.815 2.046 . . . . 0.0 108.289 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.29 165.13 11.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.633 1.173 . . . . 0.0 110.402 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.14 121.69 0.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 109.394 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 37.9 m-85 -76.45 150.73 36.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.766 -1.209 . . . . 0.0 114.191 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.456 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.315 0.0 OUTLIER -140.89 139.02 34.32 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 173.254 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 p -122.11 29.47 7.02 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 129.741 3.216 . . . . 0.0 102.582 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' A' ' 92' ' ' ARG 0.288 8.9 t70 -158.43 160.21 36.57 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 130.353 3.461 . . . . 0.0 114.004 -172.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.97 178.41 47.54 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.007 1.289 . . . . 0.0 115.768 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.04 -16.28 53.36 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.093 2.529 . . . . 0.0 110.085 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -64.76 -66.7 0.51 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.14 -31.2 70.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.289 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -68.4 -59.43 3.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . 0.258 . . -61.7 -19.41 62.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.862 -1.148 . . . . 0.0 113.39 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.339 1.2 pp -91.95 -18.08 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.326 1.421 . . . . 0.0 110.785 172.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.73 2.73 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.021 2.128 . . . . 0.0 112.747 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -50.48 -37.92 41.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.177 1.391 . . . . 0.0 112.157 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -75.55 177.9 6.39 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.64 -0.78 1.34 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 118.777 -2.452 . . . . 0.0 111.632 174.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -93.34 8.24 41.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.373 0.669 . . . . 0.0 109.697 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.84 129.69 36.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.2 1.0 . . . . 0.0 108.63 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -99.03 -16.0 18.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.466 0.706 . . . . 0.0 111.347 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.39 161.78 12.08 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.757 1.623 . . . . 0.0 108.95 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.8 110.42 22.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.755 2.822 . . . . 0.0 109.469 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.15 94.54 6.66 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.26 131.12 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mm -117.44 142.44 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 m -120.39 101.55 7.86 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.22 156.96 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.026 1.33 . . . . 0.0 109.352 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.26 -49.44 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -151.25 140.79 21.61 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 120.887 -1.133 . . . . 0.0 111.741 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.12 139.49 49.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.154 2.582 . . . . 0.0 108.528 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -142.09 163.18 33.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.783 2.033 . . . . 0.0 109.694 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -90.97 142.4 27.82 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 121.206 -0.934 . . . . 0.0 109.89 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.17 -58.0 1.07 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.939 2.496 . . . . 0.0 110.92 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.294 1.437 . . . . 0.0 110.032 -174.611 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.16 155.81 69.06 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.78 2.32 . . . . 0.0 111.142 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.94 -38.81 93.25 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.16 -38.97 63.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.839 1.256 . . . . 0.0 111.184 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -51.44 -54.23 28.92 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.823 1.192 . . . . 0.0 110.743 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -56.71 -48.27 78.08 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.27 1.028 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.6 -35.23 72.12 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.895 -0.574 . . . . 0.0 112.363 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.16 -43.5 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.909 1.231 . . . . 0.0 109.369 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.05 -43.24 77.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.219 1.372 . . . . 0.0 112.176 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -51.99 -21.35 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.099 0.863 . . . . 0.0 113.284 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -110.83 174.03 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.744 1.618 . . . . 0.0 110.965 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -73.35 129.4 37.93 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.43 164.28 34.41 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.5 145.52 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.57 164.94 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.83 160.45 43.56 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 107.952 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.4 mt -138.74 119.49 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 108.9 19.61 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -93.89 114.48 26.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 115.407 -2.235 . . . . 0.0 108.586 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -73.26 129.4 37.96 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 122.836 2.562 . . . . 0.0 107.958 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.85 -76.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 124.609 1.099 . . . . 0.0 110.892 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -158.66 -48.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.71 2.004 . . . . 0.0 108.465 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.77 38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.295 1.438 . . . . 0.0 111.268 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.36 152.33 5.96 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -56.2 147.74 64.07 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 CA-C-N 122.25 3.025 . . . . 0.0 107.386 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.46 ' CG ' ' HE2' ' A' ' 53' ' ' LYS . 70.0 t60 -111.24 101.42 9.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.343 -172.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.02 88.71 3.54 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.565 1.546 . . . . 0.0 111.649 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.93 168.86 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.861 1.264 . . . . 0.0 110.113 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -119.14 166.66 12.65 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.267 1.394 . . . . 0.0 114.203 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -168.42 171.62 8.95 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.529 1.932 . . . . 0.0 109.636 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -121.17 141.84 50.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.444 2.297 . . . . 0.0 110.738 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -53.75 -31.17 47.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.341 0.656 . . . . 0.0 112.412 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -59.38 -12.47 5.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 112.97 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -117.92 -2.78 11.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.392 -1.443 . . . . 0.0 109.805 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.3 mt -99.48 166.38 11.19 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.076 -1.015 . . . . 0.0 110.17 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -136.77 128.88 29.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.52 141.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.911 1.684 . . . . 0.0 107.581 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.94 -177.9 3.7 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.041 1.736 . . . . 0.0 108.385 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.51 175.21 5.72 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.687 1.195 . . . . 0.0 108.432 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.27 28.19 13.14 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.275 1.893 . . . . 0.0 111.053 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.335 0.1 OUTLIER 53.27 25.24 4.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.016 2.126 . . . . 0.0 114.537 -178.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -73.66 126.71 30.93 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -114.97 164.89 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.16 144.19 18.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 O-C-N 120.346 -1.471 . . . . 0.0 108.579 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.8 t -130.78 137.46 30.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.998 1.719 . . . . 0.0 108.611 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 112.32 2.71 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 124.139 3.226 . . . . 0.0 111.663 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -85.4 112.45 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.28 -20.96 5.37 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.657 1.123 . . . . 0.0 113.051 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.86 39.67 0.39 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.775 -1.569 . . . . 0.0 111.293 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 6.3 mtt -112.11 71.48 0.74 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -63.82 -53.79 45.28 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.46 -0.775 . . . . 0.0 111.952 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.46 ' HE2' ' CG ' ' A' ' 27' ' ' HIS . 3.9 ttpm? -51.93 -41.43 62.02 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.322 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -62.39 -39.36 92.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.03 1.286 . . . . 0.0 111.507 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 34.6 tt0 -55.98 -50.62 70.34 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.22 1.373 . . . . 0.0 109.482 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.2 97.88 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -67.64 -41.73 83.41 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.547 1.139 . . . . 0.0 109.156 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -48.07 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.735 1.152 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.72 31.14 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -84.05 -46.9 11.5 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.651 1.114 . . . . 0.0 113.872 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -151.13 140.88 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.03 0.919 . . . . 0.0 111.567 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.78 -23.48 55.92 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.247 -0.908 . . . . 0.0 113.015 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 122.43 15.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.798 1.181 . . . . 0.0 110.339 -173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -139.22 155.97 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 123.43 1.586 . . . . 0.0 111.453 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.85 154.51 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.3 ttt -138.85 137.35 36.49 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -131.15 129.12 41.37 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.38 173.29 6.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.604 1.093 . . . . 0.0 111.831 174.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.17 178.52 45.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.9 t -151.07 165.59 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.054 0.93 . . . . 0.0 109.418 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -98.74 -20.72 16.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.344 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -91.76 -6.2 52.27 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.114 1.366 . . . . 0.0 113.904 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.62 131.45 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.86 131.5 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.415 1.086 . . . . 0.0 109.079 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 -141.5 11.47 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -85.89 -58.86 2.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.63 102.84 11.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.337 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.48 -178.5 0.66 Allowed Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.452 1.025 . . . . 0.0 113.987 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.13 81.66 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.311 2.007 . . . . 0.0 109.828 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 103.79 0.17 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 t -98.68 169.23 9.64 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.739 1.269 . . . . 0.0 110.372 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.6 161.86 30.04 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.663 1.125 . . . . 0.0 111.741 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -134.73 145.44 48.46 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.503 1.921 . . . . 0.0 109.28 -173.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -101.01 131.53 46.85 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 128.525 2.73 . . . . 0.0 107.728 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -140.36 152.4 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.99 148.34 52.27 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.154 -0.966 . . . . 0.0 108.703 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.43 -168.17 36.16 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 118.847 0.749 . . . . 0.0 112.251 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -118.99 134.53 55.13 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.147 . . . . 0.0 108.867 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.67 158.76 15.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.556 1.142 . . . . 0.0 108.86 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.98 120.75 3.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.678 1.191 . . . . 0.0 108.297 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 29.8 m-85 -74.34 139.65 44.29 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.405 -0.809 . . . . 0.0 112.695 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -140.85 141.4 34.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.01 1.324 . . . . 0.0 109.929 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.1 p -120.67 41.1 3.35 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -159.32 159.55 34.06 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 129.478 3.111 . . . . 0.0 111.013 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.21 178.66 47.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.712 1.625 . . . . 0.0 114.003 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.77 -8.86 20.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.25 2.633 . . . . 0.0 111.059 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -65.53 0.66 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.941 2.497 . . . . 0.0 107.083 173.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -61.28 -31.77 71.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.283 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.01 -48.85 41.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.935 0.789 . . . . 0.0 110.527 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.5 67.83 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.55 -1.344 . . . . 0.0 112.568 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.4 pp -90.33 -18.14 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.107 0.867 . . . . 0.0 112.021 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.95 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.201 1.8 . . . . 0.0 111.685 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -50.56 -22.85 2.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -81.3 178.86 8.13 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.554 1.07 . . . . 0.0 110.732 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -135.63 20.44 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 119.904 -1.748 . . . . 0.0 110.025 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -132.45 10.48 4.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.675 1.59 . . . . 0.0 111.284 -174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.0 150.26 32.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.141 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -120.74 -21.91 6.49 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 129.139 2.975 . . . . 0.0 112.362 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.33 161.74 1.44 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.779 2.031 . . . . 0.0 110.01 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.89 112.36 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.2 94.62 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.78 131.29 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.5 mm -121.15 129.13 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.1 m -110.15 90.81 3.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.17 159.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.37 -56.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 104.0 -2.592 . . . . 0.0 104.0 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.6 m -148.58 141.05 24.29 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.454 0.57 . . . . 0.0 112.115 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.01 143.74 46.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.544 3.138 . . . . 0.0 106.79 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.0 145.62 39.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.701 1.6 . . . . 0.0 108.016 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.2 140.05 37.8 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -129.42 -58.41 1.12 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.252 1.227 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.063 -173.499 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.06 164.65 34.99 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.443 2.095 . . . . 0.0 110.879 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.29 -47.12 92.37 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.326 9.0 m -53.08 -38.56 62.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.648 1.179 . . . . 0.0 113.092 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -51.52 -58.56 5.96 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.0 1.273 . . . . 0.0 108.497 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -55.24 -48.25 74.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.856 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -53.99 -40.89 67.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.924 1.238 . . . . 0.0 111.009 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.7 t -68.85 -43.61 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.933 -1.105 . . . . 0.0 108.854 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.77 -36.35 72.02 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.257 1.389 . . . . 0.0 111.359 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -33.42 42.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 118.451 -2.655 . . . . 0.0 113.022 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -98.92 158.77 15.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 122.204 1.002 . . . . 0.0 110.928 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.29 141.13 41.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.44 175.09 47.41 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.13 144.76 8.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 125.143 1.377 . . . . 0.0 107.585 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.76 159.27 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.62 152.1 38.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.387 1.475 . . . . 0.0 107.289 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mt -138.99 117.94 13.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.98 108.5 19.61 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -89.03 110.83 21.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -73.95 141.81 45.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 122.11 2.232 . . . . 0.0 107.204 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.25 -81.8 0.26 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.63 -61.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.482 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 15.0 p-10 -81.55 38.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.189 2.196 . . . . 0.0 110.165 173.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.57 151.58 23.52 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.04 -1.037 . . . . 0.0 113.761 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.88 158.32 46.52 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.269 1.979 . . . . 0.0 112.918 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.32 101.86 7.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.107 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 tp -74.01 88.8 1.9 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.19 0.904 . . . . 0.0 110.666 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.86 170.97 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.986 1.315 . . . . 0.0 110.352 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.41 165.21 14.62 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.868 1.267 . . . . 0.0 111.172 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -168.41 172.31 8.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.7 2.0 . . . . 0.0 107.978 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.22 141.66 50.66 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.319 1.448 . . . . 0.0 110.235 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -51.2 -28.32 11.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.4 0.68 . . . . 0.0 111.104 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.41 -14.87 8.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.859 2.464 . . . . 0.0 111.751 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -118.13 -5.21 10.94 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.995 1.718 . . . . 0.0 109.686 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 mt -97.32 171.64 8.29 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 120.332 -1.48 . . . . 0.0 112.882 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HZ1' ' CD ' ' A' ' 97' ' ' GLU . 10.4 ptmt -136.08 135.87 39.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.55 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.4 mt -121.24 -178.18 3.71 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.073 1.749 . . . . 0.0 107.491 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 22.7 t0 -75.55 176.98 7.09 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 109.264 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 60.02 30.25 69.74 Favored Glycine 0 CA--C 1.525 0.698 0 O-C-N 120.475 -1.391 . . . . 0.0 110.831 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 p30 53.84 12.88 0.46 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.864 3.665 . . . . 0.0 114.868 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -74.8 122.44 23.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.9 mm -114.02 155.57 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.46 140.54 41.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.22 138.99 29.78 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 127.476 2.31 . . . . 0.0 108.778 -173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.5 108.02 1.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.677 1.585 . . . . 0.0 109.589 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.404 HG12 ' CE2' ' A' ' 91' ' ' PHE . 2.4 p -85.87 111.81 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.35 -21.59 5.12 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.133 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 41.38 0.34 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.6 mtt -108.78 71.23 0.77 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 173.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -64.03 -63.11 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 129.817 3.247 . . . . 0.0 112.666 -173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.482 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 54.2 tttm -51.8 -40.75 60.94 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.351 173.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -62.92 -38.86 92.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.496 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -58.45 -50.42 73.78 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.611 1.55 . . . . 0.0 109.683 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.29 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.201 -0.312 . . . . 0.0 111.375 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -62.73 -41.8 99.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.044 -1.455 . . . . 0.0 110.336 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.69 -47.98 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 120.192 1.36 . . . . 0.0 108.542 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -23.63 13.55 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.528 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -87.44 -46.55 9.52 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.25 -1.531 . . . . 0.0 114.127 173.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -151.26 137.11 18.08 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.532 1.133 . . . . 0.0 112.656 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -22.48 54.34 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.67 126.57 27.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.697 1.589 . . . . 0.0 111.017 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.07 144.06 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 111.941 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.75 150.36 21.14 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 16.8 ttt -139.17 120.8 15.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.7 p -108.82 127.97 54.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 pp -116.95 163.27 16.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 119.641 1.109 . . . . 0.0 109.229 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.05 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.5 t -158.1 166.91 31.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -99.02 -9.37 24.03 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -9.42 59.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.888 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.93 131.08 36.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.866 0.867 . . . . 0.0 110.437 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.38 5.9 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 125.575 1.56 . . . . 0.0 111.253 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.3 mmt-85 -84.08 -58.76 2.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.45 102.58 9.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.8 -168.07 0.16 Allowed Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.47 -1.394 . . . . 0.0 112.18 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.49 89.73 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 108.014 -1.571 . . . . 0.0 108.014 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.74 121.32 0.7 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-O 117.231 -1.872 . . . . 0.0 109.391 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.08 169.75 9.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.624 1.712 . . . . 0.0 110.906 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.62 -176.18 43.65 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 123.381 0.515 . . . . 0.0 112.576 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.4 145.68 49.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.127 2.171 . . . . 0.0 109.348 -174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.0 131.03 47.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.0 159.51 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -125.92 149.29 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.653 1.581 . . . . 0.0 107.782 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.84 -176.22 36.33 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.76 0.695 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.1 m -120.35 129.12 53.83 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.944 1.697 . . . . 0.0 108.102 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.23 160.23 14.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.871 1.668 . . . . 0.0 112.288 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.14 120.91 3.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.82 1.248 . . . . 0.0 108.678 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.404 ' CE2' HG12 ' A' ' 48' ' ' VAL . 3.3 m-85 -76.71 144.48 39.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -140.84 138.28 33.87 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.148 1.379 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.3 p -120.87 40.93 3.42 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -159.17 157.18 30.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.754 2.821 . . . . 0.0 111.317 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.77 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.899 1.238 . . . . 0.0 114.538 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.79 -8.67 22.05 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.329 2.686 . . . . 0.0 110.687 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.477 ' CD ' ' HZ1' ' A' ' 37' ' ' LYS . 24.7 mm-40 -70.72 -63.18 1.14 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 108.15 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.13 -31.81 71.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.436 -0.793 . . . . 0.0 111.245 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -73.45 -48.43 33.68 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.915 0.779 . . . . 0.0 111.346 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.78 -25.16 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.003 -1.685 . . . . 0.0 112.12 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.377 1.2 pp -89.51 -18.22 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.855 1.207 . . . . 0.0 110.844 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.7 -27.52 2.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.048 2.539 . . . . 0.0 110.687 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -49.02 -37.21 19.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.073 0.949 . . . . 0.0 110.543 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -80.62 178.0 8.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 -0.56 1.39 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 117.979 -2.95 . . . . 0.0 111.864 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -87.56 8.33 25.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.914 1.286 . . . . 0.0 111.127 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.64 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.914 1.286 . . . . 0.0 111.962 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 -21.97 6.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 128.47 2.708 . . . . 0.0 111.119 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.27 162.03 1.89 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.203 1.801 . . . . 0.0 110.445 -173.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.42 104.6 14.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.69 94.02 5.01 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.099 1.759 . . . . 0.0 107.079 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.0 127.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.39 128.97 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.6 m -100.15 100.5 11.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.4 158.46 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.984 0.897 . . . . 0.0 109.304 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.57 -56.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 m -140.92 124.78 17.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 119.215 -0.421 . . . . 0.0 111.432 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.5 149.57 41.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.36 2.664 . . . . 0.0 111.176 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -141.68 144.66 34.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.134 1.774 . . . . 0.0 108.232 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -74.01 140.51 45.5 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -136.86 -77.61 0.41 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.255 1.364 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 -173.244 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.82 164.73 31.36 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.238 2.625 . . . . 0.0 111.877 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.92 96.58 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -55.7 -39.5 71.12 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.232 1.413 . . . . 0.0 110.446 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -51.06 -57.09 9.56 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.974 0.806 . . . . 0.0 110.017 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -58.83 -48.7 80.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.834 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -59.21 -41.16 87.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.08 -39.49 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.634 1.106 . . . . 0.0 109.107 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -58.55 -44.92 89.82 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.837 1.198 . . . . 0.0 111.251 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -51.99 -21.31 2.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -106.91 178.47 4.55 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 125.495 1.518 . . . . 0.0 110.983 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -73.55 129.43 37.96 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.15 167.16 33.81 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.01 146.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 173.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 t -130.52 159.8 42.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.54 160.01 41.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.612 1.165 . . . . 0.0 108.999 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.3 mt -139.24 120.44 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.14 108.44 20.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.2 m -89.84 116.35 27.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 116.873 -1.536 . . . . 0.0 107.048 -173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -73.42 135.81 44.23 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 121.582 1.992 . . . . 0.0 106.394 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.66 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.2 -59.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.473 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 15.9 p-10 -78.83 39.21 0.35 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.35 2.66 . . . . 0.0 111.429 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.34 151.47 21.01 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.238 0.923 . . . . 0.0 111.053 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.08 149.08 89.59 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 118.335 1.068 . . . . 0.0 109.986 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' HG1' ' A' ' 54' ' ' THR . 0.5 OUTLIER -115.43 99.71 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.633 1.573 . . . . 0.0 110.641 -173.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 tp -82.13 103.54 11.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 110.406 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.15 168.65 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.675 1.59 . . . . 0.0 110.868 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -126.63 164.13 21.94 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -168.41 172.46 8.32 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.248 1.819 . . . . 0.0 110.242 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.37 141.77 50.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.913 2.485 . . . . 0.0 108.809 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.87 -30.38 45.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.57 0.623 . . . . 0.0 111.695 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -57.72 -13.72 4.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.576 1.95 . . . . 0.0 113.145 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -118.3 -2.47 11.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.793 1.237 . . . . 0.0 110.194 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.4 mt -101.07 168.1 9.81 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.589 1.086 . . . . 0.0 111.82 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -136.87 128.76 29.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.3 142.95 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -121.06 -178.61 3.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.39 1.876 . . . . 0.0 106.183 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 39.9 t0 -73.71 -178.81 3.31 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 59.77 29.18 66.84 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 120.392 -1.443 . . . . 0.0 110.423 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.1 13.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 129.209 3.004 . . . . 0.0 115.155 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -73.18 141.73 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.361 0.982 . . . . 0.0 110.58 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.87 154.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.36 143.98 24.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.94 134.38 26.05 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 126.649 1.98 . . . . 0.0 107.419 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.18 118.03 4.83 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.875 2.383 . . . . 0.0 107.651 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.34 111.5 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.348 0.976 . . . . 0.0 108.999 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.94 -21.68 9.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.24 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.66 18.87 0.3 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 120.467 2.134 . . . . 0.0 114.386 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.9 mtt -97.96 52.24 1.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.77 1.285 . . . . 0.0 108.176 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -64.0 -51.55 63.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.368 0.667 . . . . 0.0 111.6 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HZ1' ' CG ' ' A' ' 24' ' ' ASP 0.285 17.5 ttpp -52.19 -41.16 62.42 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.325 -1.484 . . . . 0.0 110.839 173.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.72 ' HG1' ' CD2' ' A' ' 27' ' ' HIS 0.27 1.6 m -60.35 -38.42 83.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.143 1.338 . . . . 0.0 113.026 173.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -55.39 -45.14 76.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.826 1.25 . . . . 0.0 107.829 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.31 81.07 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.958 -0.464 . . . . 0.0 111.647 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -59.6 -41.73 90.98 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 117.367 -1.301 . . . . 0.0 109.904 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.33 -48.24 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.122 1.328 . . . . 0.0 108.917 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.68 -25.98 12.49 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.439 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -85.79 -46.44 10.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 173.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -151.5 134.08 15.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.991 1.268 . . . . 0.0 111.072 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -19.77 57.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 130.63 46.8 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.274 1.397 . . . . 0.0 110.92 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.32 155.86 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 123.797 1.76 . . . . 0.0 112.99 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.9 tp -101.17 151.16 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.6 ttt -139.24 141.48 37.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 p -129.7 140.69 51.06 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.91 163.97 15.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.93 178.66 46.61 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.2 t -151.24 169.36 22.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -98.87 -18.36 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.55 1.54 . . . . 0.0 108.964 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -91.81 -1.46 57.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 117.073 -1.442 . . . . 0.0 113.938 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 t -130.99 127.03 60.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.32 131.42 36.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 109.149 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.97 -141.12 6.46 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -79.17 -59.02 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.733 1.613 . . . . 0.0 109.434 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.65 102.99 14.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.5 -169.4 2.21 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.84 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.86 69.39 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.456 2.104 . . . . 0.0 110.412 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.49 108.37 0.32 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -101.88 169.57 8.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.06 172.55 45.48 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.457 1.031 . . . . 0.0 114.472 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.09 151.25 51.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 110.248 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -100.9 131.5 46.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 128.838 2.855 . . . . 0.0 104.464 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.8 mt -135.59 153.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.1 mtt-85 -132.97 135.78 45.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.61 36.22 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.805 1.184 . . . . 0.0 112.182 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -121.23 148.21 44.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.729 0.812 . . . . 0.0 109.285 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.2 162.18 13.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.905 1.682 . . . . 0.0 110.669 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.3 113.07 2.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.536 1.134 . . . . 0.0 109.64 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -74.17 134.24 42.78 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -141.14 141.06 34.19 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.1 p -116.58 41.1 2.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.55 154.14 26.16 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.588 2.355 . . . . 0.0 110.466 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.1 178.67 47.3 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.854 1.692 . . . . 0.0 114.146 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.94 -9.42 19.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.709 2.939 . . . . 0.0 111.491 173.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -67.34 -64.8 0.78 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.402 1.481 . . . . 0.0 107.253 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -61.54 -31.4 71.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.485 1.114 . . . . 0.0 111.486 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.71 -56.07 9.32 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.304 0.956 . . . . 0.0 109.234 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.66 68.8 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.966 -1.084 . . . . 0.0 112.195 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.334 1.1 pp -85.89 -18.17 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.754 1.161 . . . . 0.0 111.869 173.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.68 -27.97 3.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.663 1.585 . . . . 0.0 112.062 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -50.53 -21.89 1.71 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.486 1.114 . . . . 0.0 113.827 173.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -80.91 178.66 8.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.706 1.139 . . . . 0.0 110.702 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -133.6 11.12 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.077 -1.639 . . . . 0.0 111.517 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -138.1 8.99 2.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.848 1.259 . . . . 0.0 112.968 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 151.84 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.307 1.043 . . . . 0.0 111.116 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 -21.93 11.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.392 1.077 . . . . 0.0 110.342 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.19 161.96 1.52 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 127.718 2.407 . . . . 0.0 109.206 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.43 105.97 18.05 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tp -79.63 92.82 5.4 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.35 129.76 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.092 1.357 . . . . 0.0 107.666 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.6 mm -117.28 133.7 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -112.02 97.28 6.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.53 161.26 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.464 1.506 . . . . 0.0 110.361 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.69 -55.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.2 m -151.54 141.46 22.02 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.832 -1.167 . . . . 0.0 112.476 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.1 138.74 48.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.938 2.895 . . . . 0.0 106.599 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -140.08 137.42 34.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.185 1.794 . . . . 0.0 107.749 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -77.15 141.16 40.28 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.6 p -129.64 -58.62 1.1 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.739 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.09 154.63 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.713 2.275 . . . . 0.0 110.049 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.79 92.87 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -49.58 -38.57 31.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.682 1.593 . . . . 0.0 112.21 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -50.53 -54.75 20.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.226 1.375 . . . . 0.0 109.729 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -61.09 -48.54 81.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.516 1.126 . . . . 0.0 109.117 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.75 -34.14 74.0 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.1 t -72.71 -42.54 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.65 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.82 -39.75 82.13 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.437 1.471 . . . . 0.0 112.596 173.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -51.88 -24.99 7.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.965 0.802 . . . . 0.0 112.546 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -99.85 159.2 15.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.865 0.866 . . . . 0.0 109.402 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.56 146.12 45.01 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.335 -0.853 . . . . 0.0 109.078 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.27 171.23 43.1 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.444 HG21 HH12 ' A' ' 71' ' ' ARG . 6.6 t -101.63 148.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.0 t -124.61 158.44 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 128.544 2.738 . . . . 0.0 104.771 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.58 153.61 47.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 mt -139.2 116.82 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.0 108.43 19.58 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -89.35 109.22 20.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 116.035 -1.935 . . . . 0.0 106.662 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -73.74 141.74 46.31 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 122.015 2.189 . . . . 0.0 107.754 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.52 -59.04 0.16 Allowed Glycine 0 C--O 1.223 -0.562 0 C-N-CA 123.56 0.6 . . . . 0.0 111.807 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 168.51 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 129.491 3.117 . . . . 0.0 107.856 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.4 ' H ' ' NH2' ' A' ' 60' ' ' ARG . 4.0 p-10 -78.7 46.98 0.7 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.819 1.771 . . . . 0.0 110.173 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.8 150.96 5.47 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.478 1.99 . . . . 0.0 111.36 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.37 162.44 38.34 Favored 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 120.463 0.775 . . . . 0.0 110.693 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -120.94 101.75 7.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 118.569 -0.729 . . . . 0.0 109.443 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tp -74.05 88.79 1.91 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.308 0.504 . . . . 0.0 110.541 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.39 169.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.719 1.208 . . . . 0.0 110.297 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -120.79 167.94 11.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.757 1.223 . . . . 0.0 111.333 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.25 170.23 10.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.549 1.94 . . . . 0.0 108.089 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -116.78 141.63 47.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.637 1.975 . . . . 0.0 109.338 -177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -55.17 -30.7 60.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -51.16 -21.05 1.76 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.174 2.589 . . . . 0.0 113.401 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -118.17 -4.33 10.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.207 1.403 . . . . 0.0 112.208 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.5 mt -97.08 166.83 11.4 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.036 1.289 . . . . 0.0 112.024 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -136.52 132.45 35.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -101.41 142.58 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.061 -2.199 . . . . 0.0 105.061 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.22 179.18 4.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.411 1.484 . . . . 0.0 108.274 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -70.33 174.81 5.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.194 0.998 . . . . 0.0 109.797 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.29 33.99 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.742 1.639 . . . . 0.0 110.928 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.277 0.1 OUTLIER 53.49 19.87 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.893 2.077 . . . . 0.0 114.694 -176.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -74.69 135.79 41.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.92 161.12 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.5 t -144.64 145.46 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 O-C-N 120.674 -1.266 . . . . 0.0 108.379 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.21 137.53 31.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.605 2.762 . . . . 0.0 107.126 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.34 108.47 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.898 2.398 . . . . 0.0 111.066 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.85 111.87 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 108.853 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.94 -21.83 4.81 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.555 1.074 . . . . 0.0 112.605 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.71 41.13 0.43 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.089 -1.395 . . . . 0.0 110.135 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.4 mtt -108.65 71.48 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.149 1.379 . . . . 0.0 107.532 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -64.21 -65.33 0.69 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.284 3.433 . . . . 0.0 114.444 -173.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -51.7 -40.29 59.86 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.245 0.93 . . . . 0.0 108.602 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -63.14 -39.58 95.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.209 -0.9 . . . . 0.0 112.984 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 22.2 tt0 -58.59 -51.04 71.59 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 120.654 1.57 . . . . 0.0 109.623 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.59 -48.02 83.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.503 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -61.02 -41.97 97.57 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 116.197 -1.858 . . . . 0.0 111.311 -173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -48.09 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 120.248 1.385 . . . . 0.0 108.845 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.26 54.15 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.066 -0.969 . . . . 0.0 113.234 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.4 ' NH2' ' H ' ' A' ' 24' ' ' ASP . 14.4 mtp180 -87.51 -46.91 9.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.027 1.285 . . . . 0.0 113.675 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -142.56 128.93 20.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.291 1.044 . . . . 0.0 111.802 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -18.86 58.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 126.48 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.389 1.45 . . . . 0.0 111.176 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.81 141.47 36.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.997 1.38 . . . . 0.0 112.584 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tp -89.59 154.24 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.1 ttt -140.25 141.23 35.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.0 p -124.97 135.88 53.21 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 pp -116.47 164.64 14.27 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.007 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.67 178.78 41.94 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.5 t -147.29 174.11 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.945 1.298 . . . . 0.0 108.948 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.444 HH12 HG21 ' A' ' 15' ' ' VAL . 69.6 mtt85 -117.01 -8.03 11.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.425 2.29 . . . . 0.0 109.797 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 mmpm? -91.64 -11.08 38.08 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 119.482 -2.011 . . . . 0.0 115.304 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.37 133.1 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.21 131.48 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.29 1.036 . . . . 0.0 111.403 -174.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.89 -141.19 6.95 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.457 HH21 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -85.9 -59.23 2.36 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.212 1.405 . . . . 0.0 107.607 176.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.49 102.95 6.24 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.82 -168.94 1.83 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 121.608 0.56 . . . . 0.0 112.964 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.0 58.98 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.612 2.208 . . . . 0.0 110.87 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.55 120.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 t -113.72 168.95 9.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 117.777 0.789 . . . . 0.0 110.222 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.7 -176.72 40.23 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 124.703 1.144 . . . . 0.0 113.2 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.76 153.6 45.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.576 1.15 . . . . 0.0 109.662 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.52 129.53 47.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.8 mp -139.98 161.46 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 108.602 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.429 HH22 ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -139.15 151.06 46.33 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.605 -1.31 . . . . 0.0 107.905 173.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.13 -174.94 33.62 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.053 0.835 . . . . 0.0 111.782 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -115.93 129.34 56.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.245 1.418 . . . . 0.0 108.161 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.01 14.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.017 1.327 . . . . 0.0 112.162 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.01 120.68 3.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.767 1.227 . . . . 0.0 108.926 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.2 m-85 -76.73 140.58 40.87 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -140.8 139.24 34.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.672 1.189 . . . . 0.0 111.249 173.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -121.21 39.84 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 103.236 -2.875 . . . . 0.0 103.236 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.253 7.5 t70 -158.87 150.19 20.5 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.951 2.9 . . . . 0.0 111.55 -172.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.04 179.03 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.35 0.976 . . . . 0.0 114.183 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.42 -9.54 13.42 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.046 3.164 . . . . 0.0 112.179 173.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -67.66 -67.61 0.45 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.584 1.953 . . . . 0.0 106.943 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.45 -31.62 71.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.813 0.845 . . . . 0.0 111.925 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.71 -54.07 18.33 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.57 -32.56 72.66 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.099 -1.001 . . . . 0.0 112.567 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.403 1.1 pp -79.08 -17.84 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.017 0.826 . . . . 0.0 112.612 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.1 -27.69 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 111.367 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -45.67 -27.95 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.822 1.249 . . . . 0.0 112.975 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.06 178.88 8.14 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.306 1.042 . . . . 0.0 110.689 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -140.48 21.04 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 119.812 -1.805 . . . . 0.0 111.002 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -136.97 8.77 3.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.246 1.418 . . . . 0.0 111.117 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.22 25.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.68 -0.637 . . . . 0.0 110.664 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -21.05 8.01 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.173 2.189 . . . . 0.0 111.282 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.58 161.57 11.56 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.948 1.299 . . . . 0.0 109.772 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.88 104.38 14.63 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.73 93.64 4.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.91 131.44 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.05 128.28 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 24.7 m -99.21 90.43 4.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.6 159.38 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.66 -57.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.0 m -148.93 141.09 23.96 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.209 0.459 . . . . 0.0 112.038 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.91 138.88 53.89 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.306 3.042 . . . . 0.0 109.485 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.429 ' CD ' HH22 ' A' ' 86' ' ' ARG . 17.7 pm0 -140.68 151.31 44.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.779 0.832 . . . . 0.0 110.874 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 138.12 57.72 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 125.036 1.334 . . . . 0.0 109.944 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -138.45 -81.31 0.32 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.432 0.458 . . . . 0.0 110.836 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.457 ' C ' HH21 ' A' ' 76' ' ' ARG . 2.1 pp . . . . . 0 C--O 1.242 0.665 0 C-N-CA 123.955 0.902 . . . . 0.0 110.43 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.47 156.28 58.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.291 1.994 . . . . 0.0 110.321 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.77 92.89 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.49 -38.68 55.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.838 1.655 . . . . 0.0 112.234 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -50.79 -54.23 25.31 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.337 1.426 . . . . 0.0 109.401 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.86 -48.58 76.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.515 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -60.26 -33.78 72.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.346 0.975 . . . . 0.0 112.482 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.05 -41.03 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.484 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -39.77 85.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.88 1.218 . . . . 0.0 112.047 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.72 -24.85 6.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.975 1.261 . . . . 0.0 112.433 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -101.48 158.6 15.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.94 0.791 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.22 148.68 41.36 Favored 'General case' 0 C--O 1.243 0.741 0 O-C-N 121.074 -1.016 . . . . 0.0 109.818 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.19 168.23 39.37 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 122.852 0.263 . . . . 0.0 112.724 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -101.08 144.53 12.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.33 159.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 127.752 2.421 . . . . 0.0 105.607 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.16 157.32 45.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.32 1.048 . . . . 0.0 109.531 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.7 118.7 12.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 125.232 1.413 . . . . 0.0 107.71 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.92 108.78 19.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m -88.79 109.42 20.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -73.53 141.23 46.73 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.42 -81.63 0.22 Allowed Glycine 0 C--O 1.221 -0.714 0 N-CA-C 106.007 -2.837 . . . . 0.0 106.007 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -170.69 -59.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.92 52.12 1.21 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.497 1.618 . . . . 0.0 110.201 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.57 144.94 3.93 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.83 2.157 . . . . 0.0 111.551 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.92 161.29 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.362 1.374 . . . . 0.0 109.983 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.654 ' CD2' ' HG1' ' A' ' 54' ' ' THR . 0.6 OUTLIER -121.12 97.46 5.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.976 1.71 . . . . 0.0 107.462 -173.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 11.0 tp -83.55 88.55 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.8 0.727 . . . . 0.0 109.322 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.23 169.04 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.013 0.925 . . . . 0.0 110.293 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.81 167.61 11.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.235 1.414 . . . . 0.0 112.856 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 t -168.35 174.61 6.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.627 1.971 . . . . 0.0 108.021 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -120.56 141.99 49.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.702 2.401 . . . . 0.0 109.463 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -53.88 -30.75 47.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.334 0.97 . . . . 0.0 109.737 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -52.15 -21.16 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.535 2.334 . . . . 0.0 112.671 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -118.12 -5.12 10.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.921 1.688 . . . . 0.0 112.108 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.7 mt -87.8 159.22 18.52 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.506 1.503 . . . . 0.0 111.588 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.403 ' HE3' ' CB ' ' A' ' 100' ' ' ALA 0.25 0.0 OUTLIER -136.36 131.85 34.79 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.802 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.18 147.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.57 178.89 4.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.397 1.879 . . . . 0.0 107.725 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 27.8 t0 -71.28 175.86 5.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.107 0.963 . . . . 0.0 110.47 173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 56.87 28.43 57.57 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.333 1.444 . . . . 0.0 111.476 -176.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.272 0.1 OUTLIER 53.72 20.73 2.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.415 1.886 . . . . 0.0 114.375 -175.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -73.97 126.31 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.152 1.381 . . . . 0.0 107.373 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.66 159.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -146.0 144.28 20.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 120.536 -1.353 . . . . 0.0 109.262 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.92 136.54 28.59 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.925 2.09 . . . . 0.0 107.534 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.69 108.32 1.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.455 2.104 . . . . 0.0 109.039 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG12 ' CE2' ' A' ' 91' ' ' PHE . 2.4 p -85.49 111.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.19 -21.33 10.11 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.338 1.447 . . . . 0.0 113.255 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.92 0.31 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 119.305 1.553 . . . . 0.0 115.09 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -97.89 67.94 1.99 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 123.394 1.568 . . . . 0.0 108.353 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -64.21 -48.79 74.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.193 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.255 81.8 tttt -52.04 -36.29 49.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.794 1.633 . . . . 0.0 110.674 173.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.654 ' HG1' ' CD2' ' A' ' 27' ' ' HIS . 1.8 m -64.86 -39.51 93.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.429 1.468 . . . . 0.0 110.705 174.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.08 -50.73 68.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.507 1.503 . . . . 0.0 110.631 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.1 79.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.131 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -58.52 -41.99 86.72 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 115.781 -2.057 . . . . 0.0 111.45 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.16 -48.36 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.874 1.216 . . . . 0.0 109.116 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.94 66.05 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.267 -0.873 . . . . 0.0 113.277 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -87.44 -47.06 9.07 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.662 1.119 . . . . 0.0 112.48 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -140.04 132.31 28.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.65 1.18 . . . . 0.0 112.325 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.97 -22.52 55.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.51 129.65 42.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.896 1.225 . . . . 0.0 112.47 -173.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.4 m -139.29 139.4 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.837 1.303 . . . . 0.0 112.336 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 tp -92.98 153.7 18.59 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 172.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.6 ttt -140.03 141.37 36.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -123.17 130.62 53.0 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 pp -115.35 166.19 12.14 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.617 1.098 . . . . 0.0 108.38 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.63 179.11 41.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 173.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.2 t -147.18 168.67 21.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.687 1.595 . . . . 0.0 108.157 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -116.42 -9.41 11.48 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.014 1.326 . . . . 0.0 109.87 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -92.38 -11.67 34.3 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.44 134.19 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 118.5 20.66 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.941 0.791 . . . . 0.0 112.33 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.5 -127.26 3.37 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.91 1.243 . . . . 0.0 111.704 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -91.68 -58.7 2.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -74.62 102.63 4.64 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 109.875 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.55 -167.9 0.4 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.27 62.85 5.25 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.72 121.88 1.39 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 129.73 3.538 . . . . 0.0 106.83 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -109.98 176.82 4.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.132 0.966 . . . . 0.0 110.699 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.52 177.41 44.38 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 124.839 1.209 . . . . 0.0 112.158 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -138.4 154.65 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.149 0.979 . . . . 0.0 108.369 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.27 129.3 47.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.46 154.04 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 119' ' ' GLU . 36.7 mtm180 -135.89 141.64 44.61 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.882 1.273 . . . . 0.0 108.618 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -169.81 34.94 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.412 0.53 . . . . 0.0 112.238 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.8 m -121.11 151.1 40.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.959 1.303 . . . . 0.0 109.074 173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.32 163.64 13.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.625 1.17 . . . . 0.0 113.017 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.59 121.19 3.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.103 1.361 . . . . 0.0 109.377 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.423 ' CE2' HG12 ' A' ' 48' ' ' VAL . 3.5 m-85 -77.55 149.07 34.93 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.231 -0.918 . . . . 0.0 111.989 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -141.03 134.42 29.78 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 125.339 1.456 . . . . 0.0 107.709 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.0 p -120.42 20.17 11.93 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.597 173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.75 150.1 20.65 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.698 2.399 . . . . 0.0 109.583 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.59 -177.83 45.45 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.917 1.246 . . . . 0.0 112.507 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.26 -14.27 19.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.133 3.222 . . . . 0.0 113.524 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.3 -63.72 1.01 Allowed 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.101 -0.999 . . . . 0.0 108.978 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.64 -31.62 71.73 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.448 1.499 . . . . 0.0 111.079 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -69.12 -49.66 55.01 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.438 0.695 . . . . 0.0 109.636 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.403 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -61.13 -35.39 76.94 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.146 -0.971 . . . . 0.0 111.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.402 0.8 OUTLIER -79.02 -17.89 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.736 173.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.2 -27.58 2.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.691 1.996 . . . . 0.0 112.22 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -47.65 -36.38 10.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.305 1.042 . . . . 0.0 111.205 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -80.89 177.95 8.72 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.308 0.958 . . . . 0.0 108.537 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -141.14 -0.6 1.44 Allowed 'General case' 0 C--O 1.222 -0.393 0 O-C-N 119.18 -2.2 . . . . 0.0 112.262 -176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -106.3 8.87 32.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.032 1.733 . . . . 0.0 110.873 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.41 145.75 29.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.389 -0.819 . . . . 0.0 110.869 -174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -121.29 -13.71 8.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.864 2.866 . . . . 0.0 111.913 -174.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -173.78 161.71 3.89 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.143 2.177 . . . . 0.0 109.536 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.17 101.97 11.42 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.386 2.275 . . . . 0.0 105.012 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.07 95.91 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.672 1.589 . . . . 0.0 106.764 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.98 131.67 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.16 128.49 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.6 m -98.92 88.46 4.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.4 t -61.03 156.13 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.827 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.49 -55.46 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.5 m -148.5 141.25 24.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.666 0.666 . . . . 0.0 112.32 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.35 138.73 51.59 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 128.919 2.887 . . . . 0.0 107.886 173.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 86' ' ' ARG . 3.3 pm0 -140.1 138.68 35.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 110.609 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 138.58 58.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 111.928 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -143.39 -80.51 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.259 0.624 . . . . 0.0 112.299 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 114.892 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 118.199 -0.905 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.12 164.34 35.68 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.813 2.342 . . . . 0.0 110.329 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.86 -47.56 89.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.367 5.0 m -50.3 -38.11 39.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.255 1.822 . . . . 0.0 113.635 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -50.65 -51.97 44.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.095 1.316 . . . . 0.0 110.649 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -63.55 -48.35 77.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.035 0.934 . . . . 0.0 110.13 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.71 -38.09 66.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.427 1.012 . . . . 0.0 111.757 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.86 -43.77 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.083 -1.011 . . . . 0.0 109.629 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.65 -35.06 75.28 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.202 1.364 . . . . 0.0 112.32 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -51.84 -27.09 11.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.025 0.93 . . . . 0.0 112.133 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -99.37 159.2 15.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.468 1.107 . . . . 0.0 108.114 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.92 153.34 39.86 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 122.077 0.941 . . . . 0.0 109.151 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.97 174.52 45.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 125.611 1.577 . . . . 0.0 109.422 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.92 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.74 160.93 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.22 154.69 44.1 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.84 116.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -174.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.56 108.86 19.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -94.36 123.05 37.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 116.971 -1.49 . . . . 0.0 108.134 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -72.91 119.55 17.31 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 121.242 1.837 . . . . 0.0 106.579 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.29 -81.65 0.23 Allowed Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.136 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -158.63 -60.7 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -78.82 41.03 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.113 2.565 . . . . 0.0 110.479 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.63 152.24 9.47 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.25 148.05 42.81 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 CA-C-N 120.791 2.295 . . . . 0.0 107.973 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.535 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 43.2 t60 -103.3 101.3 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.195 -172.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -76.22 88.53 3.08 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.168 0.587 . . . . 0.0 110.425 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -83.24 170.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.887 1.675 . . . . 0.0 110.069 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.13 166.1 13.35 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.09 1.314 . . . . 0.0 113.793 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.0 t -168.32 176.19 6.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.374 2.27 . . . . 0.0 108.054 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -118.95 141.81 48.34 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.659 1.983 . . . . 0.0 109.721 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.07 -31.56 42.37 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.372 0.669 . . . . 0.0 110.016 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -60.76 -11.79 8.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.903 3.281 . . . . 0.0 112.108 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -118.68 -6.36 10.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 111.58 -177.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.05 160.11 14.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.089 1.313 . . . . 0.0 112.084 -173.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 141.61 44.64 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.28 150.95 5.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -122.0 179.21 4.59 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 128.461 2.704 . . . . 0.0 107.103 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.97 -179.91 2.47 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.26 28.21 26.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.479 1.514 . . . . 0.0 111.245 -173.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.342 0.1 OUTLIER 53.39 24.59 4.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.891 2.076 . . . . 0.0 114.32 -175.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.45 151.26 41.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.29 164.38 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -144.43 140.93 24.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.0 124.86 26.44 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 127.483 2.313 . . . . 0.0 105.4 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.87 108.52 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.116 1.878 . . . . 0.0 109.008 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.83 111.61 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -21.24 6.85 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 112.077 173.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.3 40.89 0.31 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 119.095 1.448 . . . . 0.0 110.697 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 28.7 mtt -106.56 57.5 0.65 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.799 1.239 . . . . 0.0 108.598 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.53 -49.81 37.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.627 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.535 ' HZ3' ' CG ' ' A' ' 27' ' ' HIS . 1.2 tmmt? -52.17 -41.3 62.48 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.821 1.646 . . . . 0.0 110.854 173.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -61.1 -38.91 88.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.514 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.53 -49.51 76.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 121.04 1.746 . . . . 0.0 110.413 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.62 97.08 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -61.88 -41.94 98.46 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.567 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.36 -48.15 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.746 1.157 . . . . 0.0 109.32 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.14 53.18 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.387 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.5 mtp85 -85.56 -46.31 10.94 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.102 0.864 . . . . 0.0 112.726 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.46 129.21 15.2 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.161 0.984 . . . . 0.0 110.962 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -73.92 -17.75 60.98 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.53 123.19 16.04 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 m -138.82 141.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 123.082 1.42 . . . . 0.0 110.52 173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.32 148.48 28.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 102.091 -3.299 . . . . 0.0 102.091 172.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.4 ttt -141.66 121.06 13.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -108.93 128.36 54.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 168.52 10.01 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.042 1.292 . . . . 0.0 107.847 173.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.64 -169.22 31.8 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -147.01 175.47 10.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.409 1.099 . . . . 0.0 108.707 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -113.87 -7.94 13.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.676 2.391 . . . . 0.0 109.317 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mmpm? -91.46 -10.95 39.03 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 119.601 -1.937 . . . . 0.0 115.007 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.76 136.49 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.57 131.49 36.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.479 1.112 . . . . 0.0 111.104 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.44 -140.98 6.34 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 124.703 1.144 . . . . 0.0 110.886 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.27 -58.99 2.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.564 1.546 . . . . 0.0 107.731 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.95 102.84 8.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.072 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.24 -168.6 2.26 Favored Glycine 0 CA--C 1.538 1.499 0 O-C-N 121.754 -0.591 . . . . 0.0 112.655 176.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.52 59.74 5.61 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.815 2.344 . . . . 0.0 110.993 174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.25 121.11 1.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -113.47 169.88 8.64 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.477 1.138 . . . . 0.0 110.334 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.2 -177.36 45.15 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 123.602 0.62 . . . . 0.0 113.283 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -136.8 152.67 50.56 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.862 1.265 . . . . 0.0 109.502 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tt -101.39 131.27 47.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.648 2.379 . . . . 0.0 104.58 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -136.06 158.33 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -129.86 150.79 51.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.644 1.178 . . . . 0.0 109.453 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -174.59 40.9 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.455 1.026 . . . . 0.0 111.693 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -106.03 137.35 44.1 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.4 161.93 13.33 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.787 0.722 . . . . 0.0 111.181 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.2 119.24 3.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.148 0.979 . . . . 0.0 109.833 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -74.17 131.52 41.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.2 141.46 50.65 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.83 2.852 . . . . 0.0 109.572 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.14 27.07 8.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.384 1.873 . . . . 0.0 107.425 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -158.81 163.95 36.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.11 2.564 . . . . 0.0 107.797 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.48 178.35 46.82 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.072 1.796 . . . . 0.0 113.077 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.41 -22.91 58.95 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.167 2.578 . . . . 0.0 112.007 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -64.29 -59.31 4.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 173.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -61.56 -31.31 71.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.094 -1.431 . . . . 0.0 112.402 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -68.47 -53.99 19.83 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.957 1.708 . . . . 0.0 108.227 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.51 69.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.909 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.4 pp -93.67 -19.9 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.764 -1.113 . . . . 0.0 112.87 173.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.94 -35.21 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.533 1.969 . . . . 0.0 110.406 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.285 2.2 ptm180 -51.07 -18.18 0.78 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.947 2.099 . . . . 0.0 113.815 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -67.88 -171.2 0.2 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -132.13 4.17 4.07 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 118.597 -2.564 . . . . 0.0 113.786 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 23.3 p-90 -131.05 8.84 4.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.811 0.844 . . . . 0.0 111.704 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.86 140.61 38.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.498 -0.751 . . . . 0.0 109.062 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.21 -10.59 8.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.348 1.459 . . . . 0.0 111.418 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.0 161.85 10.77 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.79 2.436 . . . . 0.0 108.201 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.43 107.63 18.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.802 2.041 . . . . 0.0 106.6 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 tt -84.49 96.34 9.09 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.9 t -79.29 131.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.672 1.589 . . . . 0.0 107.516 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.06 128.86 75.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.4 m -106.09 92.19 4.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.08 157.42 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.888 1.275 . . . . 0.0 110.723 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.52 -56.27 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.9 m -151.29 141.66 22.43 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.37 155.2 29.99 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 128.538 2.735 . . . . 0.0 112.295 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -141.07 140.95 34.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.815 2.046 . . . . 0.0 108.208 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -76.56 140.77 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -138.7 -79.49 0.34 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.307 0.643 . . . . 0.0 111.5 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.242 0.697 0 CA-C-O 116.825 -1.559 . . . . 0.0 112.169 -174.182 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.77 152.39 42.48 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.846 2.364 . . . . 0.0 111.939 173.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.84 -39.18 93.54 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.35 -40.27 58.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.624 1.57 . . . . 0.0 111.89 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -51.28 -56.08 14.85 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.251 0.932 . . . . 0.0 110.611 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -56.06 -48.27 76.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.126 0.97 . . . . 0.0 110.454 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -55.41 -35.04 64.95 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.697 0.681 . . . . 0.0 112.565 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.6 t -69.06 -46.59 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.113 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.48 -41.32 69.42 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.169 1.35 . . . . 0.0 112.879 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -51.55 -18.71 1.19 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -119.94 158.69 26.2 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.367 0.985 . . . . 0.0 108.781 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -80.61 149.28 29.93 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.543 -1.348 . . . . 0.0 110.39 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.4 169.63 42.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.705 2.098 . . . . 0.0 110.194 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.1 151.04 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.98 159.58 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 127.574 2.349 . . . . 0.0 105.749 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.72 40.85 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.241 1.416 . . . . 0.0 109.419 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 mt -145.32 115.82 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.82 19.78 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -95.91 108.82 21.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -79.56 141.33 36.71 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 122.002 2.183 . . . . 0.0 106.168 173.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 -81.49 0.22 Allowed Glycine 0 C--O 1.224 -0.486 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -159.06 -61.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.4 45.73 0.68 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.131 1.772 . . . . 0.0 110.123 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 151.62 6.74 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.953 1.263 . . . . 0.0 112.685 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.19 157.72 53.37 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.212 1.275 . . . . 0.0 110.878 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.46 102.03 8.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.087 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.6 tt -87.35 88.71 7.76 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -175.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.58 173.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.762 2.025 . . . . 0.0 110.676 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.63 165.62 14.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.584 1.154 . . . . 0.0 111.574 173.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 178.43 4.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.247 2.219 . . . . 0.0 108.052 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -121.36 141.79 50.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.811 2.044 . . . . 0.0 110.685 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -51.52 -30.98 22.29 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.509 1.049 . . . . 0.0 110.799 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.48 -13.08 4.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.948 2.899 . . . . 0.0 112.008 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -118.14 -1.16 11.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.13 1.372 . . . . 0.0 110.48 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.6 mt -102.4 168.92 9.01 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.599 -1.313 . . . . 0.0 112.762 -173.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HZ1' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -136.72 125.3 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 172.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.3 t -101.69 148.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD23 ' HZ1' ' A' ' 37' ' ' LYS . 46.9 mt -121.58 -177.11 3.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.944 2.098 . . . . 0.0 107.973 173.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 36.2 t0 -71.44 177.99 3.68 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 49.37 28.15 8.96 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 126.098 1.809 . . . . 0.0 110.443 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.3 0.5 OUTLIER 53.23 28.27 6.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.373 2.269 . . . . 0.0 114.304 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -73.62 144.63 45.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 173.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.79 159.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 t -143.05 141.76 26.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -122.79 140.39 33.11 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.302 2.641 . . . . 0.0 106.066 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.43 110.97 2.02 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.795 2.33 . . . . 0.0 108.61 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.3 112.22 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.25 -21.77 5.44 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.081 -1.012 . . . . 0.0 112.148 173.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.78 41.31 0.35 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.344 1.572 . . . . 0.0 109.958 -175.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.0 mtt -105.71 71.13 0.9 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.677 1.191 . . . . 0.0 108.498 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.39 -65.57 0.66 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 130.048 3.339 . . . . 0.0 114.558 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -51.72 -41.27 61.39 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -63.47 -38.69 92.11 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.66 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.596 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 35.4 tt0 -56.29 -51.22 68.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.242 1.383 . . . . 0.0 109.489 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.53 93.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.175 0.59 . . . . 0.0 112.158 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -65.34 -41.93 93.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.576 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.8 -48.06 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.23 -28.82 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.157 -0.925 . . . . 0.0 112.819 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -86.81 -46.3 10.09 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.598 -1.191 . . . . 0.0 112.087 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -149.05 140.78 23.56 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.749 1.159 . . . . 0.0 110.255 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' CD ' HH21 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -68.64 -13.27 62.24 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -173.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.431 HH21 ' CD ' ' A' ' 62' ' ' GLU . 8.8 mmp_? -49.88 114.16 1.01 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.754 2.422 . . . . 0.0 115.934 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 m -141.7 146.32 23.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 CA-C-O 123.905 1.812 . . . . 0.0 114.797 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tt -111.46 148.78 32.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 101.623 -3.473 . . . . 0.0 101.623 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.4 ttt -141.05 140.98 34.33 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -121.6 128.21 51.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 175.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -117.19 169.73 9.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.227 -1.546 . . . . 0.0 108.112 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.86 -176.22 38.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 t -148.65 164.14 35.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.709 0.804 . . . . 0.0 110.364 174.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -98.35 -8.68 26.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.748 1.619 . . . . 0.0 109.447 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -91.39 -9.89 43.12 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 116.891 -1.528 . . . . 0.0 114.725 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -131.45 138.86 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 131.07 36.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.502 0.721 . . . . 0.0 110.753 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.25 -140.43 9.26 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 124.907 1.241 . . . . 0.0 111.765 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -90.68 -58.6 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 103.06 9.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.08 -168.67 3.91 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 113.129 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.28 58.82 6.81 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.658 2.238 . . . . 0.0 111.132 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.46 120.99 1.07 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -114.45 169.17 9.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.733 1.266 . . . . 0.0 110.105 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.54 178.21 41.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-O 121.725 0.625 . . . . 0.0 112.261 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.71 149.1 49.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.383 1.473 . . . . 0.0 108.473 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tt -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mm -131.35 156.53 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -135.59 146.01 47.51 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.285 1.434 . . . . 0.0 108.686 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.19 -165.54 34.46 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.942 0.782 . . . . 0.0 112.183 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.5 m -115.88 147.54 40.97 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.057 1.343 . . . . 0.0 108.045 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.99 164.35 12.89 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.794 1.637 . . . . 0.0 111.873 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.94 120.95 2.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.394 1.078 . . . . 0.0 108.853 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.596 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 63.8 m-85 -76.24 138.7 40.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -140.63 141.35 35.11 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.094 0.958 . . . . 0.0 110.112 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.3 p -117.2 39.64 3.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -159.07 156.13 28.63 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 128.115 2.566 . . . . 0.0 111.567 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.15 178.54 47.26 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.292 1.901 . . . . 0.0 114.391 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.71 -17.26 58.07 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.347 2.698 . . . . 0.0 111.584 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -63.77 1.13 Allowed 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.151 1.78 . . . . 0.0 107.488 173.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.45 -31.26 71.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.03 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -68.62 -49.08 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.555 1.07 . . . . 0.0 109.074 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.96 78.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.218 -0.926 . . . . 0.0 111.404 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.345 0.9 OUTLIER -82.58 -18.41 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.55 173.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.01 -27.96 3.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.826 1.651 . . . . 0.0 112.133 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -51.17 -35.9 38.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.72 0.808 . . . . 0.0 111.78 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.26 177.84 8.53 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -141.37 -1.11 1.36 Allowed 'General case' 0 C--O 1.222 -0.387 0 O-C-N 119.144 -2.222 . . . . 0.0 113.18 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -98.26 8.76 44.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.449 1.1 . . . . 0.0 110.271 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.37 150.8 28.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.524 -0.735 . . . . 0.0 111.03 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -120.88 -21.28 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.168 2.987 . . . . 0.0 111.024 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -171.5 161.77 6.37 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.736 2.014 . . . . 0.0 109.114 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.99 108.38 19.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.5 93.89 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.04 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.9 128.68 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.1 m -106.2 92.09 3.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.04 155.48 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.848 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.05 -41.79 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.521 1.528 . . . . 0.0 107.275 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.5 m -151.26 141.0 21.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.838 1.199 . . . . 0.0 113.618 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.5 140.13 49.43 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 129.948 3.299 . . . . 0.0 110.626 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -139.3 136.31 34.73 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.013 1.725 . . . . 0.0 109.291 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -75.91 140.82 42.33 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -137.23 -77.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.256 1.397 0 C-N-CA 125.359 1.464 . . . . 0.0 114.37 -173.539 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.43 159.39 51.63 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.677 2.251 . . . . 0.0 111.832 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.16 -38.77 93.6 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -48.5 -43.14 34.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.065 1.746 . . . . 0.0 111.427 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.34 -55.45 18.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.352 0.978 . . . . 0.0 111.247 174.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -56.7 -48.52 77.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -59.21 -33.62 71.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.759 0.709 . . . . 0.0 112.835 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.76 -41.93 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -59.6 -38.4 81.12 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.33 1.423 . . . . 0.0 112.493 173.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 -18.9 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.177 1.353 . . . . 0.0 112.63 173.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -113.73 159.05 20.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.414 1.086 . . . . 0.0 108.754 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -73.72 148.36 42.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.924 -1.11 . . . . 0.0 108.794 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.35 171.25 40.59 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 126.801 2.143 . . . . 0.0 110.079 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.42 150.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -139.82 160.46 26.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.974 2.109 . . . . 0.0 106.041 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 157.05 44.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.512 1.125 . . . . 0.0 108.46 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.0 mt -139.4 115.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.04 108.56 19.65 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -91.36 114.3 26.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 116.308 -1.806 . . . . 0.0 106.649 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.41 141.5 46.95 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 121.845 2.111 . . . . 0.0 108.47 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.28 -81.05 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -158.82 -56.98 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 20.0 p-10 -78.87 38.34 0.33 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.668 2.787 . . . . 0.0 111.517 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.37 151.67 6.48 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.416 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.92 148.9 58.53 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 CA-C-N 118.028 0.914 . . . . 0.0 111.449 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -101.88 101.39 11.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.84 88.64 3.44 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.663 0.665 . . . . 0.0 110.071 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.3 m -80.31 170.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.15 1.38 . . . . 0.0 110.046 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -119.36 165.91 13.72 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 0.989 . . . . 0.0 112.523 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -168.29 176.22 6.03 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 108.548 175.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.16 141.53 50.74 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.433 1.893 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.26 -31.06 52.65 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.111 0.869 . . . . 0.0 109.706 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -59.95 -13.33 10.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.765 2.826 . . . . 0.0 111.413 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -119.23 -2.94 10.6 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.5 mt -90.18 164.78 14.3 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.477 1.489 . . . . 0.0 112.229 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.435 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -134.98 132.2 38.08 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.17 145.74 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.48 179.13 4.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.333 1.853 . . . . 0.0 108.101 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.44 175.24 4.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.347 1.059 . . . . 0.0 109.474 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.09 28.42 33.38 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.721 1.629 . . . . 0.0 111.105 -173.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.28 0.1 OUTLIER 53.41 23.11 3.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.86 2.064 . . . . 0.0 114.102 -177.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -73.58 129.08 37.22 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -118.0 150.91 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.51 147.08 24.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 120.837 -1.164 . . . . 0.0 108.843 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.65 135.73 27.69 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 126.188 1.795 . . . . 0.0 107.869 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.0 108.36 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.022 1.815 . . . . 0.0 108.457 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.57 111.52 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.52 -21.35 6.9 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 112.256 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.75 41.38 0.32 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 117.46 -1.745 . . . . 0.0 109.901 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.1 mtt -109.12 59.82 0.6 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.654 1.181 . . . . 0.0 109.225 173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -71.48 -49.65 39.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.994 -174.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 55.0 tttp -51.99 -41.44 62.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.044 1.747 . . . . 0.0 109.296 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -60.73 -39.47 88.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.151 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.93 -48.28 80.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 121.248 1.84 . . . . 0.0 110.782 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.68 99.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.099 0.159 . . . . 0.0 111.253 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -62.88 -41.87 99.56 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.379 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.7 -48.24 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.409 1.459 . . . . 0.0 109.132 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.49 -28.17 59.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -80.74 -46.42 15.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 173.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -151.34 128.61 11.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.986 0.914 . . . . 0.0 109.204 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -15.39 60.05 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.799 -1.188 . . . . 0.0 113.969 -174.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.64 130.69 47.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.641 1.11 . . . . 0.0 111.575 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 m -139.35 156.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 123.392 1.567 . . . . 0.0 111.895 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.7 tp -108.93 149.87 28.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 173.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.3 ttt -140.01 123.02 16.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -109.02 127.99 54.57 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.97 172.4 7.29 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.421 1.464 . . . . 0.0 109.559 173.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.44 -166.16 27.03 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.0 t -146.65 159.94 42.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.83 0.852 . . . . 0.0 109.467 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -98.69 -15.47 19.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.145 0.978 . . . . 0.0 108.994 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.03 -7.01 50.01 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 116.323 -1.799 . . . . 0.0 115.388 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.02 129.69 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 121.767 2.076 . . . . 0.0 106.14 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.3 131.42 36.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.907 0.883 . . . . 0.0 110.631 -174.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.71 -140.98 7.18 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -78.98 -59.11 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.877 1.271 . . . . 0.0 108.855 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.25 103.12 15.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.716 0.77 . . . . 0.0 109.907 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.51 -172.01 3.97 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.952 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -80.54 58.87 7.21 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.208 1.939 . . . . 0.0 110.571 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.69 109.83 0.43 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 t -99.32 169.65 9.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.498 0.649 . . . . 0.0 110.375 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.97 169.91 40.87 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -125.0 157.33 36.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.84 1.256 . . . . 0.0 110.386 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.89 130.54 46.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mt -134.77 153.01 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -130.76 140.38 50.31 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.805 1.642 . . . . 0.0 107.342 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.68 36.82 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 118.691 0.678 . . . . 0.0 111.718 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -121.4 150.99 40.69 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.869 0.868 . . . . 0.0 110.163 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.13 162.33 14.36 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.167 1.387 . . . . 0.0 112.288 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.02 121.19 3.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.643 1.177 . . . . 0.0 109.289 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -74.18 138.54 43.85 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.193 0.997 . . . . 0.0 110.771 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -135.56 123.34 22.45 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 126.448 1.899 . . . . 0.0 115.399 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -121.72 32.94 5.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.177 2.991 . . . . 0.0 103.924 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.64 151.76 22.6 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 130.488 3.515 . . . . 0.0 110.141 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.55 47.59 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.543 1.068 . . . . 0.0 113.37 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.82 -9.09 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.945 2.43 . . . . 0.0 111.17 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -61.32 -60.86 3.07 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -61.56 -31.48 71.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 125.071 1.482 . . . . 0.0 111.138 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.46 -48.56 64.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.741 1.155 . . . . 0.0 109.357 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.435 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -59.58 -41.22 89.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.421 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.281 1.2 pp -79.82 -18.75 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 119.251 -0.98 . . . . 0.0 113.556 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.91 -28.84 53.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.841 1.655 . . . . 0.0 113.745 -174.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.259 0.6 OUTLIER -52.08 -38.58 57.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.124 173.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -66.05 177.88 1.26 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 -1.12 1.5 Allowed 'General case' 0 C--O 1.222 -0.385 0 O-C-N 118.308 -2.745 . . . . 0.0 113.378 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -110.32 8.35 23.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.503 0.721 . . . . 0.0 109.903 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.14 138.83 33.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.82 -8.36 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.025 1.73 . . . . 0.0 110.917 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.24 161.75 10.29 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.324 2.649 . . . . 0.0 108.506 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.85 105.14 15.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.774 2.429 . . . . 0.0 104.72 173.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.4 90.84 5.63 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.48 131.34 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.6 mt -120.22 128.23 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.9 m -99.34 88.47 3.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.622 -2.732 . . . . 0.0 103.622 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.71 157.29 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.037 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.79 -56.99 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.5 m -148.32 141.38 24.92 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.5 149.84 30.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.261 2.624 . . . . 0.0 108.534 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -139.55 133.14 30.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.31 1.844 . . . . 0.0 107.487 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -68.8 137.75 54.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -136.99 -58.23 0.72 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.247 0.937 0 C-N-CA 124.23 1.012 . . . . 0.0 113.323 -173.119 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.24 159.63 52.37 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.607 2.205 . . . . 0.0 111.818 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.75 95.38 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.26 -38.72 63.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 110.482 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -50.61 -56.01 13.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.496 1.043 . . . . 0.0 110.228 173.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -59.34 -48.56 81.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.372 0.669 . . . . 0.0 109.534 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 69.9 mm-40 -56.69 -41.05 76.67 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -41.22 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.841 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.28 -42.84 78.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.307 1.412 . . . . 0.0 111.85 173.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HZ3' ' CD ' ' A' ' 8' ' ' GLU . 7.6 mtmp? -52.02 -18.92 1.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 173.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -116.08 175.02 5.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 111.666 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -73.26 132.5 43.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.79 166.24 39.25 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 106.747 -2.541 . . . . 0.0 106.747 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.83 147.81 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.02 159.34 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.51 154.81 42.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.386 1.474 . . . . 0.0 107.183 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.09 114.03 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.38 19.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -88.68 116.17 26.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -73.3 138.18 45.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.4 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -159.79 -60.74 0.07 Allowed 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -78.94 52.53 1.26 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.657 2.383 . . . . 0.0 110.043 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.43 150.41 5.73 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.017 1.77 . . . . 0.0 111.735 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.94 150.16 82.97 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 118.241 1.02 . . . . 0.0 111.321 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -103.19 101.82 11.79 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.8 tt -87.4 88.88 7.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.5 m -76.1 169.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.117 1.767 . . . . 0.0 110.6 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -119.28 166.91 12.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.647 1.179 . . . . 0.0 113.079 174.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -168.68 174.25 6.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.315 2.246 . . . . 0.0 109.025 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -120.67 141.57 50.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.294 2.238 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -54.63 -31.21 56.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.255 0.48 . . . . 0.0 112.03 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.5 t -59.72 -8.97 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.521 1.528 . . . . 0.0 113.343 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.13 -1.77 11.33 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.644 1.178 . . . . 0.0 109.845 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.66 169.62 8.35 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.701 -1.249 . . . . 0.0 113.133 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -136.48 141.55 43.51 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.9 t -99.38 146.81 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 mt -121.68 -174.08 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.968 2.907 . . . . 0.0 111.825 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.37 158.89 6.76 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 128.122 2.569 . . . . 0.0 111.067 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.09 35.82 42.32 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.055 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.05 22.73 3.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.253 1.821 . . . . 0.0 114.347 -175.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -74.16 158.01 34.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.791 1.636 . . . . 0.0 108.084 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -140.77 170.23 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.8 t -144.89 140.06 23.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.767 1.227 . . . . 0.0 108.132 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.92 133.85 24.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 128.578 2.751 . . . . 0.0 106.885 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.37 108.43 2.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.874 2.383 . . . . 0.0 109.88 174.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.86 111.76 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.21 -21.34 6.29 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.6 1.571 . . . . 0.0 112.816 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.86 41.56 0.27 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 17.6 mtt -107.83 71.38 0.81 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.611 1.565 . . . . 0.0 107.728 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -67.21 -63.91 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 129.895 3.278 . . . . 0.0 113.278 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -51.74 -40.67 60.65 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -60.19 -40.85 91.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.306 -1.33 . . . . 0.0 112.252 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -58.19 -48.78 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.606 2.003 . . . . 0.0 110.32 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.16 95.69 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -65.1 -41.63 94.77 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 116.989 -1.481 . . . . 0.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.76 -48.25 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.3 1.409 . . . . 0.0 108.503 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -25.7 59.9 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -82.25 -44.92 15.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -151.15 136.24 17.48 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 108.791 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -21.85 63.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.162 -0.961 . . . . 0.0 112.256 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -61.05 128.88 38.58 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.68 1.192 . . . . 0.0 114.115 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.52 154.99 25.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 122.749 1.262 . . . . 0.0 110.139 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.66 150.97 29.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 103.058 -2.941 . . . . 0.0 103.058 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 13.7 ttt -139.01 135.52 34.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 p -121.05 128.45 52.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.97 165.95 12.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 109.083 173.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.11 42.5 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -159.8 170.31 21.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.974 0.892 . . . . 0.0 108.901 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -99.27 -9.32 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.873 2.069 . . . . 0.0 110.325 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -91.85 -11.26 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.54 136.73 56.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 131.42 36.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.526 0.73 . . . . 0.0 109.847 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.32 -141.1 7.31 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 124.222 0.951 . . . . 0.0 110.933 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -81.67 -58.82 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.47 102.9 13.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.615 0.721 . . . . 0.0 109.625 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.73 -168.94 3.44 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.617 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.52 59.43 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.578 2.185 . . . . 0.0 110.914 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.09 121.08 1.09 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -110.09 169.31 8.81 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 118.029 0.914 . . . . 0.0 109.836 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.87 35.16 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 123.962 0.791 . . . . 0.0 113.441 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -136.48 141.5 43.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.23 1.412 . . . . 0.0 109.348 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.18 130.68 47.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 127.174 2.189 . . . . 0.0 106.271 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.4 mt -141.32 150.99 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.812 -0.555 . . . . 0.0 109.762 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -128.03 148.82 50.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.81 2.044 . . . . 0.0 109.967 173.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.4 -168.09 34.06 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.355 1.455 . . . . 0.0 110.458 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.7 m -121.0 149.04 43.28 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.351 1.46 . . . . 0.0 108.838 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.02 163.56 13.71 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.763 1.225 . . . . 0.0 112.191 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 121.5 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.68 143.91 46.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -133.36 134.53 43.87 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 126.414 1.886 . . . . 0.0 107.537 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.8 p -121.22 28.77 7.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 108.695 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.78 155.79 28.58 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.714 2.006 . . . . 0.0 110.036 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.19 -174.8 44.1 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 124.384 0.992 . . . . 0.0 115.263 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.35 -10.77 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.713 2.942 . . . . 0.0 112.735 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.81 -62.67 1.31 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.235 1.814 . . . . 0.0 106.86 173.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.41 -31.37 71.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.751 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.67 -48.86 62.88 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.566 1.075 . . . . 0.0 109.558 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.16 66.96 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.389 -0.819 . . . . 0.0 111.661 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.333 1.2 pp -93.2 -18.45 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 173.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.42 -28.48 13.0 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.093 1.757 . . . . 0.0 112.988 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -51.43 -25.86 7.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.005 0.922 . . . . 0.0 112.893 173.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -81.11 178.61 8.3 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.029 0.831 . . . . 0.0 109.56 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -139.04 20.79 2.63 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.01 -1.681 . . . . 0.0 110.741 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -131.95 8.55 4.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.267 1.427 . . . . 0.0 111.055 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.608 -0.682 . . . . 0.0 111.071 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -21.16 6.46 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.595 2.758 . . . . 0.0 111.663 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.2 161.86 10.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.213 1.805 . . . . 0.0 109.456 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.9 100.69 10.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.651 1.98 . . . . 0.0 105.686 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.12 98.95 6.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.1 131.77 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.01 1.724 . . . . 0.0 107.508 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.51 128.52 75.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.3 m -100.91 93.75 5.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.98 154.75 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.5 t -118.71 -49.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.4 m -151.22 141.01 21.86 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 120.249 1.386 . . . . 0.0 112.129 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.3 150.58 39.24 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.987 2.915 . . . . 0.0 109.413 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.8 148.9 44.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.626 1.97 . . . . 0.0 107.3 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -85.84 134.72 33.9 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.27 -78.8 0.54 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.244 0.807 0 CA-C-O 116.056 -1.926 . . . . 0.0 112.717 -173.797 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 118.509 -0.757 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.96 161.76 44.42 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.328 2.018 . . . . 0.0 113.047 -174.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.22 -42.55 98.71 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -54.42 -42.09 70.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.86 1.264 . . . . 0.0 111.092 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -51.36 -53.39 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.392 0.677 . . . . 0.0 111.691 173.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.18 -48.53 81.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.243 0.617 . . . . 0.0 110.992 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.75 -37.47 68.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.923 0.783 . . . . 0.0 111.833 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.12 -44.09 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.164 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.48 -42.51 82.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.674 1.125 . . . . 0.0 112.32 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -51.65 -18.57 1.22 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -117.44 158.94 23.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.636 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.09 147.21 42.98 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.18 167.22 40.36 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 127.529 2.49 . . . . 0.0 109.012 173.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -83.42 150.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.95 159.87 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.256 2.222 . . . . 0.0 105.487 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.48 157.05 45.16 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.065 0.946 . . . . 0.0 109.724 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.69 108.39 4.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.95 108.41 19.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -96.38 109.41 21.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -74.27 141.09 45.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 121.38 1.9 . . . . 0.0 106.818 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.53 -81.91 0.23 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -166.16 -57.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.67 53.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.441 2.696 . . . . 0.0 109.113 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 141.42 2.31 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.008 1.766 . . . . 0.0 112.038 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 158.89 55.21 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -120.69 101.82 7.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -84.83 88.61 7.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.8 m -82.79 175.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.842 2.057 . . . . 0.0 109.982 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -118.84 166.69 12.5 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.083 0.856 . . . . 0.0 112.103 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -168.3 175.8 6.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.241 2.217 . . . . 0.0 107.611 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.43 141.52 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.995 1.718 . . . . 0.0 110.647 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -53.97 -30.88 48.85 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.124 0.874 . . . . 0.0 109.204 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.74 -13.93 7.31 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.149 2.979 . . . . 0.0 111.875 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -118.88 -4.75 10.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.777 1.631 . . . . 0.0 111.8 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.41 165.8 12.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.32 1.418 . . . . 0.0 113.034 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HZ2' ' CD2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -136.0 138.56 42.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 172.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.7 t -101.69 150.7 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.448 ' CD2' ' HZ2' ' A' ' 37' ' ' LYS . 46.1 mt -122.12 178.98 4.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.811 2.844 . . . . 0.0 107.102 172.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 40.1 t0 -76.02 -179.05 4.69 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.41 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 60.55 31.3 74.27 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.243 -1.535 . . . . 0.0 110.732 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 p30 54.08 12.99 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 130.095 3.358 . . . . 0.0 115.056 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -73.58 143.22 46.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.877 0.762 . . . . 0.0 109.627 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -129.3 163.28 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -142.86 140.88 27.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.93 127.74 26.35 Favored Pre-proline 0 N--CA 1.445 -0.707 0 C-N-CA 127.44 2.296 . . . . 0.0 104.829 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.01 108.3 2.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 107.798 -1.654 . . . . 0.0 107.798 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.65 111.63 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.58 -21.69 6.03 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.32 0.962 . . . . 0.0 112.67 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.65 41.59 0.33 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 118.099 -1.39 . . . . 0.0 110.0 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.4 mtt -106.57 71.39 0.86 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 108.28 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -67.45 -65.78 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 129.99 3.316 . . . . 0.0 113.682 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -51.85 -40.89 61.31 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.863 1.21 . . . . 0.0 109.764 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -60.92 -39.08 88.03 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.787 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.5 -48.38 81.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.812 1.642 . . . . 0.0 110.86 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.82 99.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.407 0.283 . . . . 0.0 111.24 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -63.41 -41.64 98.74 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.444 -1.265 . . . . 0.0 110.446 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.86 -48.23 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 120.11 1.323 . . . . 0.0 108.963 174.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.83 -24.65 37.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.456 -0.777 . . . . 0.0 112.567 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.55 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -85.09 -42.5 14.75 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.581 1.696 . . . . 0.0 115.581 173.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -150.95 139.48 20.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.662 1.185 . . . . 0.0 109.115 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -75.17 -18.03 60.27 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 112.312 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 mmp_? -60.8 119.76 8.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 114.492 -173.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.4 m -139.23 146.23 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 123.112 1.434 . . . . 0.0 112.588 173.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tt -111.67 149.2 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.9 ttt -141.15 141.12 34.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -125.45 128.08 47.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.2 173.39 6.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.713 1.597 . . . . 0.0 107.923 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.01 -171.27 34.59 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.4 t -146.85 157.38 43.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.65 0.78 . . . . 0.0 109.351 174.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -98.54 -17.43 18.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.493 1.517 . . . . 0.0 108.847 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -91.98 -4.43 54.59 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 116.687 -1.625 . . . . 0.0 114.864 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.49 130.2 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 121.711 2.051 . . . . 0.0 105.775 -173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.04 131.41 36.26 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.092 0.957 . . . . 0.0 111.173 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.48 -141.07 6.36 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -81.92 -58.96 2.75 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.363 1.465 . . . . 0.0 108.323 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.87 102.96 11.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.468 0.651 . . . . 0.0 109.523 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.18 -169.11 2.89 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.198 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.04 58.85 7.13 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.204 1.936 . . . . 0.0 110.692 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.73 120.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -114.66 169.45 9.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.187 0.994 . . . . 0.0 110.433 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.73 45.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.78 0.705 . . . . 0.0 113.64 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -132.99 152.76 51.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.016 1.326 . . . . 0.0 109.353 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.03 130.9 47.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.328 -2.842 . . . . 0.0 103.328 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.04 154.46 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -131.24 135.04 47.02 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.21 -169.11 28.39 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 118.765 0.711 . . . . 0.0 112.356 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 m -121.02 146.43 46.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.028 2.131 . . . . 0.0 108.287 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.24 163.71 13.65 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.566 1.075 . . . . 0.0 112.94 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.95 120.98 3.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.235 1.014 . . . . 0.0 110.331 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -75.86 141.06 42.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -140.74 135.88 31.99 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.035 1.334 . . . . 0.0 111.0 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.2 p -120.81 36.67 4.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.72 154.94 27.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.847 2.859 . . . . 0.0 111.165 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.39 47.41 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.484 1.516 . . . . 0.0 113.556 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.73 -11.78 32.22 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.193 2.595 . . . . 0.0 112.242 175.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.04 -60.27 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -31.43 71.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.318 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.85 -49.77 55.55 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.683 1.129 . . . . 0.0 109.611 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.05 76.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.309 -0.869 . . . . 0.0 111.489 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.2 pp -82.5 -18.36 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 119.061 0.846 . . . . 0.0 112.159 174.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.16 -28.07 4.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.514 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.58 -30.03 19.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.164 1.386 . . . . 0.0 112.256 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -80.67 178.32 8.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.39 -0.54 1.4 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 118.172 -2.83 . . . . 0.0 112.631 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -96.09 8.2 44.38 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.73 23.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.24 1.016 . . . . 0.0 109.402 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.6 ttp85 -121.13 -14.08 8.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.443 1.897 . . . . 0.0 111.717 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.56 161.61 11.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.041 1.736 . . . . 0.0 110.176 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.78 104.69 16.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.74 91.34 7.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.18 131.16 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.792 1.637 . . . . 0.0 106.673 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -121.71 135.61 61.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.0 m -114.12 101.36 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.01 160.57 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.335 1.454 . . . . 0.0 110.088 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.4 t -121.51 -59.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -142.9 140.49 31.21 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.85 145.65 41.93 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.853 2.861 . . . . 0.0 108.168 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -139.21 130.18 26.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.243 1.817 . . . . 0.0 106.684 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -74.04 139.59 44.8 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -129.65 -58.31 1.1 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.926 0.89 . . . . 0.0 111.437 -173.378 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.2 mt . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.77 158.63 32.18 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.504 2.136 . . . . 0.0 113.54 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -49.31 79.86 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -53.64 -41.26 66.56 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.235 1.014 . . . . 0.0 111.283 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.26 -60.4 3.15 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.62 0.768 . . . . 0.0 109.482 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -52.28 -48.23 65.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.386 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.473 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 27.7 mm-40 -54.88 -38.36 67.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.743 1.156 . . . . 0.0 112.66 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.87 -45.5 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.802 1.183 . . . . 0.0 109.135 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.09 -42.28 80.41 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.664 1.12 . . . . 0.0 112.073 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HZ2' ' CD ' ' A' ' 8' ' ' GLU . 25.4 mtmm -51.65 -18.65 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -112.99 158.65 20.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.816 1.189 . . . . 0.0 109.874 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.12 148.83 41.44 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.975 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.41 170.8 40.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 123.22 0.438 . . . . 0.0 112.058 -174.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.72 149.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -132.15 163.51 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 127.556 2.342 . . . . 0.0 105.298 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.53 153.18 40.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.851 1.26 . . . . 0.0 109.15 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.38 109.79 5.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -89.45 109.22 20.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.134 1.773 . . . . 0.0 109.886 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -97.3 107.96 20.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 98.76 9.01 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.34 -59.89 0.18 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 120.824 1.647 . . . . 0.0 113.503 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -158.36 -60.79 0.08 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.008 1.404 . . . . 0.0 113.845 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -79.28 39.08 0.38 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.878 1.672 . . . . 0.0 111.777 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.94 151.47 12.36 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.76 148.06 93.9 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.751 2.275 . . . . 0.0 109.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.51 ' CD2' ' HZ2' ' A' ' 53' ' ' LYS . 40.4 t60 -121.43 101.67 7.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -90.48 88.7 7.26 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.5 m -77.34 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 110.638 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.81 168.48 11.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.445 1.02 . . . . 0.0 113.003 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t -168.42 172.61 8.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.813 2.445 . . . . 0.0 108.183 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -120.91 141.75 50.35 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.887 2.075 . . . . 0.0 109.989 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -52.09 -30.53 26.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.685 0.675 . . . . 0.0 110.478 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -50.24 -21.31 1.31 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.663 2.385 . . . . 0.0 113.565 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.4 -6.71 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.379 1.071 . . . . 0.0 111.572 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -91.46 171.3 9.29 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.448 -1.408 . . . . 0.0 111.781 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -134.08 119.93 19.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.55 131.44 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mp -121.43 178.14 4.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -76.97 -178.0 4.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.9 29.61 75.31 Favored Glycine 0 C--O 1.223 -0.591 0 O-C-N 120.473 -1.392 . . . . 0.0 109.663 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 54.0 12.87 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 130.631 3.572 . . . . 0.0 115.483 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -79.37 128.84 33.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.205 1.366 . . . . 0.0 110.137 -174.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -124.34 155.43 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 t -145.24 142.46 22.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.78 132.8 24.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 126.993 2.117 . . . . 0.0 106.873 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.89 108.57 2.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.537 2.158 . . . . 0.0 108.666 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.418 HG12 ' CE2' ' A' ' 91' ' ' PHE . 2.4 p -85.53 111.76 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.45 -20.85 5.7 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.378 1.942 . . . . 0.0 112.281 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.18 40.99 0.45 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.047 1.423 . . . . 0.0 109.958 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 mtt -113.8 53.47 0.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.042 1.337 . . . . 0.0 108.515 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.46 91.2 m-70 -71.88 -48.18 47.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HZ2' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -51.91 -38.28 55.71 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.76 1.618 . . . . 0.0 108.933 172.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.0 m -64.41 -38.8 92.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.404 1.481 . . . . 0.0 110.291 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.21 -47.68 74.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.799 1.636 . . . . 0.0 109.391 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.38 89.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.803 0.441 . . . . 0.0 110.803 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -57.07 -41.47 78.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.744 -1.122 . . . . 0.0 113.369 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.08 -48.28 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 120.249 1.386 . . . . 0.0 109.211 175.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.36 -26.16 39.42 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.041 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.21 -47.19 13.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 173.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -152.28 141.67 21.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.433 1.015 . . . . 0.0 108.773 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.358 -1.464 . . . . 0.0 113.718 -178.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 62' ' ' GLU . 8.2 mmp_? -51.94 115.6 1.76 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.667 1.987 . . . . 0.0 114.722 -172.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.54 143.43 32.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 123.669 1.7 . . . . 0.0 112.723 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 tt -111.35 148.48 32.9 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 101.364 -3.569 . . . . 0.0 101.364 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.36 129.09 20.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 p -111.29 128.25 55.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 pp -117.01 166.88 11.67 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.548 -1.345 . . . . 0.0 108.578 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.9 -174.83 37.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.2 t -146.57 157.56 43.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.634 1.174 . . . . 0.0 107.898 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -98.86 -8.45 25.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.591 1.156 . . . . 0.0 110.05 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.46 -7.13 51.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 116.942 -1.504 . . . . 0.0 113.962 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.23 136.03 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 121.083 1.765 . . . . 0.0 106.243 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.24 131.37 36.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.884 0.874 . . . . 0.0 111.086 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.44 -140.88 6.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.219 1.39 . . . . 0.0 110.516 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -84.48 -59.05 2.49 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 102.98 9.58 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.98 -168.79 1.96 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.584 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.3 65.9 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.35 2.033 . . . . 0.0 110.37 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.97 121.1 1.05 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.54 169.53 9.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.371 1.086 . . . . 0.0 109.846 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.64 -177.76 45.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 121.418 0.454 . . . . 0.0 113.381 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.58 147.01 52.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.416 1.086 . . . . 0.0 110.39 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.401 ' HB2' ' HG1' ' A' ' 121' ' ' THR . 3.3 tm? -100.88 129.66 46.78 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 mt -141.2 157.05 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -132.75 149.12 52.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.172 1.789 . . . . 0.0 109.753 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -174.14 37.95 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.505 1.526 . . . . 0.0 110.548 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -114.14 143.15 45.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.118 1.767 . . . . 0.0 106.828 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.81 163.36 13.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.188 1.395 . . . . 0.0 111.962 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 121.11 3.33 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.882 0.873 . . . . 0.0 109.764 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.418 ' CE2' HG12 ' A' ' 48' ' ' VAL . 3.8 m-85 -74.03 138.13 43.87 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 141.48 35.0 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.121 0.968 . . . . 0.0 109.863 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -116.07 35.17 4.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.33 154.66 25.49 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 128.112 2.565 . . . . 0.0 110.742 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 178.67 46.76 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.642 2.067 . . . . 0.0 113.893 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.13 -17.92 55.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.028 3.152 . . . . 0.0 112.538 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -65.61 0.65 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.243 1.817 . . . . 0.0 107.617 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.18 -31.2 70.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.192 0.997 . . . . 0.0 111.391 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.6 -57.76 5.27 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.757 0.708 . . . . 0.0 109.138 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.65 -25.42 67.37 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.916 -1.115 . . . . 0.0 113.058 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.346 1.3 pp -87.43 -18.11 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.733 1.151 . . . . 0.0 111.919 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.48 -27.93 3.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.408 1.483 . . . . 0.0 111.685 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -49.05 -21.47 0.71 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.641 1.176 . . . . 0.0 113.949 173.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.54 178.75 8.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.669 1.122 . . . . 0.0 110.611 175.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -130.29 11.61 5.44 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.099 -1.625 . . . . 0.0 111.234 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -132.26 9.0 4.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.226 1.41 . . . . 0.0 111.202 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.94 145.21 34.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.619 -0.676 . . . . 0.0 109.874 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -21.05 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 127.951 2.5 . . . . 0.0 110.621 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.12 161.96 10.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.391 1.876 . . . . 0.0 109.137 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.59 107.9 18.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tp -78.89 93.92 5.12 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.2 t -78.98 130.88 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.37 129.49 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -112.14 99.03 7.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 t -60.99 161.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.069 2.147 . . . . 0.0 110.15 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.98 -51.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -150.93 141.04 22.15 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.154 -0.966 . . . . 0.0 111.246 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.91 146.34 43.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.693 3.197 . . . . 0.0 108.765 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -138.82 142.65 38.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.521 1.928 . . . . 0.0 107.599 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -81.16 133.51 35.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.401 ' HG1' ' HB2' ' A' ' 84' ' ' LEU . 39.9 p -135.21 -68.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -173.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.24 0.561 0 CA-C-O 117.358 -1.306 . . . . 0.0 110.221 178.092 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.407 ' H ' ' CD1' ' A' ' 2' ' ' LEU . 5.2 mp . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 118.677 -0.678 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.88 158.7 56.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.735 2.29 . . . . 0.0 111.442 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.99 -40.86 95.99 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -53.16 -38.96 63.22 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.6 1.56 . . . . 0.0 111.263 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -50.99 -56.26 13.33 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.653 1.115 . . . . 0.0 111.088 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -61.77 -48.96 78.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -61.01 -33.58 73.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.51 -41.85 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.392 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.12 -38.63 83.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.236 1.38 . . . . 0.0 111.811 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.74 -19.11 1.47 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.298 1.408 . . . . 0.0 114.345 172.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -106.4 158.93 16.53 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 119.717 1.144 . . . . 0.0 107.966 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.86 148.63 42.16 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 121.328 -0.858 . . . . 0.0 109.346 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.23 177.13 47.84 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 124.8 1.191 . . . . 0.0 112.534 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.9 t -100.75 145.82 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -129.82 163.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 106.059 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.44 159.9 42.79 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.305 1.442 . . . . 0.0 110.001 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 88.3 mt -140.34 117.32 9.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -89.08 108.35 19.54 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 173.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -94.03 110.57 22.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 115.546 -2.169 . . . . 0.0 106.806 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -73.8 141.71 46.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.271 2.305 . . . . 0.0 107.721 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.7 -81.35 0.23 Allowed Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.45 -61.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 13.3 p-10 -79.73 44.49 0.64 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.24 2.216 . . . . 0.0 109.968 174.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 151.49 5.95 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.263 1.887 . . . . 0.0 113.719 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.19 153.93 56.85 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 121.357 1.371 . . . . 0.0 111.414 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -121.37 101.97 7.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.542 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -86.13 88.73 7.65 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.04 169.14 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.082 1.753 . . . . 0.0 110.625 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -121.54 167.62 12.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.528 1.131 . . . . 0.0 112.29 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 170.32 9.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.983 2.113 . . . . 0.0 108.364 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -116.48 141.67 47.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.745 1.618 . . . . 0.0 111.265 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -56.18 -31.77 63.72 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.997 0.919 . . . . 0.0 110.834 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -60.57 -8.39 2.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.387 1.475 . . . . 0.0 113.613 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -117.92 -7.24 10.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.095 1.316 . . . . 0.0 109.099 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mt -98.24 162.19 13.32 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.151 -1.593 . . . . 0.0 112.29 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.52 41.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.409 -1.432 . . . . 0.0 108.916 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.9 t -101.8 144.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.91 179.06 4.48 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.324 1.85 . . . . 0.0 107.126 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 40.5 t0 -70.53 177.27 3.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.254 0.549 . . . . 0.0 110.429 174.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 57.47 28.45 59.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -173.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 p30 53.64 13.72 0.53 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 128.559 2.743 . . . . 0.0 114.848 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -73.21 109.33 6.65 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.487 1.04 . . . . 0.0 110.328 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.07 161.15 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.97 134.83 21.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.04 135.39 24.81 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 127.127 2.171 . . . . 0.0 107.277 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.94 108.88 2.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.53 2.153 . . . . 0.0 110.458 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.4 111.91 21.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.13 -21.34 7.42 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.979 1.752 . . . . 0.0 112.676 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.41 41.31 0.28 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.188 1.494 . . . . 0.0 109.945 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.3 mtt -109.32 66.98 0.64 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.156 0.982 . . . . 0.0 109.77 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.322 41.3 m-70 -71.47 -48.64 47.91 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 57.3 tttm -51.7 -40.95 61.06 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.799 2.09 . . . . 0.0 109.418 173.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.1 m -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 127.002 2.121 . . . . 0.0 110.495 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.28 -50.82 70.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 121.027 1.74 . . . . 0.0 110.611 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.33 94.13 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.237 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -66.3 -42.02 88.94 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.679 -1.629 . . . . 0.0 109.845 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.93 -48.19 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 120.177 1.353 . . . . 0.0 109.032 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.97 57.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.487 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -87.06 -46.02 10.19 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.926 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -145.15 132.31 20.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.275 1.036 . . . . 0.0 112.169 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.1 -21.59 56.51 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.46 122.13 14.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.499 1.045 . . . . 0.0 111.353 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.85 155.94 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 123.379 1.561 . . . . 0.0 111.503 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tt -111.13 149.95 30.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.8 ttt -138.95 140.87 38.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 p -123.72 128.6 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.93 167.78 10.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.218 1.827 . . . . 0.0 107.172 172.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.13 -175.0 38.12 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.5 t -148.14 157.38 43.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -99.28 -8.72 24.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.312 0.505 . . . . 0.0 109.923 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -90.71 3.11 55.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.087 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.0 t -130.92 133.61 62.79 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.05 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 173.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 130.32 35.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.879 0.763 . . . . 0.0 110.217 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.62 5.95 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.975 1.75 . . . . 0.0 109.318 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -88.51 -58.3 2.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.15 102.68 5.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.184 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.95 -168.26 0.16 Allowed Glycine 0 CA--C 1.539 1.573 0 O-C-N 120.794 -1.191 . . . . 0.0 111.087 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.53 91.07 0.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 N-CA-C 106.501 -2.153 . . . . 0.0 106.501 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.4 0.71 Allowed Glycine 0 N--CA 1.442 -0.947 0 CA-C-O 117.723 -1.598 . . . . 0.0 109.827 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -109.31 168.97 9.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.341 1.071 . . . . 0.0 109.715 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.4 -176.97 44.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 121.062 0.257 . . . . 0.0 112.896 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -131.42 151.94 51.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.422 1.089 . . . . 0.0 109.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.86 131.25 46.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.0 mt -139.08 156.57 27.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -132.2 150.23 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.997 1.319 . . . . 0.0 108.088 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.61 -172.13 40.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -106.28 131.93 52.93 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.26 1.024 . . . . 0.0 108.432 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.0 163.51 15.5 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.67 120.88 3.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.873 0.869 . . . . 0.0 110.045 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -74.26 130.61 40.04 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 173.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -132.16 130.7 41.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.5 p -120.85 33.47 5.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.17 1.388 . . . . 0.0 107.677 173.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -158.82 161.96 36.96 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 128.635 2.774 . . . . 0.0 109.276 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.4 -179.95 46.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 125.19 1.376 . . . . 0.0 115.104 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.94 -19.15 64.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.536 2.157 . . . . 0.0 110.773 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.86 -63.02 1.18 Allowed 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.817 0.847 . . . . 0.0 109.338 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -61.39 -31.17 71.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.346 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.26 -48.78 64.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.721 1.146 . . . . 0.0 110.481 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -30.69 69.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.782 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.29 -19.31 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.74 85.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.809 1.64 . . . . 0.0 112.188 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.551 0.0 OUTLIER -51.54 -18.36 1.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 173.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.34 179.54 0.97 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.87 1.214 . . . . 0.0 108.242 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -128.55 12.39 6.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 119.601 -1.937 . . . . 0.0 112.14 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -135.91 10.47 3.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.882 1.273 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.92 145.33 34.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 0.0 110.985 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.23 -21.38 6.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.002 2.521 . . . . 0.0 111.902 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -176.4 161.85 2.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.611 1.964 . . . . 0.0 109.431 -176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.61 110.66 23.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 tt -85.98 95.11 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.306 -2.849 . . . . 0.0 103.306 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.55 131.01 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.174 1.39 . . . . 0.0 107.806 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.6 mm -114.14 137.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.4 m -113.96 93.22 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.45 160.32 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.29 1.436 . . . . 0.0 111.072 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.97 -57.26 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -140.9 127.22 19.79 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.131 0.423 . . . . 0.0 111.944 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.08 139.34 51.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.75 3.22 . . . . 0.0 110.637 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -142.24 139.55 32.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.482 1.513 . . . . 0.0 110.668 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -72.87 135.26 45.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -174.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -143.21 -58.6 0.42 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.253 1.261 0 CA-C-O 115.753 -2.07 . . . . 0.0 113.929 -173.481 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.15 162.25 42.25 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.539 2.159 . . . . 0.0 110.683 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.21 -38.85 93.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -50.73 -40.43 54.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.125 1.77 . . . . 0.0 112.016 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.3 -56.41 13.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.8 1.182 . . . . 0.0 109.989 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -59.14 -48.45 81.55 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 110.201 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.83 -40.28 75.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.764 0.711 . . . . 0.0 112.624 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.9 -40.78 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.861 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -45.68 85.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.377 1.444 . . . . 0.0 111.501 173.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -51.91 -20.62 2.4 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -105.95 161.66 14.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.407 1.083 . . . . 0.0 110.156 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.55 139.57 45.72 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.45 174.46 47.0 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.8 143.2 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -174.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.3 164.76 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.83 158.95 43.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.759 1.224 . . . . 0.0 109.162 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.5 mt -142.63 119.94 6.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 124.768 1.227 . . . . 0.0 107.947 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -94.05 108.42 20.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 m -89.95 121.3 31.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 116.194 -1.86 . . . . 0.0 106.386 -173.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -73.47 137.23 44.38 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 122.062 2.21 . . . . 0.0 108.689 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.08 -81.21 0.22 Allowed Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -158.84 -61.51 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -79.35 39.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.203 3.001 . . . . 0.0 111.511 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 151.13 13.36 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.64 150.02 56.13 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 CA-C-N 118.177 0.989 . . . . 0.0 111.208 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -99.51 101.59 12.88 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 6.5 tt -84.86 88.97 7.45 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -173.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.99 168.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.37 1.468 . . . . 0.0 110.254 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.34 167.7 12.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.411 1.084 . . . . 0.0 112.216 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.44 172.11 8.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.86 2.064 . . . . 0.0 108.195 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -120.86 141.65 50.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.894 1.678 . . . . 0.0 110.385 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -51.11 -31.26 18.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.095 0.958 . . . . 0.0 111.905 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -57.74 -14.51 5.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.205 1.802 . . . . 0.0 112.733 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.21 -3.55 11.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.711 1.204 . . . . 0.0 110.214 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.21 163.52 13.24 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.51 -1.369 . . . . 0.0 112.759 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 140.72 43.0 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 172.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -101.55 151.78 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 109.58 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.55 178.33 4.86 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.553 1.941 . . . . 0.0 109.436 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 20.9 t0 -76.21 177.1 7.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.31 1.444 . . . . 0.0 107.903 173.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 57.25 29.34 59.92 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 120.598 -1.313 . . . . 0.0 110.721 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.321 0.0 OUTLIER 53.44 15.35 0.69 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 130.233 3.413 . . . . 0.0 115.091 -175.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -73.86 145.57 44.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -127.98 168.66 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.7 t -146.38 142.74 21.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.013 -1.055 . . . . 0.0 108.883 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -126.34 135.49 27.25 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.842 2.057 . . . . 0.0 107.769 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.82 108.53 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.743 2.296 . . . . 0.0 109.448 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.61 111.39 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.24 -21.36 6.63 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.759 1.647 . . . . 0.0 112.241 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.23 41.4 0.31 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 117.746 -1.586 . . . . 0.0 109.552 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.2 mtt -109.74 57.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.014 1.326 . . . . 0.0 107.909 173.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -71.58 -48.82 45.79 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.056 1.342 . . . . 0.0 113.42 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.98 -41.4 62.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.721 1.6 . . . . 0.0 108.87 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.9 m -59.98 -40.47 89.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.76 1.624 . . . . 0.0 110.369 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.92 -49.02 78.17 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.152 1.796 . . . . 0.0 110.988 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.66 98.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.819 0.343 . . . . 0.0 111.311 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -63.19 -41.59 99.2 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.009 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -61.55 -48.24 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.452 1.478 . . . . 0.0 109.286 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.28 59.28 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.634 -0.667 . . . . 0.0 112.423 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.7 mmm-85 -78.46 -46.46 19.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -151.26 129.53 11.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.781 1.233 . . . . 0.0 109.764 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.25 -23.23 62.87 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.492 -0.755 . . . . 0.0 112.487 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -61.28 124.09 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.947 0.899 . . . . 0.0 112.027 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.88 155.37 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 123.76 1.743 . . . . 0.0 110.253 173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tt -107.49 150.36 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.4 ttt -139.29 141.93 37.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.6 p -125.2 128.52 48.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 116.159 -1.877 . . . . 0.0 106.046 173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 160.22 20.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 122.087 2.222 . . . . 0.0 106.345 173.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.13 -172.22 45.15 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -150.07 168.37 24.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.419 ' CZ ' ' HA3' ' A' ' 80' ' ' GLY . 21.4 mmm180 -98.92 -8.8 25.01 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 109.844 173.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -79.33 -6.19 56.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.448 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.43 140.3 49.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.0 121.06 24.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.37 -130.11 3.88 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 125.158 1.361 . . . . 0.0 110.107 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.34 -63.64 1.23 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.302 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -84.03 102.63 12.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.863 -174.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.96 -168.45 0.93 Allowed Glycine 0 CA--C 1.542 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 112.194 -174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.03 91.43 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 108.997 173.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 71' ' ' ARG . . . 178.81 122.02 0.74 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 117.336 -1.813 . . . . 0.0 110.445 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 t -123.72 171.68 9.42 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.815 1.307 . . . . 0.0 110.026 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.23 -157.58 28.35 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.783 1.183 . . . . 0.0 112.579 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -148.42 154.87 40.49 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.931 1.293 . . . . 0.0 109.811 -174.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.41 131.21 47.62 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 128.916 2.886 . . . . 0.0 104.56 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 mp -138.63 163.6 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.802 1.241 . . . . 0.0 108.579 -173.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -134.37 151.09 51.0 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.204 1.402 . . . . 0.0 109.123 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -175.6 40.07 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.175 0.893 . . . . 0.0 111.715 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 m -113.93 128.8 56.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.41 1.084 . . . . 0.0 109.888 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.66 17.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.319 1.447 . . . . 0.0 111.465 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.04 120.44 2.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.02 1.328 . . . . 0.0 109.481 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -77.13 142.69 39.61 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.568 -0.707 . . . . 0.0 109.634 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 140.92 34.24 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.354 1.061 . . . . 0.0 109.714 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 p -121.25 35.94 4.75 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.457 1.903 . . . . 0.0 106.221 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -159.35 157.54 30.58 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.502 2.321 . . . . 0.0 110.091 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.71 178.25 46.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.951 2.691 . . . . 0.0 113.089 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 -8.95 22.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.187 2.591 . . . . 0.0 112.634 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.98 -56.34 12.16 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -61.4 -31.89 71.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.781 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.59 -48.61 38.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.539 0.685 . . . . 0.0 110.043 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.9 -27.45 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.061 -1.024 . . . . 0.0 111.712 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.323 1.7 pp -93.26 -18.39 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.963 173.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.33 -28.4 4.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.585 1.954 . . . . 0.0 112.656 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -50.99 -22.88 2.52 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.768 1.227 . . . . 0.0 113.293 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -80.71 178.64 8.23 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.619 1.099 . . . . 0.0 110.312 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -128.51 3.83 5.6 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.149 -1.595 . . . . 0.0 111.23 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -135.68 8.28 3.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 111.54 -174.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.55 142.4 34.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.034 0.834 . . . . 0.0 109.112 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.61 -10.76 8.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.044 1.337 . . . . 0.0 111.829 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.49 161.91 9.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.187 2.595 . . . . 0.0 108.332 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.76 107.07 16.94 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.114 2.166 . . . . 0.0 106.588 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.1 tp -82.12 98.56 8.74 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.426 1.891 . . . . 0.0 107.594 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -83.96 127.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.699 1.6 . . . . 0.0 107.373 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.74 129.06 72.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 119.367 0.985 . . . . 0.0 108.488 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 m -99.11 87.91 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.66 153.57 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.991 0.916 . . . . 0.0 109.967 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.7 -59.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -149.58 141.22 23.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.528 0.604 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.58 159.52 25.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 127.953 2.501 . . . . 0.0 112.448 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -140.87 145.25 35.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.259 2.224 . . . . 0.0 108.458 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -76.19 134.78 39.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.4 p -133.69 -58.79 0.87 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.47 0.577 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.712 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.52 163.61 38.43 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.903 2.402 . . . . 0.0 112.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.4 97.59 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 173.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.305 2.9 m -51.82 -38.11 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.966 2.107 . . . . 0.0 112.822 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -50.85 -49.11 59.67 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.519 1.054 . . . . 0.0 110.202 173.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -63.27 -48.19 79.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.775 1.23 . . . . 0.0 111.352 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.47 -41.48 63.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.562 0.619 . . . . 0.0 111.067 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.43 -45.55 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.119 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.5 mt -52.5 -28.37 20.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.576 1.08 . . . . 0.0 112.754 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -51.72 -18.51 1.24 Allowed 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.904 -1.747 . . . . 0.0 112.646 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -114.84 160.38 19.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.38 1.872 . . . . 0.0 109.719 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -74.36 156.54 36.96 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 166.3 35.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.476 -0.868 . . . . 0.0 113.64 -173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -81.97 141.36 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.7 t -133.92 160.55 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.94 155.9 40.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.714 1.205 . . . . 0.0 108.467 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.95 119.97 15.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.87 108.73 19.69 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -90.76 113.24 25.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -73.72 141.55 46.36 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.045 2.202 . . . . 0.0 108.037 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 -81.21 0.32 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -162.54 -48.97 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.671 0.788 . . . . 0.0 108.938 173.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.68 39.24 0.34 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.389 2.276 . . . . 0.0 110.657 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.27 151.16 6.03 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.911 1.719 . . . . 0.0 111.303 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.31 161.02 45.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.017 1.145 . . . . 0.0 111.411 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -112.77 101.75 9.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.242 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 tp -74.04 88.69 1.91 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -74.13 168.73 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.408 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.1 165.1 14.57 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.616 1.166 . . . . 0.0 111.669 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t -168.69 175.7 5.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.952 2.101 . . . . 0.0 108.068 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.41 142.0 49.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.492 2.317 . . . . 0.0 109.852 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -51.94 -30.3 24.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.301 -0.856 . . . . 0.0 110.402 174.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -50.47 -20.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.052 2.941 . . . . 0.0 113.295 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.5 m-30 -118.12 -12.75 9.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.775 -1.203 . . . . 0.0 110.539 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.14 158.35 15.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 120.583 -1.323 . . . . 0.0 112.872 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.9 140.96 42.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 120.892 -1.13 . . . . 0.0 109.501 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -100.86 144.09 13.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.519 -2.401 . . . . 0.0 104.519 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.4 mt -121.19 -179.09 3.94 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.84 2.056 . . . . 0.0 107.806 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.52 169.83 4.5 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.246 0.618 . . . . 0.0 111.382 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.89 28.41 52.86 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.911 1.719 . . . . 0.0 111.354 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.318 0.2 OUTLIER 53.37 27.54 6.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.06 1.744 . . . . 0.0 113.11 -175.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -73.41 150.97 41.34 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.76 158.01 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -141.35 135.8 31.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.08 130.73 24.68 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 128.743 2.817 . . . . 0.0 106.526 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.6 108.74 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.569 2.179 . . . . 0.0 110.023 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.56 111.84 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.5 -21.6 5.06 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.519 1.056 . . . . 0.0 112.422 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.02 41.26 0.34 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 119.285 1.543 . . . . 0.0 109.266 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.4 mtt -109.78 70.62 0.73 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.582 1.153 . . . . 0.0 108.125 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -71.44 -55.96 6.89 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.985 2.114 . . . . 0.0 114.876 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -51.92 -41.35 61.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 121.341 1.882 . . . . 0.0 108.469 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -63.17 -38.77 92.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.248 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 21.9 tt0 -56.79 -50.64 71.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.076 1.307 . . . . 0.0 110.134 174.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.44 98.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.899 0.48 . . . . 0.0 111.547 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -64.01 -41.61 97.4 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.689 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.22 -48.05 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 120.051 1.296 . . . . 0.0 108.27 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.02 -22.12 25.39 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -86.92 -44.38 11.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -150.95 140.81 21.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.31 1.444 . . . . 0.0 109.13 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -75.74 -18.05 59.7 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.028 -1.045 . . . . 0.0 112.221 175.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 62' ' ' GLU . 6.9 mmp_? -59.32 117.47 4.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.353 1.061 . . . . 0.0 113.564 -173.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -138.93 153.39 24.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 124.055 1.883 . . . . 0.0 112.549 173.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.6 tp -111.01 151.16 28.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 173.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 ttt -139.24 134.29 32.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.5 p -126.58 127.87 45.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -117.11 164.21 15.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.651 1.114 . . . . 0.0 108.966 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.08 178.26 42.99 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -150.7 -178.41 6.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -113.24 -9.34 13.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.116 0.966 . . . . 0.0 110.504 173.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -86.1 -4.49 59.18 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.96 138.71 52.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.6 35.61 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.594 0.634 . . . . 0.0 109.827 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.51 -132.24 4.12 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 124.573 1.082 . . . . 0.0 111.953 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -91.43 -58.84 2.31 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.56 102.57 7.99 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.83 -167.98 0.16 Allowed Glycine 0 CA--C 1.542 1.719 0 O-C-N 120.53 -1.356 . . . . 0.0 111.798 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.55 90.65 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.619 -2.108 . . . . 0.0 106.619 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.58 121.64 0.71 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.78 169.89 9.23 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 119.396 1.598 . . . . 0.0 109.544 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.29 179.48 43.85 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 123.798 0.713 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -132.53 149.32 52.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.265 1.026 . . . . 0.0 109.75 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -97.24 130.11 44.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.46 152.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -130.48 140.81 50.51 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.205 1.402 . . . . 0.0 107.247 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.3 -176.48 42.72 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.141 0.882 . . . . 0.0 112.799 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 m -103.98 143.67 32.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.91 164.4 12.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 120.058 1.299 . . . . 0.0 111.214 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.15 121.25 2.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.15 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.4 m-85 -73.84 143.27 45.97 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 141.76 38.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.993 1.317 . . . . 0.0 111.51 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 p -114.76 25.87 10.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.826 2.05 . . . . 0.0 106.863 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.59 165.08 35.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.705 2.402 . . . . 0.0 109.725 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.15 178.61 45.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 127.165 2.316 . . . . 0.0 113.173 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.55 -24.11 77.56 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.672 2.248 . . . . 0.0 111.154 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -62.3 -56.54 17.43 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.531 1.132 . . . . 0.0 109.017 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -61.34 -31.37 71.24 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.72 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -68.02 -48.17 66.44 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 121.608 2.004 . . . . 0.0 110.622 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.78 41.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.419 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.2 pp -93.67 -20.7 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.15 92.94 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 121.351 1.887 . . . . 0.0 112.453 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.505 0.0 OUTLIER -51.96 -21.92 3.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.1 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -73.05 178.97 4.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -133.92 7.88 3.77 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 118.393 -2.692 . . . . 0.0 114.388 -176.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -121.53 8.57 10.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.742 0.701 . . . . 0.0 111.796 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.42 150.78 24.47 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -115.52 -19.17 10.74 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.686 1.994 . . . . 0.0 110.397 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.2 161.49 12.35 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.581 1.182 . . . . 0.0 109.383 -173.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.52 106.9 18.96 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -83.39 95.09 8.12 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.9 t -81.95 131.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.389 1.876 . . . . 0.0 106.567 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.32 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.2 m -104.12 91.98 4.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.84 157.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.305 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.04 -53.26 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.3 m -151.34 141.58 22.31 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.505 1.048 . . . . 0.0 113.235 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.01 144.7 39.71 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 128.451 2.7 . . . . 0.0 108.836 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -139.05 136.46 35.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.945 2.098 . . . . 0.0 106.944 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.92 139.16 38.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 p -141.21 -59.1 0.49 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.252 1.186 0 CA-C-O 115.444 -2.217 . . . . 0.0 114.019 -173.334 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -137.59 153.39 74.21 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.665 1.186 . . . . 0.0 109.238 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.87 159.9 47.22 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.545 2.163 . . . . 0.0 109.788 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.21 94.04 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -51.4 -39.01 56.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.941 1.696 . . . . 0.0 111.438 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.28 -57.84 7.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.593 1.088 . . . . 0.0 110.388 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -54.78 -48.43 72.7 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.522 1.129 . . . . 0.0 109.902 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.82 -35.96 73.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.5 t -69.4 -44.07 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.618 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -41.67 77.12 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.068 1.304 . . . . 0.0 112.433 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -51.77 -24.67 6.25 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.86 168.48 9.4 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 122.42 1.105 . . . . 0.0 111.669 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.5 138.69 45.23 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.83 172.36 44.61 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.04 150.93 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.1 t -128.97 163.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 127.585 2.354 . . . . 0.0 104.926 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.19 156.09 46.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.543 1.137 . . . . 0.0 108.315 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -138.54 110.88 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.87 108.51 19.57 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -93.89 108.79 20.54 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -74.4 137.24 42.56 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 121.034 1.743 . . . . 0.0 106.441 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.72 -81.94 0.22 Allowed Glycine 0 C--O 1.222 -0.607 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -164.16 -61.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.98 55.95 3.76 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.128 1.918 . . . . 0.0 109.49 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.59 140.69 4.92 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 127.238 2.351 . . . . 0.0 112.144 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.9 151.66 77.91 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 118.248 1.024 . . . . 0.0 109.619 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -121.12 101.82 7.91 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -87.43 88.55 7.71 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.33 173.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.006 2.123 . . . . 0.0 110.521 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -119.21 167.69 11.59 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.778 1.172 . . . . 0.0 113.128 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.7 t -168.34 173.16 7.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.1 2.16 . . . . 0.0 108.758 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -120.77 141.59 50.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.448 2.299 . . . . 0.0 109.984 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.56 -31.23 63.99 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.224 0.92 . . . . 0.0 111.013 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -60.09 -9.08 2.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.7 1.6 . . . . 0.0 113.612 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -118.1 -10.74 10.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.031 1.332 . . . . 0.0 109.361 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.7 mt -92.33 164.62 13.44 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.745 -1.222 . . . . 0.0 111.232 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.78 141.27 42.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.3 t -101.68 150.05 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.3 mt -122.14 178.86 4.74 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.37 2.668 . . . . 0.0 107.64 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -73.1 174.83 7.37 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.98 28.29 32.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.591 1.567 . . . . 0.0 110.942 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.301 0.1 OUTLIER 53.49 21.99 2.72 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.0 2.12 . . . . 0.0 114.69 -176.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -73.36 139.61 46.09 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -123.69 167.49 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 t -147.62 145.97 18.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 O-C-N 120.484 -1.385 . . . . 0.0 108.582 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.4 131.79 24.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.289 2.636 . . . . 0.0 105.959 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.91 108.75 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.485 2.123 . . . . 0.0 108.84 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.42 111.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.4 -21.08 5.63 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.852 1.691 . . . . 0.0 112.966 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.07 41.55 0.29 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.7 mtt -107.88 71.41 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.553 1.541 . . . . 0.0 107.862 174.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -66.29 -64.91 0.75 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 130.348 3.459 . . . . 0.0 113.732 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -51.69 -41.11 61.21 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.982 -1.074 . . . . 0.0 109.15 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -61.5 -38.94 89.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.69 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.78 -50.18 74.91 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 121.126 1.785 . . . . 0.0 110.532 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.31 -39.31 90.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 111.498 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -68.08 -41.96 81.09 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 116.279 -1.82 . . . . 0.0 110.471 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.15 -48.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.101 1.319 . . . . 0.0 108.966 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.19 51.06 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.295 -0.86 . . . . 0.0 112.694 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.86 -45.93 10.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.36 0.982 . . . . 0.0 113.081 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -141.59 133.14 26.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.931 0.893 . . . . 0.0 110.777 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -16.15 62.21 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.948 -1.095 . . . . 0.0 112.902 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -59.76 117.12 4.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.9 147.1 25.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 123.679 1.704 . . . . 0.0 112.444 173.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.25 148.9 31.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 11.7 ttt -139.38 126.62 21.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.3 p -108.74 127.96 54.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.79 164.92 13.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.994 1.725 . . . . 0.0 108.696 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.1 -175.77 38.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.9 t -146.99 161.92 39.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.024 1.329 . . . . 0.0 108.841 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -98.73 -8.1 26.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.854 1.662 . . . . 0.0 109.922 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -8.51 48.73 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.839 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.88 133.95 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.13 131.38 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.5 1.12 . . . . 0.0 111.419 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -140.92 6.14 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.89 -59.43 2.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.746 2.019 . . . . 0.0 108.324 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.27 102.94 8.87 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.2 -168.63 1.58 Allowed Glycine 0 CA--C 1.537 1.463 0 O-C-N 121.997 -0.439 . . . . 0.0 112.289 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -75.65 64.18 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.574 2.182 . . . . 0.0 109.954 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.11 121.13 1.1 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -118.16 169.61 9.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.008 0.904 . . . . 0.0 110.155 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.61 -171.84 43.56 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 124.271 0.939 . . . . 0.0 112.406 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -145.35 156.04 43.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 109.791 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 tt -101.38 131.36 47.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.33 162.07 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -133.32 150.75 51.85 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.399 1.479 . . . . 0.0 108.923 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.97 179.6 43.52 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.216 0.912 . . . . 0.0 111.745 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -101.21 128.98 47.08 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.02 161.78 14.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.609 1.095 . . . . 0.0 111.692 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 121.28 3.11 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.41 1.484 . . . . 0.0 109.351 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.91 137.54 43.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.538 HH11 ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -138.34 141.22 39.73 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.532 1.533 . . . . 0.0 109.334 176.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.26 37.39 4.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -159.2 159.12 33.91 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 129.072 2.949 . . . . 0.0 110.613 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.44 178.56 46.84 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 126.432 1.967 . . . . 0.0 115.694 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.57 -18.26 53.47 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.891 3.06 . . . . 0.0 111.724 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.83 -64.09 0.94 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.16 -31.27 71.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.633 0.773 . . . . 0.0 111.556 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -68.58 -60.3 2.51 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.75 -19.34 62.35 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.847 -1.158 . . . . 0.0 113.517 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.8 pp -92.6 -18.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.112 1.324 . . . . 0.0 110.854 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.58 -27.97 3.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.782 1.633 . . . . 0.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -50.67 -23.22 2.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.441 1.096 . . . . 0.0 113.567 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -80.3 178.73 8.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.733 1.151 . . . . 0.0 109.604 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 tttt -137.27 20.35 2.96 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.91 -1.744 . . . . 0.0 111.331 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -136.15 8.67 3.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.902 1.281 . . . . 0.0 111.137 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.93 131.1 35.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.529 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -20.9 16.53 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 109.669 173.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.85 161.76 11.08 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.377 1.871 . . . . 0.0 109.769 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 103.5 13.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.18 95.38 5.6 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.12 131.66 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.951 1.7 . . . . 0.0 106.961 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.2 mt -117.93 128.47 75.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -99.01 85.9 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.4 t -60.78 151.7 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.494 1.118 . . . . 0.0 109.461 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.5 -54.99 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m -148.34 141.22 24.74 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.258 . . -120.59 158.15 27.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 130.698 3.599 . . . . 0.0 114.732 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -145.93 135.77 23.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.218 2.207 . . . . 0.0 107.221 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.84 138.57 42.6 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -134.83 -81.04 0.44 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.518 0.327 . . . . 0.0 110.48 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 121.38 0.609 . . . . 0.0 109.938 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mmt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.2 mt -139.09 155.39 72.71 Favored Pre-proline 0 N--CA 1.465 0.275 0 C-N-CA 124.109 0.963 . . . . 0.0 109.411 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 157.16 57.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.502 2.134 . . . . 0.0 110.956 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -38.84 93.63 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -49.16 -38.94 27.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.606 1.562 . . . . 0.0 112.121 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -51.5 -52.82 43.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.426 1.466 . . . . 0.0 111.245 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -56.11 -48.35 76.36 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.585 1.154 . . . . 0.0 108.996 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.98 -34.03 69.53 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.12 -45.35 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.349 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.08 -43.17 70.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.315 1.416 . . . . 0.0 112.839 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -51.84 -19.36 1.67 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -112.16 161.94 15.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.938 1.351 . . . . 0.0 111.472 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -73.6 131.59 41.86 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.774 1.23 . . . . 0.0 109.356 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.31 165.13 35.37 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 124.978 1.275 . . . . 0.0 111.251 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.78 150.6 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.4 t -135.15 161.44 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.59 43.01 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.032 0.933 . . . . 0.0 108.808 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.7 mt -138.71 118.83 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.9 108.38 19.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 m -89.43 116.66 27.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -73.26 141.18 47.23 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 120.916 1.689 . . . . 0.0 106.554 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.13 -81.28 0.25 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -161.42 -48.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 19.9 p-10 -78.44 40.63 0.37 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 129.61 3.164 . . . . 0.0 111.133 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.43 151.4 18.56 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.693 1.139 . . . . 0.0 110.851 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.8 149.27 72.69 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 CA-C-N 118.609 1.205 . . . . 0.0 109.51 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.635 ' CD2' ' HG1' ' A' ' 54' ' ' THR . 0.5 OUTLIER -110.91 98.12 7.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.68 2.392 . . . . 0.0 112.892 -172.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -82.14 89.21 6.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.674 0.79 . . . . 0.0 111.395 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.41 168.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.908 1.283 . . . . 0.0 110.491 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -122.23 166.07 15.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.1 t -168.42 176.57 5.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.224 2.209 . . . . 0.0 109.222 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.14 141.63 50.63 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.327 2.251 . . . . 0.0 109.848 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -55.61 -31.47 62.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.971 0.805 . . . . 0.0 111.193 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 t -60.48 -8.88 3.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.515 1.926 . . . . 0.0 114.043 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -118.72 -1.05 11.16 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.752 1.16 . . . . 0.0 111.399 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.65 163.38 12.25 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.29 0.95 . . . . 0.0 112.262 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -136.3 141.59 43.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.79 141.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.43 -178.02 3.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.839 1.655 . . . . 0.0 108.999 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.76 164.81 4.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.651 1.181 . . . . 0.0 111.298 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.82 28.21 30.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.388 1.947 . . . . 0.0 111.109 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.293 0.1 OUTLIER 53.44 22.15 2.74 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.532 1.933 . . . . 0.0 113.29 -175.151 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -73.83 131.89 41.99 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -114.11 161.09 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.63 138.54 35.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 108.669 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.15 133.14 24.34 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.742 2.017 . . . . 0.0 106.966 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.36 123.18 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.88 1.72 . . . . 0.0 107.739 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -85.08 112.16 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.65 -20.67 8.77 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 124.868 1.223 . . . . 0.0 113.458 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.62 39.99 0.19 Allowed Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.377 1.589 . . . . 0.0 112.175 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 30.9 mtt -99.12 71.06 1.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.035 0.917 . . . . 0.0 110.788 173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -71.07 -67.41 0.51 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.368 1.867 . . . . 0.0 112.749 -173.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HZ3' ' CG ' ' A' ' 24' ' ' ASP 0.259 12.2 tmtt? -51.97 -38.89 58.25 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.172 0.989 . . . . 0.0 108.966 176.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.635 ' HG1' ' CD2' ' A' ' 27' ' ' HIS . 1.6 m -64.5 -38.81 92.32 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.909 173.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 26.5 tt0 -57.45 -43.63 84.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.478 1.944 . . . . 0.0 109.657 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.24 95.35 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.239 -0.288 . . . . 0.0 111.649 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.35 -41.76 76.66 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 116.968 -1.491 . . . . 0.0 113.567 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.08 -48.11 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.436 1.471 . . . . 0.0 109.089 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.7 -23.56 29.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -85.99 -46.07 10.87 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -151.42 129.43 11.8 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.759 1.224 . . . . 0.0 110.009 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -17.53 59.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.57 131.04 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.327 1.421 . . . . 0.0 110.739 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.3 m -141.4 155.96 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 123.379 1.562 . . . . 0.0 112.332 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -101.21 152.54 20.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.9 ttt -138.93 118.77 13.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -111.03 128.1 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -116.8 170.21 8.78 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 109.623 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.59 -177.02 39.3 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.442 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.5 t -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -98.63 -7.91 27.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.801 1.64 . . . . 0.0 108.936 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -11.26 38.55 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 119.371 -2.081 . . . . 0.0 113.338 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.42 138.87 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 120.627 1.558 . . . . 0.0 107.101 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.0 130.26 35.33 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.026 0.53 . . . . 0.0 110.75 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.67 -121.7 2.79 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 124.437 1.018 . . . . 0.0 112.927 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -91.81 -78.63 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.247 1.419 . . . . 0.0 110.529 174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -73.61 104.95 4.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.166 0.984 . . . . 0.0 108.431 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.15 -168.59 10.59 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.704 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.74 63.7 5.76 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.851 2.368 . . . . 0.0 110.29 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.83 121.44 1.32 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -115.4 173.33 6.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.966 0.883 . . . . 0.0 110.726 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.3 -173.3 43.67 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 118.797 0.726 . . . . 0.0 113.133 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -151.34 157.32 42.33 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.409 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.5 130.9 47.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.62 155.14 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -126.86 143.87 51.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.626 1.57 . . . . 0.0 107.818 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.63 -165.11 32.65 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.3 m -121.39 142.87 49.58 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.313 0.645 . . . . 0.0 110.017 173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.92 161.78 15.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.623 1.169 . . . . 0.0 110.174 175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.74 114.5 2.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.702 1.201 . . . . 0.0 107.775 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 50.1 m-85 -74.57 136.26 42.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.505 HH11 ' HG3' ' A' ' 92' ' ' ARG . 6.4 mmm-85 -139.13 137.3 35.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 109.866 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -120.78 38.06 4.14 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.81 158.96 34.55 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 129.394 3.078 . . . . 0.0 111.19 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.73 46.88 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.966 1.746 . . . . 0.0 114.72 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.03 -19.55 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.645 2.23 . . . . 0.0 109.523 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -63.62 -65.86 0.62 Allowed 'General case' 0 C--O 1.25 1.11 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.58 -31.85 71.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 116.607 -1.663 . . . . 0.0 112.515 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -68.25 -53.95 21.03 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.852 1.66 . . . . 0.0 110.823 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.67 70.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 116.96 -1.495 . . . . 0.0 111.309 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pp -85.1 -20.67 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 117.507 -1.677 . . . . 0.0 113.558 173.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.05 97.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.881 1.673 . . . . 0.0 112.915 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.504 ' H ' ' HD2' ' A' ' 103' ' ' ARG 0.52 0.0 OUTLIER -51.72 -18.06 1.1 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 173.784 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.02 -179.0 0.12 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -128.38 16.11 6.59 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 118.782 -2.449 . . . . 0.0 111.998 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -139.32 12.16 2.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.042 1.337 . . . . 0.0 110.891 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.12 140.46 37.8 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.372 -0.83 . . . . 0.0 111.28 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.81 -21.53 6.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.988 2.115 . . . . 0.0 111.706 174.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.24 161.99 1.9 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.69 1.996 . . . . 0.0 109.396 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.61 112.44 24.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 tp -84.1 93.56 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.11 120.8 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.93 128.8 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.2 m -98.61 78.91 2.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.5 t -61.09 153.84 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 125.745 1.618 . . . . 0.0 109.381 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.9 t -130.15 -54.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -151.4 141.59 22.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.717 0.689 . . . . 0.0 112.844 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.58 20.22 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 127.283 2.233 . . . . 0.0 111.22 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.38 154.21 42.75 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.308 2.643 . . . . 0.0 106.689 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -100.8 133.97 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.223 -1.548 . . . . 0.0 108.404 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.0 p -135.37 -81.91 0.42 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.196 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.808 0 C-N-CA 130.415 3.486 . . . . 0.0 114.871 -177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -131.54 153.72 81.64 Favored Pre-proline 0 N--CA 1.463 0.19 0 C-N-CA 124.788 1.235 . . . . 0.0 108.873 -171.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.86 158.51 52.74 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.109 1.873 . . . . 0.0 109.197 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.2 -40.44 95.79 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -54.18 -38.84 66.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 111.827 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -51.32 -52.31 46.53 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.51 1.05 . . . . 0.0 110.692 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -60.0 -48.28 82.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.764 0.826 . . . . 0.0 110.495 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -53.21 -38.66 63.1 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.505 1.048 . . . . 0.0 112.159 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.04 -42.35 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.858 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.2 mt -58.39 -42.67 87.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.261 1.392 . . . . 0.0 112.164 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -51.87 -25.34 7.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.105 0.962 . . . . 0.0 113.04 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -101.26 161.09 13.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.62 139.99 45.86 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.13 164.4 37.75 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.53 148.5 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.8 t -135.49 161.66 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.6 158.38 41.08 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.123 0.969 . . . . 0.0 108.875 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -138.81 114.42 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.66 108.87 19.69 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 173.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -92.89 116.19 28.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 116.939 -1.505 . . . . 0.0 107.607 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -73.3 137.42 44.84 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 120.859 1.663 . . . . 0.0 108.4 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.25 -81.51 0.22 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 106.8 -2.52 . . . . 0.0 106.8 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -168.98 -48.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -78.18 38.68 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 131.326 3.85 . . . . 0.0 110.069 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.92 151.17 5.7 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.62 148.56 72.51 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 CA-C-N 119.762 1.781 . . . . 0.0 107.725 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.563 ' CD2' ' HZ3' ' A' ' 53' ' ' LYS . 52.5 t60 -108.15 101.5 10.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.347 -173.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 tp -74.68 88.8 2.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.216 1.006 . . . . 0.0 111.441 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.08 170.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.489 1.516 . . . . 0.0 110.242 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.24 168.08 11.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.802 1.183 . . . . 0.0 113.571 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.1 t -168.61 174.1 6.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.254 2.622 . . . . 0.0 108.253 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -121.11 141.96 50.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.52 2.328 . . . . 0.0 110.726 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -52.92 -31.63 41.06 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.828 1.194 . . . . 0.0 111.776 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -58.48 -8.71 1.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.701 2.001 . . . . 0.0 113.653 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -118.06 -3.35 11.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.813 1.245 . . . . 0.0 110.479 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.9 mt -99.23 170.59 8.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 120.449 1.477 . . . . 0.0 114.36 -173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -136.33 141.32 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -100.92 148.81 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 mt -121.78 178.93 4.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.17 2.188 . . . . 0.0 110.463 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -67.13 167.65 11.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.577 1.551 . . . . 0.0 109.742 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.9 28.62 57.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.073 1.321 . . . . 0.0 111.307 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.25 0.1 OUTLIER 53.73 20.43 2.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.873 2.069 . . . . 0.0 114.236 -175.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -73.44 145.56 45.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -127.27 168.15 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.02 145.0 18.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 120.392 -1.443 . . . . 0.0 108.8 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.68 138.88 32.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 128.749 2.82 . . . . 0.0 107.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.24 109.12 2.28 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.8 3.0 . . . . 0.0 109.427 173.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.28 111.84 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 173.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.77 -21.63 4.94 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.771 1.177 . . . . 0.0 113.24 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.24 37.45 0.41 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 119.183 1.491 . . . . 0.0 111.44 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 33.4 mtt -103.39 71.5 1.1 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.433 ' CD2' HH22 ' A' ' 108' ' ' ARG . 34.0 m80 -67.28 -70.53 0.25 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.401 2.68 . . . . 0.0 114.573 -173.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.563 ' HZ3' ' CD2' ' A' ' 27' ' ' HIS . 4.4 ttpm? -51.68 -40.74 60.62 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 120.791 -1.193 . . . . 0.0 109.987 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.8 m -60.39 -39.14 86.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.868 0.867 . . . . 0.0 113.323 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.85 -48.13 82.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.291 1.405 . . . . 0.0 108.587 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.2 97.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.761 173.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -63.07 -41.93 99.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.57 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.49 -48.21 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.622 1.101 . . . . 0.0 108.664 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.87 -26.81 62.61 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.122 -0.942 . . . . 0.0 113.503 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -87.18 -46.99 9.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.977 1.262 . . . . 0.0 112.187 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -147.06 128.85 15.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.399 1.08 . . . . 0.0 111.848 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -17.67 59.3 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.66 130.97 48.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.225 0.921 . . . . 0.0 110.466 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -144.24 156.15 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 123.264 1.507 . . . . 0.0 112.879 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -104.88 152.74 22.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 172.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 ttt -138.99 128.27 24.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 p -129.72 128.6 42.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -116.46 164.07 15.1 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 119.431 1.014 . . . . 0.0 109.29 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.64 42.4 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.8 t -160.95 172.04 17.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.171 -1.194 . . . . 0.0 109.428 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -99.23 -8.29 25.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.212 2.205 . . . . 0.0 108.987 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -11.18 43.88 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 115.815 -2.041 . . . . 0.0 116.265 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.87 140.33 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.76 131.29 35.88 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.727 0.811 . . . . 0.0 110.868 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.4 -139.47 5.68 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 125.441 1.496 . . . . 0.0 112.099 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -79.23 -59.04 2.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.165 1.786 . . . . 0.0 107.662 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.7 103.09 15.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.27 -168.7 4.13 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.36 61.02 6.59 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.492 2.128 . . . . 0.0 109.969 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.33 121.56 1.2 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 108.559 -1.817 . . . . 0.0 108.559 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.19 169.85 8.96 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.479 1.14 . . . . 0.0 110.197 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 171.83 43.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.295 0.95 . . . . 0.0 113.1 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -131.83 147.78 52.51 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.417 1.487 . . . . 0.0 108.696 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -100.51 131.5 46.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.893 2.477 . . . . 0.0 105.409 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.4 mt -136.4 154.73 33.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 mtt-85 -127.74 143.12 51.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.285 1.434 . . . . 0.0 107.682 -174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.09 -171.84 40.27 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 119.094 0.861 . . . . 0.0 113.407 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -121.31 134.68 55.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.323 1.449 . . . . 0.0 110.514 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.76 160.53 17.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.747 1.619 . . . . 0.0 110.565 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.62 120.64 1.5 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.464 1.506 . . . . 0.0 109.13 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.99 149.37 29.34 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.19 -0.944 . . . . 0.0 112.747 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.18 141.4 34.1 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.557 1.943 . . . . 0.0 109.179 172.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.8 p -114.11 24.8 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.546 1.539 . . . . 0.0 107.321 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.72 167.32 29.81 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 126.317 1.847 . . . . 0.0 110.39 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.8 179.74 45.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.639 2.066 . . . . 0.0 113.295 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.7 -11.46 17.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.886 3.057 . . . . 0.0 112.459 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -64.04 0.98 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.328 1.851 . . . . 0.0 107.138 173.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.29 -31.12 70.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.127 0.892 . . . . 0.0 110.749 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -68.65 -56.86 6.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.001 0.819 . . . . 0.0 109.801 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.39 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.909 -1.119 . . . . 0.0 112.428 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.343 1.5 pp -92.3 -18.12 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.666 1.121 . . . . 0.0 111.463 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.28 -28.09 2.89 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.688 1.995 . . . . 0.0 112.334 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -51.49 -32.34 27.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.237 172.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -79.07 178.02 8.36 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 173.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.69 8.18 1.93 Allowed 'General case' 0 C--O 1.221 -0.427 0 O-C-N 118.473 -2.642 . . . . 0.0 111.704 173.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -102.0 8.38 40.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.628 1.171 . . . . 0.0 110.554 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.96 22.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.519 0.727 . . . . 0.0 109.992 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.433 HH22 ' CD2' ' A' ' 52' ' ' HIS . 23.1 ttm180 -120.65 -20.93 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.887 2.075 . . . . 0.0 111.355 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.35 161.83 12.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.666 1.586 . . . . 0.0 108.519 -173.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.5 105.41 15.43 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.599 2.36 . . . . 0.0 106.695 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 tp -79.22 95.86 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.285 1.834 . . . . 0.0 107.094 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.7 t -78.91 131.52 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.676 1.59 . . . . 0.0 106.718 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.78 128.36 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.5 m -98.91 85.9 3.37 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.76 150.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.46 -58.83 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -147.95 141.53 25.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.3 154.73 25.22 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.394 2.278 . . . . 0.0 110.347 173.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -140.41 139.14 35.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.447 2.299 . . . . 0.0 106.865 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -77.84 139.97 39.33 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -132.98 -58.82 0.9 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.243 0.717 0 CA-C-O 116.561 -1.685 . . . . 0.0 111.945 -173.362 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mmm . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mp -57.04 153.54 23.52 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.15 155.48 56.61 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.576 2.184 . . . . 0.0 110.644 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.84 -42.06 97.96 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -49.48 -38.8 31.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.36 1.864 . . . . 0.0 112.327 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -51.1 -56.26 13.56 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.45 1.023 . . . . 0.0 110.145 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -58.62 -48.74 79.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.914 0.886 . . . . 0.0 109.36 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.59 -40.23 71.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.483 0.583 . . . . 0.0 112.269 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.52 -45.83 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.801 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.65 -37.25 73.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.81 1.186 . . . . 0.0 113.921 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -51.78 -29.51 19.26 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.748 1.158 . . . . 0.0 112.134 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -101.08 165.55 11.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.607 1.163 . . . . 0.0 109.83 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.21 139.05 45.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.33 167.56 40.31 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.13 144.12 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.068 1.747 . . . . 0.0 107.432 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.0 t -136.8 158.32 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.42 155.45 43.15 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.566 1.546 . . . . 0.0 108.115 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.5 mt -140.98 112.93 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.99 108.92 19.84 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -95.35 116.99 29.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -73.31 141.16 47.14 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 121.001 1.728 . . . . 0.0 106.542 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.12 -81.27 0.22 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.89 -60.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 15.8 p-10 -78.61 38.84 0.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 130.096 3.359 . . . . 0.0 111.445 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.0 151.29 17.03 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.13 0.871 . . . . 0.0 110.994 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.6 152.09 53.34 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 120.994 1.13 . . . . 0.0 111.529 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -110.5 101.6 10.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.4 tt -88.91 88.94 7.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -85.71 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.561 1.944 . . . . 0.0 110.785 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -119.23 166.72 12.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.367 0.985 . . . . 0.0 113.368 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 t -168.44 171.89 8.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.407 2.283 . . . . 0.0 108.212 174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -121.34 141.71 50.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.084 1.754 . . . . 0.0 110.192 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.69 -31.25 15.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.795 0.838 . . . . 0.0 111.376 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -59.31 -8.66 1.79 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.095 1.758 . . . . 0.0 113.682 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -118.56 -13.21 9.69 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.722 1.209 . . . . 0.0 110.623 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.8 mt -91.1 168.62 11.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.64 -1.288 . . . . 0.0 111.901 -173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.91 37.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.46 134.05 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.28 179.07 4.53 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.897 1.679 . . . . 0.0 107.337 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 35.0 t0 -75.83 -179.21 4.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.274 0.629 . . . . 0.0 110.31 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.476 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 58.6 28.85 63.16 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.419 -1.425 . . . . 0.0 110.303 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 p30 53.82 13.23 0.5 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 130.106 3.362 . . . . 0.0 114.684 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -74.01 128.05 34.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.082 0.401 . . . . 0.0 110.301 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -119.07 158.83 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.5 142.72 25.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 O-C-N 120.397 -1.439 . . . . 0.0 107.732 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.38 126.15 25.53 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 128.623 2.769 . . . . 0.0 106.522 -173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -72.9 108.4 2.57 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.453 1.436 . . . . 0.0 108.934 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.87 111.59 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.7 -21.48 5.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.35 0.976 . . . . 0.0 112.097 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.58 41.3 0.47 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.044 -174.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.7 mtt -109.75 71.74 0.77 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.271 1.429 . . . . 0.0 108.203 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -67.04 -64.13 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 130.239 3.416 . . . . 0.0 112.794 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 50.0 tttm -51.66 -41.04 61.07 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.258 174.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.8 m -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.358 1.463 . . . . 0.0 111.509 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.95 -48.97 79.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.714 1.206 . . . . 0.0 108.838 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.83 94.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.0 -41.86 90.52 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.014 0.926 . . . . 0.0 109.316 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.34 -47.96 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.39 -28.3 28.69 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.505 -0.747 . . . . 0.0 112.322 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -79.95 -45.96 17.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 173.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -150.79 138.97 20.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.051 0.842 . . . . 0.0 110.174 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -74.62 -18.52 60.54 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.362 -0.836 . . . . 0.0 111.984 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.79 118.15 6.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.804 1.241 . . . . 0.0 113.935 -174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 m -139.31 152.72 23.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 123.084 1.421 . . . . 0.0 112.762 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.7 tt -111.74 148.78 32.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 173.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.0 ttt -140.47 123.44 16.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.0 p -108.79 128.15 54.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.03 167.68 10.93 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 120.408 1.458 . . . . 0.0 109.208 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.91 178.82 46.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -151.89 155.18 37.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.6 mtt-85 -98.4 -8.4 26.99 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.284 0.634 . . . . 0.0 111.182 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -72.39 -7.66 50.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.535 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.98 135.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 174.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.01 130.36 35.44 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.24 -137.54 5.29 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -90.76 -58.39 2.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.575 0.75 . . . . 0.0 109.142 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.91 102.61 5.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 118.794 -1.162 . . . . 0.0 108.532 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.21 -168.27 0.12 Allowed Glycine 0 CA--C 1.54 1.642 0 O-C-N 120.647 -1.283 . . . . 0.0 111.086 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.37 90.78 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 106.462 -2.169 . . . . 0.0 106.462 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.41 0.71 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.748 -1.585 . . . . 0.0 109.599 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -105.99 168.87 8.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.399 1.099 . . . . 0.0 110.091 174.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.43 -166.14 35.31 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-O 121.266 0.37 . . . . 0.0 113.646 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.69 152.39 42.34 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.497 1.119 . . . . 0.0 110.009 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.22 131.12 47.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.3 mt -133.55 150.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -124.25 138.23 54.42 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.687 1.995 . . . . 0.0 106.268 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.45 -167.17 26.71 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -121.14 142.1 50.19 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.448 1.899 . . . . 0.0 108.682 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.06 160.99 16.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.913 1.233 . . . . 0.0 110.935 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.11 120.44 3.33 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.266 1.027 . . . . 0.0 109.448 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -74.13 128.7 36.21 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.56 141.12 50.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.782 2.433 . . . . 0.0 109.632 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -121.21 29.53 7.25 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.658 1.983 . . . . 0.0 107.262 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.77 165.98 33.03 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.646 2.378 . . . . 0.0 108.663 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.7 178.97 46.34 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.499 1.523 . . . . 0.0 113.643 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.73 -20.43 68.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.545 2.163 . . . . 0.0 111.11 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.32 -55.58 20.29 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.52 1.528 . . . . 0.0 108.595 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -61.34 -31.35 71.22 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 116.924 -1.512 . . . . 0.0 110.521 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.22 -48.39 65.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 121.515 1.962 . . . . 0.0 110.516 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.11 -35.99 60.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.854 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.25 1.3 pp -93.68 -20.95 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.66 93.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 121.544 1.974 . . . . 0.0 111.695 -173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.464 0.0 OUTLIER -51.35 -18.02 0.89 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.988 1.715 . . . . 0.0 114.744 173.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -174.74 0.21 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -129.22 10.59 5.82 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 119.022 -2.299 . . . . 0.0 113.003 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -139.66 8.82 2.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.495 0.718 . . . . 0.0 112.587 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.36 151.25 31.09 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.231 0.923 . . . . 0.0 111.356 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -120.65 -21.34 6.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.216 2.207 . . . . 0.0 111.657 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.78 161.63 11.16 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.659 1.584 . . . . 0.0 109.482 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.41 103.69 15.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.43 94.68 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.19 131.59 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.211 1.804 . . . . 0.0 106.59 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -118.99 138.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.7 m -114.64 101.39 9.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.15 153.77 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.639 0.733 . . . . 0.0 109.352 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.91 -40.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.6 m -151.03 128.06 11.1 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 120.857 -1.152 . . . . 0.0 110.924 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.4 138.81 49.54 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.589 2.356 . . . . 0.0 109.117 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -142.01 140.97 32.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.86 1.664 . . . . 0.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.56 133.8 47.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -152.84 -58.55 0.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.252 1.224 0 CA-C-O 115.216 -2.326 . . . . 0.0 115.687 -172.936 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . 1.407 ' N1 ' ' C10' ' A' ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtm . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.79 157.31 8.03 Favored Pre-proline 0 C--O 1.242 0.704 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.47 160.32 48.44 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.606 2.204 . . . . 0.0 111.329 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.65 -47.53 90.45 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.83 -42.11 62.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.22 1.408 . . . . 0.0 111.99 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -51.12 -56.62 11.79 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.555 0.616 . . . . 0.0 111.493 173.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -59.17 -48.52 81.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.316 0.646 . . . . 0.0 110.578 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.79 -40.5 72.76 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.935 0.789 . . . . 0.0 111.976 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.89 -44.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.021 0.828 . . . . 0.0 108.884 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.4 mt -56.71 -43.89 81.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.087 0.858 . . . . 0.0 112.437 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -51.69 -27.08 10.61 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -99.11 171.63 7.89 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.295 1.045 . . . . 0.0 111.205 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.45 131.67 42.08 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.1 168.57 41.67 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.2 t -101.01 149.88 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.95 152.44 42.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mt -138.79 116.31 11.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.91 109.23 20.06 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -89.35 114.88 26.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 -176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 118.54 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.71 -74.65 0.11 Allowed Glycine 0 C--N 1.333 0.403 0 CA-C-N 118.236 0.471 . . . . 0.0 112.91 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.23 -48.24 0.06 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -173.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.18 38.48 0.29 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.523 1.529 . . . . 0.0 110.792 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 152.47 6.59 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 105.851 -2.9 . . . . 0.0 105.851 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.19 147.76 19.91 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 122.233 3.016 . . . . 0.0 106.875 173.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.591 ' CD2' ' HZ3' ' A' ' 53' ' ' LYS . 66.5 t60 -119.71 101.26 7.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.533 -172.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.4 tp -78.13 88.57 4.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.302 1.041 . . . . 0.0 111.208 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -77.48 171.71 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.942 1.297 . . . . 0.0 110.401 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -122.12 166.32 14.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.628 1.104 . . . . 0.0 113.516 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -168.52 175.01 6.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.561 2.344 . . . . 0.0 108.473 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -120.67 141.68 50.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.327 2.251 . . . . 0.0 109.463 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -55.21 -31.42 61.43 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.77 0.714 . . . . 0.0 110.598 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -59.24 -8.81 1.79 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.99 2.116 . . . . 0.0 113.876 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -118.13 -7.05 10.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.594 1.158 . . . . 0.0 109.576 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 mt -97.18 171.41 8.47 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.747 -1.221 . . . . 0.0 112.01 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -133.64 123.15 24.54 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.8 t -101.7 139.5 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.66 178.52 4.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 40.7 t0 -76.55 -178.3 4.62 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.442 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 60.0 29.14 67.38 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 120.511 -1.368 . . . . 0.0 109.812 -176.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 53.79 13.0 0.47 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 130.337 3.455 . . . . 0.0 115.602 -174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -73.6 140.03 45.94 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.673 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -130.59 161.4 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.87 145.63 20.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.5 t -122.24 130.04 24.85 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 128.31 2.644 . . . . 0.0 106.548 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.49 108.69 2.74 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.223 2.615 . . . . 0.0 109.087 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.58 111.66 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.879 -0.513 . . . . 0.0 109.958 173.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.57 -21.31 5.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.954 1.74 . . . . 0.0 111.93 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.06 39.97 0.38 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.89 1.345 . . . . 0.0 110.353 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.2 mtt -109.23 50.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.472 1.509 . . . . 0.0 107.052 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.47 -50.06 35.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.445 -1.264 . . . . 0.0 113.484 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HZ3' ' CD2' ' A' ' 27' ' ' HIS . 3.7 ttpm? -52.27 -41.57 62.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.272 1.851 . . . . 0.0 108.611 173.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -58.77 -38.4 78.41 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.71 0.804 . . . . 0.0 110.811 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.1 -48.18 79.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.682 1.583 . . . . 0.0 110.065 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.1 98.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 119.788 -0.148 . . . . 0.0 111.122 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -61.22 -41.27 96.56 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 123.826 0.85 . . . . 0.0 110.052 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.9 -47.97 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.843 1.201 . . . . 0.0 109.361 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.92 -25.92 45.32 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.042 -1.036 . . . . 0.0 112.154 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.3 mmm-85 -78.09 -45.03 24.55 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -151.25 140.82 21.64 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.234 1.014 . . . . 0.0 109.884 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -70.33 -19.41 63.07 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.873 -1.142 . . . . 0.0 111.94 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.8 120.77 10.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.18 1.392 . . . . 0.0 113.639 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.2 m -139.06 155.91 27.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 123.001 1.382 . . . . 0.0 112.185 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.9 tp -111.11 151.95 27.53 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 172.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.02 132.79 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 p -128.47 128.07 43.68 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -116.98 167.2 11.35 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.81 1.186 . . . . 0.0 110.781 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 178.5 42.42 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -150.32 170.79 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.732 -0.864 . . . . 0.0 109.076 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -98.66 -8.79 25.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.362 1.865 . . . . 0.0 110.888 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -91.58 -10.74 39.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.4 137.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.86 131.45 36.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.214 1.005 . . . . 0.0 109.798 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.22 -140.99 6.81 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -83.99 -58.48 2.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.53 102.92 8.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.3 -168.72 2.27 Favored Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 112.6 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.5 59.53 6.76 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.867 2.378 . . . . 0.0 110.789 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.44 121.32 1.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -113.95 169.07 9.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.91 1.355 . . . . 0.0 110.181 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 176.57 44.35 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 123.463 0.554 . . . . 0.0 112.889 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -126.39 144.6 50.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.718 1.607 . . . . 0.0 110.197 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.54 128.39 46.61 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 128.253 2.621 . . . . 0.0 104.442 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt -138.41 153.83 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 -119.84 148.16 43.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.89 1.676 . . . . 0.0 107.52 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.77 -171.38 31.89 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.1 m -120.85 144.38 48.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.376 2.27 . . . . 0.0 107.179 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.93 161.05 16.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.778 1.172 . . . . 0.0 111.405 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.22 114.92 2.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.174 0.99 . . . . 0.0 109.966 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -73.94 129.45 37.91 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.67 141.57 51.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 129.119 2.967 . . . . 0.0 108.606 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 p -118.28 30.36 7.27 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.774 1.629 . . . . 0.0 107.552 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -158.81 163.82 36.34 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.209 1.804 . . . . 0.0 109.328 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.74 46.87 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.116 1.817 . . . . 0.0 113.782 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.88 -13.86 37.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.707 2.938 . . . . 0.0 112.653 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.59 -63.38 1.07 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -61.23 -31.31 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.967 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.62 -55.54 11.18 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.689 1.131 . . . . 0.0 109.42 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.53 -27.12 68.38 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.857 -1.152 . . . . 0.0 112.178 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.362 1.0 OUTLIER -86.25 -18.18 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.881 1.218 . . . . 0.0 111.567 173.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.33 -27.67 2.69 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.961 2.104 . . . . 0.0 111.675 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -49.26 -35.79 18.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.028 . . . . 0.0 111.764 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -77.94 178.05 7.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.89 -0.98 1.44 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 118.529 -2.607 . . . . 0.0 111.568 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -97.01 8.38 44.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.979 0.912 . . . . 0.0 110.682 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.72 149.41 22.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.821 0.737 . . . . 0.0 109.515 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -117.71 -11.22 10.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.244 1.818 . . . . 0.0 110.936 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.28 161.7 12.3 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 110.0 -174.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.15 104.57 14.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.512 2.725 . . . . 0.0 106.174 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.32 96.96 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.08 131.65 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.378 1.871 . . . . 0.0 107.11 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.11 139.76 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.9 m -118.9 101.44 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.2 t -60.28 160.98 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.613 1.565 . . . . 0.0 109.472 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.22 -57.14 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -141.06 122.84 15.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.17 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 146.99 42.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 128.054 2.542 . . . . 0.0 111.337 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -143.91 152.13 40.72 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.0 108.894 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -81.05 137.31 36.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.6 p -138.69 -58.49 0.62 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -173.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--O 1.251 1.168 0 C-N-CA 123.594 0.757 . . . . 0.0 111.182 -173.52 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mmt . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.9 mt -62.9 157.24 61.84 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 118.47 -0.776 . . . . 0.0 108.922 171.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.61 160.17 50.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.974 1.782 . . . . 0.0 111.756 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.26 96.86 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -52.85 -38.82 61.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.931 1.692 . . . . 0.0 112.072 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -51.14 -51.89 49.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.487 1.039 . . . . 0.0 110.962 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -60.1 -48.39 81.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.338 0.655 . . . . 0.0 110.73 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -54.97 -37.22 66.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.642 1.11 . . . . 0.0 112.638 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.09 -45.01 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.364 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.2 mt -57.21 -44.09 83.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.397 0.999 . . . . 0.0 112.018 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -51.85 -18.93 1.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -107.71 158.41 17.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.556 1.071 . . . . 0.0 110.788 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -77.0 147.69 36.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.47 168.54 31.57 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.18 149.05 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.24 161.98 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 127.343 2.257 . . . . 0.0 105.021 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.43 157.17 43.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.371 1.068 . . . . 0.0 109.139 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -139.39 120.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.91 108.77 19.73 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 173.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 m -90.6 113.45 25.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -73.2 131.71 42.32 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.93 -79.14 0.17 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 122.514 1.064 . . . . 0.0 111.131 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -158.32 -48.59 0.06 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.647 -1.277 . . . . 0.0 109.003 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.61 37.74 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.773 1.229 . . . . 0.0 112.053 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.28 152.12 5.76 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -59.23 148.02 88.02 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 121.043 2.421 . . . . 0.0 108.481 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.617 ' CD2' ' HZ3' ' A' ' 53' ' ' LYS . 70.2 t60 -117.04 101.45 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.622 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.2 tp -75.02 88.64 2.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.832 0.853 . . . . 0.0 111.531 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 m -78.1 169.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.395 1.078 . . . . 0.0 109.834 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -119.85 166.34 13.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 112.243 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -168.52 176.05 5.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.453 2.301 . . . . 0.0 107.879 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -121.28 141.62 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.517 1.527 . . . . 0.0 110.76 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -50.86 -29.96 13.26 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 119.077 0.853 . . . . 0.0 111.154 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -55.13 -19.89 8.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.669 2.388 . . . . 0.0 112.58 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -118.13 -4.23 11.01 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.144 1.378 . . . . 0.0 109.619 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 mt -98.88 167.15 10.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.94 -1.1 . . . . 0.0 111.016 -174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 140.49 42.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.4 t -101.9 149.51 6.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.8 mt -122.24 178.82 4.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.638 2.775 . . . . 0.0 106.244 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 37.3 t0 -76.03 -179.04 4.69 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 60.33 31.01 72.48 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 120.237 -1.539 . . . . 0.0 110.715 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 p30 54.08 13.06 0.53 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.765 3.226 . . . . 0.0 115.257 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -73.49 142.32 46.78 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 109.547 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.41 166.41 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 t -147.97 145.07 18.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 O-C-N 120.793 -1.192 . . . . 0.0 108.644 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.58 136.07 26.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 108.585 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.77 121.28 6.2 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 124.269 3.312 . . . . 0.0 110.582 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.48 111.94 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 119.52 1.055 . . . . 0.0 112.764 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.31 -20.81 5.76 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.774 1.654 . . . . 0.0 111.64 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.54 30.0 0.23 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.459 1.63 . . . . 0.0 112.292 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 37.2 mtt -99.4 61.96 1.21 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.103 1.452 . . . . 0.0 107.825 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -71.15 -60.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.029 0.932 . . . . 0.0 112.951 -174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HZ3' ' CD2' ' A' ' 27' ' ' HIS . 4.0 ttpm? -52.09 -41.77 62.68 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.138 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -61.62 -38.55 88.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.852 0.751 . . . . 0.0 111.641 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 36.9 tt0 -59.08 -44.74 91.93 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.927 1.239 . . . . 0.0 109.792 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.04 93.25 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.234 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -62.61 -41.39 98.96 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 124.175 0.99 . . . . 0.0 109.473 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.78 -48.17 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 108.708 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.93 29.82 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.377 -0.827 . . . . 0.0 112.616 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -45.39 19.06 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -151.04 138.95 19.92 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.747 1.219 . . . . 0.0 109.417 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.1 -19.79 61.08 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.03 -1.044 . . . . 0.0 112.009 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.1 mmp_? -60.88 119.97 9.25 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.268 1.427 . . . . 0.0 114.265 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.64 156.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 123.108 1.432 . . . . 0.0 112.8 173.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.4 tp -110.81 151.19 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.5 ttt -142.4 140.89 32.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 p -129.68 130.66 45.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -116.68 163.62 15.85 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.11 179.53 44.47 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.2 t -147.62 163.65 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -9.01 25.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.508 0.723 . . . . 0.0 109.221 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -81.1 -7.7 59.61 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.009 -0.996 . . . . 0.0 113.165 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.99 137.07 56.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.08 36.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.38 -141.48 6.15 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp-105 -81.57 -58.98 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.582 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.46 102.64 9.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.388 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 49.51 -168.71 0.2 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.236 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.3 87.52 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 107.557 -1.747 . . . . 0.0 107.557 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 121.25 0.7 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-O 117.734 -1.592 . . . . 0.0 109.16 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -115.52 -179.85 3.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.252 1.026 . . . . 0.0 108.963 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.32 -155.81 20.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 117.819 -1.545 . . . . 0.0 110.063 -173.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -151.2 157.49 42.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.306 1.442 . . . . 0.0 109.629 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.1 131.12 47.18 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 129.239 3.015 . . . . 0.0 104.811 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mt -136.95 152.31 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -119.61 140.77 50.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.4 1.88 . . . . 0.0 107.078 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.51 -171.15 30.4 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.415 0.531 . . . . 0.0 112.047 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -121.12 149.16 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.815 2.046 . . . . 0.0 108.289 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.29 165.13 11.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.633 1.173 . . . . 0.0 110.402 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.14 121.69 0.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 109.394 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 37.9 m-85 -76.45 150.73 36.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.766 -1.209 . . . . 0.0 114.191 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.456 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.315 0.0 OUTLIER -140.89 139.02 34.32 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 173.254 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 p -122.11 29.47 7.02 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 129.741 3.216 . . . . 0.0 102.582 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' A' ' 92' ' ' ARG 0.288 8.9 t70 -158.43 160.21 36.57 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 130.353 3.461 . . . . 0.0 114.004 -172.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.97 178.41 47.54 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.007 1.289 . . . . 0.0 115.768 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.04 -16.28 53.36 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.093 2.529 . . . . 0.0 110.085 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -64.76 -66.7 0.51 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.14 -31.2 70.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.289 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -68.4 -59.43 3.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . 0.258 . . -61.7 -19.41 62.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.862 -1.148 . . . . 0.0 113.39 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.339 1.2 pp -91.95 -18.08 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.326 1.421 . . . . 0.0 110.785 172.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.73 2.73 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.021 2.128 . . . . 0.0 112.747 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -50.48 -37.92 41.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.177 1.391 . . . . 0.0 112.157 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -75.55 177.9 6.39 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.64 -0.78 1.34 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 118.777 -2.452 . . . . 0.0 111.632 174.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -93.34 8.24 41.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.373 0.669 . . . . 0.0 109.697 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.84 129.69 36.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.2 1.0 . . . . 0.0 108.63 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -99.03 -16.0 18.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.466 0.706 . . . . 0.0 111.347 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.39 161.78 12.08 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.757 1.623 . . . . 0.0 108.95 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.8 110.42 22.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.755 2.822 . . . . 0.0 109.469 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.15 94.54 6.66 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.26 131.12 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mm -117.44 142.44 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 m -120.39 101.55 7.86 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.22 156.96 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.026 1.33 . . . . 0.0 109.352 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.26 -49.44 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -151.25 140.79 21.61 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 120.887 -1.133 . . . . 0.0 111.741 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.12 139.49 49.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.154 2.582 . . . . 0.0 108.528 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -142.09 163.18 33.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.783 2.033 . . . . 0.0 109.694 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -90.97 142.4 27.82 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 121.206 -0.934 . . . . 0.0 109.89 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.17 -58.0 1.07 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.939 2.496 . . . . 0.0 110.92 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.294 1.437 . . . . 0.0 110.032 -174.611 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.4 mp -135.77 157.82 75.35 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.472 1.109 . . . . 0.0 108.264 -168.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.16 155.81 69.06 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.78 2.32 . . . . 0.0 111.142 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.94 -38.81 93.25 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.16 -38.97 63.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.839 1.256 . . . . 0.0 111.184 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -51.44 -54.23 28.92 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.823 1.192 . . . . 0.0 110.743 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -56.71 -48.27 78.08 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.27 1.028 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.6 -35.23 72.12 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.895 -0.574 . . . . 0.0 112.363 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.2 t -69.16 -43.5 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.909 1.231 . . . . 0.0 109.369 174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.05 -43.24 77.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.219 1.372 . . . . 0.0 112.176 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -51.99 -21.35 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.099 0.863 . . . . 0.0 113.284 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -110.83 174.03 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.744 1.618 . . . . 0.0 110.965 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -73.35 129.4 37.93 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.43 164.28 34.41 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.5 145.52 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.57 164.94 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.83 160.45 43.56 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 107.952 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.4 mt -138.74 119.49 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 108.9 19.61 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -93.89 114.48 26.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 115.407 -2.235 . . . . 0.0 108.586 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -73.26 129.4 37.96 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 122.836 2.562 . . . . 0.0 107.958 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.85 -76.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 124.609 1.099 . . . . 0.0 110.892 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -158.66 -48.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.71 2.004 . . . . 0.0 108.465 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.77 38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.295 1.438 . . . . 0.0 111.268 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.36 152.33 5.96 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -56.2 147.74 64.07 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 CA-C-N 122.25 3.025 . . . . 0.0 107.386 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.46 ' CG ' ' HE2' ' A' ' 53' ' ' LYS . 70.0 t60 -111.24 101.42 9.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.343 -172.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.02 88.71 3.54 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.565 1.546 . . . . 0.0 111.649 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.93 168.86 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.861 1.264 . . . . 0.0 110.113 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -119.14 166.66 12.65 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.267 1.394 . . . . 0.0 114.203 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -168.42 171.62 8.95 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.529 1.932 . . . . 0.0 109.636 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -121.17 141.84 50.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.444 2.297 . . . . 0.0 110.738 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -53.75 -31.17 47.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.341 0.656 . . . . 0.0 112.412 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -59.38 -12.47 5.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 112.97 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -117.92 -2.78 11.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.392 -1.443 . . . . 0.0 109.805 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.3 mt -99.48 166.38 11.19 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.076 -1.015 . . . . 0.0 110.17 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -136.77 128.88 29.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.52 141.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.911 1.684 . . . . 0.0 107.581 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.94 -177.9 3.7 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.041 1.736 . . . . 0.0 108.385 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.51 175.21 5.72 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.687 1.195 . . . . 0.0 108.432 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.27 28.19 13.14 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.275 1.893 . . . . 0.0 111.053 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.335 0.1 OUTLIER 53.27 25.24 4.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.016 2.126 . . . . 0.0 114.537 -178.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -73.66 126.71 30.93 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -114.97 164.89 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.16 144.19 18.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 O-C-N 120.346 -1.471 . . . . 0.0 108.579 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.8 t -130.78 137.46 30.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.998 1.719 . . . . 0.0 108.611 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 112.32 2.71 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 124.139 3.226 . . . . 0.0 111.663 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -85.4 112.45 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.28 -20.96 5.37 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.657 1.123 . . . . 0.0 113.051 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.86 39.67 0.39 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.775 -1.569 . . . . 0.0 111.293 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 6.3 mtt -112.11 71.48 0.74 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -63.82 -53.79 45.28 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.46 -0.775 . . . . 0.0 111.952 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.46 ' HE2' ' CG ' ' A' ' 27' ' ' HIS . 3.9 ttpm? -51.93 -41.43 62.02 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.322 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -62.39 -39.36 92.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.03 1.286 . . . . 0.0 111.507 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 34.6 tt0 -55.98 -50.62 70.34 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.22 1.373 . . . . 0.0 109.482 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.2 97.88 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -67.64 -41.73 83.41 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.547 1.139 . . . . 0.0 109.156 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -48.07 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.735 1.152 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.72 31.14 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -84.05 -46.9 11.5 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.651 1.114 . . . . 0.0 113.872 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -151.13 140.88 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.03 0.919 . . . . 0.0 111.567 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.78 -23.48 55.92 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.247 -0.908 . . . . 0.0 113.015 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 122.43 15.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.798 1.181 . . . . 0.0 110.339 -173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.7 m -139.22 155.97 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 123.43 1.586 . . . . 0.0 111.453 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.85 154.51 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.3 ttt -138.85 137.35 36.49 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -131.15 129.12 41.37 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.38 173.29 6.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.604 1.093 . . . . 0.0 111.831 174.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.17 178.52 45.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.9 t -151.07 165.59 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.054 0.93 . . . . 0.0 109.418 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -98.74 -20.72 16.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.344 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -91.76 -6.2 52.27 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.114 1.366 . . . . 0.0 113.904 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.62 131.45 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.86 131.5 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.415 1.086 . . . . 0.0 109.079 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 -141.5 11.47 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -85.89 -58.86 2.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.63 102.84 11.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.337 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.48 -178.5 0.66 Allowed Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.452 1.025 . . . . 0.0 113.987 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.13 81.66 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.311 2.007 . . . . 0.0 109.828 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 103.79 0.17 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 t -98.68 169.23 9.64 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.739 1.269 . . . . 0.0 110.372 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.6 161.86 30.04 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.663 1.125 . . . . 0.0 111.741 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -134.73 145.44 48.46 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.503 1.921 . . . . 0.0 109.28 -173.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -101.01 131.53 46.85 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 128.525 2.73 . . . . 0.0 107.728 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -140.36 152.4 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.99 148.34 52.27 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.154 -0.966 . . . . 0.0 108.703 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.43 -168.17 36.16 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 118.847 0.749 . . . . 0.0 112.251 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -118.99 134.53 55.13 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.147 . . . . 0.0 108.867 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.67 158.76 15.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.556 1.142 . . . . 0.0 108.86 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.98 120.75 3.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.678 1.191 . . . . 0.0 108.297 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 29.8 m-85 -74.34 139.65 44.29 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.405 -0.809 . . . . 0.0 112.695 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -140.85 141.4 34.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.01 1.324 . . . . 0.0 109.929 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.1 p -120.67 41.1 3.35 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -159.32 159.55 34.06 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 129.478 3.111 . . . . 0.0 111.013 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.21 178.66 47.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.712 1.625 . . . . 0.0 114.003 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.77 -8.86 20.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.25 2.633 . . . . 0.0 111.059 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -65.53 0.66 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.941 2.497 . . . . 0.0 107.083 173.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -61.28 -31.77 71.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.283 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.01 -48.85 41.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.935 0.789 . . . . 0.0 110.527 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.5 67.83 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.55 -1.344 . . . . 0.0 112.568 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.4 pp -90.33 -18.14 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.107 0.867 . . . . 0.0 112.021 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.95 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.201 1.8 . . . . 0.0 111.685 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -50.56 -22.85 2.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -81.3 178.86 8.13 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.554 1.07 . . . . 0.0 110.732 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -135.63 20.44 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 119.904 -1.748 . . . . 0.0 110.025 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -132.45 10.48 4.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.675 1.59 . . . . 0.0 111.284 -174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.0 150.26 32.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.141 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -120.74 -21.91 6.49 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 129.139 2.975 . . . . 0.0 112.362 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.33 161.74 1.44 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.779 2.031 . . . . 0.0 110.01 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.89 112.36 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.2 94.62 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.78 131.29 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.5 mm -121.15 129.13 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.1 m -110.15 90.81 3.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.17 159.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.37 -56.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 104.0 -2.592 . . . . 0.0 104.0 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.6 m -148.58 141.05 24.29 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.454 0.57 . . . . 0.0 112.115 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.01 143.74 46.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.544 3.138 . . . . 0.0 106.79 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.0 145.62 39.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.701 1.6 . . . . 0.0 108.016 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.2 140.05 37.8 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -129.42 -58.41 1.12 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.252 1.227 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.063 -173.499 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.24 154.26 71.53 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 119.127 0.876 . . . . 0.0 108.877 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.06 164.65 34.99 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.443 2.095 . . . . 0.0 110.879 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.29 -47.12 92.37 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.326 9.0 m -53.08 -38.56 62.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.648 1.179 . . . . 0.0 113.092 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -51.52 -58.56 5.96 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.0 1.273 . . . . 0.0 108.497 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -55.24 -48.25 74.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.856 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -53.99 -40.89 67.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.924 1.238 . . . . 0.0 111.009 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.7 t -68.85 -43.61 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.933 -1.105 . . . . 0.0 108.854 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.77 -36.35 72.02 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.257 1.389 . . . . 0.0 111.359 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -33.42 42.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 118.451 -2.655 . . . . 0.0 113.022 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -98.92 158.77 15.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 122.204 1.002 . . . . 0.0 110.928 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.29 141.13 41.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.44 175.09 47.41 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.13 144.76 8.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 125.143 1.377 . . . . 0.0 107.585 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.76 159.27 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.62 152.1 38.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.387 1.475 . . . . 0.0 107.289 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mt -138.99 117.94 13.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.98 108.5 19.61 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -89.03 110.83 21.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -73.95 141.81 45.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 122.11 2.232 . . . . 0.0 107.204 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.25 -81.8 0.26 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.63 -61.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.482 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 15.0 p-10 -81.55 38.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.189 2.196 . . . . 0.0 110.165 173.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.57 151.58 23.52 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.04 -1.037 . . . . 0.0 113.761 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.88 158.32 46.52 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.269 1.979 . . . . 0.0 112.918 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.32 101.86 7.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.107 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 tp -74.01 88.8 1.9 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.19 0.904 . . . . 0.0 110.666 174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.86 170.97 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.986 1.315 . . . . 0.0 110.352 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.41 165.21 14.62 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.868 1.267 . . . . 0.0 111.172 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -168.41 172.31 8.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.7 2.0 . . . . 0.0 107.978 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.22 141.66 50.66 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.319 1.448 . . . . 0.0 110.235 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -51.2 -28.32 11.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.4 0.68 . . . . 0.0 111.104 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.41 -14.87 8.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.859 2.464 . . . . 0.0 111.751 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -118.13 -5.21 10.94 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.995 1.718 . . . . 0.0 109.686 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 mt -97.32 171.64 8.29 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 120.332 -1.48 . . . . 0.0 112.882 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' HZ1' ' CD ' ' A' ' 97' ' ' GLU . 10.4 ptmt -136.08 135.87 39.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.55 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.4 mt -121.24 -178.18 3.71 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.073 1.749 . . . . 0.0 107.491 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 22.7 t0 -75.55 176.98 7.09 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 109.264 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 60.02 30.25 69.74 Favored Glycine 0 CA--C 1.525 0.698 0 O-C-N 120.475 -1.391 . . . . 0.0 110.831 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 p30 53.84 12.88 0.46 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.864 3.665 . . . . 0.0 114.868 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -74.8 122.44 23.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.9 mm -114.02 155.57 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.46 140.54 41.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.22 138.99 29.78 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 127.476 2.31 . . . . 0.0 108.778 -173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.5 108.02 1.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.677 1.585 . . . . 0.0 109.589 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.404 HG12 ' CE2' ' A' ' 91' ' ' PHE . 2.4 p -85.87 111.81 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.35 -21.59 5.12 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.133 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 41.38 0.34 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.6 mtt -108.78 71.23 0.77 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 173.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -64.03 -63.11 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 129.817 3.247 . . . . 0.0 112.666 -173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.482 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 54.2 tttm -51.8 -40.75 60.94 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.351 173.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -62.92 -38.86 92.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.496 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -58.45 -50.42 73.78 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.611 1.55 . . . . 0.0 109.683 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.29 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.201 -0.312 . . . . 0.0 111.375 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -62.73 -41.8 99.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.044 -1.455 . . . . 0.0 110.336 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.69 -47.98 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 120.192 1.36 . . . . 0.0 108.542 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -23.63 13.55 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.528 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -87.44 -46.55 9.52 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.25 -1.531 . . . . 0.0 114.127 173.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -151.26 137.11 18.08 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.532 1.133 . . . . 0.0 112.656 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -22.48 54.34 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.67 126.57 27.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.697 1.589 . . . . 0.0 111.017 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.07 144.06 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 111.941 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.75 150.36 21.14 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 16.8 ttt -139.17 120.8 15.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.7 p -108.82 127.97 54.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 pp -116.95 163.27 16.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 119.641 1.109 . . . . 0.0 109.229 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.05 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.5 t -158.1 166.91 31.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -99.02 -9.37 24.03 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -9.42 59.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.888 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.93 131.08 36.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.866 0.867 . . . . 0.0 110.437 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.38 5.9 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 125.575 1.56 . . . . 0.0 111.253 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.3 mmt-85 -84.08 -58.76 2.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.45 102.58 9.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.8 -168.07 0.16 Allowed Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.47 -1.394 . . . . 0.0 112.18 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.49 89.73 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 108.014 -1.571 . . . . 0.0 108.014 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.74 121.32 0.7 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-O 117.231 -1.872 . . . . 0.0 109.391 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.08 169.75 9.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.624 1.712 . . . . 0.0 110.906 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.62 -176.18 43.65 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 123.381 0.515 . . . . 0.0 112.576 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.4 145.68 49.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.127 2.171 . . . . 0.0 109.348 -174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.0 131.03 47.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.0 159.51 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -125.92 149.29 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.653 1.581 . . . . 0.0 107.782 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.84 -176.22 36.33 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.76 0.695 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.1 m -120.35 129.12 53.83 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.944 1.697 . . . . 0.0 108.102 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.23 160.23 14.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.871 1.668 . . . . 0.0 112.288 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.14 120.91 3.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.82 1.248 . . . . 0.0 108.678 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.404 ' CE2' HG12 ' A' ' 48' ' ' VAL . 3.3 m-85 -76.71 144.48 39.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -140.84 138.28 33.87 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.148 1.379 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.3 p -120.87 40.93 3.42 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -159.17 157.18 30.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.754 2.821 . . . . 0.0 111.317 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.77 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.899 1.238 . . . . 0.0 114.538 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.79 -8.67 22.05 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.329 2.686 . . . . 0.0 110.687 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.477 ' CD ' ' HZ1' ' A' ' 37' ' ' LYS . 24.7 mm-40 -70.72 -63.18 1.14 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 108.15 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.13 -31.81 71.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.436 -0.793 . . . . 0.0 111.245 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -73.45 -48.43 33.68 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.915 0.779 . . . . 0.0 111.346 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.78 -25.16 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.003 -1.685 . . . . 0.0 112.12 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.377 1.2 pp -89.51 -18.22 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.855 1.207 . . . . 0.0 110.844 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.7 -27.52 2.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.048 2.539 . . . . 0.0 110.687 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -49.02 -37.21 19.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.073 0.949 . . . . 0.0 110.543 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -80.62 178.0 8.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 -0.56 1.39 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 117.979 -2.95 . . . . 0.0 111.864 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -87.56 8.33 25.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.914 1.286 . . . . 0.0 111.127 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.64 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.914 1.286 . . . . 0.0 111.962 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 -21.97 6.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 128.47 2.708 . . . . 0.0 111.119 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.27 162.03 1.89 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.203 1.801 . . . . 0.0 110.445 -173.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.42 104.6 14.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.69 94.02 5.01 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.099 1.759 . . . . 0.0 107.079 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.0 127.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.39 128.97 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.6 m -100.15 100.5 11.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.4 158.46 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.984 0.897 . . . . 0.0 109.304 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.57 -56.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 m -140.92 124.78 17.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 119.215 -0.421 . . . . 0.0 111.432 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.5 149.57 41.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.36 2.664 . . . . 0.0 111.176 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -141.68 144.66 34.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.134 1.774 . . . . 0.0 108.232 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -74.01 140.51 45.5 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -136.86 -77.61 0.41 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.255 1.364 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 -173.244 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.09 153.46 34.98 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.82 164.73 31.36 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.238 2.625 . . . . 0.0 111.877 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.92 96.58 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -55.7 -39.5 71.12 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.232 1.413 . . . . 0.0 110.446 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -51.06 -57.09 9.56 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.974 0.806 . . . . 0.0 110.017 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -58.83 -48.7 80.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.834 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -59.21 -41.16 87.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.08 -39.49 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.634 1.106 . . . . 0.0 109.107 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -58.55 -44.92 89.82 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.837 1.198 . . . . 0.0 111.251 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -51.99 -21.31 2.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -106.91 178.47 4.55 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 125.495 1.518 . . . . 0.0 110.983 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -73.55 129.43 37.96 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.15 167.16 33.81 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.01 146.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 173.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 t -130.52 159.8 42.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.54 160.01 41.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.612 1.165 . . . . 0.0 108.999 175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.3 mt -139.24 120.44 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.14 108.44 20.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.2 m -89.84 116.35 27.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 116.873 -1.536 . . . . 0.0 107.048 -173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -73.42 135.81 44.23 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 121.582 1.992 . . . . 0.0 106.394 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.66 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.2 -59.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.473 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 15.9 p-10 -78.83 39.21 0.35 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.35 2.66 . . . . 0.0 111.429 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.34 151.47 21.01 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.238 0.923 . . . . 0.0 111.053 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.08 149.08 89.59 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 118.335 1.068 . . . . 0.0 109.986 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' HG1' ' A' ' 54' ' ' THR . 0.5 OUTLIER -115.43 99.71 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.633 1.573 . . . . 0.0 110.641 -173.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.1 tp -82.13 103.54 11.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 110.406 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.15 168.65 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.675 1.59 . . . . 0.0 110.868 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -126.63 164.13 21.94 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -168.41 172.46 8.32 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.248 1.819 . . . . 0.0 110.242 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.37 141.77 50.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.913 2.485 . . . . 0.0 108.809 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.87 -30.38 45.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.57 0.623 . . . . 0.0 111.695 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -57.72 -13.72 4.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.576 1.95 . . . . 0.0 113.145 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -118.3 -2.47 11.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.793 1.237 . . . . 0.0 110.194 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.4 mt -101.07 168.1 9.81 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.589 1.086 . . . . 0.0 111.82 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -136.87 128.76 29.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.3 142.95 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -121.06 -178.61 3.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.39 1.876 . . . . 0.0 106.183 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 39.9 t0 -73.71 -178.81 3.31 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 59.77 29.18 66.84 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 120.392 -1.443 . . . . 0.0 110.423 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.1 13.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 129.209 3.004 . . . . 0.0 115.155 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -73.18 141.73 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.361 0.982 . . . . 0.0 110.58 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.87 154.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.36 143.98 24.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.94 134.38 26.05 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 126.649 1.98 . . . . 0.0 107.419 -174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.18 118.03 4.83 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.875 2.383 . . . . 0.0 107.651 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.34 111.5 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.348 0.976 . . . . 0.0 108.999 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.94 -21.68 9.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.24 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.66 18.87 0.3 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 120.467 2.134 . . . . 0.0 114.386 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.9 mtt -97.96 52.24 1.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.77 1.285 . . . . 0.0 108.176 -173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -64.0 -51.55 63.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.368 0.667 . . . . 0.0 111.6 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HZ1' ' CG ' ' A' ' 24' ' ' ASP 0.285 17.5 ttpp -52.19 -41.16 62.42 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.325 -1.484 . . . . 0.0 110.839 173.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.72 ' HG1' ' CD2' ' A' ' 27' ' ' HIS 0.27 1.6 m -60.35 -38.42 83.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.143 1.338 . . . . 0.0 113.026 173.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -55.39 -45.14 76.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.826 1.25 . . . . 0.0 107.829 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.31 81.07 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.958 -0.464 . . . . 0.0 111.647 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -59.6 -41.73 90.98 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 117.367 -1.301 . . . . 0.0 109.904 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.33 -48.24 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.122 1.328 . . . . 0.0 108.917 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.68 -25.98 12.49 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.439 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -85.79 -46.44 10.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 173.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -151.5 134.08 15.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.991 1.268 . . . . 0.0 111.072 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -19.77 57.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 130.63 46.8 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.274 1.397 . . . . 0.0 110.92 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.8 m -142.32 155.86 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 123.797 1.76 . . . . 0.0 112.99 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.9 tp -101.17 151.16 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.6 ttt -139.24 141.48 37.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 p -129.7 140.69 51.06 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.91 163.97 15.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.93 178.66 46.61 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.2 t -151.24 169.36 22.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -98.87 -18.36 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.55 1.54 . . . . 0.0 108.964 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -91.81 -1.46 57.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 117.073 -1.442 . . . . 0.0 113.938 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 t -130.99 127.03 60.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.32 131.42 36.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 109.149 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.97 -141.12 6.46 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -79.17 -59.02 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.733 1.613 . . . . 0.0 109.434 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.65 102.99 14.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.5 -169.4 2.21 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.84 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.86 69.39 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.456 2.104 . . . . 0.0 110.412 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.49 108.37 0.32 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -101.88 169.57 8.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.06 172.55 45.48 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.457 1.031 . . . . 0.0 114.472 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.09 151.25 51.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 110.248 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -100.9 131.5 46.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 128.838 2.855 . . . . 0.0 104.464 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 12.8 mt -135.59 153.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.1 mtt-85 -132.97 135.78 45.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.61 36.22 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.805 1.184 . . . . 0.0 112.182 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -121.23 148.21 44.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.729 0.812 . . . . 0.0 109.285 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.2 162.18 13.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.905 1.682 . . . . 0.0 110.669 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.3 113.07 2.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.536 1.134 . . . . 0.0 109.64 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -74.17 134.24 42.78 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -141.14 141.06 34.19 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.1 p -116.58 41.1 2.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.55 154.14 26.16 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.588 2.355 . . . . 0.0 110.466 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.1 178.67 47.3 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.854 1.692 . . . . 0.0 114.146 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.94 -9.42 19.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.709 2.939 . . . . 0.0 111.491 173.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -67.34 -64.8 0.78 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.402 1.481 . . . . 0.0 107.253 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -61.54 -31.4 71.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.485 1.114 . . . . 0.0 111.486 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.71 -56.07 9.32 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.304 0.956 . . . . 0.0 109.234 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.66 68.8 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.966 -1.084 . . . . 0.0 112.195 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.334 1.1 pp -85.89 -18.17 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.754 1.161 . . . . 0.0 111.869 173.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.68 -27.97 3.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.663 1.585 . . . . 0.0 112.062 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -50.53 -21.89 1.71 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.486 1.114 . . . . 0.0 113.827 173.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -80.91 178.66 8.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.706 1.139 . . . . 0.0 110.702 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -133.6 11.12 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.077 -1.639 . . . . 0.0 111.517 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -138.1 8.99 2.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.848 1.259 . . . . 0.0 112.968 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 151.84 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.307 1.043 . . . . 0.0 111.116 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 -21.93 11.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.392 1.077 . . . . 0.0 110.342 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.19 161.96 1.52 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 127.718 2.407 . . . . 0.0 109.206 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.43 105.97 18.05 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tp -79.63 92.82 5.4 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.35 129.76 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.092 1.357 . . . . 0.0 107.666 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.6 mm -117.28 133.7 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -112.02 97.28 6.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.53 161.26 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.464 1.506 . . . . 0.0 110.361 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.69 -55.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.2 m -151.54 141.46 22.02 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.832 -1.167 . . . . 0.0 112.476 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.1 138.74 48.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.938 2.895 . . . . 0.0 106.599 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -140.08 137.42 34.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.185 1.794 . . . . 0.0 107.749 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -77.15 141.16 40.28 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.6 p -129.64 -58.62 1.1 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.739 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . 0.481 " C5'" HO2' ' A' ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp -130.68 154.2 81.72 Favored Pre-proline 0 N--CA 1.465 0.302 0 C-N-CA 124.764 1.225 . . . . 0.0 108.748 -171.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.09 154.63 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.713 2.275 . . . . 0.0 110.049 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.79 92.87 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -49.58 -38.57 31.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.682 1.593 . . . . 0.0 112.21 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -50.53 -54.75 20.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.226 1.375 . . . . 0.0 109.729 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -61.09 -48.54 81.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.516 1.126 . . . . 0.0 109.117 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.75 -34.14 74.0 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.1 t -72.71 -42.54 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.65 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.82 -39.75 82.13 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.437 1.471 . . . . 0.0 112.596 173.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -51.88 -24.99 7.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.965 0.802 . . . . 0.0 112.546 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -99.85 159.2 15.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.865 0.866 . . . . 0.0 109.402 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.56 146.12 45.01 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.335 -0.853 . . . . 0.0 109.078 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.27 171.23 43.1 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.444 HG21 HH12 ' A' ' 71' ' ' ARG . 6.6 t -101.63 148.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.0 t -124.61 158.44 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 128.544 2.738 . . . . 0.0 104.771 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.58 153.61 47.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 mt -139.2 116.82 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.0 108.43 19.58 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -89.35 109.22 20.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 116.035 -1.935 . . . . 0.0 106.662 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -73.74 141.74 46.31 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 122.015 2.189 . . . . 0.0 107.754 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.52 -59.04 0.16 Allowed Glycine 0 C--O 1.223 -0.562 0 C-N-CA 123.56 0.6 . . . . 0.0 111.807 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 168.51 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 129.491 3.117 . . . . 0.0 107.856 -177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' H ' ' NH2' ' A' ' 60' ' ' ARG . 4.0 p-10 -78.7 46.98 0.7 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.819 1.771 . . . . 0.0 110.173 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.8 150.96 5.47 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.478 1.99 . . . . 0.0 111.36 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.37 162.44 38.34 Favored 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 120.463 0.775 . . . . 0.0 110.693 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -120.94 101.75 7.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 118.569 -0.729 . . . . 0.0 109.443 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tp -74.05 88.79 1.91 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.308 0.504 . . . . 0.0 110.541 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.39 169.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.719 1.208 . . . . 0.0 110.297 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -120.79 167.94 11.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.757 1.223 . . . . 0.0 111.333 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.25 170.23 10.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.549 1.94 . . . . 0.0 108.089 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -116.78 141.63 47.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.637 1.975 . . . . 0.0 109.338 -177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -55.17 -30.7 60.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -51.16 -21.05 1.76 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.174 2.589 . . . . 0.0 113.401 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -118.17 -4.33 10.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.207 1.403 . . . . 0.0 112.208 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.5 mt -97.08 166.83 11.4 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.036 1.289 . . . . 0.0 112.024 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -136.52 132.45 35.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -101.41 142.58 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.061 -2.199 . . . . 0.0 105.061 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.22 179.18 4.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.411 1.484 . . . . 0.0 108.274 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -70.33 174.81 5.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.194 0.998 . . . . 0.0 109.797 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.29 33.99 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.742 1.639 . . . . 0.0 110.928 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.277 0.1 OUTLIER 53.49 19.87 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.893 2.077 . . . . 0.0 114.694 -176.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -74.69 135.79 41.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.92 161.12 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.5 t -144.64 145.46 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 O-C-N 120.674 -1.266 . . . . 0.0 108.379 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.21 137.53 31.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.605 2.762 . . . . 0.0 107.126 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.34 108.47 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.898 2.398 . . . . 0.0 111.066 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.85 111.87 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 108.853 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.94 -21.83 4.81 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.555 1.074 . . . . 0.0 112.605 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.71 41.13 0.43 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.089 -1.395 . . . . 0.0 110.135 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.4 mtt -108.65 71.48 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.149 1.379 . . . . 0.0 107.532 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -64.21 -65.33 0.69 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.284 3.433 . . . . 0.0 114.444 -173.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -51.7 -40.29 59.86 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.245 0.93 . . . . 0.0 108.602 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -63.14 -39.58 95.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.209 -0.9 . . . . 0.0 112.984 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 22.2 tt0 -58.59 -51.04 71.59 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 120.654 1.57 . . . . 0.0 109.623 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.59 -48.02 83.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.503 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -61.02 -41.97 97.57 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 116.197 -1.858 . . . . 0.0 111.311 -173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -48.09 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 120.248 1.385 . . . . 0.0 108.845 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.26 54.15 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.066 -0.969 . . . . 0.0 113.234 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' NH2' ' H ' ' A' ' 24' ' ' ASP . 14.4 mtp180 -87.51 -46.91 9.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.027 1.285 . . . . 0.0 113.675 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -142.56 128.93 20.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.291 1.044 . . . . 0.0 111.802 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -18.86 58.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.65 126.48 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.389 1.45 . . . . 0.0 111.176 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.81 141.47 36.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.997 1.38 . . . . 0.0 112.584 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tp -89.59 154.24 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.1 ttt -140.25 141.23 35.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.0 p -124.97 135.88 53.21 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 pp -116.47 164.64 14.27 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.007 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.67 178.78 41.94 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.5 t -147.29 174.11 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.945 1.298 . . . . 0.0 108.948 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.444 HH12 HG21 ' A' ' 15' ' ' VAL . 69.6 mtt85 -117.01 -8.03 11.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.425 2.29 . . . . 0.0 109.797 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 mmpm? -91.64 -11.08 38.08 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 119.482 -2.011 . . . . 0.0 115.304 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.37 133.1 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.21 131.48 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.29 1.036 . . . . 0.0 111.403 -174.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.89 -141.19 6.95 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.457 HH21 ' C ' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -85.9 -59.23 2.36 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.212 1.405 . . . . 0.0 107.607 176.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.49 102.95 6.24 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.82 -168.94 1.83 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 121.608 0.56 . . . . 0.0 112.964 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.0 58.98 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.612 2.208 . . . . 0.0 110.87 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.55 120.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 t -113.72 168.95 9.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 117.777 0.789 . . . . 0.0 110.222 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.7 -176.72 40.23 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 124.703 1.144 . . . . 0.0 113.2 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.76 153.6 45.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.576 1.15 . . . . 0.0 109.662 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.52 129.53 47.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.8 mp -139.98 161.46 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 108.602 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.429 HH22 ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -139.15 151.06 46.33 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.605 -1.31 . . . . 0.0 107.905 173.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.13 -174.94 33.62 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.053 0.835 . . . . 0.0 111.782 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -115.93 129.34 56.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.245 1.418 . . . . 0.0 108.161 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.01 14.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.017 1.327 . . . . 0.0 112.162 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.01 120.68 3.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.767 1.227 . . . . 0.0 108.926 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.2 m-85 -76.73 140.58 40.87 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -140.8 139.24 34.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.672 1.189 . . . . 0.0 111.249 173.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -121.21 39.84 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 103.236 -2.875 . . . . 0.0 103.236 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.253 7.5 t70 -158.87 150.19 20.5 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.951 2.9 . . . . 0.0 111.55 -172.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.04 179.03 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.35 0.976 . . . . 0.0 114.183 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.42 -9.54 13.42 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.046 3.164 . . . . 0.0 112.179 173.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -67.66 -67.61 0.45 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.584 1.953 . . . . 0.0 106.943 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.45 -31.62 71.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.813 0.845 . . . . 0.0 111.925 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.71 -54.07 18.33 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.57 -32.56 72.66 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.099 -1.001 . . . . 0.0 112.567 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.403 1.1 pp -79.08 -17.84 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.017 0.826 . . . . 0.0 112.612 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.1 -27.69 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 111.367 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -45.67 -27.95 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.822 1.249 . . . . 0.0 112.975 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.06 178.88 8.14 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.306 1.042 . . . . 0.0 110.689 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -140.48 21.04 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 119.812 -1.805 . . . . 0.0 111.002 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -136.97 8.77 3.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.246 1.418 . . . . 0.0 111.117 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.22 25.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.68 -0.637 . . . . 0.0 110.664 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -21.05 8.01 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.173 2.189 . . . . 0.0 111.282 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.58 161.57 11.56 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.948 1.299 . . . . 0.0 109.772 -174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.88 104.38 14.63 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.73 93.64 4.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.91 131.44 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.05 128.28 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 24.7 m -99.21 90.43 4.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.6 159.38 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.66 -57.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.0 m -148.93 141.09 23.96 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.209 0.459 . . . . 0.0 112.038 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.91 138.88 53.89 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.306 3.042 . . . . 0.0 109.485 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.429 ' CD ' HH22 ' A' ' 86' ' ' ARG . 17.7 pm0 -140.68 151.31 44.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.779 0.832 . . . . 0.0 110.874 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.77 138.12 57.72 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 125.036 1.334 . . . . 0.0 109.944 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -138.45 -81.31 0.32 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.432 0.458 . . . . 0.0 110.836 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.457 ' C ' HH21 ' A' ' 76' ' ' ARG . 2.1 pp . . . . . 0 C--O 1.242 0.665 0 C-N-CA 123.955 0.902 . . . . 0.0 110.43 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mpp? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.5 mp -128.11 152.18 77.25 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 124.547 1.139 . . . . 0.0 108.197 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.47 156.28 58.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.291 1.994 . . . . 0.0 110.321 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.77 92.89 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.49 -38.68 55.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.838 1.655 . . . . 0.0 112.234 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -50.79 -54.23 25.31 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.337 1.426 . . . . 0.0 109.401 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.86 -48.58 76.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.515 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -60.26 -33.78 72.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.346 0.975 . . . . 0.0 112.482 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.05 -41.03 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.484 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -39.77 85.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.88 1.218 . . . . 0.0 112.047 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.72 -24.85 6.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.975 1.261 . . . . 0.0 112.433 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -101.48 158.6 15.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.94 0.791 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.22 148.68 41.36 Favored 'General case' 0 C--O 1.243 0.741 0 O-C-N 121.074 -1.016 . . . . 0.0 109.818 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.19 168.23 39.37 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 122.852 0.263 . . . . 0.0 112.724 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -101.08 144.53 12.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.33 159.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 127.752 2.421 . . . . 0.0 105.607 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.16 157.32 45.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.32 1.048 . . . . 0.0 109.531 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.7 118.7 12.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 125.232 1.413 . . . . 0.0 107.71 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.92 108.78 19.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m -88.79 109.42 20.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -73.53 141.23 46.73 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.42 -81.63 0.22 Allowed Glycine 0 C--O 1.221 -0.714 0 N-CA-C 106.007 -2.837 . . . . 0.0 106.007 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -170.69 -59.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.92 52.12 1.21 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.497 1.618 . . . . 0.0 110.201 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.57 144.94 3.93 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.83 2.157 . . . . 0.0 111.551 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.92 161.29 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.362 1.374 . . . . 0.0 109.983 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.654 ' CD2' ' HG1' ' A' ' 54' ' ' THR . 0.6 OUTLIER -121.12 97.46 5.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.976 1.71 . . . . 0.0 107.462 -173.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 11.0 tp -83.55 88.55 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.8 0.727 . . . . 0.0 109.322 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.23 169.04 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.013 0.925 . . . . 0.0 110.293 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.81 167.61 11.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.235 1.414 . . . . 0.0 112.856 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 t -168.35 174.61 6.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.627 1.971 . . . . 0.0 108.021 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -120.56 141.99 49.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.702 2.401 . . . . 0.0 109.463 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -53.88 -30.75 47.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.334 0.97 . . . . 0.0 109.737 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -52.15 -21.16 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.535 2.334 . . . . 0.0 112.671 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -118.12 -5.12 10.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.921 1.688 . . . . 0.0 112.108 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.7 mt -87.8 159.22 18.52 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.506 1.503 . . . . 0.0 111.588 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.403 ' HE3' ' CB ' ' A' ' 100' ' ' ALA 0.25 0.0 OUTLIER -136.36 131.85 34.79 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.802 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.18 147.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.57 178.89 4.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.397 1.879 . . . . 0.0 107.725 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 27.8 t0 -71.28 175.86 5.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.107 0.963 . . . . 0.0 110.47 173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 56.87 28.43 57.57 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.333 1.444 . . . . 0.0 111.476 -176.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.272 0.1 OUTLIER 53.72 20.73 2.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.415 1.886 . . . . 0.0 114.375 -175.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -73.97 126.31 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.152 1.381 . . . . 0.0 107.373 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.66 159.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -146.0 144.28 20.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 120.536 -1.353 . . . . 0.0 109.262 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.92 136.54 28.59 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.925 2.09 . . . . 0.0 107.534 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.69 108.32 1.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.455 2.104 . . . . 0.0 109.039 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG12 ' CE2' ' A' ' 91' ' ' PHE . 2.4 p -85.49 111.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.19 -21.33 10.11 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.338 1.447 . . . . 0.0 113.255 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.92 0.31 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 119.305 1.553 . . . . 0.0 115.09 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -97.89 67.94 1.99 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 123.394 1.568 . . . . 0.0 108.353 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -64.21 -48.79 74.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.193 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.255 81.8 tttt -52.04 -36.29 49.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.794 1.633 . . . . 0.0 110.674 173.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.654 ' HG1' ' CD2' ' A' ' 27' ' ' HIS . 1.8 m -64.86 -39.51 93.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.429 1.468 . . . . 0.0 110.705 174.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -55.08 -50.73 68.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.507 1.503 . . . . 0.0 110.631 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.1 79.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.131 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -58.52 -41.99 86.72 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 115.781 -2.057 . . . . 0.0 111.45 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.16 -48.36 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.874 1.216 . . . . 0.0 109.116 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.94 66.05 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.267 -0.873 . . . . 0.0 113.277 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -87.44 -47.06 9.07 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.662 1.119 . . . . 0.0 112.48 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -140.04 132.31 28.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.65 1.18 . . . . 0.0 112.325 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.97 -22.52 55.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.51 129.65 42.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.896 1.225 . . . . 0.0 112.47 -173.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.4 m -139.29 139.4 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.837 1.303 . . . . 0.0 112.336 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.2 tp -92.98 153.7 18.59 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 172.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.6 ttt -140.03 141.37 36.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -123.17 130.62 53.0 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 pp -115.35 166.19 12.14 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.617 1.098 . . . . 0.0 108.38 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.63 179.11 41.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 173.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.2 t -147.18 168.67 21.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.687 1.595 . . . . 0.0 108.157 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -116.42 -9.41 11.48 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.014 1.326 . . . . 0.0 109.87 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -92.38 -11.67 34.3 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.44 134.19 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 118.5 20.66 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.941 0.791 . . . . 0.0 112.33 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.5 -127.26 3.37 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.91 1.243 . . . . 0.0 111.704 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -91.68 -58.7 2.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -74.62 102.63 4.64 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 109.875 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.55 -167.9 0.4 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.27 62.85 5.25 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.72 121.88 1.39 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 129.73 3.538 . . . . 0.0 106.83 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -109.98 176.82 4.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.132 0.966 . . . . 0.0 110.699 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.52 177.41 44.38 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 124.839 1.209 . . . . 0.0 112.158 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -138.4 154.65 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.149 0.979 . . . . 0.0 108.369 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.27 129.3 47.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.46 154.04 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 119' ' ' GLU . 36.7 mtm180 -135.89 141.64 44.61 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.882 1.273 . . . . 0.0 108.618 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -169.81 34.94 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.412 0.53 . . . . 0.0 112.238 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.8 m -121.11 151.1 40.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.959 1.303 . . . . 0.0 109.074 173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.32 163.64 13.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.625 1.17 . . . . 0.0 113.017 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.59 121.19 3.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.103 1.361 . . . . 0.0 109.377 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.423 ' CE2' HG12 ' A' ' 48' ' ' VAL . 3.5 m-85 -77.55 149.07 34.93 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.231 -0.918 . . . . 0.0 111.989 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -141.03 134.42 29.78 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 125.339 1.456 . . . . 0.0 107.709 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.0 p -120.42 20.17 11.93 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.597 173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.75 150.1 20.65 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.698 2.399 . . . . 0.0 109.583 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.59 -177.83 45.45 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.917 1.246 . . . . 0.0 112.507 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.26 -14.27 19.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.133 3.222 . . . . 0.0 113.524 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.3 -63.72 1.01 Allowed 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.101 -0.999 . . . . 0.0 108.978 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.64 -31.62 71.73 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.448 1.499 . . . . 0.0 111.079 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -69.12 -49.66 55.01 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.438 0.695 . . . . 0.0 109.636 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.403 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -61.13 -35.39 76.94 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.146 -0.971 . . . . 0.0 111.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.402 0.8 OUTLIER -79.02 -17.89 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.736 173.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.2 -27.58 2.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.691 1.996 . . . . 0.0 112.22 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -47.65 -36.38 10.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.305 1.042 . . . . 0.0 111.205 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -80.89 177.95 8.72 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.308 0.958 . . . . 0.0 108.537 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -141.14 -0.6 1.44 Allowed 'General case' 0 C--O 1.222 -0.393 0 O-C-N 119.18 -2.2 . . . . 0.0 112.262 -176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -106.3 8.87 32.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.032 1.733 . . . . 0.0 110.873 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.41 145.75 29.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.389 -0.819 . . . . 0.0 110.869 -174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -121.29 -13.71 8.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.864 2.866 . . . . 0.0 111.913 -174.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -173.78 161.71 3.89 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.143 2.177 . . . . 0.0 109.536 177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.17 101.97 11.42 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.386 2.275 . . . . 0.0 105.012 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.07 95.91 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.672 1.589 . . . . 0.0 106.764 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.98 131.67 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.16 128.49 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.6 m -98.92 88.46 4.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 86.4 t -61.03 156.13 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.827 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.49 -55.46 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.5 m -148.5 141.25 24.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.666 0.666 . . . . 0.0 112.32 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.35 138.73 51.59 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 128.919 2.887 . . . . 0.0 107.886 173.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 86' ' ' ARG . 3.3 pm0 -140.1 138.68 35.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 110.609 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 138.58 58.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 111.928 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -143.39 -80.51 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.259 0.624 . . . . 0.0 112.299 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 114.892 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . 0.404 HO4' ' P ' ' A' ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -136.16 153.26 76.54 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.156 1.382 . . . . 0.0 108.691 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.12 164.34 35.68 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.813 2.342 . . . . 0.0 110.329 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.86 -47.56 89.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.367 5.0 m -50.3 -38.11 39.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.255 1.822 . . . . 0.0 113.635 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -50.65 -51.97 44.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.095 1.316 . . . . 0.0 110.649 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -63.55 -48.35 77.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.035 0.934 . . . . 0.0 110.13 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.71 -38.09 66.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.427 1.012 . . . . 0.0 111.757 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.86 -43.77 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.083 -1.011 . . . . 0.0 109.629 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.65 -35.06 75.28 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.202 1.364 . . . . 0.0 112.32 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -51.84 -27.09 11.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.025 0.93 . . . . 0.0 112.133 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -99.37 159.2 15.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.468 1.107 . . . . 0.0 108.114 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.92 153.34 39.86 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 122.077 0.941 . . . . 0.0 109.151 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.97 174.52 45.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 125.611 1.577 . . . . 0.0 109.422 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.92 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.74 160.93 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.22 154.69 44.1 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.84 116.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -174.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.56 108.86 19.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -94.36 123.05 37.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 116.971 -1.49 . . . . 0.0 108.134 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -72.91 119.55 17.31 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 121.242 1.837 . . . . 0.0 106.579 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.29 -81.65 0.23 Allowed Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.136 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -158.63 -60.7 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -78.82 41.03 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.113 2.565 . . . . 0.0 110.479 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.63 152.24 9.47 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.25 148.05 42.81 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 CA-C-N 120.791 2.295 . . . . 0.0 107.973 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.535 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 43.2 t60 -103.3 101.3 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.195 -172.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -76.22 88.53 3.08 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.168 0.587 . . . . 0.0 110.425 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -83.24 170.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.887 1.675 . . . . 0.0 110.069 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.13 166.1 13.35 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.09 1.314 . . . . 0.0 113.793 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.0 t -168.32 176.19 6.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.374 2.27 . . . . 0.0 108.054 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -118.95 141.81 48.34 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.659 1.983 . . . . 0.0 109.721 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.07 -31.56 42.37 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.372 0.669 . . . . 0.0 110.016 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -60.76 -11.79 8.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.903 3.281 . . . . 0.0 112.108 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -118.68 -6.36 10.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 111.58 -177.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.6 mt -95.05 160.11 14.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.089 1.313 . . . . 0.0 112.084 -173.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 141.61 44.64 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.28 150.95 5.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -122.0 179.21 4.59 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 128.461 2.704 . . . . 0.0 107.103 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.97 -179.91 2.47 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.26 28.21 26.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.479 1.514 . . . . 0.0 111.245 -173.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.342 0.1 OUTLIER 53.39 24.59 4.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.891 2.076 . . . . 0.0 114.32 -175.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.45 151.26 41.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.29 164.38 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -144.43 140.93 24.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.0 124.86 26.44 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 127.483 2.313 . . . . 0.0 105.4 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.87 108.52 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.116 1.878 . . . . 0.0 109.008 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.83 111.61 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -21.24 6.85 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 112.077 173.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.3 40.89 0.31 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 119.095 1.448 . . . . 0.0 110.697 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 28.7 mtt -106.56 57.5 0.65 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.799 1.239 . . . . 0.0 108.598 173.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.53 -49.81 37.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.627 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.535 ' HZ3' ' CG ' ' A' ' 27' ' ' HIS . 1.2 tmmt? -52.17 -41.3 62.48 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.821 1.646 . . . . 0.0 110.854 173.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -61.1 -38.91 88.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.514 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.53 -49.51 76.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 121.04 1.746 . . . . 0.0 110.413 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.62 97.08 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -61.88 -41.94 98.46 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.567 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.36 -48.15 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.746 1.157 . . . . 0.0 109.32 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.14 53.18 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.387 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.5 mtp85 -85.56 -46.31 10.94 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.102 0.864 . . . . 0.0 112.726 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.46 129.21 15.2 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.161 0.984 . . . . 0.0 110.962 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -73.92 -17.75 60.98 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.53 123.19 16.04 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 m -138.82 141.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 123.082 1.42 . . . . 0.0 110.52 173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 tt -107.32 148.48 28.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 102.091 -3.299 . . . . 0.0 102.091 172.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.4 ttt -141.66 121.06 13.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -108.93 128.36 54.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 168.52 10.01 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.042 1.292 . . . . 0.0 107.847 173.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.64 -169.22 31.8 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -147.01 175.47 10.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.409 1.099 . . . . 0.0 108.707 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -113.87 -7.94 13.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.676 2.391 . . . . 0.0 109.317 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mmpm? -91.46 -10.95 39.03 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 119.601 -1.937 . . . . 0.0 115.007 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.76 136.49 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.57 131.49 36.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.479 1.112 . . . . 0.0 111.104 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.44 -140.98 6.34 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 124.703 1.144 . . . . 0.0 110.886 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.27 -58.99 2.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.564 1.546 . . . . 0.0 107.731 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.95 102.84 8.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.072 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.24 -168.6 2.26 Favored Glycine 0 CA--C 1.538 1.499 0 O-C-N 121.754 -0.591 . . . . 0.0 112.655 176.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.52 59.74 5.61 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.815 2.344 . . . . 0.0 110.993 174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.25 121.11 1.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -113.47 169.88 8.64 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.477 1.138 . . . . 0.0 110.334 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.2 -177.36 45.15 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 123.602 0.62 . . . . 0.0 113.283 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -136.8 152.67 50.56 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.862 1.265 . . . . 0.0 109.502 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tt -101.39 131.27 47.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.648 2.379 . . . . 0.0 104.58 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -136.06 158.33 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -129.86 150.79 51.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.644 1.178 . . . . 0.0 109.453 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -174.59 40.9 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.455 1.026 . . . . 0.0 111.693 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -106.03 137.35 44.1 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.4 161.93 13.33 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.787 0.722 . . . . 0.0 111.181 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.2 119.24 3.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.148 0.979 . . . . 0.0 109.833 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -74.17 131.52 41.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.2 141.46 50.65 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.83 2.852 . . . . 0.0 109.572 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.14 27.07 8.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.384 1.873 . . . . 0.0 107.425 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -158.81 163.95 36.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.11 2.564 . . . . 0.0 107.797 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.48 178.35 46.82 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.072 1.796 . . . . 0.0 113.077 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.41 -22.91 58.95 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.167 2.578 . . . . 0.0 112.007 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -64.29 -59.31 4.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 173.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -61.56 -31.31 71.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.094 -1.431 . . . . 0.0 112.402 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -68.47 -53.99 19.83 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.957 1.708 . . . . 0.0 108.227 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.51 69.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.909 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.4 pp -93.67 -19.9 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.764 -1.113 . . . . 0.0 112.87 173.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.94 -35.21 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.533 1.969 . . . . 0.0 110.406 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.285 2.2 ptm180 -51.07 -18.18 0.78 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.947 2.099 . . . . 0.0 113.815 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -67.88 -171.2 0.2 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -132.13 4.17 4.07 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 118.597 -2.564 . . . . 0.0 113.786 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 23.3 p-90 -131.05 8.84 4.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.811 0.844 . . . . 0.0 111.704 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.86 140.61 38.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.498 -0.751 . . . . 0.0 109.062 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.21 -10.59 8.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.348 1.459 . . . . 0.0 111.418 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.0 161.85 10.77 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.79 2.436 . . . . 0.0 108.201 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.43 107.63 18.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.802 2.041 . . . . 0.0 106.6 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 tt -84.49 96.34 9.09 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.9 t -79.29 131.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.672 1.589 . . . . 0.0 107.516 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.06 128.86 75.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.4 m -106.09 92.19 4.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.08 157.42 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.888 1.275 . . . . 0.0 110.723 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.52 -56.27 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.9 m -151.29 141.66 22.43 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.37 155.2 29.99 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 128.538 2.735 . . . . 0.0 112.295 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -141.07 140.95 34.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.815 2.046 . . . . 0.0 108.208 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -76.56 140.77 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -138.7 -79.49 0.34 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.307 0.643 . . . . 0.0 111.5 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.242 0.697 0 CA-C-O 116.825 -1.559 . . . . 0.0 112.169 -174.182 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.0 mt -133.18 167.36 23.34 Favored Pre-proline 0 N--CA 1.466 0.368 0 C-N-CA 124.609 1.163 . . . . 0.0 110.05 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.77 152.39 42.48 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.846 2.364 . . . . 0.0 111.939 173.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.84 -39.18 93.54 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.35 -40.27 58.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.624 1.57 . . . . 0.0 111.89 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -51.28 -56.08 14.85 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.251 0.932 . . . . 0.0 110.611 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -56.06 -48.27 76.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.126 0.97 . . . . 0.0 110.454 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -55.41 -35.04 64.95 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.697 0.681 . . . . 0.0 112.565 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.6 t -69.06 -46.59 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.113 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.48 -41.32 69.42 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.169 1.35 . . . . 0.0 112.879 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -51.55 -18.71 1.19 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -119.94 158.69 26.2 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.367 0.985 . . . . 0.0 108.781 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -80.61 149.28 29.93 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.543 -1.348 . . . . 0.0 110.39 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.4 169.63 42.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.705 2.098 . . . . 0.0 110.194 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.1 151.04 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.98 159.58 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 127.574 2.349 . . . . 0.0 105.749 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.72 40.85 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.241 1.416 . . . . 0.0 109.419 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 mt -145.32 115.82 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.82 19.78 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -95.91 108.82 21.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -79.56 141.33 36.71 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 122.002 2.183 . . . . 0.0 106.168 173.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 -81.49 0.22 Allowed Glycine 0 C--O 1.224 -0.486 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -159.06 -61.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.4 45.73 0.68 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.131 1.772 . . . . 0.0 110.123 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 151.62 6.74 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.953 1.263 . . . . 0.0 112.685 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.19 157.72 53.37 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.212 1.275 . . . . 0.0 110.878 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.46 102.03 8.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.087 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.6 tt -87.35 88.71 7.76 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -175.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.58 173.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.762 2.025 . . . . 0.0 110.676 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.63 165.62 14.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.584 1.154 . . . . 0.0 111.574 173.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 178.43 4.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.247 2.219 . . . . 0.0 108.052 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -121.36 141.79 50.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.811 2.044 . . . . 0.0 110.685 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -51.52 -30.98 22.29 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.509 1.049 . . . . 0.0 110.799 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.48 -13.08 4.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.948 2.899 . . . . 0.0 112.008 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -118.14 -1.16 11.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.13 1.372 . . . . 0.0 110.48 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.6 mt -102.4 168.92 9.01 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.599 -1.313 . . . . 0.0 112.762 -173.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HZ1' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -136.72 125.3 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 172.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.3 t -101.69 148.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD23 ' HZ1' ' A' ' 37' ' ' LYS . 46.9 mt -121.58 -177.11 3.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.944 2.098 . . . . 0.0 107.973 173.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 36.2 t0 -71.44 177.99 3.68 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.45 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 49.37 28.15 8.96 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 126.098 1.809 . . . . 0.0 110.443 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.3 0.5 OUTLIER 53.23 28.27 6.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.373 2.269 . . . . 0.0 114.304 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -73.62 144.63 45.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 173.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.79 159.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 t -143.05 141.76 26.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -122.79 140.39 33.11 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.302 2.641 . . . . 0.0 106.066 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.43 110.97 2.02 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.795 2.33 . . . . 0.0 108.61 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.3 112.22 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.25 -21.77 5.44 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.081 -1.012 . . . . 0.0 112.148 173.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.78 41.31 0.35 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.344 1.572 . . . . 0.0 109.958 -175.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.0 mtt -105.71 71.13 0.9 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.677 1.191 . . . . 0.0 108.498 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.39 -65.57 0.66 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 130.048 3.339 . . . . 0.0 114.558 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -51.72 -41.27 61.39 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -63.47 -38.69 92.11 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.66 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.596 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 35.4 tt0 -56.29 -51.22 68.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.242 1.383 . . . . 0.0 109.489 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.53 93.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.175 0.59 . . . . 0.0 112.158 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -65.34 -41.93 93.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.576 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.8 -48.06 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.23 -28.82 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.157 -0.925 . . . . 0.0 112.819 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -86.81 -46.3 10.09 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.598 -1.191 . . . . 0.0 112.087 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -149.05 140.78 23.56 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.749 1.159 . . . . 0.0 110.255 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' CD ' HH21 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -68.64 -13.27 62.24 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -173.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.431 HH21 ' CD ' ' A' ' 62' ' ' GLU . 8.8 mmp_? -49.88 114.16 1.01 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.754 2.422 . . . . 0.0 115.934 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 m -141.7 146.32 23.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 CA-C-O 123.905 1.812 . . . . 0.0 114.797 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tt -111.46 148.78 32.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 101.623 -3.473 . . . . 0.0 101.623 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.4 ttt -141.05 140.98 34.33 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -121.6 128.21 51.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 175.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -117.19 169.73 9.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.227 -1.546 . . . . 0.0 108.112 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.86 -176.22 38.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.8 t -148.65 164.14 35.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.709 0.804 . . . . 0.0 110.364 174.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -98.35 -8.68 26.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.748 1.619 . . . . 0.0 109.447 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -91.39 -9.89 43.12 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 116.891 -1.528 . . . . 0.0 114.725 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -131.45 138.86 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 131.07 36.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.502 0.721 . . . . 0.0 110.753 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.25 -140.43 9.26 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 124.907 1.241 . . . . 0.0 111.765 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -90.68 -58.6 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 103.06 9.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.08 -168.67 3.91 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 113.129 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.28 58.82 6.81 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.658 2.238 . . . . 0.0 111.132 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.46 120.99 1.07 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -114.45 169.17 9.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.733 1.266 . . . . 0.0 110.105 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.54 178.21 41.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-O 121.725 0.625 . . . . 0.0 112.261 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.71 149.1 49.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.383 1.473 . . . . 0.0 108.473 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tt -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mm -131.35 156.53 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -135.59 146.01 47.51 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.285 1.434 . . . . 0.0 108.686 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.19 -165.54 34.46 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.942 0.782 . . . . 0.0 112.183 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.5 m -115.88 147.54 40.97 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.057 1.343 . . . . 0.0 108.045 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.99 164.35 12.89 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.794 1.637 . . . . 0.0 111.873 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.94 120.95 2.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.394 1.078 . . . . 0.0 108.853 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.596 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 63.8 m-85 -76.24 138.7 40.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -140.63 141.35 35.11 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.094 0.958 . . . . 0.0 110.112 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.3 p -117.2 39.64 3.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -159.07 156.13 28.63 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 128.115 2.566 . . . . 0.0 111.567 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.15 178.54 47.26 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.292 1.901 . . . . 0.0 114.391 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.71 -17.26 58.07 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.347 2.698 . . . . 0.0 111.584 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -63.77 1.13 Allowed 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.151 1.78 . . . . 0.0 107.488 173.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.45 -31.26 71.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.03 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -68.62 -49.08 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.555 1.07 . . . . 0.0 109.074 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.96 78.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.218 -0.926 . . . . 0.0 111.404 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.345 0.9 OUTLIER -82.58 -18.41 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.55 173.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.01 -27.96 3.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.826 1.651 . . . . 0.0 112.133 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -51.17 -35.9 38.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.72 0.808 . . . . 0.0 111.78 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.26 177.84 8.53 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -141.37 -1.11 1.36 Allowed 'General case' 0 C--O 1.222 -0.387 0 O-C-N 119.144 -2.222 . . . . 0.0 113.18 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -98.26 8.76 44.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.449 1.1 . . . . 0.0 110.271 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.37 150.8 28.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.524 -0.735 . . . . 0.0 111.03 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -120.88 -21.28 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.168 2.987 . . . . 0.0 111.024 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -171.5 161.77 6.37 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.736 2.014 . . . . 0.0 109.114 -177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.99 108.38 19.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.5 93.89 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.04 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.9 128.68 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.1 m -106.2 92.09 3.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.04 155.48 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.848 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.05 -41.79 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.521 1.528 . . . . 0.0 107.275 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.5 m -151.26 141.0 21.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.838 1.199 . . . . 0.0 113.618 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.5 140.13 49.43 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 129.948 3.299 . . . . 0.0 110.626 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -139.3 136.31 34.73 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.013 1.725 . . . . 0.0 109.291 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -75.91 140.82 42.33 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -137.23 -77.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.256 1.397 0 C-N-CA 125.359 1.464 . . . . 0.0 114.37 -173.539 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 mmt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mp -139.6 157.31 70.42 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 124.372 1.069 . . . . 0.0 108.877 -171.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.43 159.39 51.63 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.677 2.251 . . . . 0.0 111.832 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.16 -38.77 93.6 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -48.5 -43.14 34.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.065 1.746 . . . . 0.0 111.427 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.34 -55.45 18.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.352 0.978 . . . . 0.0 111.247 174.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -56.7 -48.52 77.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -59.21 -33.62 71.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.759 0.709 . . . . 0.0 112.835 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.76 -41.93 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -59.6 -38.4 81.12 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.33 1.423 . . . . 0.0 112.493 173.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 -18.9 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.177 1.353 . . . . 0.0 112.63 173.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -113.73 159.05 20.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.414 1.086 . . . . 0.0 108.754 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -73.72 148.36 42.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.924 -1.11 . . . . 0.0 108.794 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.35 171.25 40.59 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 126.801 2.143 . . . . 0.0 110.079 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.42 150.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -139.82 160.46 26.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.974 2.109 . . . . 0.0 106.041 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 157.05 44.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.512 1.125 . . . . 0.0 108.46 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.0 mt -139.4 115.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.04 108.56 19.65 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -91.36 114.3 26.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 116.308 -1.806 . . . . 0.0 106.649 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.41 141.5 46.95 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 121.845 2.111 . . . . 0.0 108.47 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.28 -81.05 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -158.82 -56.98 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 20.0 p-10 -78.87 38.34 0.33 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.668 2.787 . . . . 0.0 111.517 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.37 151.67 6.48 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.416 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.92 148.9 58.53 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 CA-C-N 118.028 0.914 . . . . 0.0 111.449 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -101.88 101.39 11.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.84 88.64 3.44 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.663 0.665 . . . . 0.0 110.071 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.3 m -80.31 170.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.15 1.38 . . . . 0.0 110.046 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -119.36 165.91 13.72 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 0.989 . . . . 0.0 112.523 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -168.29 176.22 6.03 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 108.548 175.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.16 141.53 50.74 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.433 1.893 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.26 -31.06 52.65 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.111 0.869 . . . . 0.0 109.706 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -59.95 -13.33 10.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.765 2.826 . . . . 0.0 111.413 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -119.23 -2.94 10.6 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.5 mt -90.18 164.78 14.3 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.477 1.489 . . . . 0.0 112.229 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.435 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -134.98 132.2 38.08 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.17 145.74 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.48 179.13 4.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.333 1.853 . . . . 0.0 108.101 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.44 175.24 4.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.347 1.059 . . . . 0.0 109.474 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.09 28.42 33.38 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.721 1.629 . . . . 0.0 111.105 -173.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.28 0.1 OUTLIER 53.41 23.11 3.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.86 2.064 . . . . 0.0 114.102 -177.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -73.58 129.08 37.22 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -118.0 150.91 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.51 147.08 24.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 120.837 -1.164 . . . . 0.0 108.843 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -126.65 135.73 27.69 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 126.188 1.795 . . . . 0.0 107.869 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.0 108.36 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.022 1.815 . . . . 0.0 108.457 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.57 111.52 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.52 -21.35 6.9 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 112.256 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.75 41.38 0.32 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 117.46 -1.745 . . . . 0.0 109.901 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.1 mtt -109.12 59.82 0.6 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.654 1.181 . . . . 0.0 109.225 173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -71.48 -49.65 39.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.994 -174.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 55.0 tttp -51.99 -41.44 62.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.044 1.747 . . . . 0.0 109.296 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -60.73 -39.47 88.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.151 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.93 -48.28 80.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 121.248 1.84 . . . . 0.0 110.782 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.68 99.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.099 0.159 . . . . 0.0 111.253 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -62.88 -41.87 99.56 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.379 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.7 -48.24 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.409 1.459 . . . . 0.0 109.132 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.49 -28.17 59.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -80.74 -46.42 15.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 173.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -151.34 128.61 11.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.986 0.914 . . . . 0.0 109.204 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -15.39 60.05 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.799 -1.188 . . . . 0.0 113.969 -174.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.64 130.69 47.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.641 1.11 . . . . 0.0 111.575 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 m -139.35 156.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 123.392 1.567 . . . . 0.0 111.895 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.7 tp -108.93 149.87 28.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 173.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.3 ttt -140.01 123.02 16.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -109.02 127.99 54.57 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.97 172.4 7.29 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.421 1.464 . . . . 0.0 109.559 173.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.44 -166.16 27.03 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.0 t -146.65 159.94 42.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.83 0.852 . . . . 0.0 109.467 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -98.69 -15.47 19.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.145 0.978 . . . . 0.0 108.994 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.03 -7.01 50.01 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 116.323 -1.799 . . . . 0.0 115.388 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.02 129.69 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 121.767 2.076 . . . . 0.0 106.14 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.3 131.42 36.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.907 0.883 . . . . 0.0 110.631 -174.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.71 -140.98 7.18 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -78.98 -59.11 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.877 1.271 . . . . 0.0 108.855 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.25 103.12 15.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.716 0.77 . . . . 0.0 109.907 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.51 -172.01 3.97 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.952 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -80.54 58.87 7.21 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.208 1.939 . . . . 0.0 110.571 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.69 109.83 0.43 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 t -99.32 169.65 9.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.498 0.649 . . . . 0.0 110.375 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.97 169.91 40.87 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -125.0 157.33 36.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.84 1.256 . . . . 0.0 110.386 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.89 130.54 46.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mt -134.77 153.01 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -130.76 140.38 50.31 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.805 1.642 . . . . 0.0 107.342 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.68 36.82 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 118.691 0.678 . . . . 0.0 111.718 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -121.4 150.99 40.69 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.869 0.868 . . . . 0.0 110.163 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.13 162.33 14.36 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.167 1.387 . . . . 0.0 112.288 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.02 121.19 3.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.643 1.177 . . . . 0.0 109.289 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -74.18 138.54 43.85 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.193 0.997 . . . . 0.0 110.771 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -135.56 123.34 22.45 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 126.448 1.899 . . . . 0.0 115.399 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -121.72 32.94 5.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.177 2.991 . . . . 0.0 103.924 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.64 151.76 22.6 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 130.488 3.515 . . . . 0.0 110.141 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.55 47.59 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.543 1.068 . . . . 0.0 113.37 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.82 -9.09 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.945 2.43 . . . . 0.0 111.17 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -61.32 -60.86 3.07 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -61.56 -31.48 71.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 125.071 1.482 . . . . 0.0 111.138 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.46 -48.56 64.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.741 1.155 . . . . 0.0 109.357 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.435 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -59.58 -41.22 89.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.421 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.281 1.2 pp -79.82 -18.75 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 119.251 -0.98 . . . . 0.0 113.556 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.91 -28.84 53.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.841 1.655 . . . . 0.0 113.745 -174.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.259 0.6 OUTLIER -52.08 -38.58 57.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.124 173.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -66.05 177.88 1.26 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 -1.12 1.5 Allowed 'General case' 0 C--O 1.222 -0.385 0 O-C-N 118.308 -2.745 . . . . 0.0 113.378 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -110.32 8.35 23.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.503 0.721 . . . . 0.0 109.903 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.14 138.83 33.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.82 -8.36 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.025 1.73 . . . . 0.0 110.917 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.24 161.75 10.29 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.324 2.649 . . . . 0.0 108.506 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.85 105.14 15.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.774 2.429 . . . . 0.0 104.72 173.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.4 90.84 5.63 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.48 131.34 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.6 mt -120.22 128.23 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.9 m -99.34 88.47 3.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.622 -2.732 . . . . 0.0 103.622 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.71 157.29 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.037 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.79 -56.99 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.5 m -148.32 141.38 24.92 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.5 149.84 30.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.261 2.624 . . . . 0.0 108.534 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -139.55 133.14 30.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.31 1.844 . . . . 0.0 107.487 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -68.8 137.75 54.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -136.99 -58.23 0.72 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.247 0.937 0 C-N-CA 124.23 1.012 . . . . 0.0 113.323 -173.119 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mp -142.73 156.75 62.7 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.24 159.63 52.37 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.607 2.205 . . . . 0.0 111.818 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.75 95.38 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.26 -38.72 63.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 110.482 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -50.61 -56.01 13.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.496 1.043 . . . . 0.0 110.228 173.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -59.34 -48.56 81.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.372 0.669 . . . . 0.0 109.534 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 69.9 mm-40 -56.69 -41.05 76.67 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -41.22 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.841 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.28 -42.84 78.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.307 1.412 . . . . 0.0 111.85 173.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HZ3' ' CD ' ' A' ' 8' ' ' GLU . 7.6 mtmp? -52.02 -18.92 1.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 173.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -116.08 175.02 5.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 111.666 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -73.26 132.5 43.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.79 166.24 39.25 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 106.747 -2.541 . . . . 0.0 106.747 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.83 147.81 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.02 159.34 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.51 154.81 42.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.386 1.474 . . . . 0.0 107.183 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.09 114.03 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.38 19.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 m -88.68 116.17 26.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -73.3 138.18 45.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.4 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -159.79 -60.74 0.07 Allowed 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -78.94 52.53 1.26 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.657 2.383 . . . . 0.0 110.043 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.43 150.41 5.73 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.017 1.77 . . . . 0.0 111.735 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.94 150.16 82.97 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 118.241 1.02 . . . . 0.0 111.321 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -103.19 101.82 11.79 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.8 tt -87.4 88.88 7.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.5 m -76.1 169.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.117 1.767 . . . . 0.0 110.6 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -119.28 166.91 12.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.647 1.179 . . . . 0.0 113.079 174.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -168.68 174.25 6.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.315 2.246 . . . . 0.0 109.025 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -120.67 141.57 50.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.294 2.238 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -54.63 -31.21 56.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.255 0.48 . . . . 0.0 112.03 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.5 t -59.72 -8.97 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.521 1.528 . . . . 0.0 113.343 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.13 -1.77 11.33 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.644 1.178 . . . . 0.0 109.845 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.66 169.62 8.35 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.701 -1.249 . . . . 0.0 113.133 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -136.48 141.55 43.51 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.9 t -99.38 146.81 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 mt -121.68 -174.08 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.968 2.907 . . . . 0.0 111.825 -177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.37 158.89 6.76 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 128.122 2.569 . . . . 0.0 111.067 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.09 35.82 42.32 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.055 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.05 22.73 3.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.253 1.821 . . . . 0.0 114.347 -175.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -74.16 158.01 34.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.791 1.636 . . . . 0.0 108.084 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -140.77 170.23 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.8 t -144.89 140.06 23.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.767 1.227 . . . . 0.0 108.132 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.92 133.85 24.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 128.578 2.751 . . . . 0.0 106.885 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.37 108.43 2.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.874 2.383 . . . . 0.0 109.88 174.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.86 111.76 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.21 -21.34 6.29 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.6 1.571 . . . . 0.0 112.816 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.86 41.56 0.27 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 17.6 mtt -107.83 71.38 0.81 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.611 1.565 . . . . 0.0 107.728 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -67.21 -63.91 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 129.895 3.278 . . . . 0.0 113.278 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -51.74 -40.67 60.65 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -60.19 -40.85 91.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.306 -1.33 . . . . 0.0 112.252 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -58.19 -48.78 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.606 2.003 . . . . 0.0 110.32 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.16 95.69 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -65.1 -41.63 94.77 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 116.989 -1.481 . . . . 0.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.76 -48.25 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.3 1.409 . . . . 0.0 108.503 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -25.7 59.9 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -82.25 -44.92 15.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -151.15 136.24 17.48 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 108.791 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -21.85 63.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.162 -0.961 . . . . 0.0 112.256 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -61.05 128.88 38.58 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.68 1.192 . . . . 0.0 114.115 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.52 154.99 25.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 122.749 1.262 . . . . 0.0 110.139 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.66 150.97 29.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 103.058 -2.941 . . . . 0.0 103.058 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 13.7 ttt -139.01 135.52 34.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 p -121.05 128.45 52.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.97 165.95 12.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 109.083 173.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.11 42.5 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -159.8 170.31 21.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.974 0.892 . . . . 0.0 108.901 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -99.27 -9.32 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.873 2.069 . . . . 0.0 110.325 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -91.85 -11.26 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.54 136.73 56.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 131.42 36.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.526 0.73 . . . . 0.0 109.847 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.32 -141.1 7.31 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 124.222 0.951 . . . . 0.0 110.933 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -81.67 -58.82 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.47 102.9 13.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.615 0.721 . . . . 0.0 109.625 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.73 -168.94 3.44 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.617 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.52 59.43 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.578 2.185 . . . . 0.0 110.914 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.09 121.08 1.09 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -110.09 169.31 8.81 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 118.029 0.914 . . . . 0.0 109.836 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.87 35.16 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 123.962 0.791 . . . . 0.0 113.441 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -136.48 141.5 43.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.23 1.412 . . . . 0.0 109.348 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.18 130.68 47.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 127.174 2.189 . . . . 0.0 106.271 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.4 mt -141.32 150.99 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.812 -0.555 . . . . 0.0 109.762 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -128.03 148.82 50.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.81 2.044 . . . . 0.0 109.967 173.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.4 -168.09 34.06 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.355 1.455 . . . . 0.0 110.458 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.7 m -121.0 149.04 43.28 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.351 1.46 . . . . 0.0 108.838 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.02 163.56 13.71 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.763 1.225 . . . . 0.0 112.191 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 121.5 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.68 143.91 46.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -133.36 134.53 43.87 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 126.414 1.886 . . . . 0.0 107.537 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.8 p -121.22 28.77 7.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 108.695 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.78 155.79 28.58 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.714 2.006 . . . . 0.0 110.036 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.19 -174.8 44.1 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 124.384 0.992 . . . . 0.0 115.263 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.35 -10.77 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.713 2.942 . . . . 0.0 112.735 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.81 -62.67 1.31 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.235 1.814 . . . . 0.0 106.86 173.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.41 -31.37 71.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.751 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.67 -48.86 62.88 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.566 1.075 . . . . 0.0 109.558 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.16 66.96 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.389 -0.819 . . . . 0.0 111.661 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.333 1.2 pp -93.2 -18.45 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 173.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.42 -28.48 13.0 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.093 1.757 . . . . 0.0 112.988 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -51.43 -25.86 7.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.005 0.922 . . . . 0.0 112.893 173.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -81.11 178.61 8.3 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.029 0.831 . . . . 0.0 109.56 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -139.04 20.79 2.63 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.01 -1.681 . . . . 0.0 110.741 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -131.95 8.55 4.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.267 1.427 . . . . 0.0 111.055 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.608 -0.682 . . . . 0.0 111.071 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -21.16 6.46 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.595 2.758 . . . . 0.0 111.663 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.2 161.86 10.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.213 1.805 . . . . 0.0 109.456 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.9 100.69 10.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.651 1.98 . . . . 0.0 105.686 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.12 98.95 6.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.1 131.77 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.01 1.724 . . . . 0.0 107.508 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.51 128.52 75.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.3 m -100.91 93.75 5.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.98 154.75 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.5 t -118.71 -49.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.4 m -151.22 141.01 21.86 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 120.249 1.386 . . . . 0.0 112.129 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.3 150.58 39.24 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.987 2.915 . . . . 0.0 109.413 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.8 148.9 44.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.626 1.97 . . . . 0.0 107.3 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -85.84 134.72 33.9 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.27 -78.8 0.54 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.244 0.807 0 CA-C-O 116.056 -1.926 . . . . 0.0 112.717 -173.797 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.76 157.39 83.86 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.509 -0.757 . . . . 0.0 109.18 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.96 161.76 44.42 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.328 2.018 . . . . 0.0 113.047 -174.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.22 -42.55 98.71 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -54.42 -42.09 70.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.86 1.264 . . . . 0.0 111.092 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -51.36 -53.39 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.392 0.677 . . . . 0.0 111.691 173.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.18 -48.53 81.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.243 0.617 . . . . 0.0 110.992 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.75 -37.47 68.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.923 0.783 . . . . 0.0 111.833 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.12 -44.09 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.164 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.48 -42.51 82.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.674 1.125 . . . . 0.0 112.32 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -51.65 -18.57 1.22 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -117.44 158.94 23.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.636 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.09 147.21 42.98 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.18 167.22 40.36 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 127.529 2.49 . . . . 0.0 109.012 173.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -83.42 150.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.95 159.87 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.256 2.222 . . . . 0.0 105.487 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.48 157.05 45.16 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.065 0.946 . . . . 0.0 109.724 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.69 108.39 4.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.95 108.41 19.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -96.38 109.41 21.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -74.27 141.09 45.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 121.38 1.9 . . . . 0.0 106.818 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.53 -81.91 0.23 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -166.16 -57.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.67 53.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.441 2.696 . . . . 0.0 109.113 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 141.42 2.31 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.008 1.766 . . . . 0.0 112.038 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 158.89 55.21 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -120.69 101.82 7.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -84.83 88.61 7.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.8 m -82.79 175.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.842 2.057 . . . . 0.0 109.982 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -118.84 166.69 12.5 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.083 0.856 . . . . 0.0 112.103 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -168.3 175.8 6.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.241 2.217 . . . . 0.0 107.611 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.43 141.52 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.995 1.718 . . . . 0.0 110.647 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -53.97 -30.88 48.85 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.124 0.874 . . . . 0.0 109.204 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.74 -13.93 7.31 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.149 2.979 . . . . 0.0 111.875 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -118.88 -4.75 10.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.777 1.631 . . . . 0.0 111.8 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.41 165.8 12.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.32 1.418 . . . . 0.0 113.034 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' HZ2' ' CD2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -136.0 138.56 42.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 172.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.7 t -101.69 150.7 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.448 ' CD2' ' HZ2' ' A' ' 37' ' ' LYS . 46.1 mt -122.12 178.98 4.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.811 2.844 . . . . 0.0 107.102 172.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 40.1 t0 -76.02 -179.05 4.69 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 60.55 31.3 74.27 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.243 -1.535 . . . . 0.0 110.732 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 p30 54.08 12.99 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 130.095 3.358 . . . . 0.0 115.056 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -73.58 143.22 46.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.877 0.762 . . . . 0.0 109.627 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -129.3 163.28 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -142.86 140.88 27.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.93 127.74 26.35 Favored Pre-proline 0 N--CA 1.445 -0.707 0 C-N-CA 127.44 2.296 . . . . 0.0 104.829 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.01 108.3 2.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 107.798 -1.654 . . . . 0.0 107.798 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.65 111.63 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.58 -21.69 6.03 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.32 0.962 . . . . 0.0 112.67 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.65 41.59 0.33 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 118.099 -1.39 . . . . 0.0 110.0 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.4 mtt -106.57 71.39 0.86 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 108.28 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -67.45 -65.78 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 129.99 3.316 . . . . 0.0 113.682 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -51.85 -40.89 61.31 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.863 1.21 . . . . 0.0 109.764 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -60.92 -39.08 88.03 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.787 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.5 -48.38 81.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.812 1.642 . . . . 0.0 110.86 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.82 99.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.407 0.283 . . . . 0.0 111.24 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -63.41 -41.64 98.74 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.444 -1.265 . . . . 0.0 110.446 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.86 -48.23 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 120.11 1.323 . . . . 0.0 108.963 174.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.83 -24.65 37.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.456 -0.777 . . . . 0.0 112.567 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.55 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -85.09 -42.5 14.75 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.581 1.696 . . . . 0.0 115.581 173.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -150.95 139.48 20.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.662 1.185 . . . . 0.0 109.115 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -75.17 -18.03 60.27 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 112.312 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 mmp_? -60.8 119.76 8.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 114.492 -173.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.4 m -139.23 146.23 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 123.112 1.434 . . . . 0.0 112.588 173.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tt -111.67 149.2 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.9 ttt -141.15 141.12 34.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -125.45 128.08 47.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.2 173.39 6.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.713 1.597 . . . . 0.0 107.923 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.01 -171.27 34.59 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.4 t -146.85 157.38 43.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.65 0.78 . . . . 0.0 109.351 174.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -98.54 -17.43 18.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.493 1.517 . . . . 0.0 108.847 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -91.98 -4.43 54.59 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 116.687 -1.625 . . . . 0.0 114.864 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.49 130.2 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 121.711 2.051 . . . . 0.0 105.775 -173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.04 131.41 36.26 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.092 0.957 . . . . 0.0 111.173 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.48 -141.07 6.36 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -81.92 -58.96 2.75 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.363 1.465 . . . . 0.0 108.323 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.87 102.96 11.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.468 0.651 . . . . 0.0 109.523 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.18 -169.11 2.89 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.198 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.04 58.85 7.13 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.204 1.936 . . . . 0.0 110.692 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.73 120.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -114.66 169.45 9.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.187 0.994 . . . . 0.0 110.433 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.73 45.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.78 0.705 . . . . 0.0 113.64 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -132.99 152.76 51.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.016 1.326 . . . . 0.0 109.353 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.03 130.9 47.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.328 -2.842 . . . . 0.0 103.328 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.04 154.46 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -131.24 135.04 47.02 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.21 -169.11 28.39 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 118.765 0.711 . . . . 0.0 112.356 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 m -121.02 146.43 46.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.028 2.131 . . . . 0.0 108.287 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.24 163.71 13.65 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.566 1.075 . . . . 0.0 112.94 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.95 120.98 3.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.235 1.014 . . . . 0.0 110.331 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -75.86 141.06 42.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -140.74 135.88 31.99 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.035 1.334 . . . . 0.0 111.0 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.2 p -120.81 36.67 4.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.72 154.94 27.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.847 2.859 . . . . 0.0 111.165 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.39 47.41 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.484 1.516 . . . . 0.0 113.556 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.73 -11.78 32.22 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.193 2.595 . . . . 0.0 112.242 175.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.04 -60.27 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -31.43 71.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.318 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.85 -49.77 55.55 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.683 1.129 . . . . 0.0 109.611 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.05 76.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.309 -0.869 . . . . 0.0 111.489 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.2 pp -82.5 -18.36 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 119.061 0.846 . . . . 0.0 112.159 174.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.16 -28.07 4.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.514 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.58 -30.03 19.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.164 1.386 . . . . 0.0 112.256 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -80.67 178.32 8.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.39 -0.54 1.4 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 118.172 -2.83 . . . . 0.0 112.631 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -96.09 8.2 44.38 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.73 23.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.24 1.016 . . . . 0.0 109.402 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.6 ttp85 -121.13 -14.08 8.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.443 1.897 . . . . 0.0 111.717 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.56 161.61 11.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.041 1.736 . . . . 0.0 110.176 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.78 104.69 16.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.74 91.34 7.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.18 131.16 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.792 1.637 . . . . 0.0 106.673 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -121.71 135.61 61.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.0 m -114.12 101.36 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.01 160.57 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.335 1.454 . . . . 0.0 110.088 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.4 t -121.51 -59.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -142.9 140.49 31.21 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.85 145.65 41.93 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.853 2.861 . . . . 0.0 108.168 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -139.21 130.18 26.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.243 1.817 . . . . 0.0 106.684 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -74.04 139.59 44.8 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -129.65 -58.31 1.1 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.926 0.89 . . . . 0.0 111.437 -173.378 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.93 160.91 42.84 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 119.969 1.258 . . . . 0.0 109.171 170.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.77 158.63 32.18 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.504 2.136 . . . . 0.0 113.54 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -49.31 79.86 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -53.64 -41.26 66.56 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.235 1.014 . . . . 0.0 111.283 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.26 -60.4 3.15 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.62 0.768 . . . . 0.0 109.482 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -52.28 -48.23 65.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.386 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.473 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 27.7 mm-40 -54.88 -38.36 67.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.743 1.156 . . . . 0.0 112.66 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.87 -45.5 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.802 1.183 . . . . 0.0 109.135 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.09 -42.28 80.41 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.664 1.12 . . . . 0.0 112.073 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HZ2' ' CD ' ' A' ' 8' ' ' GLU . 25.4 mtmm -51.65 -18.65 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -112.99 158.65 20.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.816 1.189 . . . . 0.0 109.874 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.12 148.83 41.44 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.975 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.41 170.8 40.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 123.22 0.438 . . . . 0.0 112.058 -174.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.72 149.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -132.15 163.51 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 127.556 2.342 . . . . 0.0 105.298 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.53 153.18 40.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.851 1.26 . . . . 0.0 109.15 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.38 109.79 5.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -89.45 109.22 20.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.134 1.773 . . . . 0.0 109.886 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -97.3 107.96 20.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 98.76 9.01 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.34 -59.89 0.18 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 120.824 1.647 . . . . 0.0 113.503 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -158.36 -60.79 0.08 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.008 1.404 . . . . 0.0 113.845 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -79.28 39.08 0.38 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.878 1.672 . . . . 0.0 111.777 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.94 151.47 12.36 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.76 148.06 93.9 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.751 2.275 . . . . 0.0 109.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.51 ' CD2' ' HZ2' ' A' ' 53' ' ' LYS . 40.4 t60 -121.43 101.67 7.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -90.48 88.7 7.26 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.5 m -77.34 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 110.638 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.81 168.48 11.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.445 1.02 . . . . 0.0 113.003 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t -168.42 172.61 8.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.813 2.445 . . . . 0.0 108.183 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -120.91 141.75 50.35 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.887 2.075 . . . . 0.0 109.989 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -52.09 -30.53 26.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.685 0.675 . . . . 0.0 110.478 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -50.24 -21.31 1.31 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.663 2.385 . . . . 0.0 113.565 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.4 -6.71 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.379 1.071 . . . . 0.0 111.572 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -91.46 171.3 9.29 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.448 -1.408 . . . . 0.0 111.781 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -134.08 119.93 19.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.55 131.44 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 mp -121.43 178.14 4.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -76.97 -178.0 4.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.9 29.61 75.31 Favored Glycine 0 C--O 1.223 -0.591 0 O-C-N 120.473 -1.392 . . . . 0.0 109.663 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 54.0 12.87 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 130.631 3.572 . . . . 0.0 115.483 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -79.37 128.84 33.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.205 1.366 . . . . 0.0 110.137 -174.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -124.34 155.43 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 t -145.24 142.46 22.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.78 132.8 24.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 126.993 2.117 . . . . 0.0 106.873 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.89 108.57 2.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.537 2.158 . . . . 0.0 108.666 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.418 HG12 ' CE2' ' A' ' 91' ' ' PHE . 2.4 p -85.53 111.76 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.45 -20.85 5.7 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.378 1.942 . . . . 0.0 112.281 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.18 40.99 0.45 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.047 1.423 . . . . 0.0 109.958 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 mtt -113.8 53.47 0.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.042 1.337 . . . . 0.0 108.515 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.46 91.2 m-70 -71.88 -48.18 47.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HZ2' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -51.91 -38.28 55.71 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.76 1.618 . . . . 0.0 108.933 172.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.0 m -64.41 -38.8 92.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.404 1.481 . . . . 0.0 110.291 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.21 -47.68 74.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.799 1.636 . . . . 0.0 109.391 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.38 89.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.803 0.441 . . . . 0.0 110.803 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -57.07 -41.47 78.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.744 -1.122 . . . . 0.0 113.369 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.08 -48.28 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 120.249 1.386 . . . . 0.0 109.211 175.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.36 -26.16 39.42 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.041 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.21 -47.19 13.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 173.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -152.28 141.67 21.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.433 1.015 . . . . 0.0 108.773 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.358 -1.464 . . . . 0.0 113.718 -178.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 62' ' ' GLU . 8.2 mmp_? -51.94 115.6 1.76 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.667 1.987 . . . . 0.0 114.722 -172.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.54 143.43 32.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 123.669 1.7 . . . . 0.0 112.723 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.8 tt -111.35 148.48 32.9 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 101.364 -3.569 . . . . 0.0 101.364 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.36 129.09 20.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 p -111.29 128.25 55.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 pp -117.01 166.88 11.67 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.548 -1.345 . . . . 0.0 108.578 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.9 -174.83 37.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.2 t -146.57 157.56 43.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.634 1.174 . . . . 0.0 107.898 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -98.86 -8.45 25.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.591 1.156 . . . . 0.0 110.05 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.46 -7.13 51.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 116.942 -1.504 . . . . 0.0 113.962 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.23 136.03 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 121.083 1.765 . . . . 0.0 106.243 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.24 131.37 36.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.884 0.874 . . . . 0.0 111.086 -175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.44 -140.88 6.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.219 1.39 . . . . 0.0 110.516 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -84.48 -59.05 2.49 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 102.98 9.58 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.98 -168.79 1.96 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.584 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.3 65.9 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.35 2.033 . . . . 0.0 110.37 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.97 121.1 1.05 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.54 169.53 9.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.371 1.086 . . . . 0.0 109.846 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.64 -177.76 45.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 121.418 0.454 . . . . 0.0 113.381 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.58 147.01 52.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.416 1.086 . . . . 0.0 110.39 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.401 ' HB2' ' HG1' ' A' ' 121' ' ' THR . 3.3 tm? -100.88 129.66 46.78 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 mt -141.2 157.05 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -132.75 149.12 52.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.172 1.789 . . . . 0.0 109.753 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -174.14 37.95 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.505 1.526 . . . . 0.0 110.548 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -114.14 143.15 45.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.118 1.767 . . . . 0.0 106.828 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.81 163.36 13.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.188 1.395 . . . . 0.0 111.962 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 121.11 3.33 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.882 0.873 . . . . 0.0 109.764 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.418 ' CE2' HG12 ' A' ' 48' ' ' VAL . 3.8 m-85 -74.03 138.13 43.87 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 141.48 35.0 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.121 0.968 . . . . 0.0 109.863 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -116.07 35.17 4.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.33 154.66 25.49 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 128.112 2.565 . . . . 0.0 110.742 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 178.67 46.76 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.642 2.067 . . . . 0.0 113.893 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.13 -17.92 55.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.028 3.152 . . . . 0.0 112.538 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -65.61 0.65 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.243 1.817 . . . . 0.0 107.617 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.18 -31.2 70.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.192 0.997 . . . . 0.0 111.391 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.6 -57.76 5.27 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.757 0.708 . . . . 0.0 109.138 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.65 -25.42 67.37 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.916 -1.115 . . . . 0.0 113.058 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.346 1.3 pp -87.43 -18.11 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.733 1.151 . . . . 0.0 111.919 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.48 -27.93 3.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.408 1.483 . . . . 0.0 111.685 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -49.05 -21.47 0.71 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.641 1.176 . . . . 0.0 113.949 173.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.54 178.75 8.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.669 1.122 . . . . 0.0 110.611 175.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -130.29 11.61 5.44 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.099 -1.625 . . . . 0.0 111.234 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -132.26 9.0 4.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.226 1.41 . . . . 0.0 111.202 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.94 145.21 34.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.619 -0.676 . . . . 0.0 109.874 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -21.05 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 127.951 2.5 . . . . 0.0 110.621 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.12 161.96 10.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.391 1.876 . . . . 0.0 109.137 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.59 107.9 18.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tp -78.89 93.92 5.12 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.2 t -78.98 130.88 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.37 129.49 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -112.14 99.03 7.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 t -60.99 161.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.069 2.147 . . . . 0.0 110.15 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.98 -51.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -150.93 141.04 22.15 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.154 -0.966 . . . . 0.0 111.246 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.91 146.34 43.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.693 3.197 . . . . 0.0 108.765 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -138.82 142.65 38.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.521 1.928 . . . . 0.0 107.599 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -81.16 133.51 35.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.401 ' HG1' ' HB2' ' A' ' 84' ' ' LEU . 39.9 p -135.21 -68.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -173.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.24 0.561 0 CA-C-O 117.358 -1.306 . . . . 0.0 110.221 178.092 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.5 mtm . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.407 ' H ' ' CD1' ' A' ' 2' ' ' LEU . 5.2 mp -60.04 156.21 39.03 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.339 1.856 . . . . 0.0 109.593 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.88 158.7 56.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.735 2.29 . . . . 0.0 111.442 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.99 -40.86 95.99 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -53.16 -38.96 63.22 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.6 1.56 . . . . 0.0 111.263 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -50.99 -56.26 13.33 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.653 1.115 . . . . 0.0 111.088 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -61.77 -48.96 78.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -61.01 -33.58 73.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.51 -41.85 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.392 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.12 -38.63 83.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.236 1.38 . . . . 0.0 111.811 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.74 -19.11 1.47 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.298 1.408 . . . . 0.0 114.345 172.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -106.4 158.93 16.53 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 119.717 1.144 . . . . 0.0 107.966 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.86 148.63 42.16 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 121.328 -0.858 . . . . 0.0 109.346 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.23 177.13 47.84 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 124.8 1.191 . . . . 0.0 112.534 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.9 t -100.75 145.82 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -129.82 163.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 106.059 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.44 159.9 42.79 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.305 1.442 . . . . 0.0 110.001 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 88.3 mt -140.34 117.32 9.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -89.08 108.35 19.54 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 173.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -94.03 110.57 22.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 115.546 -2.169 . . . . 0.0 106.806 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -73.8 141.71 46.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.271 2.305 . . . . 0.0 107.721 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.7 -81.35 0.23 Allowed Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.45 -61.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 13.3 p-10 -79.73 44.49 0.64 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.24 2.216 . . . . 0.0 109.968 174.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 151.49 5.95 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.263 1.887 . . . . 0.0 113.719 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.19 153.93 56.85 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 121.357 1.371 . . . . 0.0 111.414 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -121.37 101.97 7.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.542 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -86.13 88.73 7.65 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.04 169.14 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.082 1.753 . . . . 0.0 110.625 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -121.54 167.62 12.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.528 1.131 . . . . 0.0 112.29 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 170.32 9.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.983 2.113 . . . . 0.0 108.364 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -116.48 141.67 47.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.745 1.618 . . . . 0.0 111.265 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -56.18 -31.77 63.72 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.997 0.919 . . . . 0.0 110.834 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -60.57 -8.39 2.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.387 1.475 . . . . 0.0 113.613 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -117.92 -7.24 10.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.095 1.316 . . . . 0.0 109.099 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mt -98.24 162.19 13.32 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.151 -1.593 . . . . 0.0 112.29 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.52 41.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.409 -1.432 . . . . 0.0 108.916 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.9 t -101.8 144.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.91 179.06 4.48 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.324 1.85 . . . . 0.0 107.126 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 40.5 t0 -70.53 177.27 3.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.254 0.549 . . . . 0.0 110.429 174.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 57.47 28.45 59.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -173.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 p30 53.64 13.72 0.53 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 128.559 2.743 . . . . 0.0 114.848 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -73.21 109.33 6.65 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.487 1.04 . . . . 0.0 110.328 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.07 161.15 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.97 134.83 21.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.04 135.39 24.81 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 127.127 2.171 . . . . 0.0 107.277 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.94 108.88 2.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.53 2.153 . . . . 0.0 110.458 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.4 111.91 21.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.13 -21.34 7.42 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.979 1.752 . . . . 0.0 112.676 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.41 41.31 0.28 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.188 1.494 . . . . 0.0 109.945 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.3 mtt -109.32 66.98 0.64 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.156 0.982 . . . . 0.0 109.77 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.322 41.3 m-70 -71.47 -48.64 47.91 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' HZ2' ' CG ' ' A' ' 24' ' ' ASP . 57.3 tttm -51.7 -40.95 61.06 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.799 2.09 . . . . 0.0 109.418 173.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.1 m -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 127.002 2.121 . . . . 0.0 110.495 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.28 -50.82 70.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 121.027 1.74 . . . . 0.0 110.611 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.33 94.13 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.237 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -66.3 -42.02 88.94 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.679 -1.629 . . . . 0.0 109.845 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.93 -48.19 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 120.177 1.353 . . . . 0.0 109.032 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.97 57.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.487 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -87.06 -46.02 10.19 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.926 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -145.15 132.31 20.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.275 1.036 . . . . 0.0 112.169 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.1 -21.59 56.51 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.46 122.13 14.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.499 1.045 . . . . 0.0 111.353 -173.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.85 155.94 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 123.379 1.561 . . . . 0.0 111.503 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tt -111.13 149.95 30.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.8 ttt -138.95 140.87 38.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 p -123.72 128.6 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.93 167.78 10.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.218 1.827 . . . . 0.0 107.172 172.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.13 -175.0 38.12 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.5 t -148.14 157.38 43.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -99.28 -8.72 24.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.312 0.505 . . . . 0.0 109.923 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -90.71 3.11 55.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.087 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.0 t -130.92 133.61 62.79 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.05 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 173.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 130.32 35.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.879 0.763 . . . . 0.0 110.217 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.62 5.95 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.975 1.75 . . . . 0.0 109.318 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -88.51 -58.3 2.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.15 102.68 5.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.184 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.95 -168.26 0.16 Allowed Glycine 0 CA--C 1.539 1.573 0 O-C-N 120.794 -1.191 . . . . 0.0 111.087 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.53 91.07 0.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 N-CA-C 106.501 -2.153 . . . . 0.0 106.501 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.4 0.71 Allowed Glycine 0 N--CA 1.442 -0.947 0 CA-C-O 117.723 -1.598 . . . . 0.0 109.827 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -109.31 168.97 9.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.341 1.071 . . . . 0.0 109.715 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.4 -176.97 44.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 121.062 0.257 . . . . 0.0 112.896 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -131.42 151.94 51.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.422 1.089 . . . . 0.0 109.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.86 131.25 46.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.0 mt -139.08 156.57 27.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -132.2 150.23 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.997 1.319 . . . . 0.0 108.088 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.61 -172.13 40.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -106.28 131.93 52.93 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.26 1.024 . . . . 0.0 108.432 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.0 163.51 15.5 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.67 120.88 3.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.873 0.869 . . . . 0.0 110.045 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -74.26 130.61 40.04 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 173.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -132.16 130.7 41.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.5 p -120.85 33.47 5.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.17 1.388 . . . . 0.0 107.677 173.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -158.82 161.96 36.96 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 128.635 2.774 . . . . 0.0 109.276 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.4 -179.95 46.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 125.19 1.376 . . . . 0.0 115.104 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.94 -19.15 64.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.536 2.157 . . . . 0.0 110.773 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.86 -63.02 1.18 Allowed 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.817 0.847 . . . . 0.0 109.338 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -61.39 -31.17 71.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.346 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.26 -48.78 64.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.721 1.146 . . . . 0.0 110.481 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -30.69 69.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.782 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.29 -19.31 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.74 85.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.809 1.64 . . . . 0.0 112.188 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.551 0.0 OUTLIER -51.54 -18.36 1.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 173.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.34 179.54 0.97 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.87 1.214 . . . . 0.0 108.242 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -128.55 12.39 6.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 119.601 -1.937 . . . . 0.0 112.14 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -135.91 10.47 3.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.882 1.273 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.92 145.33 34.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 0.0 110.985 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.23 -21.38 6.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.002 2.521 . . . . 0.0 111.902 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -176.4 161.85 2.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.611 1.964 . . . . 0.0 109.431 -176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.61 110.66 23.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 tt -85.98 95.11 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.306 -2.849 . . . . 0.0 103.306 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.55 131.01 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.174 1.39 . . . . 0.0 107.806 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.6 mm -114.14 137.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.4 m -113.96 93.22 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.45 160.32 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.29 1.436 . . . . 0.0 111.072 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.97 -57.26 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -140.9 127.22 19.79 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.131 0.423 . . . . 0.0 111.944 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.08 139.34 51.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.75 3.22 . . . . 0.0 110.637 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -142.24 139.55 32.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.482 1.513 . . . . 0.0 110.668 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -72.87 135.26 45.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -174.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -143.21 -58.6 0.42 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.253 1.261 0 CA-C-O 115.753 -2.07 . . . . 0.0 113.929 -173.481 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mmm . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -136.19 157.43 75.65 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.997 1.319 . . . . 0.0 108.664 -177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.15 162.25 42.25 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.539 2.159 . . . . 0.0 110.683 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.21 -38.85 93.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -50.73 -40.43 54.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.125 1.77 . . . . 0.0 112.016 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.3 -56.41 13.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.8 1.182 . . . . 0.0 109.989 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -59.14 -48.45 81.55 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 110.201 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.83 -40.28 75.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.764 0.711 . . . . 0.0 112.624 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.9 -40.78 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.861 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -45.68 85.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.377 1.444 . . . . 0.0 111.501 173.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -51.91 -20.62 2.4 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -105.95 161.66 14.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.407 1.083 . . . . 0.0 110.156 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.55 139.57 45.72 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.45 174.46 47.0 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.8 143.2 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -174.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.3 164.76 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.83 158.95 43.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.759 1.224 . . . . 0.0 109.162 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.5 mt -142.63 119.94 6.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 124.768 1.227 . . . . 0.0 107.947 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -94.05 108.42 20.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 m -89.95 121.3 31.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 116.194 -1.86 . . . . 0.0 106.386 -173.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -73.47 137.23 44.38 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 122.062 2.21 . . . . 0.0 108.689 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.08 -81.21 0.22 Allowed Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -158.84 -61.51 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -79.35 39.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.203 3.001 . . . . 0.0 111.511 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 151.13 13.36 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.64 150.02 56.13 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 CA-C-N 118.177 0.989 . . . . 0.0 111.208 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -99.51 101.59 12.88 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 6.5 tt -84.86 88.97 7.45 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -173.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.99 168.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.37 1.468 . . . . 0.0 110.254 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.34 167.7 12.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.411 1.084 . . . . 0.0 112.216 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.44 172.11 8.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.86 2.064 . . . . 0.0 108.195 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -120.86 141.65 50.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.894 1.678 . . . . 0.0 110.385 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -51.11 -31.26 18.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.095 0.958 . . . . 0.0 111.905 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -57.74 -14.51 5.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.205 1.802 . . . . 0.0 112.733 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.21 -3.55 11.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.711 1.204 . . . . 0.0 110.214 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.21 163.52 13.24 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.51 -1.369 . . . . 0.0 112.759 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 140.72 43.0 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 172.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -101.55 151.78 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 109.58 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 mt -121.55 178.33 4.86 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.553 1.941 . . . . 0.0 109.436 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 20.9 t0 -76.21 177.1 7.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.31 1.444 . . . . 0.0 107.903 173.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 57.25 29.34 59.92 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 120.598 -1.313 . . . . 0.0 110.721 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.321 0.0 OUTLIER 53.44 15.35 0.69 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 130.233 3.413 . . . . 0.0 115.091 -175.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -73.86 145.57 44.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -127.98 168.66 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.7 t -146.38 142.74 21.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.013 -1.055 . . . . 0.0 108.883 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -126.34 135.49 27.25 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.842 2.057 . . . . 0.0 107.769 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.82 108.53 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.743 2.296 . . . . 0.0 109.448 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.61 111.39 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.24 -21.36 6.63 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.759 1.647 . . . . 0.0 112.241 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.23 41.4 0.31 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 117.746 -1.586 . . . . 0.0 109.552 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 20.2 mtt -109.74 57.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.014 1.326 . . . . 0.0 107.909 173.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -71.58 -48.82 45.79 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.056 1.342 . . . . 0.0 113.42 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.98 -41.4 62.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.721 1.6 . . . . 0.0 108.87 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.9 m -59.98 -40.47 89.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.76 1.624 . . . . 0.0 110.369 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.92 -49.02 78.17 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.152 1.796 . . . . 0.0 110.988 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.66 98.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.819 0.343 . . . . 0.0 111.311 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -63.19 -41.59 99.2 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.009 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -61.55 -48.24 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.452 1.478 . . . . 0.0 109.286 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.28 59.28 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.634 -0.667 . . . . 0.0 112.423 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.7 mmm-85 -78.46 -46.46 19.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -151.26 129.53 11.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.781 1.233 . . . . 0.0 109.764 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.25 -23.23 62.87 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.492 -0.755 . . . . 0.0 112.487 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -61.28 124.09 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.947 0.899 . . . . 0.0 112.027 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.88 155.37 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 123.76 1.743 . . . . 0.0 110.253 173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tt -107.49 150.36 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 173.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.4 ttt -139.29 141.93 37.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.6 p -125.2 128.52 48.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 116.159 -1.877 . . . . 0.0 106.046 173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 160.22 20.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 122.087 2.222 . . . . 0.0 106.345 173.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.13 -172.22 45.15 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -150.07 168.37 24.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.419 ' CZ ' ' HA3' ' A' ' 80' ' ' GLY . 21.4 mmm180 -98.92 -8.8 25.01 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 109.844 173.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -79.33 -6.19 56.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.448 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.43 140.3 49.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.0 121.06 24.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.37 -130.11 3.88 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 125.158 1.361 . . . . 0.0 110.107 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.34 -63.64 1.23 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.302 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -84.03 102.63 12.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.863 -174.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.96 -168.45 0.93 Allowed Glycine 0 CA--C 1.542 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 112.194 -174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.03 91.43 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 108.997 173.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 71' ' ' ARG . . . 178.81 122.02 0.74 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 117.336 -1.813 . . . . 0.0 110.445 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 t -123.72 171.68 9.42 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.815 1.307 . . . . 0.0 110.026 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.23 -157.58 28.35 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.783 1.183 . . . . 0.0 112.579 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -148.42 154.87 40.49 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.931 1.293 . . . . 0.0 109.811 -174.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.41 131.21 47.62 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 128.916 2.886 . . . . 0.0 104.56 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 mp -138.63 163.6 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.802 1.241 . . . . 0.0 108.579 -173.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -134.37 151.09 51.0 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.204 1.402 . . . . 0.0 109.123 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -175.6 40.07 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.175 0.893 . . . . 0.0 111.715 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 m -113.93 128.8 56.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.41 1.084 . . . . 0.0 109.888 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.66 17.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.319 1.447 . . . . 0.0 111.465 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.04 120.44 2.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.02 1.328 . . . . 0.0 109.481 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -77.13 142.69 39.61 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.568 -0.707 . . . . 0.0 109.634 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 140.92 34.24 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.354 1.061 . . . . 0.0 109.714 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 p -121.25 35.94 4.75 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.457 1.903 . . . . 0.0 106.221 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -159.35 157.54 30.58 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.502 2.321 . . . . 0.0 110.091 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.71 178.25 46.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.951 2.691 . . . . 0.0 113.089 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 -8.95 22.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.187 2.591 . . . . 0.0 112.634 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.98 -56.34 12.16 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -61.4 -31.89 71.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.781 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.59 -48.61 38.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.539 0.685 . . . . 0.0 110.043 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.9 -27.45 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.061 -1.024 . . . . 0.0 111.712 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.323 1.7 pp -93.26 -18.39 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.963 173.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.33 -28.4 4.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.585 1.954 . . . . 0.0 112.656 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -50.99 -22.88 2.52 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.768 1.227 . . . . 0.0 113.293 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -80.71 178.64 8.23 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.619 1.099 . . . . 0.0 110.312 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -128.51 3.83 5.6 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.149 -1.595 . . . . 0.0 111.23 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -135.68 8.28 3.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 111.54 -174.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.55 142.4 34.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.034 0.834 . . . . 0.0 109.112 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.61 -10.76 8.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.044 1.337 . . . . 0.0 111.829 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.49 161.91 9.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.187 2.595 . . . . 0.0 108.332 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.76 107.07 16.94 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.114 2.166 . . . . 0.0 106.588 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.1 tp -82.12 98.56 8.74 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.426 1.891 . . . . 0.0 107.594 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -83.96 127.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.699 1.6 . . . . 0.0 107.373 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.74 129.06 72.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 119.367 0.985 . . . . 0.0 108.488 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 m -99.11 87.91 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.66 153.57 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.991 0.916 . . . . 0.0 109.967 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.7 -59.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -149.58 141.22 23.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.528 0.604 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.58 159.52 25.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 127.953 2.501 . . . . 0.0 112.448 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -140.87 145.25 35.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.259 2.224 . . . . 0.0 108.458 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -76.19 134.78 39.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.4 p -133.69 -58.79 0.87 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.47 0.577 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.712 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mmm . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 121.159 0.504 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mp -141.38 155.6 67.51 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.52 163.61 38.43 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.903 2.402 . . . . 0.0 112.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.4 97.59 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 173.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.305 2.9 m -51.82 -38.11 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.966 2.107 . . . . 0.0 112.822 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -50.85 -49.11 59.67 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.519 1.054 . . . . 0.0 110.202 173.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -63.27 -48.19 79.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.775 1.23 . . . . 0.0 111.352 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.47 -41.48 63.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.562 0.619 . . . . 0.0 111.067 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.43 -45.55 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.119 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.5 mt -52.5 -28.37 20.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.576 1.08 . . . . 0.0 112.754 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -51.72 -18.51 1.24 Allowed 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.904 -1.747 . . . . 0.0 112.646 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -114.84 160.38 19.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.38 1.872 . . . . 0.0 109.719 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -74.36 156.54 36.96 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 166.3 35.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.476 -0.868 . . . . 0.0 113.64 -173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -81.97 141.36 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.7 t -133.92 160.55 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.94 155.9 40.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.714 1.205 . . . . 0.0 108.467 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.95 119.97 15.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.87 108.73 19.69 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 m -90.76 113.24 25.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -73.72 141.55 46.36 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.045 2.202 . . . . 0.0 108.037 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 -81.21 0.32 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -162.54 -48.97 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.671 0.788 . . . . 0.0 108.938 173.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.68 39.24 0.34 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.389 2.276 . . . . 0.0 110.657 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.27 151.16 6.03 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.911 1.719 . . . . 0.0 111.303 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.31 161.02 45.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.017 1.145 . . . . 0.0 111.411 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -112.77 101.75 9.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.242 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 tp -74.04 88.69 1.91 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -74.13 168.73 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.408 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.1 165.1 14.57 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.616 1.166 . . . . 0.0 111.669 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t -168.69 175.7 5.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.952 2.101 . . . . 0.0 108.068 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.41 142.0 49.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.492 2.317 . . . . 0.0 109.852 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -51.94 -30.3 24.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.301 -0.856 . . . . 0.0 110.402 174.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -50.47 -20.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.052 2.941 . . . . 0.0 113.295 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.5 m-30 -118.12 -12.75 9.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.775 -1.203 . . . . 0.0 110.539 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.14 158.35 15.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 120.583 -1.323 . . . . 0.0 112.872 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.9 140.96 42.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 120.892 -1.13 . . . . 0.0 109.501 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -100.86 144.09 13.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.519 -2.401 . . . . 0.0 104.519 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.4 mt -121.19 -179.09 3.94 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.84 2.056 . . . . 0.0 107.806 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.52 169.83 4.5 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.246 0.618 . . . . 0.0 111.382 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.89 28.41 52.86 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.911 1.719 . . . . 0.0 111.354 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.318 0.2 OUTLIER 53.37 27.54 6.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.06 1.744 . . . . 0.0 113.11 -175.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -73.41 150.97 41.34 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.76 158.01 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -141.35 135.8 31.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.08 130.73 24.68 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 128.743 2.817 . . . . 0.0 106.526 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.6 108.74 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.569 2.179 . . . . 0.0 110.023 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.56 111.84 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.5 -21.6 5.06 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.519 1.056 . . . . 0.0 112.422 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.02 41.26 0.34 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 119.285 1.543 . . . . 0.0 109.266 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.4 mtt -109.78 70.62 0.73 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.582 1.153 . . . . 0.0 108.125 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -71.44 -55.96 6.89 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.985 2.114 . . . . 0.0 114.876 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -51.92 -41.35 61.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 121.341 1.882 . . . . 0.0 108.469 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -63.17 -38.77 92.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.248 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 21.9 tt0 -56.79 -50.64 71.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.076 1.307 . . . . 0.0 110.134 174.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.44 98.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.899 0.48 . . . . 0.0 111.547 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -64.01 -41.61 97.4 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.689 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.22 -48.05 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 120.051 1.296 . . . . 0.0 108.27 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.02 -22.12 25.39 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -86.92 -44.38 11.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -150.95 140.81 21.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.31 1.444 . . . . 0.0 109.13 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -75.74 -18.05 59.7 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.028 -1.045 . . . . 0.0 112.221 175.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 62' ' ' GLU . 6.9 mmp_? -59.32 117.47 4.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.353 1.061 . . . . 0.0 113.564 -173.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -138.93 153.39 24.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 124.055 1.883 . . . . 0.0 112.549 173.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.6 tp -111.01 151.16 28.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 173.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 ttt -139.24 134.29 32.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.5 p -126.58 127.87 45.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -117.11 164.21 15.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.651 1.114 . . . . 0.0 108.966 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.08 178.26 42.99 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -150.7 -178.41 6.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -113.24 -9.34 13.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.116 0.966 . . . . 0.0 110.504 173.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -86.1 -4.49 59.18 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.96 138.71 52.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.6 35.61 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.594 0.634 . . . . 0.0 109.827 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.51 -132.24 4.12 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 124.573 1.082 . . . . 0.0 111.953 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -91.43 -58.84 2.31 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.56 102.57 7.99 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.83 -167.98 0.16 Allowed Glycine 0 CA--C 1.542 1.719 0 O-C-N 120.53 -1.356 . . . . 0.0 111.798 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.55 90.65 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.619 -2.108 . . . . 0.0 106.619 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.58 121.64 0.71 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.78 169.89 9.23 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 119.396 1.598 . . . . 0.0 109.544 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.29 179.48 43.85 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 123.798 0.713 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -132.53 149.32 52.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.265 1.026 . . . . 0.0 109.75 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -97.24 130.11 44.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.46 152.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -130.48 140.81 50.51 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.205 1.402 . . . . 0.0 107.247 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.3 -176.48 42.72 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.141 0.882 . . . . 0.0 112.799 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 m -103.98 143.67 32.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.91 164.4 12.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 120.058 1.299 . . . . 0.0 111.214 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.15 121.25 2.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.15 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.4 m-85 -73.84 143.27 45.97 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 141.76 38.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.993 1.317 . . . . 0.0 111.51 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 p -114.76 25.87 10.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.826 2.05 . . . . 0.0 106.863 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.59 165.08 35.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.705 2.402 . . . . 0.0 109.725 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.15 178.61 45.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 127.165 2.316 . . . . 0.0 113.173 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.55 -24.11 77.56 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.672 2.248 . . . . 0.0 111.154 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -62.3 -56.54 17.43 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.531 1.132 . . . . 0.0 109.017 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -61.34 -31.37 71.24 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.72 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -68.02 -48.17 66.44 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 121.608 2.004 . . . . 0.0 110.622 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.78 41.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.419 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.2 pp -93.67 -20.7 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.15 92.94 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 121.351 1.887 . . . . 0.0 112.453 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.505 0.0 OUTLIER -51.96 -21.92 3.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.1 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -73.05 178.97 4.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -133.92 7.88 3.77 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 118.393 -2.692 . . . . 0.0 114.388 -176.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -121.53 8.57 10.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.742 0.701 . . . . 0.0 111.796 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.42 150.78 24.47 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -115.52 -19.17 10.74 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.686 1.994 . . . . 0.0 110.397 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.2 161.49 12.35 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.581 1.182 . . . . 0.0 109.383 -173.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.52 106.9 18.96 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -83.39 95.09 8.12 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.9 t -81.95 131.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.389 1.876 . . . . 0.0 106.567 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.32 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.2 m -104.12 91.98 4.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.84 157.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.305 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.04 -53.26 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.3 m -151.34 141.58 22.31 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.505 1.048 . . . . 0.0 113.235 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.01 144.7 39.71 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 128.451 2.7 . . . . 0.0 108.836 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -139.05 136.46 35.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.945 2.098 . . . . 0.0 106.944 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.92 139.16 38.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 p -141.21 -59.1 0.49 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.252 1.186 0 CA-C-O 115.444 -2.217 . . . . 0.0 114.019 -173.334 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.2 mm? . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.87 159.9 47.22 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.545 2.163 . . . . 0.0 109.788 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.21 94.04 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -51.4 -39.01 56.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.941 1.696 . . . . 0.0 111.438 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.28 -57.84 7.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.593 1.088 . . . . 0.0 110.388 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -54.78 -48.43 72.7 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.522 1.129 . . . . 0.0 109.902 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.82 -35.96 73.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.5 t -69.4 -44.07 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.618 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -41.67 77.12 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.068 1.304 . . . . 0.0 112.433 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -51.77 -24.67 6.25 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.86 168.48 9.4 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 122.42 1.105 . . . . 0.0 111.669 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.5 138.69 45.23 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -178.83 172.36 44.61 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.04 150.93 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.1 t -128.97 163.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 127.585 2.354 . . . . 0.0 104.926 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.19 156.09 46.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.543 1.137 . . . . 0.0 108.315 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -138.54 110.88 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.87 108.51 19.57 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.496 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -93.89 108.79 20.54 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -74.4 137.24 42.56 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 121.034 1.743 . . . . 0.0 106.441 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.72 -81.94 0.22 Allowed Glycine 0 C--O 1.222 -0.607 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -164.16 -61.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.98 55.95 3.76 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.128 1.918 . . . . 0.0 109.49 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.59 140.69 4.92 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 127.238 2.351 . . . . 0.0 112.144 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.9 151.66 77.91 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 118.248 1.024 . . . . 0.0 109.619 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -121.12 101.82 7.91 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -87.43 88.55 7.71 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.33 173.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.006 2.123 . . . . 0.0 110.521 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -119.21 167.69 11.59 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.778 1.172 . . . . 0.0 113.128 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.7 t -168.34 173.16 7.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.1 2.16 . . . . 0.0 108.758 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -120.77 141.59 50.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.448 2.299 . . . . 0.0 109.984 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.56 -31.23 63.99 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.224 0.92 . . . . 0.0 111.013 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -60.09 -9.08 2.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.7 1.6 . . . . 0.0 113.612 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -118.1 -10.74 10.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.031 1.332 . . . . 0.0 109.361 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.7 mt -92.33 164.62 13.44 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.745 -1.222 . . . . 0.0 111.232 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD2' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.78 141.27 42.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.3 t -101.68 150.05 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.3 mt -122.14 178.86 4.74 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.37 2.668 . . . . 0.0 107.64 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -73.1 174.83 7.37 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.98 28.29 32.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.591 1.567 . . . . 0.0 110.942 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.657 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.301 0.1 OUTLIER 53.49 21.99 2.72 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.0 2.12 . . . . 0.0 114.69 -176.605 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -73.36 139.61 46.09 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -123.69 167.49 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 t -147.62 145.97 18.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 O-C-N 120.484 -1.385 . . . . 0.0 108.582 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.4 131.79 24.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.289 2.636 . . . . 0.0 105.959 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.91 108.75 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.485 2.123 . . . . 0.0 108.84 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.761 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.42 111.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.4 -21.08 5.63 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.852 1.691 . . . . 0.0 112.966 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.07 41.55 0.29 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 48' ' ' VAL . 22.7 mtt -107.88 71.41 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.553 1.541 . . . . 0.0 107.862 174.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -66.29 -64.91 0.75 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 130.348 3.459 . . . . 0.0 113.732 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -51.69 -41.11 61.21 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.982 -1.074 . . . . 0.0 109.15 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -61.5 -38.94 89.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.69 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.78 -50.18 74.91 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 121.126 1.785 . . . . 0.0 110.532 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.31 -39.31 90.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 111.498 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -68.08 -41.96 81.09 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 116.279 -1.82 . . . . 0.0 110.471 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.15 -48.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.101 1.319 . . . . 0.0 108.966 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.19 51.06 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.295 -0.86 . . . . 0.0 112.694 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.86 -45.93 10.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.36 0.982 . . . . 0.0 113.081 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -141.59 133.14 26.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.931 0.893 . . . . 0.0 110.777 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -16.15 62.21 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.948 -1.095 . . . . 0.0 112.902 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -59.76 117.12 4.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.6 m -138.9 147.1 25.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 123.679 1.704 . . . . 0.0 112.444 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.25 148.9 31.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 11.7 ttt -139.38 126.62 21.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.3 p -108.74 127.96 54.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.79 164.92 13.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.994 1.725 . . . . 0.0 108.696 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.1 -175.77 38.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 46.9 t -146.99 161.92 39.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.024 1.329 . . . . 0.0 108.841 174.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -98.73 -8.1 26.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.854 1.662 . . . . 0.0 109.922 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -8.51 48.73 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.839 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.88 133.95 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.13 131.38 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.5 1.12 . . . . 0.0 111.419 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -140.92 6.14 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.89 -59.43 2.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.746 2.019 . . . . 0.0 108.324 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.27 102.94 8.87 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.2 -168.63 1.58 Allowed Glycine 0 CA--C 1.537 1.463 0 O-C-N 121.997 -0.439 . . . . 0.0 112.289 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -75.65 64.18 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.574 2.182 . . . . 0.0 109.954 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.11 121.13 1.1 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -118.16 169.61 9.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.008 0.904 . . . . 0.0 110.155 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.61 -171.84 43.56 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 124.271 0.939 . . . . 0.0 112.406 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -145.35 156.04 43.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 109.791 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 tt -101.38 131.36 47.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.33 162.07 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -133.32 150.75 51.85 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.399 1.479 . . . . 0.0 108.923 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.97 179.6 43.52 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.216 0.912 . . . . 0.0 111.745 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -101.21 128.98 47.08 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.02 161.78 14.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.609 1.095 . . . . 0.0 111.692 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 121.28 3.11 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.41 1.484 . . . . 0.0 109.351 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.91 137.54 43.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.613 HH11 ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -138.34 141.22 39.73 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.532 1.533 . . . . 0.0 109.334 176.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.26 37.39 4.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -159.2 159.12 33.91 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 129.072 2.949 . . . . 0.0 110.613 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.44 178.56 46.84 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 126.432 1.967 . . . . 0.0 115.694 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.57 -18.26 53.47 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.891 3.06 . . . . 0.0 111.724 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.83 -64.09 0.94 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.16 -31.27 71.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.633 0.773 . . . . 0.0 111.556 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -68.58 -60.3 2.51 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.75 -19.34 62.35 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.847 -1.158 . . . . 0.0 113.517 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.8 pp -92.6 -18.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.112 1.324 . . . . 0.0 110.854 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.58 -27.97 3.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.782 1.633 . . . . 0.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -50.67 -23.22 2.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.441 1.096 . . . . 0.0 113.567 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -80.3 178.73 8.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.733 1.151 . . . . 0.0 109.604 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 tttt -137.27 20.35 2.96 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.91 -1.744 . . . . 0.0 111.331 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -136.15 8.67 3.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.902 1.281 . . . . 0.0 111.137 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.93 131.1 35.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.529 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -20.9 16.53 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 109.669 173.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.761 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.85 161.76 11.08 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.377 1.871 . . . . 0.0 109.769 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 103.5 13.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.18 95.38 5.6 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.12 131.66 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.951 1.7 . . . . 0.0 106.961 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.2 mt -117.93 128.47 75.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -99.01 85.9 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 2' ' ' LEU . 31.4 t -60.78 151.7 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.494 1.118 . . . . 0.0 109.461 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.5 -54.99 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m -148.34 141.22 24.74 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.258 . . -120.59 158.15 27.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 130.698 3.599 . . . . 0.0 114.732 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -145.93 135.77 23.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.218 2.207 . . . . 0.0 107.221 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.84 138.57 42.6 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -134.83 -81.04 0.44 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.518 0.327 . . . . 0.0 110.48 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 121.38 0.609 . . . . 0.0 109.938 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.556 HD11 HG11 ' A' ' 115' ' ' VAL . 80.2 mt . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 157.16 57.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.502 2.134 . . . . 0.0 110.956 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -38.84 93.63 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -49.16 -38.94 27.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.606 1.562 . . . . 0.0 112.121 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -51.5 -52.82 43.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.426 1.466 . . . . 0.0 111.245 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -56.11 -48.35 76.36 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.585 1.154 . . . . 0.0 108.996 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.98 -34.03 69.53 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.12 -45.35 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.349 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.08 -43.17 70.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.315 1.416 . . . . 0.0 112.839 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -51.84 -19.36 1.67 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -112.16 161.94 15.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.938 1.351 . . . . 0.0 111.472 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -73.6 131.59 41.86 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.774 1.23 . . . . 0.0 109.356 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.31 165.13 35.37 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 124.978 1.275 . . . . 0.0 111.251 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.78 150.6 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 31' ' ' THR . 31.4 t -135.15 161.44 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.59 43.01 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.032 0.933 . . . . 0.0 108.808 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.7 mt -138.71 118.83 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.9 108.38 19.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.549 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.0 m -89.43 116.66 27.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -73.26 141.18 47.23 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 120.916 1.689 . . . . 0.0 106.554 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.13 -81.28 0.25 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -161.42 -48.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 19.9 p-10 -78.44 40.63 0.37 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 129.61 3.164 . . . . 0.0 111.133 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.43 151.4 18.56 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.693 1.139 . . . . 0.0 110.851 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 73.0 Cg_endo -68.8 149.27 72.69 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 CA-C-N 118.609 1.205 . . . . 0.0 109.51 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.522 ' HE1' ' HB3' ' A' ' 53' ' ' LYS . 19.4 t-160 -110.91 98.12 7.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.68 2.392 . . . . 0.0 112.892 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -82.14 89.21 6.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.674 0.79 . . . . 0.0 111.395 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.41 168.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.908 1.283 . . . . 0.0 110.491 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -122.23 166.07 15.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.426 HG23 ' HB ' ' A' ' 16' ' ' VAL . 12.1 t -168.42 176.57 5.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.224 2.209 . . . . 0.0 109.222 175.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.14 141.63 50.63 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.327 2.251 . . . . 0.0 109.848 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -55.61 -31.47 62.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.971 0.805 . . . . 0.0 111.193 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 t -60.48 -8.88 3.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.515 1.926 . . . . 0.0 114.043 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -118.72 -1.05 11.16 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.752 1.16 . . . . 0.0 111.399 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.511 HD22 HG22 ' A' ' 46' ' ' VAL . 11.5 mt -102.65 163.38 12.25 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.29 0.95 . . . . 0.0 112.262 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -136.3 141.59 43.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.79 141.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.43 -178.02 3.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.839 1.655 . . . . 0.0 108.999 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.76 164.81 4.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.651 1.181 . . . . 0.0 111.298 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.82 28.21 30.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.388 1.947 . . . . 0.0 111.109 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' HB2' HD12 ' A' ' 2' ' ' LEU 0.293 0.1 OUTLIER 53.44 22.15 2.74 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.532 1.933 . . . . 0.0 113.29 -175.151 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -73.83 131.89 41.99 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -114.11 161.09 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.63 138.54 35.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 108.669 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.511 HG22 HD22 ' A' ' 36' ' ' LEU . 59.1 t -123.15 133.14 24.34 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.742 2.017 . . . . 0.0 106.966 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.36 123.18 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.88 1.72 . . . . 0.0 107.739 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 51' ' ' MET . 7.8 p -85.08 112.16 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.65 -20.67 8.77 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 124.868 1.223 . . . . 0.0 113.458 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.62 39.99 0.19 Allowed Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.377 1.589 . . . . 0.0 112.175 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.446 ' HB2' HG23 ' A' ' 48' ' ' VAL . 30.9 mtt -99.12 71.06 1.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.035 0.917 . . . . 0.0 110.788 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -71.07 -67.41 0.51 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.368 1.867 . . . . 0.0 112.749 -173.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.522 ' HB3' ' HE1' ' A' ' 27' ' ' HIS 0.259 12.2 tmtt? -51.97 -38.89 58.25 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.172 0.989 . . . . 0.0 108.966 176.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -64.5 -38.81 92.32 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.909 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.53 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 26.5 tt0 -57.45 -43.63 84.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.478 1.944 . . . . 0.0 109.657 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.24 95.35 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.239 -0.288 . . . . 0.0 111.649 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.35 -41.76 76.66 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 116.968 -1.491 . . . . 0.0 113.567 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.08 -48.11 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.436 1.471 . . . . 0.0 109.089 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.7 -23.56 29.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -85.99 -46.07 10.87 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -151.42 129.43 11.8 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.759 1.224 . . . . 0.0 110.009 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -17.53 59.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.57 131.04 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.327 1.421 . . . . 0.0 110.739 -178.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.3 m -141.4 155.96 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 123.379 1.562 . . . . 0.0 112.332 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.5 tp -101.21 152.54 20.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.9 ttt -138.93 118.77 13.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -111.03 128.1 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.4 pt? -116.8 170.21 8.78 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 109.623 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.59 -177.02 39.3 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.533 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.5 t -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -98.63 -7.91 27.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.801 1.64 . . . . 0.0 108.936 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -11.26 38.55 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 119.371 -2.081 . . . . 0.0 113.338 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.42 138.87 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 120.627 1.558 . . . . 0.0 107.101 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.0 130.26 35.33 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.026 0.53 . . . . 0.0 110.75 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.67 -121.7 2.79 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 124.437 1.018 . . . . 0.0 112.927 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.445 ' H ' HD11 ' A' ' 122' ' ' LEU . 3.4 mmp_? -91.81 -78.63 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.247 1.419 . . . . 0.0 110.529 174.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -73.61 104.95 4.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.166 0.984 . . . . 0.0 108.431 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.15 -168.59 10.59 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.704 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 67.0 Cg_endo -74.74 63.7 5.76 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.851 2.368 . . . . 0.0 110.29 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.83 121.44 1.32 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -115.4 173.33 6.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.966 0.883 . . . . 0.0 110.726 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.3 -173.3 43.67 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 118.797 0.726 . . . . 0.0 113.133 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -151.34 157.32 42.33 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.409 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.5 130.9 47.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.62 155.14 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -126.86 143.87 51.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.626 1.57 . . . . 0.0 107.818 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.63 -165.11 32.65 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.3 m -121.39 142.87 49.58 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.313 0.645 . . . . 0.0 110.017 173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -89.92 161.78 15.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.623 1.169 . . . . 0.0 110.174 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.74 114.5 2.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.702 1.201 . . . . 0.0 107.775 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 50.1 m-85 -74.57 136.26 42.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.533 HH11 ' HG3' ' A' ' 92' ' ' ARG . 6.4 mmm-85 -139.13 137.3 35.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 109.866 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -120.78 38.06 4.14 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.81 158.96 34.55 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 129.394 3.078 . . . . 0.0 111.19 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.73 46.88 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.966 1.746 . . . . 0.0 114.72 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.03 -19.55 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.645 2.23 . . . . 0.0 109.523 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -63.62 -65.86 0.62 Allowed 'General case' 0 C--O 1.25 1.11 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.58 -31.85 71.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 116.607 -1.663 . . . . 0.0 112.515 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -68.25 -53.95 21.03 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.852 1.66 . . . . 0.0 110.823 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.67 70.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 116.96 -1.495 . . . . 0.0 111.309 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pp -85.1 -20.67 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 117.507 -1.677 . . . . 0.0 113.558 173.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.05 97.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.881 1.673 . . . . 0.0 112.915 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.599 ' H ' ' HD2' ' A' ' 103' ' ' ARG 0.52 0.0 OUTLIER -51.72 -18.06 1.1 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 173.784 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.02 -179.0 0.12 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -128.38 16.11 6.59 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 118.782 -2.449 . . . . 0.0 111.998 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -139.32 12.16 2.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.042 1.337 . . . . 0.0 110.891 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.12 140.46 37.8 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.372 -0.83 . . . . 0.0 111.28 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.81 -21.53 6.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.988 2.115 . . . . 0.0 111.706 174.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.24 161.99 1.9 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.69 1.996 . . . . 0.0 109.396 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.61 112.44 24.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 tp -84.1 93.56 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.11 120.8 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.93 128.8 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.2 m -98.61 78.91 2.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 2' ' ' LEU . 38.5 t -61.09 153.84 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 125.745 1.618 . . . . 0.0 109.381 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.9 t -130.15 -54.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -151.4 141.59 22.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.717 0.689 . . . . 0.0 112.844 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.58 20.22 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 127.283 2.233 . . . . 0.0 111.22 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.38 154.21 42.75 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.308 2.643 . . . . 0.0 106.689 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -100.8 133.97 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.223 -1.548 . . . . 0.0 108.404 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.0 p -135.37 -81.91 0.42 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.196 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.445 HD11 ' H ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.808 0 C-N-CA 130.415 3.486 . . . . 0.0 114.871 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.3 mm? . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.86 158.51 52.74 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.109 1.873 . . . . 0.0 109.197 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.2 -40.44 95.79 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -54.18 -38.84 66.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 111.827 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -51.32 -52.31 46.53 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.51 1.05 . . . . 0.0 110.692 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -60.0 -48.28 82.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.764 0.826 . . . . 0.0 110.495 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -53.21 -38.66 63.1 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.505 1.048 . . . . 0.0 112.159 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.04 -42.35 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.858 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.2 mt -58.39 -42.67 87.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.261 1.392 . . . . 0.0 112.164 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -51.87 -25.34 7.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.105 0.962 . . . . 0.0 113.04 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -101.26 161.09 13.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.62 139.99 45.86 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.13 164.4 37.75 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.53 148.5 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.421 ' HB ' HG23 ' A' ' 31' ' ' THR . 13.8 t -135.49 161.66 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.6 158.38 41.08 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.123 0.969 . . . . 0.0 108.875 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -138.81 114.42 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.66 108.87 19.69 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.607 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -92.89 116.19 28.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 116.939 -1.505 . . . . 0.0 107.607 -173.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -73.3 137.42 44.84 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 120.859 1.663 . . . . 0.0 108.4 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.25 -81.51 0.22 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 106.8 -2.52 . . . . 0.0 106.8 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -168.98 -48.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -78.18 38.68 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 131.326 3.85 . . . . 0.0 110.069 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.92 151.17 5.7 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 39.4 Cg_endo -68.62 148.56 72.51 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 CA-C-N 119.762 1.781 . . . . 0.0 107.725 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -108.15 101.5 10.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.347 -173.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 tp -74.68 88.8 2.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.216 1.006 . . . . 0.0 111.441 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.08 170.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.489 1.516 . . . . 0.0 110.242 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.24 168.08 11.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.802 1.183 . . . . 0.0 113.571 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.421 HG23 ' HB ' ' A' ' 16' ' ' VAL . 14.1 t -168.61 174.1 6.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.254 2.622 . . . . 0.0 108.253 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -121.11 141.96 50.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.52 2.328 . . . . 0.0 110.726 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -52.92 -31.63 41.06 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.828 1.194 . . . . 0.0 111.776 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -58.48 -8.71 1.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.701 2.001 . . . . 0.0 113.653 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -118.06 -3.35 11.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.813 1.245 . . . . 0.0 110.479 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.9 mt -99.23 170.59 8.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 120.449 1.477 . . . . 0.0 114.36 -173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -136.33 141.32 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -100.92 148.81 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 mt -121.78 178.93 4.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.17 2.188 . . . . 0.0 110.463 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -67.13 167.65 11.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.577 1.551 . . . . 0.0 109.742 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.9 28.62 57.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.073 1.321 . . . . 0.0 111.307 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.25 0.1 OUTLIER 53.73 20.43 2.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.873 2.069 . . . . 0.0 114.236 -175.21 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -73.44 145.56 45.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -127.27 168.15 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.02 145.0 18.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 120.392 -1.443 . . . . 0.0 108.8 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.68 138.88 32.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 128.749 2.82 . . . . 0.0 107.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.24 109.12 2.28 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.8 3.0 . . . . 0.0 109.427 173.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.28 111.84 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 173.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.77 -21.63 4.94 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.771 1.177 . . . . 0.0 113.24 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.24 37.45 0.41 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 119.183 1.491 . . . . 0.0 111.44 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.465 ' HB2' HG23 ' A' ' 48' ' ' VAL . 33.4 mtt -103.39 71.5 1.1 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.423 ' CD2' HH22 ' A' ' 108' ' ' ARG . 34.0 m80 -67.28 -70.53 0.25 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.401 2.68 . . . . 0.0 114.573 -173.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -51.68 -40.74 60.62 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 120.791 -1.193 . . . . 0.0 109.987 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 12.8 m -60.39 -39.14 86.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.868 0.867 . . . . 0.0 113.323 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.85 -48.13 82.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.291 1.405 . . . . 0.0 108.587 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.2 97.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.761 173.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 15.6 m-20 -63.07 -41.93 99.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.57 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.49 -48.21 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.622 1.101 . . . . 0.0 108.664 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.87 -26.81 62.61 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.122 -0.942 . . . . 0.0 113.503 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -87.18 -46.99 9.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.977 1.262 . . . . 0.0 112.187 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -147.06 128.85 15.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.399 1.08 . . . . 0.0 111.848 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -17.67 59.3 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.488 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.66 130.97 48.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.225 0.921 . . . . 0.0 110.466 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 20' ' ' THR . 35.5 m -144.24 156.15 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 123.264 1.507 . . . . 0.0 112.879 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.5 tp -104.88 152.74 22.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 172.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 ttt -138.99 128.27 24.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 p -129.72 128.6 42.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -116.46 164.07 15.1 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 119.431 1.014 . . . . 0.0 109.29 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.64 42.4 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.8 t -160.95 172.04 17.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.171 -1.194 . . . . 0.0 109.428 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -99.23 -8.29 25.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.212 2.205 . . . . 0.0 108.987 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -11.18 43.88 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 115.815 -2.041 . . . . 0.0 116.265 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.87 140.33 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.76 131.29 35.88 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.727 0.811 . . . . 0.0 110.868 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.4 -139.47 5.68 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 125.441 1.496 . . . . 0.0 112.099 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -79.23 -59.04 2.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.165 1.786 . . . . 0.0 107.662 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.7 103.09 15.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.27 -168.7 4.13 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.36 61.02 6.59 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.492 2.128 . . . . 0.0 109.969 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.33 121.56 1.2 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 108.559 -1.817 . . . . 0.0 108.559 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.19 169.85 8.96 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.479 1.14 . . . . 0.0 110.197 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 171.83 43.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.295 0.95 . . . . 0.0 113.1 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -131.83 147.78 52.51 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.417 1.487 . . . . 0.0 108.696 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -100.51 131.5 46.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.893 2.477 . . . . 0.0 105.409 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 115' ' ' VAL . 6.4 mt -136.4 154.73 33.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 mtt-85 -127.74 143.12 51.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.285 1.434 . . . . 0.0 107.682 -174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.09 -171.84 40.27 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 119.094 0.861 . . . . 0.0 113.407 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -121.31 134.68 55.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.323 1.449 . . . . 0.0 110.514 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -88.76 160.53 17.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.747 1.619 . . . . 0.0 110.565 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.62 120.64 1.5 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.464 1.506 . . . . 0.0 109.13 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.99 149.37 29.34 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.19 -0.944 . . . . 0.0 112.747 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.18 141.4 34.1 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.557 1.943 . . . . 0.0 109.179 172.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.8 p -114.11 24.8 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.546 1.539 . . . . 0.0 107.321 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.72 167.32 29.81 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 126.317 1.847 . . . . 0.0 110.39 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.8 179.74 45.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.639 2.066 . . . . 0.0 113.295 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.7 -11.46 17.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.886 3.057 . . . . 0.0 112.459 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -64.04 0.98 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.328 1.851 . . . . 0.0 107.138 173.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.29 -31.12 70.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.127 0.892 . . . . 0.0 110.749 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -68.65 -56.86 6.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.001 0.819 . . . . 0.0 109.801 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.39 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.909 -1.119 . . . . 0.0 112.428 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.343 1.5 pp -92.3 -18.12 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.666 1.121 . . . . 0.0 111.463 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.28 -28.09 2.89 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.688 1.995 . . . . 0.0 112.334 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -51.49 -32.34 27.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.237 172.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -79.07 178.02 8.36 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 173.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.69 8.18 1.93 Allowed 'General case' 0 C--O 1.221 -0.427 0 O-C-N 118.473 -2.642 . . . . 0.0 111.704 173.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -102.0 8.38 40.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.628 1.171 . . . . 0.0 110.554 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.96 22.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.519 0.727 . . . . 0.0 109.992 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.423 HH22 ' CD2' ' A' ' 52' ' ' HIS . 23.1 ttm180 -120.65 -20.93 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.887 2.075 . . . . 0.0 111.355 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.35 161.83 12.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.666 1.586 . . . . 0.0 108.519 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.5 105.41 15.43 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.599 2.36 . . . . 0.0 106.695 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 tp -79.22 95.86 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.285 1.834 . . . . 0.0 107.094 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.7 t -78.91 131.52 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.676 1.59 . . . . 0.0 106.718 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.78 128.36 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.5 m -98.91 85.9 3.37 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.475 HG11 HD21 ' A' ' 2' ' ' LEU . 22.6 t -60.76 150.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.46 -58.83 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -147.95 141.53 25.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.3 154.73 25.22 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.394 2.278 . . . . 0.0 110.347 173.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -140.41 139.14 35.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.447 2.299 . . . . 0.0 106.865 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -77.84 139.97 39.33 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -132.98 -58.82 0.9 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.243 0.717 0 CA-C-O 116.561 -1.685 . . . . 0.0 111.945 -173.362 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.15 155.48 56.61 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.576 2.184 . . . . 0.0 110.644 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.84 -42.06 97.96 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -49.48 -38.8 31.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.36 1.864 . . . . 0.0 112.327 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -51.1 -56.26 13.56 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.45 1.023 . . . . 0.0 110.145 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -58.62 -48.74 79.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.914 0.886 . . . . 0.0 109.36 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.59 -40.23 71.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.483 0.583 . . . . 0.0 112.269 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.52 -45.83 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.801 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.65 -37.25 73.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.81 1.186 . . . . 0.0 113.921 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -51.78 -29.51 19.26 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.748 1.158 . . . . 0.0 112.134 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -101.08 165.55 11.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.607 1.163 . . . . 0.0 109.83 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.21 139.05 45.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.33 167.56 40.31 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.13 144.12 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.068 1.747 . . . . 0.0 107.432 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.419 ' HB ' HG23 ' A' ' 31' ' ' THR . 59.0 t -136.8 158.32 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -145.42 155.45 43.15 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.566 1.546 . . . . 0.0 108.115 173.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.489 HD11 HG21 ' A' ' 46' ' ' VAL . 39.5 mt -140.98 112.93 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.99 108.92 19.84 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.458 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -95.35 116.99 29.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -73.31 141.16 47.14 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 121.001 1.728 . . . . 0.0 106.542 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.12 -81.27 0.22 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.89 -60.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -78.61 38.84 0.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 130.096 3.359 . . . . 0.0 111.445 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.0 151.29 17.03 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.13 0.871 . . . . 0.0 110.994 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.6 152.09 53.34 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 120.994 1.13 . . . . 0.0 111.529 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -110.5 101.6 10.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.4 tt -88.91 88.94 7.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -85.71 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.561 1.944 . . . . 0.0 110.785 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -119.23 166.72 12.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.367 0.985 . . . . 0.0 113.368 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.419 HG23 ' HB ' ' A' ' 16' ' ' VAL . 13.2 t -168.44 171.89 8.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.407 2.283 . . . . 0.0 108.212 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -121.34 141.71 50.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.084 1.754 . . . . 0.0 110.192 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.69 -31.25 15.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.795 0.838 . . . . 0.0 111.376 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -59.31 -8.66 1.79 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.095 1.758 . . . . 0.0 113.682 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -118.56 -13.21 9.69 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.722 1.209 . . . . 0.0 110.623 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.543 HD22 HG22 ' A' ' 46' ' ' VAL . 27.8 mt -91.1 168.62 11.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.64 -1.288 . . . . 0.0 111.901 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.91 37.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.46 134.05 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.28 179.07 4.53 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.897 1.679 . . . . 0.0 107.337 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 35.0 t0 -75.83 -179.21 4.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.274 0.629 . . . . 0.0 110.31 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 58.6 28.85 63.16 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.419 -1.425 . . . . 0.0 110.303 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 p30 53.82 13.23 0.5 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 130.106 3.362 . . . . 0.0 114.684 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -74.01 128.05 34.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.082 0.401 . . . . 0.0 110.301 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -119.07 158.83 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.5 142.72 25.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 O-C-N 120.397 -1.439 . . . . 0.0 107.732 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.543 HG22 HD22 ' A' ' 36' ' ' LEU . 58.2 t -124.38 126.15 25.53 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 128.623 2.769 . . . . 0.0 106.522 -173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -72.9 108.4 2.57 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.453 1.436 . . . . 0.0 108.934 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.87 111.59 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.7 -21.48 5.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.35 0.976 . . . . 0.0 112.097 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.58 41.3 0.47 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.044 -174.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB2' HG23 ' A' ' 48' ' ' VAL . 8.7 mtt -109.75 71.74 0.77 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.271 1.429 . . . . 0.0 108.203 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -67.04 -64.13 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 130.239 3.416 . . . . 0.0 112.794 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -51.66 -41.04 61.07 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.258 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.8 m -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.358 1.463 . . . . 0.0 111.509 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.95 -48.97 79.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.714 1.206 . . . . 0.0 108.838 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.83 94.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.0 -41.86 90.52 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.014 0.926 . . . . 0.0 109.316 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.34 -47.96 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.39 -28.3 28.69 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.505 -0.747 . . . . 0.0 112.322 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -45.96 17.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -150.79 138.97 20.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.051 0.842 . . . . 0.0 110.174 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -74.62 -18.52 60.54 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.362 -0.836 . . . . 0.0 111.984 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.79 118.15 6.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.804 1.241 . . . . 0.0 113.935 -174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 20' ' ' THR . 9.2 m -139.31 152.72 23.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 123.084 1.421 . . . . 0.0 112.762 173.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.7 tt -111.74 148.78 32.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.0 ttt -140.47 123.44 16.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 8.0 p -108.79 128.15 54.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.03 167.68 10.93 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 120.408 1.458 . . . . 0.0 109.208 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.91 178.82 46.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -151.89 155.18 37.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.6 mtt-85 -98.4 -8.4 26.99 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.284 0.634 . . . . 0.0 111.182 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -72.39 -7.66 50.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.535 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.98 135.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 174.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.01 130.36 35.44 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.24 -137.54 5.29 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -90.76 -58.39 2.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.575 0.75 . . . . 0.0 109.142 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.91 102.61 5.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 118.794 -1.162 . . . . 0.0 108.532 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.21 -168.27 0.12 Allowed Glycine 0 CA--C 1.54 1.642 0 O-C-N 120.647 -1.283 . . . . 0.0 111.086 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.37 90.78 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 106.462 -2.169 . . . . 0.0 106.462 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.41 0.71 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.748 -1.585 . . . . 0.0 109.599 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -105.99 168.87 8.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.399 1.099 . . . . 0.0 110.091 174.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.43 -166.14 35.31 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-O 121.266 0.37 . . . . 0.0 113.646 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.69 152.39 42.34 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.497 1.119 . . . . 0.0 110.009 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.22 131.12 47.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.502 ' CG2' HG13 ' A' ' 115' ' ' VAL . 5.3 mt -133.55 150.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -124.25 138.23 54.42 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.687 1.995 . . . . 0.0 106.268 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.45 -167.17 26.71 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -121.14 142.1 50.19 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.448 1.899 . . . . 0.0 108.682 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.06 160.99 16.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.913 1.233 . . . . 0.0 110.935 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.11 120.44 3.33 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.266 1.027 . . . . 0.0 109.448 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.413 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 3.4 m-85 -74.13 128.7 36.21 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -120.56 141.12 50.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.782 2.433 . . . . 0.0 109.632 173.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -121.21 29.53 7.25 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.658 1.983 . . . . 0.0 107.262 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.77 165.98 33.03 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.646 2.378 . . . . 0.0 108.663 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.7 178.97 46.34 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.499 1.523 . . . . 0.0 113.643 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.73 -20.43 68.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.545 2.163 . . . . 0.0 111.11 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.32 -55.58 20.29 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.52 1.528 . . . . 0.0 108.595 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CD1' HD11 ' A' ' 101' ' ' ILE . 33.1 t80 -61.34 -31.35 71.22 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 116.924 -1.512 . . . . 0.0 110.521 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.22 -48.39 65.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 121.515 1.962 . . . . 0.0 110.516 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.11 -35.99 60.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.854 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.436 HD13 ' HB1' ' A' ' 107' ' ' ALA 0.25 1.3 pp -93.68 -20.95 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 173.435 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.66 93.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 121.544 1.974 . . . . 0.0 111.695 -173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.464 0.0 OUTLIER -51.35 -18.02 0.89 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.988 1.715 . . . . 0.0 114.744 173.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -174.74 0.21 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -129.22 10.59 5.82 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 119.022 -2.299 . . . . 0.0 113.003 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -139.66 8.82 2.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.495 0.718 . . . . 0.0 112.587 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 101' ' ' ILE . . . -79.36 151.25 31.09 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.231 0.923 . . . . 0.0 111.356 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -120.65 -21.34 6.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.216 2.207 . . . . 0.0 111.657 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.784 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.78 161.63 11.16 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.659 1.584 . . . . 0.0 109.482 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.41 103.69 15.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.43 94.68 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.19 131.59 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.211 1.804 . . . . 0.0 106.59 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -118.99 138.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.7 m -114.64 101.39 9.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 85' ' ' ILE . 59.7 t -60.15 153.77 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.639 0.733 . . . . 0.0 109.352 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.91 -40.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.6 m -151.03 128.06 11.1 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 120.857 -1.152 . . . . 0.0 110.924 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.4 138.81 49.54 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.589 2.356 . . . . 0.0 109.117 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -142.01 140.97 32.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.86 1.664 . . . . 0.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.56 133.8 47.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -152.84 -58.55 0.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.252 1.224 0 CA-C-O 115.216 -2.326 . . . . 0.0 115.687 -172.936 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.242 0.704 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.47 160.32 48.44 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.606 2.204 . . . . 0.0 111.329 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.65 -47.53 90.45 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.83 -42.11 62.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.22 1.408 . . . . 0.0 111.99 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.569 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 34.7 t80 -51.12 -56.62 11.79 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.555 0.616 . . . . 0.0 111.493 173.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -59.17 -48.52 81.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.316 0.646 . . . . 0.0 110.578 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.79 -40.5 72.76 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.935 0.789 . . . . 0.0 111.976 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.89 -44.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.021 0.828 . . . . 0.0 108.884 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 25.4 mt -56.71 -43.89 81.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.087 0.858 . . . . 0.0 112.437 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -51.69 -27.08 10.61 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -99.11 171.63 7.89 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.295 1.045 . . . . 0.0 111.205 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.45 131.67 42.08 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.1 168.57 41.67 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.2 t -101.01 149.88 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.95 152.44 42.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mt -138.79 116.31 11.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.91 109.23 20.06 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -89.35 114.88 26.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 118.54 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.71 -74.65 0.11 Allowed Glycine 0 C--N 1.333 0.403 0 CA-C-N 118.236 0.471 . . . . 0.0 112.91 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.23 -48.24 0.06 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -173.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.18 38.48 0.29 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.523 1.529 . . . . 0.0 110.792 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 152.47 6.59 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 105.851 -2.9 . . . . 0.0 105.851 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 10.1 Cg_endo -51.19 147.76 19.91 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 122.233 3.016 . . . . 0.0 106.875 173.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -119.71 101.26 7.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.533 -172.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.4 tp -78.13 88.57 4.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.302 1.041 . . . . 0.0 111.208 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -77.48 171.71 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.942 1.297 . . . . 0.0 110.401 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -122.12 166.32 14.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.628 1.104 . . . . 0.0 113.516 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -168.52 175.01 6.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.561 2.344 . . . . 0.0 108.473 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -120.67 141.68 50.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.327 2.251 . . . . 0.0 109.463 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -55.21 -31.42 61.43 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.77 0.714 . . . . 0.0 110.598 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -59.24 -8.81 1.79 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.99 2.116 . . . . 0.0 113.876 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -118.13 -7.05 10.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.594 1.158 . . . . 0.0 109.576 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.429 HD22 HG22 ' A' ' 46' ' ' VAL . 28.9 mt -97.18 171.41 8.47 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.747 -1.221 . . . . 0.0 112.01 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.537 ' HE2' HD11 ' A' ' 39' ' ' LEU . 15.9 ptmt -133.64 123.15 24.54 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 10' ' ' LEU . 58.8 t -101.7 139.5 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.537 HD11 ' HE2' ' A' ' 37' ' ' LYS . 3.2 mp -121.66 178.52 4.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -76.55 -178.3 4.62 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.14 67.38 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 120.511 -1.368 . . . . 0.0 109.812 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 53.79 13.0 0.47 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 130.337 3.455 . . . . 0.0 115.602 -174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -73.6 140.03 45.94 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.673 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -130.59 161.4 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.87 145.63 20.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG22 HD22 ' A' ' 36' ' ' LEU . 60.5 t -122.24 130.04 24.85 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 128.31 2.644 . . . . 0.0 106.548 -174.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.49 108.69 2.74 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.223 2.615 . . . . 0.0 109.087 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.725 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.58 111.66 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.879 -0.513 . . . . 0.0 109.958 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.57 -21.31 5.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.954 1.74 . . . . 0.0 111.93 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.06 39.97 0.38 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.89 1.345 . . . . 0.0 110.353 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 48' ' ' VAL . 31.2 mtt -109.23 50.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.472 1.509 . . . . 0.0 107.052 173.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.47 -50.06 35.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.445 -1.264 . . . . 0.0 113.484 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -52.27 -41.57 62.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.272 1.851 . . . . 0.0 108.611 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 3.1 m -58.77 -38.4 78.41 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.71 0.804 . . . . 0.0 110.811 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.1 -48.18 79.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.682 1.583 . . . . 0.0 110.065 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.1 98.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 119.788 -0.148 . . . . 0.0 111.122 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 9.5 m-20 -61.22 -41.27 96.56 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 123.826 0.85 . . . . 0.0 110.052 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.9 -47.97 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.843 1.201 . . . . 0.0 109.361 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.92 -25.92 45.32 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.042 -1.036 . . . . 0.0 112.154 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . 1.3 mmm-85 -78.09 -45.03 24.55 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 173.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -151.25 140.82 21.64 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.234 1.014 . . . . 0.0 109.884 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -70.33 -19.41 63.07 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.873 -1.142 . . . . 0.0 111.94 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.8 120.77 10.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.18 1.392 . . . . 0.0 113.639 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 20' ' ' THR . 15.2 m -139.06 155.91 27.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 123.001 1.382 . . . . 0.0 112.185 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.9 tp -111.11 151.95 27.53 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 172.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.02 132.79 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 p -128.47 128.07 43.68 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -116.98 167.2 11.35 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.81 1.186 . . . . 0.0 110.781 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 178.5 42.42 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -150.32 170.79 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.732 -0.864 . . . . 0.0 109.076 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -98.66 -8.79 25.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.362 1.865 . . . . 0.0 110.888 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -91.58 -10.74 39.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.4 137.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.86 131.45 36.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.214 1.005 . . . . 0.0 109.798 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.22 -140.99 6.81 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -83.99 -58.48 2.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -78.53 102.92 8.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.3 -168.72 2.27 Favored Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 112.6 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.5 59.53 6.76 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.867 2.378 . . . . 0.0 110.789 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.44 121.32 1.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -113.95 169.07 9.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.91 1.355 . . . . 0.0 110.181 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 176.57 44.35 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 123.463 0.554 . . . . 0.0 112.889 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -126.39 144.6 50.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.718 1.607 . . . . 0.0 110.197 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.54 128.39 46.61 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 128.253 2.621 . . . . 0.0 104.442 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt -138.41 153.83 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 -119.84 148.16 43.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.89 1.676 . . . . 0.0 107.52 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.77 -171.38 31.89 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.1 m -120.85 144.38 48.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.376 2.27 . . . . 0.0 107.179 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.93 161.05 16.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.778 1.172 . . . . 0.0 111.405 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.22 114.92 2.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.174 0.99 . . . . 0.0 109.966 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -73.94 129.45 37.91 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.67 141.57 51.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 129.119 2.967 . . . . 0.0 108.606 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 p -118.28 30.36 7.27 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.774 1.629 . . . . 0.0 107.552 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -158.81 163.82 36.34 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.209 1.804 . . . . 0.0 109.328 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.74 46.87 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.116 1.817 . . . . 0.0 113.782 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.88 -13.86 37.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.707 2.938 . . . . 0.0 112.653 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.59 -63.38 1.07 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -61.23 -31.31 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.967 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.62 -55.54 11.18 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.689 1.131 . . . . 0.0 109.42 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.462 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.53 -27.12 68.38 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.857 -1.152 . . . . 0.0 112.178 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.362 1.0 OUTLIER -86.25 -18.18 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.881 1.218 . . . . 0.0 111.567 173.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.33 -27.67 2.69 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.961 2.104 . . . . 0.0 111.675 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -49.26 -35.79 18.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.028 . . . . 0.0 111.764 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -77.94 178.05 7.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.89 -0.98 1.44 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 118.529 -2.607 . . . . 0.0 111.568 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -97.01 8.38 44.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.979 0.912 . . . . 0.0 110.682 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.72 149.41 22.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.821 0.737 . . . . 0.0 109.515 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -117.71 -11.22 10.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.244 1.818 . . . . 0.0 110.936 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.28 161.7 12.3 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 110.0 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.15 104.57 14.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.512 2.725 . . . . 0.0 106.174 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.32 96.96 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.08 131.65 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.378 1.871 . . . . 0.0 107.11 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.11 139.76 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.9 m -118.9 101.44 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.2 t -60.28 160.98 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.613 1.565 . . . . 0.0 109.472 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.22 -57.14 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -141.06 122.84 15.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.17 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 146.99 42.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 128.054 2.542 . . . . 0.0 111.337 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -143.91 152.13 40.72 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.0 108.894 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -81.05 137.31 36.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.6 p -138.69 -58.49 0.62 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -173.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--O 1.251 1.168 0 C-N-CA 123.594 0.757 . . . . 0.0 111.182 -173.52 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 118.47 -0.776 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.61 160.17 50.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.974 1.782 . . . . 0.0 111.756 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.26 96.86 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -52.85 -38.82 61.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.931 1.692 . . . . 0.0 112.072 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 32.6 t80 -51.14 -51.89 49.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.487 1.039 . . . . 0.0 110.962 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -60.1 -48.39 81.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.338 0.655 . . . . 0.0 110.73 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -54.97 -37.22 66.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.642 1.11 . . . . 0.0 112.638 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.09 -45.01 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.364 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 38' ' ' VAL . 34.2 mt -57.21 -44.09 83.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.397 0.999 . . . . 0.0 112.018 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -51.85 -18.93 1.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -107.71 158.41 17.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.556 1.071 . . . . 0.0 110.788 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -77.0 147.69 36.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.47 168.54 31.57 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.18 149.05 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.24 161.98 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 127.343 2.257 . . . . 0.0 105.021 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.43 157.17 43.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.371 1.068 . . . . 0.0 109.139 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -139.39 120.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.91 108.77 19.73 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 173.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.485 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.8 m -90.6 113.45 25.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -73.2 131.71 42.32 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.93 -79.14 0.17 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 122.514 1.064 . . . . 0.0 111.131 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -158.32 -48.59 0.06 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.647 -1.277 . . . . 0.0 109.003 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.61 37.74 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.773 1.229 . . . . 0.0 112.053 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.28 152.12 5.76 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 25.6 Cg_endo -59.23 148.02 88.02 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 121.043 2.421 . . . . 0.0 108.481 177.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' CD2' ' HZ1' ' A' ' 53' ' ' LYS . 70.2 t60 -117.04 101.45 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.622 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 13.2 tp -75.02 88.64 2.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.832 0.853 . . . . 0.0 111.531 -175.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 m -78.1 169.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.395 1.078 . . . . 0.0 109.834 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -119.85 166.34 13.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 112.243 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -168.52 176.05 5.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.453 2.301 . . . . 0.0 107.879 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -121.28 141.62 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.517 1.527 . . . . 0.0 110.76 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -50.86 -29.96 13.26 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 119.077 0.853 . . . . 0.0 111.154 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -55.13 -19.89 8.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.669 2.388 . . . . 0.0 112.58 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -118.13 -4.23 11.01 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.144 1.378 . . . . 0.0 109.619 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.468 HD22 HG22 ' A' ' 46' ' ' VAL . 6.3 mt -98.88 167.15 10.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.94 -1.1 . . . . 0.0 111.016 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.65 140.49 42.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 10' ' ' LEU . 85.4 t -101.9 149.51 6.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.8 mt -122.24 178.82 4.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.638 2.775 . . . . 0.0 106.244 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -76.03 -179.04 4.69 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.33 31.01 72.48 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 120.237 -1.539 . . . . 0.0 110.715 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 p30 54.08 13.06 0.53 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.765 3.226 . . . . 0.0 115.257 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -73.49 142.32 46.78 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 109.547 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.41 166.41 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.408 ' CG1' ' HB1' ' A' ' 110' ' ' ALA . 16.9 t -147.97 145.07 18.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 O-C-N 120.793 -1.192 . . . . 0.0 108.644 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG22 HD22 ' A' ' 36' ' ' LEU . 60.9 t -123.58 136.07 26.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 108.585 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.77 121.28 6.2 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 124.269 3.312 . . . . 0.0 110.582 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.558 HG23 ' HB2' ' A' ' 51' ' ' MET . 7.7 p -85.48 111.94 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 119.52 1.055 . . . . 0.0 112.764 173.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.31 -20.81 5.76 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.774 1.654 . . . . 0.0 111.64 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.54 30.0 0.23 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.459 1.63 . . . . 0.0 112.292 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.558 ' HB2' HG23 ' A' ' 48' ' ' VAL . 37.2 mtt -99.4 61.96 1.21 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.103 1.452 . . . . 0.0 107.825 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -71.15 -60.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.029 0.932 . . . . 0.0 112.951 -174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.426 ' HZ1' ' CD2' ' A' ' 27' ' ' HIS . 4.0 ttpm? -52.09 -41.77 62.68 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.138 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 2.0 m -61.62 -38.55 88.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.852 0.751 . . . . 0.0 111.641 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 36.9 tt0 -59.08 -44.74 91.93 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.927 1.239 . . . . 0.0 109.792 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.04 93.25 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.234 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 8.8 m-20 -62.61 -41.39 98.96 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 124.175 0.99 . . . . 0.0 109.473 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.78 -48.17 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 108.708 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.93 29.82 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.377 -0.827 . . . . 0.0 112.616 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -45.39 19.06 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -151.04 138.95 19.92 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.747 1.219 . . . . 0.0 109.417 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.1 -19.79 61.08 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.03 -1.044 . . . . 0.0 112.009 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.1 mmp_? -60.88 119.97 9.25 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.268 1.427 . . . . 0.0 114.265 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 89' ' ' ALA . 16.1 m -139.64 156.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 123.108 1.432 . . . . 0.0 112.8 173.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 15.4 tp -110.81 151.19 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 172.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.5 ttt -142.4 140.89 32.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 p -129.68 130.66 45.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.3 pt? -116.68 163.62 15.85 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.11 179.53 44.47 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.2 t -147.62 163.65 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -9.01 25.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.508 0.723 . . . . 0.0 109.221 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -81.1 -7.7 59.61 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.009 -0.996 . . . . 0.0 113.165 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.99 137.07 56.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.08 36.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.38 -141.48 6.15 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp-105 -81.57 -58.98 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.582 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -80.46 102.64 9.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.388 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 49.51 -168.71 0.2 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.236 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.3 87.52 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 107.557 -1.747 . . . . 0.0 107.557 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 121.25 0.7 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-O 117.734 -1.592 . . . . 0.0 109.16 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -115.52 -179.85 3.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.252 1.026 . . . . 0.0 108.963 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.32 -155.81 20.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 117.819 -1.545 . . . . 0.0 110.063 -173.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -151.2 157.49 42.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.306 1.442 . . . . 0.0 109.629 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.1 131.12 47.18 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 129.239 3.015 . . . . 0.0 104.811 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 115' ' ' VAL . 4.8 mt -136.95 152.31 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -119.61 140.77 50.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.4 1.88 . . . . 0.0 107.078 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.51 -171.15 30.4 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.415 0.531 . . . . 0.0 112.047 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -121.12 149.16 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.815 2.046 . . . . 0.0 108.289 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -107.29 165.13 11.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.633 1.173 . . . . 0.0 110.402 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.14 121.69 0.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 109.394 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 37.9 m-85 -76.45 150.73 36.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.766 -1.209 . . . . 0.0 114.191 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.315 0.0 OUTLIER -140.89 139.02 34.32 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 173.254 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 p -122.11 29.47 7.02 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 129.741 3.216 . . . . 0.0 102.582 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 92' ' ' ARG 0.288 8.9 t70 -158.43 160.21 36.57 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 130.353 3.461 . . . . 0.0 114.004 -172.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.97 178.41 47.54 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.007 1.289 . . . . 0.0 115.768 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.04 -16.28 53.36 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.093 2.529 . . . . 0.0 110.085 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -64.76 -66.7 0.51 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.14 -31.2 70.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.289 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -68.4 -59.43 3.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HB3' ' HD2' ' A' ' 37' ' ' LYS 0.258 . . -61.7 -19.41 62.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.862 -1.148 . . . . 0.0 113.39 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.339 1.2 pp -91.95 -18.08 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.326 1.421 . . . . 0.0 110.785 172.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.73 2.73 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.021 2.128 . . . . 0.0 112.747 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -50.48 -37.92 41.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.177 1.391 . . . . 0.0 112.157 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -75.55 177.9 6.39 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.64 -0.78 1.34 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 118.777 -2.452 . . . . 0.0 111.632 174.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -93.34 8.24 41.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.373 0.669 . . . . 0.0 109.697 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.84 129.69 36.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.2 1.0 . . . . 0.0 108.63 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -99.03 -16.0 18.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.466 0.706 . . . . 0.0 111.347 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.39 161.78 12.08 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.757 1.623 . . . . 0.0 108.95 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB1' ' CG1' ' A' ' 45' ' ' VAL . . . -100.8 110.42 22.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.755 2.822 . . . . 0.0 109.469 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.15 94.54 6.66 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.26 131.12 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mm -117.44 142.44 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 m -120.39 101.55 7.86 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.451 HG13 ' CG2' ' A' ' 85' ' ' ILE . 25.0 t -60.22 156.96 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.026 1.33 . . . . 0.0 109.352 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.26 -49.44 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -151.25 140.79 21.61 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 120.887 -1.133 . . . . 0.0 111.741 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.12 139.49 49.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.154 2.582 . . . . 0.0 108.528 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -142.09 163.18 33.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.783 2.033 . . . . 0.0 109.694 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -90.97 142.4 27.82 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 121.206 -0.934 . . . . 0.0 109.89 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.17 -58.0 1.07 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.939 2.496 . . . . 0.0 110.92 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.6 pt? . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.294 1.437 . . . . 0.0 110.032 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 42' ' ' ASN . 8.4 mp . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.16 155.81 69.06 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.78 2.32 . . . . 0.0 111.142 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.94 -38.81 93.25 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.16 -38.97 63.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.839 1.256 . . . . 0.0 111.184 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -51.44 -54.23 28.92 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.823 1.192 . . . . 0.0 110.743 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -56.71 -48.27 78.08 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.27 1.028 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.6 -35.23 72.12 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.895 -0.574 . . . . 0.0 112.363 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 68' ' ' LEU . 88.2 t -69.16 -43.5 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.909 1.231 . . . . 0.0 109.369 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.05 -43.24 77.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.219 1.372 . . . . 0.0 112.176 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -51.99 -21.35 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.099 0.863 . . . . 0.0 113.284 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -110.83 174.03 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.744 1.618 . . . . 0.0 110.965 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -73.35 129.4 37.93 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.43 164.28 34.41 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.5 145.52 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.57 164.94 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.83 160.45 43.56 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 107.952 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 46' ' ' VAL . 90.4 mt -138.74 119.49 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.41 108.9 19.61 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 173.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.573 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -93.89 114.48 26.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 115.407 -2.235 . . . . 0.0 108.586 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -73.26 129.4 37.96 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 122.836 2.562 . . . . 0.0 107.958 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.85 -76.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 124.609 1.099 . . . . 0.0 110.892 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -158.66 -48.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.71 2.004 . . . . 0.0 108.465 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.77 38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.295 1.438 . . . . 0.0 111.268 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.36 152.33 5.96 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 22.3 Cg_endo -56.2 147.74 64.07 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 CA-C-N 122.25 3.025 . . . . 0.0 107.386 174.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.471 ' CG ' ' HE2' ' A' ' 53' ' ' LYS . 70.0 t60 -111.24 101.42 9.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.343 -172.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.02 88.71 3.54 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.565 1.546 . . . . 0.0 111.649 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.93 168.86 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.861 1.264 . . . . 0.0 110.113 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -119.14 166.66 12.65 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.267 1.394 . . . . 0.0 114.203 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -168.42 171.62 8.95 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.529 1.932 . . . . 0.0 109.636 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -121.17 141.84 50.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.444 2.297 . . . . 0.0 110.738 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -53.75 -31.17 47.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.341 0.656 . . . . 0.0 112.412 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -59.38 -12.47 5.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 112.97 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -117.92 -2.78 11.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.392 -1.443 . . . . 0.0 109.805 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 46' ' ' VAL . 10.3 mt -99.48 166.38 11.19 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.076 -1.015 . . . . 0.0 110.17 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -136.77 128.88 29.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.52 141.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.911 1.684 . . . . 0.0 107.581 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.94 -177.9 3.7 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.041 1.736 . . . . 0.0 108.385 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.51 175.21 5.72 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.687 1.195 . . . . 0.0 108.432 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.27 28.19 13.14 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.275 1.893 . . . . 0.0 111.053 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.533 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.335 0.1 OUTLIER 53.27 25.24 4.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.016 2.126 . . . . 0.0 114.537 -178.5 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -73.66 126.71 30.93 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -114.97 164.89 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.16 144.19 18.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 O-C-N 120.346 -1.471 . . . . 0.0 108.579 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.587 HG22 HD22 ' A' ' 36' ' ' LEU . 58.8 t -130.78 137.46 30.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.998 1.719 . . . . 0.0 108.611 -176.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 112.32 2.71 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 124.139 3.226 . . . . 0.0 111.663 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -85.4 112.45 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.28 -20.96 5.37 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.657 1.123 . . . . 0.0 113.051 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.86 39.67 0.39 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.775 -1.569 . . . . 0.0 111.293 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 6.3 mtt -112.11 71.48 0.74 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -63.82 -53.79 45.28 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.46 -0.775 . . . . 0.0 111.952 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HE2' ' CG ' ' A' ' 27' ' ' HIS . 3.9 ttpm? -51.93 -41.43 62.02 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.322 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -62.39 -39.36 92.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.03 1.286 . . . . 0.0 111.507 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 34.6 tt0 -55.98 -50.62 70.34 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.22 1.373 . . . . 0.0 109.482 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.2 97.88 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -67.64 -41.73 83.41 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.547 1.139 . . . . 0.0 109.156 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -48.07 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.735 1.152 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.72 31.14 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HE ' ' HB3' ' A' ' 60' ' ' ARG . 5.7 mmm180 -84.05 -46.9 11.5 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.651 1.114 . . . . 0.0 113.872 173.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -151.13 140.88 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.03 0.919 . . . . 0.0 111.567 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.78 -23.48 55.92 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.247 -0.908 . . . . 0.0 113.015 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.38 122.43 15.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.798 1.181 . . . . 0.0 110.339 -173.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 20' ' ' THR . 22.7 m -139.22 155.97 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 123.43 1.586 . . . . 0.0 111.453 174.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.8 tp -106.85 154.51 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.3 ttt -138.85 137.35 36.49 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -131.15 129.12 41.37 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -116.38 173.29 6.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.604 1.093 . . . . 0.0 111.831 174.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.17 178.52 45.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.9 t -151.07 165.59 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.054 0.93 . . . . 0.0 109.418 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -98.74 -20.72 16.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.344 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -91.76 -6.2 52.27 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.114 1.366 . . . . 0.0 113.904 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.62 131.45 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -78.86 131.5 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.415 1.086 . . . . 0.0 109.079 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 -141.5 11.47 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -85.89 -58.86 2.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.63 102.84 11.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.337 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.48 -178.5 0.66 Allowed Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.452 1.025 . . . . 0.0 113.987 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 85.0 Cg_endo -78.13 81.66 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.311 2.007 . . . . 0.0 109.828 175.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 103.79 0.17 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 t -98.68 169.23 9.64 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.739 1.269 . . . . 0.0 110.372 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.6 161.86 30.04 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.663 1.125 . . . . 0.0 111.741 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -134.73 145.44 48.46 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.503 1.921 . . . . 0.0 109.28 -173.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -101.01 131.53 46.85 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 128.525 2.73 . . . . 0.0 107.728 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -140.36 152.4 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.99 148.34 52.27 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.154 -0.966 . . . . 0.0 108.703 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.43 -168.17 36.16 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 118.847 0.749 . . . . 0.0 112.251 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -118.99 134.53 55.13 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.147 . . . . 0.0 108.867 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.67 158.76 15.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.556 1.142 . . . . 0.0 108.86 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.98 120.75 3.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.678 1.191 . . . . 0.0 108.297 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 29.8 m-85 -74.34 139.65 44.29 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.405 -0.809 . . . . 0.0 112.695 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -140.85 141.4 34.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.01 1.324 . . . . 0.0 109.929 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.1 p -120.67 41.1 3.35 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -159.32 159.55 34.06 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 129.478 3.111 . . . . 0.0 111.013 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.21 178.66 47.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.712 1.625 . . . . 0.0 114.003 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.77 -8.86 20.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.25 2.633 . . . . 0.0 111.059 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -65.53 0.66 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.941 2.497 . . . . 0.0 107.083 173.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -61.28 -31.77 71.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.283 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.01 -48.85 41.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.935 0.789 . . . . 0.0 110.527 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.5 67.83 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.55 -1.344 . . . . 0.0 112.568 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.4 pp -90.33 -18.14 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.107 0.867 . . . . 0.0 112.021 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.95 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.201 1.8 . . . . 0.0 111.685 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -50.56 -22.85 2.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -81.3 178.86 8.13 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.554 1.07 . . . . 0.0 110.732 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -135.63 20.44 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 119.904 -1.748 . . . . 0.0 110.025 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -132.45 10.48 4.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.675 1.59 . . . . 0.0 111.284 -174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.0 150.26 32.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.141 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -120.74 -21.91 6.49 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 129.139 2.975 . . . . 0.0 112.362 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.33 161.74 1.44 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.779 2.031 . . . . 0.0 110.01 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.89 112.36 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.2 94.62 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.78 131.29 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.5 mm -121.15 129.13 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.1 m -110.15 90.81 3.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 2' ' ' LEU . 94.0 t -61.17 159.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.37 -56.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 104.0 -2.592 . . . . 0.0 104.0 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.6 m -148.58 141.05 24.29 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.454 0.57 . . . . 0.0 112.115 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.01 143.74 46.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.544 3.138 . . . . 0.0 106.79 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.0 145.62 39.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.701 1.6 . . . . 0.0 108.016 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.2 140.05 37.8 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -129.42 -58.41 1.12 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.252 1.227 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.063 -173.499 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.06 164.65 34.99 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.443 2.095 . . . . 0.0 110.879 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.29 -47.12 92.37 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.326 9.0 m -53.08 -38.56 62.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.648 1.179 . . . . 0.0 113.092 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -51.52 -58.56 5.96 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.0 1.273 . . . . 0.0 108.497 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -55.24 -48.25 74.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.856 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -53.99 -40.89 67.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.924 1.238 . . . . 0.0 111.009 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.7 t -68.85 -43.61 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.933 -1.105 . . . . 0.0 108.854 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.77 -36.35 72.02 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.257 1.389 . . . . 0.0 111.359 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -33.42 42.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 118.451 -2.655 . . . . 0.0 113.022 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -98.92 158.77 15.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 122.204 1.002 . . . . 0.0 110.928 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.29 141.13 41.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.44 175.09 47.41 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.13 144.76 8.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 125.143 1.377 . . . . 0.0 107.585 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.76 159.27 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.62 152.1 38.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.387 1.475 . . . . 0.0 107.289 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 46' ' ' VAL . 6.9 mt -138.99 117.94 13.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.5 19.61 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.555 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -89.03 110.83 21.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -73.95 141.81 45.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 122.11 2.232 . . . . 0.0 107.204 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.25 -81.8 0.26 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.63 -61.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.55 38.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.189 2.196 . . . . 0.0 110.165 173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.57 151.58 23.52 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.04 -1.037 . . . . 0.0 113.761 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.88 158.32 46.52 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.269 1.979 . . . . 0.0 112.918 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -121.32 101.86 7.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.107 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 10.9 tp -74.01 88.8 1.9 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.19 0.904 . . . . 0.0 110.666 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.86 170.97 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.986 1.315 . . . . 0.0 110.352 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.41 165.21 14.62 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.868 1.267 . . . . 0.0 111.172 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -168.41 172.31 8.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.7 2.0 . . . . 0.0 107.978 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.22 141.66 50.66 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.319 1.448 . . . . 0.0 110.235 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -51.2 -28.32 11.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.4 0.68 . . . . 0.0 111.104 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.41 -14.87 8.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.859 2.464 . . . . 0.0 111.751 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -118.13 -5.21 10.94 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.995 1.718 . . . . 0.0 109.686 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 46' ' ' VAL . 31.6 mt -97.32 171.64 8.29 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 120.332 -1.48 . . . . 0.0 112.882 -173.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 10.4 ptmt -136.08 135.87 39.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.55 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.4 mt -121.24 -178.18 3.71 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.073 1.749 . . . . 0.0 107.491 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -75.55 176.98 7.09 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 109.264 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.02 30.25 69.74 Favored Glycine 0 CA--C 1.525 0.698 0 O-C-N 120.475 -1.391 . . . . 0.0 110.831 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 p30 53.84 12.88 0.46 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.864 3.665 . . . . 0.0 114.868 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -74.8 122.44 23.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.9 mm -114.02 155.57 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 112' ' ' VAL . 41.0 t -137.46 140.54 41.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 18' ' ' ILE . 58.7 t -122.22 138.99 29.78 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 127.476 2.31 . . . . 0.0 108.778 -173.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.5 108.02 1.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.677 1.585 . . . . 0.0 109.589 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.729 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.87 111.81 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.35 -21.59 5.12 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.133 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 41.38 0.34 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.559 ' HB2' HG23 ' A' ' 48' ' ' VAL . 8.6 mtt -108.78 71.23 0.77 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 173.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -64.03 -63.11 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 129.817 3.247 . . . . 0.0 112.666 -173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -51.8 -40.75 60.94 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.351 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -62.92 -38.86 92.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.496 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -58.45 -50.42 73.78 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.611 1.55 . . . . 0.0 109.683 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.29 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.201 -0.312 . . . . 0.0 111.375 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -62.73 -41.8 99.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.044 -1.455 . . . . 0.0 110.336 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.69 -47.98 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 120.192 1.36 . . . . 0.0 108.542 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -23.63 13.55 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -87.44 -46.55 9.52 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.25 -1.531 . . . . 0.0 114.127 173.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -151.26 137.11 18.08 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.532 1.133 . . . . 0.0 112.656 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -22.48 54.34 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.67 126.57 27.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.697 1.589 . . . . 0.0 111.017 -173.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.6 m -139.07 144.06 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 111.941 173.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.75 150.36 21.14 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 16.8 ttt -139.17 120.8 15.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.7 p -108.82 127.97 54.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 pp -116.95 163.27 16.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 119.641 1.109 . . . . 0.0 109.229 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.05 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.5 t -158.1 166.91 31.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -99.02 -9.37 24.03 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -9.42 59.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.888 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.93 131.08 36.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.866 0.867 . . . . 0.0 110.437 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.38 5.9 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 125.575 1.56 . . . . 0.0 111.253 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.3 mmt-85 -84.08 -58.76 2.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.45 102.58 9.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.8 -168.07 0.16 Allowed Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.47 -1.394 . . . . 0.0 112.18 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.49 89.73 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 108.014 -1.571 . . . . 0.0 108.014 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.74 121.32 0.7 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-O 117.231 -1.872 . . . . 0.0 109.391 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.08 169.75 9.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.624 1.712 . . . . 0.0 110.906 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.62 -176.18 43.65 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 123.381 0.515 . . . . 0.0 112.576 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.4 145.68 49.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.127 2.171 . . . . 0.0 109.348 -174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.0 131.03 47.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.0 159.51 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -125.92 149.29 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.653 1.581 . . . . 0.0 107.782 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.84 -176.22 36.33 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.76 0.695 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.1 m -120.35 129.12 53.83 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.944 1.697 . . . . 0.0 108.102 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.23 160.23 14.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.871 1.668 . . . . 0.0 112.288 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.14 120.91 3.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.82 1.248 . . . . 0.0 108.678 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.71 144.48 39.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -140.84 138.28 33.87 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.148 1.379 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.3 p -120.87 40.93 3.42 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -159.17 157.18 30.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.754 2.821 . . . . 0.0 111.317 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.77 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.899 1.238 . . . . 0.0 114.538 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.79 -8.67 22.05 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.329 2.686 . . . . 0.0 110.687 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.418 ' CD ' ' HZ3' ' A' ' 37' ' ' LYS . 24.7 mm-40 -70.72 -63.18 1.14 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 108.15 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.13 -31.81 71.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.436 -0.793 . . . . 0.0 111.245 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -73.45 -48.43 33.68 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.915 0.779 . . . . 0.0 111.346 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.78 -25.16 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.003 -1.685 . . . . 0.0 112.12 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.377 1.2 pp -89.51 -18.22 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.855 1.207 . . . . 0.0 110.844 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.7 -27.52 2.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.048 2.539 . . . . 0.0 110.687 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -49.02 -37.21 19.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.073 0.949 . . . . 0.0 110.543 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -80.62 178.0 8.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 -0.56 1.39 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 117.979 -2.95 . . . . 0.0 111.864 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -87.56 8.33 25.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.914 1.286 . . . . 0.0 111.127 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.64 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.914 1.286 . . . . 0.0 111.962 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 -21.97 6.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 128.47 2.708 . . . . 0.0 111.119 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -177.27 162.03 1.89 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.203 1.801 . . . . 0.0 110.445 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.42 104.6 14.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.69 94.02 5.01 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.099 1.759 . . . . 0.0 107.079 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 45' ' ' VAL . 48.7 t -80.0 127.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.39 128.97 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.6 m -100.15 100.5 11.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.4 158.46 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.984 0.897 . . . . 0.0 109.304 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.57 -56.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 m -140.92 124.78 17.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 119.215 -0.421 . . . . 0.0 111.432 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.5 149.57 41.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.36 2.664 . . . . 0.0 111.176 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -141.68 144.66 34.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.134 1.774 . . . . 0.0 108.232 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -74.01 140.51 45.5 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -136.86 -77.61 0.41 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.255 1.364 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 -173.244 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.82 164.73 31.36 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.238 2.625 . . . . 0.0 111.877 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.92 96.58 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -55.7 -39.5 71.12 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.232 1.413 . . . . 0.0 110.446 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -51.06 -57.09 9.56 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.974 0.806 . . . . 0.0 110.017 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -58.83 -48.7 80.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.834 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -59.21 -41.16 87.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.08 -39.49 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.634 1.106 . . . . 0.0 109.107 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -58.55 -44.92 89.82 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.837 1.198 . . . . 0.0 111.251 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -51.99 -21.31 2.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -106.91 178.47 4.55 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 125.495 1.518 . . . . 0.0 110.983 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -73.55 129.43 37.96 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.15 167.16 33.81 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.01 146.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 173.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 t -130.52 159.8 42.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 28' ' ' LEU . . . -144.54 160.01 41.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.612 1.165 . . . . 0.0 108.999 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.3 mt -139.24 120.44 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -93.14 108.44 20.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 173.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.2 m -89.84 116.35 27.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 116.873 -1.536 . . . . 0.0 107.048 -173.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -73.42 135.81 44.23 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 121.582 1.992 . . . . 0.0 106.394 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.66 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.2 -59.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 15.9 p-10 -78.83 39.21 0.35 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.35 2.66 . . . . 0.0 111.429 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.34 151.47 21.01 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.238 0.923 . . . . 0.0 111.053 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.08 149.08 89.59 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 118.335 1.068 . . . . 0.0 109.986 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.463 ' CE1' ' HB3' ' A' ' 53' ' ' LYS . 15.3 t-160 -115.43 99.71 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.633 1.573 . . . . 0.0 110.641 -173.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD11 ' HB1' ' A' ' 17' ' ' ALA . 8.1 tp -82.13 103.54 11.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 110.406 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.15 168.65 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.675 1.59 . . . . 0.0 110.868 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 10.0 m120 -126.63 164.13 21.94 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -168.41 172.46 8.32 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.248 1.819 . . . . 0.0 110.242 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.37 141.77 50.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.913 2.485 . . . . 0.0 108.809 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.87 -30.38 45.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.57 0.623 . . . . 0.0 111.695 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -57.72 -13.72 4.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.576 1.95 . . . . 0.0 113.145 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -118.3 -2.47 11.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.793 1.237 . . . . 0.0 110.194 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 46' ' ' VAL . 17.4 mt -101.07 168.1 9.81 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.589 1.086 . . . . 0.0 111.82 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -136.87 128.76 29.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.3 142.95 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -121.06 -178.61 3.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.39 1.876 . . . . 0.0 106.183 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -73.71 -178.81 3.31 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.77 29.18 66.84 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 120.392 -1.443 . . . . 0.0 110.423 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.1 13.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 129.209 3.004 . . . . 0.0 115.155 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -73.18 141.73 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.361 0.982 . . . . 0.0 110.58 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.87 154.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.36 143.98 24.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 36' ' ' LEU . 61.9 t -126.94 134.38 26.05 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 126.649 1.98 . . . . 0.0 107.419 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.18 118.03 4.83 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.875 2.383 . . . . 0.0 107.651 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 109' ' ' ALA . 2.6 p -79.34 111.5 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.348 0.976 . . . . 0.0 108.999 173.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.94 -21.68 9.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.24 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.66 18.87 0.3 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 120.467 2.134 . . . . 0.0 114.386 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.433 ' HB2' HG23 ' A' ' 48' ' ' VAL . 29.9 mtt -97.96 52.24 1.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.77 1.285 . . . . 0.0 108.176 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -64.0 -51.55 63.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.368 0.667 . . . . 0.0 111.6 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.463 ' HB3' ' CE1' ' A' ' 27' ' ' HIS 0.285 17.5 ttpp -52.19 -41.16 62.42 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.325 -1.484 . . . . 0.0 110.839 173.443 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 57' ' ' ASN 0.27 1.6 m -60.35 -38.42 83.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.143 1.338 . . . . 0.0 113.026 173.363 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -55.39 -45.14 76.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.826 1.25 . . . . 0.0 107.829 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.31 81.07 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.958 -0.464 . . . . 0.0 111.647 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 3.8 m120 -59.6 -41.73 90.98 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 117.367 -1.301 . . . . 0.0 109.904 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.33 -48.24 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.122 1.328 . . . . 0.0 108.917 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.68 -25.98 12.49 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -46.44 10.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 173.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -151.5 134.08 15.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.991 1.268 . . . . 0.0 111.072 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -19.77 57.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.449 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.61 130.63 46.8 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.274 1.397 . . . . 0.0 110.92 -177.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.8 m -142.32 155.86 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 123.797 1.76 . . . . 0.0 112.99 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.9 tp -101.17 151.16 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.6 ttt -139.24 141.48 37.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 p -129.7 140.69 51.06 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -116.91 163.97 15.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.93 178.66 46.61 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.2 t -151.24 169.36 22.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -98.87 -18.36 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.55 1.54 . . . . 0.0 108.964 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -91.81 -1.46 57.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 117.073 -1.442 . . . . 0.0 113.938 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 t -130.99 127.03 60.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.32 131.42 36.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 109.149 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.97 -141.12 6.46 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -79.17 -59.02 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.733 1.613 . . . . 0.0 109.434 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.65 102.99 14.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.5 -169.4 2.21 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.84 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 69.7 Cg_endo -77.86 69.39 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.456 2.104 . . . . 0.0 110.412 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.49 108.37 0.32 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -101.88 169.57 8.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.06 172.55 45.48 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.457 1.031 . . . . 0.0 114.472 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.09 151.25 51.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 110.248 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -100.9 131.5 46.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 128.838 2.855 . . . . 0.0 104.464 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 68' ' ' LEU . 12.8 mt -135.59 153.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.1 mtt-85 -132.97 135.78 45.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.61 36.22 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.805 1.184 . . . . 0.0 112.182 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -121.23 148.21 44.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.729 0.812 . . . . 0.0 109.285 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -104.2 162.18 13.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.905 1.682 . . . . 0.0 110.669 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.3 113.07 2.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.536 1.134 . . . . 0.0 109.64 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 111' ' ' LEU . 8.5 m-85 -74.17 134.24 42.78 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -141.14 141.06 34.19 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.1 p -116.58 41.1 2.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.55 154.14 26.16 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.588 2.355 . . . . 0.0 110.466 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.1 178.67 47.3 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.854 1.692 . . . . 0.0 114.146 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.94 -9.42 19.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.709 2.939 . . . . 0.0 111.491 173.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -67.34 -64.8 0.78 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.402 1.481 . . . . 0.0 107.253 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -61.54 -31.4 71.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.485 1.114 . . . . 0.0 111.486 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.71 -56.07 9.32 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.304 0.956 . . . . 0.0 109.234 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.66 68.8 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.966 -1.084 . . . . 0.0 112.195 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.334 1.1 pp -85.89 -18.17 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.754 1.161 . . . . 0.0 111.869 173.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.68 -27.97 3.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.663 1.585 . . . . 0.0 112.062 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -50.53 -21.89 1.71 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.486 1.114 . . . . 0.0 113.827 173.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -80.91 178.66 8.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.706 1.139 . . . . 0.0 110.702 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -133.6 11.12 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.077 -1.639 . . . . 0.0 111.517 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -138.1 8.99 2.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.848 1.259 . . . . 0.0 112.968 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 151.84 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.307 1.043 . . . . 0.0 111.116 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -111.72 -21.93 11.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.392 1.077 . . . . 0.0 110.342 174.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 48' ' ' VAL . . . -178.19 161.96 1.52 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 127.718 2.407 . . . . 0.0 109.206 -173.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.43 105.97 18.05 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 91' ' ' PHE . 7.7 tp -79.63 92.82 5.4 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.35 129.76 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.092 1.357 . . . . 0.0 107.666 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.404 HD12 HG21 ' A' ' 64' ' ' VAL . 36.6 mm -117.28 133.7 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -112.02 97.28 6.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.53 161.26 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.464 1.506 . . . . 0.0 110.361 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.69 -55.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.2 m -151.54 141.46 22.02 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.832 -1.167 . . . . 0.0 112.476 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.1 138.74 48.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.938 2.895 . . . . 0.0 106.599 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -140.08 137.42 34.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.185 1.794 . . . . 0.0 107.749 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -77.15 141.16 40.28 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.6 p -129.64 -58.62 1.1 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.739 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.5 HD13 ' CB ' ' A' ' 42' ' ' ASN . 8.1 mp . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.09 154.63 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.713 2.275 . . . . 0.0 110.049 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.79 92.87 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -49.58 -38.57 31.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.682 1.593 . . . . 0.0 112.21 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -50.53 -54.75 20.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.226 1.375 . . . . 0.0 109.729 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -61.09 -48.54 81.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.516 1.126 . . . . 0.0 109.117 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.75 -34.14 74.0 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.1 t -72.71 -42.54 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.65 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.82 -39.75 82.13 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.437 1.471 . . . . 0.0 112.596 173.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -51.88 -24.99 7.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.965 0.802 . . . . 0.0 112.546 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -99.85 159.2 15.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.865 0.866 . . . . 0.0 109.402 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.56 146.12 45.01 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.335 -0.853 . . . . 0.0 109.078 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -179.27 171.23 43.1 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.551 HG23 HH12 ' A' ' 71' ' ' ARG . 6.6 t -101.63 148.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 68' ' ' LEU . 6.0 t -124.61 158.44 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 128.544 2.738 . . . . 0.0 104.771 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 28' ' ' LEU . . . -139.58 153.61 47.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 46' ' ' VAL . 7.4 mt -139.2 116.82 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.0 108.43 19.58 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.536 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -89.35 109.22 20.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 116.035 -1.935 . . . . 0.0 106.662 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -73.74 141.74 46.31 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 122.015 2.189 . . . . 0.0 107.754 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.52 -59.04 0.16 Allowed Glycine 0 C--O 1.223 -0.562 0 C-N-CA 123.56 0.6 . . . . 0.0 111.807 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HB3' HH21 ' A' ' 60' ' ' ARG . 4.2 tm-20 168.51 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 129.491 3.117 . . . . 0.0 107.856 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.7 46.98 0.7 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.819 1.771 . . . . 0.0 110.173 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.8 150.96 5.47 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.478 1.99 . . . . 0.0 111.36 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.37 162.44 38.34 Favored 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 120.463 0.775 . . . . 0.0 110.693 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -120.94 101.75 7.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 118.569 -0.729 . . . . 0.0 109.443 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 17' ' ' ALA . 10.0 tp -74.05 88.79 1.91 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.308 0.504 . . . . 0.0 110.541 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.39 169.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.719 1.208 . . . . 0.0 110.297 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -120.79 167.94 11.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.757 1.223 . . . . 0.0 111.333 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.25 170.23 10.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.549 1.94 . . . . 0.0 108.089 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -116.78 141.63 47.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.637 1.975 . . . . 0.0 109.338 -177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -55.17 -30.7 60.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -51.16 -21.05 1.76 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.174 2.589 . . . . 0.0 113.401 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -118.17 -4.33 10.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.207 1.403 . . . . 0.0 112.208 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 HG22 ' A' ' 46' ' ' VAL . 53.5 mt -97.08 166.83 11.4 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.036 1.289 . . . . 0.0 112.024 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -136.52 132.45 35.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -101.41 142.58 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.061 -2.199 . . . . 0.0 105.061 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.22 179.18 4.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.411 1.484 . . . . 0.0 108.274 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -70.33 174.81 5.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.194 0.998 . . . . 0.0 109.797 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.29 33.99 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.742 1.639 . . . . 0.0 110.928 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.5 ' CB ' HD13 ' A' ' 2' ' ' LEU 0.277 0.1 OUTLIER 53.49 19.87 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.893 2.077 . . . . 0.0 114.694 -176.833 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -74.69 135.79 41.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.92 161.12 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.5 t -144.64 145.46 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 O-C-N 120.674 -1.266 . . . . 0.0 108.379 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 HD22 ' A' ' 36' ' ' LEU . 59.3 t -129.21 137.53 31.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.605 2.762 . . . . 0.0 107.126 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.34 108.47 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.898 2.398 . . . . 0.0 111.066 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.85 111.87 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 108.853 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.94 -21.83 4.81 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.555 1.074 . . . . 0.0 112.605 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.71 41.13 0.43 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.089 -1.395 . . . . 0.0 110.135 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.491 ' HB2' HG23 ' A' ' 48' ' ' VAL . 18.4 mtt -108.65 71.48 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.149 1.379 . . . . 0.0 107.532 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -64.21 -65.33 0.69 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.284 3.433 . . . . 0.0 114.444 -173.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -51.7 -40.29 59.86 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.245 0.93 . . . . 0.0 108.602 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -63.14 -39.58 95.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.209 -0.9 . . . . 0.0 112.984 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 22.2 tt0 -58.59 -51.04 71.59 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 120.654 1.57 . . . . 0.0 109.623 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.59 -48.02 83.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.503 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -61.02 -41.97 97.57 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 116.197 -1.858 . . . . 0.0 111.311 -173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -48.09 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 120.248 1.385 . . . . 0.0 108.845 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.26 54.15 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.066 -0.969 . . . . 0.0 113.234 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.441 HH21 ' HB3' ' A' ' 23' ' ' GLU . 14.4 mtp180 -87.51 -46.91 9.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.027 1.285 . . . . 0.0 113.675 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -142.56 128.93 20.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.291 1.044 . . . . 0.0 111.802 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -18.86 58.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.65 126.48 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.389 1.45 . . . . 0.0 111.176 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.3 m -138.81 141.47 36.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.997 1.38 . . . . 0.0 112.584 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 3.5 tp -89.59 154.24 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.1 ttt -140.25 141.23 35.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.0 p -124.97 135.88 53.21 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.532 ' HA ' HG22 ' A' ' 16' ' ' VAL . 1.7 pp -116.47 164.64 14.27 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.007 173.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.67 178.78 41.94 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 38.5 t -147.29 174.11 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.945 1.298 . . . . 0.0 108.948 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.551 HH12 HG23 ' A' ' 15' ' ' VAL . 69.6 mtt85 -117.01 -8.03 11.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.425 2.29 . . . . 0.0 109.797 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 mmpm? -91.64 -11.08 38.08 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 119.482 -2.011 . . . . 0.0 115.304 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.37 133.1 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.21 131.48 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.29 1.036 . . . . 0.0 111.403 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.89 -141.19 6.95 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.463 HH22 ' CD ' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -85.9 -59.23 2.36 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.212 1.405 . . . . 0.0 107.607 176.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.49 102.95 6.24 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.82 -168.94 1.83 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 121.608 0.56 . . . . 0.0 112.964 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 62.4 Cg_endo -78.0 58.98 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.612 2.208 . . . . 0.0 110.87 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.55 120.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 t -113.72 168.95 9.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 117.777 0.789 . . . . 0.0 110.222 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.7 -176.72 40.23 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 124.703 1.144 . . . . 0.0 113.2 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.76 153.6 45.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.576 1.15 . . . . 0.0 109.662 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.52 129.53 47.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.8 mp -139.98 161.46 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 108.602 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.417 HH22 ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -139.15 151.06 46.33 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.605 -1.31 . . . . 0.0 107.905 173.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.13 -174.94 33.62 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.053 0.835 . . . . 0.0 111.782 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -115.93 129.34 56.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.245 1.418 . . . . 0.0 108.161 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.01 14.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.017 1.327 . . . . 0.0 112.162 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.01 120.68 3.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.767 1.227 . . . . 0.0 108.926 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.2 m-85 -76.73 140.58 40.87 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -140.8 139.24 34.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.672 1.189 . . . . 0.0 111.249 173.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -121.21 39.84 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 103.236 -2.875 . . . . 0.0 103.236 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.253 7.5 t70 -158.87 150.19 20.5 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.951 2.9 . . . . 0.0 111.55 -172.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.04 179.03 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.35 0.976 . . . . 0.0 114.183 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.42 -9.54 13.42 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.046 3.164 . . . . 0.0 112.179 173.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -67.66 -67.61 0.45 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.584 1.953 . . . . 0.0 106.943 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.45 -31.62 71.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.813 0.845 . . . . 0.0 111.925 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.71 -54.07 18.33 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.57 -32.56 72.66 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.099 -1.001 . . . . 0.0 112.567 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.403 1.1 pp -79.08 -17.84 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.017 0.826 . . . . 0.0 112.612 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.1 -27.69 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 111.367 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -45.67 -27.95 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.822 1.249 . . . . 0.0 112.975 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.06 178.88 8.14 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.306 1.042 . . . . 0.0 110.689 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -140.48 21.04 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 119.812 -1.805 . . . . 0.0 111.002 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -136.97 8.77 3.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.246 1.418 . . . . 0.0 111.117 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.22 25.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.68 -0.637 . . . . 0.0 110.664 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -21.05 8.01 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.173 2.189 . . . . 0.0 111.282 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.785 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.58 161.57 11.56 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.948 1.299 . . . . 0.0 109.772 -174.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.88 104.38 14.63 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.73 93.64 4.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.91 131.44 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.05 128.28 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 24.7 m -99.21 90.43 4.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 2' ' ' LEU . 77.7 t -60.6 159.38 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.66 -57.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.0 m -148.93 141.09 23.96 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.209 0.459 . . . . 0.0 112.038 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.91 138.88 53.89 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.306 3.042 . . . . 0.0 109.485 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CD ' HH22 ' A' ' 86' ' ' ARG . 17.7 pm0 -140.68 151.31 44.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.779 0.832 . . . . 0.0 110.874 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' HH22 ' A' ' 76' ' ' ARG . 0.0 OUTLIER -65.77 138.12 57.72 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 125.036 1.334 . . . . 0.0 109.944 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -138.45 -81.31 0.32 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.432 0.458 . . . . 0.0 110.836 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.456 ' C ' HH21 ' A' ' 76' ' ' ARG . 2.1 pp . . . . . 0 C--O 1.242 0.665 0 C-N-CA 123.955 0.902 . . . . 0.0 110.43 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.569 HD11 ' CG1' ' A' ' 115' ' ' VAL . 9.5 mp . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.47 156.28 58.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.291 1.994 . . . . 0.0 110.321 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.77 92.89 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.49 -38.68 55.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.838 1.655 . . . . 0.0 112.234 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -50.79 -54.23 25.31 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.337 1.426 . . . . 0.0 109.401 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.86 -48.58 76.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.515 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -60.26 -33.78 72.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.346 0.975 . . . . 0.0 112.482 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.05 -41.03 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.484 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -39.77 85.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.88 1.218 . . . . 0.0 112.047 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.72 -24.85 6.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.975 1.261 . . . . 0.0 112.433 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -101.48 158.6 15.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.94 0.791 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.22 148.68 41.36 Favored 'General case' 0 C--O 1.243 0.741 0 O-C-N 121.074 -1.016 . . . . 0.0 109.818 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -178.19 168.23 39.37 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 122.852 0.263 . . . . 0.0 112.724 -174.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -101.08 144.53 12.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.33 159.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 127.752 2.421 . . . . 0.0 105.607 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.16 157.32 45.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.32 1.048 . . . . 0.0 109.531 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.7 118.7 12.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 125.232 1.413 . . . . 0.0 107.71 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.92 108.78 19.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.3 m -88.79 109.42 20.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -73.53 141.23 46.73 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.42 -81.63 0.22 Allowed Glycine 0 C--O 1.221 -0.714 0 N-CA-C 106.007 -2.837 . . . . 0.0 106.007 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -170.69 -59.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.92 52.12 1.21 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.497 1.618 . . . . 0.0 110.201 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.57 144.94 3.93 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.83 2.157 . . . . 0.0 111.551 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.92 161.29 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.362 1.374 . . . . 0.0 109.983 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -121.12 97.46 5.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.976 1.71 . . . . 0.0 107.462 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 11.0 tp -83.55 88.55 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.8 0.727 . . . . 0.0 109.322 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.23 169.04 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.013 0.925 . . . . 0.0 110.293 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.81 167.61 11.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.235 1.414 . . . . 0.0 112.856 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 t -168.35 174.61 6.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.627 1.971 . . . . 0.0 108.021 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -120.56 141.99 49.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.702 2.401 . . . . 0.0 109.463 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -53.88 -30.75 47.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.334 0.97 . . . . 0.0 109.737 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -52.15 -21.16 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.535 2.334 . . . . 0.0 112.671 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -118.12 -5.12 10.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.921 1.688 . . . . 0.0 112.108 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.7 mt -87.8 159.22 18.52 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.506 1.503 . . . . 0.0 111.588 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 100' ' ' ALA 0.25 0.0 OUTLIER -136.36 131.85 34.79 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.802 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.18 147.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.57 178.89 4.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.397 1.879 . . . . 0.0 107.725 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -71.28 175.86 5.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.107 0.963 . . . . 0.0 110.47 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.87 28.43 57.57 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.333 1.444 . . . . 0.0 111.476 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.518 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.272 0.1 OUTLIER 53.72 20.73 2.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.415 1.886 . . . . 0.0 114.375 -175.239 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -73.97 126.31 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.152 1.381 . . . . 0.0 107.373 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.66 159.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -146.0 144.28 20.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 120.536 -1.353 . . . . 0.0 109.262 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.92 136.54 28.59 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.925 2.09 . . . . 0.0 107.534 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.69 108.32 1.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.455 2.104 . . . . 0.0 109.039 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.49 111.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.19 -21.33 10.11 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.338 1.447 . . . . 0.0 113.255 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.92 0.31 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 119.305 1.553 . . . . 0.0 115.09 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -97.89 67.94 1.99 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 123.394 1.568 . . . . 0.0 108.353 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -64.21 -48.79 74.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.193 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.255 81.8 tttt -52.04 -36.29 49.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.794 1.633 . . . . 0.0 110.674 173.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -64.86 -39.51 93.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.429 1.468 . . . . 0.0 110.705 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 32.3 tt0 -55.08 -50.73 68.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.507 1.503 . . . . 0.0 110.631 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.1 79.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.131 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -58.52 -41.99 86.72 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 115.781 -2.057 . . . . 0.0 111.45 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.16 -48.36 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.874 1.216 . . . . 0.0 109.116 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.94 66.05 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.267 -0.873 . . . . 0.0 113.277 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -87.44 -47.06 9.07 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.662 1.119 . . . . 0.0 112.48 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -140.04 132.31 28.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.65 1.18 . . . . 0.0 112.325 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.97 -22.52 55.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.452 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.51 129.65 42.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.896 1.225 . . . . 0.0 112.47 -173.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.4 m -139.29 139.4 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.837 1.303 . . . . 0.0 112.336 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 20.2 tp -92.98 153.7 18.59 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 172.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.6 ttt -140.03 141.37 36.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -123.17 130.62 53.0 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 pp -115.35 166.19 12.14 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.617 1.098 . . . . 0.0 108.38 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.63 179.11 41.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 173.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.443 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 47.2 t -147.18 168.67 21.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.687 1.595 . . . . 0.0 108.157 174.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -116.42 -9.41 11.48 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.014 1.326 . . . . 0.0 109.87 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -92.38 -11.67 34.3 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.44 134.19 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 118.5 20.66 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.941 0.791 . . . . 0.0 112.33 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 81' ' ' THR . . . -121.5 -127.26 3.37 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.91 1.243 . . . . 0.0 111.704 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -91.68 -58.7 2.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -74.62 102.63 4.64 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 109.875 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.55 -167.9 0.4 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.27 62.85 5.25 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.72 121.88 1.39 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 129.73 3.538 . . . . 0.0 106.83 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.415 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 3.5 t -109.98 176.82 4.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.132 0.966 . . . . 0.0 110.699 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.52 177.41 44.38 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 124.839 1.209 . . . . 0.0 112.158 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -138.4 154.65 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.149 0.979 . . . . 0.0 108.369 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.27 129.3 47.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.46 154.04 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 119' ' ' GLU . 36.7 mtm180 -135.89 141.64 44.61 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.882 1.273 . . . . 0.0 108.618 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -169.81 34.94 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.412 0.53 . . . . 0.0 112.238 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.8 m -121.11 151.1 40.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.959 1.303 . . . . 0.0 109.074 173.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.32 163.64 13.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.625 1.17 . . . . 0.0 113.017 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.59 121.19 3.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.103 1.361 . . . . 0.0 109.377 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.5 m-85 -77.55 149.07 34.93 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.231 -0.918 . . . . 0.0 111.989 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -141.03 134.42 29.78 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 125.339 1.456 . . . . 0.0 107.709 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.0 p -120.42 20.17 11.93 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.597 173.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.75 150.1 20.65 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.698 2.399 . . . . 0.0 109.583 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.59 -177.83 45.45 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.917 1.246 . . . . 0.0 112.507 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.26 -14.27 19.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.133 3.222 . . . . 0.0 113.524 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.3 -63.72 1.01 Allowed 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.101 -0.999 . . . . 0.0 108.978 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.64 -31.62 71.73 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.448 1.499 . . . . 0.0 111.079 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -69.12 -49.66 55.01 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.438 0.695 . . . . 0.0 109.636 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -61.13 -35.39 76.94 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.146 -0.971 . . . . 0.0 111.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.402 0.8 OUTLIER -79.02 -17.89 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.736 173.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.2 -27.58 2.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.691 1.996 . . . . 0.0 112.22 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -47.65 -36.38 10.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.305 1.042 . . . . 0.0 111.205 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -80.89 177.95 8.72 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.308 0.958 . . . . 0.0 108.537 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -141.14 -0.6 1.44 Allowed 'General case' 0 C--O 1.222 -0.393 0 O-C-N 119.18 -2.2 . . . . 0.0 112.262 -176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -106.3 8.87 32.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.032 1.733 . . . . 0.0 110.873 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.41 145.75 29.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.389 -0.819 . . . . 0.0 110.869 -174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -121.29 -13.71 8.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.864 2.866 . . . . 0.0 111.913 -174.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -173.78 161.71 3.89 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.143 2.177 . . . . 0.0 109.536 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.17 101.97 11.42 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.386 2.275 . . . . 0.0 105.012 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.07 95.91 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.672 1.589 . . . . 0.0 106.764 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.98 131.67 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.16 128.49 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.6 m -98.92 88.46 4.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.569 ' CG1' HD11 ' A' ' 2' ' ' LEU . 86.4 t -61.03 156.13 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.827 175.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.49 -55.46 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.5 m -148.5 141.25 24.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.666 0.666 . . . . 0.0 112.32 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.35 138.73 51.59 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 128.919 2.887 . . . . 0.0 107.886 173.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 86' ' ' ARG . 3.3 pm0 -140.1 138.68 35.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 110.609 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 138.58 58.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 111.928 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -143.39 -80.51 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.259 0.624 . . . . 0.0 112.299 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 114.892 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.4 mm? . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 118.199 -0.905 . . . . 0.0 108.691 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.12 164.34 35.68 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.813 2.342 . . . . 0.0 110.329 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.86 -47.56 89.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.367 5.0 m -50.3 -38.11 39.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.255 1.822 . . . . 0.0 113.635 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -50.65 -51.97 44.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.095 1.316 . . . . 0.0 110.649 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -63.55 -48.35 77.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.035 0.934 . . . . 0.0 110.13 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.71 -38.09 66.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.427 1.012 . . . . 0.0 111.757 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.86 -43.77 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.083 -1.011 . . . . 0.0 109.629 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.65 -35.06 75.28 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.202 1.364 . . . . 0.0 112.32 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -51.84 -27.09 11.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.025 0.93 . . . . 0.0 112.133 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -99.37 159.2 15.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.468 1.107 . . . . 0.0 108.114 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.92 153.34 39.86 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 122.077 0.941 . . . . 0.0 109.151 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.97 174.52 45.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 125.611 1.577 . . . . 0.0 109.422 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.92 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.74 160.93 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.22 154.69 44.1 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.84 116.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -174.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 26' ' ' PRO . . . -88.56 108.86 19.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -94.36 123.05 37.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 116.971 -1.49 . . . . 0.0 108.134 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -72.91 119.55 17.31 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 121.242 1.837 . . . . 0.0 106.579 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.29 -81.65 0.23 Allowed Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.136 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -158.63 -60.7 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -78.82 41.03 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.113 2.565 . . . . 0.0 110.479 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.63 152.24 9.47 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.572 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 18.8 Cg_endo -54.25 148.05 42.81 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 CA-C-N 120.791 2.295 . . . . 0.0 107.973 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -103.3 101.3 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.195 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -76.22 88.53 3.08 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.168 0.587 . . . . 0.0 110.425 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -83.24 170.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.887 1.675 . . . . 0.0 110.069 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.13 166.1 13.35 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.09 1.314 . . . . 0.0 113.793 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.0 t -168.32 176.19 6.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.374 2.27 . . . . 0.0 108.054 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -118.95 141.81 48.34 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.659 1.983 . . . . 0.0 109.721 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.07 -31.56 42.37 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.372 0.669 . . . . 0.0 110.016 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -60.76 -11.79 8.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.903 3.281 . . . . 0.0 112.108 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -118.68 -6.36 10.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 111.58 -177.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD22 HG22 ' A' ' 46' ' ' VAL . 22.6 mt -95.05 160.11 14.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.089 1.313 . . . . 0.0 112.084 -173.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 141.61 44.64 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.28 150.95 5.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -122.0 179.21 4.59 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 128.461 2.704 . . . . 0.0 107.103 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.97 -179.91 2.47 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.26 28.21 26.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.479 1.514 . . . . 0.0 111.245 -173.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.6 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.342 0.1 OUTLIER 53.39 24.59 4.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.891 2.076 . . . . 0.0 114.32 -175.817 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.45 151.26 41.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.29 164.38 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -144.43 140.93 24.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 36' ' ' LEU . 59.8 t -123.0 124.86 26.44 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 127.483 2.313 . . . . 0.0 105.4 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.87 108.52 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.116 1.878 . . . . 0.0 109.008 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.833 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.83 111.61 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -21.24 6.85 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 112.077 173.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.3 40.89 0.31 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 119.095 1.448 . . . . 0.0 110.697 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.496 ' HB2' HG23 ' A' ' 48' ' ' VAL . 28.7 mtt -106.56 57.5 0.65 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.799 1.239 . . . . 0.0 108.598 173.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.53 -49.81 37.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.627 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -52.17 -41.3 62.48 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.821 1.646 . . . . 0.0 110.854 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -61.1 -38.91 88.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.514 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.53 -49.51 76.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 121.04 1.746 . . . . 0.0 110.413 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.62 97.08 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -61.88 -41.94 98.46 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.567 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.36 -48.15 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.746 1.157 . . . . 0.0 109.32 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.14 53.18 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.387 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.5 mtp85 -85.56 -46.31 10.94 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.102 0.864 . . . . 0.0 112.726 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.46 129.21 15.2 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.161 0.984 . . . . 0.0 110.962 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -73.92 -17.75 60.98 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.53 123.19 16.04 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 20' ' ' THR . 11.9 m -138.82 141.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 123.082 1.42 . . . . 0.0 110.52 173.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.0 tt -107.32 148.48 28.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 102.091 -3.299 . . . . 0.0 102.091 172.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.4 ttt -141.66 121.06 13.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -108.93 128.36 54.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 168.52 10.01 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.042 1.292 . . . . 0.0 107.847 173.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.64 -169.22 31.8 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -147.01 175.47 10.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.409 1.099 . . . . 0.0 108.707 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -113.87 -7.94 13.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.676 2.391 . . . . 0.0 109.317 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mmpm? -91.46 -10.95 39.03 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 119.601 -1.937 . . . . 0.0 115.007 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.76 136.49 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.57 131.49 36.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.479 1.112 . . . . 0.0 111.104 -175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.44 -140.98 6.34 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 124.703 1.144 . . . . 0.0 110.886 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.27 -58.99 2.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.564 1.546 . . . . 0.0 107.731 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.95 102.84 8.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.072 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.24 -168.6 2.26 Favored Glycine 0 CA--C 1.538 1.499 0 O-C-N 121.754 -0.591 . . . . 0.0 112.655 176.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 77.9 Cg_endo -75.52 59.74 5.61 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.815 2.344 . . . . 0.0 110.993 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.25 121.11 1.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -113.47 169.88 8.64 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.477 1.138 . . . . 0.0 110.334 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.2 -177.36 45.15 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 123.602 0.62 . . . . 0.0 113.283 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -136.8 152.67 50.56 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.862 1.265 . . . . 0.0 109.502 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tt -101.39 131.27 47.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.648 2.379 . . . . 0.0 104.58 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -136.06 158.33 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -129.86 150.79 51.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.644 1.178 . . . . 0.0 109.453 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -174.59 40.9 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.455 1.026 . . . . 0.0 111.693 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -106.03 137.35 44.1 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.4 161.93 13.33 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.787 0.722 . . . . 0.0 111.181 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.2 119.24 3.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.148 0.979 . . . . 0.0 109.833 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -74.17 131.52 41.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.2 141.46 50.65 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.83 2.852 . . . . 0.0 109.572 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.14 27.07 8.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.384 1.873 . . . . 0.0 107.425 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -158.81 163.95 36.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.11 2.564 . . . . 0.0 107.797 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.48 178.35 46.82 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.072 1.796 . . . . 0.0 113.077 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.41 -22.91 58.95 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.167 2.578 . . . . 0.0 112.007 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -64.29 -59.31 4.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 173.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -61.56 -31.31 71.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.094 -1.431 . . . . 0.0 112.402 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -68.47 -53.99 19.83 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.957 1.708 . . . . 0.0 108.227 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.51 69.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.909 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.4 pp -93.67 -19.9 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.764 -1.113 . . . . 0.0 112.87 173.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.94 -35.21 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.533 1.969 . . . . 0.0 110.406 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.285 2.2 ptm180 -51.07 -18.18 0.78 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.947 2.099 . . . . 0.0 113.815 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -67.88 -171.2 0.2 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -132.13 4.17 4.07 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 118.597 -2.564 . . . . 0.0 113.786 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 23.3 p-90 -131.05 8.84 4.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.811 0.844 . . . . 0.0 111.704 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.86 140.61 38.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.498 -0.751 . . . . 0.0 109.062 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.21 -10.59 8.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.348 1.459 . . . . 0.0 111.418 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.833 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.0 161.85 10.77 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.79 2.436 . . . . 0.0 108.201 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.43 107.63 18.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.802 2.041 . . . . 0.0 106.6 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 tt -84.49 96.34 9.09 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.9 t -79.29 131.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.672 1.589 . . . . 0.0 107.516 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.06 128.86 75.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.4 m -106.09 92.19 4.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 2' ' ' LEU . 14.3 t -61.08 157.42 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.888 1.275 . . . . 0.0 110.723 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.52 -56.27 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.9 m -151.29 141.66 22.43 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.37 155.2 29.99 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 128.538 2.735 . . . . 0.0 112.295 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -141.07 140.95 34.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.815 2.046 . . . . 0.0 108.208 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -76.56 140.77 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -138.7 -79.49 0.34 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.307 0.643 . . . . 0.0 111.5 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.242 0.697 0 CA-C-O 116.825 -1.559 . . . . 0.0 112.169 -174.182 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 118' ' ' ALA . 67.0 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.77 152.39 42.48 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.846 2.364 . . . . 0.0 111.939 173.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.84 -39.18 93.54 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.35 -40.27 58.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.624 1.57 . . . . 0.0 111.89 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -51.28 -56.08 14.85 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.251 0.932 . . . . 0.0 110.611 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -56.06 -48.27 76.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.126 0.97 . . . . 0.0 110.454 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -55.41 -35.04 64.95 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.697 0.681 . . . . 0.0 112.565 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.6 t -69.06 -46.59 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.113 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.422 ' HG ' HG21 ' A' ' 38' ' ' VAL . 4.0 mm? -54.48 -41.32 69.42 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.169 1.35 . . . . 0.0 112.879 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -51.55 -18.71 1.19 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -119.94 158.69 26.2 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.367 0.985 . . . . 0.0 108.781 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -80.61 149.28 29.93 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.543 -1.348 . . . . 0.0 110.39 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.4 169.63 42.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.705 2.098 . . . . 0.0 110.194 174.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.1 151.04 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.98 159.58 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 127.574 2.349 . . . . 0.0 105.749 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.72 40.85 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.241 1.416 . . . . 0.0 109.419 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.589 HD11 HG21 ' A' ' 46' ' ' VAL . 9.8 mt -145.32 115.82 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.82 19.78 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -95.91 108.82 21.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -79.56 141.33 36.71 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 122.002 2.183 . . . . 0.0 106.168 173.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 -81.49 0.22 Allowed Glycine 0 C--O 1.224 -0.486 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -159.06 -61.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.4 45.73 0.68 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.131 1.772 . . . . 0.0 110.123 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 151.62 6.74 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.953 1.263 . . . . 0.0 112.685 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.19 157.72 53.37 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.212 1.275 . . . . 0.0 110.878 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -121.46 102.03 8.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.087 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.6 tt -87.35 88.71 7.76 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -175.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.58 173.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.762 2.025 . . . . 0.0 110.676 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.63 165.62 14.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.584 1.154 . . . . 0.0 111.574 173.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 178.43 4.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.247 2.219 . . . . 0.0 108.052 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -121.36 141.79 50.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.811 2.044 . . . . 0.0 110.685 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -51.52 -30.98 22.29 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.509 1.049 . . . . 0.0 110.799 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.48 -13.08 4.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.948 2.899 . . . . 0.0 112.008 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -118.14 -1.16 11.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.13 1.372 . . . . 0.0 110.48 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.613 HD22 HG22 ' A' ' 46' ' ' VAL . 27.6 mt -102.4 168.92 9.01 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.599 -1.313 . . . . 0.0 112.762 -173.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 125.3 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 172.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.422 HG21 ' HG ' ' A' ' 10' ' ' LEU . 35.3 t -101.69 148.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.9 mt -121.58 -177.11 3.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.944 2.098 . . . . 0.0 107.973 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 36.2 t0 -71.44 177.99 3.68 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 49.37 28.15 8.96 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 126.098 1.809 . . . . 0.0 110.443 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.3 0.5 OUTLIER 53.23 28.27 6.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.373 2.269 . . . . 0.0 114.304 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -73.62 144.63 45.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 173.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.79 159.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 t -143.05 141.76 26.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.613 HG22 HD22 ' A' ' 36' ' ' LEU . 57.7 t -122.79 140.39 33.11 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.302 2.641 . . . . 0.0 106.066 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.43 110.97 2.02 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.795 2.33 . . . . 0.0 108.61 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.754 ' CG1' ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.3 112.22 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.25 -21.77 5.44 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.081 -1.012 . . . . 0.0 112.148 173.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.78 41.31 0.35 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.344 1.572 . . . . 0.0 109.958 -175.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 48' ' ' VAL . 22.0 mtt -105.71 71.13 0.9 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.677 1.191 . . . . 0.0 108.498 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.39 -65.57 0.66 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 130.048 3.339 . . . . 0.0 114.558 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -51.72 -41.27 61.39 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -63.47 -38.69 92.11 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.66 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 35.4 tt0 -56.29 -51.22 68.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.242 1.383 . . . . 0.0 109.489 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.53 93.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.175 0.59 . . . . 0.0 112.158 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -65.34 -41.93 93.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.576 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.8 -48.06 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.23 -28.82 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.157 -0.925 . . . . 0.0 112.819 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -86.81 -46.3 10.09 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.598 -1.191 . . . . 0.0 112.087 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -149.05 140.78 23.56 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.749 1.159 . . . . 0.0 110.255 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -13.27 62.24 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 63' ' ' ARG . 8.8 mmp_? -49.88 114.16 1.01 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.754 2.422 . . . . 0.0 115.934 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 20' ' ' THR . 7.7 m -141.7 146.32 23.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 CA-C-O 123.905 1.812 . . . . 0.0 114.797 173.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 4.0 tt -111.46 148.78 32.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 101.623 -3.473 . . . . 0.0 101.623 172.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.4 ttt -141.05 140.98 34.33 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -121.6 128.21 51.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 175.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -117.19 169.73 9.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.227 -1.546 . . . . 0.0 108.112 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.86 -176.22 38.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.441 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 t -148.65 164.14 35.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.709 0.804 . . . . 0.0 110.364 174.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -98.35 -8.68 26.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.748 1.619 . . . . 0.0 109.447 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -91.39 -9.89 43.12 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 116.891 -1.528 . . . . 0.0 114.725 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -131.45 138.86 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 131.07 36.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.502 0.721 . . . . 0.0 110.753 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.25 -140.43 9.26 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 124.907 1.241 . . . . 0.0 111.765 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -90.68 -58.6 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.38 103.06 9.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.08 -168.67 3.91 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 113.129 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.28 58.82 6.81 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.658 2.238 . . . . 0.0 111.132 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.46 120.99 1.07 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -114.45 169.17 9.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.733 1.266 . . . . 0.0 110.105 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.54 178.21 41.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-O 121.725 0.625 . . . . 0.0 112.261 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.71 149.1 49.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.383 1.473 . . . . 0.0 108.473 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tt -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mm -131.35 156.53 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -135.59 146.01 47.51 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.285 1.434 . . . . 0.0 108.686 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.19 -165.54 34.46 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.942 0.782 . . . . 0.0 112.183 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.5 m -115.88 147.54 40.97 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.057 1.343 . . . . 0.0 108.045 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.99 164.35 12.89 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.794 1.637 . . . . 0.0 111.873 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.94 120.95 2.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.394 1.078 . . . . 0.0 108.853 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 63.8 m-85 -76.24 138.7 40.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -140.63 141.35 35.11 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.094 0.958 . . . . 0.0 110.112 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.3 p -117.2 39.64 3.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -159.07 156.13 28.63 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 128.115 2.566 . . . . 0.0 111.567 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.15 178.54 47.26 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.292 1.901 . . . . 0.0 114.391 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.71 -17.26 58.07 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.347 2.698 . . . . 0.0 111.584 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -63.77 1.13 Allowed 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.151 1.78 . . . . 0.0 107.488 173.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.45 -31.26 71.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.03 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -68.62 -49.08 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.555 1.07 . . . . 0.0 109.074 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.96 78.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.218 -0.926 . . . . 0.0 111.404 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.345 0.9 OUTLIER -82.58 -18.41 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.55 173.776 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.01 -27.96 3.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.826 1.651 . . . . 0.0 112.133 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -51.17 -35.9 38.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.72 0.808 . . . . 0.0 111.78 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.26 177.84 8.53 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -141.37 -1.11 1.36 Allowed 'General case' 0 C--O 1.222 -0.387 0 O-C-N 119.144 -2.222 . . . . 0.0 113.18 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -98.26 8.76 44.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.449 1.1 . . . . 0.0 110.271 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.37 150.8 28.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.524 -0.735 . . . . 0.0 111.03 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -120.88 -21.28 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.168 2.987 . . . . 0.0 111.024 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . . . -171.5 161.77 6.37 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.736 2.014 . . . . 0.0 109.114 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.99 108.38 19.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.5 93.89 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.04 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.9 128.68 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.1 m -106.2 92.09 3.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.04 155.48 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.848 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.05 -41.79 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.521 1.528 . . . . 0.0 107.275 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.5 m -151.26 141.0 21.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.838 1.199 . . . . 0.0 113.618 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 2' ' ' LEU . . . -115.5 140.13 49.43 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 129.948 3.299 . . . . 0.0 110.626 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -139.3 136.31 34.73 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.013 1.725 . . . . 0.0 109.291 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -75.91 140.82 42.33 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -137.23 -77.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.256 1.397 0 C-N-CA 125.359 1.464 . . . . 0.0 114.37 -173.539 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 42' ' ' ASN . 7.4 mp . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.43 159.39 51.63 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.677 2.251 . . . . 0.0 111.832 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.16 -38.77 93.6 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -48.5 -43.14 34.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.065 1.746 . . . . 0.0 111.427 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.34 -55.45 18.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.352 0.978 . . . . 0.0 111.247 174.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -56.7 -48.52 77.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -59.21 -33.62 71.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.759 0.709 . . . . 0.0 112.835 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.76 -41.93 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -59.6 -38.4 81.12 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.33 1.423 . . . . 0.0 112.493 173.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 -18.9 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.177 1.353 . . . . 0.0 112.63 173.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -113.73 159.05 20.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.414 1.086 . . . . 0.0 108.754 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -73.72 148.36 42.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.924 -1.11 . . . . 0.0 108.794 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -165.35 171.25 40.59 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 126.801 2.143 . . . . 0.0 110.079 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.42 150.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -139.82 160.46 26.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.974 2.109 . . . . 0.0 106.041 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 157.05 44.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.512 1.125 . . . . 0.0 108.46 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 HG21 ' A' ' 46' ' ' VAL . 23.0 mt -139.4 115.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -176.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.04 108.56 19.65 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 174.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -91.36 114.3 26.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 116.308 -1.806 . . . . 0.0 106.649 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.41 141.5 46.95 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 121.845 2.111 . . . . 0.0 108.47 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.28 -81.05 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -158.82 -56.98 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 20.0 p-10 -78.87 38.34 0.33 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.668 2.787 . . . . 0.0 111.517 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.37 151.67 6.48 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.416 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.92 148.9 58.53 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 CA-C-N 118.028 0.914 . . . . 0.0 111.449 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -101.88 101.39 11.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.84 88.64 3.44 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.663 0.665 . . . . 0.0 110.071 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.3 m -80.31 170.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.15 1.38 . . . . 0.0 110.046 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -119.36 165.91 13.72 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 0.989 . . . . 0.0 112.523 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -168.29 176.22 6.03 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 108.548 175.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.16 141.53 50.74 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.433 1.893 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.26 -31.06 52.65 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.111 0.869 . . . . 0.0 109.706 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -59.95 -13.33 10.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.765 2.826 . . . . 0.0 111.413 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -119.23 -2.94 10.6 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 46' ' ' VAL . 42.5 mt -90.18 164.78 14.3 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.477 1.489 . . . . 0.0 112.229 -173.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -134.98 132.2 38.08 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.17 145.74 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.48 179.13 4.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.333 1.853 . . . . 0.0 108.101 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.44 175.24 4.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.347 1.059 . . . . 0.0 109.474 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.09 28.42 33.38 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.721 1.629 . . . . 0.0 111.105 -173.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.61 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.28 0.1 OUTLIER 53.41 23.11 3.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.86 2.064 . . . . 0.0 114.102 -177.029 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -73.58 129.08 37.22 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -118.0 150.91 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.51 147.08 24.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 120.837 -1.164 . . . . 0.0 108.843 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 18' ' ' ILE . 58.7 t -126.65 135.73 27.69 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 126.188 1.795 . . . . 0.0 107.869 -173.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.0 108.36 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.022 1.815 . . . . 0.0 108.457 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.877 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.57 111.52 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.52 -21.35 6.9 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 112.256 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.75 41.38 0.32 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 117.46 -1.745 . . . . 0.0 109.901 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.503 ' HB2' HG23 ' A' ' 48' ' ' VAL . 20.1 mtt -109.12 59.82 0.6 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.654 1.181 . . . . 0.0 109.225 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -71.48 -49.65 39.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.994 -174.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HZ1' ' CG ' ' A' ' 24' ' ' ASP . 55.0 tttp -51.99 -41.44 62.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.044 1.747 . . . . 0.0 109.296 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -60.73 -39.47 88.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.151 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.93 -48.28 80.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 121.248 1.84 . . . . 0.0 110.782 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.68 99.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.099 0.159 . . . . 0.0 111.253 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -62.88 -41.87 99.56 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.379 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.7 -48.24 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.409 1.459 . . . . 0.0 109.132 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.49 -28.17 59.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -46.42 15.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -151.34 128.61 11.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.986 0.914 . . . . 0.0 109.204 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -15.39 60.05 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.799 -1.188 . . . . 0.0 113.969 -174.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.495 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.64 130.69 47.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.641 1.11 . . . . 0.0 111.575 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 20' ' ' THR . 11.7 m -139.35 156.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 123.392 1.567 . . . . 0.0 111.895 173.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.7 tp -108.93 149.87 28.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.3 ttt -140.01 123.02 16.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -109.02 127.99 54.57 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.97 172.4 7.29 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.421 1.464 . . . . 0.0 109.559 173.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.44 -166.16 27.03 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.0 t -146.65 159.94 42.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.83 0.852 . . . . 0.0 109.467 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -98.69 -15.47 19.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.145 0.978 . . . . 0.0 108.994 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.03 -7.01 50.01 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 116.323 -1.799 . . . . 0.0 115.388 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.02 129.69 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 121.767 2.076 . . . . 0.0 106.14 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.3 131.42 36.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.907 0.883 . . . . 0.0 110.631 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.71 -140.98 7.18 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -78.98 -59.11 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.877 1.271 . . . . 0.0 108.855 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -88.25 103.12 15.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.716 0.77 . . . . 0.0 109.907 -174.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.51 -172.01 3.97 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.952 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 54.0 Cg_endo -80.54 58.87 7.21 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.208 1.939 . . . . 0.0 110.571 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.69 109.83 0.43 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 t -99.32 169.65 9.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.498 0.649 . . . . 0.0 110.375 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.97 169.91 40.87 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -125.0 157.33 36.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.84 1.256 . . . . 0.0 110.386 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.89 130.54 46.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mt -134.77 153.01 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -130.76 140.38 50.31 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.805 1.642 . . . . 0.0 107.342 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.68 36.82 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 118.691 0.678 . . . . 0.0 111.718 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -121.4 150.99 40.69 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.869 0.868 . . . . 0.0 110.163 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.13 162.33 14.36 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.167 1.387 . . . . 0.0 112.288 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.02 121.19 3.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.643 1.177 . . . . 0.0 109.289 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -74.18 138.54 43.85 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.193 0.997 . . . . 0.0 110.771 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -135.56 123.34 22.45 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 126.448 1.899 . . . . 0.0 115.399 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -121.72 32.94 5.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.177 2.991 . . . . 0.0 103.924 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.64 151.76 22.6 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 130.488 3.515 . . . . 0.0 110.141 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.55 47.59 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.543 1.068 . . . . 0.0 113.37 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.82 -9.09 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.945 2.43 . . . . 0.0 111.17 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -61.32 -60.86 3.07 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -61.56 -31.48 71.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 125.071 1.482 . . . . 0.0 111.138 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.46 -48.56 64.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.741 1.155 . . . . 0.0 109.357 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.461 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -59.58 -41.22 89.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.421 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.281 1.2 pp -79.82 -18.75 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 119.251 -0.98 . . . . 0.0 113.556 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.91 -28.84 53.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.841 1.655 . . . . 0.0 113.745 -174.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.259 0.6 OUTLIER -52.08 -38.58 57.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.124 173.08 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -66.05 177.88 1.26 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 -1.12 1.5 Allowed 'General case' 0 C--O 1.222 -0.385 0 O-C-N 118.308 -2.745 . . . . 0.0 113.378 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -110.32 8.35 23.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.503 0.721 . . . . 0.0 109.903 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.14 138.83 33.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.82 -8.36 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.025 1.73 . . . . 0.0 110.917 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.877 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.24 161.75 10.29 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.324 2.649 . . . . 0.0 108.506 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.85 105.14 15.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.774 2.429 . . . . 0.0 104.72 173.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.4 90.84 5.63 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.48 131.34 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.6 mt -120.22 128.23 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.9 m -99.34 88.47 3.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.622 -2.732 . . . . 0.0 103.622 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 2' ' ' LEU . 25.0 t -60.71 157.29 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.037 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.79 -56.99 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.5 m -148.32 141.38 24.92 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.5 149.84 30.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.261 2.624 . . . . 0.0 108.534 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -139.55 133.14 30.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.31 1.844 . . . . 0.0 107.487 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -68.8 137.75 54.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -136.99 -58.23 0.72 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 77' ' ' ASN . 2.3 pp . . . . . 0 C--O 1.247 0.937 0 C-N-CA 124.23 1.012 . . . . 0.0 113.323 -173.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 42' ' ' ASN . 7.2 mp . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.24 159.63 52.37 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.607 2.205 . . . . 0.0 111.818 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.75 95.38 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.26 -38.72 63.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 110.482 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -50.61 -56.01 13.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.496 1.043 . . . . 0.0 110.228 173.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -59.34 -48.56 81.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.372 0.669 . . . . 0.0 109.534 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -56.69 -41.05 76.67 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -41.22 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.841 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.28 -42.84 78.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.307 1.412 . . . . 0.0 111.85 173.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -52.02 -18.92 1.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -116.08 175.02 5.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 111.666 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -73.26 132.5 43.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.79 166.24 39.25 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 106.747 -2.541 . . . . 0.0 106.747 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.83 147.81 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.02 159.34 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -145.51 154.81 42.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.386 1.474 . . . . 0.0 107.183 174.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.09 114.03 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.774 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.98 108.38 19.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.475 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -88.68 116.17 26.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -73.3 138.18 45.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.4 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -159.79 -60.74 0.07 Allowed 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -78.94 52.53 1.26 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.657 2.383 . . . . 0.0 110.043 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.43 150.41 5.73 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.017 1.77 . . . . 0.0 111.735 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 36.5 Cg_endo -66.94 150.16 82.97 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 118.241 1.02 . . . . 0.0 111.321 174.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -103.19 101.82 11.79 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.8 tt -87.4 88.88 7.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.5 m -76.1 169.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.117 1.767 . . . . 0.0 110.6 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 9.7 m120 -119.28 166.91 12.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.647 1.179 . . . . 0.0 113.079 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -168.68 174.25 6.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.315 2.246 . . . . 0.0 109.025 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -120.67 141.57 50.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.294 2.238 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -54.63 -31.21 56.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.255 0.48 . . . . 0.0 112.03 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.5 t -59.72 -8.97 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.521 1.528 . . . . 0.0 113.343 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.13 -1.77 11.33 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.644 1.178 . . . . 0.0 109.845 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.66 169.62 8.35 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.701 -1.249 . . . . 0.0 113.133 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' NZ ' HD21 ' A' ' 39' ' ' LEU . 2.0 pttt -136.48 141.55 43.51 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.9 t -99.38 146.81 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.407 HD21 ' NZ ' ' A' ' 37' ' ' LYS . 22.7 mt -121.68 -174.08 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.968 2.907 . . . . 0.0 111.825 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.37 158.89 6.76 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 128.122 2.569 . . . . 0.0 111.067 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.09 35.82 42.32 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.055 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' HB2' HD13 ' A' ' 2' ' ' LEU . 0.2 OUTLIER 54.05 22.73 3.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.253 1.821 . . . . 0.0 114.347 -175.125 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -74.16 158.01 34.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.791 1.636 . . . . 0.0 108.084 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -140.77 170.23 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.8 t -144.89 140.06 23.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.767 1.227 . . . . 0.0 108.132 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.92 133.85 24.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 128.578 2.751 . . . . 0.0 106.885 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.37 108.43 2.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.874 2.383 . . . . 0.0 109.88 174.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.786 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.86 111.76 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.21 -21.34 6.29 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.6 1.571 . . . . 0.0 112.816 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.86 41.56 0.27 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.512 ' HB2' HG23 ' A' ' 48' ' ' VAL . 17.6 mtt -107.83 71.38 0.81 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.611 1.565 . . . . 0.0 107.728 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -67.21 -63.91 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 129.895 3.278 . . . . 0.0 113.278 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -51.74 -40.67 60.65 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -60.19 -40.85 91.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.306 -1.33 . . . . 0.0 112.252 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -58.19 -48.78 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.606 2.003 . . . . 0.0 110.32 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.16 95.69 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -65.1 -41.63 94.77 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 116.989 -1.481 . . . . 0.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.76 -48.25 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.3 1.409 . . . . 0.0 108.503 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -25.7 59.9 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -82.25 -44.92 15.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -151.15 136.24 17.48 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 108.791 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -21.85 63.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.162 -0.961 . . . . 0.0 112.256 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -61.05 128.88 38.58 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.68 1.192 . . . . 0.0 114.115 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 20' ' ' THR . 6.3 m -139.52 154.99 25.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 122.749 1.262 . . . . 0.0 110.139 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.774 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 9.3 tt -111.66 150.97 29.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 103.058 -2.941 . . . . 0.0 103.058 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 13.7 ttt -139.01 135.52 34.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 18.5 p -121.05 128.45 52.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.97 165.95 12.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 109.083 173.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.11 42.5 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -159.8 170.31 21.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.974 0.892 . . . . 0.0 108.901 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -99.27 -9.32 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.873 2.069 . . . . 0.0 110.325 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -91.85 -11.26 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.54 136.73 56.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -78.92 131.42 36.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.526 0.73 . . . . 0.0 109.847 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.32 -141.1 7.31 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 124.222 0.951 . . . . 0.0 110.933 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -81.67 -58.82 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.47 102.9 13.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.615 0.721 . . . . 0.0 109.625 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.73 -168.94 3.44 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.617 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 57.9 Cg_endo -78.52 59.43 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.578 2.185 . . . . 0.0 110.914 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.09 121.08 1.09 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -110.09 169.31 8.81 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 118.029 0.914 . . . . 0.0 109.836 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.87 35.16 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 123.962 0.791 . . . . 0.0 113.441 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -136.48 141.5 43.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.23 1.412 . . . . 0.0 109.348 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.18 130.68 47.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 127.174 2.189 . . . . 0.0 106.271 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.4 mt -141.32 150.99 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.812 -0.555 . . . . 0.0 109.762 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -128.03 148.82 50.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.81 2.044 . . . . 0.0 109.967 173.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.4 -168.09 34.06 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.355 1.455 . . . . 0.0 110.458 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.7 m -121.0 149.04 43.28 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.351 1.46 . . . . 0.0 108.838 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.02 163.56 13.71 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.763 1.225 . . . . 0.0 112.191 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 121.5 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.68 143.91 46.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -133.36 134.53 43.87 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 126.414 1.886 . . . . 0.0 107.537 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.8 p -121.22 28.77 7.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 108.695 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.78 155.79 28.58 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.714 2.006 . . . . 0.0 110.036 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.19 -174.8 44.1 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 124.384 0.992 . . . . 0.0 115.263 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.35 -10.77 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.713 2.942 . . . . 0.0 112.735 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.81 -62.67 1.31 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.235 1.814 . . . . 0.0 106.86 173.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.41 -31.37 71.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.751 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.67 -48.86 62.88 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.566 1.075 . . . . 0.0 109.558 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.16 66.96 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.389 -0.819 . . . . 0.0 111.661 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.333 1.2 pp -93.2 -18.45 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 173.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.42 -28.48 13.0 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.093 1.757 . . . . 0.0 112.988 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -51.43 -25.86 7.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.005 0.922 . . . . 0.0 112.893 173.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -81.11 178.61 8.3 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.029 0.831 . . . . 0.0 109.56 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -139.04 20.79 2.63 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.01 -1.681 . . . . 0.0 110.741 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -131.95 8.55 4.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.267 1.427 . . . . 0.0 111.055 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.608 -0.682 . . . . 0.0 111.071 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -21.16 6.46 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.595 2.758 . . . . 0.0 111.663 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.786 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.2 161.86 10.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.213 1.805 . . . . 0.0 109.456 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.9 100.69 10.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.651 1.98 . . . . 0.0 105.686 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.12 98.95 6.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.1 131.77 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.01 1.724 . . . . 0.0 107.508 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.51 128.52 75.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.3 m -100.91 93.75 5.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.98 154.75 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.5 t -118.71 -49.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.4 m -151.22 141.01 21.86 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 120.249 1.386 . . . . 0.0 112.129 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.3 150.58 39.24 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.987 2.915 . . . . 0.0 109.413 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.8 148.9 44.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.626 1.97 . . . . 0.0 107.3 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -85.84 134.72 33.9 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.27 -78.8 0.54 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.244 0.807 0 CA-C-O 116.056 -1.926 . . . . 0.0 112.717 -173.797 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 118.509 -0.757 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.96 161.76 44.42 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.328 2.018 . . . . 0.0 113.047 -174.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.22 -42.55 98.71 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -54.42 -42.09 70.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.86 1.264 . . . . 0.0 111.092 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.561 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 32.4 t80 -51.36 -53.39 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.392 0.677 . . . . 0.0 111.691 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.18 -48.53 81.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.243 0.617 . . . . 0.0 110.992 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.75 -37.47 68.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.923 0.783 . . . . 0.0 111.833 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.12 -44.09 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.164 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 16.7 mt -57.48 -42.51 82.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.674 1.125 . . . . 0.0 112.32 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -51.65 -18.57 1.22 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -117.44 158.94 23.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.636 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.09 147.21 42.98 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -170.18 167.22 40.36 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 127.529 2.49 . . . . 0.0 109.012 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -83.42 150.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.95 159.87 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.256 2.222 . . . . 0.0 105.487 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.48 157.05 45.16 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.065 0.946 . . . . 0.0 109.724 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.69 108.39 4.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.95 108.41 19.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.464 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -96.38 109.41 21.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -74.27 141.09 45.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 121.38 1.9 . . . . 0.0 106.818 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.53 -81.91 0.23 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -166.16 -57.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.67 53.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.441 2.696 . . . . 0.0 109.113 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 141.42 2.31 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.008 1.766 . . . . 0.0 112.038 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 158.89 55.21 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -120.69 101.82 7.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -84.83 88.61 7.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.8 m -82.79 175.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.842 2.057 . . . . 0.0 109.982 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -118.84 166.69 12.5 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.083 0.856 . . . . 0.0 112.103 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -168.3 175.8 6.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.241 2.217 . . . . 0.0 107.611 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.43 141.52 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.995 1.718 . . . . 0.0 110.647 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -53.97 -30.88 48.85 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.124 0.874 . . . . 0.0 109.204 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.74 -13.93 7.31 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.149 2.979 . . . . 0.0 111.875 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -118.88 -4.75 10.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.777 1.631 . . . . 0.0 111.8 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.41 165.8 12.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.32 1.418 . . . . 0.0 113.034 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.0 138.56 42.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 10' ' ' LEU . 86.7 t -101.69 150.7 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -122.12 178.98 4.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.811 2.844 . . . . 0.0 107.102 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -76.02 -179.05 4.69 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.55 31.3 74.27 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.243 -1.535 . . . . 0.0 110.732 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 p30 54.08 12.99 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 130.095 3.358 . . . . 0.0 115.056 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -73.58 143.22 46.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.877 0.762 . . . . 0.0 109.627 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -129.3 163.28 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -142.86 140.88 27.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.93 127.74 26.35 Favored Pre-proline 0 N--CA 1.445 -0.707 0 C-N-CA 127.44 2.296 . . . . 0.0 104.829 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.01 108.3 2.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 107.798 -1.654 . . . . 0.0 107.798 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.65 111.63 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.58 -21.69 6.03 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.32 0.962 . . . . 0.0 112.67 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.65 41.59 0.33 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 118.099 -1.39 . . . . 0.0 110.0 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 48' ' ' VAL . 21.4 mtt -106.57 71.39 0.86 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 108.28 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -67.45 -65.78 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 129.99 3.316 . . . . 0.0 113.682 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -51.85 -40.89 61.31 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.863 1.21 . . . . 0.0 109.764 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -60.92 -39.08 88.03 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.787 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.5 -48.38 81.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.812 1.642 . . . . 0.0 110.86 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.82 99.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.407 0.283 . . . . 0.0 111.24 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -63.41 -41.64 98.74 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.444 -1.265 . . . . 0.0 110.446 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.86 -48.23 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 120.11 1.323 . . . . 0.0 108.963 174.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.83 -24.65 37.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.456 -0.777 . . . . 0.0 112.567 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -85.09 -42.5 14.75 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.581 1.696 . . . . 0.0 115.581 173.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -150.95 139.48 20.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.662 1.185 . . . . 0.0 109.115 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -75.17 -18.03 60.27 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 112.312 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 mmp_? -60.8 119.76 8.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 114.492 -173.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 89' ' ' ALA . 20.4 m -139.23 146.23 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 123.112 1.434 . . . . 0.0 112.588 173.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 3.7 tt -111.67 149.2 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.9 ttt -141.15 141.12 34.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -125.45 128.08 47.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.2 173.39 6.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.713 1.597 . . . . 0.0 107.923 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.01 -171.27 34.59 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.424 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 23.4 t -146.85 157.38 43.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.65 0.78 . . . . 0.0 109.351 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -98.54 -17.43 18.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.493 1.517 . . . . 0.0 108.847 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -91.98 -4.43 54.59 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 116.687 -1.625 . . . . 0.0 114.864 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.49 130.2 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 121.711 2.051 . . . . 0.0 105.775 -173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.04 131.41 36.26 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.092 0.957 . . . . 0.0 111.173 -173.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.48 -141.07 6.36 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -81.92 -58.96 2.75 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.363 1.465 . . . . 0.0 108.323 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.414 HD21 HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.87 102.96 11.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.468 0.651 . . . . 0.0 109.523 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.18 -169.11 2.89 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.198 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 60.2 Cg_endo -79.04 58.85 7.13 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.204 1.936 . . . . 0.0 110.692 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.73 120.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -114.66 169.45 9.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.187 0.994 . . . . 0.0 110.433 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.73 45.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.78 0.705 . . . . 0.0 113.64 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -132.99 152.76 51.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.016 1.326 . . . . 0.0 109.353 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.03 130.9 47.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.328 -2.842 . . . . 0.0 103.328 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.04 154.46 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -131.24 135.04 47.02 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.21 -169.11 28.39 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 118.765 0.711 . . . . 0.0 112.356 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 m -121.02 146.43 46.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.028 2.131 . . . . 0.0 108.287 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -111.24 163.71 13.65 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.566 1.075 . . . . 0.0 112.94 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.95 120.98 3.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.235 1.014 . . . . 0.0 110.331 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -75.86 141.06 42.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -140.74 135.88 31.99 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.035 1.334 . . . . 0.0 111.0 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.2 p -120.81 36.67 4.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.72 154.94 27.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.847 2.859 . . . . 0.0 111.165 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.39 47.41 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.484 1.516 . . . . 0.0 113.556 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.73 -11.78 32.22 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.193 2.595 . . . . 0.0 112.242 175.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.04 -60.27 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -31.43 71.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.318 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.85 -49.77 55.55 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.683 1.129 . . . . 0.0 109.611 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.05 76.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.309 -0.869 . . . . 0.0 111.489 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.2 pp -82.5 -18.36 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 119.061 0.846 . . . . 0.0 112.159 174.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.16 -28.07 4.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.514 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.58 -30.03 19.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.164 1.386 . . . . 0.0 112.256 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -80.67 178.32 8.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.39 -0.54 1.4 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 118.172 -2.83 . . . . 0.0 112.631 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -96.09 8.2 44.38 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.73 23.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.24 1.016 . . . . 0.0 109.402 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.6 ttp85 -121.13 -14.08 8.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.443 1.897 . . . . 0.0 111.717 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.809 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.56 161.61 11.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.041 1.736 . . . . 0.0 110.176 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.78 104.69 16.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.74 91.34 7.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.18 131.16 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.792 1.637 . . . . 0.0 106.673 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -121.71 135.61 61.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.0 m -114.12 101.36 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.01 160.57 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.335 1.454 . . . . 0.0 110.088 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.4 t -121.51 -59.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -142.9 140.49 31.21 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.85 145.65 41.93 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.853 2.861 . . . . 0.0 108.168 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -139.21 130.18 26.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.243 1.817 . . . . 0.0 106.684 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -74.04 139.59 44.8 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -129.65 -58.31 1.1 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.414 HD13 HD21 ' A' ' 77' ' ' ASN . 2.6 pp . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.926 0.89 . . . . 0.0 111.437 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.2 mt . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.77 158.63 32.18 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.504 2.136 . . . . 0.0 113.54 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -49.31 79.86 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -53.64 -41.26 66.56 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.235 1.014 . . . . 0.0 111.283 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.26 -60.4 3.15 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.62 0.768 . . . . 0.0 109.482 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -52.28 -48.23 65.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.386 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 27.7 mm-40 -54.88 -38.36 67.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.743 1.156 . . . . 0.0 112.66 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.87 -45.5 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.802 1.183 . . . . 0.0 109.135 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.09 -42.28 80.41 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.664 1.12 . . . . 0.0 112.073 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 8' ' ' GLU . 25.4 mtmm -51.65 -18.65 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -112.99 158.65 20.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.816 1.189 . . . . 0.0 109.874 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.12 148.83 41.44 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.975 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . 177.41 170.8 40.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 123.22 0.438 . . . . 0.0 112.058 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.72 149.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -132.15 163.51 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 127.556 2.342 . . . . 0.0 105.298 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.53 153.18 40.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.851 1.26 . . . . 0.0 109.15 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.38 109.79 5.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.45 109.22 20.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.134 1.773 . . . . 0.0 109.886 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 54' ' ' THR . 4.7 m -97.3 107.96 20.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 98.76 9.01 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.34 -59.89 0.18 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 120.824 1.647 . . . . 0.0 113.503 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -158.36 -60.79 0.08 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.008 1.404 . . . . 0.0 113.845 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -79.28 39.08 0.38 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.878 1.672 . . . . 0.0 111.777 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.94 151.47 12.36 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.76 148.06 93.9 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.751 2.275 . . . . 0.0 109.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -121.43 101.67 7.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -90.48 88.7 7.26 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.5 m -77.34 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 110.638 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.81 168.48 11.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.445 1.02 . . . . 0.0 113.003 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t -168.42 172.61 8.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.813 2.445 . . . . 0.0 108.183 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -120.91 141.75 50.35 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.887 2.075 . . . . 0.0 109.989 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -52.09 -30.53 26.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.685 0.675 . . . . 0.0 110.478 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -50.24 -21.31 1.31 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.663 2.385 . . . . 0.0 113.565 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.4 -6.71 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.379 1.071 . . . . 0.0 111.572 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -91.46 171.3 9.29 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.448 -1.408 . . . . 0.0 111.781 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.727 ' HE2' HD11 ' A' ' 39' ' ' LEU . 13.6 ptmt -134.08 119.93 19.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 172.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.55 131.44 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.727 HD11 ' HE2' ' A' ' 37' ' ' LYS . 2.7 mp -121.43 178.14 4.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -76.97 -178.0 4.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.9 29.61 75.31 Favored Glycine 0 C--O 1.223 -0.591 0 O-C-N 120.473 -1.392 . . . . 0.0 109.663 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 54.0 12.87 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 130.631 3.572 . . . . 0.0 115.483 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -79.37 128.84 33.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.205 1.366 . . . . 0.0 110.137 -174.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -124.34 155.43 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 t -145.24 142.46 22.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.78 132.8 24.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 126.993 2.117 . . . . 0.0 106.873 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.89 108.57 2.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.537 2.158 . . . . 0.0 108.666 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.53 111.76 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.45 -20.85 5.7 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.378 1.942 . . . . 0.0 112.281 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.18 40.99 0.45 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.047 1.423 . . . . 0.0 109.958 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.509 ' HB2' HG23 ' A' ' 48' ' ' VAL . 25.4 mtt -113.8 53.47 0.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.042 1.337 . . . . 0.0 108.515 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.46 91.2 m-70 -71.88 -48.18 47.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.91 -38.28 55.71 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.76 1.618 . . . . 0.0 108.933 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.412 HG23 ' OG1' ' A' ' 20' ' ' THR . 48.0 m -64.41 -38.8 92.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.404 1.481 . . . . 0.0 110.291 173.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.21 -47.68 74.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.799 1.636 . . . . 0.0 109.391 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.38 89.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.803 0.441 . . . . 0.0 110.803 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -57.07 -41.47 78.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.744 -1.122 . . . . 0.0 113.369 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.08 -48.28 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 120.249 1.386 . . . . 0.0 109.211 175.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.36 -26.16 39.42 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.041 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.21 -47.19 13.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 173.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -152.28 141.67 21.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.433 1.015 . . . . 0.0 108.773 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.358 -1.464 . . . . 0.0 113.718 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -51.94 115.6 1.76 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.667 1.987 . . . . 0.0 114.722 -172.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.54 143.43 32.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 123.669 1.7 . . . . 0.0 112.723 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 2.8 tt -111.35 148.48 32.9 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 101.364 -3.569 . . . . 0.0 101.364 172.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.36 129.09 20.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 p -111.29 128.25 55.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 pp -117.01 166.88 11.67 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.548 -1.345 . . . . 0.0 108.578 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.9 -174.83 37.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.452 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.2 t -146.57 157.56 43.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.634 1.174 . . . . 0.0 107.898 174.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -98.86 -8.45 25.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.591 1.156 . . . . 0.0 110.05 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.46 -7.13 51.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 116.942 -1.504 . . . . 0.0 113.962 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.23 136.03 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 121.083 1.765 . . . . 0.0 106.243 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.24 131.37 36.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.884 0.874 . . . . 0.0 111.086 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.44 -140.88 6.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.219 1.39 . . . . 0.0 110.516 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -84.48 -59.05 2.49 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 102.98 9.58 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.98 -168.79 1.96 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.584 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 70.5 Cg_endo -76.3 65.9 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.35 2.033 . . . . 0.0 110.37 174.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.97 121.1 1.05 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.54 169.53 9.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.371 1.086 . . . . 0.0 109.846 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.64 -177.76 45.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 121.418 0.454 . . . . 0.0 113.381 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.58 147.01 52.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.416 1.086 . . . . 0.0 110.39 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -100.88 129.66 46.78 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 mt -141.2 157.05 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -132.75 149.12 52.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.172 1.789 . . . . 0.0 109.753 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -174.14 37.95 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.505 1.526 . . . . 0.0 110.548 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -114.14 143.15 45.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.118 1.767 . . . . 0.0 106.828 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.81 163.36 13.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.188 1.395 . . . . 0.0 111.962 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 121.11 3.33 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.882 0.873 . . . . 0.0 109.764 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.03 138.13 43.87 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 141.48 35.0 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.121 0.968 . . . . 0.0 109.863 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -116.07 35.17 4.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.33 154.66 25.49 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 128.112 2.565 . . . . 0.0 110.742 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 178.67 46.76 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.642 2.067 . . . . 0.0 113.893 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.13 -17.92 55.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.028 3.152 . . . . 0.0 112.538 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -65.61 0.65 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.243 1.817 . . . . 0.0 107.617 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.18 -31.2 70.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.192 0.997 . . . . 0.0 111.391 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.6 -57.76 5.27 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.757 0.708 . . . . 0.0 109.138 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.456 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.65 -25.42 67.37 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.916 -1.115 . . . . 0.0 113.058 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.346 1.3 pp -87.43 -18.11 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.733 1.151 . . . . 0.0 111.919 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.48 -27.93 3.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.408 1.483 . . . . 0.0 111.685 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -49.05 -21.47 0.71 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.641 1.176 . . . . 0.0 113.949 173.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.54 178.75 8.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.669 1.122 . . . . 0.0 110.611 175.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -130.29 11.61 5.44 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.099 -1.625 . . . . 0.0 111.234 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -132.26 9.0 4.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.226 1.41 . . . . 0.0 111.202 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.94 145.21 34.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.619 -0.676 . . . . 0.0 109.874 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -21.05 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 127.951 2.5 . . . . 0.0 110.621 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.764 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.12 161.96 10.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.391 1.876 . . . . 0.0 109.137 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.59 107.9 18.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tp -78.89 93.92 5.12 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.2 t -78.98 130.88 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.37 129.49 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -112.14 99.03 7.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 t -60.99 161.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.069 2.147 . . . . 0.0 110.15 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.98 -51.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -150.93 141.04 22.15 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.154 -0.966 . . . . 0.0 111.246 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.91 146.34 43.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.693 3.197 . . . . 0.0 108.765 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -138.82 142.65 38.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.521 1.928 . . . . 0.0 107.599 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -81.16 133.51 35.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -135.21 -68.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.24 0.561 0 CA-C-O 117.358 -1.306 . . . . 0.0 110.221 178.092 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 2' ' ' LEU . 5.2 mp . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 118.677 -0.678 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.88 158.7 56.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.735 2.29 . . . . 0.0 111.442 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.99 -40.86 95.99 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -53.16 -38.96 63.22 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.6 1.56 . . . . 0.0 111.263 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -50.99 -56.26 13.33 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.653 1.115 . . . . 0.0 111.088 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -61.77 -48.96 78.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -61.01 -33.58 73.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.51 -41.85 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.392 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.12 -38.63 83.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.236 1.38 . . . . 0.0 111.811 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.74 -19.11 1.47 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.298 1.408 . . . . 0.0 114.345 172.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -106.4 158.93 16.53 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 119.717 1.144 . . . . 0.0 107.966 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.86 148.63 42.16 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 121.328 -0.858 . . . . 0.0 109.346 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.23 177.13 47.84 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 124.8 1.191 . . . . 0.0 112.534 -174.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.9 t -100.75 145.82 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -129.82 163.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 106.059 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.44 159.9 42.79 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.305 1.442 . . . . 0.0 110.001 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.44 HD11 HG21 ' A' ' 46' ' ' VAL . 88.3 mt -140.34 117.32 9.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -89.08 108.35 19.54 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 173.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.627 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -94.03 110.57 22.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 115.546 -2.169 . . . . 0.0 106.806 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -73.8 141.71 46.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.271 2.305 . . . . 0.0 107.721 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.7 -81.35 0.23 Allowed Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.45 -61.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -79.73 44.49 0.64 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.24 2.216 . . . . 0.0 109.968 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 151.49 5.95 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.263 1.887 . . . . 0.0 113.719 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.19 153.93 56.85 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 121.357 1.371 . . . . 0.0 111.414 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -121.37 101.97 7.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.542 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -86.13 88.73 7.65 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.04 169.14 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.082 1.753 . . . . 0.0 110.625 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -121.54 167.62 12.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.528 1.131 . . . . 0.0 112.29 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 170.32 9.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.983 2.113 . . . . 0.0 108.364 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -116.48 141.67 47.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.745 1.618 . . . . 0.0 111.265 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -56.18 -31.77 63.72 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.997 0.919 . . . . 0.0 110.834 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -60.57 -8.39 2.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.387 1.475 . . . . 0.0 113.613 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -117.92 -7.24 10.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.095 1.316 . . . . 0.0 109.099 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mt -98.24 162.19 13.32 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.151 -1.593 . . . . 0.0 112.29 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.52 41.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.409 -1.432 . . . . 0.0 108.916 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.9 t -101.8 144.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.91 179.06 4.48 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.324 1.85 . . . . 0.0 107.126 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.53 177.27 3.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.254 0.549 . . . . 0.0 110.429 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.47 28.45 59.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 p30 53.64 13.72 0.53 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 128.559 2.743 . . . . 0.0 114.848 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -73.21 109.33 6.65 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.487 1.04 . . . . 0.0 110.328 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.07 161.15 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.97 134.83 21.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 18' ' ' ILE . 60.6 t -121.04 135.39 24.81 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 127.127 2.171 . . . . 0.0 107.277 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.94 108.88 2.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.53 2.153 . . . . 0.0 110.458 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.742 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.4 111.91 21.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.13 -21.34 7.42 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.979 1.752 . . . . 0.0 112.676 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.41 41.31 0.28 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.188 1.494 . . . . 0.0 109.945 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.471 ' HB2' HG23 ' A' ' 48' ' ' VAL . 14.3 mtt -109.32 66.98 0.64 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.156 0.982 . . . . 0.0 109.77 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.322 41.3 m-70 -71.47 -48.64 47.91 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -51.7 -40.95 61.06 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.799 2.09 . . . . 0.0 109.418 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.1 m -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 127.002 2.121 . . . . 0.0 110.495 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.28 -50.82 70.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 121.027 1.74 . . . . 0.0 110.611 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.33 94.13 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.237 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -66.3 -42.02 88.94 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.679 -1.629 . . . . 0.0 109.845 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.93 -48.19 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 120.177 1.353 . . . . 0.0 109.032 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.97 57.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.487 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -87.06 -46.02 10.19 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.926 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -145.15 132.31 20.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.275 1.036 . . . . 0.0 112.169 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.1 -21.59 56.51 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.454 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.46 122.13 14.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.499 1.045 . . . . 0.0 111.353 -173.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.2 m -138.85 155.94 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 123.379 1.561 . . . . 0.0 111.503 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tt -111.13 149.95 30.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.8 ttt -138.95 140.87 38.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 p -123.72 128.6 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -116.93 167.78 10.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.218 1.827 . . . . 0.0 107.172 172.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.13 -175.0 38.12 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.434 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 44.5 t -148.14 157.38 43.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -99.28 -8.72 24.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.312 0.505 . . . . 0.0 109.923 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -90.71 3.11 55.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.087 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.0 t -130.92 133.61 62.79 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.05 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 173.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 130.32 35.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.879 0.763 . . . . 0.0 110.217 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.62 5.95 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.975 1.75 . . . . 0.0 109.318 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -88.51 -58.3 2.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.15 102.68 5.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.184 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.95 -168.26 0.16 Allowed Glycine 0 CA--C 1.539 1.573 0 O-C-N 120.794 -1.191 . . . . 0.0 111.087 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.53 91.07 0.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 N-CA-C 106.501 -2.153 . . . . 0.0 106.501 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.4 0.71 Allowed Glycine 0 N--CA 1.442 -0.947 0 CA-C-O 117.723 -1.598 . . . . 0.0 109.827 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -109.31 168.97 9.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.341 1.071 . . . . 0.0 109.715 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.4 -176.97 44.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 121.062 0.257 . . . . 0.0 112.896 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -131.42 151.94 51.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.422 1.089 . . . . 0.0 109.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.86 131.25 46.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.422 ' CG2' HG13 ' A' ' 115' ' ' VAL . 6.0 mt -139.08 156.57 27.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -132.2 150.23 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.997 1.319 . . . . 0.0 108.088 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.61 -172.13 40.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -106.28 131.93 52.93 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.26 1.024 . . . . 0.0 108.432 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -89.0 163.51 15.5 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.67 120.88 3.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.873 0.869 . . . . 0.0 110.045 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -74.26 130.61 40.04 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 173.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -132.16 130.7 41.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.5 p -120.85 33.47 5.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.17 1.388 . . . . 0.0 107.677 173.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -158.82 161.96 36.96 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 128.635 2.774 . . . . 0.0 109.276 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.4 -179.95 46.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 125.19 1.376 . . . . 0.0 115.104 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.94 -19.15 64.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.536 2.157 . . . . 0.0 110.773 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.86 -63.02 1.18 Allowed 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.817 0.847 . . . . 0.0 109.338 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -61.39 -31.17 71.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.346 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.26 -48.78 64.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.721 1.146 . . . . 0.0 110.481 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -30.69 69.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.782 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.29 -19.31 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.74 85.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.809 1.64 . . . . 0.0 112.188 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.551 0.0 OUTLIER -51.54 -18.36 1.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 173.221 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.34 179.54 0.97 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.87 1.214 . . . . 0.0 108.242 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -128.55 12.39 6.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 119.601 -1.937 . . . . 0.0 112.14 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -135.91 10.47 3.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.882 1.273 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.92 145.33 34.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 0.0 110.985 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.23 -21.38 6.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.002 2.521 . . . . 0.0 111.902 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.742 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -176.4 161.85 2.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.611 1.964 . . . . 0.0 109.431 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.61 110.66 23.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 tt -85.98 95.11 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.306 -2.849 . . . . 0.0 103.306 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.55 131.01 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.174 1.39 . . . . 0.0 107.806 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 64' ' ' VAL . 42.6 mm -114.14 137.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.4 m -113.96 93.22 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.422 HG13 ' CG2' ' A' ' 85' ' ' ILE . 60.8 t -61.45 160.32 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.29 1.436 . . . . 0.0 111.072 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.97 -57.26 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -140.9 127.22 19.79 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.131 0.423 . . . . 0.0 111.944 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.08 139.34 51.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.75 3.22 . . . . 0.0 110.637 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -142.24 139.55 32.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.482 1.513 . . . . 0.0 110.668 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -72.87 135.26 45.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -174.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -143.21 -58.6 0.42 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.253 1.261 0 CA-C-O 115.753 -2.07 . . . . 0.0 113.929 -173.481 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.642 HD21 HG11 ' A' ' 115' ' ' VAL . 3.6 mm? . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.15 162.25 42.25 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.539 2.159 . . . . 0.0 110.683 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.21 -38.85 93.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -50.73 -40.43 54.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.125 1.77 . . . . 0.0 112.016 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.3 -56.41 13.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.8 1.182 . . . . 0.0 109.989 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -59.14 -48.45 81.55 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 110.201 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.83 -40.28 75.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.764 0.711 . . . . 0.0 112.624 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.9 -40.78 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.861 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -45.68 85.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.377 1.444 . . . . 0.0 111.501 173.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -51.91 -20.62 2.4 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -105.95 161.66 14.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.407 1.083 . . . . 0.0 110.156 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.55 139.57 45.72 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.45 174.46 47.0 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.8 143.2 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -174.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.3 164.76 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -151.83 158.95 43.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.759 1.224 . . . . 0.0 109.162 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 46' ' ' VAL . 89.5 mt -142.63 119.94 6.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 124.768 1.227 . . . . 0.0 107.947 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -94.05 108.42 20.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.568 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.8 m -89.95 121.3 31.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 116.194 -1.86 . . . . 0.0 106.386 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -73.47 137.23 44.38 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 122.062 2.21 . . . . 0.0 108.689 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.08 -81.21 0.22 Allowed Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -158.84 -61.51 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -79.35 39.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.203 3.001 . . . . 0.0 111.511 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 151.13 13.36 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.64 150.02 56.13 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 CA-C-N 118.177 0.989 . . . . 0.0 111.208 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -99.51 101.59 12.88 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 6.5 tt -84.86 88.97 7.45 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -173.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.99 168.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.37 1.468 . . . . 0.0 110.254 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.34 167.7 12.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.411 1.084 . . . . 0.0 112.216 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.44 172.11 8.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.86 2.064 . . . . 0.0 108.195 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -120.86 141.65 50.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.894 1.678 . . . . 0.0 110.385 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -51.11 -31.26 18.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.095 0.958 . . . . 0.0 111.905 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -57.74 -14.51 5.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.205 1.802 . . . . 0.0 112.733 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.21 -3.55 11.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.711 1.204 . . . . 0.0 110.214 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.489 HD22 HG22 ' A' ' 46' ' ' VAL . 20.4 mt -95.21 163.52 13.24 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.51 -1.369 . . . . 0.0 112.759 -173.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.63 140.72 43.0 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 172.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -101.55 151.78 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 109.58 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.42 HD11 ' CD ' ' A' ' 97' ' ' GLU . 25.0 mt -121.55 178.33 4.86 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.553 1.941 . . . . 0.0 109.436 173.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -76.21 177.1 7.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.31 1.444 . . . . 0.0 107.903 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.25 29.34 59.92 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 120.598 -1.313 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.321 0.0 OUTLIER 53.44 15.35 0.69 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 130.233 3.413 . . . . 0.0 115.091 -175.744 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -73.86 145.57 44.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -127.98 168.66 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.7 t -146.38 142.74 21.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.013 -1.055 . . . . 0.0 108.883 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 36' ' ' LEU . 61.2 t -126.34 135.49 27.25 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.842 2.057 . . . . 0.0 107.769 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.82 108.53 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.743 2.296 . . . . 0.0 109.448 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.61 111.39 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.24 -21.36 6.63 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.759 1.647 . . . . 0.0 112.241 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.23 41.4 0.31 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 117.746 -1.586 . . . . 0.0 109.552 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.513 ' HB2' HG23 ' A' ' 48' ' ' VAL . 20.2 mtt -109.74 57.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.014 1.326 . . . . 0.0 107.909 173.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -71.58 -48.82 45.79 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.056 1.342 . . . . 0.0 113.42 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.98 -41.4 62.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.721 1.6 . . . . 0.0 108.87 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.9 m -59.98 -40.47 89.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.76 1.624 . . . . 0.0 110.369 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.92 -49.02 78.17 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.152 1.796 . . . . 0.0 110.988 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.66 98.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.819 0.343 . . . . 0.0 111.311 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -63.19 -41.59 99.2 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.009 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -61.55 -48.24 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.452 1.478 . . . . 0.0 109.286 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.28 59.28 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.634 -0.667 . . . . 0.0 112.423 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.7 mmm-85 -78.46 -46.46 19.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -151.26 129.53 11.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.781 1.233 . . . . 0.0 109.764 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.25 -23.23 62.87 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.492 -0.755 . . . . 0.0 112.487 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -61.28 124.09 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.947 0.899 . . . . 0.0 112.027 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 20' ' ' THR . 6.9 m -138.88 155.37 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 123.76 1.743 . . . . 0.0 110.253 173.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 4.5 tt -107.49 150.36 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 173.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.4 ttt -139.29 141.93 37.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 4.6 p -125.2 128.52 48.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 116.159 -1.877 . . . . 0.0 106.046 173.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.494 HD12 HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -116.42 160.22 20.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 122.087 2.222 . . . . 0.0 106.345 173.041 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.13 -172.22 45.15 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -150.07 168.37 24.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 80' ' ' GLY . 21.4 mmm180 -98.92 -8.8 25.01 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 109.844 173.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -79.33 -6.19 56.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.448 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.43 140.3 49.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.0 121.06 24.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.37 -130.11 3.88 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 125.158 1.361 . . . . 0.0 110.107 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.34 -63.64 1.23 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.302 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -84.03 102.63 12.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.863 -174.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.96 -168.45 0.93 Allowed Glycine 0 CA--C 1.542 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 112.194 -174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.03 91.43 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 108.997 173.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 71' ' ' ARG . . . 178.81 122.02 0.74 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 117.336 -1.813 . . . . 0.0 110.445 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 t -123.72 171.68 9.42 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.815 1.307 . . . . 0.0 110.026 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.23 -157.58 28.35 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.783 1.183 . . . . 0.0 112.579 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -148.42 154.87 40.49 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.931 1.293 . . . . 0.0 109.811 -174.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.41 131.21 47.62 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 128.916 2.886 . . . . 0.0 104.56 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.494 HD11 HD12 ' A' ' 68' ' ' LEU . 2.9 mp -138.63 163.6 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.802 1.241 . . . . 0.0 108.579 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -134.37 151.09 51.0 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.204 1.402 . . . . 0.0 109.123 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -175.6 40.07 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.175 0.893 . . . . 0.0 111.715 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 m -113.93 128.8 56.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.41 1.084 . . . . 0.0 109.888 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.66 17.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.319 1.447 . . . . 0.0 111.465 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.04 120.44 2.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.02 1.328 . . . . 0.0 109.481 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -77.13 142.69 39.61 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.568 -0.707 . . . . 0.0 109.634 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 140.92 34.24 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.354 1.061 . . . . 0.0 109.714 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 p -121.25 35.94 4.75 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.457 1.903 . . . . 0.0 106.221 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -159.35 157.54 30.58 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.502 2.321 . . . . 0.0 110.091 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.71 178.25 46.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.951 2.691 . . . . 0.0 113.089 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 -8.95 22.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.187 2.591 . . . . 0.0 112.634 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.42 ' CD ' HD11 ' A' ' 39' ' ' LEU . 7.6 mm-40 -65.98 -56.34 12.16 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -61.4 -31.89 71.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.781 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.59 -48.61 38.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.539 0.685 . . . . 0.0 110.043 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -58.9 -27.45 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.061 -1.024 . . . . 0.0 111.712 177.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.323 1.7 pp -93.26 -18.39 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.963 173.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.33 -28.4 4.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.585 1.954 . . . . 0.0 112.656 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -50.99 -22.88 2.52 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.768 1.227 . . . . 0.0 113.293 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -80.71 178.64 8.23 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.619 1.099 . . . . 0.0 110.312 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -128.51 3.83 5.6 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.149 -1.595 . . . . 0.0 111.23 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -135.68 8.28 3.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 111.54 -174.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.55 142.4 34.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.034 0.834 . . . . 0.0 109.112 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.61 -10.76 8.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.044 1.337 . . . . 0.0 111.829 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.9 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.49 161.91 9.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.187 2.595 . . . . 0.0 108.332 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.76 107.07 16.94 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.114 2.166 . . . . 0.0 106.588 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.1 tp -82.12 98.56 8.74 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.426 1.891 . . . . 0.0 107.594 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -83.96 127.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.699 1.6 . . . . 0.0 107.373 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.74 129.06 72.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 119.367 0.985 . . . . 0.0 108.488 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 m -99.11 87.91 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.642 HG11 HD21 ' A' ' 2' ' ' LEU . 71.1 t -60.66 153.57 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.991 0.916 . . . . 0.0 109.967 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.7 -59.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -149.58 141.22 23.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.528 0.604 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.58 159.52 25.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 127.953 2.501 . . . . 0.0 112.448 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -140.87 145.25 35.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.259 2.224 . . . . 0.0 108.458 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -76.19 134.78 39.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.4 p -133.69 -58.79 0.87 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.47 0.577 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.463 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.712 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.52 163.61 38.43 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.903 2.402 . . . . 0.0 112.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.4 97.59 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 173.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.305 2.9 m -51.82 -38.11 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.966 2.107 . . . . 0.0 112.822 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -50.85 -49.11 59.67 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.519 1.054 . . . . 0.0 110.202 173.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -63.27 -48.19 79.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.775 1.23 . . . . 0.0 111.352 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.47 -41.48 63.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.562 0.619 . . . . 0.0 111.067 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.43 -45.55 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.119 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.5 mt -52.5 -28.37 20.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.576 1.08 . . . . 0.0 112.754 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -51.72 -18.51 1.24 Allowed 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.904 -1.747 . . . . 0.0 112.646 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -114.84 160.38 19.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.38 1.872 . . . . 0.0 109.719 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -74.36 156.54 36.96 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 166.3 35.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.476 -0.868 . . . . 0.0 113.64 -173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -81.97 141.36 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 31' ' ' THR . 12.7 t -133.92 160.55 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.94 155.9 40.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.714 1.205 . . . . 0.0 108.467 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.95 119.97 15.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.87 108.73 19.69 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.511 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -90.76 113.24 25.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -73.72 141.55 46.36 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.045 2.202 . . . . 0.0 108.037 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 -81.21 0.32 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -162.54 -48.97 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.671 0.788 . . . . 0.0 108.938 173.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.68 39.24 0.34 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.389 2.276 . . . . 0.0 110.657 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.27 151.16 6.03 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.911 1.719 . . . . 0.0 111.303 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.31 161.02 45.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.017 1.145 . . . . 0.0 111.411 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -112.77 101.75 9.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.242 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 tp -74.04 88.69 1.91 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -74.13 168.73 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.408 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.1 165.1 14.57 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.616 1.166 . . . . 0.0 111.669 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 16' ' ' VAL . 15.4 t -168.69 175.7 5.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.952 2.101 . . . . 0.0 108.068 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.41 142.0 49.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.492 2.317 . . . . 0.0 109.852 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -51.94 -30.3 24.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.301 -0.856 . . . . 0.0 110.402 174.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -50.47 -20.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.052 2.941 . . . . 0.0 113.295 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.5 m-30 -118.12 -12.75 9.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.775 -1.203 . . . . 0.0 110.539 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.14 158.35 15.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 120.583 -1.323 . . . . 0.0 112.872 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.9 140.96 42.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 120.892 -1.13 . . . . 0.0 109.501 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -100.86 144.09 13.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.519 -2.401 . . . . 0.0 104.519 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.4 mt -121.19 -179.09 3.94 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.84 2.056 . . . . 0.0 107.806 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.52 169.83 4.5 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.246 0.618 . . . . 0.0 111.382 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.89 28.41 52.86 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.911 1.719 . . . . 0.0 111.354 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.318 0.2 OUTLIER 53.37 27.54 6.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.06 1.744 . . . . 0.0 113.11 -175.563 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -73.41 150.97 41.34 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.76 158.01 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -141.35 135.8 31.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.08 130.73 24.68 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 128.743 2.817 . . . . 0.0 106.526 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.6 108.74 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.569 2.179 . . . . 0.0 110.023 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.725 ' CG1' ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.56 111.84 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.5 -21.6 5.06 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.519 1.056 . . . . 0.0 112.422 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.02 41.26 0.34 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 119.285 1.543 . . . . 0.0 109.266 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 48' ' ' VAL . 21.4 mtt -109.78 70.62 0.73 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.582 1.153 . . . . 0.0 108.125 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -71.44 -55.96 6.89 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.985 2.114 . . . . 0.0 114.876 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -51.92 -41.35 61.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 121.341 1.882 . . . . 0.0 108.469 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -63.17 -38.77 92.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.248 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -56.79 -50.64 71.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.076 1.307 . . . . 0.0 110.134 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.44 98.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.899 0.48 . . . . 0.0 111.547 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -64.01 -41.61 97.4 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.689 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.22 -48.05 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 120.051 1.296 . . . . 0.0 108.27 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.02 -22.12 25.39 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -86.92 -44.38 11.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -150.95 140.81 21.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.31 1.444 . . . . 0.0 109.13 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 -18.05 59.7 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.028 -1.045 . . . . 0.0 112.221 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -59.32 117.47 4.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.353 1.061 . . . . 0.0 113.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.1 m -138.93 153.39 24.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 124.055 1.883 . . . . 0.0 112.549 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.6 tp -111.01 151.16 28.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 ttt -139.24 134.29 32.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.5 p -126.58 127.87 45.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -117.11 164.21 15.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.651 1.114 . . . . 0.0 108.966 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.08 178.26 42.99 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -150.7 -178.41 6.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -113.24 -9.34 13.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.116 0.966 . . . . 0.0 110.504 173.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -86.1 -4.49 59.18 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.96 138.71 52.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.6 35.61 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.594 0.634 . . . . 0.0 109.827 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.51 -132.24 4.12 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 124.573 1.082 . . . . 0.0 111.953 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -91.43 -58.84 2.31 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.56 102.57 7.99 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.83 -167.98 0.16 Allowed Glycine 0 CA--C 1.542 1.719 0 O-C-N 120.53 -1.356 . . . . 0.0 111.798 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.55 90.65 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.619 -2.108 . . . . 0.0 106.619 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.58 121.64 0.71 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.78 169.89 9.23 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 119.396 1.598 . . . . 0.0 109.544 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.29 179.48 43.85 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 123.798 0.713 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -132.53 149.32 52.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.265 1.026 . . . . 0.0 109.75 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -97.24 130.11 44.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.46 152.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -130.48 140.81 50.51 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.205 1.402 . . . . 0.0 107.247 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.3 -176.48 42.72 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.141 0.882 . . . . 0.0 112.799 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 m -103.98 143.67 32.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.91 164.4 12.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 120.058 1.299 . . . . 0.0 111.214 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.15 121.25 2.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.15 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.84 143.27 45.97 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 141.76 38.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.993 1.317 . . . . 0.0 111.51 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 p -114.76 25.87 10.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.826 2.05 . . . . 0.0 106.863 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.59 165.08 35.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.705 2.402 . . . . 0.0 109.725 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.15 178.61 45.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 127.165 2.316 . . . . 0.0 113.173 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.55 -24.11 77.56 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.672 2.248 . . . . 0.0 111.154 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -62.3 -56.54 17.43 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.531 1.132 . . . . 0.0 109.017 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' A' ' 101' ' ' ILE . 37.3 t80 -61.34 -31.37 71.24 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.72 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -68.02 -48.17 66.44 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 121.608 2.004 . . . . 0.0 110.622 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.78 41.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.419 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' A' ' 98' ' ' PHE . 1.2 pp -93.67 -20.7 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.15 92.94 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 121.351 1.887 . . . . 0.0 112.453 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.505 0.0 OUTLIER -51.96 -21.92 3.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.1 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -73.05 178.97 4.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -133.92 7.88 3.77 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 118.393 -2.692 . . . . 0.0 114.388 -176.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -121.53 8.57 10.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.742 0.701 . . . . 0.0 111.796 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.42 150.78 24.47 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -115.52 -19.17 10.74 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.686 1.994 . . . . 0.0 110.397 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . . . -168.2 161.49 12.35 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.581 1.182 . . . . 0.0 109.383 -173.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.52 106.9 18.96 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -83.39 95.09 8.12 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.9 t -81.95 131.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.389 1.876 . . . . 0.0 106.567 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.32 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.2 m -104.12 91.98 4.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.84 157.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.305 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.04 -53.26 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.3 m -151.34 141.58 22.31 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.505 1.048 . . . . 0.0 113.235 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.01 144.7 39.71 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 128.451 2.7 . . . . 0.0 108.836 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -139.05 136.46 35.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.945 2.098 . . . . 0.0 106.944 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.92 139.16 38.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 p -141.21 -59.1 0.49 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.252 1.186 0 CA-C-O 115.444 -2.217 . . . . 0.0 114.019 -173.334 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.515 ' C ' HD22 ' A' ' 2' ' ' LEU . 2.0 mpt? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.2 mm? -137.59 153.39 74.21 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.665 1.186 . . . . 0.0 109.238 -172.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.87 159.9 47.22 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.545 2.163 . . . . 0.0 109.788 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.21 94.04 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -51.4 -39.01 56.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.941 1.696 . . . . 0.0 111.438 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.28 -57.84 7.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.593 1.088 . . . . 0.0 110.388 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -54.78 -48.43 72.7 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.522 1.129 . . . . 0.0 109.902 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.82 -35.96 73.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.5 t -69.4 -44.07 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.618 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -41.67 77.12 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.068 1.304 . . . . 0.0 112.433 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -51.77 -24.67 6.25 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.86 168.48 9.4 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 122.42 1.105 . . . . 0.0 111.669 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.5 138.69 45.23 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -178.83 172.36 44.61 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.04 150.93 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.1 t -128.97 163.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 127.585 2.354 . . . . 0.0 104.926 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.19 156.09 46.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.543 1.137 . . . . 0.0 108.315 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -138.54 110.88 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.87 108.51 19.57 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.496 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -93.89 108.79 20.54 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -74.4 137.24 42.56 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 121.034 1.743 . . . . 0.0 106.441 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.72 -81.94 0.22 Allowed Glycine 0 C--O 1.222 -0.607 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -164.16 -61.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.98 55.95 3.76 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.128 1.918 . . . . 0.0 109.49 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.59 140.69 4.92 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 127.238 2.351 . . . . 0.0 112.144 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.9 151.66 77.91 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 118.248 1.024 . . . . 0.0 109.619 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -121.12 101.82 7.91 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -87.43 88.55 7.71 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.33 173.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.006 2.123 . . . . 0.0 110.521 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -119.21 167.69 11.59 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.778 1.172 . . . . 0.0 113.128 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.7 t -168.34 173.16 7.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.1 2.16 . . . . 0.0 108.758 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.519 ' HE1' HM73 ' A' ' 123' ' ' FMN . 79.8 m95 -120.77 141.59 50.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.448 2.299 . . . . 0.0 109.984 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.56 -31.23 63.99 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.224 0.92 . . . . 0.0 111.013 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -60.09 -9.08 2.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.7 1.6 . . . . 0.0 113.612 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -118.1 -10.74 10.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.031 1.332 . . . . 0.0 109.361 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.7 mt -92.33 164.62 13.44 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.745 -1.222 . . . . 0.0 111.232 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD2' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.78 141.27 42.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.3 t -101.68 150.05 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.3 mt -122.14 178.86 4.74 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.37 2.668 . . . . 0.0 107.64 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -73.1 174.83 7.37 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.98 28.29 32.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.591 1.567 . . . . 0.0 110.942 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.657 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.301 0.1 OUTLIER 53.49 21.99 2.72 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.0 2.12 . . . . 0.0 114.69 -176.605 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -73.36 139.61 46.09 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -123.69 167.49 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 t -147.62 145.97 18.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 O-C-N 120.484 -1.385 . . . . 0.0 108.582 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.4 131.79 24.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.289 2.636 . . . . 0.0 105.959 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.91 108.75 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.485 2.123 . . . . 0.0 108.84 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.761 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.42 111.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.4 -21.08 5.63 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.852 1.691 . . . . 0.0 112.966 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.07 41.55 0.29 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 48' ' ' VAL . 22.7 mtt -107.88 71.41 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.553 1.541 . . . . 0.0 107.862 174.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -66.29 -64.91 0.75 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 130.348 3.459 . . . . 0.0 113.732 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -51.69 -41.11 61.21 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.982 -1.074 . . . . 0.0 109.15 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -61.5 -38.94 89.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.69 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.78 -50.18 74.91 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 121.126 1.785 . . . . 0.0 110.532 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.31 -39.31 90.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 111.498 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -68.08 -41.96 81.09 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 116.279 -1.82 . . . . 0.0 110.471 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.15 -48.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.101 1.319 . . . . 0.0 108.966 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.19 51.06 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.295 -0.86 . . . . 0.0 112.694 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.86 -45.93 10.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.36 0.982 . . . . 0.0 113.081 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -141.59 133.14 26.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.931 0.893 . . . . 0.0 110.777 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -16.15 62.21 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.948 -1.095 . . . . 0.0 112.902 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -59.76 117.12 4.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.6 m -138.9 147.1 25.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 123.679 1.704 . . . . 0.0 112.444 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.25 148.9 31.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 11.7 ttt -139.38 126.62 21.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.3 p -108.74 127.96 54.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.79 164.92 13.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.994 1.725 . . . . 0.0 108.696 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.1 -175.77 38.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 46.9 t -146.99 161.92 39.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.024 1.329 . . . . 0.0 108.841 174.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -98.73 -8.1 26.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.854 1.662 . . . . 0.0 109.922 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -8.51 48.73 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.839 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.88 133.95 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.13 131.38 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.5 1.12 . . . . 0.0 111.419 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -140.92 6.14 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.89 -59.43 2.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.746 2.019 . . . . 0.0 108.324 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.27 102.94 8.87 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.2 -168.63 1.58 Allowed Glycine 0 CA--C 1.537 1.463 0 O-C-N 121.997 -0.439 . . . . 0.0 112.289 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -75.65 64.18 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.574 2.182 . . . . 0.0 109.954 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.11 121.13 1.1 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -118.16 169.61 9.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.008 0.904 . . . . 0.0 110.155 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.61 -171.84 43.56 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 124.271 0.939 . . . . 0.0 112.406 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -145.35 156.04 43.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 109.791 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 tt -101.38 131.36 47.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.33 162.07 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -133.32 150.75 51.85 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.399 1.479 . . . . 0.0 108.923 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.97 179.6 43.52 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.216 0.912 . . . . 0.0 111.745 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -101.21 128.98 47.08 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.02 161.78 14.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.609 1.095 . . . . 0.0 111.692 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 121.28 3.11 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.41 1.484 . . . . 0.0 109.351 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.91 137.54 43.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.613 HH11 ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -138.34 141.22 39.73 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.532 1.533 . . . . 0.0 109.334 176.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.26 37.39 4.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -159.2 159.12 33.91 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 129.072 2.949 . . . . 0.0 110.613 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.44 178.56 46.84 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 126.432 1.967 . . . . 0.0 115.694 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.57 -18.26 53.47 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.891 3.06 . . . . 0.0 111.724 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.83 -64.09 0.94 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.16 -31.27 71.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.633 0.773 . . . . 0.0 111.556 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -68.58 -60.3 2.51 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.75 -19.34 62.35 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.847 -1.158 . . . . 0.0 113.517 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.8 pp -92.6 -18.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.112 1.324 . . . . 0.0 110.854 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.58 -27.97 3.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.782 1.633 . . . . 0.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -50.67 -23.22 2.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.441 1.096 . . . . 0.0 113.567 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -80.3 178.73 8.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.733 1.151 . . . . 0.0 109.604 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 tttt -137.27 20.35 2.96 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.91 -1.744 . . . . 0.0 111.331 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -136.15 8.67 3.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.902 1.281 . . . . 0.0 111.137 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.93 131.1 35.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.529 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -20.9 16.53 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 109.669 173.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.761 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.85 161.76 11.08 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.377 1.871 . . . . 0.0 109.769 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 103.5 13.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.18 95.38 5.6 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.12 131.66 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.951 1.7 . . . . 0.0 106.961 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.2 mt -117.93 128.47 75.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -99.01 85.9 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 2' ' ' LEU . 31.4 t -60.78 151.7 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.494 1.118 . . . . 0.0 109.461 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.5 -54.99 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m -148.34 141.22 24.74 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.258 . . -120.59 158.15 27.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 130.698 3.599 . . . . 0.0 114.732 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -145.93 135.77 23.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.218 2.207 . . . . 0.0 107.221 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.84 138.57 42.6 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -134.83 -81.04 0.44 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.518 0.327 . . . . 0.0 110.48 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 121.38 0.609 . . . . 0.0 109.938 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.519 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mmt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.556 HD11 HG11 ' A' ' 115' ' ' VAL . 80.2 mt -139.09 155.39 72.71 Favored Pre-proline 0 N--CA 1.465 0.275 0 C-N-CA 124.109 0.963 . . . . 0.0 109.411 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 157.16 57.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.502 2.134 . . . . 0.0 110.956 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -38.84 93.63 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -49.16 -38.94 27.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.606 1.562 . . . . 0.0 112.121 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -51.5 -52.82 43.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.426 1.466 . . . . 0.0 111.245 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -56.11 -48.35 76.36 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.585 1.154 . . . . 0.0 108.996 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.98 -34.03 69.53 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.12 -45.35 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.349 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.08 -43.17 70.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.315 1.416 . . . . 0.0 112.839 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -51.84 -19.36 1.67 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -112.16 161.94 15.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.938 1.351 . . . . 0.0 111.472 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -73.6 131.59 41.86 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.774 1.23 . . . . 0.0 109.356 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.31 165.13 35.37 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 124.978 1.275 . . . . 0.0 111.251 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.78 150.6 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 31' ' ' THR . 31.4 t -135.15 161.44 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.59 43.01 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.032 0.933 . . . . 0.0 108.808 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.7 mt -138.71 118.83 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.9 108.38 19.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.549 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.0 m -89.43 116.66 27.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -73.26 141.18 47.23 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 120.916 1.689 . . . . 0.0 106.554 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.13 -81.28 0.25 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -161.42 -48.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 19.9 p-10 -78.44 40.63 0.37 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 129.61 3.164 . . . . 0.0 111.133 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.43 151.4 18.56 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.693 1.139 . . . . 0.0 110.851 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 73.0 Cg_endo -68.8 149.27 72.69 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 CA-C-N 118.609 1.205 . . . . 0.0 109.51 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.522 ' HE1' ' HB3' ' A' ' 53' ' ' LYS . 19.4 t-160 -110.91 98.12 7.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.68 2.392 . . . . 0.0 112.892 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -82.14 89.21 6.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.674 0.79 . . . . 0.0 111.395 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.41 168.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.908 1.283 . . . . 0.0 110.491 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -122.23 166.07 15.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.426 HG23 ' HB ' ' A' ' 16' ' ' VAL . 12.1 t -168.42 176.57 5.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.224 2.209 . . . . 0.0 109.222 175.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.14 141.63 50.63 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.327 2.251 . . . . 0.0 109.848 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -55.61 -31.47 62.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.971 0.805 . . . . 0.0 111.193 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 t -60.48 -8.88 3.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.515 1.926 . . . . 0.0 114.043 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -118.72 -1.05 11.16 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.752 1.16 . . . . 0.0 111.399 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.511 HD22 HG22 ' A' ' 46' ' ' VAL . 11.5 mt -102.65 163.38 12.25 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.29 0.95 . . . . 0.0 112.262 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -136.3 141.59 43.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.79 141.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.43 -178.02 3.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.839 1.655 . . . . 0.0 108.999 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.76 164.81 4.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.651 1.181 . . . . 0.0 111.298 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.82 28.21 30.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.388 1.947 . . . . 0.0 111.109 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' HB2' HD12 ' A' ' 2' ' ' LEU 0.293 0.1 OUTLIER 53.44 22.15 2.74 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.532 1.933 . . . . 0.0 113.29 -175.151 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -73.83 131.89 41.99 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -114.11 161.09 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.63 138.54 35.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 108.669 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.511 HG22 HD22 ' A' ' 36' ' ' LEU . 59.1 t -123.15 133.14 24.34 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.742 2.017 . . . . 0.0 106.966 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.36 123.18 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.88 1.72 . . . . 0.0 107.739 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 51' ' ' MET . 7.8 p -85.08 112.16 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.65 -20.67 8.77 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 124.868 1.223 . . . . 0.0 113.458 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.62 39.99 0.19 Allowed Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.377 1.589 . . . . 0.0 112.175 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.446 ' HB2' HG23 ' A' ' 48' ' ' VAL . 30.9 mtt -99.12 71.06 1.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.035 0.917 . . . . 0.0 110.788 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -71.07 -67.41 0.51 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.368 1.867 . . . . 0.0 112.749 -173.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.522 ' HB3' ' HE1' ' A' ' 27' ' ' HIS 0.259 12.2 tmtt? -51.97 -38.89 58.25 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.172 0.989 . . . . 0.0 108.966 176.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -64.5 -38.81 92.32 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.909 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.53 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 26.5 tt0 -57.45 -43.63 84.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.478 1.944 . . . . 0.0 109.657 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.24 95.35 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.239 -0.288 . . . . 0.0 111.649 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.35 -41.76 76.66 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 116.968 -1.491 . . . . 0.0 113.567 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.08 -48.11 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.436 1.471 . . . . 0.0 109.089 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.7 -23.56 29.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -85.99 -46.07 10.87 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -151.42 129.43 11.8 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.759 1.224 . . . . 0.0 110.009 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -17.53 59.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.57 131.04 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.327 1.421 . . . . 0.0 110.739 -178.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.3 m -141.4 155.96 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 123.379 1.562 . . . . 0.0 112.332 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.5 tp -101.21 152.54 20.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.9 ttt -138.93 118.77 13.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -111.03 128.1 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.4 pt? -116.8 170.21 8.78 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 109.623 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.59 -177.02 39.3 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.533 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.5 t -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -98.63 -7.91 27.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.801 1.64 . . . . 0.0 108.936 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -11.26 38.55 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 119.371 -2.081 . . . . 0.0 113.338 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.42 138.87 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 120.627 1.558 . . . . 0.0 107.101 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.0 130.26 35.33 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.026 0.53 . . . . 0.0 110.75 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.67 -121.7 2.79 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 124.437 1.018 . . . . 0.0 112.927 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.445 ' H ' HD11 ' A' ' 122' ' ' LEU . 3.4 mmp_? -91.81 -78.63 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.247 1.419 . . . . 0.0 110.529 174.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -73.61 104.95 4.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.166 0.984 . . . . 0.0 108.431 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.15 -168.59 10.59 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.704 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 67.0 Cg_endo -74.74 63.7 5.76 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.851 2.368 . . . . 0.0 110.29 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.83 121.44 1.32 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -115.4 173.33 6.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.966 0.883 . . . . 0.0 110.726 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.3 -173.3 43.67 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 118.797 0.726 . . . . 0.0 113.133 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -151.34 157.32 42.33 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.409 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.5 130.9 47.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.62 155.14 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -126.86 143.87 51.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.626 1.57 . . . . 0.0 107.818 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.63 -165.11 32.65 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.3 m -121.39 142.87 49.58 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.313 0.645 . . . . 0.0 110.017 173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -89.92 161.78 15.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.623 1.169 . . . . 0.0 110.174 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.74 114.5 2.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.702 1.201 . . . . 0.0 107.775 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 50.1 m-85 -74.57 136.26 42.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.533 HH11 ' HG3' ' A' ' 92' ' ' ARG . 6.4 mmm-85 -139.13 137.3 35.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 109.866 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -120.78 38.06 4.14 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.81 158.96 34.55 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 129.394 3.078 . . . . 0.0 111.19 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.73 46.88 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.966 1.746 . . . . 0.0 114.72 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.03 -19.55 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.645 2.23 . . . . 0.0 109.523 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -63.62 -65.86 0.62 Allowed 'General case' 0 C--O 1.25 1.11 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.58 -31.85 71.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 116.607 -1.663 . . . . 0.0 112.515 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -68.25 -53.95 21.03 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.852 1.66 . . . . 0.0 110.823 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.67 70.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 116.96 -1.495 . . . . 0.0 111.309 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pp -85.1 -20.67 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 117.507 -1.677 . . . . 0.0 113.558 173.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.05 97.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.881 1.673 . . . . 0.0 112.915 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.599 ' H ' ' HD2' ' A' ' 103' ' ' ARG 0.52 0.0 OUTLIER -51.72 -18.06 1.1 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 173.784 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.02 -179.0 0.12 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -128.38 16.11 6.59 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 118.782 -2.449 . . . . 0.0 111.998 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -139.32 12.16 2.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.042 1.337 . . . . 0.0 110.891 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.12 140.46 37.8 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.372 -0.83 . . . . 0.0 111.28 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.81 -21.53 6.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.988 2.115 . . . . 0.0 111.706 174.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.24 161.99 1.9 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.69 1.996 . . . . 0.0 109.396 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.61 112.44 24.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 tp -84.1 93.56 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.11 120.8 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.93 128.8 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.2 m -98.61 78.91 2.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 2' ' ' LEU . 38.5 t -61.09 153.84 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 125.745 1.618 . . . . 0.0 109.381 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.9 t -130.15 -54.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -151.4 141.59 22.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.717 0.689 . . . . 0.0 112.844 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.58 20.22 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 127.283 2.233 . . . . 0.0 111.22 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.38 154.21 42.75 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.308 2.643 . . . . 0.0 106.689 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -100.8 133.97 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.223 -1.548 . . . . 0.0 108.404 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.0 p -135.37 -81.91 0.42 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.196 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.445 HD11 ' H ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.808 0 C-N-CA 130.415 3.486 . . . . 0.0 114.871 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' C ' HD22 ' A' ' 2' ' ' LEU . 18.5 mmt . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.3 mm? -131.54 153.72 81.64 Favored Pre-proline 0 N--CA 1.463 0.19 0 C-N-CA 124.788 1.235 . . . . 0.0 108.873 -171.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.86 158.51 52.74 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.109 1.873 . . . . 0.0 109.197 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.2 -40.44 95.79 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -54.18 -38.84 66.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 111.827 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -51.32 -52.31 46.53 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.51 1.05 . . . . 0.0 110.692 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -60.0 -48.28 82.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.764 0.826 . . . . 0.0 110.495 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -53.21 -38.66 63.1 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.505 1.048 . . . . 0.0 112.159 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.04 -42.35 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.858 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.2 mt -58.39 -42.67 87.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.261 1.392 . . . . 0.0 112.164 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -51.87 -25.34 7.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.105 0.962 . . . . 0.0 113.04 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -101.26 161.09 13.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.62 139.99 45.86 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.13 164.4 37.75 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.53 148.5 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.421 ' HB ' HG23 ' A' ' 31' ' ' THR . 13.8 t -135.49 161.66 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.6 158.38 41.08 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.123 0.969 . . . . 0.0 108.875 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -138.81 114.42 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.66 108.87 19.69 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.607 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -92.89 116.19 28.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 116.939 -1.505 . . . . 0.0 107.607 -173.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -73.3 137.42 44.84 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 120.859 1.663 . . . . 0.0 108.4 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.25 -81.51 0.22 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 106.8 -2.52 . . . . 0.0 106.8 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -168.98 -48.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -78.18 38.68 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 131.326 3.85 . . . . 0.0 110.069 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.92 151.17 5.7 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 39.4 Cg_endo -68.62 148.56 72.51 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 CA-C-N 119.762 1.781 . . . . 0.0 107.725 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -108.15 101.5 10.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.347 -173.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 tp -74.68 88.8 2.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.216 1.006 . . . . 0.0 111.441 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.08 170.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.489 1.516 . . . . 0.0 110.242 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.24 168.08 11.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.802 1.183 . . . . 0.0 113.571 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.421 HG23 ' HB ' ' A' ' 16' ' ' VAL . 14.1 t -168.61 174.1 6.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.254 2.622 . . . . 0.0 108.253 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.428 ' HE1' HM73 ' A' ' 123' ' ' FMN . 95.9 m95 -121.11 141.96 50.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.52 2.328 . . . . 0.0 110.726 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -52.92 -31.63 41.06 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.828 1.194 . . . . 0.0 111.776 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -58.48 -8.71 1.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.701 2.001 . . . . 0.0 113.653 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -118.06 -3.35 11.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.813 1.245 . . . . 0.0 110.479 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.9 mt -99.23 170.59 8.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 120.449 1.477 . . . . 0.0 114.36 -173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -136.33 141.32 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -100.92 148.81 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 mt -121.78 178.93 4.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.17 2.188 . . . . 0.0 110.463 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -67.13 167.65 11.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.577 1.551 . . . . 0.0 109.742 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.9 28.62 57.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.073 1.321 . . . . 0.0 111.307 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.25 0.1 OUTLIER 53.73 20.43 2.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.873 2.069 . . . . 0.0 114.236 -175.21 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -73.44 145.56 45.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -127.27 168.15 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.02 145.0 18.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 120.392 -1.443 . . . . 0.0 108.8 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.68 138.88 32.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 128.749 2.82 . . . . 0.0 107.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.24 109.12 2.28 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.8 3.0 . . . . 0.0 109.427 173.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.28 111.84 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 173.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.77 -21.63 4.94 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.771 1.177 . . . . 0.0 113.24 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.24 37.45 0.41 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 119.183 1.491 . . . . 0.0 111.44 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.465 ' HB2' HG23 ' A' ' 48' ' ' VAL . 33.4 mtt -103.39 71.5 1.1 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.423 ' CD2' HH22 ' A' ' 108' ' ' ARG . 34.0 m80 -67.28 -70.53 0.25 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.401 2.68 . . . . 0.0 114.573 -173.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -51.68 -40.74 60.62 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 120.791 -1.193 . . . . 0.0 109.987 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 12.8 m -60.39 -39.14 86.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.868 0.867 . . . . 0.0 113.323 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.85 -48.13 82.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.291 1.405 . . . . 0.0 108.587 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.2 97.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.761 173.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 15.6 m-20 -63.07 -41.93 99.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.57 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.49 -48.21 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.622 1.101 . . . . 0.0 108.664 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.87 -26.81 62.61 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.122 -0.942 . . . . 0.0 113.503 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -87.18 -46.99 9.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.977 1.262 . . . . 0.0 112.187 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -147.06 128.85 15.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.399 1.08 . . . . 0.0 111.848 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -17.67 59.3 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.488 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.66 130.97 48.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.225 0.921 . . . . 0.0 110.466 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 20' ' ' THR . 35.5 m -144.24 156.15 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 123.264 1.507 . . . . 0.0 112.879 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.5 tp -104.88 152.74 22.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 172.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 ttt -138.99 128.27 24.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 p -129.72 128.6 42.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -116.46 164.07 15.1 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 119.431 1.014 . . . . 0.0 109.29 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.64 42.4 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.8 t -160.95 172.04 17.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.171 -1.194 . . . . 0.0 109.428 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -99.23 -8.29 25.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.212 2.205 . . . . 0.0 108.987 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -11.18 43.88 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 115.815 -2.041 . . . . 0.0 116.265 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.87 140.33 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.76 131.29 35.88 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.727 0.811 . . . . 0.0 110.868 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.4 -139.47 5.68 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 125.441 1.496 . . . . 0.0 112.099 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -79.23 -59.04 2.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.165 1.786 . . . . 0.0 107.662 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.7 103.09 15.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.27 -168.7 4.13 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.36 61.02 6.59 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.492 2.128 . . . . 0.0 109.969 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.33 121.56 1.2 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 108.559 -1.817 . . . . 0.0 108.559 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.19 169.85 8.96 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.479 1.14 . . . . 0.0 110.197 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 171.83 43.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.295 0.95 . . . . 0.0 113.1 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -131.83 147.78 52.51 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.417 1.487 . . . . 0.0 108.696 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -100.51 131.5 46.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.893 2.477 . . . . 0.0 105.409 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 115' ' ' VAL . 6.4 mt -136.4 154.73 33.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 mtt-85 -127.74 143.12 51.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.285 1.434 . . . . 0.0 107.682 -174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.09 -171.84 40.27 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 119.094 0.861 . . . . 0.0 113.407 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -121.31 134.68 55.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.323 1.449 . . . . 0.0 110.514 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -88.76 160.53 17.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.747 1.619 . . . . 0.0 110.565 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.62 120.64 1.5 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.464 1.506 . . . . 0.0 109.13 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.99 149.37 29.34 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.19 -0.944 . . . . 0.0 112.747 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.18 141.4 34.1 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.557 1.943 . . . . 0.0 109.179 172.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.8 p -114.11 24.8 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.546 1.539 . . . . 0.0 107.321 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.72 167.32 29.81 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 126.317 1.847 . . . . 0.0 110.39 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.8 179.74 45.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.639 2.066 . . . . 0.0 113.295 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.7 -11.46 17.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.886 3.057 . . . . 0.0 112.459 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -64.04 0.98 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.328 1.851 . . . . 0.0 107.138 173.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.29 -31.12 70.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.127 0.892 . . . . 0.0 110.749 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -68.65 -56.86 6.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.001 0.819 . . . . 0.0 109.801 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.39 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.909 -1.119 . . . . 0.0 112.428 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.343 1.5 pp -92.3 -18.12 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.666 1.121 . . . . 0.0 111.463 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.28 -28.09 2.89 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.688 1.995 . . . . 0.0 112.334 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -51.49 -32.34 27.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.237 172.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -79.07 178.02 8.36 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 173.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.69 8.18 1.93 Allowed 'General case' 0 C--O 1.221 -0.427 0 O-C-N 118.473 -2.642 . . . . 0.0 111.704 173.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -102.0 8.38 40.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.628 1.171 . . . . 0.0 110.554 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.96 22.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.519 0.727 . . . . 0.0 109.992 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.423 HH22 ' CD2' ' A' ' 52' ' ' HIS . 23.1 ttm180 -120.65 -20.93 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.887 2.075 . . . . 0.0 111.355 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.35 161.83 12.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.666 1.586 . . . . 0.0 108.519 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.5 105.41 15.43 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.599 2.36 . . . . 0.0 106.695 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 tp -79.22 95.86 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.285 1.834 . . . . 0.0 107.094 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.7 t -78.91 131.52 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.676 1.59 . . . . 0.0 106.718 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.78 128.36 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.5 m -98.91 85.9 3.37 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.475 HG11 HD21 ' A' ' 2' ' ' LEU . 22.6 t -60.76 150.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.46 -58.83 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -147.95 141.53 25.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.3 154.73 25.22 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.394 2.278 . . . . 0.0 110.347 173.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -140.41 139.14 35.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.447 2.299 . . . . 0.0 106.865 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -77.84 139.97 39.33 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -132.98 -58.82 0.9 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.243 0.717 0 CA-C-O 116.561 -1.685 . . . . 0.0 111.945 -173.362 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.428 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mmm . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mp -57.04 153.54 23.52 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.15 155.48 56.61 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.576 2.184 . . . . 0.0 110.644 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.84 -42.06 97.96 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -49.48 -38.8 31.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.36 1.864 . . . . 0.0 112.327 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -51.1 -56.26 13.56 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.45 1.023 . . . . 0.0 110.145 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -58.62 -48.74 79.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.914 0.886 . . . . 0.0 109.36 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.59 -40.23 71.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.483 0.583 . . . . 0.0 112.269 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.52 -45.83 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.801 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.65 -37.25 73.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.81 1.186 . . . . 0.0 113.921 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -51.78 -29.51 19.26 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.748 1.158 . . . . 0.0 112.134 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -101.08 165.55 11.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.607 1.163 . . . . 0.0 109.83 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.21 139.05 45.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.33 167.56 40.31 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.13 144.12 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.068 1.747 . . . . 0.0 107.432 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.419 ' HB ' HG23 ' A' ' 31' ' ' THR . 59.0 t -136.8 158.32 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -145.42 155.45 43.15 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.566 1.546 . . . . 0.0 108.115 173.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.489 HD11 HG21 ' A' ' 46' ' ' VAL . 39.5 mt -140.98 112.93 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.99 108.92 19.84 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.458 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -95.35 116.99 29.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -73.31 141.16 47.14 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 121.001 1.728 . . . . 0.0 106.542 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.12 -81.27 0.22 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.89 -60.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -78.61 38.84 0.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 130.096 3.359 . . . . 0.0 111.445 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.0 151.29 17.03 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.13 0.871 . . . . 0.0 110.994 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.6 152.09 53.34 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 120.994 1.13 . . . . 0.0 111.529 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -110.5 101.6 10.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.4 tt -88.91 88.94 7.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -85.71 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.561 1.944 . . . . 0.0 110.785 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -119.23 166.72 12.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.367 0.985 . . . . 0.0 113.368 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.419 HG23 ' HB ' ' A' ' 16' ' ' VAL . 13.2 t -168.44 171.89 8.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.407 2.283 . . . . 0.0 108.212 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.666 ' HE1' HM73 ' A' ' 123' ' ' FMN . 83.1 m95 -121.34 141.71 50.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.084 1.754 . . . . 0.0 110.192 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.69 -31.25 15.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.795 0.838 . . . . 0.0 111.376 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -59.31 -8.66 1.79 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.095 1.758 . . . . 0.0 113.682 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -118.56 -13.21 9.69 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.722 1.209 . . . . 0.0 110.623 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.543 HD22 HG22 ' A' ' 46' ' ' VAL . 27.8 mt -91.1 168.62 11.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.64 -1.288 . . . . 0.0 111.901 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.91 37.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.46 134.05 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.28 179.07 4.53 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.897 1.679 . . . . 0.0 107.337 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 35.0 t0 -75.83 -179.21 4.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.274 0.629 . . . . 0.0 110.31 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 58.6 28.85 63.16 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.419 -1.425 . . . . 0.0 110.303 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 p30 53.82 13.23 0.5 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 130.106 3.362 . . . . 0.0 114.684 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -74.01 128.05 34.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.082 0.401 . . . . 0.0 110.301 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -119.07 158.83 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.5 142.72 25.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 O-C-N 120.397 -1.439 . . . . 0.0 107.732 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.543 HG22 HD22 ' A' ' 36' ' ' LEU . 58.2 t -124.38 126.15 25.53 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 128.623 2.769 . . . . 0.0 106.522 -173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -72.9 108.4 2.57 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.453 1.436 . . . . 0.0 108.934 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.87 111.59 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.7 -21.48 5.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.35 0.976 . . . . 0.0 112.097 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.58 41.3 0.47 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.044 -174.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB2' HG23 ' A' ' 48' ' ' VAL . 8.7 mtt -109.75 71.74 0.77 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.271 1.429 . . . . 0.0 108.203 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -67.04 -64.13 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 130.239 3.416 . . . . 0.0 112.794 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -51.66 -41.04 61.07 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.258 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.8 m -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.358 1.463 . . . . 0.0 111.509 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.95 -48.97 79.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.714 1.206 . . . . 0.0 108.838 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.83 94.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.0 -41.86 90.52 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.014 0.926 . . . . 0.0 109.316 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.34 -47.96 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.39 -28.3 28.69 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.505 -0.747 . . . . 0.0 112.322 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -45.96 17.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -150.79 138.97 20.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.051 0.842 . . . . 0.0 110.174 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -74.62 -18.52 60.54 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.362 -0.836 . . . . 0.0 111.984 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.79 118.15 6.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.804 1.241 . . . . 0.0 113.935 -174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 20' ' ' THR . 9.2 m -139.31 152.72 23.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 123.084 1.421 . . . . 0.0 112.762 173.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.7 tt -111.74 148.78 32.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.0 ttt -140.47 123.44 16.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 8.0 p -108.79 128.15 54.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.03 167.68 10.93 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 120.408 1.458 . . . . 0.0 109.208 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.91 178.82 46.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -151.89 155.18 37.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.6 mtt-85 -98.4 -8.4 26.99 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.284 0.634 . . . . 0.0 111.182 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -72.39 -7.66 50.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.535 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.98 135.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 174.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.01 130.36 35.44 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.24 -137.54 5.29 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -90.76 -58.39 2.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.575 0.75 . . . . 0.0 109.142 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.91 102.61 5.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 118.794 -1.162 . . . . 0.0 108.532 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.21 -168.27 0.12 Allowed Glycine 0 CA--C 1.54 1.642 0 O-C-N 120.647 -1.283 . . . . 0.0 111.086 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.37 90.78 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 106.462 -2.169 . . . . 0.0 106.462 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.41 0.71 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.748 -1.585 . . . . 0.0 109.599 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -105.99 168.87 8.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.399 1.099 . . . . 0.0 110.091 174.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.43 -166.14 35.31 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-O 121.266 0.37 . . . . 0.0 113.646 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.69 152.39 42.34 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.497 1.119 . . . . 0.0 110.009 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.22 131.12 47.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.502 ' CG2' HG13 ' A' ' 115' ' ' VAL . 5.3 mt -133.55 150.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -124.25 138.23 54.42 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.687 1.995 . . . . 0.0 106.268 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.45 -167.17 26.71 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -121.14 142.1 50.19 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.448 1.899 . . . . 0.0 108.682 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.06 160.99 16.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.913 1.233 . . . . 0.0 110.935 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.11 120.44 3.33 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.266 1.027 . . . . 0.0 109.448 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.413 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 3.4 m-85 -74.13 128.7 36.21 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -120.56 141.12 50.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.782 2.433 . . . . 0.0 109.632 173.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -121.21 29.53 7.25 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.658 1.983 . . . . 0.0 107.262 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.77 165.98 33.03 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.646 2.378 . . . . 0.0 108.663 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.7 178.97 46.34 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.499 1.523 . . . . 0.0 113.643 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.73 -20.43 68.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.545 2.163 . . . . 0.0 111.11 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.32 -55.58 20.29 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.52 1.528 . . . . 0.0 108.595 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CD1' HD11 ' A' ' 101' ' ' ILE . 33.1 t80 -61.34 -31.35 71.22 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 116.924 -1.512 . . . . 0.0 110.521 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.22 -48.39 65.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 121.515 1.962 . . . . 0.0 110.516 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.11 -35.99 60.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.854 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.436 HD13 ' HB1' ' A' ' 107' ' ' ALA 0.25 1.3 pp -93.68 -20.95 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 173.435 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.66 93.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 121.544 1.974 . . . . 0.0 111.695 -173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.464 0.0 OUTLIER -51.35 -18.02 0.89 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.988 1.715 . . . . 0.0 114.744 173.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -174.74 0.21 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -129.22 10.59 5.82 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 119.022 -2.299 . . . . 0.0 113.003 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -139.66 8.82 2.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.495 0.718 . . . . 0.0 112.587 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 101' ' ' ILE . . . -79.36 151.25 31.09 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.231 0.923 . . . . 0.0 111.356 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -120.65 -21.34 6.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.216 2.207 . . . . 0.0 111.657 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.784 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.78 161.63 11.16 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.659 1.584 . . . . 0.0 109.482 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.41 103.69 15.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.43 94.68 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.19 131.59 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.211 1.804 . . . . 0.0 106.59 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -118.99 138.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.7 m -114.64 101.39 9.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 85' ' ' ILE . 59.7 t -60.15 153.77 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.639 0.733 . . . . 0.0 109.352 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.91 -40.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.6 m -151.03 128.06 11.1 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 120.857 -1.152 . . . . 0.0 110.924 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.4 138.81 49.54 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.589 2.356 . . . . 0.0 109.117 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -142.01 140.97 32.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.86 1.664 . . . . 0.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.56 133.8 47.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -152.84 -58.55 0.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.252 1.224 0 CA-C-O 115.216 -2.326 . . . . 0.0 115.687 -172.936 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 1.407 ' C10' ' N1 ' ' A' ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtm . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.79 157.31 8.03 Favored Pre-proline 0 C--O 1.242 0.704 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.47 160.32 48.44 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.606 2.204 . . . . 0.0 111.329 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.65 -47.53 90.45 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.83 -42.11 62.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.22 1.408 . . . . 0.0 111.99 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.569 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 34.7 t80 -51.12 -56.62 11.79 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.555 0.616 . . . . 0.0 111.493 173.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -59.17 -48.52 81.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.316 0.646 . . . . 0.0 110.578 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.79 -40.5 72.76 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.935 0.789 . . . . 0.0 111.976 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.89 -44.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.021 0.828 . . . . 0.0 108.884 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 25.4 mt -56.71 -43.89 81.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.087 0.858 . . . . 0.0 112.437 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -51.69 -27.08 10.61 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -99.11 171.63 7.89 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.295 1.045 . . . . 0.0 111.205 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.45 131.67 42.08 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.1 168.57 41.67 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.2 t -101.01 149.88 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.95 152.44 42.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mt -138.79 116.31 11.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.91 109.23 20.06 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -89.35 114.88 26.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 118.54 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.71 -74.65 0.11 Allowed Glycine 0 C--N 1.333 0.403 0 CA-C-N 118.236 0.471 . . . . 0.0 112.91 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.23 -48.24 0.06 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -173.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.18 38.48 0.29 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.523 1.529 . . . . 0.0 110.792 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 152.47 6.59 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 105.851 -2.9 . . . . 0.0 105.851 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 10.1 Cg_endo -51.19 147.76 19.91 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 122.233 3.016 . . . . 0.0 106.875 173.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -119.71 101.26 7.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.533 -172.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.4 tp -78.13 88.57 4.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.302 1.041 . . . . 0.0 111.208 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -77.48 171.71 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.942 1.297 . . . . 0.0 110.401 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -122.12 166.32 14.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.628 1.104 . . . . 0.0 113.516 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -168.52 175.01 6.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.561 2.344 . . . . 0.0 108.473 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.44 ' HE1' HM73 ' A' ' 123' ' ' FMN . 92.9 m95 -120.67 141.68 50.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.327 2.251 . . . . 0.0 109.463 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -55.21 -31.42 61.43 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.77 0.714 . . . . 0.0 110.598 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -59.24 -8.81 1.79 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.99 2.116 . . . . 0.0 113.876 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -118.13 -7.05 10.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.594 1.158 . . . . 0.0 109.576 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.429 HD22 HG22 ' A' ' 46' ' ' VAL . 28.9 mt -97.18 171.41 8.47 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.747 -1.221 . . . . 0.0 112.01 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.537 ' HE2' HD11 ' A' ' 39' ' ' LEU . 15.9 ptmt -133.64 123.15 24.54 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 10' ' ' LEU . 58.8 t -101.7 139.5 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.537 HD11 ' HE2' ' A' ' 37' ' ' LYS . 3.2 mp -121.66 178.52 4.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -76.55 -178.3 4.62 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.14 67.38 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 120.511 -1.368 . . . . 0.0 109.812 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 53.79 13.0 0.47 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 130.337 3.455 . . . . 0.0 115.602 -174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -73.6 140.03 45.94 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.673 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -130.59 161.4 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.87 145.63 20.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG22 HD22 ' A' ' 36' ' ' LEU . 60.5 t -122.24 130.04 24.85 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 128.31 2.644 . . . . 0.0 106.548 -174.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.49 108.69 2.74 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.223 2.615 . . . . 0.0 109.087 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.725 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.58 111.66 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.879 -0.513 . . . . 0.0 109.958 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.57 -21.31 5.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.954 1.74 . . . . 0.0 111.93 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.06 39.97 0.38 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.89 1.345 . . . . 0.0 110.353 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 48' ' ' VAL . 31.2 mtt -109.23 50.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.472 1.509 . . . . 0.0 107.052 173.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.47 -50.06 35.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.445 -1.264 . . . . 0.0 113.484 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -52.27 -41.57 62.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.272 1.851 . . . . 0.0 108.611 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 3.1 m -58.77 -38.4 78.41 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.71 0.804 . . . . 0.0 110.811 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.1 -48.18 79.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.682 1.583 . . . . 0.0 110.065 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.1 98.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 119.788 -0.148 . . . . 0.0 111.122 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 9.5 m-20 -61.22 -41.27 96.56 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 123.826 0.85 . . . . 0.0 110.052 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.9 -47.97 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.843 1.201 . . . . 0.0 109.361 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.92 -25.92 45.32 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.042 -1.036 . . . . 0.0 112.154 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . 1.3 mmm-85 -78.09 -45.03 24.55 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 173.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -151.25 140.82 21.64 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.234 1.014 . . . . 0.0 109.884 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -70.33 -19.41 63.07 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.873 -1.142 . . . . 0.0 111.94 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.8 120.77 10.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.18 1.392 . . . . 0.0 113.639 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 20' ' ' THR . 15.2 m -139.06 155.91 27.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 123.001 1.382 . . . . 0.0 112.185 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.9 tp -111.11 151.95 27.53 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 172.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.02 132.79 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 p -128.47 128.07 43.68 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -116.98 167.2 11.35 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.81 1.186 . . . . 0.0 110.781 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 178.5 42.42 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -150.32 170.79 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.732 -0.864 . . . . 0.0 109.076 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -98.66 -8.79 25.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.362 1.865 . . . . 0.0 110.888 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -91.58 -10.74 39.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.4 137.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.86 131.45 36.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.214 1.005 . . . . 0.0 109.798 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.22 -140.99 6.81 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -83.99 -58.48 2.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -78.53 102.92 8.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.3 -168.72 2.27 Favored Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 112.6 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.5 59.53 6.76 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.867 2.378 . . . . 0.0 110.789 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.44 121.32 1.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -113.95 169.07 9.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.91 1.355 . . . . 0.0 110.181 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 176.57 44.35 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 123.463 0.554 . . . . 0.0 112.889 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -126.39 144.6 50.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.718 1.607 . . . . 0.0 110.197 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.54 128.39 46.61 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 128.253 2.621 . . . . 0.0 104.442 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt -138.41 153.83 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 -119.84 148.16 43.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.89 1.676 . . . . 0.0 107.52 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.77 -171.38 31.89 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.1 m -120.85 144.38 48.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.376 2.27 . . . . 0.0 107.179 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.93 161.05 16.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.778 1.172 . . . . 0.0 111.405 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.22 114.92 2.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.174 0.99 . . . . 0.0 109.966 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -73.94 129.45 37.91 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.67 141.57 51.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 129.119 2.967 . . . . 0.0 108.606 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 p -118.28 30.36 7.27 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.774 1.629 . . . . 0.0 107.552 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -158.81 163.82 36.34 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.209 1.804 . . . . 0.0 109.328 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.74 46.87 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.116 1.817 . . . . 0.0 113.782 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.88 -13.86 37.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.707 2.938 . . . . 0.0 112.653 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.59 -63.38 1.07 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -61.23 -31.31 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.967 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.62 -55.54 11.18 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.689 1.131 . . . . 0.0 109.42 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.462 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.53 -27.12 68.38 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.857 -1.152 . . . . 0.0 112.178 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.362 1.0 OUTLIER -86.25 -18.18 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.881 1.218 . . . . 0.0 111.567 173.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.33 -27.67 2.69 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.961 2.104 . . . . 0.0 111.675 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -49.26 -35.79 18.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.028 . . . . 0.0 111.764 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -77.94 178.05 7.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.89 -0.98 1.44 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 118.529 -2.607 . . . . 0.0 111.568 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -97.01 8.38 44.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.979 0.912 . . . . 0.0 110.682 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.72 149.41 22.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.821 0.737 . . . . 0.0 109.515 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -117.71 -11.22 10.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.244 1.818 . . . . 0.0 110.936 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.28 161.7 12.3 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 110.0 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.15 104.57 14.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.512 2.725 . . . . 0.0 106.174 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.32 96.96 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.08 131.65 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.378 1.871 . . . . 0.0 107.11 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.11 139.76 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.9 m -118.9 101.44 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.2 t -60.28 160.98 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.613 1.565 . . . . 0.0 109.472 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.22 -57.14 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -141.06 122.84 15.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.17 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 146.99 42.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 128.054 2.542 . . . . 0.0 111.337 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -143.91 152.13 40.72 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.0 108.894 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -81.05 137.31 36.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.6 p -138.69 -58.49 0.62 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -173.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--O 1.251 1.168 0 C-N-CA 123.594 0.757 . . . . 0.0 111.182 -173.52 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.44 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mmt . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.9 mt -62.9 157.24 61.84 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 118.47 -0.776 . . . . 0.0 108.922 171.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.61 160.17 50.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.974 1.782 . . . . 0.0 111.756 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.26 96.86 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -52.85 -38.82 61.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.931 1.692 . . . . 0.0 112.072 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 32.6 t80 -51.14 -51.89 49.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.487 1.039 . . . . 0.0 110.962 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -60.1 -48.39 81.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.338 0.655 . . . . 0.0 110.73 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -54.97 -37.22 66.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.642 1.11 . . . . 0.0 112.638 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.09 -45.01 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.364 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 38' ' ' VAL . 34.2 mt -57.21 -44.09 83.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.397 0.999 . . . . 0.0 112.018 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -51.85 -18.93 1.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -107.71 158.41 17.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.556 1.071 . . . . 0.0 110.788 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -77.0 147.69 36.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.47 168.54 31.57 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.18 149.05 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.24 161.98 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 127.343 2.257 . . . . 0.0 105.021 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.43 157.17 43.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.371 1.068 . . . . 0.0 109.139 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -139.39 120.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.91 108.77 19.73 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 173.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.485 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.8 m -90.6 113.45 25.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -73.2 131.71 42.32 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.93 -79.14 0.17 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 122.514 1.064 . . . . 0.0 111.131 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -158.32 -48.59 0.06 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.647 -1.277 . . . . 0.0 109.003 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.61 37.74 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.773 1.229 . . . . 0.0 112.053 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.28 152.12 5.76 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 25.6 Cg_endo -59.23 148.02 88.02 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 121.043 2.421 . . . . 0.0 108.481 177.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' CD2' ' HZ1' ' A' ' 53' ' ' LYS . 70.2 t60 -117.04 101.45 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.622 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 13.2 tp -75.02 88.64 2.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.832 0.853 . . . . 0.0 111.531 -175.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 m -78.1 169.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.395 1.078 . . . . 0.0 109.834 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -119.85 166.34 13.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 112.243 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -168.52 176.05 5.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.453 2.301 . . . . 0.0 107.879 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.516 ' HE1' HM73 ' A' ' 123' ' ' FMN . 84.6 m95 -121.28 141.62 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.517 1.527 . . . . 0.0 110.76 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -50.86 -29.96 13.26 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 119.077 0.853 . . . . 0.0 111.154 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -55.13 -19.89 8.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.669 2.388 . . . . 0.0 112.58 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -118.13 -4.23 11.01 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.144 1.378 . . . . 0.0 109.619 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.468 HD22 HG22 ' A' ' 46' ' ' VAL . 6.3 mt -98.88 167.15 10.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.94 -1.1 . . . . 0.0 111.016 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.65 140.49 42.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 10' ' ' LEU . 85.4 t -101.9 149.51 6.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.8 mt -122.24 178.82 4.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.638 2.775 . . . . 0.0 106.244 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -76.03 -179.04 4.69 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.33 31.01 72.48 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 120.237 -1.539 . . . . 0.0 110.715 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 p30 54.08 13.06 0.53 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.765 3.226 . . . . 0.0 115.257 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -73.49 142.32 46.78 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 109.547 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.41 166.41 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.408 ' CG1' ' HB1' ' A' ' 110' ' ' ALA . 16.9 t -147.97 145.07 18.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 O-C-N 120.793 -1.192 . . . . 0.0 108.644 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG22 HD22 ' A' ' 36' ' ' LEU . 60.9 t -123.58 136.07 26.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 108.585 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.77 121.28 6.2 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 124.269 3.312 . . . . 0.0 110.582 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.558 HG23 ' HB2' ' A' ' 51' ' ' MET . 7.7 p -85.48 111.94 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 119.52 1.055 . . . . 0.0 112.764 173.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.31 -20.81 5.76 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.774 1.654 . . . . 0.0 111.64 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.54 30.0 0.23 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.459 1.63 . . . . 0.0 112.292 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.558 ' HB2' HG23 ' A' ' 48' ' ' VAL . 37.2 mtt -99.4 61.96 1.21 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.103 1.452 . . . . 0.0 107.825 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -71.15 -60.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.029 0.932 . . . . 0.0 112.951 -174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.426 ' HZ1' ' CD2' ' A' ' 27' ' ' HIS . 4.0 ttpm? -52.09 -41.77 62.68 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.138 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 2.0 m -61.62 -38.55 88.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.852 0.751 . . . . 0.0 111.641 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 36.9 tt0 -59.08 -44.74 91.93 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.927 1.239 . . . . 0.0 109.792 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.04 93.25 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.234 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 8.8 m-20 -62.61 -41.39 98.96 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 124.175 0.99 . . . . 0.0 109.473 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.78 -48.17 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 108.708 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.93 29.82 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.377 -0.827 . . . . 0.0 112.616 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -45.39 19.06 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -151.04 138.95 19.92 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.747 1.219 . . . . 0.0 109.417 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.1 -19.79 61.08 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.03 -1.044 . . . . 0.0 112.009 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.1 mmp_? -60.88 119.97 9.25 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.268 1.427 . . . . 0.0 114.265 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 89' ' ' ALA . 16.1 m -139.64 156.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 123.108 1.432 . . . . 0.0 112.8 173.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 15.4 tp -110.81 151.19 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 172.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.5 ttt -142.4 140.89 32.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 p -129.68 130.66 45.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.3 pt? -116.68 163.62 15.85 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.11 179.53 44.47 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.2 t -147.62 163.65 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -9.01 25.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.508 0.723 . . . . 0.0 109.221 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -81.1 -7.7 59.61 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.009 -0.996 . . . . 0.0 113.165 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.99 137.07 56.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.08 36.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.38 -141.48 6.15 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp-105 -81.57 -58.98 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.582 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -80.46 102.64 9.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.388 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 49.51 -168.71 0.2 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.236 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.3 87.52 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 107.557 -1.747 . . . . 0.0 107.557 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 121.25 0.7 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-O 117.734 -1.592 . . . . 0.0 109.16 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -115.52 -179.85 3.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.252 1.026 . . . . 0.0 108.963 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.32 -155.81 20.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 117.819 -1.545 . . . . 0.0 110.063 -173.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -151.2 157.49 42.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.306 1.442 . . . . 0.0 109.629 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.1 131.12 47.18 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 129.239 3.015 . . . . 0.0 104.811 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 115' ' ' VAL . 4.8 mt -136.95 152.31 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -119.61 140.77 50.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.4 1.88 . . . . 0.0 107.078 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.51 -171.15 30.4 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.415 0.531 . . . . 0.0 112.047 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -121.12 149.16 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.815 2.046 . . . . 0.0 108.289 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -107.29 165.13 11.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.633 1.173 . . . . 0.0 110.402 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.14 121.69 0.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 109.394 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 37.9 m-85 -76.45 150.73 36.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.766 -1.209 . . . . 0.0 114.191 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.315 0.0 OUTLIER -140.89 139.02 34.32 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 173.254 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 p -122.11 29.47 7.02 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 129.741 3.216 . . . . 0.0 102.582 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 92' ' ' ARG 0.288 8.9 t70 -158.43 160.21 36.57 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 130.353 3.461 . . . . 0.0 114.004 -172.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.97 178.41 47.54 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.007 1.289 . . . . 0.0 115.768 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.04 -16.28 53.36 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.093 2.529 . . . . 0.0 110.085 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -64.76 -66.7 0.51 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.14 -31.2 70.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.289 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -68.4 -59.43 3.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HB3' ' HD2' ' A' ' 37' ' ' LYS 0.258 . . -61.7 -19.41 62.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.862 -1.148 . . . . 0.0 113.39 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.339 1.2 pp -91.95 -18.08 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.326 1.421 . . . . 0.0 110.785 172.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.73 2.73 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.021 2.128 . . . . 0.0 112.747 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -50.48 -37.92 41.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.177 1.391 . . . . 0.0 112.157 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -75.55 177.9 6.39 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.64 -0.78 1.34 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 118.777 -2.452 . . . . 0.0 111.632 174.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -93.34 8.24 41.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.373 0.669 . . . . 0.0 109.697 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.84 129.69 36.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.2 1.0 . . . . 0.0 108.63 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -99.03 -16.0 18.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.466 0.706 . . . . 0.0 111.347 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.39 161.78 12.08 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.757 1.623 . . . . 0.0 108.95 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB1' ' CG1' ' A' ' 45' ' ' VAL . . . -100.8 110.42 22.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.755 2.822 . . . . 0.0 109.469 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.15 94.54 6.66 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.26 131.12 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mm -117.44 142.44 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 m -120.39 101.55 7.86 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.451 HG13 ' CG2' ' A' ' 85' ' ' ILE . 25.0 t -60.22 156.96 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.026 1.33 . . . . 0.0 109.352 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.26 -49.44 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -151.25 140.79 21.61 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 120.887 -1.133 . . . . 0.0 111.741 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.12 139.49 49.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.154 2.582 . . . . 0.0 108.528 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -142.09 163.18 33.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.783 2.033 . . . . 0.0 109.694 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -90.97 142.4 27.82 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 121.206 -0.934 . . . . 0.0 109.89 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.17 -58.0 1.07 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.939 2.496 . . . . 0.0 110.92 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.6 pt? . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.294 1.437 . . . . 0.0 110.032 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.516 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.632 ' C ' HD12 ' A' ' 2' ' ' LEU . 4.9 mpp? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 1' ' ' MET . 8.4 mp -135.77 157.82 75.35 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.472 1.109 . . . . 0.0 108.264 -168.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.16 155.81 69.06 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.78 2.32 . . . . 0.0 111.142 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.94 -38.81 93.25 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.16 -38.97 63.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.839 1.256 . . . . 0.0 111.184 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -51.44 -54.23 28.92 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.823 1.192 . . . . 0.0 110.743 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -56.71 -48.27 78.08 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.27 1.028 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.6 -35.23 72.12 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.895 -0.574 . . . . 0.0 112.363 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 68' ' ' LEU . 88.2 t -69.16 -43.5 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.909 1.231 . . . . 0.0 109.369 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.05 -43.24 77.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.219 1.372 . . . . 0.0 112.176 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -51.99 -21.35 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.099 0.863 . . . . 0.0 113.284 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -110.83 174.03 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.744 1.618 . . . . 0.0 110.965 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -73.35 129.4 37.93 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.43 164.28 34.41 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.5 145.52 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.57 164.94 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.83 160.45 43.56 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 107.952 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 46' ' ' VAL . 90.4 mt -138.74 119.49 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.41 108.9 19.61 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 173.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.573 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -93.89 114.48 26.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 115.407 -2.235 . . . . 0.0 108.586 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -73.26 129.4 37.96 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 122.836 2.562 . . . . 0.0 107.958 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.85 -76.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 124.609 1.099 . . . . 0.0 110.892 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -158.66 -48.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.71 2.004 . . . . 0.0 108.465 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.77 38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.295 1.438 . . . . 0.0 111.268 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.36 152.33 5.96 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 22.3 Cg_endo -56.2 147.74 64.07 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 CA-C-N 122.25 3.025 . . . . 0.0 107.386 174.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.471 ' CG ' ' HE2' ' A' ' 53' ' ' LYS . 70.0 t60 -111.24 101.42 9.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.343 -172.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.02 88.71 3.54 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.565 1.546 . . . . 0.0 111.649 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.93 168.86 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.861 1.264 . . . . 0.0 110.113 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -119.14 166.66 12.65 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.267 1.394 . . . . 0.0 114.203 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -168.42 171.62 8.95 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.529 1.932 . . . . 0.0 109.636 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' HE1' HM73 ' A' ' 123' ' ' FMN . 89.9 m95 -121.17 141.84 50.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.444 2.297 . . . . 0.0 110.738 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -53.75 -31.17 47.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.341 0.656 . . . . 0.0 112.412 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -59.38 -12.47 5.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 112.97 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -117.92 -2.78 11.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.392 -1.443 . . . . 0.0 109.805 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 46' ' ' VAL . 10.3 mt -99.48 166.38 11.19 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.076 -1.015 . . . . 0.0 110.17 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -136.77 128.88 29.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.52 141.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.911 1.684 . . . . 0.0 107.581 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.94 -177.9 3.7 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.041 1.736 . . . . 0.0 108.385 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.51 175.21 5.72 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.687 1.195 . . . . 0.0 108.432 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.27 28.19 13.14 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.275 1.893 . . . . 0.0 111.053 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.533 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.335 0.1 OUTLIER 53.27 25.24 4.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.016 2.126 . . . . 0.0 114.537 -178.5 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -73.66 126.71 30.93 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -114.97 164.89 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.16 144.19 18.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 O-C-N 120.346 -1.471 . . . . 0.0 108.579 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.587 HG22 HD22 ' A' ' 36' ' ' LEU . 58.8 t -130.78 137.46 30.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.998 1.719 . . . . 0.0 108.611 -176.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 112.32 2.71 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 124.139 3.226 . . . . 0.0 111.663 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -85.4 112.45 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.28 -20.96 5.37 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.657 1.123 . . . . 0.0 113.051 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.86 39.67 0.39 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.775 -1.569 . . . . 0.0 111.293 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 6.3 mtt -112.11 71.48 0.74 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -63.82 -53.79 45.28 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.46 -0.775 . . . . 0.0 111.952 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HE2' ' CG ' ' A' ' 27' ' ' HIS . 3.9 ttpm? -51.93 -41.43 62.02 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.322 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -62.39 -39.36 92.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.03 1.286 . . . . 0.0 111.507 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 34.6 tt0 -55.98 -50.62 70.34 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.22 1.373 . . . . 0.0 109.482 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.2 97.88 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -67.64 -41.73 83.41 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.547 1.139 . . . . 0.0 109.156 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -48.07 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.735 1.152 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.72 31.14 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HE ' ' HB3' ' A' ' 60' ' ' ARG . 5.7 mmm180 -84.05 -46.9 11.5 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.651 1.114 . . . . 0.0 113.872 173.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -151.13 140.88 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.03 0.919 . . . . 0.0 111.567 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.78 -23.48 55.92 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.247 -0.908 . . . . 0.0 113.015 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.38 122.43 15.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.798 1.181 . . . . 0.0 110.339 -173.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 20' ' ' THR . 22.7 m -139.22 155.97 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 123.43 1.586 . . . . 0.0 111.453 174.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.8 tp -106.85 154.51 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.3 ttt -138.85 137.35 36.49 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -131.15 129.12 41.37 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -116.38 173.29 6.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.604 1.093 . . . . 0.0 111.831 174.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.17 178.52 45.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.9 t -151.07 165.59 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.054 0.93 . . . . 0.0 109.418 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -98.74 -20.72 16.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.344 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -91.76 -6.2 52.27 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.114 1.366 . . . . 0.0 113.904 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.62 131.45 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -78.86 131.5 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.415 1.086 . . . . 0.0 109.079 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 -141.5 11.47 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -85.89 -58.86 2.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.63 102.84 11.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.337 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.48 -178.5 0.66 Allowed Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.452 1.025 . . . . 0.0 113.987 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 85.0 Cg_endo -78.13 81.66 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.311 2.007 . . . . 0.0 109.828 175.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 103.79 0.17 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 t -98.68 169.23 9.64 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.739 1.269 . . . . 0.0 110.372 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.6 161.86 30.04 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.663 1.125 . . . . 0.0 111.741 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -134.73 145.44 48.46 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.503 1.921 . . . . 0.0 109.28 -173.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -101.01 131.53 46.85 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 128.525 2.73 . . . . 0.0 107.728 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -140.36 152.4 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.99 148.34 52.27 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.154 -0.966 . . . . 0.0 108.703 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.43 -168.17 36.16 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 118.847 0.749 . . . . 0.0 112.251 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -118.99 134.53 55.13 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.147 . . . . 0.0 108.867 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.67 158.76 15.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.556 1.142 . . . . 0.0 108.86 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.98 120.75 3.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.678 1.191 . . . . 0.0 108.297 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 29.8 m-85 -74.34 139.65 44.29 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.405 -0.809 . . . . 0.0 112.695 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -140.85 141.4 34.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.01 1.324 . . . . 0.0 109.929 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.1 p -120.67 41.1 3.35 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -159.32 159.55 34.06 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 129.478 3.111 . . . . 0.0 111.013 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.21 178.66 47.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.712 1.625 . . . . 0.0 114.003 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.77 -8.86 20.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.25 2.633 . . . . 0.0 111.059 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -65.53 0.66 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.941 2.497 . . . . 0.0 107.083 173.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -61.28 -31.77 71.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.283 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.01 -48.85 41.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.935 0.789 . . . . 0.0 110.527 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.5 67.83 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.55 -1.344 . . . . 0.0 112.568 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.4 pp -90.33 -18.14 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.107 0.867 . . . . 0.0 112.021 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.95 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.201 1.8 . . . . 0.0 111.685 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -50.56 -22.85 2.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -81.3 178.86 8.13 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.554 1.07 . . . . 0.0 110.732 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -135.63 20.44 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 119.904 -1.748 . . . . 0.0 110.025 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -132.45 10.48 4.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.675 1.59 . . . . 0.0 111.284 -174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.0 150.26 32.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.141 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -120.74 -21.91 6.49 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 129.139 2.975 . . . . 0.0 112.362 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.33 161.74 1.44 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.779 2.031 . . . . 0.0 110.01 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.89 112.36 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.2 94.62 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.78 131.29 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.5 mm -121.15 129.13 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.1 m -110.15 90.81 3.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 2' ' ' LEU . 94.0 t -61.17 159.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.37 -56.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 104.0 -2.592 . . . . 0.0 104.0 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.6 m -148.58 141.05 24.29 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.454 0.57 . . . . 0.0 112.115 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.01 143.74 46.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.544 3.138 . . . . 0.0 106.79 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.0 145.62 39.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.701 1.6 . . . . 0.0 108.016 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.2 140.05 37.8 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -129.42 -58.41 1.12 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.252 1.227 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.063 -173.499 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.528 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.24 154.26 71.53 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 119.127 0.876 . . . . 0.0 108.877 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.06 164.65 34.99 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.443 2.095 . . . . 0.0 110.879 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.29 -47.12 92.37 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.326 9.0 m -53.08 -38.56 62.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.648 1.179 . . . . 0.0 113.092 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -51.52 -58.56 5.96 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.0 1.273 . . . . 0.0 108.497 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -55.24 -48.25 74.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.856 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -53.99 -40.89 67.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.924 1.238 . . . . 0.0 111.009 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.7 t -68.85 -43.61 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.933 -1.105 . . . . 0.0 108.854 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.77 -36.35 72.02 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.257 1.389 . . . . 0.0 111.359 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -33.42 42.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 118.451 -2.655 . . . . 0.0 113.022 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -98.92 158.77 15.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 122.204 1.002 . . . . 0.0 110.928 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.29 141.13 41.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.44 175.09 47.41 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.13 144.76 8.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 125.143 1.377 . . . . 0.0 107.585 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.76 159.27 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.62 152.1 38.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.387 1.475 . . . . 0.0 107.289 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 46' ' ' VAL . 6.9 mt -138.99 117.94 13.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.5 19.61 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.555 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -89.03 110.83 21.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -73.95 141.81 45.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 122.11 2.232 . . . . 0.0 107.204 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.25 -81.8 0.26 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.63 -61.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.55 38.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.189 2.196 . . . . 0.0 110.165 173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.57 151.58 23.52 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.04 -1.037 . . . . 0.0 113.761 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.88 158.32 46.52 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.269 1.979 . . . . 0.0 112.918 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.32 101.86 7.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.107 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 10.9 tp -74.01 88.8 1.9 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.19 0.904 . . . . 0.0 110.666 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.86 170.97 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.986 1.315 . . . . 0.0 110.352 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.41 165.21 14.62 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.868 1.267 . . . . 0.0 111.172 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -168.41 172.31 8.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.7 2.0 . . . . 0.0 107.978 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.619 ' HE1' HM73 ' A' ' 123' ' ' FMN . 80.6 m95 -121.22 141.66 50.66 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.319 1.448 . . . . 0.0 110.235 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -51.2 -28.32 11.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.4 0.68 . . . . 0.0 111.104 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.41 -14.87 8.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.859 2.464 . . . . 0.0 111.751 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -118.13 -5.21 10.94 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.995 1.718 . . . . 0.0 109.686 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 46' ' ' VAL . 31.6 mt -97.32 171.64 8.29 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 120.332 -1.48 . . . . 0.0 112.882 -173.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 10.4 ptmt -136.08 135.87 39.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.55 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.4 mt -121.24 -178.18 3.71 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.073 1.749 . . . . 0.0 107.491 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -75.55 176.98 7.09 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 109.264 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.02 30.25 69.74 Favored Glycine 0 CA--C 1.525 0.698 0 O-C-N 120.475 -1.391 . . . . 0.0 110.831 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 p30 53.84 12.88 0.46 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.864 3.665 . . . . 0.0 114.868 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -74.8 122.44 23.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.9 mm -114.02 155.57 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 112' ' ' VAL . 41.0 t -137.46 140.54 41.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 18' ' ' ILE . 58.7 t -122.22 138.99 29.78 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 127.476 2.31 . . . . 0.0 108.778 -173.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.5 108.02 1.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.677 1.585 . . . . 0.0 109.589 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.729 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.87 111.81 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.35 -21.59 5.12 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.133 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 41.38 0.34 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.559 ' HB2' HG23 ' A' ' 48' ' ' VAL . 8.6 mtt -108.78 71.23 0.77 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 173.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -64.03 -63.11 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 129.817 3.247 . . . . 0.0 112.666 -173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -51.8 -40.75 60.94 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.351 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -62.92 -38.86 92.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.496 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -58.45 -50.42 73.78 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.611 1.55 . . . . 0.0 109.683 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.29 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.201 -0.312 . . . . 0.0 111.375 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -62.73 -41.8 99.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.044 -1.455 . . . . 0.0 110.336 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.69 -47.98 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 120.192 1.36 . . . . 0.0 108.542 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -23.63 13.55 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -87.44 -46.55 9.52 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.25 -1.531 . . . . 0.0 114.127 173.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -151.26 137.11 18.08 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.532 1.133 . . . . 0.0 112.656 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -22.48 54.34 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.67 126.57 27.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.697 1.589 . . . . 0.0 111.017 -173.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.6 m -139.07 144.06 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 111.941 173.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.75 150.36 21.14 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 16.8 ttt -139.17 120.8 15.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.7 p -108.82 127.97 54.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 pp -116.95 163.27 16.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 119.641 1.109 . . . . 0.0 109.229 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.05 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.5 t -158.1 166.91 31.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -99.02 -9.37 24.03 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -9.42 59.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.888 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.93 131.08 36.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.866 0.867 . . . . 0.0 110.437 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.38 5.9 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 125.575 1.56 . . . . 0.0 111.253 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.3 mmt-85 -84.08 -58.76 2.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.45 102.58 9.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.8 -168.07 0.16 Allowed Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.47 -1.394 . . . . 0.0 112.18 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.49 89.73 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 108.014 -1.571 . . . . 0.0 108.014 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.74 121.32 0.7 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-O 117.231 -1.872 . . . . 0.0 109.391 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.08 169.75 9.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.624 1.712 . . . . 0.0 110.906 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.62 -176.18 43.65 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 123.381 0.515 . . . . 0.0 112.576 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.4 145.68 49.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.127 2.171 . . . . 0.0 109.348 -174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.0 131.03 47.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.0 159.51 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -125.92 149.29 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.653 1.581 . . . . 0.0 107.782 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.84 -176.22 36.33 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.76 0.695 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.1 m -120.35 129.12 53.83 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.944 1.697 . . . . 0.0 108.102 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.23 160.23 14.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.871 1.668 . . . . 0.0 112.288 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.14 120.91 3.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.82 1.248 . . . . 0.0 108.678 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.71 144.48 39.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -140.84 138.28 33.87 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.148 1.379 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.3 p -120.87 40.93 3.42 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -159.17 157.18 30.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.754 2.821 . . . . 0.0 111.317 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.77 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.899 1.238 . . . . 0.0 114.538 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.79 -8.67 22.05 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.329 2.686 . . . . 0.0 110.687 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' CD ' ' HZ3' ' A' ' 37' ' ' LYS . 24.7 mm-40 -70.72 -63.18 1.14 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 108.15 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.13 -31.81 71.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.436 -0.793 . . . . 0.0 111.245 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -73.45 -48.43 33.68 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.915 0.779 . . . . 0.0 111.346 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.78 -25.16 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.003 -1.685 . . . . 0.0 112.12 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.377 1.2 pp -89.51 -18.22 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.855 1.207 . . . . 0.0 110.844 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.7 -27.52 2.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.048 2.539 . . . . 0.0 110.687 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -49.02 -37.21 19.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.073 0.949 . . . . 0.0 110.543 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -80.62 178.0 8.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 -0.56 1.39 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 117.979 -2.95 . . . . 0.0 111.864 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -87.56 8.33 25.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.914 1.286 . . . . 0.0 111.127 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.64 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.914 1.286 . . . . 0.0 111.962 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 -21.97 6.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 128.47 2.708 . . . . 0.0 111.119 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -177.27 162.03 1.89 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.203 1.801 . . . . 0.0 110.445 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.42 104.6 14.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.69 94.02 5.01 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.099 1.759 . . . . 0.0 107.079 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 45' ' ' VAL . 48.7 t -80.0 127.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.39 128.97 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.6 m -100.15 100.5 11.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.4 158.46 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.984 0.897 . . . . 0.0 109.304 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.57 -56.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 m -140.92 124.78 17.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 119.215 -0.421 . . . . 0.0 111.432 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.5 149.57 41.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.36 2.664 . . . . 0.0 111.176 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -141.68 144.66 34.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.134 1.774 . . . . 0.0 108.232 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -74.01 140.51 45.5 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -136.86 -77.61 0.41 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.255 1.364 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 -173.244 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.619 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.09 153.46 34.98 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.82 164.73 31.36 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.238 2.625 . . . . 0.0 111.877 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.92 96.58 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -55.7 -39.5 71.12 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.232 1.413 . . . . 0.0 110.446 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -51.06 -57.09 9.56 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.974 0.806 . . . . 0.0 110.017 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -58.83 -48.7 80.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.834 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -59.21 -41.16 87.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.08 -39.49 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.634 1.106 . . . . 0.0 109.107 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -58.55 -44.92 89.82 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.837 1.198 . . . . 0.0 111.251 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -51.99 -21.31 2.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -106.91 178.47 4.55 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 125.495 1.518 . . . . 0.0 110.983 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -73.55 129.43 37.96 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.15 167.16 33.81 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.01 146.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 173.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 t -130.52 159.8 42.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 28' ' ' LEU . . . -144.54 160.01 41.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.612 1.165 . . . . 0.0 108.999 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.3 mt -139.24 120.44 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -93.14 108.44 20.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 173.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.2 m -89.84 116.35 27.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 116.873 -1.536 . . . . 0.0 107.048 -173.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -73.42 135.81 44.23 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 121.582 1.992 . . . . 0.0 106.394 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.66 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.2 -59.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 15.9 p-10 -78.83 39.21 0.35 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.35 2.66 . . . . 0.0 111.429 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.34 151.47 21.01 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.238 0.923 . . . . 0.0 111.053 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.08 149.08 89.59 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 118.335 1.068 . . . . 0.0 109.986 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.463 ' CE1' ' HB3' ' A' ' 53' ' ' LYS . 15.3 t-160 -115.43 99.71 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.633 1.573 . . . . 0.0 110.641 -173.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD11 ' HB1' ' A' ' 17' ' ' ALA . 8.1 tp -82.13 103.54 11.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 110.406 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.15 168.65 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.675 1.59 . . . . 0.0 110.868 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 10.0 m120 -126.63 164.13 21.94 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -168.41 172.46 8.32 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.248 1.819 . . . . 0.0 110.242 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.457 ' NE1' HM73 ' A' ' 123' ' ' FMN . 96.2 m95 -121.37 141.77 50.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.913 2.485 . . . . 0.0 108.809 -178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.87 -30.38 45.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.57 0.623 . . . . 0.0 111.695 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -57.72 -13.72 4.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.576 1.95 . . . . 0.0 113.145 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -118.3 -2.47 11.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.793 1.237 . . . . 0.0 110.194 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 46' ' ' VAL . 17.4 mt -101.07 168.1 9.81 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.589 1.086 . . . . 0.0 111.82 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -136.87 128.76 29.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.3 142.95 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -121.06 -178.61 3.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.39 1.876 . . . . 0.0 106.183 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -73.71 -178.81 3.31 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.77 29.18 66.84 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 120.392 -1.443 . . . . 0.0 110.423 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.1 13.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 129.209 3.004 . . . . 0.0 115.155 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -73.18 141.73 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.361 0.982 . . . . 0.0 110.58 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.87 154.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.36 143.98 24.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 36' ' ' LEU . 61.9 t -126.94 134.38 26.05 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 126.649 1.98 . . . . 0.0 107.419 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.18 118.03 4.83 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.875 2.383 . . . . 0.0 107.651 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 109' ' ' ALA . 2.6 p -79.34 111.5 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.348 0.976 . . . . 0.0 108.999 173.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.94 -21.68 9.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.24 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.66 18.87 0.3 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 120.467 2.134 . . . . 0.0 114.386 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.433 ' HB2' HG23 ' A' ' 48' ' ' VAL . 29.9 mtt -97.96 52.24 1.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.77 1.285 . . . . 0.0 108.176 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -64.0 -51.55 63.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.368 0.667 . . . . 0.0 111.6 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.463 ' HB3' ' CE1' ' A' ' 27' ' ' HIS 0.285 17.5 ttpp -52.19 -41.16 62.42 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.325 -1.484 . . . . 0.0 110.839 173.443 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 57' ' ' ASN 0.27 1.6 m -60.35 -38.42 83.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.143 1.338 . . . . 0.0 113.026 173.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -55.39 -45.14 76.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.826 1.25 . . . . 0.0 107.829 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.31 81.07 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.958 -0.464 . . . . 0.0 111.647 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 3.8 m120 -59.6 -41.73 90.98 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 117.367 -1.301 . . . . 0.0 109.904 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.33 -48.24 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.122 1.328 . . . . 0.0 108.917 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.68 -25.98 12.49 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -46.44 10.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 173.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -151.5 134.08 15.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.991 1.268 . . . . 0.0 111.072 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -19.77 57.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.449 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.61 130.63 46.8 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.274 1.397 . . . . 0.0 110.92 -177.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.8 m -142.32 155.86 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 123.797 1.76 . . . . 0.0 112.99 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.9 tp -101.17 151.16 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.6 ttt -139.24 141.48 37.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 p -129.7 140.69 51.06 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -116.91 163.97 15.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.93 178.66 46.61 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.2 t -151.24 169.36 22.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -98.87 -18.36 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.55 1.54 . . . . 0.0 108.964 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -91.81 -1.46 57.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 117.073 -1.442 . . . . 0.0 113.938 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 t -130.99 127.03 60.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.32 131.42 36.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 109.149 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.97 -141.12 6.46 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -79.17 -59.02 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.733 1.613 . . . . 0.0 109.434 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.65 102.99 14.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.5 -169.4 2.21 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.84 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 69.7 Cg_endo -77.86 69.39 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.456 2.104 . . . . 0.0 110.412 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.49 108.37 0.32 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -101.88 169.57 8.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.06 172.55 45.48 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.457 1.031 . . . . 0.0 114.472 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.09 151.25 51.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 110.248 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -100.9 131.5 46.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 128.838 2.855 . . . . 0.0 104.464 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 68' ' ' LEU . 12.8 mt -135.59 153.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.1 mtt-85 -132.97 135.78 45.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.61 36.22 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.805 1.184 . . . . 0.0 112.182 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -121.23 148.21 44.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.729 0.812 . . . . 0.0 109.285 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -104.2 162.18 13.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.905 1.682 . . . . 0.0 110.669 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.3 113.07 2.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.536 1.134 . . . . 0.0 109.64 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 111' ' ' LEU . 8.5 m-85 -74.17 134.24 42.78 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -141.14 141.06 34.19 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.1 p -116.58 41.1 2.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.55 154.14 26.16 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.588 2.355 . . . . 0.0 110.466 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.1 178.67 47.3 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.854 1.692 . . . . 0.0 114.146 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.94 -9.42 19.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.709 2.939 . . . . 0.0 111.491 173.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -67.34 -64.8 0.78 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.402 1.481 . . . . 0.0 107.253 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -61.54 -31.4 71.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.485 1.114 . . . . 0.0 111.486 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.71 -56.07 9.32 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.304 0.956 . . . . 0.0 109.234 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.66 68.8 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.966 -1.084 . . . . 0.0 112.195 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.334 1.1 pp -85.89 -18.17 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.754 1.161 . . . . 0.0 111.869 173.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.68 -27.97 3.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.663 1.585 . . . . 0.0 112.062 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -50.53 -21.89 1.71 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.486 1.114 . . . . 0.0 113.827 173.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -80.91 178.66 8.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.706 1.139 . . . . 0.0 110.702 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -133.6 11.12 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.077 -1.639 . . . . 0.0 111.517 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -138.1 8.99 2.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.848 1.259 . . . . 0.0 112.968 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 151.84 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.307 1.043 . . . . 0.0 111.116 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -111.72 -21.93 11.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.392 1.077 . . . . 0.0 110.342 174.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 48' ' ' VAL . . . -178.19 161.96 1.52 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 127.718 2.407 . . . . 0.0 109.206 -173.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.43 105.97 18.05 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 91' ' ' PHE . 7.7 tp -79.63 92.82 5.4 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.35 129.76 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.092 1.357 . . . . 0.0 107.666 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.404 HD12 HG21 ' A' ' 64' ' ' VAL . 36.6 mm -117.28 133.7 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -112.02 97.28 6.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.53 161.26 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.464 1.506 . . . . 0.0 110.361 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.69 -55.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.2 m -151.54 141.46 22.02 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.832 -1.167 . . . . 0.0 112.476 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.1 138.74 48.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.938 2.895 . . . . 0.0 106.599 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -140.08 137.42 34.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.185 1.794 . . . . 0.0 107.749 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -77.15 141.16 40.28 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.6 p -129.64 -58.62 1.1 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.739 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.457 HM73 ' NE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' C ' HD12 ' A' ' 2' ' ' LEU . 4.9 mpp? . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.5 HD13 ' CB ' ' A' ' 42' ' ' ASN . 8.1 mp -130.68 154.2 81.72 Favored Pre-proline 0 N--CA 1.465 0.302 0 C-N-CA 124.764 1.225 . . . . 0.0 108.748 -171.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.09 154.63 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.713 2.275 . . . . 0.0 110.049 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.79 92.87 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -49.58 -38.57 31.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.682 1.593 . . . . 0.0 112.21 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -50.53 -54.75 20.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.226 1.375 . . . . 0.0 109.729 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -61.09 -48.54 81.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.516 1.126 . . . . 0.0 109.117 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.75 -34.14 74.0 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.1 t -72.71 -42.54 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.65 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.82 -39.75 82.13 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.437 1.471 . . . . 0.0 112.596 173.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -51.88 -24.99 7.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.965 0.802 . . . . 0.0 112.546 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -99.85 159.2 15.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.865 0.866 . . . . 0.0 109.402 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.56 146.12 45.01 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.335 -0.853 . . . . 0.0 109.078 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -179.27 171.23 43.1 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.551 HG23 HH12 ' A' ' 71' ' ' ARG . 6.6 t -101.63 148.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 68' ' ' LEU . 6.0 t -124.61 158.44 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 128.544 2.738 . . . . 0.0 104.771 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 28' ' ' LEU . . . -139.58 153.61 47.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 46' ' ' VAL . 7.4 mt -139.2 116.82 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.0 108.43 19.58 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.536 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -89.35 109.22 20.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 116.035 -1.935 . . . . 0.0 106.662 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -73.74 141.74 46.31 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 122.015 2.189 . . . . 0.0 107.754 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.52 -59.04 0.16 Allowed Glycine 0 C--O 1.223 -0.562 0 C-N-CA 123.56 0.6 . . . . 0.0 111.807 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HB3' HH21 ' A' ' 60' ' ' ARG . 4.2 tm-20 168.51 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 129.491 3.117 . . . . 0.0 107.856 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.7 46.98 0.7 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.819 1.771 . . . . 0.0 110.173 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.8 150.96 5.47 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.478 1.99 . . . . 0.0 111.36 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.37 162.44 38.34 Favored 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 120.463 0.775 . . . . 0.0 110.693 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -120.94 101.75 7.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 118.569 -0.729 . . . . 0.0 109.443 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 17' ' ' ALA . 10.0 tp -74.05 88.79 1.91 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.308 0.504 . . . . 0.0 110.541 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.39 169.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.719 1.208 . . . . 0.0 110.297 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -120.79 167.94 11.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.757 1.223 . . . . 0.0 111.333 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.25 170.23 10.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.549 1.94 . . . . 0.0 108.089 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.471 ' HE1' HM73 ' A' ' 123' ' ' FMN . 78.5 m95 -116.78 141.63 47.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.637 1.975 . . . . 0.0 109.338 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -55.17 -30.7 60.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -51.16 -21.05 1.76 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.174 2.589 . . . . 0.0 113.401 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -118.17 -4.33 10.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.207 1.403 . . . . 0.0 112.208 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 HG22 ' A' ' 46' ' ' VAL . 53.5 mt -97.08 166.83 11.4 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.036 1.289 . . . . 0.0 112.024 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -136.52 132.45 35.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -101.41 142.58 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.061 -2.199 . . . . 0.0 105.061 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.22 179.18 4.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.411 1.484 . . . . 0.0 108.274 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -70.33 174.81 5.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.194 0.998 . . . . 0.0 109.797 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.29 33.99 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.742 1.639 . . . . 0.0 110.928 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.5 ' CB ' HD13 ' A' ' 2' ' ' LEU 0.277 0.1 OUTLIER 53.49 19.87 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.893 2.077 . . . . 0.0 114.694 -176.833 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -74.69 135.79 41.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.92 161.12 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.5 t -144.64 145.46 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 O-C-N 120.674 -1.266 . . . . 0.0 108.379 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 HD22 ' A' ' 36' ' ' LEU . 59.3 t -129.21 137.53 31.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.605 2.762 . . . . 0.0 107.126 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.34 108.47 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.898 2.398 . . . . 0.0 111.066 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.85 111.87 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 108.853 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.94 -21.83 4.81 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.555 1.074 . . . . 0.0 112.605 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.71 41.13 0.43 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.089 -1.395 . . . . 0.0 110.135 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.491 ' HB2' HG23 ' A' ' 48' ' ' VAL . 18.4 mtt -108.65 71.48 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.149 1.379 . . . . 0.0 107.532 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -64.21 -65.33 0.69 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.284 3.433 . . . . 0.0 114.444 -173.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -51.7 -40.29 59.86 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.245 0.93 . . . . 0.0 108.602 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -63.14 -39.58 95.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.209 -0.9 . . . . 0.0 112.984 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 22.2 tt0 -58.59 -51.04 71.59 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 120.654 1.57 . . . . 0.0 109.623 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.59 -48.02 83.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.503 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -61.02 -41.97 97.57 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 116.197 -1.858 . . . . 0.0 111.311 -173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -48.09 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 120.248 1.385 . . . . 0.0 108.845 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.26 54.15 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.066 -0.969 . . . . 0.0 113.234 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.441 HH21 ' HB3' ' A' ' 23' ' ' GLU . 14.4 mtp180 -87.51 -46.91 9.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.027 1.285 . . . . 0.0 113.675 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -142.56 128.93 20.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.291 1.044 . . . . 0.0 111.802 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -18.86 58.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.65 126.48 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.389 1.45 . . . . 0.0 111.176 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.3 m -138.81 141.47 36.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.997 1.38 . . . . 0.0 112.584 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 3.5 tp -89.59 154.24 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.1 ttt -140.25 141.23 35.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.0 p -124.97 135.88 53.21 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.532 ' HA ' HG22 ' A' ' 16' ' ' VAL . 1.7 pp -116.47 164.64 14.27 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.007 173.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.67 178.78 41.94 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 38.5 t -147.29 174.11 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.945 1.298 . . . . 0.0 108.948 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.551 HH12 HG23 ' A' ' 15' ' ' VAL . 69.6 mtt85 -117.01 -8.03 11.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.425 2.29 . . . . 0.0 109.797 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 mmpm? -91.64 -11.08 38.08 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 119.482 -2.011 . . . . 0.0 115.304 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.37 133.1 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.21 131.48 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.29 1.036 . . . . 0.0 111.403 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.89 -141.19 6.95 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.463 HH22 ' CD ' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -85.9 -59.23 2.36 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.212 1.405 . . . . 0.0 107.607 176.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.49 102.95 6.24 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.82 -168.94 1.83 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 121.608 0.56 . . . . 0.0 112.964 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 62.4 Cg_endo -78.0 58.98 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.612 2.208 . . . . 0.0 110.87 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.55 120.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 t -113.72 168.95 9.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 117.777 0.789 . . . . 0.0 110.222 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.7 -176.72 40.23 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 124.703 1.144 . . . . 0.0 113.2 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.76 153.6 45.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.576 1.15 . . . . 0.0 109.662 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.52 129.53 47.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.8 mp -139.98 161.46 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 108.602 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.417 HH22 ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -139.15 151.06 46.33 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.605 -1.31 . . . . 0.0 107.905 173.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.13 -174.94 33.62 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.053 0.835 . . . . 0.0 111.782 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -115.93 129.34 56.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.245 1.418 . . . . 0.0 108.161 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.01 14.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.017 1.327 . . . . 0.0 112.162 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.01 120.68 3.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.767 1.227 . . . . 0.0 108.926 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.2 m-85 -76.73 140.58 40.87 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -140.8 139.24 34.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.672 1.189 . . . . 0.0 111.249 173.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -121.21 39.84 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 103.236 -2.875 . . . . 0.0 103.236 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.253 7.5 t70 -158.87 150.19 20.5 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.951 2.9 . . . . 0.0 111.55 -172.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.04 179.03 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.35 0.976 . . . . 0.0 114.183 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.42 -9.54 13.42 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.046 3.164 . . . . 0.0 112.179 173.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -67.66 -67.61 0.45 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.584 1.953 . . . . 0.0 106.943 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.45 -31.62 71.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.813 0.845 . . . . 0.0 111.925 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.71 -54.07 18.33 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.57 -32.56 72.66 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.099 -1.001 . . . . 0.0 112.567 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.403 1.1 pp -79.08 -17.84 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.017 0.826 . . . . 0.0 112.612 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.1 -27.69 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 111.367 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -45.67 -27.95 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.822 1.249 . . . . 0.0 112.975 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.06 178.88 8.14 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.306 1.042 . . . . 0.0 110.689 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -140.48 21.04 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 119.812 -1.805 . . . . 0.0 111.002 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -136.97 8.77 3.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.246 1.418 . . . . 0.0 111.117 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.22 25.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.68 -0.637 . . . . 0.0 110.664 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -21.05 8.01 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.173 2.189 . . . . 0.0 111.282 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.785 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.58 161.57 11.56 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.948 1.299 . . . . 0.0 109.772 -174.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.88 104.38 14.63 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.73 93.64 4.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.91 131.44 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.05 128.28 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 24.7 m -99.21 90.43 4.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 2' ' ' LEU . 77.7 t -60.6 159.38 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.66 -57.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.0 m -148.93 141.09 23.96 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.209 0.459 . . . . 0.0 112.038 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.91 138.88 53.89 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.306 3.042 . . . . 0.0 109.485 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CD ' HH22 ' A' ' 86' ' ' ARG . 17.7 pm0 -140.68 151.31 44.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.779 0.832 . . . . 0.0 110.874 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' HH22 ' A' ' 76' ' ' ARG . 0.0 OUTLIER -65.77 138.12 57.72 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 125.036 1.334 . . . . 0.0 109.944 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -138.45 -81.31 0.32 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.432 0.458 . . . . 0.0 110.836 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.456 ' C ' HH21 ' A' ' 76' ' ' ARG . 2.1 pp . . . . . 0 C--O 1.242 0.665 0 C-N-CA 123.955 0.902 . . . . 0.0 110.43 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.471 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' C ' HD12 ' A' ' 2' ' ' LEU . 5.1 mpp? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.569 HD11 ' CG1' ' A' ' 115' ' ' VAL . 9.5 mp -128.11 152.18 77.25 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 124.547 1.139 . . . . 0.0 108.197 -173.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.47 156.28 58.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.291 1.994 . . . . 0.0 110.321 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.77 92.89 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.49 -38.68 55.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.838 1.655 . . . . 0.0 112.234 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -50.79 -54.23 25.31 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.337 1.426 . . . . 0.0 109.401 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.86 -48.58 76.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.515 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -60.26 -33.78 72.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.346 0.975 . . . . 0.0 112.482 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.05 -41.03 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.484 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -39.77 85.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.88 1.218 . . . . 0.0 112.047 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.72 -24.85 6.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.975 1.261 . . . . 0.0 112.433 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -101.48 158.6 15.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.94 0.791 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.22 148.68 41.36 Favored 'General case' 0 C--O 1.243 0.741 0 O-C-N 121.074 -1.016 . . . . 0.0 109.818 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -178.19 168.23 39.37 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 122.852 0.263 . . . . 0.0 112.724 -174.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -101.08 144.53 12.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.33 159.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 127.752 2.421 . . . . 0.0 105.607 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.16 157.32 45.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.32 1.048 . . . . 0.0 109.531 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.7 118.7 12.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 125.232 1.413 . . . . 0.0 107.71 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.92 108.78 19.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.3 m -88.79 109.42 20.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -73.53 141.23 46.73 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.42 -81.63 0.22 Allowed Glycine 0 C--O 1.221 -0.714 0 N-CA-C 106.007 -2.837 . . . . 0.0 106.007 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -170.69 -59.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.92 52.12 1.21 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.497 1.618 . . . . 0.0 110.201 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.57 144.94 3.93 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.83 2.157 . . . . 0.0 111.551 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.92 161.29 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.362 1.374 . . . . 0.0 109.983 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -121.12 97.46 5.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.976 1.71 . . . . 0.0 107.462 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 11.0 tp -83.55 88.55 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.8 0.727 . . . . 0.0 109.322 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.23 169.04 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.013 0.925 . . . . 0.0 110.293 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.81 167.61 11.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.235 1.414 . . . . 0.0 112.856 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 t -168.35 174.61 6.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.627 1.971 . . . . 0.0 108.021 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.451 ' NE1' HM73 ' A' ' 123' ' ' FMN . 83.4 m95 -120.56 141.99 49.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.702 2.401 . . . . 0.0 109.463 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -53.88 -30.75 47.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.334 0.97 . . . . 0.0 109.737 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -52.15 -21.16 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.535 2.334 . . . . 0.0 112.671 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -118.12 -5.12 10.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.921 1.688 . . . . 0.0 112.108 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.7 mt -87.8 159.22 18.52 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.506 1.503 . . . . 0.0 111.588 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 100' ' ' ALA 0.25 0.0 OUTLIER -136.36 131.85 34.79 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.802 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.18 147.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.57 178.89 4.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.397 1.879 . . . . 0.0 107.725 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -71.28 175.86 5.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.107 0.963 . . . . 0.0 110.47 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.87 28.43 57.57 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.333 1.444 . . . . 0.0 111.476 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.518 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.272 0.1 OUTLIER 53.72 20.73 2.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.415 1.886 . . . . 0.0 114.375 -175.239 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -73.97 126.31 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.152 1.381 . . . . 0.0 107.373 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.66 159.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -146.0 144.28 20.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 120.536 -1.353 . . . . 0.0 109.262 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.92 136.54 28.59 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.925 2.09 . . . . 0.0 107.534 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.69 108.32 1.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.455 2.104 . . . . 0.0 109.039 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.49 111.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.19 -21.33 10.11 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.338 1.447 . . . . 0.0 113.255 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.92 0.31 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 119.305 1.553 . . . . 0.0 115.09 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -97.89 67.94 1.99 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 123.394 1.568 . . . . 0.0 108.353 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -64.21 -48.79 74.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.193 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.255 81.8 tttt -52.04 -36.29 49.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.794 1.633 . . . . 0.0 110.674 173.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -64.86 -39.51 93.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.429 1.468 . . . . 0.0 110.705 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 32.3 tt0 -55.08 -50.73 68.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.507 1.503 . . . . 0.0 110.631 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.1 79.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.131 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -58.52 -41.99 86.72 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 115.781 -2.057 . . . . 0.0 111.45 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.16 -48.36 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.874 1.216 . . . . 0.0 109.116 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.94 66.05 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.267 -0.873 . . . . 0.0 113.277 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -87.44 -47.06 9.07 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.662 1.119 . . . . 0.0 112.48 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -140.04 132.31 28.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.65 1.18 . . . . 0.0 112.325 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.97 -22.52 55.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.452 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.51 129.65 42.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.896 1.225 . . . . 0.0 112.47 -173.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.4 m -139.29 139.4 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.837 1.303 . . . . 0.0 112.336 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 20.2 tp -92.98 153.7 18.59 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 172.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.6 ttt -140.03 141.37 36.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -123.17 130.62 53.0 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 pp -115.35 166.19 12.14 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.617 1.098 . . . . 0.0 108.38 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.63 179.11 41.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 173.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.443 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 47.2 t -147.18 168.67 21.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.687 1.595 . . . . 0.0 108.157 174.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -116.42 -9.41 11.48 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.014 1.326 . . . . 0.0 109.87 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -92.38 -11.67 34.3 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.44 134.19 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 118.5 20.66 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.941 0.791 . . . . 0.0 112.33 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 81' ' ' THR . . . -121.5 -127.26 3.37 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.91 1.243 . . . . 0.0 111.704 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -91.68 -58.7 2.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -74.62 102.63 4.64 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 109.875 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.55 -167.9 0.4 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.27 62.85 5.25 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.72 121.88 1.39 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 129.73 3.538 . . . . 0.0 106.83 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.415 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 3.5 t -109.98 176.82 4.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.132 0.966 . . . . 0.0 110.699 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.52 177.41 44.38 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 124.839 1.209 . . . . 0.0 112.158 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -138.4 154.65 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.149 0.979 . . . . 0.0 108.369 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.27 129.3 47.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.46 154.04 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 119' ' ' GLU . 36.7 mtm180 -135.89 141.64 44.61 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.882 1.273 . . . . 0.0 108.618 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -169.81 34.94 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.412 0.53 . . . . 0.0 112.238 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.8 m -121.11 151.1 40.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.959 1.303 . . . . 0.0 109.074 173.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.32 163.64 13.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.625 1.17 . . . . 0.0 113.017 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.59 121.19 3.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.103 1.361 . . . . 0.0 109.377 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.5 m-85 -77.55 149.07 34.93 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.231 -0.918 . . . . 0.0 111.989 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -141.03 134.42 29.78 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 125.339 1.456 . . . . 0.0 107.709 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.0 p -120.42 20.17 11.93 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.597 173.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.75 150.1 20.65 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.698 2.399 . . . . 0.0 109.583 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.59 -177.83 45.45 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.917 1.246 . . . . 0.0 112.507 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.26 -14.27 19.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.133 3.222 . . . . 0.0 113.524 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.3 -63.72 1.01 Allowed 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.101 -0.999 . . . . 0.0 108.978 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.64 -31.62 71.73 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.448 1.499 . . . . 0.0 111.079 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -69.12 -49.66 55.01 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.438 0.695 . . . . 0.0 109.636 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -61.13 -35.39 76.94 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.146 -0.971 . . . . 0.0 111.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.402 0.8 OUTLIER -79.02 -17.89 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.736 173.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.2 -27.58 2.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.691 1.996 . . . . 0.0 112.22 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -47.65 -36.38 10.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.305 1.042 . . . . 0.0 111.205 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -80.89 177.95 8.72 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.308 0.958 . . . . 0.0 108.537 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -141.14 -0.6 1.44 Allowed 'General case' 0 C--O 1.222 -0.393 0 O-C-N 119.18 -2.2 . . . . 0.0 112.262 -176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -106.3 8.87 32.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.032 1.733 . . . . 0.0 110.873 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.41 145.75 29.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.389 -0.819 . . . . 0.0 110.869 -174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -121.29 -13.71 8.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.864 2.866 . . . . 0.0 111.913 -174.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -173.78 161.71 3.89 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.143 2.177 . . . . 0.0 109.536 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.17 101.97 11.42 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.386 2.275 . . . . 0.0 105.012 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.07 95.91 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.672 1.589 . . . . 0.0 106.764 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.98 131.67 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.16 128.49 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.6 m -98.92 88.46 4.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.569 ' CG1' HD11 ' A' ' 2' ' ' LEU . 86.4 t -61.03 156.13 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.827 175.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.49 -55.46 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.5 m -148.5 141.25 24.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.666 0.666 . . . . 0.0 112.32 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.35 138.73 51.59 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 128.919 2.887 . . . . 0.0 107.886 173.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 86' ' ' ARG . 3.3 pm0 -140.1 138.68 35.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 110.609 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 138.58 58.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 111.928 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -143.39 -80.51 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.259 0.624 . . . . 0.0 112.299 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 114.892 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.451 HM73 ' NE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' C ' HD22 ' A' ' 2' ' ' LEU . 66.2 mtt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.4 mm? -136.16 153.26 76.54 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.156 1.382 . . . . 0.0 108.691 -172.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.12 164.34 35.68 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.813 2.342 . . . . 0.0 110.329 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.86 -47.56 89.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.367 5.0 m -50.3 -38.11 39.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.255 1.822 . . . . 0.0 113.635 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -50.65 -51.97 44.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.095 1.316 . . . . 0.0 110.649 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -63.55 -48.35 77.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.035 0.934 . . . . 0.0 110.13 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.71 -38.09 66.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.427 1.012 . . . . 0.0 111.757 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.86 -43.77 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.083 -1.011 . . . . 0.0 109.629 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.65 -35.06 75.28 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.202 1.364 . . . . 0.0 112.32 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -51.84 -27.09 11.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.025 0.93 . . . . 0.0 112.133 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -99.37 159.2 15.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.468 1.107 . . . . 0.0 108.114 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.92 153.34 39.86 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 122.077 0.941 . . . . 0.0 109.151 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.97 174.52 45.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 125.611 1.577 . . . . 0.0 109.422 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.92 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.74 160.93 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.22 154.69 44.1 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.84 116.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -174.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 26' ' ' PRO . . . -88.56 108.86 19.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -94.36 123.05 37.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 116.971 -1.49 . . . . 0.0 108.134 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -72.91 119.55 17.31 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 121.242 1.837 . . . . 0.0 106.579 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.29 -81.65 0.23 Allowed Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.136 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -158.63 -60.7 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -78.82 41.03 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.113 2.565 . . . . 0.0 110.479 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.63 152.24 9.47 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.572 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 18.8 Cg_endo -54.25 148.05 42.81 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 CA-C-N 120.791 2.295 . . . . 0.0 107.973 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -103.3 101.3 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.195 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -76.22 88.53 3.08 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.168 0.587 . . . . 0.0 110.425 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -83.24 170.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.887 1.675 . . . . 0.0 110.069 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.13 166.1 13.35 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.09 1.314 . . . . 0.0 113.793 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.0 t -168.32 176.19 6.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.374 2.27 . . . . 0.0 108.054 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.458 ' HE1' HM73 ' A' ' 123' ' ' FMN . 82.2 m95 -118.95 141.81 48.34 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.659 1.983 . . . . 0.0 109.721 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.07 -31.56 42.37 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.372 0.669 . . . . 0.0 110.016 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -60.76 -11.79 8.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.903 3.281 . . . . 0.0 112.108 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -118.68 -6.36 10.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 111.58 -177.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.4 HD22 HG22 ' A' ' 46' ' ' VAL . 22.6 mt -95.05 160.11 14.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.089 1.313 . . . . 0.0 112.084 -173.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 141.61 44.64 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.28 150.95 5.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -122.0 179.21 4.59 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 128.461 2.704 . . . . 0.0 107.103 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.97 -179.91 2.47 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.26 28.21 26.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.479 1.514 . . . . 0.0 111.245 -173.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.6 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.342 0.1 OUTLIER 53.39 24.59 4.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.891 2.076 . . . . 0.0 114.32 -175.817 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.45 151.26 41.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.29 164.38 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -144.43 140.93 24.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 36' ' ' LEU . 59.8 t -123.0 124.86 26.44 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 127.483 2.313 . . . . 0.0 105.4 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.87 108.52 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.116 1.878 . . . . 0.0 109.008 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.833 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.83 111.61 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -21.24 6.85 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 112.077 173.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.3 40.89 0.31 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 119.095 1.448 . . . . 0.0 110.697 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.496 ' HB2' HG23 ' A' ' 48' ' ' VAL . 28.7 mtt -106.56 57.5 0.65 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.799 1.239 . . . . 0.0 108.598 173.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.53 -49.81 37.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.627 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -52.17 -41.3 62.48 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.821 1.646 . . . . 0.0 110.854 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -61.1 -38.91 88.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.514 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.53 -49.51 76.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 121.04 1.746 . . . . 0.0 110.413 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.62 97.08 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -61.88 -41.94 98.46 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.567 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.36 -48.15 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.746 1.157 . . . . 0.0 109.32 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.14 53.18 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.387 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.5 mtp85 -85.56 -46.31 10.94 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.102 0.864 . . . . 0.0 112.726 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.46 129.21 15.2 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.161 0.984 . . . . 0.0 110.962 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -73.92 -17.75 60.98 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.53 123.19 16.04 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 20' ' ' THR . 11.9 m -138.82 141.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 123.082 1.42 . . . . 0.0 110.52 173.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.0 tt -107.32 148.48 28.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 102.091 -3.299 . . . . 0.0 102.091 172.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.4 ttt -141.66 121.06 13.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -108.93 128.36 54.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 168.52 10.01 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.042 1.292 . . . . 0.0 107.847 173.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.64 -169.22 31.8 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -147.01 175.47 10.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.409 1.099 . . . . 0.0 108.707 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -113.87 -7.94 13.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.676 2.391 . . . . 0.0 109.317 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mmpm? -91.46 -10.95 39.03 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 119.601 -1.937 . . . . 0.0 115.007 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.76 136.49 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.57 131.49 36.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.479 1.112 . . . . 0.0 111.104 -175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.44 -140.98 6.34 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 124.703 1.144 . . . . 0.0 110.886 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.27 -58.99 2.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.564 1.546 . . . . 0.0 107.731 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.95 102.84 8.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.072 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.24 -168.6 2.26 Favored Glycine 0 CA--C 1.538 1.499 0 O-C-N 121.754 -0.591 . . . . 0.0 112.655 176.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 77.9 Cg_endo -75.52 59.74 5.61 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.815 2.344 . . . . 0.0 110.993 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.25 121.11 1.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -113.47 169.88 8.64 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.477 1.138 . . . . 0.0 110.334 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.2 -177.36 45.15 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 123.602 0.62 . . . . 0.0 113.283 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -136.8 152.67 50.56 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.862 1.265 . . . . 0.0 109.502 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tt -101.39 131.27 47.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.648 2.379 . . . . 0.0 104.58 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -136.06 158.33 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -129.86 150.79 51.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.644 1.178 . . . . 0.0 109.453 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -174.59 40.9 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.455 1.026 . . . . 0.0 111.693 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -106.03 137.35 44.1 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.4 161.93 13.33 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.787 0.722 . . . . 0.0 111.181 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.2 119.24 3.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.148 0.979 . . . . 0.0 109.833 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -74.17 131.52 41.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.2 141.46 50.65 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.83 2.852 . . . . 0.0 109.572 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.14 27.07 8.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.384 1.873 . . . . 0.0 107.425 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -158.81 163.95 36.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.11 2.564 . . . . 0.0 107.797 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.48 178.35 46.82 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.072 1.796 . . . . 0.0 113.077 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.41 -22.91 58.95 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.167 2.578 . . . . 0.0 112.007 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -64.29 -59.31 4.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 173.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -61.56 -31.31 71.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.094 -1.431 . . . . 0.0 112.402 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -68.47 -53.99 19.83 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.957 1.708 . . . . 0.0 108.227 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.51 69.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.909 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.4 pp -93.67 -19.9 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.764 -1.113 . . . . 0.0 112.87 173.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.94 -35.21 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.533 1.969 . . . . 0.0 110.406 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.285 2.2 ptm180 -51.07 -18.18 0.78 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.947 2.099 . . . . 0.0 113.815 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -67.88 -171.2 0.2 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -132.13 4.17 4.07 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 118.597 -2.564 . . . . 0.0 113.786 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 23.3 p-90 -131.05 8.84 4.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.811 0.844 . . . . 0.0 111.704 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.86 140.61 38.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.498 -0.751 . . . . 0.0 109.062 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.21 -10.59 8.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.348 1.459 . . . . 0.0 111.418 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.833 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.0 161.85 10.77 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.79 2.436 . . . . 0.0 108.201 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.43 107.63 18.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.802 2.041 . . . . 0.0 106.6 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 tt -84.49 96.34 9.09 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.9 t -79.29 131.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.672 1.589 . . . . 0.0 107.516 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.06 128.86 75.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.4 m -106.09 92.19 4.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 2' ' ' LEU . 14.3 t -61.08 157.42 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.888 1.275 . . . . 0.0 110.723 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.52 -56.27 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.9 m -151.29 141.66 22.43 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.37 155.2 29.99 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 128.538 2.735 . . . . 0.0 112.295 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -141.07 140.95 34.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.815 2.046 . . . . 0.0 108.208 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -76.56 140.77 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -138.7 -79.49 0.34 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.307 0.643 . . . . 0.0 111.5 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.242 0.697 0 CA-C-O 116.825 -1.559 . . . . 0.0 112.169 -174.182 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.458 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 118' ' ' ALA . 67.0 mt -133.18 167.36 23.34 Favored Pre-proline 0 N--CA 1.466 0.368 0 C-N-CA 124.609 1.163 . . . . 0.0 110.05 -169.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.77 152.39 42.48 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.846 2.364 . . . . 0.0 111.939 173.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.84 -39.18 93.54 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.35 -40.27 58.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.624 1.57 . . . . 0.0 111.89 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -51.28 -56.08 14.85 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.251 0.932 . . . . 0.0 110.611 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -56.06 -48.27 76.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.126 0.97 . . . . 0.0 110.454 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -55.41 -35.04 64.95 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.697 0.681 . . . . 0.0 112.565 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.6 t -69.06 -46.59 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.113 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' HG ' HG21 ' A' ' 38' ' ' VAL . 4.0 mm? -54.48 -41.32 69.42 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.169 1.35 . . . . 0.0 112.879 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -51.55 -18.71 1.19 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -119.94 158.69 26.2 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.367 0.985 . . . . 0.0 108.781 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -80.61 149.28 29.93 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.543 -1.348 . . . . 0.0 110.39 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.4 169.63 42.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.705 2.098 . . . . 0.0 110.194 174.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.1 151.04 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.98 159.58 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 127.574 2.349 . . . . 0.0 105.749 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.72 40.85 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.241 1.416 . . . . 0.0 109.419 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.589 HD11 HG21 ' A' ' 46' ' ' VAL . 9.8 mt -145.32 115.82 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.82 19.78 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -95.91 108.82 21.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -79.56 141.33 36.71 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 122.002 2.183 . . . . 0.0 106.168 173.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 -81.49 0.22 Allowed Glycine 0 C--O 1.224 -0.486 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -159.06 -61.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.4 45.73 0.68 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.131 1.772 . . . . 0.0 110.123 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 151.62 6.74 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.953 1.263 . . . . 0.0 112.685 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.19 157.72 53.37 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.212 1.275 . . . . 0.0 110.878 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.46 102.03 8.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.087 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.6 tt -87.35 88.71 7.76 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -175.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.58 173.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.762 2.025 . . . . 0.0 110.676 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.63 165.62 14.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.584 1.154 . . . . 0.0 111.574 173.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 178.43 4.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.247 2.219 . . . . 0.0 108.052 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -121.36 141.79 50.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.811 2.044 . . . . 0.0 110.685 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -51.52 -30.98 22.29 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.509 1.049 . . . . 0.0 110.799 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.48 -13.08 4.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.948 2.899 . . . . 0.0 112.008 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -118.14 -1.16 11.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.13 1.372 . . . . 0.0 110.48 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.613 HD22 HG22 ' A' ' 46' ' ' VAL . 27.6 mt -102.4 168.92 9.01 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.599 -1.313 . . . . 0.0 112.762 -173.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 125.3 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 172.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.422 HG21 ' HG ' ' A' ' 10' ' ' LEU . 35.3 t -101.69 148.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.9 mt -121.58 -177.11 3.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.944 2.098 . . . . 0.0 107.973 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 36.2 t0 -71.44 177.99 3.68 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 49.37 28.15 8.96 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 126.098 1.809 . . . . 0.0 110.443 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.3 0.5 OUTLIER 53.23 28.27 6.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.373 2.269 . . . . 0.0 114.304 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -73.62 144.63 45.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 173.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.79 159.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 t -143.05 141.76 26.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.613 HG22 HD22 ' A' ' 36' ' ' LEU . 57.7 t -122.79 140.39 33.11 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.302 2.641 . . . . 0.0 106.066 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.43 110.97 2.02 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.795 2.33 . . . . 0.0 108.61 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.754 ' CG1' ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.3 112.22 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.25 -21.77 5.44 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.081 -1.012 . . . . 0.0 112.148 173.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.78 41.31 0.35 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.344 1.572 . . . . 0.0 109.958 -175.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 48' ' ' VAL . 22.0 mtt -105.71 71.13 0.9 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.677 1.191 . . . . 0.0 108.498 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.39 -65.57 0.66 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 130.048 3.339 . . . . 0.0 114.558 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -51.72 -41.27 61.39 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -63.47 -38.69 92.11 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.66 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 35.4 tt0 -56.29 -51.22 68.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.242 1.383 . . . . 0.0 109.489 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.53 93.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.175 0.59 . . . . 0.0 112.158 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -65.34 -41.93 93.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.576 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.8 -48.06 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.23 -28.82 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.157 -0.925 . . . . 0.0 112.819 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -86.81 -46.3 10.09 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.598 -1.191 . . . . 0.0 112.087 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -149.05 140.78 23.56 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.749 1.159 . . . . 0.0 110.255 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -13.27 62.24 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 63' ' ' ARG . 8.8 mmp_? -49.88 114.16 1.01 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.754 2.422 . . . . 0.0 115.934 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 20' ' ' THR . 7.7 m -141.7 146.32 23.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 CA-C-O 123.905 1.812 . . . . 0.0 114.797 173.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 4.0 tt -111.46 148.78 32.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 101.623 -3.473 . . . . 0.0 101.623 172.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.4 ttt -141.05 140.98 34.33 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -121.6 128.21 51.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 175.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -117.19 169.73 9.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.227 -1.546 . . . . 0.0 108.112 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.86 -176.22 38.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.441 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 t -148.65 164.14 35.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.709 0.804 . . . . 0.0 110.364 174.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -98.35 -8.68 26.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.748 1.619 . . . . 0.0 109.447 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -91.39 -9.89 43.12 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 116.891 -1.528 . . . . 0.0 114.725 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -131.45 138.86 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 131.07 36.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.502 0.721 . . . . 0.0 110.753 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.25 -140.43 9.26 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 124.907 1.241 . . . . 0.0 111.765 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -90.68 -58.6 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.38 103.06 9.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.08 -168.67 3.91 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 113.129 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.28 58.82 6.81 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.658 2.238 . . . . 0.0 111.132 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.46 120.99 1.07 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -114.45 169.17 9.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.733 1.266 . . . . 0.0 110.105 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.54 178.21 41.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-O 121.725 0.625 . . . . 0.0 112.261 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.71 149.1 49.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.383 1.473 . . . . 0.0 108.473 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tt -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mm -131.35 156.53 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -135.59 146.01 47.51 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.285 1.434 . . . . 0.0 108.686 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.19 -165.54 34.46 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.942 0.782 . . . . 0.0 112.183 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.5 m -115.88 147.54 40.97 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.057 1.343 . . . . 0.0 108.045 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.99 164.35 12.89 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.794 1.637 . . . . 0.0 111.873 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.94 120.95 2.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.394 1.078 . . . . 0.0 108.853 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 63.8 m-85 -76.24 138.7 40.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -140.63 141.35 35.11 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.094 0.958 . . . . 0.0 110.112 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.3 p -117.2 39.64 3.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -159.07 156.13 28.63 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 128.115 2.566 . . . . 0.0 111.567 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.15 178.54 47.26 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.292 1.901 . . . . 0.0 114.391 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.71 -17.26 58.07 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.347 2.698 . . . . 0.0 111.584 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -63.77 1.13 Allowed 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.151 1.78 . . . . 0.0 107.488 173.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.45 -31.26 71.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.03 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -68.62 -49.08 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.555 1.07 . . . . 0.0 109.074 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.96 78.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.218 -0.926 . . . . 0.0 111.404 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.345 0.9 OUTLIER -82.58 -18.41 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.55 173.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.01 -27.96 3.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.826 1.651 . . . . 0.0 112.133 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -51.17 -35.9 38.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.72 0.808 . . . . 0.0 111.78 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.26 177.84 8.53 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -141.37 -1.11 1.36 Allowed 'General case' 0 C--O 1.222 -0.387 0 O-C-N 119.144 -2.222 . . . . 0.0 113.18 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -98.26 8.76 44.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.449 1.1 . . . . 0.0 110.271 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.37 150.8 28.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.524 -0.735 . . . . 0.0 111.03 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -120.88 -21.28 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.168 2.987 . . . . 0.0 111.024 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . . . -171.5 161.77 6.37 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.736 2.014 . . . . 0.0 109.114 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.99 108.38 19.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.5 93.89 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.04 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.9 128.68 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.1 m -106.2 92.09 3.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.04 155.48 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.848 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.05 -41.79 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.521 1.528 . . . . 0.0 107.275 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.5 m -151.26 141.0 21.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.838 1.199 . . . . 0.0 113.618 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 2' ' ' LEU . . . -115.5 140.13 49.43 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 129.948 3.299 . . . . 0.0 110.626 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -139.3 136.31 34.73 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.013 1.725 . . . . 0.0 109.291 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -75.91 140.82 42.33 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -137.23 -77.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.256 1.397 0 C-N-CA 125.359 1.464 . . . . 0.0 114.37 -173.539 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.6 ' C ' HD12 ' A' ' 2' ' ' LEU . 19.0 mmt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 42' ' ' ASN . 7.4 mp -139.6 157.31 70.42 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 124.372 1.069 . . . . 0.0 108.877 -171.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.43 159.39 51.63 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.677 2.251 . . . . 0.0 111.832 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.16 -38.77 93.6 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -48.5 -43.14 34.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.065 1.746 . . . . 0.0 111.427 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.34 -55.45 18.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.352 0.978 . . . . 0.0 111.247 174.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -56.7 -48.52 77.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -59.21 -33.62 71.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.759 0.709 . . . . 0.0 112.835 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.76 -41.93 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -59.6 -38.4 81.12 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.33 1.423 . . . . 0.0 112.493 173.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 -18.9 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.177 1.353 . . . . 0.0 112.63 173.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -113.73 159.05 20.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.414 1.086 . . . . 0.0 108.754 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -73.72 148.36 42.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.924 -1.11 . . . . 0.0 108.794 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -165.35 171.25 40.59 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 126.801 2.143 . . . . 0.0 110.079 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.42 150.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -139.82 160.46 26.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.974 2.109 . . . . 0.0 106.041 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 157.05 44.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.512 1.125 . . . . 0.0 108.46 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 HG21 ' A' ' 46' ' ' VAL . 23.0 mt -139.4 115.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -176.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.04 108.56 19.65 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 174.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -91.36 114.3 26.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 116.308 -1.806 . . . . 0.0 106.649 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.41 141.5 46.95 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 121.845 2.111 . . . . 0.0 108.47 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.28 -81.05 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -158.82 -56.98 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 20.0 p-10 -78.87 38.34 0.33 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.668 2.787 . . . . 0.0 111.517 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.37 151.67 6.48 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.416 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.92 148.9 58.53 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 CA-C-N 118.028 0.914 . . . . 0.0 111.449 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -101.88 101.39 11.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.84 88.64 3.44 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.663 0.665 . . . . 0.0 110.071 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.3 m -80.31 170.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.15 1.38 . . . . 0.0 110.046 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -119.36 165.91 13.72 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 0.989 . . . . 0.0 112.523 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -168.29 176.22 6.03 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 108.548 175.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.16 141.53 50.74 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.433 1.893 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.26 -31.06 52.65 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.111 0.869 . . . . 0.0 109.706 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -59.95 -13.33 10.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.765 2.826 . . . . 0.0 111.413 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -119.23 -2.94 10.6 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 46' ' ' VAL . 42.5 mt -90.18 164.78 14.3 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.477 1.489 . . . . 0.0 112.229 -173.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -134.98 132.2 38.08 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.17 145.74 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.48 179.13 4.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.333 1.853 . . . . 0.0 108.101 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.44 175.24 4.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.347 1.059 . . . . 0.0 109.474 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.09 28.42 33.38 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.721 1.629 . . . . 0.0 111.105 -173.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.61 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.28 0.1 OUTLIER 53.41 23.11 3.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.86 2.064 . . . . 0.0 114.102 -177.029 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -73.58 129.08 37.22 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -118.0 150.91 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.51 147.08 24.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 120.837 -1.164 . . . . 0.0 108.843 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 18' ' ' ILE . 58.7 t -126.65 135.73 27.69 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 126.188 1.795 . . . . 0.0 107.869 -173.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.0 108.36 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.022 1.815 . . . . 0.0 108.457 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.877 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.57 111.52 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.52 -21.35 6.9 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 112.256 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.75 41.38 0.32 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 117.46 -1.745 . . . . 0.0 109.901 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.503 ' HB2' HG23 ' A' ' 48' ' ' VAL . 20.1 mtt -109.12 59.82 0.6 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.654 1.181 . . . . 0.0 109.225 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -71.48 -49.65 39.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.994 -174.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HZ1' ' CG ' ' A' ' 24' ' ' ASP . 55.0 tttp -51.99 -41.44 62.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.044 1.747 . . . . 0.0 109.296 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -60.73 -39.47 88.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.151 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.93 -48.28 80.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 121.248 1.84 . . . . 0.0 110.782 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.68 99.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.099 0.159 . . . . 0.0 111.253 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -62.88 -41.87 99.56 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.379 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.7 -48.24 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.409 1.459 . . . . 0.0 109.132 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.49 -28.17 59.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -46.42 15.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -151.34 128.61 11.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.986 0.914 . . . . 0.0 109.204 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -15.39 60.05 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.799 -1.188 . . . . 0.0 113.969 -174.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.495 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.64 130.69 47.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.641 1.11 . . . . 0.0 111.575 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 20' ' ' THR . 11.7 m -139.35 156.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 123.392 1.567 . . . . 0.0 111.895 173.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.7 tp -108.93 149.87 28.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.3 ttt -140.01 123.02 16.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -109.02 127.99 54.57 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.97 172.4 7.29 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.421 1.464 . . . . 0.0 109.559 173.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.44 -166.16 27.03 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.0 t -146.65 159.94 42.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.83 0.852 . . . . 0.0 109.467 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -98.69 -15.47 19.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.145 0.978 . . . . 0.0 108.994 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.03 -7.01 50.01 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 116.323 -1.799 . . . . 0.0 115.388 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.02 129.69 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 121.767 2.076 . . . . 0.0 106.14 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.3 131.42 36.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.907 0.883 . . . . 0.0 110.631 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.71 -140.98 7.18 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -78.98 -59.11 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.877 1.271 . . . . 0.0 108.855 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -88.25 103.12 15.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.716 0.77 . . . . 0.0 109.907 -174.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.51 -172.01 3.97 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.952 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 54.0 Cg_endo -80.54 58.87 7.21 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.208 1.939 . . . . 0.0 110.571 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.69 109.83 0.43 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 t -99.32 169.65 9.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.498 0.649 . . . . 0.0 110.375 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.97 169.91 40.87 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -125.0 157.33 36.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.84 1.256 . . . . 0.0 110.386 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.89 130.54 46.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mt -134.77 153.01 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -130.76 140.38 50.31 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.805 1.642 . . . . 0.0 107.342 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.68 36.82 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 118.691 0.678 . . . . 0.0 111.718 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -121.4 150.99 40.69 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.869 0.868 . . . . 0.0 110.163 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.13 162.33 14.36 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.167 1.387 . . . . 0.0 112.288 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.02 121.19 3.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.643 1.177 . . . . 0.0 109.289 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -74.18 138.54 43.85 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.193 0.997 . . . . 0.0 110.771 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -135.56 123.34 22.45 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 126.448 1.899 . . . . 0.0 115.399 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -121.72 32.94 5.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.177 2.991 . . . . 0.0 103.924 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.64 151.76 22.6 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 130.488 3.515 . . . . 0.0 110.141 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.55 47.59 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.543 1.068 . . . . 0.0 113.37 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.82 -9.09 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.945 2.43 . . . . 0.0 111.17 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -61.32 -60.86 3.07 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -61.56 -31.48 71.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 125.071 1.482 . . . . 0.0 111.138 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.46 -48.56 64.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.741 1.155 . . . . 0.0 109.357 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.461 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -59.58 -41.22 89.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.421 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.281 1.2 pp -79.82 -18.75 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 119.251 -0.98 . . . . 0.0 113.556 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.91 -28.84 53.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.841 1.655 . . . . 0.0 113.745 -174.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.259 0.6 OUTLIER -52.08 -38.58 57.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.124 173.08 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -66.05 177.88 1.26 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 -1.12 1.5 Allowed 'General case' 0 C--O 1.222 -0.385 0 O-C-N 118.308 -2.745 . . . . 0.0 113.378 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -110.32 8.35 23.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.503 0.721 . . . . 0.0 109.903 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.14 138.83 33.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.82 -8.36 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.025 1.73 . . . . 0.0 110.917 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.877 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.24 161.75 10.29 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.324 2.649 . . . . 0.0 108.506 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.85 105.14 15.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.774 2.429 . . . . 0.0 104.72 173.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.4 90.84 5.63 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.48 131.34 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.6 mt -120.22 128.23 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.9 m -99.34 88.47 3.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.622 -2.732 . . . . 0.0 103.622 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 2' ' ' LEU . 25.0 t -60.71 157.29 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.037 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.79 -56.99 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.5 m -148.32 141.38 24.92 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.5 149.84 30.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.261 2.624 . . . . 0.0 108.534 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -139.55 133.14 30.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.31 1.844 . . . . 0.0 107.487 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -68.8 137.75 54.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -136.99 -58.23 0.72 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 77' ' ' ASN . 2.3 pp . . . . . 0 C--O 1.247 0.937 0 C-N-CA 124.23 1.012 . . . . 0.0 113.323 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' C ' HD12 ' A' ' 2' ' ' LEU . 4.4 mpp? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 1' ' ' MET . 7.2 mp -142.73 156.75 62.7 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.24 159.63 52.37 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.607 2.205 . . . . 0.0 111.818 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.75 95.38 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.26 -38.72 63.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 110.482 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -50.61 -56.01 13.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.496 1.043 . . . . 0.0 110.228 173.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -59.34 -48.56 81.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.372 0.669 . . . . 0.0 109.534 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -56.69 -41.05 76.67 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -41.22 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.841 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.28 -42.84 78.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.307 1.412 . . . . 0.0 111.85 173.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -52.02 -18.92 1.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -116.08 175.02 5.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 111.666 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -73.26 132.5 43.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.79 166.24 39.25 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 106.747 -2.541 . . . . 0.0 106.747 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.83 147.81 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.02 159.34 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -145.51 154.81 42.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.386 1.474 . . . . 0.0 107.183 174.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.09 114.03 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.774 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.98 108.38 19.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.475 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -88.68 116.17 26.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -73.3 138.18 45.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.4 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -159.79 -60.74 0.07 Allowed 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -78.94 52.53 1.26 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.657 2.383 . . . . 0.0 110.043 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.43 150.41 5.73 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.017 1.77 . . . . 0.0 111.735 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 36.5 Cg_endo -66.94 150.16 82.97 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 118.241 1.02 . . . . 0.0 111.321 174.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -103.19 101.82 11.79 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.8 tt -87.4 88.88 7.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.5 m -76.1 169.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.117 1.767 . . . . 0.0 110.6 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 9.7 m120 -119.28 166.91 12.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.647 1.179 . . . . 0.0 113.079 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -168.68 174.25 6.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.315 2.246 . . . . 0.0 109.025 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.488 ' HE1' HM73 ' A' ' 123' ' ' FMN . 89.0 m95 -120.67 141.57 50.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.294 2.238 . . . . 0.0 110.218 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -54.63 -31.21 56.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.255 0.48 . . . . 0.0 112.03 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.5 t -59.72 -8.97 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.521 1.528 . . . . 0.0 113.343 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.13 -1.77 11.33 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.644 1.178 . . . . 0.0 109.845 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.66 169.62 8.35 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.701 -1.249 . . . . 0.0 113.133 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' NZ ' HD21 ' A' ' 39' ' ' LEU . 2.0 pttt -136.48 141.55 43.51 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.9 t -99.38 146.81 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.407 HD21 ' NZ ' ' A' ' 37' ' ' LYS . 22.7 mt -121.68 -174.08 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.968 2.907 . . . . 0.0 111.825 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.37 158.89 6.76 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 128.122 2.569 . . . . 0.0 111.067 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.09 35.82 42.32 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.055 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' HB2' HD13 ' A' ' 2' ' ' LEU . 0.2 OUTLIER 54.05 22.73 3.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.253 1.821 . . . . 0.0 114.347 -175.125 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -74.16 158.01 34.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.791 1.636 . . . . 0.0 108.084 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -140.77 170.23 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.8 t -144.89 140.06 23.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.767 1.227 . . . . 0.0 108.132 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.92 133.85 24.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 128.578 2.751 . . . . 0.0 106.885 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.37 108.43 2.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.874 2.383 . . . . 0.0 109.88 174.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.786 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.86 111.76 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.21 -21.34 6.29 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.6 1.571 . . . . 0.0 112.816 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.86 41.56 0.27 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.512 ' HB2' HG23 ' A' ' 48' ' ' VAL . 17.6 mtt -107.83 71.38 0.81 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.611 1.565 . . . . 0.0 107.728 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -67.21 -63.91 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 129.895 3.278 . . . . 0.0 113.278 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -51.74 -40.67 60.65 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -60.19 -40.85 91.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.306 -1.33 . . . . 0.0 112.252 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -58.19 -48.78 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.606 2.003 . . . . 0.0 110.32 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.16 95.69 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -65.1 -41.63 94.77 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 116.989 -1.481 . . . . 0.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.76 -48.25 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.3 1.409 . . . . 0.0 108.503 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -25.7 59.9 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -82.25 -44.92 15.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -151.15 136.24 17.48 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 108.791 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -21.85 63.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.162 -0.961 . . . . 0.0 112.256 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -61.05 128.88 38.58 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.68 1.192 . . . . 0.0 114.115 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 20' ' ' THR . 6.3 m -139.52 154.99 25.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 122.749 1.262 . . . . 0.0 110.139 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.774 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 9.3 tt -111.66 150.97 29.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 103.058 -2.941 . . . . 0.0 103.058 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 13.7 ttt -139.01 135.52 34.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 18.5 p -121.05 128.45 52.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.97 165.95 12.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 109.083 173.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.11 42.5 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -159.8 170.31 21.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.974 0.892 . . . . 0.0 108.901 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -99.27 -9.32 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.873 2.069 . . . . 0.0 110.325 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -91.85 -11.26 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.54 136.73 56.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -78.92 131.42 36.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.526 0.73 . . . . 0.0 109.847 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.32 -141.1 7.31 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 124.222 0.951 . . . . 0.0 110.933 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -81.67 -58.82 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.47 102.9 13.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.615 0.721 . . . . 0.0 109.625 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.73 -168.94 3.44 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.617 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 57.9 Cg_endo -78.52 59.43 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.578 2.185 . . . . 0.0 110.914 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.09 121.08 1.09 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -110.09 169.31 8.81 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 118.029 0.914 . . . . 0.0 109.836 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.87 35.16 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 123.962 0.791 . . . . 0.0 113.441 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -136.48 141.5 43.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.23 1.412 . . . . 0.0 109.348 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.18 130.68 47.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 127.174 2.189 . . . . 0.0 106.271 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.4 mt -141.32 150.99 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.812 -0.555 . . . . 0.0 109.762 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -128.03 148.82 50.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.81 2.044 . . . . 0.0 109.967 173.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.4 -168.09 34.06 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.355 1.455 . . . . 0.0 110.458 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.7 m -121.0 149.04 43.28 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.351 1.46 . . . . 0.0 108.838 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.02 163.56 13.71 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.763 1.225 . . . . 0.0 112.191 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 121.5 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.68 143.91 46.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -133.36 134.53 43.87 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 126.414 1.886 . . . . 0.0 107.537 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.8 p -121.22 28.77 7.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 108.695 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.78 155.79 28.58 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.714 2.006 . . . . 0.0 110.036 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.19 -174.8 44.1 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 124.384 0.992 . . . . 0.0 115.263 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.35 -10.77 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.713 2.942 . . . . 0.0 112.735 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.81 -62.67 1.31 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.235 1.814 . . . . 0.0 106.86 173.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.41 -31.37 71.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.751 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.67 -48.86 62.88 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.566 1.075 . . . . 0.0 109.558 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.16 66.96 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.389 -0.819 . . . . 0.0 111.661 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.333 1.2 pp -93.2 -18.45 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 173.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.42 -28.48 13.0 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.093 1.757 . . . . 0.0 112.988 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -51.43 -25.86 7.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.005 0.922 . . . . 0.0 112.893 173.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -81.11 178.61 8.3 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.029 0.831 . . . . 0.0 109.56 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -139.04 20.79 2.63 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.01 -1.681 . . . . 0.0 110.741 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -131.95 8.55 4.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.267 1.427 . . . . 0.0 111.055 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.608 -0.682 . . . . 0.0 111.071 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -21.16 6.46 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.595 2.758 . . . . 0.0 111.663 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.786 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.2 161.86 10.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.213 1.805 . . . . 0.0 109.456 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.9 100.69 10.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.651 1.98 . . . . 0.0 105.686 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.12 98.95 6.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.1 131.77 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.01 1.724 . . . . 0.0 107.508 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.51 128.52 75.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.3 m -100.91 93.75 5.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.98 154.75 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.5 t -118.71 -49.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.4 m -151.22 141.01 21.86 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 120.249 1.386 . . . . 0.0 112.129 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.3 150.58 39.24 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.987 2.915 . . . . 0.0 109.413 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.8 148.9 44.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.626 1.97 . . . . 0.0 107.3 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -85.84 134.72 33.9 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.27 -78.8 0.54 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.244 0.807 0 CA-C-O 116.056 -1.926 . . . . 0.0 112.717 -173.797 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.488 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.76 157.39 83.86 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.509 -0.757 . . . . 0.0 109.18 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.96 161.76 44.42 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.328 2.018 . . . . 0.0 113.047 -174.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.22 -42.55 98.71 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -54.42 -42.09 70.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.86 1.264 . . . . 0.0 111.092 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.561 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 32.4 t80 -51.36 -53.39 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.392 0.677 . . . . 0.0 111.691 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.18 -48.53 81.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.243 0.617 . . . . 0.0 110.992 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.75 -37.47 68.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.923 0.783 . . . . 0.0 111.833 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.12 -44.09 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.164 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 16.7 mt -57.48 -42.51 82.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.674 1.125 . . . . 0.0 112.32 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -51.65 -18.57 1.22 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -117.44 158.94 23.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.636 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.09 147.21 42.98 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -170.18 167.22 40.36 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 127.529 2.49 . . . . 0.0 109.012 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -83.42 150.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.95 159.87 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.256 2.222 . . . . 0.0 105.487 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.48 157.05 45.16 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.065 0.946 . . . . 0.0 109.724 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.69 108.39 4.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.95 108.41 19.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.464 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -96.38 109.41 21.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -74.27 141.09 45.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 121.38 1.9 . . . . 0.0 106.818 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.53 -81.91 0.23 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -166.16 -57.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.67 53.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.441 2.696 . . . . 0.0 109.113 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 141.42 2.31 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.008 1.766 . . . . 0.0 112.038 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 158.89 55.21 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -120.69 101.82 7.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -84.83 88.61 7.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.8 m -82.79 175.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.842 2.057 . . . . 0.0 109.982 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -118.84 166.69 12.5 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.083 0.856 . . . . 0.0 112.103 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -168.3 175.8 6.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.241 2.217 . . . . 0.0 107.611 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.43 141.52 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.995 1.718 . . . . 0.0 110.647 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -53.97 -30.88 48.85 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.124 0.874 . . . . 0.0 109.204 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.74 -13.93 7.31 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.149 2.979 . . . . 0.0 111.875 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -118.88 -4.75 10.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.777 1.631 . . . . 0.0 111.8 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.41 165.8 12.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.32 1.418 . . . . 0.0 113.034 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.0 138.56 42.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 10' ' ' LEU . 86.7 t -101.69 150.7 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -122.12 178.98 4.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.811 2.844 . . . . 0.0 107.102 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -76.02 -179.05 4.69 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.55 31.3 74.27 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.243 -1.535 . . . . 0.0 110.732 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 p30 54.08 12.99 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 130.095 3.358 . . . . 0.0 115.056 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -73.58 143.22 46.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.877 0.762 . . . . 0.0 109.627 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -129.3 163.28 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -142.86 140.88 27.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.93 127.74 26.35 Favored Pre-proline 0 N--CA 1.445 -0.707 0 C-N-CA 127.44 2.296 . . . . 0.0 104.829 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.01 108.3 2.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 107.798 -1.654 . . . . 0.0 107.798 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.65 111.63 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.58 -21.69 6.03 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.32 0.962 . . . . 0.0 112.67 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.65 41.59 0.33 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 118.099 -1.39 . . . . 0.0 110.0 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 48' ' ' VAL . 21.4 mtt -106.57 71.39 0.86 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 108.28 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -67.45 -65.78 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 129.99 3.316 . . . . 0.0 113.682 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -51.85 -40.89 61.31 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.863 1.21 . . . . 0.0 109.764 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -60.92 -39.08 88.03 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.787 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.5 -48.38 81.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.812 1.642 . . . . 0.0 110.86 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.82 99.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.407 0.283 . . . . 0.0 111.24 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -63.41 -41.64 98.74 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.444 -1.265 . . . . 0.0 110.446 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.86 -48.23 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 120.11 1.323 . . . . 0.0 108.963 174.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.83 -24.65 37.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.456 -0.777 . . . . 0.0 112.567 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -85.09 -42.5 14.75 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.581 1.696 . . . . 0.0 115.581 173.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -150.95 139.48 20.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.662 1.185 . . . . 0.0 109.115 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -75.17 -18.03 60.27 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 112.312 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 mmp_? -60.8 119.76 8.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 114.492 -173.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 89' ' ' ALA . 20.4 m -139.23 146.23 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 123.112 1.434 . . . . 0.0 112.588 173.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 3.7 tt -111.67 149.2 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.9 ttt -141.15 141.12 34.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -125.45 128.08 47.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.2 173.39 6.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.713 1.597 . . . . 0.0 107.923 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.01 -171.27 34.59 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.424 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 23.4 t -146.85 157.38 43.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.65 0.78 . . . . 0.0 109.351 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -98.54 -17.43 18.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.493 1.517 . . . . 0.0 108.847 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -91.98 -4.43 54.59 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 116.687 -1.625 . . . . 0.0 114.864 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.49 130.2 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 121.711 2.051 . . . . 0.0 105.775 -173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.04 131.41 36.26 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.092 0.957 . . . . 0.0 111.173 -173.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.48 -141.07 6.36 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -81.92 -58.96 2.75 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.363 1.465 . . . . 0.0 108.323 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.414 HD21 HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.87 102.96 11.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.468 0.651 . . . . 0.0 109.523 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.18 -169.11 2.89 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.198 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 60.2 Cg_endo -79.04 58.85 7.13 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.204 1.936 . . . . 0.0 110.692 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.73 120.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -114.66 169.45 9.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.187 0.994 . . . . 0.0 110.433 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.73 45.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.78 0.705 . . . . 0.0 113.64 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -132.99 152.76 51.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.016 1.326 . . . . 0.0 109.353 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.03 130.9 47.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.328 -2.842 . . . . 0.0 103.328 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.04 154.46 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -131.24 135.04 47.02 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.21 -169.11 28.39 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 118.765 0.711 . . . . 0.0 112.356 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 m -121.02 146.43 46.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.028 2.131 . . . . 0.0 108.287 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -111.24 163.71 13.65 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.566 1.075 . . . . 0.0 112.94 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.95 120.98 3.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.235 1.014 . . . . 0.0 110.331 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -75.86 141.06 42.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -140.74 135.88 31.99 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.035 1.334 . . . . 0.0 111.0 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.2 p -120.81 36.67 4.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.72 154.94 27.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.847 2.859 . . . . 0.0 111.165 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.39 47.41 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.484 1.516 . . . . 0.0 113.556 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.73 -11.78 32.22 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.193 2.595 . . . . 0.0 112.242 175.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.04 -60.27 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -31.43 71.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.318 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.85 -49.77 55.55 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.683 1.129 . . . . 0.0 109.611 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.05 76.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.309 -0.869 . . . . 0.0 111.489 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.2 pp -82.5 -18.36 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 119.061 0.846 . . . . 0.0 112.159 174.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.16 -28.07 4.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.514 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.58 -30.03 19.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.164 1.386 . . . . 0.0 112.256 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -80.67 178.32 8.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.39 -0.54 1.4 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 118.172 -2.83 . . . . 0.0 112.631 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -96.09 8.2 44.38 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.73 23.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.24 1.016 . . . . 0.0 109.402 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.6 ttp85 -121.13 -14.08 8.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.443 1.897 . . . . 0.0 111.717 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.809 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.56 161.61 11.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.041 1.736 . . . . 0.0 110.176 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.78 104.69 16.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.74 91.34 7.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.18 131.16 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.792 1.637 . . . . 0.0 106.673 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -121.71 135.61 61.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.0 m -114.12 101.36 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.01 160.57 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.335 1.454 . . . . 0.0 110.088 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.4 t -121.51 -59.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -142.9 140.49 31.21 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.85 145.65 41.93 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.853 2.861 . . . . 0.0 108.168 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -139.21 130.18 26.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.243 1.817 . . . . 0.0 106.684 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -74.04 139.59 44.8 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -129.65 -58.31 1.1 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.414 HD13 HD21 ' A' ' 77' ' ' ASN . 2.6 pp . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.926 0.89 . . . . 0.0 111.437 -173.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.93 160.91 42.84 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 119.969 1.258 . . . . 0.0 109.171 170.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.77 158.63 32.18 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.504 2.136 . . . . 0.0 113.54 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -49.31 79.86 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -53.64 -41.26 66.56 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.235 1.014 . . . . 0.0 111.283 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.26 -60.4 3.15 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.62 0.768 . . . . 0.0 109.482 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -52.28 -48.23 65.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.386 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 27.7 mm-40 -54.88 -38.36 67.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.743 1.156 . . . . 0.0 112.66 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.87 -45.5 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.802 1.183 . . . . 0.0 109.135 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.09 -42.28 80.41 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.664 1.12 . . . . 0.0 112.073 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 8' ' ' GLU . 25.4 mtmm -51.65 -18.65 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -112.99 158.65 20.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.816 1.189 . . . . 0.0 109.874 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.12 148.83 41.44 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.975 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . 177.41 170.8 40.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 123.22 0.438 . . . . 0.0 112.058 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.72 149.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -132.15 163.51 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 127.556 2.342 . . . . 0.0 105.298 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.53 153.18 40.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.851 1.26 . . . . 0.0 109.15 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.38 109.79 5.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.45 109.22 20.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.134 1.773 . . . . 0.0 109.886 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 54' ' ' THR . 4.7 m -97.3 107.96 20.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 98.76 9.01 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.34 -59.89 0.18 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 120.824 1.647 . . . . 0.0 113.503 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -158.36 -60.79 0.08 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.008 1.404 . . . . 0.0 113.845 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -79.28 39.08 0.38 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.878 1.672 . . . . 0.0 111.777 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.94 151.47 12.36 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.76 148.06 93.9 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.751 2.275 . . . . 0.0 109.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.488 ' CE1' ' HZ3' ' A' ' 53' ' ' LYS . 40.4 t60 -121.43 101.67 7.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -90.48 88.7 7.26 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.5 m -77.34 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 110.638 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.81 168.48 11.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.445 1.02 . . . . 0.0 113.003 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t -168.42 172.61 8.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.813 2.445 . . . . 0.0 108.183 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' HE1' HM73 ' A' ' 123' ' ' FMN . 85.5 m95 -120.91 141.75 50.35 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.887 2.075 . . . . 0.0 109.989 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -52.09 -30.53 26.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.685 0.675 . . . . 0.0 110.478 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -50.24 -21.31 1.31 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.663 2.385 . . . . 0.0 113.565 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.4 -6.71 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.379 1.071 . . . . 0.0 111.572 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -91.46 171.3 9.29 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.448 -1.408 . . . . 0.0 111.781 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.727 ' HE2' HD11 ' A' ' 39' ' ' LEU . 13.6 ptmt -134.08 119.93 19.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 172.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.55 131.44 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.727 HD11 ' HE2' ' A' ' 37' ' ' LYS . 2.7 mp -121.43 178.14 4.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -76.97 -178.0 4.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.9 29.61 75.31 Favored Glycine 0 C--O 1.223 -0.591 0 O-C-N 120.473 -1.392 . . . . 0.0 109.663 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 54.0 12.87 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 130.631 3.572 . . . . 0.0 115.483 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -79.37 128.84 33.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.205 1.366 . . . . 0.0 110.137 -174.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -124.34 155.43 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 t -145.24 142.46 22.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.78 132.8 24.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 126.993 2.117 . . . . 0.0 106.873 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.89 108.57 2.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.537 2.158 . . . . 0.0 108.666 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.53 111.76 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.45 -20.85 5.7 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.378 1.942 . . . . 0.0 112.281 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.18 40.99 0.45 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.047 1.423 . . . . 0.0 109.958 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.509 ' HB2' HG23 ' A' ' 48' ' ' VAL . 25.4 mtt -113.8 53.47 0.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.042 1.337 . . . . 0.0 108.515 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.46 91.2 m-70 -71.88 -48.18 47.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.488 ' HZ3' ' CE1' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -51.91 -38.28 55.71 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.76 1.618 . . . . 0.0 108.933 172.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.412 HG23 ' OG1' ' A' ' 20' ' ' THR . 48.0 m -64.41 -38.8 92.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.404 1.481 . . . . 0.0 110.291 173.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.21 -47.68 74.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.799 1.636 . . . . 0.0 109.391 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.38 89.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.803 0.441 . . . . 0.0 110.803 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -57.07 -41.47 78.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.744 -1.122 . . . . 0.0 113.369 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.08 -48.28 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 120.249 1.386 . . . . 0.0 109.211 175.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.36 -26.16 39.42 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.041 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.21 -47.19 13.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 173.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -152.28 141.67 21.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.433 1.015 . . . . 0.0 108.773 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.358 -1.464 . . . . 0.0 113.718 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -51.94 115.6 1.76 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.667 1.987 . . . . 0.0 114.722 -172.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.54 143.43 32.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 123.669 1.7 . . . . 0.0 112.723 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 2.8 tt -111.35 148.48 32.9 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 101.364 -3.569 . . . . 0.0 101.364 172.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.36 129.09 20.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 p -111.29 128.25 55.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 pp -117.01 166.88 11.67 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.548 -1.345 . . . . 0.0 108.578 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.9 -174.83 37.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.452 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.2 t -146.57 157.56 43.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.634 1.174 . . . . 0.0 107.898 174.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -98.86 -8.45 25.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.591 1.156 . . . . 0.0 110.05 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.46 -7.13 51.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 116.942 -1.504 . . . . 0.0 113.962 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.23 136.03 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 121.083 1.765 . . . . 0.0 106.243 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.24 131.37 36.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.884 0.874 . . . . 0.0 111.086 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.44 -140.88 6.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.219 1.39 . . . . 0.0 110.516 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -84.48 -59.05 2.49 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 102.98 9.58 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.98 -168.79 1.96 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.584 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 70.5 Cg_endo -76.3 65.9 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.35 2.033 . . . . 0.0 110.37 174.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.97 121.1 1.05 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.54 169.53 9.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.371 1.086 . . . . 0.0 109.846 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.64 -177.76 45.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 121.418 0.454 . . . . 0.0 113.381 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.58 147.01 52.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.416 1.086 . . . . 0.0 110.39 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -100.88 129.66 46.78 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 mt -141.2 157.05 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -132.75 149.12 52.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.172 1.789 . . . . 0.0 109.753 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -174.14 37.95 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.505 1.526 . . . . 0.0 110.548 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -114.14 143.15 45.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.118 1.767 . . . . 0.0 106.828 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.81 163.36 13.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.188 1.395 . . . . 0.0 111.962 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 121.11 3.33 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.882 0.873 . . . . 0.0 109.764 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.03 138.13 43.87 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 141.48 35.0 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.121 0.968 . . . . 0.0 109.863 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -116.07 35.17 4.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.33 154.66 25.49 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 128.112 2.565 . . . . 0.0 110.742 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 178.67 46.76 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.642 2.067 . . . . 0.0 113.893 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.13 -17.92 55.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.028 3.152 . . . . 0.0 112.538 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -65.61 0.65 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.243 1.817 . . . . 0.0 107.617 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.18 -31.2 70.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.192 0.997 . . . . 0.0 111.391 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.6 -57.76 5.27 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.757 0.708 . . . . 0.0 109.138 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.456 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.65 -25.42 67.37 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.916 -1.115 . . . . 0.0 113.058 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.346 1.3 pp -87.43 -18.11 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.733 1.151 . . . . 0.0 111.919 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.48 -27.93 3.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.408 1.483 . . . . 0.0 111.685 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -49.05 -21.47 0.71 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.641 1.176 . . . . 0.0 113.949 173.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.54 178.75 8.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.669 1.122 . . . . 0.0 110.611 175.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -130.29 11.61 5.44 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.099 -1.625 . . . . 0.0 111.234 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -132.26 9.0 4.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.226 1.41 . . . . 0.0 111.202 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.94 145.21 34.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.619 -0.676 . . . . 0.0 109.874 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -21.05 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 127.951 2.5 . . . . 0.0 110.621 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.764 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.12 161.96 10.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.391 1.876 . . . . 0.0 109.137 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.59 107.9 18.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tp -78.89 93.92 5.12 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.2 t -78.98 130.88 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.37 129.49 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -112.14 99.03 7.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 t -60.99 161.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.069 2.147 . . . . 0.0 110.15 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.98 -51.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -150.93 141.04 22.15 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.154 -0.966 . . . . 0.0 111.246 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.91 146.34 43.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.693 3.197 . . . . 0.0 108.765 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -138.82 142.65 38.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.521 1.928 . . . . 0.0 107.599 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -81.16 133.51 35.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -135.21 -68.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.24 0.561 0 CA-C-O 117.358 -1.306 . . . . 0.0 110.221 178.092 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.498 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.5 mtm . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.431 ' CD1' ' H ' ' A' ' 2' ' ' LEU . 5.2 mp -60.04 156.21 39.03 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.339 1.856 . . . . 0.0 109.593 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.88 158.7 56.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.735 2.29 . . . . 0.0 111.442 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.99 -40.86 95.99 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -53.16 -38.96 63.22 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.6 1.56 . . . . 0.0 111.263 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -50.99 -56.26 13.33 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.653 1.115 . . . . 0.0 111.088 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -61.77 -48.96 78.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -61.01 -33.58 73.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.51 -41.85 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.392 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.12 -38.63 83.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.236 1.38 . . . . 0.0 111.811 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.74 -19.11 1.47 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.298 1.408 . . . . 0.0 114.345 172.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -106.4 158.93 16.53 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 119.717 1.144 . . . . 0.0 107.966 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.86 148.63 42.16 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 121.328 -0.858 . . . . 0.0 109.346 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.23 177.13 47.84 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 124.8 1.191 . . . . 0.0 112.534 -174.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.9 t -100.75 145.82 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -129.82 163.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 106.059 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.44 159.9 42.79 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.305 1.442 . . . . 0.0 110.001 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.44 HD11 HG21 ' A' ' 46' ' ' VAL . 88.3 mt -140.34 117.32 9.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -89.08 108.35 19.54 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 173.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.627 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -94.03 110.57 22.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 115.546 -2.169 . . . . 0.0 106.806 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -73.8 141.71 46.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.271 2.305 . . . . 0.0 107.721 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.7 -81.35 0.23 Allowed Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.45 -61.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -79.73 44.49 0.64 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.24 2.216 . . . . 0.0 109.968 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 151.49 5.95 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.263 1.887 . . . . 0.0 113.719 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.19 153.93 56.85 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 121.357 1.371 . . . . 0.0 111.414 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -121.37 101.97 7.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.542 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -86.13 88.73 7.65 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.04 169.14 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.082 1.753 . . . . 0.0 110.625 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -121.54 167.62 12.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.528 1.131 . . . . 0.0 112.29 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 170.32 9.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.983 2.113 . . . . 0.0 108.364 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.461 ' HE1' HM73 ' A' ' 123' ' ' FMN . 84.2 m95 -116.48 141.67 47.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.745 1.618 . . . . 0.0 111.265 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -56.18 -31.77 63.72 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.997 0.919 . . . . 0.0 110.834 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -60.57 -8.39 2.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.387 1.475 . . . . 0.0 113.613 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -117.92 -7.24 10.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.095 1.316 . . . . 0.0 109.099 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mt -98.24 162.19 13.32 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.151 -1.593 . . . . 0.0 112.29 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.52 41.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.409 -1.432 . . . . 0.0 108.916 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.9 t -101.8 144.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.91 179.06 4.48 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.324 1.85 . . . . 0.0 107.126 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.53 177.27 3.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.254 0.549 . . . . 0.0 110.429 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.47 28.45 59.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 p30 53.64 13.72 0.53 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 128.559 2.743 . . . . 0.0 114.848 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -73.21 109.33 6.65 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.487 1.04 . . . . 0.0 110.328 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.07 161.15 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.97 134.83 21.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 18' ' ' ILE . 60.6 t -121.04 135.39 24.81 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 127.127 2.171 . . . . 0.0 107.277 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.94 108.88 2.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.53 2.153 . . . . 0.0 110.458 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.742 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.4 111.91 21.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.13 -21.34 7.42 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.979 1.752 . . . . 0.0 112.676 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.41 41.31 0.28 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.188 1.494 . . . . 0.0 109.945 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.471 ' HB2' HG23 ' A' ' 48' ' ' VAL . 14.3 mtt -109.32 66.98 0.64 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.156 0.982 . . . . 0.0 109.77 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.322 41.3 m-70 -71.47 -48.64 47.91 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -51.7 -40.95 61.06 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.799 2.09 . . . . 0.0 109.418 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.1 m -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 127.002 2.121 . . . . 0.0 110.495 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.28 -50.82 70.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 121.027 1.74 . . . . 0.0 110.611 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.33 94.13 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.237 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -66.3 -42.02 88.94 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.679 -1.629 . . . . 0.0 109.845 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.93 -48.19 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 120.177 1.353 . . . . 0.0 109.032 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.97 57.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.487 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -87.06 -46.02 10.19 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.926 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -145.15 132.31 20.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.275 1.036 . . . . 0.0 112.169 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.1 -21.59 56.51 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.454 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.46 122.13 14.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.499 1.045 . . . . 0.0 111.353 -173.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.2 m -138.85 155.94 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 123.379 1.561 . . . . 0.0 111.503 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tt -111.13 149.95 30.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.8 ttt -138.95 140.87 38.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 p -123.72 128.6 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -116.93 167.78 10.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.218 1.827 . . . . 0.0 107.172 172.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.13 -175.0 38.12 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.434 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 44.5 t -148.14 157.38 43.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -99.28 -8.72 24.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.312 0.505 . . . . 0.0 109.923 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -90.71 3.11 55.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.087 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.0 t -130.92 133.61 62.79 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.05 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 173.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 130.32 35.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.879 0.763 . . . . 0.0 110.217 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.62 5.95 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.975 1.75 . . . . 0.0 109.318 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -88.51 -58.3 2.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.15 102.68 5.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.184 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.95 -168.26 0.16 Allowed Glycine 0 CA--C 1.539 1.573 0 O-C-N 120.794 -1.191 . . . . 0.0 111.087 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.53 91.07 0.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 N-CA-C 106.501 -2.153 . . . . 0.0 106.501 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.4 0.71 Allowed Glycine 0 N--CA 1.442 -0.947 0 CA-C-O 117.723 -1.598 . . . . 0.0 109.827 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -109.31 168.97 9.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.341 1.071 . . . . 0.0 109.715 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.4 -176.97 44.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 121.062 0.257 . . . . 0.0 112.896 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -131.42 151.94 51.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.422 1.089 . . . . 0.0 109.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.86 131.25 46.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.422 ' CG2' HG13 ' A' ' 115' ' ' VAL . 6.0 mt -139.08 156.57 27.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -132.2 150.23 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.997 1.319 . . . . 0.0 108.088 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.61 -172.13 40.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -106.28 131.93 52.93 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.26 1.024 . . . . 0.0 108.432 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -89.0 163.51 15.5 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.67 120.88 3.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.873 0.869 . . . . 0.0 110.045 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -74.26 130.61 40.04 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 173.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -132.16 130.7 41.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.5 p -120.85 33.47 5.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.17 1.388 . . . . 0.0 107.677 173.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -158.82 161.96 36.96 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 128.635 2.774 . . . . 0.0 109.276 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.4 -179.95 46.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 125.19 1.376 . . . . 0.0 115.104 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.94 -19.15 64.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.536 2.157 . . . . 0.0 110.773 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.86 -63.02 1.18 Allowed 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.817 0.847 . . . . 0.0 109.338 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -61.39 -31.17 71.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.346 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.26 -48.78 64.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.721 1.146 . . . . 0.0 110.481 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -30.69 69.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.782 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.29 -19.31 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.74 85.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.809 1.64 . . . . 0.0 112.188 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.551 0.0 OUTLIER -51.54 -18.36 1.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 173.221 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.34 179.54 0.97 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.87 1.214 . . . . 0.0 108.242 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -128.55 12.39 6.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 119.601 -1.937 . . . . 0.0 112.14 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -135.91 10.47 3.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.882 1.273 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.92 145.33 34.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 0.0 110.985 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.23 -21.38 6.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.002 2.521 . . . . 0.0 111.902 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.742 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -176.4 161.85 2.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.611 1.964 . . . . 0.0 109.431 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.61 110.66 23.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 tt -85.98 95.11 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.306 -2.849 . . . . 0.0 103.306 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.55 131.01 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.174 1.39 . . . . 0.0 107.806 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 64' ' ' VAL . 42.6 mm -114.14 137.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.4 m -113.96 93.22 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.422 HG13 ' CG2' ' A' ' 85' ' ' ILE . 60.8 t -61.45 160.32 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.29 1.436 . . . . 0.0 111.072 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.97 -57.26 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -140.9 127.22 19.79 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.131 0.423 . . . . 0.0 111.944 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.08 139.34 51.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.75 3.22 . . . . 0.0 110.637 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -142.24 139.55 32.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.482 1.513 . . . . 0.0 110.668 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -72.87 135.26 45.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -174.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -143.21 -58.6 0.42 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.253 1.261 0 CA-C-O 115.753 -2.07 . . . . 0.0 113.929 -173.481 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.461 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' C ' HD22 ' A' ' 2' ' ' LEU . 75.8 mmm . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.642 HD21 HG11 ' A' ' 115' ' ' VAL . 3.6 mm? -136.19 157.43 75.65 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.997 1.319 . . . . 0.0 108.664 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.15 162.25 42.25 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.539 2.159 . . . . 0.0 110.683 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.21 -38.85 93.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -50.73 -40.43 54.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.125 1.77 . . . . 0.0 112.016 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.3 -56.41 13.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.8 1.182 . . . . 0.0 109.989 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -59.14 -48.45 81.55 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 110.201 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.83 -40.28 75.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.764 0.711 . . . . 0.0 112.624 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.9 -40.78 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.861 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -45.68 85.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.377 1.444 . . . . 0.0 111.501 173.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -51.91 -20.62 2.4 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -105.95 161.66 14.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.407 1.083 . . . . 0.0 110.156 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.55 139.57 45.72 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.45 174.46 47.0 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.8 143.2 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -174.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.3 164.76 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -151.83 158.95 43.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.759 1.224 . . . . 0.0 109.162 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 46' ' ' VAL . 89.5 mt -142.63 119.94 6.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 124.768 1.227 . . . . 0.0 107.947 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -94.05 108.42 20.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.568 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.8 m -89.95 121.3 31.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 116.194 -1.86 . . . . 0.0 106.386 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -73.47 137.23 44.38 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 122.062 2.21 . . . . 0.0 108.689 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.08 -81.21 0.22 Allowed Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -158.84 -61.51 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -79.35 39.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.203 3.001 . . . . 0.0 111.511 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 151.13 13.36 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.64 150.02 56.13 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 CA-C-N 118.177 0.989 . . . . 0.0 111.208 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -99.51 101.59 12.88 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 6.5 tt -84.86 88.97 7.45 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -173.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.99 168.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.37 1.468 . . . . 0.0 110.254 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.34 167.7 12.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.411 1.084 . . . . 0.0 112.216 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.44 172.11 8.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.86 2.064 . . . . 0.0 108.195 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' HE1' HM73 ' A' ' 123' ' ' FMN . 86.2 m95 -120.86 141.65 50.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.894 1.678 . . . . 0.0 110.385 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -51.11 -31.26 18.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.095 0.958 . . . . 0.0 111.905 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -57.74 -14.51 5.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.205 1.802 . . . . 0.0 112.733 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.21 -3.55 11.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.711 1.204 . . . . 0.0 110.214 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.489 HD22 HG22 ' A' ' 46' ' ' VAL . 20.4 mt -95.21 163.52 13.24 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.51 -1.369 . . . . 0.0 112.759 -173.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.63 140.72 43.0 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 172.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -101.55 151.78 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 109.58 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.42 HD11 ' CD ' ' A' ' 97' ' ' GLU . 25.0 mt -121.55 178.33 4.86 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.553 1.941 . . . . 0.0 109.436 173.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -76.21 177.1 7.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.31 1.444 . . . . 0.0 107.903 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.25 29.34 59.92 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 120.598 -1.313 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.321 0.0 OUTLIER 53.44 15.35 0.69 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 130.233 3.413 . . . . 0.0 115.091 -175.744 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -73.86 145.57 44.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -127.98 168.66 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.7 t -146.38 142.74 21.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.013 -1.055 . . . . 0.0 108.883 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 36' ' ' LEU . 61.2 t -126.34 135.49 27.25 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.842 2.057 . . . . 0.0 107.769 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.82 108.53 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.743 2.296 . . . . 0.0 109.448 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.61 111.39 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.24 -21.36 6.63 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.759 1.647 . . . . 0.0 112.241 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.23 41.4 0.31 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 117.746 -1.586 . . . . 0.0 109.552 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.513 ' HB2' HG23 ' A' ' 48' ' ' VAL . 20.2 mtt -109.74 57.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.014 1.326 . . . . 0.0 107.909 173.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -71.58 -48.82 45.79 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.056 1.342 . . . . 0.0 113.42 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.98 -41.4 62.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.721 1.6 . . . . 0.0 108.87 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.9 m -59.98 -40.47 89.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.76 1.624 . . . . 0.0 110.369 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.92 -49.02 78.17 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.152 1.796 . . . . 0.0 110.988 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.66 98.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.819 0.343 . . . . 0.0 111.311 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -63.19 -41.59 99.2 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.009 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -61.55 -48.24 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.452 1.478 . . . . 0.0 109.286 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.28 59.28 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.634 -0.667 . . . . 0.0 112.423 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.7 mmm-85 -78.46 -46.46 19.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -151.26 129.53 11.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.781 1.233 . . . . 0.0 109.764 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.25 -23.23 62.87 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.492 -0.755 . . . . 0.0 112.487 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -61.28 124.09 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.947 0.899 . . . . 0.0 112.027 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 20' ' ' THR . 6.9 m -138.88 155.37 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 123.76 1.743 . . . . 0.0 110.253 173.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 4.5 tt -107.49 150.36 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 173.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.4 ttt -139.29 141.93 37.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 4.6 p -125.2 128.52 48.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 116.159 -1.877 . . . . 0.0 106.046 173.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.494 HD12 HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -116.42 160.22 20.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 122.087 2.222 . . . . 0.0 106.345 173.041 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.13 -172.22 45.15 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -150.07 168.37 24.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 80' ' ' GLY . 21.4 mmm180 -98.92 -8.8 25.01 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 109.844 173.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -79.33 -6.19 56.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.448 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.43 140.3 49.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.0 121.06 24.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.37 -130.11 3.88 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 125.158 1.361 . . . . 0.0 110.107 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.34 -63.64 1.23 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.302 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -84.03 102.63 12.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.863 -174.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.96 -168.45 0.93 Allowed Glycine 0 CA--C 1.542 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 112.194 -174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.03 91.43 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 108.997 173.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 71' ' ' ARG . . . 178.81 122.02 0.74 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 117.336 -1.813 . . . . 0.0 110.445 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 t -123.72 171.68 9.42 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.815 1.307 . . . . 0.0 110.026 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.23 -157.58 28.35 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.783 1.183 . . . . 0.0 112.579 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -148.42 154.87 40.49 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.931 1.293 . . . . 0.0 109.811 -174.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.41 131.21 47.62 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 128.916 2.886 . . . . 0.0 104.56 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.494 HD11 HD12 ' A' ' 68' ' ' LEU . 2.9 mp -138.63 163.6 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.802 1.241 . . . . 0.0 108.579 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -134.37 151.09 51.0 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.204 1.402 . . . . 0.0 109.123 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -175.6 40.07 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.175 0.893 . . . . 0.0 111.715 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 m -113.93 128.8 56.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.41 1.084 . . . . 0.0 109.888 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.66 17.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.319 1.447 . . . . 0.0 111.465 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.04 120.44 2.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.02 1.328 . . . . 0.0 109.481 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -77.13 142.69 39.61 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.568 -0.707 . . . . 0.0 109.634 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 140.92 34.24 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.354 1.061 . . . . 0.0 109.714 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 p -121.25 35.94 4.75 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.457 1.903 . . . . 0.0 106.221 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -159.35 157.54 30.58 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.502 2.321 . . . . 0.0 110.091 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.71 178.25 46.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.951 2.691 . . . . 0.0 113.089 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 -8.95 22.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.187 2.591 . . . . 0.0 112.634 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.42 ' CD ' HD11 ' A' ' 39' ' ' LEU . 7.6 mm-40 -65.98 -56.34 12.16 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -61.4 -31.89 71.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.781 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.59 -48.61 38.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.539 0.685 . . . . 0.0 110.043 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -58.9 -27.45 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.061 -1.024 . . . . 0.0 111.712 177.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.323 1.7 pp -93.26 -18.39 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.963 173.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.33 -28.4 4.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.585 1.954 . . . . 0.0 112.656 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -50.99 -22.88 2.52 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.768 1.227 . . . . 0.0 113.293 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -80.71 178.64 8.23 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.619 1.099 . . . . 0.0 110.312 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -128.51 3.83 5.6 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.149 -1.595 . . . . 0.0 111.23 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -135.68 8.28 3.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 111.54 -174.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.55 142.4 34.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.034 0.834 . . . . 0.0 109.112 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.61 -10.76 8.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.044 1.337 . . . . 0.0 111.829 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.9 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.49 161.91 9.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.187 2.595 . . . . 0.0 108.332 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.76 107.07 16.94 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.114 2.166 . . . . 0.0 106.588 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.1 tp -82.12 98.56 8.74 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.426 1.891 . . . . 0.0 107.594 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -83.96 127.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.699 1.6 . . . . 0.0 107.373 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.74 129.06 72.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 119.367 0.985 . . . . 0.0 108.488 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 m -99.11 87.91 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.642 HG11 HD21 ' A' ' 2' ' ' LEU . 71.1 t -60.66 153.57 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.991 0.916 . . . . 0.0 109.967 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.7 -59.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -149.58 141.22 23.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.528 0.604 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.58 159.52 25.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 127.953 2.501 . . . . 0.0 112.448 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -140.87 145.25 35.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.259 2.224 . . . . 0.0 108.458 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -76.19 134.78 39.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.4 p -133.69 -58.79 0.87 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.47 0.577 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.463 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.712 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.498 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' C ' HD12 ' A' ' 2' ' ' LEU . 87.0 mmm . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 121.159 0.504 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 1' ' ' MET . 6.8 mp -141.38 155.6 67.51 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.52 163.61 38.43 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.903 2.402 . . . . 0.0 112.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.4 97.59 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 173.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.305 2.9 m -51.82 -38.11 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.966 2.107 . . . . 0.0 112.822 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -50.85 -49.11 59.67 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.519 1.054 . . . . 0.0 110.202 173.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -63.27 -48.19 79.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.775 1.23 . . . . 0.0 111.352 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.47 -41.48 63.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.562 0.619 . . . . 0.0 111.067 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.43 -45.55 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.119 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.5 mt -52.5 -28.37 20.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.576 1.08 . . . . 0.0 112.754 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -51.72 -18.51 1.24 Allowed 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.904 -1.747 . . . . 0.0 112.646 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -114.84 160.38 19.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.38 1.872 . . . . 0.0 109.719 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -74.36 156.54 36.96 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 166.3 35.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.476 -0.868 . . . . 0.0 113.64 -173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -81.97 141.36 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 31' ' ' THR . 12.7 t -133.92 160.55 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.94 155.9 40.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.714 1.205 . . . . 0.0 108.467 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.95 119.97 15.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.87 108.73 19.69 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.511 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -90.76 113.24 25.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -73.72 141.55 46.36 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.045 2.202 . . . . 0.0 108.037 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 -81.21 0.32 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -162.54 -48.97 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.671 0.788 . . . . 0.0 108.938 173.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.68 39.24 0.34 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.389 2.276 . . . . 0.0 110.657 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.27 151.16 6.03 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.911 1.719 . . . . 0.0 111.303 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.31 161.02 45.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.017 1.145 . . . . 0.0 111.411 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -112.77 101.75 9.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.242 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 tp -74.04 88.69 1.91 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -74.13 168.73 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.408 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.1 165.1 14.57 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.616 1.166 . . . . 0.0 111.669 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 16' ' ' VAL . 15.4 t -168.69 175.7 5.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.952 2.101 . . . . 0.0 108.068 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.644 ' HE1' HM73 ' A' ' 123' ' ' FMN . 82.7 m95 -120.41 142.0 49.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.492 2.317 . . . . 0.0 109.852 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -51.94 -30.3 24.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.301 -0.856 . . . . 0.0 110.402 174.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -50.47 -20.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.052 2.941 . . . . 0.0 113.295 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.5 m-30 -118.12 -12.75 9.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.775 -1.203 . . . . 0.0 110.539 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.14 158.35 15.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 120.583 -1.323 . . . . 0.0 112.872 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.9 140.96 42.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 120.892 -1.13 . . . . 0.0 109.501 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -100.86 144.09 13.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.519 -2.401 . . . . 0.0 104.519 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.4 mt -121.19 -179.09 3.94 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.84 2.056 . . . . 0.0 107.806 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.52 169.83 4.5 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.246 0.618 . . . . 0.0 111.382 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.89 28.41 52.86 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.911 1.719 . . . . 0.0 111.354 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.318 0.2 OUTLIER 53.37 27.54 6.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.06 1.744 . . . . 0.0 113.11 -175.563 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -73.41 150.97 41.34 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.76 158.01 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -141.35 135.8 31.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.08 130.73 24.68 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 128.743 2.817 . . . . 0.0 106.526 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.6 108.74 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.569 2.179 . . . . 0.0 110.023 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.725 ' CG1' ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.56 111.84 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.5 -21.6 5.06 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.519 1.056 . . . . 0.0 112.422 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.02 41.26 0.34 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 119.285 1.543 . . . . 0.0 109.266 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 48' ' ' VAL . 21.4 mtt -109.78 70.62 0.73 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.582 1.153 . . . . 0.0 108.125 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -71.44 -55.96 6.89 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.985 2.114 . . . . 0.0 114.876 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -51.92 -41.35 61.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 121.341 1.882 . . . . 0.0 108.469 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -63.17 -38.77 92.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.248 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -56.79 -50.64 71.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.076 1.307 . . . . 0.0 110.134 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.44 98.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.899 0.48 . . . . 0.0 111.547 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -64.01 -41.61 97.4 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.689 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.22 -48.05 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 120.051 1.296 . . . . 0.0 108.27 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.02 -22.12 25.39 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -86.92 -44.38 11.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -150.95 140.81 21.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.31 1.444 . . . . 0.0 109.13 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 -18.05 59.7 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.028 -1.045 . . . . 0.0 112.221 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -59.32 117.47 4.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.353 1.061 . . . . 0.0 113.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.1 m -138.93 153.39 24.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 124.055 1.883 . . . . 0.0 112.549 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.6 tp -111.01 151.16 28.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 ttt -139.24 134.29 32.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.5 p -126.58 127.87 45.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -117.11 164.21 15.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.651 1.114 . . . . 0.0 108.966 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.08 178.26 42.99 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -150.7 -178.41 6.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -113.24 -9.34 13.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.116 0.966 . . . . 0.0 110.504 173.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -86.1 -4.49 59.18 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.96 138.71 52.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.6 35.61 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.594 0.634 . . . . 0.0 109.827 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.51 -132.24 4.12 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 124.573 1.082 . . . . 0.0 111.953 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -91.43 -58.84 2.31 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.56 102.57 7.99 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.83 -167.98 0.16 Allowed Glycine 0 CA--C 1.542 1.719 0 O-C-N 120.53 -1.356 . . . . 0.0 111.798 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.55 90.65 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.619 -2.108 . . . . 0.0 106.619 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.58 121.64 0.71 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.78 169.89 9.23 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 119.396 1.598 . . . . 0.0 109.544 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.29 179.48 43.85 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 123.798 0.713 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -132.53 149.32 52.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.265 1.026 . . . . 0.0 109.75 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -97.24 130.11 44.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.46 152.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -130.48 140.81 50.51 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.205 1.402 . . . . 0.0 107.247 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.3 -176.48 42.72 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.141 0.882 . . . . 0.0 112.799 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 m -103.98 143.67 32.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.91 164.4 12.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 120.058 1.299 . . . . 0.0 111.214 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.15 121.25 2.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.15 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.84 143.27 45.97 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 141.76 38.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.993 1.317 . . . . 0.0 111.51 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 p -114.76 25.87 10.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.826 2.05 . . . . 0.0 106.863 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.59 165.08 35.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.705 2.402 . . . . 0.0 109.725 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.15 178.61 45.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 127.165 2.316 . . . . 0.0 113.173 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.55 -24.11 77.56 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.672 2.248 . . . . 0.0 111.154 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -62.3 -56.54 17.43 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.531 1.132 . . . . 0.0 109.017 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' A' ' 101' ' ' ILE . 37.3 t80 -61.34 -31.37 71.24 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.72 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -68.02 -48.17 66.44 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 121.608 2.004 . . . . 0.0 110.622 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.78 41.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.419 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' A' ' 98' ' ' PHE . 1.2 pp -93.67 -20.7 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.15 92.94 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 121.351 1.887 . . . . 0.0 112.453 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.505 0.0 OUTLIER -51.96 -21.92 3.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.1 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -73.05 178.97 4.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -133.92 7.88 3.77 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 118.393 -2.692 . . . . 0.0 114.388 -176.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -121.53 8.57 10.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.742 0.701 . . . . 0.0 111.796 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.42 150.78 24.47 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -115.52 -19.17 10.74 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.686 1.994 . . . . 0.0 110.397 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . . . -168.2 161.49 12.35 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.581 1.182 . . . . 0.0 109.383 -173.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.52 106.9 18.96 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -83.39 95.09 8.12 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.9 t -81.95 131.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.389 1.876 . . . . 0.0 106.567 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.32 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.2 m -104.12 91.98 4.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.84 157.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.305 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.04 -53.26 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.3 m -151.34 141.58 22.31 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.505 1.048 . . . . 0.0 113.235 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.01 144.7 39.71 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 128.451 2.7 . . . . 0.0 108.836 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -139.05 136.46 35.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.945 2.098 . . . . 0.0 106.944 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.92 139.16 38.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 p -141.21 -59.1 0.49 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.252 1.186 0 CA-C-O 115.444 -2.217 . . . . 0.0 114.019 -173.334 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 123' ' ' FMN . . . . . 0.644 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.2 mm? . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.87 159.9 47.22 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.545 2.163 . . . . 0.0 109.788 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.21 94.04 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -51.4 -39.01 56.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.941 1.696 . . . . 0.0 111.438 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.28 -57.84 7.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.593 1.088 . . . . 0.0 110.388 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -54.78 -48.43 72.7 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.522 1.129 . . . . 0.0 109.902 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.82 -35.96 73.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.5 t -69.4 -44.07 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.618 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -41.67 77.12 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.068 1.304 . . . . 0.0 112.433 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -51.77 -24.67 6.25 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.86 168.48 9.4 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 122.42 1.105 . . . . 0.0 111.669 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.5 138.69 45.23 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -178.83 172.36 44.61 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.04 150.93 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.1 t -128.97 163.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 127.585 2.354 . . . . 0.0 104.926 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.19 156.09 46.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.543 1.137 . . . . 0.0 108.315 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -138.54 110.88 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.87 108.51 19.57 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.496 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -93.89 108.79 20.54 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -74.4 137.24 42.56 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 121.034 1.743 . . . . 0.0 106.441 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.72 -81.94 0.22 Allowed Glycine 0 C--O 1.222 -0.607 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -164.16 -61.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.98 55.95 3.76 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.128 1.918 . . . . 0.0 109.49 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.59 140.69 4.92 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 127.238 2.351 . . . . 0.0 112.144 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.9 151.66 77.91 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 118.248 1.024 . . . . 0.0 109.619 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -121.12 101.82 7.91 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -87.43 88.55 7.71 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.33 173.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.006 2.123 . . . . 0.0 110.521 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -119.21 167.69 11.59 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.778 1.172 . . . . 0.0 113.128 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.7 t -168.34 173.16 7.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.1 2.16 . . . . 0.0 108.758 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -120.77 141.59 50.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.448 2.299 . . . . 0.0 109.984 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.56 -31.23 63.99 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.224 0.92 . . . . 0.0 111.013 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -60.09 -9.08 2.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.7 1.6 . . . . 0.0 113.612 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -118.1 -10.74 10.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.031 1.332 . . . . 0.0 109.361 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.7 mt -92.33 164.62 13.44 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.745 -1.222 . . . . 0.0 111.232 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD2' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.78 141.27 42.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.3 t -101.68 150.05 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.3 mt -122.14 178.86 4.74 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.37 2.668 . . . . 0.0 107.64 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -73.1 174.83 7.37 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.98 28.29 32.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.591 1.567 . . . . 0.0 110.942 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.657 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.301 0.1 OUTLIER 53.49 21.99 2.72 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.0 2.12 . . . . 0.0 114.69 -176.605 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -73.36 139.61 46.09 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -123.69 167.49 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 t -147.62 145.97 18.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 O-C-N 120.484 -1.385 . . . . 0.0 108.582 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.4 131.79 24.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.289 2.636 . . . . 0.0 105.959 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.91 108.75 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.485 2.123 . . . . 0.0 108.84 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.761 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.42 111.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.4 -21.08 5.63 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.852 1.691 . . . . 0.0 112.966 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.07 41.55 0.29 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 48' ' ' VAL . 22.7 mtt -107.88 71.41 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.553 1.541 . . . . 0.0 107.862 174.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -66.29 -64.91 0.75 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 130.348 3.459 . . . . 0.0 113.732 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -51.69 -41.11 61.21 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.982 -1.074 . . . . 0.0 109.15 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -61.5 -38.94 89.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.69 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.78 -50.18 74.91 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 121.126 1.785 . . . . 0.0 110.532 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.31 -39.31 90.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 111.498 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -68.08 -41.96 81.09 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 116.279 -1.82 . . . . 0.0 110.471 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.15 -48.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.101 1.319 . . . . 0.0 108.966 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.19 51.06 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.295 -0.86 . . . . 0.0 112.694 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.86 -45.93 10.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.36 0.982 . . . . 0.0 113.081 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -141.59 133.14 26.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.931 0.893 . . . . 0.0 110.777 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -16.15 62.21 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.948 -1.095 . . . . 0.0 112.902 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -59.76 117.12 4.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.6 m -138.9 147.1 25.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 123.679 1.704 . . . . 0.0 112.444 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.25 148.9 31.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 11.7 ttt -139.38 126.62 21.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.3 p -108.74 127.96 54.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.79 164.92 13.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.994 1.725 . . . . 0.0 108.696 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.1 -175.77 38.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 46.9 t -146.99 161.92 39.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.024 1.329 . . . . 0.0 108.841 174.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -98.73 -8.1 26.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.854 1.662 . . . . 0.0 109.922 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -8.51 48.73 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.839 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.88 133.95 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.13 131.38 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.5 1.12 . . . . 0.0 111.419 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -140.92 6.14 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.89 -59.43 2.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.746 2.019 . . . . 0.0 108.324 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.27 102.94 8.87 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.2 -168.63 1.58 Allowed Glycine 0 CA--C 1.537 1.463 0 O-C-N 121.997 -0.439 . . . . 0.0 112.289 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -75.65 64.18 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.574 2.182 . . . . 0.0 109.954 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.11 121.13 1.1 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -118.16 169.61 9.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.008 0.904 . . . . 0.0 110.155 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.61 -171.84 43.56 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 124.271 0.939 . . . . 0.0 112.406 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -145.35 156.04 43.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 109.791 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 tt -101.38 131.36 47.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.33 162.07 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -133.32 150.75 51.85 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.399 1.479 . . . . 0.0 108.923 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.97 179.6 43.52 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.216 0.912 . . . . 0.0 111.745 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -101.21 128.98 47.08 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.02 161.78 14.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.609 1.095 . . . . 0.0 111.692 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 121.28 3.11 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.41 1.484 . . . . 0.0 109.351 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.91 137.54 43.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.613 HH11 ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -138.34 141.22 39.73 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.532 1.533 . . . . 0.0 109.334 176.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.26 37.39 4.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -159.2 159.12 33.91 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 129.072 2.949 . . . . 0.0 110.613 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.44 178.56 46.84 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 126.432 1.967 . . . . 0.0 115.694 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.57 -18.26 53.47 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.891 3.06 . . . . 0.0 111.724 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.83 -64.09 0.94 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.16 -31.27 71.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.633 0.773 . . . . 0.0 111.556 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -68.58 -60.3 2.51 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.75 -19.34 62.35 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.847 -1.158 . . . . 0.0 113.517 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.8 pp -92.6 -18.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.112 1.324 . . . . 0.0 110.854 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.58 -27.97 3.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.782 1.633 . . . . 0.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -50.67 -23.22 2.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.441 1.096 . . . . 0.0 113.567 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -80.3 178.73 8.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.733 1.151 . . . . 0.0 109.604 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 tttt -137.27 20.35 2.96 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.91 -1.744 . . . . 0.0 111.331 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -136.15 8.67 3.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.902 1.281 . . . . 0.0 111.137 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.93 131.1 35.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.529 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -20.9 16.53 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 109.669 173.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.761 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.85 161.76 11.08 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.377 1.871 . . . . 0.0 109.769 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 103.5 13.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.18 95.38 5.6 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.12 131.66 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.951 1.7 . . . . 0.0 106.961 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.2 mt -117.93 128.47 75.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -99.01 85.9 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 2' ' ' LEU . 31.4 t -60.78 151.7 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.494 1.118 . . . . 0.0 109.461 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.5 -54.99 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m -148.34 141.22 24.74 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.258 . . -120.59 158.15 27.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 130.698 3.599 . . . . 0.0 114.732 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -145.93 135.77 23.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.218 2.207 . . . . 0.0 107.221 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.84 138.57 42.6 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -134.83 -81.04 0.44 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.518 0.327 . . . . 0.0 110.48 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 121.38 0.609 . . . . 0.0 109.938 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.556 HD11 HG11 ' A' ' 115' ' ' VAL . 80.2 mt . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 157.16 57.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.502 2.134 . . . . 0.0 110.956 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -38.84 93.63 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -49.16 -38.94 27.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.606 1.562 . . . . 0.0 112.121 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -51.5 -52.82 43.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.426 1.466 . . . . 0.0 111.245 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -56.11 -48.35 76.36 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.585 1.154 . . . . 0.0 108.996 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.98 -34.03 69.53 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.12 -45.35 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.349 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.08 -43.17 70.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.315 1.416 . . . . 0.0 112.839 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -51.84 -19.36 1.67 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -112.16 161.94 15.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.938 1.351 . . . . 0.0 111.472 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -73.6 131.59 41.86 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.774 1.23 . . . . 0.0 109.356 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.31 165.13 35.37 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 124.978 1.275 . . . . 0.0 111.251 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.78 150.6 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 31' ' ' THR . 31.4 t -135.15 161.44 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.59 43.01 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.032 0.933 . . . . 0.0 108.808 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.7 mt -138.71 118.83 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.9 108.38 19.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.549 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.0 m -89.43 116.66 27.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -73.26 141.18 47.23 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 120.916 1.689 . . . . 0.0 106.554 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.13 -81.28 0.25 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -161.42 -48.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 19.9 p-10 -78.44 40.63 0.37 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 129.61 3.164 . . . . 0.0 111.133 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.43 151.4 18.56 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.693 1.139 . . . . 0.0 110.851 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 73.0 Cg_endo -68.8 149.27 72.69 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 CA-C-N 118.609 1.205 . . . . 0.0 109.51 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.91 98.12 7.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.68 2.392 . . . . 0.0 112.892 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -82.14 89.21 6.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.674 0.79 . . . . 0.0 111.395 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.41 168.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.908 1.283 . . . . 0.0 110.491 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -122.23 166.07 15.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.426 HG23 ' HB ' ' A' ' 16' ' ' VAL . 12.1 t -168.42 176.57 5.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.224 2.209 . . . . 0.0 109.222 175.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.14 141.63 50.63 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.327 2.251 . . . . 0.0 109.848 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -55.61 -31.47 62.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.971 0.805 . . . . 0.0 111.193 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 t -60.48 -8.88 3.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.515 1.926 . . . . 0.0 114.043 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -118.72 -1.05 11.16 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.752 1.16 . . . . 0.0 111.399 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.511 HD22 HG22 ' A' ' 46' ' ' VAL . 11.5 mt -102.65 163.38 12.25 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.29 0.95 . . . . 0.0 112.262 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -136.3 141.59 43.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.79 141.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.43 -178.02 3.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.839 1.655 . . . . 0.0 108.999 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.76 164.81 4.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.651 1.181 . . . . 0.0 111.298 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.82 28.21 30.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.388 1.947 . . . . 0.0 111.109 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' HB2' HD12 ' A' ' 2' ' ' LEU 0.293 0.1 OUTLIER 53.44 22.15 2.74 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.532 1.933 . . . . 0.0 113.29 -175.151 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -73.83 131.89 41.99 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -114.11 161.09 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.63 138.54 35.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 108.669 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.511 HG22 HD22 ' A' ' 36' ' ' LEU . 59.1 t -123.15 133.14 24.34 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.742 2.017 . . . . 0.0 106.966 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.36 123.18 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.88 1.72 . . . . 0.0 107.739 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 51' ' ' MET . 7.8 p -85.08 112.16 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.65 -20.67 8.77 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 124.868 1.223 . . . . 0.0 113.458 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.62 39.99 0.19 Allowed Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.377 1.589 . . . . 0.0 112.175 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.446 ' HB2' HG23 ' A' ' 48' ' ' VAL . 30.9 mtt -99.12 71.06 1.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.035 0.917 . . . . 0.0 110.788 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -71.07 -67.41 0.51 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.368 1.867 . . . . 0.0 112.749 -173.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HZ1' ' CG ' ' A' ' 24' ' ' ASP 0.259 12.2 tmtt? -51.97 -38.89 58.25 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.172 0.989 . . . . 0.0 108.966 176.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -64.5 -38.81 92.32 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.909 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.53 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 26.5 tt0 -57.45 -43.63 84.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.478 1.944 . . . . 0.0 109.657 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.24 95.35 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.239 -0.288 . . . . 0.0 111.649 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.35 -41.76 76.66 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 116.968 -1.491 . . . . 0.0 113.567 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.08 -48.11 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.436 1.471 . . . . 0.0 109.089 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.7 -23.56 29.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -85.99 -46.07 10.87 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -151.42 129.43 11.8 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.759 1.224 . . . . 0.0 110.009 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -17.53 59.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.57 131.04 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.327 1.421 . . . . 0.0 110.739 -178.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.3 m -141.4 155.96 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 123.379 1.562 . . . . 0.0 112.332 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.5 tp -101.21 152.54 20.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.9 ttt -138.93 118.77 13.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -111.03 128.1 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.4 pt? -116.8 170.21 8.78 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 109.623 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.59 -177.02 39.3 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.533 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.5 t -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -98.63 -7.91 27.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.801 1.64 . . . . 0.0 108.936 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -11.26 38.55 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 119.371 -2.081 . . . . 0.0 113.338 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.42 138.87 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 120.627 1.558 . . . . 0.0 107.101 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.0 130.26 35.33 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.026 0.53 . . . . 0.0 110.75 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.67 -121.7 2.79 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 124.437 1.018 . . . . 0.0 112.927 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.445 ' H ' HD11 ' A' ' 122' ' ' LEU . 3.4 mmp_? -91.81 -78.63 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.247 1.419 . . . . 0.0 110.529 174.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -73.61 104.95 4.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.166 0.984 . . . . 0.0 108.431 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.15 -168.59 10.59 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.704 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 67.0 Cg_endo -74.74 63.7 5.76 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.851 2.368 . . . . 0.0 110.29 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.83 121.44 1.32 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -115.4 173.33 6.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.966 0.883 . . . . 0.0 110.726 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.3 -173.3 43.67 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 118.797 0.726 . . . . 0.0 113.133 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -151.34 157.32 42.33 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.409 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.5 130.9 47.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.62 155.14 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -126.86 143.87 51.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.626 1.57 . . . . 0.0 107.818 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.63 -165.11 32.65 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.3 m -121.39 142.87 49.58 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.313 0.645 . . . . 0.0 110.017 173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -89.92 161.78 15.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.623 1.169 . . . . 0.0 110.174 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.74 114.5 2.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.702 1.201 . . . . 0.0 107.775 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 50.1 m-85 -74.57 136.26 42.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.533 HH11 ' HG3' ' A' ' 92' ' ' ARG . 6.4 mmm-85 -139.13 137.3 35.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 109.866 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -120.78 38.06 4.14 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.81 158.96 34.55 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 129.394 3.078 . . . . 0.0 111.19 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.73 46.88 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.966 1.746 . . . . 0.0 114.72 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.03 -19.55 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.645 2.23 . . . . 0.0 109.523 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -63.62 -65.86 0.62 Allowed 'General case' 0 C--O 1.25 1.11 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.58 -31.85 71.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 116.607 -1.663 . . . . 0.0 112.515 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -68.25 -53.95 21.03 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.852 1.66 . . . . 0.0 110.823 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.67 70.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 116.96 -1.495 . . . . 0.0 111.309 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pp -85.1 -20.67 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 117.507 -1.677 . . . . 0.0 113.558 173.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.05 97.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.881 1.673 . . . . 0.0 112.915 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.599 ' H ' ' HD2' ' A' ' 103' ' ' ARG 0.52 0.0 OUTLIER -51.72 -18.06 1.1 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 173.784 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.02 -179.0 0.12 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -128.38 16.11 6.59 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 118.782 -2.449 . . . . 0.0 111.998 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -139.32 12.16 2.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.042 1.337 . . . . 0.0 110.891 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.12 140.46 37.8 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.372 -0.83 . . . . 0.0 111.28 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.81 -21.53 6.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.988 2.115 . . . . 0.0 111.706 174.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.24 161.99 1.9 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.69 1.996 . . . . 0.0 109.396 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.61 112.44 24.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 tp -84.1 93.56 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.11 120.8 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.93 128.8 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.2 m -98.61 78.91 2.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 2' ' ' LEU . 38.5 t -61.09 153.84 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 125.745 1.618 . . . . 0.0 109.381 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.9 t -130.15 -54.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -151.4 141.59 22.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.717 0.689 . . . . 0.0 112.844 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.58 20.22 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 127.283 2.233 . . . . 0.0 111.22 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.38 154.21 42.75 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.308 2.643 . . . . 0.0 106.689 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -100.8 133.97 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.223 -1.548 . . . . 0.0 108.404 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.0 p -135.37 -81.91 0.42 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.196 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.445 HD11 ' H ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.808 0 C-N-CA 130.415 3.486 . . . . 0.0 114.871 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.3 mm? . . . . . 0 N--CA 1.463 0.19 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.86 158.51 52.74 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.109 1.873 . . . . 0.0 109.197 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.2 -40.44 95.79 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -54.18 -38.84 66.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 111.827 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -51.32 -52.31 46.53 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.51 1.05 . . . . 0.0 110.692 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -60.0 -48.28 82.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.764 0.826 . . . . 0.0 110.495 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -53.21 -38.66 63.1 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.505 1.048 . . . . 0.0 112.159 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.04 -42.35 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.858 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.2 mt -58.39 -42.67 87.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.261 1.392 . . . . 0.0 112.164 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -51.87 -25.34 7.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.105 0.962 . . . . 0.0 113.04 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -101.26 161.09 13.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.62 139.99 45.86 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.13 164.4 37.75 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.53 148.5 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.421 ' HB ' HG23 ' A' ' 31' ' ' THR . 13.8 t -135.49 161.66 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.6 158.38 41.08 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.123 0.969 . . . . 0.0 108.875 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -138.81 114.42 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.66 108.87 19.69 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.607 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -92.89 116.19 28.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 116.939 -1.505 . . . . 0.0 107.607 -173.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -73.3 137.42 44.84 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 120.859 1.663 . . . . 0.0 108.4 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.25 -81.51 0.22 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 106.8 -2.52 . . . . 0.0 106.8 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -168.98 -48.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -78.18 38.68 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 131.326 3.85 . . . . 0.0 110.069 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.92 151.17 5.7 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 39.4 Cg_endo -68.62 148.56 72.51 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 CA-C-N 119.762 1.781 . . . . 0.0 107.725 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -108.15 101.5 10.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.347 -173.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 tp -74.68 88.8 2.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.216 1.006 . . . . 0.0 111.441 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.08 170.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.489 1.516 . . . . 0.0 110.242 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.24 168.08 11.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.802 1.183 . . . . 0.0 113.571 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.421 HG23 ' HB ' ' A' ' 16' ' ' VAL . 14.1 t -168.61 174.1 6.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.254 2.622 . . . . 0.0 108.253 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -121.11 141.96 50.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.52 2.328 . . . . 0.0 110.726 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -52.92 -31.63 41.06 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.828 1.194 . . . . 0.0 111.776 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -58.48 -8.71 1.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.701 2.001 . . . . 0.0 113.653 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -118.06 -3.35 11.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.813 1.245 . . . . 0.0 110.479 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.9 mt -99.23 170.59 8.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 120.449 1.477 . . . . 0.0 114.36 -173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -136.33 141.32 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -100.92 148.81 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 mt -121.78 178.93 4.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.17 2.188 . . . . 0.0 110.463 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -67.13 167.65 11.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.577 1.551 . . . . 0.0 109.742 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.9 28.62 57.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.073 1.321 . . . . 0.0 111.307 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.25 0.1 OUTLIER 53.73 20.43 2.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.873 2.069 . . . . 0.0 114.236 -175.21 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -73.44 145.56 45.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -127.27 168.15 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.02 145.0 18.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 120.392 -1.443 . . . . 0.0 108.8 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.68 138.88 32.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 128.749 2.82 . . . . 0.0 107.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.24 109.12 2.28 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.8 3.0 . . . . 0.0 109.427 173.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.28 111.84 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 173.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.77 -21.63 4.94 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.771 1.177 . . . . 0.0 113.24 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.24 37.45 0.41 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 119.183 1.491 . . . . 0.0 111.44 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.465 ' HB2' HG23 ' A' ' 48' ' ' VAL . 33.4 mtt -103.39 71.5 1.1 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.423 ' CD2' HH22 ' A' ' 108' ' ' ARG . 34.0 m80 -67.28 -70.53 0.25 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.401 2.68 . . . . 0.0 114.573 -173.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -51.68 -40.74 60.62 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 120.791 -1.193 . . . . 0.0 109.987 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 12.8 m -60.39 -39.14 86.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.868 0.867 . . . . 0.0 113.323 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.85 -48.13 82.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.291 1.405 . . . . 0.0 108.587 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.2 97.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.761 173.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 15.6 m-20 -63.07 -41.93 99.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.57 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.49 -48.21 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.622 1.101 . . . . 0.0 108.664 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.87 -26.81 62.61 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.122 -0.942 . . . . 0.0 113.503 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -87.18 -46.99 9.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.977 1.262 . . . . 0.0 112.187 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -147.06 128.85 15.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.399 1.08 . . . . 0.0 111.848 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -17.67 59.3 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.488 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.66 130.97 48.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.225 0.921 . . . . 0.0 110.466 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 20' ' ' THR . 35.5 m -144.24 156.15 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 123.264 1.507 . . . . 0.0 112.879 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.5 tp -104.88 152.74 22.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 172.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 ttt -138.99 128.27 24.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 p -129.72 128.6 42.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -116.46 164.07 15.1 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 119.431 1.014 . . . . 0.0 109.29 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.64 42.4 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.8 t -160.95 172.04 17.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.171 -1.194 . . . . 0.0 109.428 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -99.23 -8.29 25.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.212 2.205 . . . . 0.0 108.987 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -11.18 43.88 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 115.815 -2.041 . . . . 0.0 116.265 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.87 140.33 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.76 131.29 35.88 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.727 0.811 . . . . 0.0 110.868 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.4 -139.47 5.68 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 125.441 1.496 . . . . 0.0 112.099 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -79.23 -59.04 2.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.165 1.786 . . . . 0.0 107.662 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.7 103.09 15.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.27 -168.7 4.13 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.36 61.02 6.59 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.492 2.128 . . . . 0.0 109.969 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.33 121.56 1.2 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 108.559 -1.817 . . . . 0.0 108.559 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.19 169.85 8.96 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.479 1.14 . . . . 0.0 110.197 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 171.83 43.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.295 0.95 . . . . 0.0 113.1 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -131.83 147.78 52.51 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.417 1.487 . . . . 0.0 108.696 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -100.51 131.5 46.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.893 2.477 . . . . 0.0 105.409 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 115' ' ' VAL . 6.4 mt -136.4 154.73 33.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 mtt-85 -127.74 143.12 51.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.285 1.434 . . . . 0.0 107.682 -174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.09 -171.84 40.27 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 119.094 0.861 . . . . 0.0 113.407 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -121.31 134.68 55.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.323 1.449 . . . . 0.0 110.514 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -88.76 160.53 17.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.747 1.619 . . . . 0.0 110.565 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.62 120.64 1.5 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.464 1.506 . . . . 0.0 109.13 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.99 149.37 29.34 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.19 -0.944 . . . . 0.0 112.747 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.18 141.4 34.1 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.557 1.943 . . . . 0.0 109.179 172.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.8 p -114.11 24.8 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.546 1.539 . . . . 0.0 107.321 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.72 167.32 29.81 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 126.317 1.847 . . . . 0.0 110.39 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.8 179.74 45.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.639 2.066 . . . . 0.0 113.295 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.7 -11.46 17.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.886 3.057 . . . . 0.0 112.459 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -64.04 0.98 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.328 1.851 . . . . 0.0 107.138 173.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.29 -31.12 70.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.127 0.892 . . . . 0.0 110.749 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -68.65 -56.86 6.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.001 0.819 . . . . 0.0 109.801 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.39 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.909 -1.119 . . . . 0.0 112.428 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.343 1.5 pp -92.3 -18.12 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.666 1.121 . . . . 0.0 111.463 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.28 -28.09 2.89 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.688 1.995 . . . . 0.0 112.334 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -51.49 -32.34 27.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.237 172.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -79.07 178.02 8.36 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 173.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.69 8.18 1.93 Allowed 'General case' 0 C--O 1.221 -0.427 0 O-C-N 118.473 -2.642 . . . . 0.0 111.704 173.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -102.0 8.38 40.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.628 1.171 . . . . 0.0 110.554 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.96 22.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.519 0.727 . . . . 0.0 109.992 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.423 HH22 ' CD2' ' A' ' 52' ' ' HIS . 23.1 ttm180 -120.65 -20.93 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.887 2.075 . . . . 0.0 111.355 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.35 161.83 12.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.666 1.586 . . . . 0.0 108.519 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.5 105.41 15.43 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.599 2.36 . . . . 0.0 106.695 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 tp -79.22 95.86 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.285 1.834 . . . . 0.0 107.094 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.7 t -78.91 131.52 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.676 1.59 . . . . 0.0 106.718 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.78 128.36 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.5 m -98.91 85.9 3.37 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.475 HG11 HD21 ' A' ' 2' ' ' LEU . 22.6 t -60.76 150.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.46 -58.83 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -147.95 141.53 25.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.3 154.73 25.22 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.394 2.278 . . . . 0.0 110.347 173.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -140.41 139.14 35.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.447 2.299 . . . . 0.0 106.865 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -77.84 139.97 39.33 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -132.98 -58.82 0.9 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.243 0.717 0 CA-C-O 116.561 -1.685 . . . . 0.0 111.945 -173.362 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.15 155.48 56.61 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.576 2.184 . . . . 0.0 110.644 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.84 -42.06 97.96 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -49.48 -38.8 31.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.36 1.864 . . . . 0.0 112.327 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -51.1 -56.26 13.56 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.45 1.023 . . . . 0.0 110.145 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -58.62 -48.74 79.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.914 0.886 . . . . 0.0 109.36 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.59 -40.23 71.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.483 0.583 . . . . 0.0 112.269 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.52 -45.83 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.801 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.65 -37.25 73.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.81 1.186 . . . . 0.0 113.921 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -51.78 -29.51 19.26 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.748 1.158 . . . . 0.0 112.134 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -101.08 165.55 11.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.607 1.163 . . . . 0.0 109.83 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.21 139.05 45.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.33 167.56 40.31 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.13 144.12 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.068 1.747 . . . . 0.0 107.432 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.419 ' HB ' HG23 ' A' ' 31' ' ' THR . 59.0 t -136.8 158.32 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -145.42 155.45 43.15 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.566 1.546 . . . . 0.0 108.115 173.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.489 HD11 HG21 ' A' ' 46' ' ' VAL . 39.5 mt -140.98 112.93 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.99 108.92 19.84 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.458 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -95.35 116.99 29.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -73.31 141.16 47.14 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 121.001 1.728 . . . . 0.0 106.542 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.12 -81.27 0.22 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.89 -60.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -78.61 38.84 0.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 130.096 3.359 . . . . 0.0 111.445 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.0 151.29 17.03 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.13 0.871 . . . . 0.0 110.994 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.6 152.09 53.34 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 120.994 1.13 . . . . 0.0 111.529 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -110.5 101.6 10.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.4 tt -88.91 88.94 7.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -85.71 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.561 1.944 . . . . 0.0 110.785 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -119.23 166.72 12.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.367 0.985 . . . . 0.0 113.368 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.419 HG23 ' HB ' ' A' ' 16' ' ' VAL . 13.2 t -168.44 171.89 8.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.407 2.283 . . . . 0.0 108.212 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -121.34 141.71 50.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.084 1.754 . . . . 0.0 110.192 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.69 -31.25 15.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.795 0.838 . . . . 0.0 111.376 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -59.31 -8.66 1.79 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.095 1.758 . . . . 0.0 113.682 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -118.56 -13.21 9.69 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.722 1.209 . . . . 0.0 110.623 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.543 HD22 HG22 ' A' ' 46' ' ' VAL . 27.8 mt -91.1 168.62 11.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.64 -1.288 . . . . 0.0 111.901 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.91 37.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.46 134.05 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.28 179.07 4.53 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.897 1.679 . . . . 0.0 107.337 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 35.0 t0 -75.83 -179.21 4.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.274 0.629 . . . . 0.0 110.31 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 58.6 28.85 63.16 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.419 -1.425 . . . . 0.0 110.303 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 p30 53.82 13.23 0.5 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 130.106 3.362 . . . . 0.0 114.684 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -74.01 128.05 34.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.082 0.401 . . . . 0.0 110.301 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -119.07 158.83 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.5 142.72 25.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 O-C-N 120.397 -1.439 . . . . 0.0 107.732 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.543 HG22 HD22 ' A' ' 36' ' ' LEU . 58.2 t -124.38 126.15 25.53 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 128.623 2.769 . . . . 0.0 106.522 -173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -72.9 108.4 2.57 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.453 1.436 . . . . 0.0 108.934 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.87 111.59 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.7 -21.48 5.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.35 0.976 . . . . 0.0 112.097 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.58 41.3 0.47 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.044 -174.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB2' HG23 ' A' ' 48' ' ' VAL . 8.7 mtt -109.75 71.74 0.77 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.271 1.429 . . . . 0.0 108.203 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -67.04 -64.13 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 130.239 3.416 . . . . 0.0 112.794 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -51.66 -41.04 61.07 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.258 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.8 m -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.358 1.463 . . . . 0.0 111.509 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.95 -48.97 79.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.714 1.206 . . . . 0.0 108.838 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.83 94.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.0 -41.86 90.52 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.014 0.926 . . . . 0.0 109.316 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.34 -47.96 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.39 -28.3 28.69 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.505 -0.747 . . . . 0.0 112.322 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -45.96 17.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -150.79 138.97 20.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.051 0.842 . . . . 0.0 110.174 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -74.62 -18.52 60.54 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.362 -0.836 . . . . 0.0 111.984 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.79 118.15 6.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.804 1.241 . . . . 0.0 113.935 -174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 20' ' ' THR . 9.2 m -139.31 152.72 23.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 123.084 1.421 . . . . 0.0 112.762 173.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.7 tt -111.74 148.78 32.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.0 ttt -140.47 123.44 16.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 8.0 p -108.79 128.15 54.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.03 167.68 10.93 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 120.408 1.458 . . . . 0.0 109.208 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.91 178.82 46.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -151.89 155.18 37.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.6 mtt-85 -98.4 -8.4 26.99 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.284 0.634 . . . . 0.0 111.182 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -72.39 -7.66 50.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.535 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.98 135.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 174.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.01 130.36 35.44 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.24 -137.54 5.29 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -90.76 -58.39 2.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.575 0.75 . . . . 0.0 109.142 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.91 102.61 5.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 118.794 -1.162 . . . . 0.0 108.532 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.21 -168.27 0.12 Allowed Glycine 0 CA--C 1.54 1.642 0 O-C-N 120.647 -1.283 . . . . 0.0 111.086 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.37 90.78 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 106.462 -2.169 . . . . 0.0 106.462 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.41 0.71 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.748 -1.585 . . . . 0.0 109.599 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -105.99 168.87 8.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.399 1.099 . . . . 0.0 110.091 174.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.43 -166.14 35.31 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-O 121.266 0.37 . . . . 0.0 113.646 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.69 152.39 42.34 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.497 1.119 . . . . 0.0 110.009 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.22 131.12 47.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.502 ' CG2' HG13 ' A' ' 115' ' ' VAL . 5.3 mt -133.55 150.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -124.25 138.23 54.42 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.687 1.995 . . . . 0.0 106.268 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.45 -167.17 26.71 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -121.14 142.1 50.19 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.448 1.899 . . . . 0.0 108.682 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.06 160.99 16.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.913 1.233 . . . . 0.0 110.935 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.11 120.44 3.33 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.266 1.027 . . . . 0.0 109.448 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.413 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 3.4 m-85 -74.13 128.7 36.21 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -120.56 141.12 50.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.782 2.433 . . . . 0.0 109.632 173.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -121.21 29.53 7.25 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.658 1.983 . . . . 0.0 107.262 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.77 165.98 33.03 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.646 2.378 . . . . 0.0 108.663 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.7 178.97 46.34 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.499 1.523 . . . . 0.0 113.643 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.73 -20.43 68.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.545 2.163 . . . . 0.0 111.11 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.32 -55.58 20.29 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.52 1.528 . . . . 0.0 108.595 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CD1' HD11 ' A' ' 101' ' ' ILE . 33.1 t80 -61.34 -31.35 71.22 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 116.924 -1.512 . . . . 0.0 110.521 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.22 -48.39 65.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 121.515 1.962 . . . . 0.0 110.516 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.11 -35.99 60.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.854 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.436 HD13 ' HB1' ' A' ' 107' ' ' ALA 0.25 1.3 pp -93.68 -20.95 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 173.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.66 93.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 121.544 1.974 . . . . 0.0 111.695 -173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.464 0.0 OUTLIER -51.35 -18.02 0.89 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.988 1.715 . . . . 0.0 114.744 173.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -174.74 0.21 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -129.22 10.59 5.82 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 119.022 -2.299 . . . . 0.0 113.003 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -139.66 8.82 2.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.495 0.718 . . . . 0.0 112.587 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 101' ' ' ILE . . . -79.36 151.25 31.09 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.231 0.923 . . . . 0.0 111.356 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -120.65 -21.34 6.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.216 2.207 . . . . 0.0 111.657 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.784 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.78 161.63 11.16 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.659 1.584 . . . . 0.0 109.482 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.41 103.69 15.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.43 94.68 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.19 131.59 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.211 1.804 . . . . 0.0 106.59 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -118.99 138.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.7 m -114.64 101.39 9.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 85' ' ' ILE . 59.7 t -60.15 153.77 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.639 0.733 . . . . 0.0 109.352 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.91 -40.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.6 m -151.03 128.06 11.1 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 120.857 -1.152 . . . . 0.0 110.924 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.4 138.81 49.54 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.589 2.356 . . . . 0.0 109.117 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -142.01 140.97 32.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.86 1.664 . . . . 0.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.56 133.8 47.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -152.84 -58.55 0.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.252 1.224 0 CA-C-O 115.216 -2.326 . . . . 0.0 115.687 -172.936 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.242 0.704 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.47 160.32 48.44 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.606 2.204 . . . . 0.0 111.329 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.65 -47.53 90.45 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.83 -42.11 62.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.22 1.408 . . . . 0.0 111.99 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.569 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 34.7 t80 -51.12 -56.62 11.79 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.555 0.616 . . . . 0.0 111.493 173.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -59.17 -48.52 81.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.316 0.646 . . . . 0.0 110.578 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.79 -40.5 72.76 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.935 0.789 . . . . 0.0 111.976 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.89 -44.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.021 0.828 . . . . 0.0 108.884 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 25.4 mt -56.71 -43.89 81.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.087 0.858 . . . . 0.0 112.437 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -51.69 -27.08 10.61 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -99.11 171.63 7.89 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.295 1.045 . . . . 0.0 111.205 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.45 131.67 42.08 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.1 168.57 41.67 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.2 t -101.01 149.88 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.95 152.44 42.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mt -138.79 116.31 11.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.91 109.23 20.06 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -89.35 114.88 26.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 118.54 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.71 -74.65 0.11 Allowed Glycine 0 C--N 1.333 0.403 0 CA-C-N 118.236 0.471 . . . . 0.0 112.91 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.23 -48.24 0.06 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -173.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.18 38.48 0.29 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.523 1.529 . . . . 0.0 110.792 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 152.47 6.59 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 105.851 -2.9 . . . . 0.0 105.851 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 10.1 Cg_endo -51.19 147.76 19.91 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 122.233 3.016 . . . . 0.0 106.875 173.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -119.71 101.26 7.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.533 -172.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.4 tp -78.13 88.57 4.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.302 1.041 . . . . 0.0 111.208 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -77.48 171.71 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.942 1.297 . . . . 0.0 110.401 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -122.12 166.32 14.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.628 1.104 . . . . 0.0 113.516 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -168.52 175.01 6.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.561 2.344 . . . . 0.0 108.473 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -120.67 141.68 50.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.327 2.251 . . . . 0.0 109.463 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -55.21 -31.42 61.43 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.77 0.714 . . . . 0.0 110.598 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -59.24 -8.81 1.79 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.99 2.116 . . . . 0.0 113.876 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -118.13 -7.05 10.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.594 1.158 . . . . 0.0 109.576 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.429 HD22 HG22 ' A' ' 46' ' ' VAL . 28.9 mt -97.18 171.41 8.47 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.747 -1.221 . . . . 0.0 112.01 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.537 ' HE2' HD11 ' A' ' 39' ' ' LEU . 15.9 ptmt -133.64 123.15 24.54 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 10' ' ' LEU . 58.8 t -101.7 139.5 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.537 HD11 ' HE2' ' A' ' 37' ' ' LYS . 3.2 mp -121.66 178.52 4.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -76.55 -178.3 4.62 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.14 67.38 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 120.511 -1.368 . . . . 0.0 109.812 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 53.79 13.0 0.47 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 130.337 3.455 . . . . 0.0 115.602 -174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -73.6 140.03 45.94 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.673 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -130.59 161.4 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.87 145.63 20.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG22 HD22 ' A' ' 36' ' ' LEU . 60.5 t -122.24 130.04 24.85 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 128.31 2.644 . . . . 0.0 106.548 -174.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.49 108.69 2.74 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.223 2.615 . . . . 0.0 109.087 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.725 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.58 111.66 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.879 -0.513 . . . . 0.0 109.958 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.57 -21.31 5.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.954 1.74 . . . . 0.0 111.93 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.06 39.97 0.38 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.89 1.345 . . . . 0.0 110.353 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 48' ' ' VAL . 31.2 mtt -109.23 50.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.472 1.509 . . . . 0.0 107.052 173.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.47 -50.06 35.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.445 -1.264 . . . . 0.0 113.484 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -52.27 -41.57 62.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.272 1.851 . . . . 0.0 108.611 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 3.1 m -58.77 -38.4 78.41 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.71 0.804 . . . . 0.0 110.811 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.1 -48.18 79.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.682 1.583 . . . . 0.0 110.065 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.1 98.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 119.788 -0.148 . . . . 0.0 111.122 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 9.5 m-20 -61.22 -41.27 96.56 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 123.826 0.85 . . . . 0.0 110.052 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.9 -47.97 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.843 1.201 . . . . 0.0 109.361 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.92 -25.92 45.32 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.042 -1.036 . . . . 0.0 112.154 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . 1.3 mmm-85 -78.09 -45.03 24.55 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 173.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -151.25 140.82 21.64 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.234 1.014 . . . . 0.0 109.884 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -70.33 -19.41 63.07 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.873 -1.142 . . . . 0.0 111.94 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.8 120.77 10.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.18 1.392 . . . . 0.0 113.639 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 20' ' ' THR . 15.2 m -139.06 155.91 27.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 123.001 1.382 . . . . 0.0 112.185 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.9 tp -111.11 151.95 27.53 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 172.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.02 132.79 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 p -128.47 128.07 43.68 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -116.98 167.2 11.35 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.81 1.186 . . . . 0.0 110.781 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 178.5 42.42 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -150.32 170.79 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.732 -0.864 . . . . 0.0 109.076 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -98.66 -8.79 25.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.362 1.865 . . . . 0.0 110.888 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -91.58 -10.74 39.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.4 137.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.86 131.45 36.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.214 1.005 . . . . 0.0 109.798 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.22 -140.99 6.81 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -83.99 -58.48 2.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.53 102.92 8.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.3 -168.72 2.27 Favored Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 112.6 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.5 59.53 6.76 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.867 2.378 . . . . 0.0 110.789 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.44 121.32 1.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -113.95 169.07 9.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.91 1.355 . . . . 0.0 110.181 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 176.57 44.35 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 123.463 0.554 . . . . 0.0 112.889 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -126.39 144.6 50.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.718 1.607 . . . . 0.0 110.197 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.54 128.39 46.61 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 128.253 2.621 . . . . 0.0 104.442 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt -138.41 153.83 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 -119.84 148.16 43.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.89 1.676 . . . . 0.0 107.52 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.77 -171.38 31.89 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.1 m -120.85 144.38 48.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.376 2.27 . . . . 0.0 107.179 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.93 161.05 16.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.778 1.172 . . . . 0.0 111.405 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.22 114.92 2.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.174 0.99 . . . . 0.0 109.966 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -73.94 129.45 37.91 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.67 141.57 51.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 129.119 2.967 . . . . 0.0 108.606 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 p -118.28 30.36 7.27 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.774 1.629 . . . . 0.0 107.552 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -158.81 163.82 36.34 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.209 1.804 . . . . 0.0 109.328 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.74 46.87 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.116 1.817 . . . . 0.0 113.782 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.88 -13.86 37.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.707 2.938 . . . . 0.0 112.653 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.59 -63.38 1.07 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -61.23 -31.31 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.967 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.62 -55.54 11.18 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.689 1.131 . . . . 0.0 109.42 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.462 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.53 -27.12 68.38 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.857 -1.152 . . . . 0.0 112.178 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.362 1.0 OUTLIER -86.25 -18.18 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.881 1.218 . . . . 0.0 111.567 173.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.33 -27.67 2.69 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.961 2.104 . . . . 0.0 111.675 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -49.26 -35.79 18.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.028 . . . . 0.0 111.764 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -77.94 178.05 7.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.89 -0.98 1.44 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 118.529 -2.607 . . . . 0.0 111.568 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -97.01 8.38 44.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.979 0.912 . . . . 0.0 110.682 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.72 149.41 22.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.821 0.737 . . . . 0.0 109.515 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -117.71 -11.22 10.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.244 1.818 . . . . 0.0 110.936 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.28 161.7 12.3 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 110.0 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.15 104.57 14.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.512 2.725 . . . . 0.0 106.174 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.32 96.96 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.08 131.65 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.378 1.871 . . . . 0.0 107.11 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.11 139.76 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.9 m -118.9 101.44 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.2 t -60.28 160.98 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.613 1.565 . . . . 0.0 109.472 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.22 -57.14 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -141.06 122.84 15.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.17 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 146.99 42.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 128.054 2.542 . . . . 0.0 111.337 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -143.91 152.13 40.72 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.0 108.894 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -81.05 137.31 36.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.6 p -138.69 -58.49 0.62 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -173.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--O 1.251 1.168 0 C-N-CA 123.594 0.757 . . . . 0.0 111.182 -173.52 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.9 mt . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 118.47 -0.776 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.61 160.17 50.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.974 1.782 . . . . 0.0 111.756 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.26 96.86 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -52.85 -38.82 61.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.931 1.692 . . . . 0.0 112.072 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 32.6 t80 -51.14 -51.89 49.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.487 1.039 . . . . 0.0 110.962 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -60.1 -48.39 81.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.338 0.655 . . . . 0.0 110.73 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -54.97 -37.22 66.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.642 1.11 . . . . 0.0 112.638 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.09 -45.01 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.364 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 38' ' ' VAL . 34.2 mt -57.21 -44.09 83.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.397 0.999 . . . . 0.0 112.018 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -51.85 -18.93 1.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -107.71 158.41 17.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.556 1.071 . . . . 0.0 110.788 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -77.0 147.69 36.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.47 168.54 31.57 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.18 149.05 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.24 161.98 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 127.343 2.257 . . . . 0.0 105.021 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.43 157.17 43.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.371 1.068 . . . . 0.0 109.139 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -139.39 120.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.91 108.77 19.73 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 173.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.485 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.8 m -90.6 113.45 25.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -73.2 131.71 42.32 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.93 -79.14 0.17 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 122.514 1.064 . . . . 0.0 111.131 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -158.32 -48.59 0.06 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.647 -1.277 . . . . 0.0 109.003 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.61 37.74 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.773 1.229 . . . . 0.0 112.053 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.28 152.12 5.76 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 25.6 Cg_endo -59.23 148.02 88.02 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 121.043 2.421 . . . . 0.0 108.481 177.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' CD2' ' HZ1' ' A' ' 53' ' ' LYS . 70.2 t60 -117.04 101.45 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.622 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 13.2 tp -75.02 88.64 2.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.832 0.853 . . . . 0.0 111.531 -175.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 m -78.1 169.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.395 1.078 . . . . 0.0 109.834 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -119.85 166.34 13.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 112.243 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -168.52 176.05 5.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.453 2.301 . . . . 0.0 107.879 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -121.28 141.62 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.517 1.527 . . . . 0.0 110.76 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -50.86 -29.96 13.26 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 119.077 0.853 . . . . 0.0 111.154 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -55.13 -19.89 8.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.669 2.388 . . . . 0.0 112.58 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -118.13 -4.23 11.01 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.144 1.378 . . . . 0.0 109.619 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.468 HD22 HG22 ' A' ' 46' ' ' VAL . 6.3 mt -98.88 167.15 10.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.94 -1.1 . . . . 0.0 111.016 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.65 140.49 42.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 10' ' ' LEU . 85.4 t -101.9 149.51 6.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.8 mt -122.24 178.82 4.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.638 2.775 . . . . 0.0 106.244 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -76.03 -179.04 4.69 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.33 31.01 72.48 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 120.237 -1.539 . . . . 0.0 110.715 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 p30 54.08 13.06 0.53 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.765 3.226 . . . . 0.0 115.257 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -73.49 142.32 46.78 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 109.547 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.41 166.41 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.408 ' CG1' ' HB1' ' A' ' 110' ' ' ALA . 16.9 t -147.97 145.07 18.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 O-C-N 120.793 -1.192 . . . . 0.0 108.644 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG22 HD22 ' A' ' 36' ' ' LEU . 60.9 t -123.58 136.07 26.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 108.585 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.77 121.28 6.2 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 124.269 3.312 . . . . 0.0 110.582 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.558 HG23 ' HB2' ' A' ' 51' ' ' MET . 7.7 p -85.48 111.94 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 119.52 1.055 . . . . 0.0 112.764 173.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.31 -20.81 5.76 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.774 1.654 . . . . 0.0 111.64 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.54 30.0 0.23 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.459 1.63 . . . . 0.0 112.292 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.558 ' HB2' HG23 ' A' ' 48' ' ' VAL . 37.2 mtt -99.4 61.96 1.21 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.103 1.452 . . . . 0.0 107.825 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -71.15 -60.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.029 0.932 . . . . 0.0 112.951 -174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.426 ' HZ1' ' CD2' ' A' ' 27' ' ' HIS . 4.0 ttpm? -52.09 -41.77 62.68 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.138 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 2.0 m -61.62 -38.55 88.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.852 0.751 . . . . 0.0 111.641 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 36.9 tt0 -59.08 -44.74 91.93 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.927 1.239 . . . . 0.0 109.792 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.04 93.25 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.234 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 8.8 m-20 -62.61 -41.39 98.96 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 124.175 0.99 . . . . 0.0 109.473 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.78 -48.17 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 108.708 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.93 29.82 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.377 -0.827 . . . . 0.0 112.616 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -45.39 19.06 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -151.04 138.95 19.92 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.747 1.219 . . . . 0.0 109.417 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.1 -19.79 61.08 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.03 -1.044 . . . . 0.0 112.009 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.1 mmp_? -60.88 119.97 9.25 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.268 1.427 . . . . 0.0 114.265 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 89' ' ' ALA . 16.1 m -139.64 156.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 123.108 1.432 . . . . 0.0 112.8 173.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 15.4 tp -110.81 151.19 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 172.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.5 ttt -142.4 140.89 32.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 p -129.68 130.66 45.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.3 pt? -116.68 163.62 15.85 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.11 179.53 44.47 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.2 t -147.62 163.65 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -9.01 25.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.508 0.723 . . . . 0.0 109.221 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -81.1 -7.7 59.61 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.009 -0.996 . . . . 0.0 113.165 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.99 137.07 56.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.08 36.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.38 -141.48 6.15 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp-105 -81.57 -58.98 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.582 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.46 102.64 9.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.388 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 49.51 -168.71 0.2 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.236 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.3 87.52 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 107.557 -1.747 . . . . 0.0 107.557 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 121.25 0.7 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-O 117.734 -1.592 . . . . 0.0 109.16 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -115.52 -179.85 3.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.252 1.026 . . . . 0.0 108.963 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.32 -155.81 20.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 117.819 -1.545 . . . . 0.0 110.063 -173.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -151.2 157.49 42.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.306 1.442 . . . . 0.0 109.629 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.1 131.12 47.18 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 129.239 3.015 . . . . 0.0 104.811 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 115' ' ' VAL . 4.8 mt -136.95 152.31 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -119.61 140.77 50.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.4 1.88 . . . . 0.0 107.078 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.51 -171.15 30.4 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.415 0.531 . . . . 0.0 112.047 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -121.12 149.16 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.815 2.046 . . . . 0.0 108.289 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -107.29 165.13 11.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.633 1.173 . . . . 0.0 110.402 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.14 121.69 0.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 109.394 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 37.9 m-85 -76.45 150.73 36.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.766 -1.209 . . . . 0.0 114.191 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.315 0.0 OUTLIER -140.89 139.02 34.32 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 173.254 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 p -122.11 29.47 7.02 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 129.741 3.216 . . . . 0.0 102.582 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 92' ' ' ARG 0.288 8.9 t70 -158.43 160.21 36.57 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 130.353 3.461 . . . . 0.0 114.004 -172.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.97 178.41 47.54 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.007 1.289 . . . . 0.0 115.768 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.04 -16.28 53.36 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.093 2.529 . . . . 0.0 110.085 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -64.76 -66.7 0.51 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.14 -31.2 70.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.289 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -68.4 -59.43 3.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HB3' ' HD2' ' A' ' 37' ' ' LYS 0.258 . . -61.7 -19.41 62.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.862 -1.148 . . . . 0.0 113.39 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.339 1.2 pp -91.95 -18.08 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.326 1.421 . . . . 0.0 110.785 172.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.73 2.73 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.021 2.128 . . . . 0.0 112.747 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -50.48 -37.92 41.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.177 1.391 . . . . 0.0 112.157 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -75.55 177.9 6.39 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.64 -0.78 1.34 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 118.777 -2.452 . . . . 0.0 111.632 174.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -93.34 8.24 41.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.373 0.669 . . . . 0.0 109.697 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.84 129.69 36.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.2 1.0 . . . . 0.0 108.63 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -99.03 -16.0 18.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.466 0.706 . . . . 0.0 111.347 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.39 161.78 12.08 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.757 1.623 . . . . 0.0 108.95 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB1' ' CG1' ' A' ' 45' ' ' VAL . . . -100.8 110.42 22.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.755 2.822 . . . . 0.0 109.469 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.15 94.54 6.66 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.26 131.12 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mm -117.44 142.44 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 m -120.39 101.55 7.86 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.451 HG13 ' CG2' ' A' ' 85' ' ' ILE . 25.0 t -60.22 156.96 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.026 1.33 . . . . 0.0 109.352 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.26 -49.44 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -151.25 140.79 21.61 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 120.887 -1.133 . . . . 0.0 111.741 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.12 139.49 49.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.154 2.582 . . . . 0.0 108.528 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -142.09 163.18 33.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.783 2.033 . . . . 0.0 109.694 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -90.97 142.4 27.82 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 121.206 -0.934 . . . . 0.0 109.89 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.17 -58.0 1.07 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.939 2.496 . . . . 0.0 110.92 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.6 pt? . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.294 1.437 . . . . 0.0 110.032 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 42' ' ' ASN . 8.4 mp . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.16 155.81 69.06 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.78 2.32 . . . . 0.0 111.142 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.94 -38.81 93.25 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.16 -38.97 63.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.839 1.256 . . . . 0.0 111.184 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -51.44 -54.23 28.92 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.823 1.192 . . . . 0.0 110.743 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -56.71 -48.27 78.08 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.27 1.028 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.6 -35.23 72.12 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.895 -0.574 . . . . 0.0 112.363 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 68' ' ' LEU . 88.2 t -69.16 -43.5 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.909 1.231 . . . . 0.0 109.369 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.05 -43.24 77.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.219 1.372 . . . . 0.0 112.176 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -51.99 -21.35 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.099 0.863 . . . . 0.0 113.284 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -110.83 174.03 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.744 1.618 . . . . 0.0 110.965 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -73.35 129.4 37.93 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.43 164.28 34.41 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.5 145.52 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.57 164.94 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.83 160.45 43.56 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 107.952 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 46' ' ' VAL . 90.4 mt -138.74 119.49 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.41 108.9 19.61 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 173.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.573 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -93.89 114.48 26.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 115.407 -2.235 . . . . 0.0 108.586 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -73.26 129.4 37.96 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 122.836 2.562 . . . . 0.0 107.958 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.85 -76.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 124.609 1.099 . . . . 0.0 110.892 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -158.66 -48.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.71 2.004 . . . . 0.0 108.465 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.77 38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.295 1.438 . . . . 0.0 111.268 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.36 152.33 5.96 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 22.3 Cg_endo -56.2 147.74 64.07 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 CA-C-N 122.25 3.025 . . . . 0.0 107.386 174.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.471 ' CG ' ' HE2' ' A' ' 53' ' ' LYS . 70.0 t60 -111.24 101.42 9.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.343 -172.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.02 88.71 3.54 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.565 1.546 . . . . 0.0 111.649 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.93 168.86 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.861 1.264 . . . . 0.0 110.113 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -119.14 166.66 12.65 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.267 1.394 . . . . 0.0 114.203 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -168.42 171.62 8.95 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.529 1.932 . . . . 0.0 109.636 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -121.17 141.84 50.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.444 2.297 . . . . 0.0 110.738 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -53.75 -31.17 47.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.341 0.656 . . . . 0.0 112.412 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -59.38 -12.47 5.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 112.97 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -117.92 -2.78 11.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.392 -1.443 . . . . 0.0 109.805 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 46' ' ' VAL . 10.3 mt -99.48 166.38 11.19 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.076 -1.015 . . . . 0.0 110.17 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -136.77 128.88 29.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.52 141.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.911 1.684 . . . . 0.0 107.581 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.94 -177.9 3.7 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.041 1.736 . . . . 0.0 108.385 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.51 175.21 5.72 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.687 1.195 . . . . 0.0 108.432 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.27 28.19 13.14 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.275 1.893 . . . . 0.0 111.053 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.533 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.335 0.1 OUTLIER 53.27 25.24 4.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.016 2.126 . . . . 0.0 114.537 -178.5 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -73.66 126.71 30.93 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -114.97 164.89 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.16 144.19 18.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 O-C-N 120.346 -1.471 . . . . 0.0 108.579 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.587 HG22 HD22 ' A' ' 36' ' ' LEU . 58.8 t -130.78 137.46 30.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.998 1.719 . . . . 0.0 108.611 -176.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 112.32 2.71 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 124.139 3.226 . . . . 0.0 111.663 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -85.4 112.45 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.28 -20.96 5.37 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.657 1.123 . . . . 0.0 113.051 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.86 39.67 0.39 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.775 -1.569 . . . . 0.0 111.293 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 6.3 mtt -112.11 71.48 0.74 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -63.82 -53.79 45.28 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.46 -0.775 . . . . 0.0 111.952 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HE2' ' CG ' ' A' ' 27' ' ' HIS . 3.9 ttpm? -51.93 -41.43 62.02 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.322 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -62.39 -39.36 92.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.03 1.286 . . . . 0.0 111.507 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 34.6 tt0 -55.98 -50.62 70.34 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.22 1.373 . . . . 0.0 109.482 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.2 97.88 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -67.64 -41.73 83.41 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.547 1.139 . . . . 0.0 109.156 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -48.07 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.735 1.152 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.72 31.14 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HE ' ' HB3' ' A' ' 60' ' ' ARG . 5.7 mmm180 -84.05 -46.9 11.5 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.651 1.114 . . . . 0.0 113.872 173.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -151.13 140.88 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.03 0.919 . . . . 0.0 111.567 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.78 -23.48 55.92 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.247 -0.908 . . . . 0.0 113.015 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.38 122.43 15.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.798 1.181 . . . . 0.0 110.339 -173.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 20' ' ' THR . 22.7 m -139.22 155.97 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 123.43 1.586 . . . . 0.0 111.453 174.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.8 tp -106.85 154.51 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.3 ttt -138.85 137.35 36.49 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -131.15 129.12 41.37 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -116.38 173.29 6.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.604 1.093 . . . . 0.0 111.831 174.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.17 178.52 45.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.9 t -151.07 165.59 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.054 0.93 . . . . 0.0 109.418 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -98.74 -20.72 16.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.344 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -91.76 -6.2 52.27 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.114 1.366 . . . . 0.0 113.904 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.62 131.45 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -78.86 131.5 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.415 1.086 . . . . 0.0 109.079 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 -141.5 11.47 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -85.89 -58.86 2.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.63 102.84 11.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.337 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.48 -178.5 0.66 Allowed Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.452 1.025 . . . . 0.0 113.987 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 85.0 Cg_endo -78.13 81.66 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.311 2.007 . . . . 0.0 109.828 175.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 103.79 0.17 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 t -98.68 169.23 9.64 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.739 1.269 . . . . 0.0 110.372 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.6 161.86 30.04 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.663 1.125 . . . . 0.0 111.741 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -134.73 145.44 48.46 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.503 1.921 . . . . 0.0 109.28 -173.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -101.01 131.53 46.85 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 128.525 2.73 . . . . 0.0 107.728 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -140.36 152.4 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.99 148.34 52.27 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.154 -0.966 . . . . 0.0 108.703 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.43 -168.17 36.16 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 118.847 0.749 . . . . 0.0 112.251 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -118.99 134.53 55.13 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.147 . . . . 0.0 108.867 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.67 158.76 15.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.556 1.142 . . . . 0.0 108.86 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.98 120.75 3.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.678 1.191 . . . . 0.0 108.297 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 29.8 m-85 -74.34 139.65 44.29 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.405 -0.809 . . . . 0.0 112.695 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -140.85 141.4 34.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.01 1.324 . . . . 0.0 109.929 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.1 p -120.67 41.1 3.35 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -159.32 159.55 34.06 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 129.478 3.111 . . . . 0.0 111.013 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.21 178.66 47.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.712 1.625 . . . . 0.0 114.003 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.77 -8.86 20.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.25 2.633 . . . . 0.0 111.059 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -65.53 0.66 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.941 2.497 . . . . 0.0 107.083 173.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -61.28 -31.77 71.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.283 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.01 -48.85 41.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.935 0.789 . . . . 0.0 110.527 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.5 67.83 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.55 -1.344 . . . . 0.0 112.568 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.4 pp -90.33 -18.14 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.107 0.867 . . . . 0.0 112.021 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.95 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.201 1.8 . . . . 0.0 111.685 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -50.56 -22.85 2.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -81.3 178.86 8.13 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.554 1.07 . . . . 0.0 110.732 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -135.63 20.44 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 119.904 -1.748 . . . . 0.0 110.025 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -132.45 10.48 4.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.675 1.59 . . . . 0.0 111.284 -174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.0 150.26 32.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.141 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -120.74 -21.91 6.49 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 129.139 2.975 . . . . 0.0 112.362 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.33 161.74 1.44 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.779 2.031 . . . . 0.0 110.01 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.89 112.36 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.2 94.62 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.78 131.29 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.5 mm -121.15 129.13 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.1 m -110.15 90.81 3.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 2' ' ' LEU . 94.0 t -61.17 159.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.37 -56.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 104.0 -2.592 . . . . 0.0 104.0 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.6 m -148.58 141.05 24.29 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.454 0.57 . . . . 0.0 112.115 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.01 143.74 46.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.544 3.138 . . . . 0.0 106.79 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.0 145.62 39.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.701 1.6 . . . . 0.0 108.016 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.2 140.05 37.8 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -129.42 -58.41 1.12 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.252 1.227 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.063 -173.499 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.06 164.65 34.99 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.443 2.095 . . . . 0.0 110.879 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.29 -47.12 92.37 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.326 9.0 m -53.08 -38.56 62.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.648 1.179 . . . . 0.0 113.092 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -51.52 -58.56 5.96 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.0 1.273 . . . . 0.0 108.497 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -55.24 -48.25 74.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.856 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -53.99 -40.89 67.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.924 1.238 . . . . 0.0 111.009 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.7 t -68.85 -43.61 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.933 -1.105 . . . . 0.0 108.854 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.77 -36.35 72.02 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.257 1.389 . . . . 0.0 111.359 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -33.42 42.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 118.451 -2.655 . . . . 0.0 113.022 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -98.92 158.77 15.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 122.204 1.002 . . . . 0.0 110.928 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.29 141.13 41.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.44 175.09 47.41 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.13 144.76 8.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 125.143 1.377 . . . . 0.0 107.585 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.76 159.27 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.62 152.1 38.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.387 1.475 . . . . 0.0 107.289 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 46' ' ' VAL . 6.9 mt -138.99 117.94 13.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.5 19.61 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.555 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -89.03 110.83 21.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -73.95 141.81 45.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 122.11 2.232 . . . . 0.0 107.204 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.25 -81.8 0.26 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.63 -61.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.55 38.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.189 2.196 . . . . 0.0 110.165 173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.57 151.58 23.52 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.04 -1.037 . . . . 0.0 113.761 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.88 158.32 46.52 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.269 1.979 . . . . 0.0 112.918 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.32 101.86 7.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.107 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 10.9 tp -74.01 88.8 1.9 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.19 0.904 . . . . 0.0 110.666 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.86 170.97 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.986 1.315 . . . . 0.0 110.352 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.41 165.21 14.62 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.868 1.267 . . . . 0.0 111.172 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -168.41 172.31 8.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.7 2.0 . . . . 0.0 107.978 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -121.22 141.66 50.66 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.319 1.448 . . . . 0.0 110.235 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -51.2 -28.32 11.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.4 0.68 . . . . 0.0 111.104 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.41 -14.87 8.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.859 2.464 . . . . 0.0 111.751 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -118.13 -5.21 10.94 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.995 1.718 . . . . 0.0 109.686 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 46' ' ' VAL . 31.6 mt -97.32 171.64 8.29 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 120.332 -1.48 . . . . 0.0 112.882 -173.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 10.4 ptmt -136.08 135.87 39.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.55 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.4 mt -121.24 -178.18 3.71 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.073 1.749 . . . . 0.0 107.491 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -75.55 176.98 7.09 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 109.264 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.02 30.25 69.74 Favored Glycine 0 CA--C 1.525 0.698 0 O-C-N 120.475 -1.391 . . . . 0.0 110.831 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 p30 53.84 12.88 0.46 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.864 3.665 . . . . 0.0 114.868 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -74.8 122.44 23.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.9 mm -114.02 155.57 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 112' ' ' VAL . 41.0 t -137.46 140.54 41.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 18' ' ' ILE . 58.7 t -122.22 138.99 29.78 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 127.476 2.31 . . . . 0.0 108.778 -173.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.5 108.02 1.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.677 1.585 . . . . 0.0 109.589 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.729 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.87 111.81 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.35 -21.59 5.12 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.133 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 41.38 0.34 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.559 ' HB2' HG23 ' A' ' 48' ' ' VAL . 8.6 mtt -108.78 71.23 0.77 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 173.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -64.03 -63.11 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 129.817 3.247 . . . . 0.0 112.666 -173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -51.8 -40.75 60.94 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.351 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -62.92 -38.86 92.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.496 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -58.45 -50.42 73.78 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.611 1.55 . . . . 0.0 109.683 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.29 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.201 -0.312 . . . . 0.0 111.375 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -62.73 -41.8 99.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.044 -1.455 . . . . 0.0 110.336 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.69 -47.98 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 120.192 1.36 . . . . 0.0 108.542 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -23.63 13.55 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -87.44 -46.55 9.52 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.25 -1.531 . . . . 0.0 114.127 173.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -151.26 137.11 18.08 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.532 1.133 . . . . 0.0 112.656 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -22.48 54.34 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.67 126.57 27.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.697 1.589 . . . . 0.0 111.017 -173.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.6 m -139.07 144.06 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 111.941 173.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.75 150.36 21.14 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 16.8 ttt -139.17 120.8 15.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.7 p -108.82 127.97 54.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 pp -116.95 163.27 16.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 119.641 1.109 . . . . 0.0 109.229 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.05 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.5 t -158.1 166.91 31.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -99.02 -9.37 24.03 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -9.42 59.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.888 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.93 131.08 36.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.866 0.867 . . . . 0.0 110.437 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.38 5.9 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 125.575 1.56 . . . . 0.0 111.253 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.3 mmt-85 -84.08 -58.76 2.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.45 102.58 9.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.8 -168.07 0.16 Allowed Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.47 -1.394 . . . . 0.0 112.18 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.49 89.73 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 108.014 -1.571 . . . . 0.0 108.014 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.74 121.32 0.7 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-O 117.231 -1.872 . . . . 0.0 109.391 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.08 169.75 9.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.624 1.712 . . . . 0.0 110.906 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.62 -176.18 43.65 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 123.381 0.515 . . . . 0.0 112.576 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.4 145.68 49.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.127 2.171 . . . . 0.0 109.348 -174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.0 131.03 47.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.0 159.51 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -125.92 149.29 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.653 1.581 . . . . 0.0 107.782 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.84 -176.22 36.33 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.76 0.695 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.1 m -120.35 129.12 53.83 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.944 1.697 . . . . 0.0 108.102 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.23 160.23 14.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.871 1.668 . . . . 0.0 112.288 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.14 120.91 3.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.82 1.248 . . . . 0.0 108.678 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.71 144.48 39.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -140.84 138.28 33.87 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.148 1.379 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.3 p -120.87 40.93 3.42 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -159.17 157.18 30.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.754 2.821 . . . . 0.0 111.317 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.77 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.899 1.238 . . . . 0.0 114.538 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.79 -8.67 22.05 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.329 2.686 . . . . 0.0 110.687 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.418 ' CD ' ' HZ3' ' A' ' 37' ' ' LYS . 24.7 mm-40 -70.72 -63.18 1.14 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 108.15 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.13 -31.81 71.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.436 -0.793 . . . . 0.0 111.245 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -73.45 -48.43 33.68 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.915 0.779 . . . . 0.0 111.346 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.78 -25.16 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.003 -1.685 . . . . 0.0 112.12 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.377 1.2 pp -89.51 -18.22 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.855 1.207 . . . . 0.0 110.844 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.7 -27.52 2.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.048 2.539 . . . . 0.0 110.687 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -49.02 -37.21 19.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.073 0.949 . . . . 0.0 110.543 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -80.62 178.0 8.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 -0.56 1.39 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 117.979 -2.95 . . . . 0.0 111.864 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -87.56 8.33 25.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.914 1.286 . . . . 0.0 111.127 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.64 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.914 1.286 . . . . 0.0 111.962 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 -21.97 6.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 128.47 2.708 . . . . 0.0 111.119 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -177.27 162.03 1.89 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.203 1.801 . . . . 0.0 110.445 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.42 104.6 14.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.69 94.02 5.01 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.099 1.759 . . . . 0.0 107.079 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 45' ' ' VAL . 48.7 t -80.0 127.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.39 128.97 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.6 m -100.15 100.5 11.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.4 158.46 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.984 0.897 . . . . 0.0 109.304 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.57 -56.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 m -140.92 124.78 17.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 119.215 -0.421 . . . . 0.0 111.432 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.5 149.57 41.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.36 2.664 . . . . 0.0 111.176 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -141.68 144.66 34.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.134 1.774 . . . . 0.0 108.232 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -74.01 140.51 45.5 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -136.86 -77.61 0.41 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.255 1.364 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 -173.244 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.82 164.73 31.36 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.238 2.625 . . . . 0.0 111.877 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.92 96.58 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -55.7 -39.5 71.12 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.232 1.413 . . . . 0.0 110.446 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -51.06 -57.09 9.56 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.974 0.806 . . . . 0.0 110.017 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -58.83 -48.7 80.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.834 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -59.21 -41.16 87.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.08 -39.49 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.634 1.106 . . . . 0.0 109.107 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -58.55 -44.92 89.82 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.837 1.198 . . . . 0.0 111.251 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -51.99 -21.31 2.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -106.91 178.47 4.55 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 125.495 1.518 . . . . 0.0 110.983 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -73.55 129.43 37.96 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.15 167.16 33.81 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.01 146.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 173.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 t -130.52 159.8 42.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 28' ' ' LEU . . . -144.54 160.01 41.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.612 1.165 . . . . 0.0 108.999 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.3 mt -139.24 120.44 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -93.14 108.44 20.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 173.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.2 m -89.84 116.35 27.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 116.873 -1.536 . . . . 0.0 107.048 -173.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -73.42 135.81 44.23 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 121.582 1.992 . . . . 0.0 106.394 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.66 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.2 -59.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 15.9 p-10 -78.83 39.21 0.35 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.35 2.66 . . . . 0.0 111.429 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.34 151.47 21.01 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.238 0.923 . . . . 0.0 111.053 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.08 149.08 89.59 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 118.335 1.068 . . . . 0.0 109.986 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.428 ' CD2' ' HE3' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -115.43 99.71 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.633 1.573 . . . . 0.0 110.641 -173.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD11 ' HB1' ' A' ' 17' ' ' ALA . 8.1 tp -82.13 103.54 11.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 110.406 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.15 168.65 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.675 1.59 . . . . 0.0 110.868 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 10.0 m120 -126.63 164.13 21.94 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -168.41 172.46 8.32 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.248 1.819 . . . . 0.0 110.242 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.37 141.77 50.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.913 2.485 . . . . 0.0 108.809 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.87 -30.38 45.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.57 0.623 . . . . 0.0 111.695 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -57.72 -13.72 4.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.576 1.95 . . . . 0.0 113.145 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -118.3 -2.47 11.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.793 1.237 . . . . 0.0 110.194 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 46' ' ' VAL . 17.4 mt -101.07 168.1 9.81 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.589 1.086 . . . . 0.0 111.82 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -136.87 128.76 29.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.3 142.95 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -121.06 -178.61 3.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.39 1.876 . . . . 0.0 106.183 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -73.71 -178.81 3.31 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.77 29.18 66.84 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 120.392 -1.443 . . . . 0.0 110.423 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.1 13.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 129.209 3.004 . . . . 0.0 115.155 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -73.18 141.73 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.361 0.982 . . . . 0.0 110.58 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.87 154.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.36 143.98 24.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 36' ' ' LEU . 61.9 t -126.94 134.38 26.05 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 126.649 1.98 . . . . 0.0 107.419 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.18 118.03 4.83 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.875 2.383 . . . . 0.0 107.651 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 109' ' ' ALA . 2.6 p -79.34 111.5 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.348 0.976 . . . . 0.0 108.999 173.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.94 -21.68 9.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.24 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.66 18.87 0.3 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 120.467 2.134 . . . . 0.0 114.386 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.433 ' HB2' HG23 ' A' ' 48' ' ' VAL . 29.9 mtt -97.96 52.24 1.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.77 1.285 . . . . 0.0 108.176 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -64.0 -51.55 63.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.368 0.667 . . . . 0.0 111.6 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HE3' ' CD2' ' A' ' 27' ' ' HIS 0.285 17.5 ttpp -52.19 -41.16 62.42 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.325 -1.484 . . . . 0.0 110.839 173.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 57' ' ' ASN 0.27 1.6 m -60.35 -38.42 83.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.143 1.338 . . . . 0.0 113.026 173.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -55.39 -45.14 76.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.826 1.25 . . . . 0.0 107.829 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.31 81.07 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.958 -0.464 . . . . 0.0 111.647 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 3.8 m120 -59.6 -41.73 90.98 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 117.367 -1.301 . . . . 0.0 109.904 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.33 -48.24 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.122 1.328 . . . . 0.0 108.917 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.68 -25.98 12.49 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -46.44 10.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 173.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -151.5 134.08 15.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.991 1.268 . . . . 0.0 111.072 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -19.77 57.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.449 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.61 130.63 46.8 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.274 1.397 . . . . 0.0 110.92 -177.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.8 m -142.32 155.86 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 123.797 1.76 . . . . 0.0 112.99 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.9 tp -101.17 151.16 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.6 ttt -139.24 141.48 37.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 p -129.7 140.69 51.06 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -116.91 163.97 15.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.93 178.66 46.61 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.2 t -151.24 169.36 22.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -98.87 -18.36 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.55 1.54 . . . . 0.0 108.964 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -91.81 -1.46 57.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 117.073 -1.442 . . . . 0.0 113.938 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 t -130.99 127.03 60.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.32 131.42 36.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 109.149 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.97 -141.12 6.46 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -79.17 -59.02 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.733 1.613 . . . . 0.0 109.434 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.65 102.99 14.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.5 -169.4 2.21 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.84 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 69.7 Cg_endo -77.86 69.39 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.456 2.104 . . . . 0.0 110.412 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.49 108.37 0.32 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -101.88 169.57 8.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.06 172.55 45.48 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.457 1.031 . . . . 0.0 114.472 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.09 151.25 51.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 110.248 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -100.9 131.5 46.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 128.838 2.855 . . . . 0.0 104.464 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 68' ' ' LEU . 12.8 mt -135.59 153.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.1 mtt-85 -132.97 135.78 45.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.61 36.22 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.805 1.184 . . . . 0.0 112.182 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -121.23 148.21 44.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.729 0.812 . . . . 0.0 109.285 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -104.2 162.18 13.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.905 1.682 . . . . 0.0 110.669 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.3 113.07 2.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.536 1.134 . . . . 0.0 109.64 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 111' ' ' LEU . 8.5 m-85 -74.17 134.24 42.78 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -141.14 141.06 34.19 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.1 p -116.58 41.1 2.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.55 154.14 26.16 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.588 2.355 . . . . 0.0 110.466 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.1 178.67 47.3 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.854 1.692 . . . . 0.0 114.146 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.94 -9.42 19.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.709 2.939 . . . . 0.0 111.491 173.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -67.34 -64.8 0.78 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.402 1.481 . . . . 0.0 107.253 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -61.54 -31.4 71.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.485 1.114 . . . . 0.0 111.486 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.71 -56.07 9.32 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.304 0.956 . . . . 0.0 109.234 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.66 68.8 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.966 -1.084 . . . . 0.0 112.195 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.334 1.1 pp -85.89 -18.17 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.754 1.161 . . . . 0.0 111.869 173.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.68 -27.97 3.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.663 1.585 . . . . 0.0 112.062 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -50.53 -21.89 1.71 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.486 1.114 . . . . 0.0 113.827 173.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -80.91 178.66 8.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.706 1.139 . . . . 0.0 110.702 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -133.6 11.12 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.077 -1.639 . . . . 0.0 111.517 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -138.1 8.99 2.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.848 1.259 . . . . 0.0 112.968 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 151.84 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.307 1.043 . . . . 0.0 111.116 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -111.72 -21.93 11.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.392 1.077 . . . . 0.0 110.342 174.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 48' ' ' VAL . . . -178.19 161.96 1.52 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 127.718 2.407 . . . . 0.0 109.206 -173.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.43 105.97 18.05 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 91' ' ' PHE . 7.7 tp -79.63 92.82 5.4 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.35 129.76 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.092 1.357 . . . . 0.0 107.666 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.404 HD12 HG21 ' A' ' 64' ' ' VAL . 36.6 mm -117.28 133.7 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -112.02 97.28 6.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.53 161.26 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.464 1.506 . . . . 0.0 110.361 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.69 -55.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.2 m -151.54 141.46 22.02 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.832 -1.167 . . . . 0.0 112.476 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.1 138.74 48.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.938 2.895 . . . . 0.0 106.599 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -140.08 137.42 34.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.185 1.794 . . . . 0.0 107.749 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -77.15 141.16 40.28 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.6 p -129.64 -58.62 1.1 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.739 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.5 HD13 ' CB ' ' A' ' 42' ' ' ASN . 8.1 mp . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.09 154.63 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.713 2.275 . . . . 0.0 110.049 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.79 92.87 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -49.58 -38.57 31.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.682 1.593 . . . . 0.0 112.21 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -50.53 -54.75 20.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.226 1.375 . . . . 0.0 109.729 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -61.09 -48.54 81.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.516 1.126 . . . . 0.0 109.117 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.75 -34.14 74.0 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.1 t -72.71 -42.54 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.65 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.82 -39.75 82.13 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.437 1.471 . . . . 0.0 112.596 173.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -51.88 -24.99 7.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.965 0.802 . . . . 0.0 112.546 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -99.85 159.2 15.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.865 0.866 . . . . 0.0 109.402 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.56 146.12 45.01 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.335 -0.853 . . . . 0.0 109.078 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -179.27 171.23 43.1 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.551 HG23 HH12 ' A' ' 71' ' ' ARG . 6.6 t -101.63 148.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 68' ' ' LEU . 6.0 t -124.61 158.44 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 128.544 2.738 . . . . 0.0 104.771 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 28' ' ' LEU . . . -139.58 153.61 47.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 46' ' ' VAL . 7.4 mt -139.2 116.82 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.0 108.43 19.58 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.536 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -89.35 109.22 20.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 116.035 -1.935 . . . . 0.0 106.662 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -73.74 141.74 46.31 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 122.015 2.189 . . . . 0.0 107.754 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.52 -59.04 0.16 Allowed Glycine 0 C--O 1.223 -0.562 0 C-N-CA 123.56 0.6 . . . . 0.0 111.807 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HB3' HH21 ' A' ' 60' ' ' ARG . 4.2 tm-20 168.51 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 129.491 3.117 . . . . 0.0 107.856 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.7 46.98 0.7 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.819 1.771 . . . . 0.0 110.173 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.8 150.96 5.47 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.478 1.99 . . . . 0.0 111.36 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.37 162.44 38.34 Favored 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 120.463 0.775 . . . . 0.0 110.693 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -120.94 101.75 7.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 118.569 -0.729 . . . . 0.0 109.443 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 17' ' ' ALA . 10.0 tp -74.05 88.79 1.91 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.308 0.504 . . . . 0.0 110.541 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.39 169.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.719 1.208 . . . . 0.0 110.297 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -120.79 167.94 11.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.757 1.223 . . . . 0.0 111.333 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.25 170.23 10.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.549 1.94 . . . . 0.0 108.089 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -116.78 141.63 47.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.637 1.975 . . . . 0.0 109.338 -177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -55.17 -30.7 60.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -51.16 -21.05 1.76 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.174 2.589 . . . . 0.0 113.401 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -118.17 -4.33 10.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.207 1.403 . . . . 0.0 112.208 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 HG22 ' A' ' 46' ' ' VAL . 53.5 mt -97.08 166.83 11.4 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.036 1.289 . . . . 0.0 112.024 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -136.52 132.45 35.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -101.41 142.58 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.061 -2.199 . . . . 0.0 105.061 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.22 179.18 4.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.411 1.484 . . . . 0.0 108.274 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -70.33 174.81 5.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.194 0.998 . . . . 0.0 109.797 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.29 33.99 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.742 1.639 . . . . 0.0 110.928 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.5 ' CB ' HD13 ' A' ' 2' ' ' LEU 0.277 0.1 OUTLIER 53.49 19.87 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.893 2.077 . . . . 0.0 114.694 -176.833 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -74.69 135.79 41.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.92 161.12 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.5 t -144.64 145.46 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 O-C-N 120.674 -1.266 . . . . 0.0 108.379 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 HD22 ' A' ' 36' ' ' LEU . 59.3 t -129.21 137.53 31.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.605 2.762 . . . . 0.0 107.126 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.34 108.47 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.898 2.398 . . . . 0.0 111.066 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.85 111.87 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 108.853 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.94 -21.83 4.81 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.555 1.074 . . . . 0.0 112.605 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.71 41.13 0.43 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.089 -1.395 . . . . 0.0 110.135 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.491 ' HB2' HG23 ' A' ' 48' ' ' VAL . 18.4 mtt -108.65 71.48 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.149 1.379 . . . . 0.0 107.532 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -64.21 -65.33 0.69 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.284 3.433 . . . . 0.0 114.444 -173.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -51.7 -40.29 59.86 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.245 0.93 . . . . 0.0 108.602 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -63.14 -39.58 95.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.209 -0.9 . . . . 0.0 112.984 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 22.2 tt0 -58.59 -51.04 71.59 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 120.654 1.57 . . . . 0.0 109.623 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.59 -48.02 83.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.503 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -61.02 -41.97 97.57 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 116.197 -1.858 . . . . 0.0 111.311 -173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -48.09 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 120.248 1.385 . . . . 0.0 108.845 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.26 54.15 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.066 -0.969 . . . . 0.0 113.234 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.441 HH21 ' HB3' ' A' ' 23' ' ' GLU . 14.4 mtp180 -87.51 -46.91 9.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.027 1.285 . . . . 0.0 113.675 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -142.56 128.93 20.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.291 1.044 . . . . 0.0 111.802 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -18.86 58.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.65 126.48 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.389 1.45 . . . . 0.0 111.176 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.3 m -138.81 141.47 36.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.997 1.38 . . . . 0.0 112.584 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 3.5 tp -89.59 154.24 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.1 ttt -140.25 141.23 35.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.0 p -124.97 135.88 53.21 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.532 ' HA ' HG22 ' A' ' 16' ' ' VAL . 1.7 pp -116.47 164.64 14.27 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.007 173.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.67 178.78 41.94 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 38.5 t -147.29 174.11 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.945 1.298 . . . . 0.0 108.948 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.551 HH12 HG23 ' A' ' 15' ' ' VAL . 69.6 mtt85 -117.01 -8.03 11.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.425 2.29 . . . . 0.0 109.797 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 mmpm? -91.64 -11.08 38.08 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 119.482 -2.011 . . . . 0.0 115.304 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.37 133.1 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.21 131.48 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.29 1.036 . . . . 0.0 111.403 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.89 -141.19 6.95 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.463 HH22 ' CD ' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -85.9 -59.23 2.36 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.212 1.405 . . . . 0.0 107.607 176.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.49 102.95 6.24 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.82 -168.94 1.83 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 121.608 0.56 . . . . 0.0 112.964 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 62.4 Cg_endo -78.0 58.98 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.612 2.208 . . . . 0.0 110.87 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.55 120.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 t -113.72 168.95 9.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 117.777 0.789 . . . . 0.0 110.222 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.7 -176.72 40.23 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 124.703 1.144 . . . . 0.0 113.2 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.76 153.6 45.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.576 1.15 . . . . 0.0 109.662 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.52 129.53 47.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.8 mp -139.98 161.46 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 108.602 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.417 HH22 ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -139.15 151.06 46.33 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.605 -1.31 . . . . 0.0 107.905 173.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.13 -174.94 33.62 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.053 0.835 . . . . 0.0 111.782 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -115.93 129.34 56.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.245 1.418 . . . . 0.0 108.161 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.01 14.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.017 1.327 . . . . 0.0 112.162 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.01 120.68 3.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.767 1.227 . . . . 0.0 108.926 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.2 m-85 -76.73 140.58 40.87 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -140.8 139.24 34.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.672 1.189 . . . . 0.0 111.249 173.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -121.21 39.84 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 103.236 -2.875 . . . . 0.0 103.236 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.253 7.5 t70 -158.87 150.19 20.5 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.951 2.9 . . . . 0.0 111.55 -172.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.04 179.03 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.35 0.976 . . . . 0.0 114.183 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.42 -9.54 13.42 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.046 3.164 . . . . 0.0 112.179 173.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -67.66 -67.61 0.45 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.584 1.953 . . . . 0.0 106.943 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.45 -31.62 71.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.813 0.845 . . . . 0.0 111.925 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.71 -54.07 18.33 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.57 -32.56 72.66 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.099 -1.001 . . . . 0.0 112.567 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.403 1.1 pp -79.08 -17.84 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.017 0.826 . . . . 0.0 112.612 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.1 -27.69 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 111.367 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -45.67 -27.95 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.822 1.249 . . . . 0.0 112.975 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.06 178.88 8.14 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.306 1.042 . . . . 0.0 110.689 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -140.48 21.04 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 119.812 -1.805 . . . . 0.0 111.002 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -136.97 8.77 3.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.246 1.418 . . . . 0.0 111.117 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.22 25.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.68 -0.637 . . . . 0.0 110.664 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -21.05 8.01 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.173 2.189 . . . . 0.0 111.282 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.785 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.58 161.57 11.56 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.948 1.299 . . . . 0.0 109.772 -174.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.88 104.38 14.63 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.73 93.64 4.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.91 131.44 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.05 128.28 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 24.7 m -99.21 90.43 4.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 2' ' ' LEU . 77.7 t -60.6 159.38 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.66 -57.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.0 m -148.93 141.09 23.96 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.209 0.459 . . . . 0.0 112.038 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.91 138.88 53.89 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.306 3.042 . . . . 0.0 109.485 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CD ' HH22 ' A' ' 86' ' ' ARG . 17.7 pm0 -140.68 151.31 44.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.779 0.832 . . . . 0.0 110.874 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' HH22 ' A' ' 76' ' ' ARG . 0.0 OUTLIER -65.77 138.12 57.72 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 125.036 1.334 . . . . 0.0 109.944 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -138.45 -81.31 0.32 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.432 0.458 . . . . 0.0 110.836 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.456 ' C ' HH21 ' A' ' 76' ' ' ARG . 2.1 pp . . . . . 0 C--O 1.242 0.665 0 C-N-CA 123.955 0.902 . . . . 0.0 110.43 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.569 HD11 ' CG1' ' A' ' 115' ' ' VAL . 9.5 mp . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.47 156.28 58.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.291 1.994 . . . . 0.0 110.321 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.77 92.89 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.49 -38.68 55.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.838 1.655 . . . . 0.0 112.234 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -50.79 -54.23 25.31 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.337 1.426 . . . . 0.0 109.401 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.86 -48.58 76.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.515 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -60.26 -33.78 72.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.346 0.975 . . . . 0.0 112.482 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.05 -41.03 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.484 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -39.77 85.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.88 1.218 . . . . 0.0 112.047 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.72 -24.85 6.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.975 1.261 . . . . 0.0 112.433 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -101.48 158.6 15.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.94 0.791 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.22 148.68 41.36 Favored 'General case' 0 C--O 1.243 0.741 0 O-C-N 121.074 -1.016 . . . . 0.0 109.818 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -178.19 168.23 39.37 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 122.852 0.263 . . . . 0.0 112.724 -174.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -101.08 144.53 12.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.33 159.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 127.752 2.421 . . . . 0.0 105.607 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.16 157.32 45.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.32 1.048 . . . . 0.0 109.531 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.7 118.7 12.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 125.232 1.413 . . . . 0.0 107.71 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.92 108.78 19.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.3 m -88.79 109.42 20.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -73.53 141.23 46.73 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.42 -81.63 0.22 Allowed Glycine 0 C--O 1.221 -0.714 0 N-CA-C 106.007 -2.837 . . . . 0.0 106.007 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -170.69 -59.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.92 52.12 1.21 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.497 1.618 . . . . 0.0 110.201 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.57 144.94 3.93 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.83 2.157 . . . . 0.0 111.551 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.92 161.29 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.362 1.374 . . . . 0.0 109.983 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.12 97.46 5.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.976 1.71 . . . . 0.0 107.462 -173.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 11.0 tp -83.55 88.55 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.8 0.727 . . . . 0.0 109.322 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.23 169.04 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.013 0.925 . . . . 0.0 110.293 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.81 167.61 11.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.235 1.414 . . . . 0.0 112.856 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 t -168.35 174.61 6.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.627 1.971 . . . . 0.0 108.021 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -120.56 141.99 49.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.702 2.401 . . . . 0.0 109.463 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -53.88 -30.75 47.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.334 0.97 . . . . 0.0 109.737 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -52.15 -21.16 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.535 2.334 . . . . 0.0 112.671 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -118.12 -5.12 10.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.921 1.688 . . . . 0.0 112.108 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.7 mt -87.8 159.22 18.52 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.506 1.503 . . . . 0.0 111.588 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 100' ' ' ALA 0.25 0.0 OUTLIER -136.36 131.85 34.79 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.802 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.18 147.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.57 178.89 4.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.397 1.879 . . . . 0.0 107.725 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -71.28 175.86 5.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.107 0.963 . . . . 0.0 110.47 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.87 28.43 57.57 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.333 1.444 . . . . 0.0 111.476 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.518 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.272 0.1 OUTLIER 53.72 20.73 2.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.415 1.886 . . . . 0.0 114.375 -175.239 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -73.97 126.31 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.152 1.381 . . . . 0.0 107.373 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.66 159.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -146.0 144.28 20.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 120.536 -1.353 . . . . 0.0 109.262 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.92 136.54 28.59 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.925 2.09 . . . . 0.0 107.534 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.69 108.32 1.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.455 2.104 . . . . 0.0 109.039 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.49 111.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.19 -21.33 10.11 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.338 1.447 . . . . 0.0 113.255 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.92 0.31 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 119.305 1.553 . . . . 0.0 115.09 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -97.89 67.94 1.99 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 123.394 1.568 . . . . 0.0 108.353 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -64.21 -48.79 74.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.193 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.255 81.8 tttt -52.04 -36.29 49.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.794 1.633 . . . . 0.0 110.674 173.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -64.86 -39.51 93.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.429 1.468 . . . . 0.0 110.705 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 32.3 tt0 -55.08 -50.73 68.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.507 1.503 . . . . 0.0 110.631 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.1 79.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.131 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -58.52 -41.99 86.72 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 115.781 -2.057 . . . . 0.0 111.45 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.16 -48.36 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.874 1.216 . . . . 0.0 109.116 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.94 66.05 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.267 -0.873 . . . . 0.0 113.277 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -87.44 -47.06 9.07 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.662 1.119 . . . . 0.0 112.48 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -140.04 132.31 28.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.65 1.18 . . . . 0.0 112.325 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.97 -22.52 55.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.452 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.51 129.65 42.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.896 1.225 . . . . 0.0 112.47 -173.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.4 m -139.29 139.4 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.837 1.303 . . . . 0.0 112.336 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 20.2 tp -92.98 153.7 18.59 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 172.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.6 ttt -140.03 141.37 36.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -123.17 130.62 53.0 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 pp -115.35 166.19 12.14 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.617 1.098 . . . . 0.0 108.38 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.63 179.11 41.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 173.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.443 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 47.2 t -147.18 168.67 21.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.687 1.595 . . . . 0.0 108.157 174.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -116.42 -9.41 11.48 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.014 1.326 . . . . 0.0 109.87 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -92.38 -11.67 34.3 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.44 134.19 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 118.5 20.66 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.941 0.791 . . . . 0.0 112.33 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 81' ' ' THR . . . -121.5 -127.26 3.37 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.91 1.243 . . . . 0.0 111.704 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -91.68 -58.7 2.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -74.62 102.63 4.64 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 109.875 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.55 -167.9 0.4 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.27 62.85 5.25 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.72 121.88 1.39 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 129.73 3.538 . . . . 0.0 106.83 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.415 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 3.5 t -109.98 176.82 4.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.132 0.966 . . . . 0.0 110.699 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.52 177.41 44.38 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 124.839 1.209 . . . . 0.0 112.158 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -138.4 154.65 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.149 0.979 . . . . 0.0 108.369 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.27 129.3 47.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.46 154.04 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 119' ' ' GLU . 36.7 mtm180 -135.89 141.64 44.61 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.882 1.273 . . . . 0.0 108.618 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -169.81 34.94 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.412 0.53 . . . . 0.0 112.238 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.8 m -121.11 151.1 40.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.959 1.303 . . . . 0.0 109.074 173.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.32 163.64 13.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.625 1.17 . . . . 0.0 113.017 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.59 121.19 3.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.103 1.361 . . . . 0.0 109.377 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.5 m-85 -77.55 149.07 34.93 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.231 -0.918 . . . . 0.0 111.989 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -141.03 134.42 29.78 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 125.339 1.456 . . . . 0.0 107.709 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.0 p -120.42 20.17 11.93 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.597 173.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.75 150.1 20.65 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.698 2.399 . . . . 0.0 109.583 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.59 -177.83 45.45 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.917 1.246 . . . . 0.0 112.507 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.26 -14.27 19.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.133 3.222 . . . . 0.0 113.524 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.3 -63.72 1.01 Allowed 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.101 -0.999 . . . . 0.0 108.978 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.64 -31.62 71.73 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.448 1.499 . . . . 0.0 111.079 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -69.12 -49.66 55.01 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.438 0.695 . . . . 0.0 109.636 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -61.13 -35.39 76.94 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.146 -0.971 . . . . 0.0 111.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.402 0.8 OUTLIER -79.02 -17.89 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.736 173.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.2 -27.58 2.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.691 1.996 . . . . 0.0 112.22 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -47.65 -36.38 10.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.305 1.042 . . . . 0.0 111.205 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -80.89 177.95 8.72 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.308 0.958 . . . . 0.0 108.537 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -141.14 -0.6 1.44 Allowed 'General case' 0 C--O 1.222 -0.393 0 O-C-N 119.18 -2.2 . . . . 0.0 112.262 -176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -106.3 8.87 32.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.032 1.733 . . . . 0.0 110.873 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.41 145.75 29.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.389 -0.819 . . . . 0.0 110.869 -174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -121.29 -13.71 8.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.864 2.866 . . . . 0.0 111.913 -174.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -173.78 161.71 3.89 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.143 2.177 . . . . 0.0 109.536 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.17 101.97 11.42 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.386 2.275 . . . . 0.0 105.012 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.07 95.91 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.672 1.589 . . . . 0.0 106.764 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.98 131.67 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.16 128.49 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.6 m -98.92 88.46 4.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.569 ' CG1' HD11 ' A' ' 2' ' ' LEU . 86.4 t -61.03 156.13 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.827 175.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.49 -55.46 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.5 m -148.5 141.25 24.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.666 0.666 . . . . 0.0 112.32 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.35 138.73 51.59 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 128.919 2.887 . . . . 0.0 107.886 173.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 86' ' ' ARG . 3.3 pm0 -140.1 138.68 35.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 110.609 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 138.58 58.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 111.928 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -143.39 -80.51 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.259 0.624 . . . . 0.0 112.299 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 114.892 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.4 mm? . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 118.199 -0.905 . . . . 0.0 108.691 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.12 164.34 35.68 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.813 2.342 . . . . 0.0 110.329 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.86 -47.56 89.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.367 5.0 m -50.3 -38.11 39.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.255 1.822 . . . . 0.0 113.635 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -50.65 -51.97 44.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.095 1.316 . . . . 0.0 110.649 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -63.55 -48.35 77.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.035 0.934 . . . . 0.0 110.13 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.71 -38.09 66.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.427 1.012 . . . . 0.0 111.757 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.86 -43.77 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.083 -1.011 . . . . 0.0 109.629 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.65 -35.06 75.28 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.202 1.364 . . . . 0.0 112.32 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -51.84 -27.09 11.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.025 0.93 . . . . 0.0 112.133 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -99.37 159.2 15.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.468 1.107 . . . . 0.0 108.114 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.92 153.34 39.86 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 122.077 0.941 . . . . 0.0 109.151 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.97 174.52 45.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 125.611 1.577 . . . . 0.0 109.422 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.92 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.74 160.93 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.22 154.69 44.1 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.84 116.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -174.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 26' ' ' PRO . . . -88.56 108.86 19.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -94.36 123.05 37.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 116.971 -1.49 . . . . 0.0 108.134 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -72.91 119.55 17.31 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 121.242 1.837 . . . . 0.0 106.579 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.29 -81.65 0.23 Allowed Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.136 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -158.63 -60.7 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -78.82 41.03 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.113 2.565 . . . . 0.0 110.479 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.63 152.24 9.47 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.572 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 18.8 Cg_endo -54.25 148.05 42.81 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 CA-C-N 120.791 2.295 . . . . 0.0 107.973 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -103.3 101.3 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.195 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -76.22 88.53 3.08 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.168 0.587 . . . . 0.0 110.425 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -83.24 170.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.887 1.675 . . . . 0.0 110.069 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.13 166.1 13.35 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.09 1.314 . . . . 0.0 113.793 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.0 t -168.32 176.19 6.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.374 2.27 . . . . 0.0 108.054 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -118.95 141.81 48.34 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.659 1.983 . . . . 0.0 109.721 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.07 -31.56 42.37 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.372 0.669 . . . . 0.0 110.016 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -60.76 -11.79 8.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.903 3.281 . . . . 0.0 112.108 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -118.68 -6.36 10.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 111.58 -177.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD22 HG22 ' A' ' 46' ' ' VAL . 22.6 mt -95.05 160.11 14.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.089 1.313 . . . . 0.0 112.084 -173.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 141.61 44.64 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.28 150.95 5.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -122.0 179.21 4.59 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 128.461 2.704 . . . . 0.0 107.103 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.97 -179.91 2.47 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.26 28.21 26.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.479 1.514 . . . . 0.0 111.245 -173.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.6 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.342 0.1 OUTLIER 53.39 24.59 4.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.891 2.076 . . . . 0.0 114.32 -175.817 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.45 151.26 41.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.29 164.38 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -144.43 140.93 24.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 36' ' ' LEU . 59.8 t -123.0 124.86 26.44 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 127.483 2.313 . . . . 0.0 105.4 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.87 108.52 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.116 1.878 . . . . 0.0 109.008 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.833 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.83 111.61 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -21.24 6.85 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 112.077 173.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.3 40.89 0.31 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 119.095 1.448 . . . . 0.0 110.697 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.496 ' HB2' HG23 ' A' ' 48' ' ' VAL . 28.7 mtt -106.56 57.5 0.65 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.799 1.239 . . . . 0.0 108.598 173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.53 -49.81 37.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.627 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -52.17 -41.3 62.48 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.821 1.646 . . . . 0.0 110.854 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -61.1 -38.91 88.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.514 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.53 -49.51 76.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 121.04 1.746 . . . . 0.0 110.413 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.62 97.08 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -61.88 -41.94 98.46 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.567 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.36 -48.15 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.746 1.157 . . . . 0.0 109.32 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.14 53.18 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.387 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.5 mtp85 -85.56 -46.31 10.94 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.102 0.864 . . . . 0.0 112.726 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.46 129.21 15.2 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.161 0.984 . . . . 0.0 110.962 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -73.92 -17.75 60.98 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.53 123.19 16.04 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 20' ' ' THR . 11.9 m -138.82 141.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 123.082 1.42 . . . . 0.0 110.52 173.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.0 tt -107.32 148.48 28.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 102.091 -3.299 . . . . 0.0 102.091 172.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.4 ttt -141.66 121.06 13.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -108.93 128.36 54.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 168.52 10.01 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.042 1.292 . . . . 0.0 107.847 173.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.64 -169.22 31.8 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -147.01 175.47 10.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.409 1.099 . . . . 0.0 108.707 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -113.87 -7.94 13.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.676 2.391 . . . . 0.0 109.317 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mmpm? -91.46 -10.95 39.03 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 119.601 -1.937 . . . . 0.0 115.007 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.76 136.49 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.57 131.49 36.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.479 1.112 . . . . 0.0 111.104 -175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.44 -140.98 6.34 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 124.703 1.144 . . . . 0.0 110.886 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.27 -58.99 2.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.564 1.546 . . . . 0.0 107.731 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.95 102.84 8.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.072 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.24 -168.6 2.26 Favored Glycine 0 CA--C 1.538 1.499 0 O-C-N 121.754 -0.591 . . . . 0.0 112.655 176.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 77.9 Cg_endo -75.52 59.74 5.61 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.815 2.344 . . . . 0.0 110.993 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.25 121.11 1.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -113.47 169.88 8.64 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.477 1.138 . . . . 0.0 110.334 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.2 -177.36 45.15 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 123.602 0.62 . . . . 0.0 113.283 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -136.8 152.67 50.56 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.862 1.265 . . . . 0.0 109.502 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tt -101.39 131.27 47.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.648 2.379 . . . . 0.0 104.58 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -136.06 158.33 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -129.86 150.79 51.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.644 1.178 . . . . 0.0 109.453 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -174.59 40.9 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.455 1.026 . . . . 0.0 111.693 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -106.03 137.35 44.1 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.4 161.93 13.33 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.787 0.722 . . . . 0.0 111.181 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.2 119.24 3.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.148 0.979 . . . . 0.0 109.833 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -74.17 131.52 41.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.2 141.46 50.65 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.83 2.852 . . . . 0.0 109.572 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.14 27.07 8.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.384 1.873 . . . . 0.0 107.425 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -158.81 163.95 36.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.11 2.564 . . . . 0.0 107.797 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.48 178.35 46.82 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.072 1.796 . . . . 0.0 113.077 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.41 -22.91 58.95 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.167 2.578 . . . . 0.0 112.007 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -64.29 -59.31 4.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 173.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -61.56 -31.31 71.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.094 -1.431 . . . . 0.0 112.402 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -68.47 -53.99 19.83 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.957 1.708 . . . . 0.0 108.227 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.51 69.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.909 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.4 pp -93.67 -19.9 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.764 -1.113 . . . . 0.0 112.87 173.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.94 -35.21 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.533 1.969 . . . . 0.0 110.406 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.285 2.2 ptm180 -51.07 -18.18 0.78 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.947 2.099 . . . . 0.0 113.815 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -67.88 -171.2 0.2 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -132.13 4.17 4.07 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 118.597 -2.564 . . . . 0.0 113.786 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 23.3 p-90 -131.05 8.84 4.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.811 0.844 . . . . 0.0 111.704 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.86 140.61 38.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.498 -0.751 . . . . 0.0 109.062 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.21 -10.59 8.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.348 1.459 . . . . 0.0 111.418 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.833 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.0 161.85 10.77 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.79 2.436 . . . . 0.0 108.201 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.43 107.63 18.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.802 2.041 . . . . 0.0 106.6 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 tt -84.49 96.34 9.09 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.9 t -79.29 131.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.672 1.589 . . . . 0.0 107.516 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.06 128.86 75.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.4 m -106.09 92.19 4.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 2' ' ' LEU . 14.3 t -61.08 157.42 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.888 1.275 . . . . 0.0 110.723 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.52 -56.27 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.9 m -151.29 141.66 22.43 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.37 155.2 29.99 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 128.538 2.735 . . . . 0.0 112.295 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -141.07 140.95 34.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.815 2.046 . . . . 0.0 108.208 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -76.56 140.77 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -138.7 -79.49 0.34 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.307 0.643 . . . . 0.0 111.5 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.242 0.697 0 CA-C-O 116.825 -1.559 . . . . 0.0 112.169 -174.182 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 118' ' ' ALA . 67.0 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.77 152.39 42.48 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.846 2.364 . . . . 0.0 111.939 173.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.84 -39.18 93.54 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.35 -40.27 58.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.624 1.57 . . . . 0.0 111.89 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -51.28 -56.08 14.85 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.251 0.932 . . . . 0.0 110.611 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -56.06 -48.27 76.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.126 0.97 . . . . 0.0 110.454 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -55.41 -35.04 64.95 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.697 0.681 . . . . 0.0 112.565 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.6 t -69.06 -46.59 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.113 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.422 ' HG ' HG21 ' A' ' 38' ' ' VAL . 4.0 mm? -54.48 -41.32 69.42 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.169 1.35 . . . . 0.0 112.879 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -51.55 -18.71 1.19 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -119.94 158.69 26.2 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.367 0.985 . . . . 0.0 108.781 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -80.61 149.28 29.93 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.543 -1.348 . . . . 0.0 110.39 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.4 169.63 42.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.705 2.098 . . . . 0.0 110.194 174.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.1 151.04 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.98 159.58 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 127.574 2.349 . . . . 0.0 105.749 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.72 40.85 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.241 1.416 . . . . 0.0 109.419 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.589 HD11 HG21 ' A' ' 46' ' ' VAL . 9.8 mt -145.32 115.82 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.82 19.78 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -95.91 108.82 21.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -79.56 141.33 36.71 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 122.002 2.183 . . . . 0.0 106.168 173.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 -81.49 0.22 Allowed Glycine 0 C--O 1.224 -0.486 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -159.06 -61.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.4 45.73 0.68 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.131 1.772 . . . . 0.0 110.123 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 151.62 6.74 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.953 1.263 . . . . 0.0 112.685 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.19 157.72 53.37 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.212 1.275 . . . . 0.0 110.878 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.46 102.03 8.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.087 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.6 tt -87.35 88.71 7.76 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -175.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.58 173.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.762 2.025 . . . . 0.0 110.676 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.63 165.62 14.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.584 1.154 . . . . 0.0 111.574 173.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 178.43 4.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.247 2.219 . . . . 0.0 108.052 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -121.36 141.79 50.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.811 2.044 . . . . 0.0 110.685 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -51.52 -30.98 22.29 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.509 1.049 . . . . 0.0 110.799 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.48 -13.08 4.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.948 2.899 . . . . 0.0 112.008 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -118.14 -1.16 11.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.13 1.372 . . . . 0.0 110.48 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.613 HD22 HG22 ' A' ' 46' ' ' VAL . 27.6 mt -102.4 168.92 9.01 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.599 -1.313 . . . . 0.0 112.762 -173.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 125.3 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 172.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.422 HG21 ' HG ' ' A' ' 10' ' ' LEU . 35.3 t -101.69 148.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.9 mt -121.58 -177.11 3.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.944 2.098 . . . . 0.0 107.973 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 36.2 t0 -71.44 177.99 3.68 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 49.37 28.15 8.96 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 126.098 1.809 . . . . 0.0 110.443 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.3 0.5 OUTLIER 53.23 28.27 6.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.373 2.269 . . . . 0.0 114.304 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -73.62 144.63 45.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 173.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.79 159.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 t -143.05 141.76 26.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.613 HG22 HD22 ' A' ' 36' ' ' LEU . 57.7 t -122.79 140.39 33.11 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.302 2.641 . . . . 0.0 106.066 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.43 110.97 2.02 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.795 2.33 . . . . 0.0 108.61 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.754 ' CG1' ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.3 112.22 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.25 -21.77 5.44 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.081 -1.012 . . . . 0.0 112.148 173.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.78 41.31 0.35 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.344 1.572 . . . . 0.0 109.958 -175.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 48' ' ' VAL . 22.0 mtt -105.71 71.13 0.9 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.677 1.191 . . . . 0.0 108.498 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.39 -65.57 0.66 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 130.048 3.339 . . . . 0.0 114.558 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -51.72 -41.27 61.39 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -63.47 -38.69 92.11 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.66 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 35.4 tt0 -56.29 -51.22 68.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.242 1.383 . . . . 0.0 109.489 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.53 93.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.175 0.59 . . . . 0.0 112.158 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -65.34 -41.93 93.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.576 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.8 -48.06 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.23 -28.82 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.157 -0.925 . . . . 0.0 112.819 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -86.81 -46.3 10.09 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.598 -1.191 . . . . 0.0 112.087 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -149.05 140.78 23.56 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.749 1.159 . . . . 0.0 110.255 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -13.27 62.24 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 63' ' ' ARG . 8.8 mmp_? -49.88 114.16 1.01 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.754 2.422 . . . . 0.0 115.934 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 20' ' ' THR . 7.7 m -141.7 146.32 23.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 CA-C-O 123.905 1.812 . . . . 0.0 114.797 173.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 4.0 tt -111.46 148.78 32.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 101.623 -3.473 . . . . 0.0 101.623 172.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.4 ttt -141.05 140.98 34.33 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -121.6 128.21 51.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 175.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -117.19 169.73 9.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.227 -1.546 . . . . 0.0 108.112 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.86 -176.22 38.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.441 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 t -148.65 164.14 35.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.709 0.804 . . . . 0.0 110.364 174.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -98.35 -8.68 26.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.748 1.619 . . . . 0.0 109.447 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -91.39 -9.89 43.12 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 116.891 -1.528 . . . . 0.0 114.725 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -131.45 138.86 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 131.07 36.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.502 0.721 . . . . 0.0 110.753 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.25 -140.43 9.26 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 124.907 1.241 . . . . 0.0 111.765 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -90.68 -58.6 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 103.06 9.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.08 -168.67 3.91 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 113.129 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.28 58.82 6.81 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.658 2.238 . . . . 0.0 111.132 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.46 120.99 1.07 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -114.45 169.17 9.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.733 1.266 . . . . 0.0 110.105 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.54 178.21 41.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-O 121.725 0.625 . . . . 0.0 112.261 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.71 149.1 49.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.383 1.473 . . . . 0.0 108.473 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tt -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mm -131.35 156.53 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -135.59 146.01 47.51 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.285 1.434 . . . . 0.0 108.686 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.19 -165.54 34.46 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.942 0.782 . . . . 0.0 112.183 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.5 m -115.88 147.54 40.97 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.057 1.343 . . . . 0.0 108.045 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.99 164.35 12.89 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.794 1.637 . . . . 0.0 111.873 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.94 120.95 2.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.394 1.078 . . . . 0.0 108.853 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 63.8 m-85 -76.24 138.7 40.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -140.63 141.35 35.11 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.094 0.958 . . . . 0.0 110.112 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.3 p -117.2 39.64 3.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -159.07 156.13 28.63 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 128.115 2.566 . . . . 0.0 111.567 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.15 178.54 47.26 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.292 1.901 . . . . 0.0 114.391 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.71 -17.26 58.07 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.347 2.698 . . . . 0.0 111.584 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -63.77 1.13 Allowed 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.151 1.78 . . . . 0.0 107.488 173.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.45 -31.26 71.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.03 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -68.62 -49.08 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.555 1.07 . . . . 0.0 109.074 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.96 78.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.218 -0.926 . . . . 0.0 111.404 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.345 0.9 OUTLIER -82.58 -18.41 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.55 173.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.01 -27.96 3.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.826 1.651 . . . . 0.0 112.133 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -51.17 -35.9 38.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.72 0.808 . . . . 0.0 111.78 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.26 177.84 8.53 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -141.37 -1.11 1.36 Allowed 'General case' 0 C--O 1.222 -0.387 0 O-C-N 119.144 -2.222 . . . . 0.0 113.18 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -98.26 8.76 44.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.449 1.1 . . . . 0.0 110.271 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.37 150.8 28.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.524 -0.735 . . . . 0.0 111.03 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -120.88 -21.28 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.168 2.987 . . . . 0.0 111.024 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . . . -171.5 161.77 6.37 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.736 2.014 . . . . 0.0 109.114 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.99 108.38 19.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.5 93.89 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.04 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.9 128.68 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.1 m -106.2 92.09 3.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.04 155.48 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.848 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.05 -41.79 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.521 1.528 . . . . 0.0 107.275 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.5 m -151.26 141.0 21.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.838 1.199 . . . . 0.0 113.618 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 2' ' ' LEU . . . -115.5 140.13 49.43 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 129.948 3.299 . . . . 0.0 110.626 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -139.3 136.31 34.73 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.013 1.725 . . . . 0.0 109.291 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -75.91 140.82 42.33 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -137.23 -77.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.256 1.397 0 C-N-CA 125.359 1.464 . . . . 0.0 114.37 -173.539 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 42' ' ' ASN . 7.4 mp . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.43 159.39 51.63 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.677 2.251 . . . . 0.0 111.832 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.16 -38.77 93.6 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -48.5 -43.14 34.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.065 1.746 . . . . 0.0 111.427 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.34 -55.45 18.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.352 0.978 . . . . 0.0 111.247 174.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -56.7 -48.52 77.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -59.21 -33.62 71.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.759 0.709 . . . . 0.0 112.835 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.76 -41.93 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -59.6 -38.4 81.12 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.33 1.423 . . . . 0.0 112.493 173.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 -18.9 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.177 1.353 . . . . 0.0 112.63 173.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -113.73 159.05 20.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.414 1.086 . . . . 0.0 108.754 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -73.72 148.36 42.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.924 -1.11 . . . . 0.0 108.794 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -165.35 171.25 40.59 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 126.801 2.143 . . . . 0.0 110.079 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.42 150.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -139.82 160.46 26.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.974 2.109 . . . . 0.0 106.041 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 157.05 44.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.512 1.125 . . . . 0.0 108.46 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 HG21 ' A' ' 46' ' ' VAL . 23.0 mt -139.4 115.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -176.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.04 108.56 19.65 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 174.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -91.36 114.3 26.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 116.308 -1.806 . . . . 0.0 106.649 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.41 141.5 46.95 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 121.845 2.111 . . . . 0.0 108.47 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.28 -81.05 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -158.82 -56.98 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 20.0 p-10 -78.87 38.34 0.33 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.668 2.787 . . . . 0.0 111.517 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.37 151.67 6.48 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.416 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.92 148.9 58.53 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 CA-C-N 118.028 0.914 . . . . 0.0 111.449 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -101.88 101.39 11.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.84 88.64 3.44 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.663 0.665 . . . . 0.0 110.071 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.3 m -80.31 170.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.15 1.38 . . . . 0.0 110.046 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -119.36 165.91 13.72 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 0.989 . . . . 0.0 112.523 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -168.29 176.22 6.03 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 108.548 175.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.16 141.53 50.74 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.433 1.893 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.26 -31.06 52.65 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.111 0.869 . . . . 0.0 109.706 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -59.95 -13.33 10.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.765 2.826 . . . . 0.0 111.413 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -119.23 -2.94 10.6 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 46' ' ' VAL . 42.5 mt -90.18 164.78 14.3 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.477 1.489 . . . . 0.0 112.229 -173.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -134.98 132.2 38.08 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.17 145.74 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.48 179.13 4.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.333 1.853 . . . . 0.0 108.101 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.44 175.24 4.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.347 1.059 . . . . 0.0 109.474 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.09 28.42 33.38 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.721 1.629 . . . . 0.0 111.105 -173.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.61 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.28 0.1 OUTLIER 53.41 23.11 3.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.86 2.064 . . . . 0.0 114.102 -177.029 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -73.58 129.08 37.22 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -118.0 150.91 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.51 147.08 24.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 120.837 -1.164 . . . . 0.0 108.843 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 18' ' ' ILE . 58.7 t -126.65 135.73 27.69 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 126.188 1.795 . . . . 0.0 107.869 -173.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.0 108.36 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.022 1.815 . . . . 0.0 108.457 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.877 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.57 111.52 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.52 -21.35 6.9 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 112.256 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.75 41.38 0.32 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 117.46 -1.745 . . . . 0.0 109.901 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.503 ' HB2' HG23 ' A' ' 48' ' ' VAL . 20.1 mtt -109.12 59.82 0.6 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.654 1.181 . . . . 0.0 109.225 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -71.48 -49.65 39.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.994 -174.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HZ1' ' CG ' ' A' ' 24' ' ' ASP . 55.0 tttp -51.99 -41.44 62.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.044 1.747 . . . . 0.0 109.296 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -60.73 -39.47 88.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.151 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.93 -48.28 80.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 121.248 1.84 . . . . 0.0 110.782 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.68 99.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.099 0.159 . . . . 0.0 111.253 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -62.88 -41.87 99.56 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.379 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.7 -48.24 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.409 1.459 . . . . 0.0 109.132 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.49 -28.17 59.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -46.42 15.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -151.34 128.61 11.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.986 0.914 . . . . 0.0 109.204 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -15.39 60.05 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.799 -1.188 . . . . 0.0 113.969 -174.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.495 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.64 130.69 47.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.641 1.11 . . . . 0.0 111.575 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 20' ' ' THR . 11.7 m -139.35 156.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 123.392 1.567 . . . . 0.0 111.895 173.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.7 tp -108.93 149.87 28.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.3 ttt -140.01 123.02 16.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -109.02 127.99 54.57 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.97 172.4 7.29 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.421 1.464 . . . . 0.0 109.559 173.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.44 -166.16 27.03 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.0 t -146.65 159.94 42.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.83 0.852 . . . . 0.0 109.467 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -98.69 -15.47 19.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.145 0.978 . . . . 0.0 108.994 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.03 -7.01 50.01 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 116.323 -1.799 . . . . 0.0 115.388 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.02 129.69 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 121.767 2.076 . . . . 0.0 106.14 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.3 131.42 36.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.907 0.883 . . . . 0.0 110.631 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.71 -140.98 7.18 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -78.98 -59.11 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.877 1.271 . . . . 0.0 108.855 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -88.25 103.12 15.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.716 0.77 . . . . 0.0 109.907 -174.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.51 -172.01 3.97 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.952 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 54.0 Cg_endo -80.54 58.87 7.21 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.208 1.939 . . . . 0.0 110.571 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.69 109.83 0.43 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 t -99.32 169.65 9.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.498 0.649 . . . . 0.0 110.375 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.97 169.91 40.87 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -125.0 157.33 36.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.84 1.256 . . . . 0.0 110.386 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.89 130.54 46.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mt -134.77 153.01 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -130.76 140.38 50.31 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.805 1.642 . . . . 0.0 107.342 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.68 36.82 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 118.691 0.678 . . . . 0.0 111.718 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -121.4 150.99 40.69 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.869 0.868 . . . . 0.0 110.163 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.13 162.33 14.36 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.167 1.387 . . . . 0.0 112.288 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.02 121.19 3.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.643 1.177 . . . . 0.0 109.289 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -74.18 138.54 43.85 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.193 0.997 . . . . 0.0 110.771 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -135.56 123.34 22.45 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 126.448 1.899 . . . . 0.0 115.399 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -121.72 32.94 5.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.177 2.991 . . . . 0.0 103.924 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.64 151.76 22.6 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 130.488 3.515 . . . . 0.0 110.141 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.55 47.59 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.543 1.068 . . . . 0.0 113.37 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.82 -9.09 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.945 2.43 . . . . 0.0 111.17 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -61.32 -60.86 3.07 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -61.56 -31.48 71.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 125.071 1.482 . . . . 0.0 111.138 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.46 -48.56 64.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.741 1.155 . . . . 0.0 109.357 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.461 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -59.58 -41.22 89.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.421 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.281 1.2 pp -79.82 -18.75 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 119.251 -0.98 . . . . 0.0 113.556 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.91 -28.84 53.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.841 1.655 . . . . 0.0 113.745 -174.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.259 0.6 OUTLIER -52.08 -38.58 57.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.124 173.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -66.05 177.88 1.26 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 -1.12 1.5 Allowed 'General case' 0 C--O 1.222 -0.385 0 O-C-N 118.308 -2.745 . . . . 0.0 113.378 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -110.32 8.35 23.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.503 0.721 . . . . 0.0 109.903 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.14 138.83 33.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.82 -8.36 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.025 1.73 . . . . 0.0 110.917 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.877 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.24 161.75 10.29 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.324 2.649 . . . . 0.0 108.506 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.85 105.14 15.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.774 2.429 . . . . 0.0 104.72 173.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.4 90.84 5.63 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.48 131.34 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.6 mt -120.22 128.23 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.9 m -99.34 88.47 3.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.622 -2.732 . . . . 0.0 103.622 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 2' ' ' LEU . 25.0 t -60.71 157.29 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.037 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.79 -56.99 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.5 m -148.32 141.38 24.92 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.5 149.84 30.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.261 2.624 . . . . 0.0 108.534 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -139.55 133.14 30.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.31 1.844 . . . . 0.0 107.487 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -68.8 137.75 54.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -136.99 -58.23 0.72 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 77' ' ' ASN . 2.3 pp . . . . . 0 C--O 1.247 0.937 0 C-N-CA 124.23 1.012 . . . . 0.0 113.323 -173.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 42' ' ' ASN . 7.2 mp . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.24 159.63 52.37 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.607 2.205 . . . . 0.0 111.818 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.75 95.38 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.26 -38.72 63.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 110.482 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -50.61 -56.01 13.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.496 1.043 . . . . 0.0 110.228 173.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -59.34 -48.56 81.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.372 0.669 . . . . 0.0 109.534 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -56.69 -41.05 76.67 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -41.22 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.841 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.28 -42.84 78.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.307 1.412 . . . . 0.0 111.85 173.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -52.02 -18.92 1.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -116.08 175.02 5.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 111.666 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -73.26 132.5 43.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.79 166.24 39.25 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 106.747 -2.541 . . . . 0.0 106.747 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.83 147.81 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.02 159.34 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -145.51 154.81 42.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.386 1.474 . . . . 0.0 107.183 174.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.09 114.03 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.774 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.98 108.38 19.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.475 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -88.68 116.17 26.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -73.3 138.18 45.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.4 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -159.79 -60.74 0.07 Allowed 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -78.94 52.53 1.26 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.657 2.383 . . . . 0.0 110.043 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.43 150.41 5.73 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.017 1.77 . . . . 0.0 111.735 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 36.5 Cg_endo -66.94 150.16 82.97 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 118.241 1.02 . . . . 0.0 111.321 174.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -103.19 101.82 11.79 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.8 tt -87.4 88.88 7.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.5 m -76.1 169.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.117 1.767 . . . . 0.0 110.6 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 9.7 m120 -119.28 166.91 12.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.647 1.179 . . . . 0.0 113.079 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -168.68 174.25 6.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.315 2.246 . . . . 0.0 109.025 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -120.67 141.57 50.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.294 2.238 . . . . 0.0 110.218 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -54.63 -31.21 56.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.255 0.48 . . . . 0.0 112.03 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.5 t -59.72 -8.97 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.521 1.528 . . . . 0.0 113.343 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.13 -1.77 11.33 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.644 1.178 . . . . 0.0 109.845 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.66 169.62 8.35 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.701 -1.249 . . . . 0.0 113.133 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' NZ ' HD21 ' A' ' 39' ' ' LEU . 2.0 pttt -136.48 141.55 43.51 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.9 t -99.38 146.81 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.407 HD21 ' NZ ' ' A' ' 37' ' ' LYS . 22.7 mt -121.68 -174.08 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.968 2.907 . . . . 0.0 111.825 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.37 158.89 6.76 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 128.122 2.569 . . . . 0.0 111.067 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.09 35.82 42.32 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.055 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' HB2' HD13 ' A' ' 2' ' ' LEU . 0.2 OUTLIER 54.05 22.73 3.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.253 1.821 . . . . 0.0 114.347 -175.125 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -74.16 158.01 34.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.791 1.636 . . . . 0.0 108.084 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -140.77 170.23 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.8 t -144.89 140.06 23.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.767 1.227 . . . . 0.0 108.132 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.92 133.85 24.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 128.578 2.751 . . . . 0.0 106.885 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.37 108.43 2.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.874 2.383 . . . . 0.0 109.88 174.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.786 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.86 111.76 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.21 -21.34 6.29 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.6 1.571 . . . . 0.0 112.816 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.86 41.56 0.27 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.512 ' HB2' HG23 ' A' ' 48' ' ' VAL . 17.6 mtt -107.83 71.38 0.81 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.611 1.565 . . . . 0.0 107.728 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -67.21 -63.91 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 129.895 3.278 . . . . 0.0 113.278 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -51.74 -40.67 60.65 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -60.19 -40.85 91.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.306 -1.33 . . . . 0.0 112.252 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -58.19 -48.78 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.606 2.003 . . . . 0.0 110.32 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.16 95.69 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -65.1 -41.63 94.77 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 116.989 -1.481 . . . . 0.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.76 -48.25 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.3 1.409 . . . . 0.0 108.503 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -25.7 59.9 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -82.25 -44.92 15.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -151.15 136.24 17.48 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 108.791 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -21.85 63.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.162 -0.961 . . . . 0.0 112.256 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -61.05 128.88 38.58 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.68 1.192 . . . . 0.0 114.115 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 20' ' ' THR . 6.3 m -139.52 154.99 25.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 122.749 1.262 . . . . 0.0 110.139 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.774 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 9.3 tt -111.66 150.97 29.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 103.058 -2.941 . . . . 0.0 103.058 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 13.7 ttt -139.01 135.52 34.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 18.5 p -121.05 128.45 52.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.97 165.95 12.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 109.083 173.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.11 42.5 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -159.8 170.31 21.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.974 0.892 . . . . 0.0 108.901 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -99.27 -9.32 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.873 2.069 . . . . 0.0 110.325 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -91.85 -11.26 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.54 136.73 56.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -78.92 131.42 36.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.526 0.73 . . . . 0.0 109.847 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.32 -141.1 7.31 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 124.222 0.951 . . . . 0.0 110.933 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -81.67 -58.82 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.47 102.9 13.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.615 0.721 . . . . 0.0 109.625 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.73 -168.94 3.44 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.617 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 57.9 Cg_endo -78.52 59.43 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.578 2.185 . . . . 0.0 110.914 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.09 121.08 1.09 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -110.09 169.31 8.81 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 118.029 0.914 . . . . 0.0 109.836 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.87 35.16 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 123.962 0.791 . . . . 0.0 113.441 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -136.48 141.5 43.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.23 1.412 . . . . 0.0 109.348 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.18 130.68 47.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 127.174 2.189 . . . . 0.0 106.271 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.4 mt -141.32 150.99 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.812 -0.555 . . . . 0.0 109.762 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -128.03 148.82 50.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.81 2.044 . . . . 0.0 109.967 173.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.4 -168.09 34.06 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.355 1.455 . . . . 0.0 110.458 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.7 m -121.0 149.04 43.28 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.351 1.46 . . . . 0.0 108.838 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.02 163.56 13.71 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.763 1.225 . . . . 0.0 112.191 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 121.5 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.68 143.91 46.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -133.36 134.53 43.87 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 126.414 1.886 . . . . 0.0 107.537 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.8 p -121.22 28.77 7.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 108.695 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.78 155.79 28.58 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.714 2.006 . . . . 0.0 110.036 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.19 -174.8 44.1 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 124.384 0.992 . . . . 0.0 115.263 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.35 -10.77 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.713 2.942 . . . . 0.0 112.735 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.81 -62.67 1.31 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.235 1.814 . . . . 0.0 106.86 173.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.41 -31.37 71.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.751 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.67 -48.86 62.88 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.566 1.075 . . . . 0.0 109.558 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.16 66.96 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.389 -0.819 . . . . 0.0 111.661 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.333 1.2 pp -93.2 -18.45 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 173.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.42 -28.48 13.0 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.093 1.757 . . . . 0.0 112.988 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -51.43 -25.86 7.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.005 0.922 . . . . 0.0 112.893 173.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -81.11 178.61 8.3 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.029 0.831 . . . . 0.0 109.56 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -139.04 20.79 2.63 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.01 -1.681 . . . . 0.0 110.741 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -131.95 8.55 4.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.267 1.427 . . . . 0.0 111.055 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.608 -0.682 . . . . 0.0 111.071 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -21.16 6.46 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.595 2.758 . . . . 0.0 111.663 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.786 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.2 161.86 10.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.213 1.805 . . . . 0.0 109.456 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.9 100.69 10.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.651 1.98 . . . . 0.0 105.686 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.12 98.95 6.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.1 131.77 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.01 1.724 . . . . 0.0 107.508 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.51 128.52 75.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.3 m -100.91 93.75 5.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.98 154.75 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.5 t -118.71 -49.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.4 m -151.22 141.01 21.86 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 120.249 1.386 . . . . 0.0 112.129 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.3 150.58 39.24 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.987 2.915 . . . . 0.0 109.413 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.8 148.9 44.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.626 1.97 . . . . 0.0 107.3 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -85.84 134.72 33.9 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.27 -78.8 0.54 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.244 0.807 0 CA-C-O 116.056 -1.926 . . . . 0.0 112.717 -173.797 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 118.509 -0.757 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.96 161.76 44.42 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.328 2.018 . . . . 0.0 113.047 -174.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.22 -42.55 98.71 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -54.42 -42.09 70.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.86 1.264 . . . . 0.0 111.092 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.561 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 32.4 t80 -51.36 -53.39 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.392 0.677 . . . . 0.0 111.691 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.18 -48.53 81.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.243 0.617 . . . . 0.0 110.992 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.75 -37.47 68.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.923 0.783 . . . . 0.0 111.833 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.12 -44.09 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.164 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 16.7 mt -57.48 -42.51 82.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.674 1.125 . . . . 0.0 112.32 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -51.65 -18.57 1.22 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -117.44 158.94 23.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.636 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.09 147.21 42.98 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -170.18 167.22 40.36 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 127.529 2.49 . . . . 0.0 109.012 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -83.42 150.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.95 159.87 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.256 2.222 . . . . 0.0 105.487 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.48 157.05 45.16 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.065 0.946 . . . . 0.0 109.724 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.69 108.39 4.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.95 108.41 19.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.464 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -96.38 109.41 21.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -74.27 141.09 45.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 121.38 1.9 . . . . 0.0 106.818 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.53 -81.91 0.23 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -166.16 -57.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.67 53.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.441 2.696 . . . . 0.0 109.113 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 141.42 2.31 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.008 1.766 . . . . 0.0 112.038 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 158.89 55.21 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -120.69 101.82 7.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -84.83 88.61 7.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.8 m -82.79 175.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.842 2.057 . . . . 0.0 109.982 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -118.84 166.69 12.5 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.083 0.856 . . . . 0.0 112.103 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -168.3 175.8 6.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.241 2.217 . . . . 0.0 107.611 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.43 141.52 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.995 1.718 . . . . 0.0 110.647 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -53.97 -30.88 48.85 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.124 0.874 . . . . 0.0 109.204 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.74 -13.93 7.31 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.149 2.979 . . . . 0.0 111.875 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -118.88 -4.75 10.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.777 1.631 . . . . 0.0 111.8 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.41 165.8 12.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.32 1.418 . . . . 0.0 113.034 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.0 138.56 42.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 10' ' ' LEU . 86.7 t -101.69 150.7 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -122.12 178.98 4.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.811 2.844 . . . . 0.0 107.102 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -76.02 -179.05 4.69 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.55 31.3 74.27 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.243 -1.535 . . . . 0.0 110.732 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 p30 54.08 12.99 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 130.095 3.358 . . . . 0.0 115.056 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -73.58 143.22 46.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.877 0.762 . . . . 0.0 109.627 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -129.3 163.28 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -142.86 140.88 27.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.93 127.74 26.35 Favored Pre-proline 0 N--CA 1.445 -0.707 0 C-N-CA 127.44 2.296 . . . . 0.0 104.829 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.01 108.3 2.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 107.798 -1.654 . . . . 0.0 107.798 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.65 111.63 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.58 -21.69 6.03 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.32 0.962 . . . . 0.0 112.67 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.65 41.59 0.33 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 118.099 -1.39 . . . . 0.0 110.0 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 48' ' ' VAL . 21.4 mtt -106.57 71.39 0.86 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 108.28 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -67.45 -65.78 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 129.99 3.316 . . . . 0.0 113.682 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -51.85 -40.89 61.31 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.863 1.21 . . . . 0.0 109.764 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -60.92 -39.08 88.03 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.787 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.5 -48.38 81.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.812 1.642 . . . . 0.0 110.86 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.82 99.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.407 0.283 . . . . 0.0 111.24 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -63.41 -41.64 98.74 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.444 -1.265 . . . . 0.0 110.446 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.86 -48.23 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 120.11 1.323 . . . . 0.0 108.963 174.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.83 -24.65 37.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.456 -0.777 . . . . 0.0 112.567 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -85.09 -42.5 14.75 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.581 1.696 . . . . 0.0 115.581 173.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -150.95 139.48 20.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.662 1.185 . . . . 0.0 109.115 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -75.17 -18.03 60.27 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 112.312 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 mmp_? -60.8 119.76 8.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 114.492 -173.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 89' ' ' ALA . 20.4 m -139.23 146.23 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 123.112 1.434 . . . . 0.0 112.588 173.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 3.7 tt -111.67 149.2 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.9 ttt -141.15 141.12 34.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -125.45 128.08 47.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.2 173.39 6.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.713 1.597 . . . . 0.0 107.923 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.01 -171.27 34.59 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.424 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 23.4 t -146.85 157.38 43.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.65 0.78 . . . . 0.0 109.351 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -98.54 -17.43 18.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.493 1.517 . . . . 0.0 108.847 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -91.98 -4.43 54.59 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 116.687 -1.625 . . . . 0.0 114.864 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.49 130.2 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 121.711 2.051 . . . . 0.0 105.775 -173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.04 131.41 36.26 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.092 0.957 . . . . 0.0 111.173 -173.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.48 -141.07 6.36 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -81.92 -58.96 2.75 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.363 1.465 . . . . 0.0 108.323 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.414 HD21 HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.87 102.96 11.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.468 0.651 . . . . 0.0 109.523 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.18 -169.11 2.89 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.198 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 60.2 Cg_endo -79.04 58.85 7.13 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.204 1.936 . . . . 0.0 110.692 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.73 120.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -114.66 169.45 9.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.187 0.994 . . . . 0.0 110.433 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.73 45.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.78 0.705 . . . . 0.0 113.64 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -132.99 152.76 51.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.016 1.326 . . . . 0.0 109.353 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.03 130.9 47.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.328 -2.842 . . . . 0.0 103.328 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.04 154.46 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -131.24 135.04 47.02 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.21 -169.11 28.39 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 118.765 0.711 . . . . 0.0 112.356 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 m -121.02 146.43 46.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.028 2.131 . . . . 0.0 108.287 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -111.24 163.71 13.65 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.566 1.075 . . . . 0.0 112.94 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.95 120.98 3.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.235 1.014 . . . . 0.0 110.331 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -75.86 141.06 42.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -140.74 135.88 31.99 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.035 1.334 . . . . 0.0 111.0 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.2 p -120.81 36.67 4.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.72 154.94 27.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.847 2.859 . . . . 0.0 111.165 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.39 47.41 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.484 1.516 . . . . 0.0 113.556 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.73 -11.78 32.22 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.193 2.595 . . . . 0.0 112.242 175.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.04 -60.27 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -31.43 71.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.318 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.85 -49.77 55.55 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.683 1.129 . . . . 0.0 109.611 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.05 76.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.309 -0.869 . . . . 0.0 111.489 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.2 pp -82.5 -18.36 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 119.061 0.846 . . . . 0.0 112.159 174.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.16 -28.07 4.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.514 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.58 -30.03 19.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.164 1.386 . . . . 0.0 112.256 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -80.67 178.32 8.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.39 -0.54 1.4 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 118.172 -2.83 . . . . 0.0 112.631 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -96.09 8.2 44.38 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.73 23.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.24 1.016 . . . . 0.0 109.402 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.6 ttp85 -121.13 -14.08 8.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.443 1.897 . . . . 0.0 111.717 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.809 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.56 161.61 11.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.041 1.736 . . . . 0.0 110.176 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.78 104.69 16.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.74 91.34 7.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.18 131.16 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.792 1.637 . . . . 0.0 106.673 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -121.71 135.61 61.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.0 m -114.12 101.36 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.01 160.57 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.335 1.454 . . . . 0.0 110.088 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.4 t -121.51 -59.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -142.9 140.49 31.21 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.85 145.65 41.93 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.853 2.861 . . . . 0.0 108.168 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -139.21 130.18 26.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.243 1.817 . . . . 0.0 106.684 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -74.04 139.59 44.8 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -129.65 -58.31 1.1 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.414 HD13 HD21 ' A' ' 77' ' ' ASN . 2.6 pp . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.926 0.89 . . . . 0.0 111.437 -173.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.2 mt . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 118.637 -0.697 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.77 158.63 32.18 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.504 2.136 . . . . 0.0 113.54 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -49.31 79.86 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -53.64 -41.26 66.56 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.235 1.014 . . . . 0.0 111.283 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.26 -60.4 3.15 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.62 0.768 . . . . 0.0 109.482 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -52.28 -48.23 65.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.386 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 27.7 mm-40 -54.88 -38.36 67.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.743 1.156 . . . . 0.0 112.66 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.87 -45.5 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.802 1.183 . . . . 0.0 109.135 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.09 -42.28 80.41 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.664 1.12 . . . . 0.0 112.073 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 8' ' ' GLU . 25.4 mtmm -51.65 -18.65 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -112.99 158.65 20.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.816 1.189 . . . . 0.0 109.874 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.12 148.83 41.44 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.975 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . 177.41 170.8 40.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 123.22 0.438 . . . . 0.0 112.058 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.72 149.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -132.15 163.51 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 127.556 2.342 . . . . 0.0 105.298 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.53 153.18 40.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.851 1.26 . . . . 0.0 109.15 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.38 109.79 5.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.45 109.22 20.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.134 1.773 . . . . 0.0 109.886 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 54' ' ' THR . 4.7 m -97.3 107.96 20.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 98.76 9.01 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.34 -59.89 0.18 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 120.824 1.647 . . . . 0.0 113.503 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -158.36 -60.79 0.08 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.008 1.404 . . . . 0.0 113.845 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -79.28 39.08 0.38 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.878 1.672 . . . . 0.0 111.777 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.94 151.47 12.36 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.76 148.06 93.9 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.751 2.275 . . . . 0.0 109.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -121.43 101.67 7.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -90.48 88.7 7.26 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.5 m -77.34 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 110.638 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.81 168.48 11.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.445 1.02 . . . . 0.0 113.003 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t -168.42 172.61 8.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.813 2.445 . . . . 0.0 108.183 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -120.91 141.75 50.35 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.887 2.075 . . . . 0.0 109.989 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -52.09 -30.53 26.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.685 0.675 . . . . 0.0 110.478 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -50.24 -21.31 1.31 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.663 2.385 . . . . 0.0 113.565 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.4 -6.71 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.379 1.071 . . . . 0.0 111.572 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -91.46 171.3 9.29 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.448 -1.408 . . . . 0.0 111.781 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.727 ' HE2' HD11 ' A' ' 39' ' ' LEU . 13.6 ptmt -134.08 119.93 19.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 172.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.55 131.44 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.727 HD11 ' HE2' ' A' ' 37' ' ' LYS . 2.7 mp -121.43 178.14 4.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -76.97 -178.0 4.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.9 29.61 75.31 Favored Glycine 0 C--O 1.223 -0.591 0 O-C-N 120.473 -1.392 . . . . 0.0 109.663 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 54.0 12.87 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 130.631 3.572 . . . . 0.0 115.483 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -79.37 128.84 33.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.205 1.366 . . . . 0.0 110.137 -174.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -124.34 155.43 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 t -145.24 142.46 22.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.78 132.8 24.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 126.993 2.117 . . . . 0.0 106.873 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.89 108.57 2.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.537 2.158 . . . . 0.0 108.666 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.53 111.76 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.45 -20.85 5.7 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.378 1.942 . . . . 0.0 112.281 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.18 40.99 0.45 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.047 1.423 . . . . 0.0 109.958 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.509 ' HB2' HG23 ' A' ' 48' ' ' VAL . 25.4 mtt -113.8 53.47 0.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.042 1.337 . . . . 0.0 108.515 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.46 91.2 m-70 -71.88 -48.18 47.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.91 -38.28 55.71 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.76 1.618 . . . . 0.0 108.933 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.412 HG23 ' OG1' ' A' ' 20' ' ' THR . 48.0 m -64.41 -38.8 92.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.404 1.481 . . . . 0.0 110.291 173.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.21 -47.68 74.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.799 1.636 . . . . 0.0 109.391 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.38 89.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.803 0.441 . . . . 0.0 110.803 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -57.07 -41.47 78.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.744 -1.122 . . . . 0.0 113.369 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.08 -48.28 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 120.249 1.386 . . . . 0.0 109.211 175.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.36 -26.16 39.42 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.041 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.21 -47.19 13.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 173.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -152.28 141.67 21.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.433 1.015 . . . . 0.0 108.773 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.358 -1.464 . . . . 0.0 113.718 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -51.94 115.6 1.76 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.667 1.987 . . . . 0.0 114.722 -172.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.54 143.43 32.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 123.669 1.7 . . . . 0.0 112.723 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 2.8 tt -111.35 148.48 32.9 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 101.364 -3.569 . . . . 0.0 101.364 172.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.36 129.09 20.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 p -111.29 128.25 55.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 pp -117.01 166.88 11.67 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.548 -1.345 . . . . 0.0 108.578 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.9 -174.83 37.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.452 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.2 t -146.57 157.56 43.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.634 1.174 . . . . 0.0 107.898 174.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -98.86 -8.45 25.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.591 1.156 . . . . 0.0 110.05 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.46 -7.13 51.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 116.942 -1.504 . . . . 0.0 113.962 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.23 136.03 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 121.083 1.765 . . . . 0.0 106.243 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.24 131.37 36.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.884 0.874 . . . . 0.0 111.086 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.44 -140.88 6.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.219 1.39 . . . . 0.0 110.516 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -84.48 -59.05 2.49 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 102.98 9.58 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.98 -168.79 1.96 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.584 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 70.5 Cg_endo -76.3 65.9 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.35 2.033 . . . . 0.0 110.37 174.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.97 121.1 1.05 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.54 169.53 9.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.371 1.086 . . . . 0.0 109.846 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.64 -177.76 45.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 121.418 0.454 . . . . 0.0 113.381 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.58 147.01 52.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.416 1.086 . . . . 0.0 110.39 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -100.88 129.66 46.78 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 mt -141.2 157.05 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -132.75 149.12 52.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.172 1.789 . . . . 0.0 109.753 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -174.14 37.95 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.505 1.526 . . . . 0.0 110.548 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -114.14 143.15 45.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.118 1.767 . . . . 0.0 106.828 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.81 163.36 13.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.188 1.395 . . . . 0.0 111.962 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 121.11 3.33 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.882 0.873 . . . . 0.0 109.764 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.03 138.13 43.87 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 141.48 35.0 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.121 0.968 . . . . 0.0 109.863 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -116.07 35.17 4.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.33 154.66 25.49 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 128.112 2.565 . . . . 0.0 110.742 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 178.67 46.76 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.642 2.067 . . . . 0.0 113.893 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.13 -17.92 55.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.028 3.152 . . . . 0.0 112.538 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -65.61 0.65 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.243 1.817 . . . . 0.0 107.617 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.18 -31.2 70.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.192 0.997 . . . . 0.0 111.391 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.6 -57.76 5.27 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.757 0.708 . . . . 0.0 109.138 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.456 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.65 -25.42 67.37 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.916 -1.115 . . . . 0.0 113.058 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.346 1.3 pp -87.43 -18.11 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.733 1.151 . . . . 0.0 111.919 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.48 -27.93 3.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.408 1.483 . . . . 0.0 111.685 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -49.05 -21.47 0.71 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.641 1.176 . . . . 0.0 113.949 173.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.54 178.75 8.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.669 1.122 . . . . 0.0 110.611 175.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -130.29 11.61 5.44 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.099 -1.625 . . . . 0.0 111.234 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -132.26 9.0 4.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.226 1.41 . . . . 0.0 111.202 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.94 145.21 34.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.619 -0.676 . . . . 0.0 109.874 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -21.05 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 127.951 2.5 . . . . 0.0 110.621 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.764 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.12 161.96 10.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.391 1.876 . . . . 0.0 109.137 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.59 107.9 18.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tp -78.89 93.92 5.12 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.2 t -78.98 130.88 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.37 129.49 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -112.14 99.03 7.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 t -60.99 161.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.069 2.147 . . . . 0.0 110.15 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.98 -51.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -150.93 141.04 22.15 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.154 -0.966 . . . . 0.0 111.246 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.91 146.34 43.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.693 3.197 . . . . 0.0 108.765 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -138.82 142.65 38.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.521 1.928 . . . . 0.0 107.599 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -81.16 133.51 35.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -135.21 -68.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.24 0.561 0 CA-C-O 117.358 -1.306 . . . . 0.0 110.221 178.092 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 2' ' ' LEU . 5.2 mp . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 118.677 -0.678 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.88 158.7 56.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.735 2.29 . . . . 0.0 111.442 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.99 -40.86 95.99 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -53.16 -38.96 63.22 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.6 1.56 . . . . 0.0 111.263 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -50.99 -56.26 13.33 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.653 1.115 . . . . 0.0 111.088 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -61.77 -48.96 78.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -61.01 -33.58 73.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.51 -41.85 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.392 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.12 -38.63 83.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.236 1.38 . . . . 0.0 111.811 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.74 -19.11 1.47 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.298 1.408 . . . . 0.0 114.345 172.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -106.4 158.93 16.53 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 119.717 1.144 . . . . 0.0 107.966 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.86 148.63 42.16 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 121.328 -0.858 . . . . 0.0 109.346 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.23 177.13 47.84 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 124.8 1.191 . . . . 0.0 112.534 -174.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.9 t -100.75 145.82 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -129.82 163.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 106.059 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.44 159.9 42.79 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.305 1.442 . . . . 0.0 110.001 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.44 HD11 HG21 ' A' ' 46' ' ' VAL . 88.3 mt -140.34 117.32 9.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -89.08 108.35 19.54 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 173.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.627 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -94.03 110.57 22.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 115.546 -2.169 . . . . 0.0 106.806 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -73.8 141.71 46.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.271 2.305 . . . . 0.0 107.721 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.7 -81.35 0.23 Allowed Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.45 -61.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -79.73 44.49 0.64 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.24 2.216 . . . . 0.0 109.968 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 151.49 5.95 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.263 1.887 . . . . 0.0 113.719 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.19 153.93 56.85 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 121.357 1.371 . . . . 0.0 111.414 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -121.37 101.97 7.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.542 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -86.13 88.73 7.65 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.04 169.14 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.082 1.753 . . . . 0.0 110.625 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -121.54 167.62 12.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.528 1.131 . . . . 0.0 112.29 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 170.32 9.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.983 2.113 . . . . 0.0 108.364 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -116.48 141.67 47.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.745 1.618 . . . . 0.0 111.265 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -56.18 -31.77 63.72 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.997 0.919 . . . . 0.0 110.834 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -60.57 -8.39 2.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.387 1.475 . . . . 0.0 113.613 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -117.92 -7.24 10.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.095 1.316 . . . . 0.0 109.099 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mt -98.24 162.19 13.32 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.151 -1.593 . . . . 0.0 112.29 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.52 41.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.409 -1.432 . . . . 0.0 108.916 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.9 t -101.8 144.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.91 179.06 4.48 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.324 1.85 . . . . 0.0 107.126 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.53 177.27 3.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.254 0.549 . . . . 0.0 110.429 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.47 28.45 59.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 p30 53.64 13.72 0.53 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 128.559 2.743 . . . . 0.0 114.848 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -73.21 109.33 6.65 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.487 1.04 . . . . 0.0 110.328 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.07 161.15 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.97 134.83 21.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 18' ' ' ILE . 60.6 t -121.04 135.39 24.81 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 127.127 2.171 . . . . 0.0 107.277 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.94 108.88 2.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.53 2.153 . . . . 0.0 110.458 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.742 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.4 111.91 21.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.13 -21.34 7.42 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.979 1.752 . . . . 0.0 112.676 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.41 41.31 0.28 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.188 1.494 . . . . 0.0 109.945 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.471 ' HB2' HG23 ' A' ' 48' ' ' VAL . 14.3 mtt -109.32 66.98 0.64 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.156 0.982 . . . . 0.0 109.77 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.322 41.3 m-70 -71.47 -48.64 47.91 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -51.7 -40.95 61.06 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.799 2.09 . . . . 0.0 109.418 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.1 m -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 127.002 2.121 . . . . 0.0 110.495 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.28 -50.82 70.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 121.027 1.74 . . . . 0.0 110.611 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.33 94.13 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.237 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -66.3 -42.02 88.94 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.679 -1.629 . . . . 0.0 109.845 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.93 -48.19 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 120.177 1.353 . . . . 0.0 109.032 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.97 57.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.487 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -87.06 -46.02 10.19 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.926 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -145.15 132.31 20.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.275 1.036 . . . . 0.0 112.169 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.1 -21.59 56.51 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.454 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.46 122.13 14.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.499 1.045 . . . . 0.0 111.353 -173.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.2 m -138.85 155.94 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 123.379 1.561 . . . . 0.0 111.503 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tt -111.13 149.95 30.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.8 ttt -138.95 140.87 38.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 p -123.72 128.6 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -116.93 167.78 10.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.218 1.827 . . . . 0.0 107.172 172.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.13 -175.0 38.12 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.434 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 44.5 t -148.14 157.38 43.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -99.28 -8.72 24.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.312 0.505 . . . . 0.0 109.923 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -90.71 3.11 55.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.087 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.0 t -130.92 133.61 62.79 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.05 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 173.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 130.32 35.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.879 0.763 . . . . 0.0 110.217 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.62 5.95 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.975 1.75 . . . . 0.0 109.318 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -88.51 -58.3 2.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.15 102.68 5.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.184 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.95 -168.26 0.16 Allowed Glycine 0 CA--C 1.539 1.573 0 O-C-N 120.794 -1.191 . . . . 0.0 111.087 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.53 91.07 0.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 N-CA-C 106.501 -2.153 . . . . 0.0 106.501 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.4 0.71 Allowed Glycine 0 N--CA 1.442 -0.947 0 CA-C-O 117.723 -1.598 . . . . 0.0 109.827 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -109.31 168.97 9.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.341 1.071 . . . . 0.0 109.715 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.4 -176.97 44.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 121.062 0.257 . . . . 0.0 112.896 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -131.42 151.94 51.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.422 1.089 . . . . 0.0 109.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.86 131.25 46.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.422 ' CG2' HG13 ' A' ' 115' ' ' VAL . 6.0 mt -139.08 156.57 27.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -132.2 150.23 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.997 1.319 . . . . 0.0 108.088 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.61 -172.13 40.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -106.28 131.93 52.93 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.26 1.024 . . . . 0.0 108.432 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -89.0 163.51 15.5 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.67 120.88 3.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.873 0.869 . . . . 0.0 110.045 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -74.26 130.61 40.04 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 173.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -132.16 130.7 41.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.5 p -120.85 33.47 5.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.17 1.388 . . . . 0.0 107.677 173.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -158.82 161.96 36.96 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 128.635 2.774 . . . . 0.0 109.276 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.4 -179.95 46.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 125.19 1.376 . . . . 0.0 115.104 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.94 -19.15 64.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.536 2.157 . . . . 0.0 110.773 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.86 -63.02 1.18 Allowed 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.817 0.847 . . . . 0.0 109.338 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -61.39 -31.17 71.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.346 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.26 -48.78 64.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.721 1.146 . . . . 0.0 110.481 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -30.69 69.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.782 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.29 -19.31 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.74 85.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.809 1.64 . . . . 0.0 112.188 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.551 0.0 OUTLIER -51.54 -18.36 1.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 173.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.34 179.54 0.97 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.87 1.214 . . . . 0.0 108.242 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -128.55 12.39 6.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 119.601 -1.937 . . . . 0.0 112.14 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -135.91 10.47 3.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.882 1.273 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.92 145.33 34.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 0.0 110.985 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.23 -21.38 6.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.002 2.521 . . . . 0.0 111.902 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.742 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -176.4 161.85 2.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.611 1.964 . . . . 0.0 109.431 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.61 110.66 23.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 tt -85.98 95.11 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.306 -2.849 . . . . 0.0 103.306 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.55 131.01 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.174 1.39 . . . . 0.0 107.806 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 64' ' ' VAL . 42.6 mm -114.14 137.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.4 m -113.96 93.22 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.422 HG13 ' CG2' ' A' ' 85' ' ' ILE . 60.8 t -61.45 160.32 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.29 1.436 . . . . 0.0 111.072 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.97 -57.26 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -140.9 127.22 19.79 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.131 0.423 . . . . 0.0 111.944 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.08 139.34 51.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.75 3.22 . . . . 0.0 110.637 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -142.24 139.55 32.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.482 1.513 . . . . 0.0 110.668 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -72.87 135.26 45.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -174.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -143.21 -58.6 0.42 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.253 1.261 0 CA-C-O 115.753 -2.07 . . . . 0.0 113.929 -173.481 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.642 HD21 HG11 ' A' ' 115' ' ' VAL . 3.6 mm? . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.15 162.25 42.25 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.539 2.159 . . . . 0.0 110.683 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.21 -38.85 93.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -50.73 -40.43 54.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.125 1.77 . . . . 0.0 112.016 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.3 -56.41 13.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.8 1.182 . . . . 0.0 109.989 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -59.14 -48.45 81.55 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 110.201 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.83 -40.28 75.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.764 0.711 . . . . 0.0 112.624 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.9 -40.78 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.861 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -45.68 85.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.377 1.444 . . . . 0.0 111.501 173.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -51.91 -20.62 2.4 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -105.95 161.66 14.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.407 1.083 . . . . 0.0 110.156 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.55 139.57 45.72 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.45 174.46 47.0 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.8 143.2 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -174.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.3 164.76 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -151.83 158.95 43.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.759 1.224 . . . . 0.0 109.162 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 46' ' ' VAL . 89.5 mt -142.63 119.94 6.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 124.768 1.227 . . . . 0.0 107.947 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -94.05 108.42 20.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.568 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.8 m -89.95 121.3 31.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 116.194 -1.86 . . . . 0.0 106.386 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -73.47 137.23 44.38 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 122.062 2.21 . . . . 0.0 108.689 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.08 -81.21 0.22 Allowed Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -158.84 -61.51 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -79.35 39.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.203 3.001 . . . . 0.0 111.511 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 151.13 13.36 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.64 150.02 56.13 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 CA-C-N 118.177 0.989 . . . . 0.0 111.208 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -99.51 101.59 12.88 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 6.5 tt -84.86 88.97 7.45 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -173.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.99 168.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.37 1.468 . . . . 0.0 110.254 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.34 167.7 12.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.411 1.084 . . . . 0.0 112.216 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.44 172.11 8.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.86 2.064 . . . . 0.0 108.195 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -120.86 141.65 50.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.894 1.678 . . . . 0.0 110.385 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -51.11 -31.26 18.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.095 0.958 . . . . 0.0 111.905 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -57.74 -14.51 5.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.205 1.802 . . . . 0.0 112.733 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.21 -3.55 11.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.711 1.204 . . . . 0.0 110.214 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.489 HD22 HG22 ' A' ' 46' ' ' VAL . 20.4 mt -95.21 163.52 13.24 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.51 -1.369 . . . . 0.0 112.759 -173.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.63 140.72 43.0 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 172.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -101.55 151.78 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 109.58 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.42 HD11 ' CD ' ' A' ' 97' ' ' GLU . 25.0 mt -121.55 178.33 4.86 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.553 1.941 . . . . 0.0 109.436 173.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -76.21 177.1 7.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.31 1.444 . . . . 0.0 107.903 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.25 29.34 59.92 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 120.598 -1.313 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.321 0.0 OUTLIER 53.44 15.35 0.69 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 130.233 3.413 . . . . 0.0 115.091 -175.744 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -73.86 145.57 44.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -127.98 168.66 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.7 t -146.38 142.74 21.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.013 -1.055 . . . . 0.0 108.883 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 36' ' ' LEU . 61.2 t -126.34 135.49 27.25 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.842 2.057 . . . . 0.0 107.769 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.82 108.53 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.743 2.296 . . . . 0.0 109.448 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.61 111.39 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.24 -21.36 6.63 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.759 1.647 . . . . 0.0 112.241 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.23 41.4 0.31 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 117.746 -1.586 . . . . 0.0 109.552 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.513 ' HB2' HG23 ' A' ' 48' ' ' VAL . 20.2 mtt -109.74 57.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.014 1.326 . . . . 0.0 107.909 173.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -71.58 -48.82 45.79 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.056 1.342 . . . . 0.0 113.42 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.98 -41.4 62.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.721 1.6 . . . . 0.0 108.87 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.9 m -59.98 -40.47 89.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.76 1.624 . . . . 0.0 110.369 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.92 -49.02 78.17 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.152 1.796 . . . . 0.0 110.988 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.66 98.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.819 0.343 . . . . 0.0 111.311 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -63.19 -41.59 99.2 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.009 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -61.55 -48.24 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.452 1.478 . . . . 0.0 109.286 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.28 59.28 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.634 -0.667 . . . . 0.0 112.423 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.7 mmm-85 -78.46 -46.46 19.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -151.26 129.53 11.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.781 1.233 . . . . 0.0 109.764 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.25 -23.23 62.87 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.492 -0.755 . . . . 0.0 112.487 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -61.28 124.09 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.947 0.899 . . . . 0.0 112.027 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 20' ' ' THR . 6.9 m -138.88 155.37 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 123.76 1.743 . . . . 0.0 110.253 173.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 4.5 tt -107.49 150.36 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 173.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.4 ttt -139.29 141.93 37.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 4.6 p -125.2 128.52 48.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 116.159 -1.877 . . . . 0.0 106.046 173.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.494 HD12 HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -116.42 160.22 20.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 122.087 2.222 . . . . 0.0 106.345 173.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.13 -172.22 45.15 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -150.07 168.37 24.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 80' ' ' GLY . 21.4 mmm180 -98.92 -8.8 25.01 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 109.844 173.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -79.33 -6.19 56.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.448 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.43 140.3 49.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.0 121.06 24.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.37 -130.11 3.88 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 125.158 1.361 . . . . 0.0 110.107 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.34 -63.64 1.23 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.302 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -84.03 102.63 12.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.863 -174.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.96 -168.45 0.93 Allowed Glycine 0 CA--C 1.542 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 112.194 -174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.03 91.43 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 108.997 173.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 71' ' ' ARG . . . 178.81 122.02 0.74 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 117.336 -1.813 . . . . 0.0 110.445 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 t -123.72 171.68 9.42 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.815 1.307 . . . . 0.0 110.026 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.23 -157.58 28.35 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.783 1.183 . . . . 0.0 112.579 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -148.42 154.87 40.49 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.931 1.293 . . . . 0.0 109.811 -174.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.41 131.21 47.62 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 128.916 2.886 . . . . 0.0 104.56 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.494 HD11 HD12 ' A' ' 68' ' ' LEU . 2.9 mp -138.63 163.6 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.802 1.241 . . . . 0.0 108.579 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -134.37 151.09 51.0 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.204 1.402 . . . . 0.0 109.123 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -175.6 40.07 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.175 0.893 . . . . 0.0 111.715 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 m -113.93 128.8 56.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.41 1.084 . . . . 0.0 109.888 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.66 17.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.319 1.447 . . . . 0.0 111.465 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.04 120.44 2.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.02 1.328 . . . . 0.0 109.481 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -77.13 142.69 39.61 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.568 -0.707 . . . . 0.0 109.634 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 140.92 34.24 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.354 1.061 . . . . 0.0 109.714 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 p -121.25 35.94 4.75 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.457 1.903 . . . . 0.0 106.221 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -159.35 157.54 30.58 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.502 2.321 . . . . 0.0 110.091 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.71 178.25 46.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.951 2.691 . . . . 0.0 113.089 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 -8.95 22.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.187 2.591 . . . . 0.0 112.634 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.42 ' CD ' HD11 ' A' ' 39' ' ' LEU . 7.6 mm-40 -65.98 -56.34 12.16 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -61.4 -31.89 71.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.781 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.59 -48.61 38.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.539 0.685 . . . . 0.0 110.043 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -58.9 -27.45 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.061 -1.024 . . . . 0.0 111.712 177.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.323 1.7 pp -93.26 -18.39 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.963 173.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.33 -28.4 4.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.585 1.954 . . . . 0.0 112.656 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -50.99 -22.88 2.52 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.768 1.227 . . . . 0.0 113.293 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -80.71 178.64 8.23 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.619 1.099 . . . . 0.0 110.312 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -128.51 3.83 5.6 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.149 -1.595 . . . . 0.0 111.23 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -135.68 8.28 3.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 111.54 -174.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.55 142.4 34.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.034 0.834 . . . . 0.0 109.112 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.61 -10.76 8.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.044 1.337 . . . . 0.0 111.829 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.9 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.49 161.91 9.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.187 2.595 . . . . 0.0 108.332 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.76 107.07 16.94 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.114 2.166 . . . . 0.0 106.588 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.1 tp -82.12 98.56 8.74 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.426 1.891 . . . . 0.0 107.594 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -83.96 127.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.699 1.6 . . . . 0.0 107.373 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.74 129.06 72.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 119.367 0.985 . . . . 0.0 108.488 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 m -99.11 87.91 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.642 HG11 HD21 ' A' ' 2' ' ' LEU . 71.1 t -60.66 153.57 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.991 0.916 . . . . 0.0 109.967 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.7 -59.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -149.58 141.22 23.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.528 0.604 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.58 159.52 25.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 127.953 2.501 . . . . 0.0 112.448 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -140.87 145.25 35.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.259 2.224 . . . . 0.0 108.458 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -76.19 134.78 39.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.4 p -133.69 -58.79 0.87 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.47 0.577 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.463 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.712 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.52 163.61 38.43 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.903 2.402 . . . . 0.0 112.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.4 97.59 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 173.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.305 2.9 m -51.82 -38.11 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.966 2.107 . . . . 0.0 112.822 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -50.85 -49.11 59.67 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.519 1.054 . . . . 0.0 110.202 173.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -63.27 -48.19 79.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.775 1.23 . . . . 0.0 111.352 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.47 -41.48 63.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.562 0.619 . . . . 0.0 111.067 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.43 -45.55 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.119 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.5 mt -52.5 -28.37 20.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.576 1.08 . . . . 0.0 112.754 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -51.72 -18.51 1.24 Allowed 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.904 -1.747 . . . . 0.0 112.646 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -114.84 160.38 19.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.38 1.872 . . . . 0.0 109.719 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -74.36 156.54 36.96 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 166.3 35.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.476 -0.868 . . . . 0.0 113.64 -173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -81.97 141.36 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 31' ' ' THR . 12.7 t -133.92 160.55 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.94 155.9 40.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.714 1.205 . . . . 0.0 108.467 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.95 119.97 15.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.87 108.73 19.69 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.511 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -90.76 113.24 25.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -73.72 141.55 46.36 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.045 2.202 . . . . 0.0 108.037 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 -81.21 0.32 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -162.54 -48.97 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.671 0.788 . . . . 0.0 108.938 173.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.68 39.24 0.34 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.389 2.276 . . . . 0.0 110.657 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.27 151.16 6.03 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.911 1.719 . . . . 0.0 111.303 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.31 161.02 45.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.017 1.145 . . . . 0.0 111.411 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -112.77 101.75 9.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.242 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 tp -74.04 88.69 1.91 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -74.13 168.73 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.408 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.1 165.1 14.57 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.616 1.166 . . . . 0.0 111.669 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 16' ' ' VAL . 15.4 t -168.69 175.7 5.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.952 2.101 . . . . 0.0 108.068 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -120.41 142.0 49.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.492 2.317 . . . . 0.0 109.852 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -51.94 -30.3 24.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.301 -0.856 . . . . 0.0 110.402 174.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -50.47 -20.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.052 2.941 . . . . 0.0 113.295 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.5 m-30 -118.12 -12.75 9.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.775 -1.203 . . . . 0.0 110.539 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.14 158.35 15.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 120.583 -1.323 . . . . 0.0 112.872 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.9 140.96 42.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 120.892 -1.13 . . . . 0.0 109.501 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -100.86 144.09 13.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.519 -2.401 . . . . 0.0 104.519 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.4 mt -121.19 -179.09 3.94 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.84 2.056 . . . . 0.0 107.806 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.52 169.83 4.5 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.246 0.618 . . . . 0.0 111.382 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.89 28.41 52.86 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.911 1.719 . . . . 0.0 111.354 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.318 0.2 OUTLIER 53.37 27.54 6.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.06 1.744 . . . . 0.0 113.11 -175.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -73.41 150.97 41.34 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.76 158.01 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -141.35 135.8 31.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.08 130.73 24.68 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 128.743 2.817 . . . . 0.0 106.526 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.6 108.74 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.569 2.179 . . . . 0.0 110.023 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.725 ' CG1' ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.56 111.84 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.5 -21.6 5.06 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.519 1.056 . . . . 0.0 112.422 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.02 41.26 0.34 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 119.285 1.543 . . . . 0.0 109.266 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 48' ' ' VAL . 21.4 mtt -109.78 70.62 0.73 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.582 1.153 . . . . 0.0 108.125 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -71.44 -55.96 6.89 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.985 2.114 . . . . 0.0 114.876 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -51.92 -41.35 61.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 121.341 1.882 . . . . 0.0 108.469 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -63.17 -38.77 92.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.248 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -56.79 -50.64 71.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.076 1.307 . . . . 0.0 110.134 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.44 98.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.899 0.48 . . . . 0.0 111.547 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -64.01 -41.61 97.4 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.689 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.22 -48.05 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 120.051 1.296 . . . . 0.0 108.27 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.02 -22.12 25.39 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -86.92 -44.38 11.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -150.95 140.81 21.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.31 1.444 . . . . 0.0 109.13 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 -18.05 59.7 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.028 -1.045 . . . . 0.0 112.221 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -59.32 117.47 4.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.353 1.061 . . . . 0.0 113.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.1 m -138.93 153.39 24.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 124.055 1.883 . . . . 0.0 112.549 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.6 tp -111.01 151.16 28.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 ttt -139.24 134.29 32.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.5 p -126.58 127.87 45.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -117.11 164.21 15.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.651 1.114 . . . . 0.0 108.966 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.08 178.26 42.99 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -150.7 -178.41 6.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -113.24 -9.34 13.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.116 0.966 . . . . 0.0 110.504 173.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -86.1 -4.49 59.18 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.96 138.71 52.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.6 35.61 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.594 0.634 . . . . 0.0 109.827 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.51 -132.24 4.12 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 124.573 1.082 . . . . 0.0 111.953 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -91.43 -58.84 2.31 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.56 102.57 7.99 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.83 -167.98 0.16 Allowed Glycine 0 CA--C 1.542 1.719 0 O-C-N 120.53 -1.356 . . . . 0.0 111.798 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.55 90.65 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.619 -2.108 . . . . 0.0 106.619 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.58 121.64 0.71 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.78 169.89 9.23 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 119.396 1.598 . . . . 0.0 109.544 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.29 179.48 43.85 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 123.798 0.713 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -132.53 149.32 52.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.265 1.026 . . . . 0.0 109.75 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -97.24 130.11 44.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.46 152.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -130.48 140.81 50.51 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.205 1.402 . . . . 0.0 107.247 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.3 -176.48 42.72 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.141 0.882 . . . . 0.0 112.799 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 m -103.98 143.67 32.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.91 164.4 12.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 120.058 1.299 . . . . 0.0 111.214 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.15 121.25 2.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.15 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.84 143.27 45.97 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 141.76 38.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.993 1.317 . . . . 0.0 111.51 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 p -114.76 25.87 10.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.826 2.05 . . . . 0.0 106.863 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.59 165.08 35.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.705 2.402 . . . . 0.0 109.725 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.15 178.61 45.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 127.165 2.316 . . . . 0.0 113.173 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.55 -24.11 77.56 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.672 2.248 . . . . 0.0 111.154 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -62.3 -56.54 17.43 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.531 1.132 . . . . 0.0 109.017 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' A' ' 101' ' ' ILE . 37.3 t80 -61.34 -31.37 71.24 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.72 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -68.02 -48.17 66.44 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 121.608 2.004 . . . . 0.0 110.622 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.78 41.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.419 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' A' ' 98' ' ' PHE . 1.2 pp -93.67 -20.7 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.15 92.94 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 121.351 1.887 . . . . 0.0 112.453 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.505 0.0 OUTLIER -51.96 -21.92 3.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -73.05 178.97 4.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -133.92 7.88 3.77 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 118.393 -2.692 . . . . 0.0 114.388 -176.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -121.53 8.57 10.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.742 0.701 . . . . 0.0 111.796 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.42 150.78 24.47 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -115.52 -19.17 10.74 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.686 1.994 . . . . 0.0 110.397 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . . . -168.2 161.49 12.35 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.581 1.182 . . . . 0.0 109.383 -173.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.52 106.9 18.96 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -83.39 95.09 8.12 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.9 t -81.95 131.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.389 1.876 . . . . 0.0 106.567 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.32 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.2 m -104.12 91.98 4.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.84 157.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.305 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.04 -53.26 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.3 m -151.34 141.58 22.31 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.505 1.048 . . . . 0.0 113.235 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.01 144.7 39.71 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 128.451 2.7 . . . . 0.0 108.836 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -139.05 136.46 35.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.945 2.098 . . . . 0.0 106.944 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.92 139.16 38.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 p -141.21 -59.1 0.49 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.252 1.186 0 CA-C-O 115.444 -2.217 . . . . 0.0 114.019 -173.334 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.515 ' C ' HD22 ' A' ' 2' ' ' LEU . 2.0 mpt? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.2 mm? -137.59 153.39 74.21 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.665 1.186 . . . . 0.0 109.238 -172.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.87 159.9 47.22 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.545 2.163 . . . . 0.0 109.788 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.21 94.04 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -51.4 -39.01 56.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.941 1.696 . . . . 0.0 111.438 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.28 -57.84 7.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.593 1.088 . . . . 0.0 110.388 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -54.78 -48.43 72.7 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.522 1.129 . . . . 0.0 109.902 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.82 -35.96 73.73 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.5 t -69.4 -44.07 80.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.618 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.52 -41.67 77.12 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.068 1.304 . . . . 0.0 112.433 173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -51.77 -24.67 6.25 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -101.86 168.48 9.4 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-O 122.42 1.105 . . . . 0.0 111.669 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.5 138.69 45.23 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -178.83 172.36 44.61 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.04 150.93 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 82.1 t -128.97 163.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 127.585 2.354 . . . . 0.0 104.926 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.19 156.09 46.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.543 1.137 . . . . 0.0 108.315 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -138.54 110.88 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.87 108.51 19.57 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.496 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -93.89 108.79 20.54 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -74.4 137.24 42.56 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-N 121.034 1.743 . . . . 0.0 106.441 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.72 -81.94 0.22 Allowed Glycine 0 C--O 1.222 -0.607 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -164.16 -61.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.98 55.95 3.76 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 124.128 1.918 . . . . 0.0 109.49 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.59 140.69 4.92 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 127.238 2.351 . . . . 0.0 112.144 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.9 151.66 77.91 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 CA-C-N 118.248 1.024 . . . . 0.0 109.619 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -121.12 101.82 7.91 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -87.43 88.55 7.71 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.33 173.08 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.006 2.123 . . . . 0.0 110.521 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -119.21 167.69 11.59 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.778 1.172 . . . . 0.0 113.128 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.7 t -168.34 173.16 7.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.1 2.16 . . . . 0.0 108.758 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.519 ' HE1' HM73 ' A' ' 123' ' ' FMN . 79.8 m95 -120.77 141.59 50.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.448 2.299 . . . . 0.0 109.984 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.56 -31.23 63.99 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.224 0.92 . . . . 0.0 111.013 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 t -60.09 -9.08 2.81 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.7 1.6 . . . . 0.0 113.612 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -118.1 -10.74 10.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.031 1.332 . . . . 0.0 109.361 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.7 mt -92.33 164.62 13.44 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.745 -1.222 . . . . 0.0 111.232 -174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD2' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.78 141.27 42.95 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.3 t -101.68 150.05 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 173.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.3 mt -122.14 178.86 4.74 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.37 2.668 . . . . 0.0 107.64 172.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -73.1 174.83 7.37 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.98 28.29 32.16 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.591 1.567 . . . . 0.0 110.942 -173.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.657 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.301 0.1 OUTLIER 53.49 21.99 2.72 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.0 2.12 . . . . 0.0 114.69 -176.605 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -73.36 139.61 46.09 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -123.69 167.49 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.3 t -147.62 145.97 18.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 O-C-N 120.484 -1.385 . . . . 0.0 108.582 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -121.4 131.79 24.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.289 2.636 . . . . 0.0 105.959 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.91 108.75 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.485 2.123 . . . . 0.0 108.84 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.761 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.42 111.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.4 -21.08 5.63 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.852 1.691 . . . . 0.0 112.966 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.07 41.55 0.29 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.524 ' HB2' HG23 ' A' ' 48' ' ' VAL . 22.7 mtt -107.88 71.41 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.553 1.541 . . . . 0.0 107.862 174.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -66.29 -64.91 0.75 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 130.348 3.459 . . . . 0.0 113.732 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -51.69 -41.11 61.21 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.982 -1.074 . . . . 0.0 109.15 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -61.5 -38.94 89.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.69 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.78 -50.18 74.91 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 121.126 1.785 . . . . 0.0 110.532 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.31 -39.31 90.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.168 0.508 . . . . 0.0 111.498 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -68.08 -41.96 81.09 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 116.279 -1.82 . . . . 0.0 110.471 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.15 -48.13 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 120.101 1.319 . . . . 0.0 108.966 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.38 -30.19 51.06 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.295 -0.86 . . . . 0.0 112.694 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.86 -45.93 10.4 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.36 0.982 . . . . 0.0 113.081 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -141.59 133.14 26.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.931 0.893 . . . . 0.0 110.777 -176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -16.15 62.21 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.948 -1.095 . . . . 0.0 112.902 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -59.76 117.12 4.61 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.6 m -138.9 147.1 25.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-O 123.679 1.704 . . . . 0.0 112.444 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.25 148.9 31.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.662 -2.718 . . . . 0.0 103.662 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 11.7 ttt -139.38 126.62 21.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.3 p -108.74 127.96 54.45 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.79 164.92 13.93 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.994 1.725 . . . . 0.0 108.696 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.1 -175.77 38.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 46.9 t -146.99 161.92 39.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.024 1.329 . . . . 0.0 108.841 174.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -98.73 -8.1 26.62 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.854 1.662 . . . . 0.0 109.922 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -8.51 48.73 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.839 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.88 133.95 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.13 131.38 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.5 1.12 . . . . 0.0 111.419 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.53 -140.92 6.14 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.89 -59.43 2.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.746 2.019 . . . . 0.0 108.324 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.27 102.94 8.87 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.2 -168.63 1.58 Allowed Glycine 0 CA--C 1.537 1.463 0 O-C-N 121.997 -0.439 . . . . 0.0 112.289 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -75.65 64.18 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.574 2.182 . . . . 0.0 109.954 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.11 121.13 1.1 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -118.16 169.61 9.55 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.008 0.904 . . . . 0.0 110.155 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.61 -171.84 43.56 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 124.271 0.939 . . . . 0.0 112.406 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -145.35 156.04 43.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 109.791 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.5 tt -101.38 131.36 47.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 173.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 mm -134.33 162.07 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 -174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -133.32 150.75 51.85 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.399 1.479 . . . . 0.0 108.923 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.97 179.6 43.52 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.216 0.912 . . . . 0.0 111.745 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -101.21 128.98 47.08 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.02 161.78 14.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.609 1.095 . . . . 0.0 111.692 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.08 121.28 3.11 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.41 1.484 . . . . 0.0 109.351 173.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.91 137.54 43.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.613 HH11 ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -138.34 141.22 39.73 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.532 1.533 . . . . 0.0 109.334 176.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.26 37.39 4.35 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -159.2 159.12 33.91 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 129.072 2.949 . . . . 0.0 110.613 -172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.44 178.56 46.84 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 126.432 1.967 . . . . 0.0 115.694 173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.57 -18.26 53.47 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.891 3.06 . . . . 0.0 111.724 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.83 -64.09 0.94 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.16 -31.27 71.01 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.633 0.773 . . . . 0.0 111.556 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -68.58 -60.3 2.51 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.75 -19.34 62.35 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.847 -1.158 . . . . 0.0 113.517 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.8 pp -92.6 -18.15 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.112 1.324 . . . . 0.0 110.854 172.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.58 -27.97 3.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.782 1.633 . . . . 0.0 112.529 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -50.67 -23.22 2.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.441 1.096 . . . . 0.0 113.567 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -80.3 178.73 8.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.733 1.151 . . . . 0.0 109.604 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 tttt -137.27 20.35 2.96 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.91 -1.744 . . . . 0.0 111.331 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -136.15 8.67 3.21 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.902 1.281 . . . . 0.0 111.137 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.93 131.1 35.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.369 -0.832 . . . . 0.0 109.529 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -20.9 16.53 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 109.669 173.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.761 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.85 161.76 11.08 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.377 1.871 . . . . 0.0 109.769 -176.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.14 103.5 13.57 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.18 95.38 5.6 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.12 131.66 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.951 1.7 . . . . 0.0 106.961 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 62.2 mt -117.93 128.47 75.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -99.01 85.9 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 2' ' ' LEU . 31.4 t -60.78 151.7 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 124.494 1.118 . . . . 0.0 109.461 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.5 -54.99 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m -148.34 141.22 24.74 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.258 . . -120.59 158.15 27.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 130.698 3.599 . . . . 0.0 114.732 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -145.93 135.77 23.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.218 2.207 . . . . 0.0 107.221 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.84 138.57 42.6 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -134.83 -81.04 0.44 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 122.518 0.327 . . . . 0.0 110.48 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-O 121.38 0.609 . . . . 0.0 109.938 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.519 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mmt . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.556 HD11 HG11 ' A' ' 115' ' ' VAL . 80.2 mt -139.09 155.39 72.71 Favored Pre-proline 0 N--CA 1.465 0.275 0 C-N-CA 124.109 0.963 . . . . 0.0 109.411 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 157.16 57.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.502 2.134 . . . . 0.0 110.956 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -38.84 93.63 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -49.16 -38.94 27.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.606 1.562 . . . . 0.0 112.121 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -51.5 -52.82 43.47 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.426 1.466 . . . . 0.0 111.245 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -56.11 -48.35 76.36 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.585 1.154 . . . . 0.0 108.996 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -57.98 -34.03 69.53 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.12 -45.35 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.349 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.08 -43.17 70.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.315 1.416 . . . . 0.0 112.839 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -51.84 -19.36 1.67 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -112.16 161.94 15.99 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.938 1.351 . . . . 0.0 111.472 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -73.6 131.59 41.86 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.774 1.23 . . . . 0.0 109.356 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.31 165.13 35.37 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 124.978 1.275 . . . . 0.0 111.251 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.78 150.6 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 31' ' ' THR . 31.4 t -135.15 161.44 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.59 43.01 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.032 0.933 . . . . 0.0 108.808 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.7 mt -138.71 118.83 14.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.9 108.38 19.51 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.549 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.0 m -89.43 116.66 27.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -73.26 141.18 47.23 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 120.916 1.689 . . . . 0.0 106.554 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.13 -81.28 0.25 Allowed Glycine 0 C--O 1.225 -0.428 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -161.42 -48.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 19.9 p-10 -78.44 40.63 0.37 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 129.61 3.164 . . . . 0.0 111.133 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.43 151.4 18.56 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.693 1.139 . . . . 0.0 110.851 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 73.0 Cg_endo -68.8 149.27 72.69 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 CA-C-N 118.609 1.205 . . . . 0.0 109.51 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.91 98.12 7.33 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.68 2.392 . . . . 0.0 112.892 -172.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -82.14 89.21 6.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.674 0.79 . . . . 0.0 111.395 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.41 168.79 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.908 1.283 . . . . 0.0 110.491 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -122.23 166.07 15.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.426 HG23 ' HB ' ' A' ' 16' ' ' VAL . 12.1 t -168.42 176.57 5.75 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.224 2.209 . . . . 0.0 109.222 175.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -121.14 141.63 50.63 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.327 2.251 . . . . 0.0 109.848 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -55.61 -31.47 62.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.971 0.805 . . . . 0.0 111.193 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 t -60.48 -8.88 3.03 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.515 1.926 . . . . 0.0 114.043 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -118.72 -1.05 11.16 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.752 1.16 . . . . 0.0 111.399 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.511 HD22 HG22 ' A' ' 46' ' ' VAL . 11.5 mt -102.65 163.38 12.25 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 119.29 0.95 . . . . 0.0 112.262 -173.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -136.3 141.59 43.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.79 141.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.43 -178.02 3.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.839 1.655 . . . . 0.0 108.999 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -60.76 164.81 4.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.651 1.181 . . . . 0.0 111.298 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.82 28.21 30.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.388 1.947 . . . . 0.0 111.109 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' HB2' HD12 ' A' ' 2' ' ' LEU 0.293 0.1 OUTLIER 53.44 22.15 2.74 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.532 1.933 . . . . 0.0 113.29 -175.151 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -73.83 131.89 41.99 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -114.11 161.09 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 -174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.5 t -140.63 138.54 35.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 O-C-N 120.78 -1.2 . . . . 0.0 108.669 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.511 HG22 HD22 ' A' ' 36' ' ' LEU . 59.1 t -123.15 133.14 24.34 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.742 2.017 . . . . 0.0 106.966 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -74.36 123.18 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.88 1.72 . . . . 0.0 107.739 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.446 HG23 ' HB2' ' A' ' 51' ' ' MET . 7.8 p -85.08 112.16 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.65 -20.67 8.77 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 124.868 1.223 . . . . 0.0 113.458 173.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -170.62 39.99 0.19 Allowed Glycine 0 C--N 1.336 0.547 0 CA-C-N 119.377 1.589 . . . . 0.0 112.175 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.446 ' HB2' HG23 ' A' ' 48' ' ' VAL . 30.9 mtt -99.12 71.06 1.82 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.035 0.917 . . . . 0.0 110.788 173.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -71.07 -67.41 0.51 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.368 1.867 . . . . 0.0 112.749 -173.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HZ1' ' CG ' ' A' ' 24' ' ' ASP 0.259 12.2 tmtt? -51.97 -38.89 58.25 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.172 0.989 . . . . 0.0 108.966 176.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m -64.5 -38.81 92.32 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.909 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.53 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 26.5 tt0 -57.45 -43.63 84.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.478 1.944 . . . . 0.0 109.657 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.24 95.35 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.239 -0.288 . . . . 0.0 111.649 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.35 -41.76 76.66 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-O 116.968 -1.491 . . . . 0.0 113.567 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.08 -48.11 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 120.436 1.471 . . . . 0.0 109.089 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.7 -23.56 29.49 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -85.99 -46.07 10.87 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 173.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -151.42 129.43 11.8 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.759 1.224 . . . . 0.0 110.009 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -17.53 59.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.57 131.04 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.327 1.421 . . . . 0.0 110.739 -178.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.3 m -141.4 155.96 21.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 123.379 1.562 . . . . 0.0 112.332 173.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.5 tp -101.21 152.54 20.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 172.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.9 ttt -138.93 118.77 13.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 78.8 p -111.03 128.1 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.4 pt? -116.8 170.21 8.78 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 109.623 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.59 -177.02 39.3 Favored Glycine 0 N--CA 1.435 -1.398 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.533 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.5 t -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -98.63 -7.91 27.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.801 1.64 . . . . 0.0 108.936 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 -11.26 38.55 Favored 'General case' 0 C--N 1.34 0.164 0 O-C-N 119.371 -2.081 . . . . 0.0 113.338 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.42 138.87 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 120.627 1.558 . . . . 0.0 107.101 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.0 130.26 35.33 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.026 0.53 . . . . 0.0 110.75 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.67 -121.7 2.79 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 124.437 1.018 . . . . 0.0 112.927 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.445 ' H ' HD11 ' A' ' 122' ' ' LEU . 3.4 mmp_? -91.81 -78.63 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.247 1.419 . . . . 0.0 110.529 174.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -73.61 104.95 4.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.166 0.984 . . . . 0.0 108.431 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.15 -168.59 10.59 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.704 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 67.0 Cg_endo -74.74 63.7 5.76 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.851 2.368 . . . . 0.0 110.29 174.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.83 121.44 1.32 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -115.4 173.33 6.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.966 0.883 . . . . 0.0 110.726 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.3 -173.3 43.67 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 118.797 0.726 . . . . 0.0 113.133 -174.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -151.34 157.32 42.33 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.745 1.218 . . . . 0.0 110.409 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.5 130.9 47.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 172.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.62 155.14 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -126.86 143.87 51.14 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.626 1.57 . . . . 0.0 107.818 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.63 -165.11 32.65 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.3 m -121.39 142.87 49.58 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.313 0.645 . . . . 0.0 110.017 173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -89.92 161.78 15.75 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.623 1.169 . . . . 0.0 110.174 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.74 114.5 2.35 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.702 1.201 . . . . 0.0 107.775 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 50.1 m-85 -74.57 136.26 42.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.533 HH11 ' HG3' ' A' ' 92' ' ' ARG . 6.4 mmm-85 -139.13 137.3 35.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 109.866 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.1 p -120.78 38.06 4.14 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -158.81 158.96 34.55 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 129.394 3.078 . . . . 0.0 111.19 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.73 46.88 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.966 1.746 . . . . 0.0 114.72 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.03 -19.55 63.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.645 2.23 . . . . 0.0 109.523 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -63.62 -65.86 0.62 Allowed 'General case' 0 C--O 1.25 1.11 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -61.58 -31.85 71.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 116.607 -1.663 . . . . 0.0 112.515 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -68.25 -53.95 21.03 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 120.852 1.66 . . . . 0.0 110.823 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.67 70.54 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 116.96 -1.495 . . . . 0.0 111.309 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pp -85.1 -20.67 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 117.507 -1.677 . . . . 0.0 113.558 173.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.71 -44.05 97.08 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 120.881 1.673 . . . . 0.0 112.915 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.599 ' H ' ' HD2' ' A' ' 103' ' ' ARG 0.52 0.0 OUTLIER -51.72 -18.06 1.1 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 173.784 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.02 -179.0 0.12 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -128.38 16.11 6.59 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 118.782 -2.449 . . . . 0.0 111.998 -174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -139.32 12.16 2.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.042 1.337 . . . . 0.0 110.891 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.12 140.46 37.8 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.372 -0.83 . . . . 0.0 111.28 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.81 -21.53 6.58 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.988 2.115 . . . . 0.0 111.706 174.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.24 161.99 1.9 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.69 1.996 . . . . 0.0 109.396 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.61 112.44 24.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.6 tp -84.1 93.56 8.15 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.11 120.8 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.4 mm -102.93 128.8 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.2 m -98.61 78.91 2.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 2' ' ' LEU . 38.5 t -61.09 153.84 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 125.745 1.618 . . . . 0.0 109.381 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.9 t -130.15 -54.77 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -151.4 141.59 22.27 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.717 0.689 . . . . 0.0 112.844 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -109.89 156.58 20.22 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 127.283 2.233 . . . . 0.0 111.22 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.38 154.21 42.75 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.308 2.643 . . . . 0.0 106.689 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -100.8 133.97 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.223 -1.548 . . . . 0.0 108.404 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.0 p -135.37 -81.91 0.42 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.196 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.445 HD11 ' H ' ' A' ' 76' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.244 0.808 0 C-N-CA 130.415 3.486 . . . . 0.0 114.871 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' C ' HD22 ' A' ' 2' ' ' LEU . 18.5 mmt . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.3 mm? -131.54 153.72 81.64 Favored Pre-proline 0 N--CA 1.463 0.19 0 C-N-CA 124.788 1.235 . . . . 0.0 108.873 -171.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.86 158.51 52.74 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.109 1.873 . . . . 0.0 109.197 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.2 -40.44 95.79 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -54.18 -38.84 66.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.504 1.522 . . . . 0.0 111.827 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -51.32 -52.31 46.53 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.51 1.05 . . . . 0.0 110.692 173.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -60.0 -48.28 82.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.764 0.826 . . . . 0.0 110.495 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -53.21 -38.66 63.1 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.505 1.048 . . . . 0.0 112.159 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.1 t -69.04 -42.35 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.858 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.2 mt -58.39 -42.67 87.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.261 1.392 . . . . 0.0 112.164 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -51.87 -25.34 7.73 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.105 0.962 . . . . 0.0 113.04 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -101.26 161.09 13.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.62 139.99 45.86 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.13 164.4 37.75 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.53 148.5 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.421 ' HB ' HG23 ' A' ' 31' ' ' THR . 13.8 t -135.49 161.66 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.6 158.38 41.08 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.123 0.969 . . . . 0.0 108.875 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -138.81 114.42 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.66 108.87 19.69 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.607 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -92.89 116.19 28.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 116.939 -1.505 . . . . 0.0 107.607 -173.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -73.3 137.42 44.84 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 120.859 1.663 . . . . 0.0 108.4 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.25 -81.51 0.22 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 106.8 -2.52 . . . . 0.0 106.8 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -168.98 -48.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -78.18 38.68 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 131.326 3.85 . . . . 0.0 110.069 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.92 151.17 5.7 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 39.4 Cg_endo -68.62 148.56 72.51 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 CA-C-N 119.762 1.781 . . . . 0.0 107.725 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -108.15 101.5 10.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.347 -173.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 tp -74.68 88.8 2.23 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.216 1.006 . . . . 0.0 111.441 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.9 m -82.08 170.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.489 1.516 . . . . 0.0 110.242 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.24 168.08 11.6 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.802 1.183 . . . . 0.0 113.571 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.421 HG23 ' HB ' ' A' ' 16' ' ' VAL . 14.1 t -168.61 174.1 6.95 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 128.254 2.622 . . . . 0.0 108.253 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.428 ' HE1' HM73 ' A' ' 123' ' ' FMN . 95.9 m95 -121.11 141.96 50.3 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.52 2.328 . . . . 0.0 110.726 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -52.92 -31.63 41.06 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.828 1.194 . . . . 0.0 111.776 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -58.48 -8.71 1.29 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.701 2.001 . . . . 0.0 113.653 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -118.06 -3.35 11.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.813 1.245 . . . . 0.0 110.479 -173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.9 mt -99.23 170.59 8.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 120.449 1.477 . . . . 0.0 114.36 -173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -136.33 141.32 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 172.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -100.92 148.81 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 mt -121.78 178.93 4.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 127.17 2.188 . . . . 0.0 110.463 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -67.13 167.65 11.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.577 1.551 . . . . 0.0 109.742 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.9 28.62 57.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.073 1.321 . . . . 0.0 111.307 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.25 0.1 OUTLIER 53.73 20.43 2.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.873 2.069 . . . . 0.0 114.236 -175.21 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -73.44 145.56 45.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -127.27 168.15 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -148.02 145.0 18.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 O-C-N 120.392 -1.443 . . . . 0.0 108.8 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.68 138.88 32.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 128.749 2.82 . . . . 0.0 107.772 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.24 109.12 2.28 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.8 3.0 . . . . 0.0 109.427 173.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.28 111.84 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 173.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.77 -21.63 4.94 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.771 1.177 . . . . 0.0 113.24 173.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.24 37.45 0.41 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 119.183 1.491 . . . . 0.0 111.44 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.465 ' HB2' HG23 ' A' ' 48' ' ' VAL . 33.4 mtt -103.39 71.5 1.1 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.423 ' CD2' HH22 ' A' ' 108' ' ' ARG . 34.0 m80 -67.28 -70.53 0.25 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 128.401 2.68 . . . . 0.0 114.573 -173.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -51.68 -40.74 60.62 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 120.791 -1.193 . . . . 0.0 109.987 174.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 12.8 m -60.39 -39.14 86.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.868 0.867 . . . . 0.0 113.323 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.85 -48.13 82.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.291 1.405 . . . . 0.0 108.587 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.2 97.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.761 173.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 15.6 m-20 -63.07 -41.93 99.56 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.032 -1.461 . . . . 0.0 110.57 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.49 -48.21 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.622 1.101 . . . . 0.0 108.664 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.87 -26.81 62.61 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.122 -0.942 . . . . 0.0 113.503 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -87.18 -46.99 9.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.977 1.262 . . . . 0.0 112.187 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -147.06 128.85 15.27 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.399 1.08 . . . . 0.0 111.848 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 -17.67 59.3 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -174.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.488 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.66 130.97 48.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.225 0.921 . . . . 0.0 110.466 -174.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 20' ' ' THR . 35.5 m -144.24 156.15 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 123.264 1.507 . . . . 0.0 112.879 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.5 tp -104.88 152.74 22.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 172.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.5 ttt -138.99 128.27 24.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 p -129.72 128.6 42.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -116.46 164.07 15.1 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 119.431 1.014 . . . . 0.0 109.29 173.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.64 42.4 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.8 t -160.95 172.04 17.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.171 -1.194 . . . . 0.0 109.428 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -99.23 -8.29 25.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.212 2.205 . . . . 0.0 108.987 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -11.18 43.88 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 115.815 -2.041 . . . . 0.0 116.265 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.87 140.33 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.76 131.29 35.88 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.727 0.811 . . . . 0.0 110.868 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.4 -139.47 5.68 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 125.441 1.496 . . . . 0.0 112.099 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -79.23 -59.04 2.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.165 1.786 . . . . 0.0 107.662 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.7 103.09 15.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.27 -168.7 4.13 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.36 61.02 6.59 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.492 2.128 . . . . 0.0 109.969 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.33 121.56 1.2 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 108.559 -1.817 . . . . 0.0 108.559 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.19 169.85 8.96 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 118.479 1.14 . . . . 0.0 110.197 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 171.83 43.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.295 0.95 . . . . 0.0 113.1 175.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -131.83 147.78 52.51 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.417 1.487 . . . . 0.0 108.696 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tt -100.51 131.5 46.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.893 2.477 . . . . 0.0 105.409 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 115' ' ' VAL . 6.4 mt -136.4 154.73 33.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 55.7 mtt-85 -127.74 143.12 51.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.285 1.434 . . . . 0.0 107.682 -174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.09 -171.84 40.27 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 119.094 0.861 . . . . 0.0 113.407 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -121.31 134.68 55.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.323 1.449 . . . . 0.0 110.514 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -88.76 160.53 17.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.747 1.619 . . . . 0.0 110.565 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.62 120.64 1.5 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.464 1.506 . . . . 0.0 109.13 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.99 149.37 29.34 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.19 -0.944 . . . . 0.0 112.747 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.18 141.4 34.1 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 126.557 1.943 . . . . 0.0 109.179 172.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.8 p -114.11 24.8 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.546 1.539 . . . . 0.0 107.321 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.72 167.32 29.81 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 126.317 1.847 . . . . 0.0 110.39 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.8 179.74 45.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.639 2.066 . . . . 0.0 113.295 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.7 -11.46 17.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.886 3.057 . . . . 0.0 112.459 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -64.04 0.98 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.328 1.851 . . . . 0.0 107.138 173.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.29 -31.12 70.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 124.127 0.892 . . . . 0.0 110.749 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -68.65 -56.86 6.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.001 0.819 . . . . 0.0 109.801 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.39 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.909 -1.119 . . . . 0.0 112.428 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.343 1.5 pp -92.3 -18.12 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.666 1.121 . . . . 0.0 111.463 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.28 -28.09 2.89 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.688 1.995 . . . . 0.0 112.334 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.281 0.0 OUTLIER -51.49 -32.34 27.08 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.237 172.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -79.07 178.02 8.36 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 173.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.69 8.18 1.93 Allowed 'General case' 0 C--O 1.221 -0.427 0 O-C-N 118.473 -2.642 . . . . 0.0 111.704 173.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -102.0 8.38 40.99 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.628 1.171 . . . . 0.0 110.554 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.85 150.96 22.0 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.519 0.727 . . . . 0.0 109.992 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.423 HH22 ' CD2' ' A' ' 52' ' ' HIS . 23.1 ttm180 -120.65 -20.93 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.887 2.075 . . . . 0.0 111.355 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.35 161.83 12.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.666 1.586 . . . . 0.0 108.519 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.5 105.41 15.43 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 127.599 2.36 . . . . 0.0 106.695 173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 tp -79.22 95.86 5.75 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.285 1.834 . . . . 0.0 107.094 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.7 t -78.91 131.52 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 125.676 1.59 . . . . 0.0 106.718 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.2 mm -120.78 128.36 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.5 m -98.91 85.9 3.37 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.175 -2.158 . . . . 0.0 105.175 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.475 HG11 HD21 ' A' ' 2' ' ' LEU . 22.6 t -60.76 150.82 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.46 -58.83 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -147.95 141.53 25.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.3 154.73 25.22 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.394 2.278 . . . . 0.0 110.347 173.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -140.41 139.14 35.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.447 2.299 . . . . 0.0 106.865 174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -77.84 139.97 39.33 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -132.98 -58.82 0.9 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.243 0.717 0 CA-C-O 116.561 -1.685 . . . . 0.0 111.945 -173.362 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.428 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mmm . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mp -57.04 153.54 23.52 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.15 155.48 56.61 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.576 2.184 . . . . 0.0 110.644 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.84 -42.06 97.96 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -49.48 -38.8 31.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.36 1.864 . . . . 0.0 112.327 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -51.1 -56.26 13.56 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.45 1.023 . . . . 0.0 110.145 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -58.62 -48.74 79.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.914 0.886 . . . . 0.0 109.36 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.59 -40.23 71.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.483 0.583 . . . . 0.0 112.269 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.0 t -69.52 -45.83 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.801 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -57.65 -37.25 73.04 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.81 1.186 . . . . 0.0 113.921 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -51.78 -29.51 19.26 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.748 1.158 . . . . 0.0 112.134 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -101.08 165.55 11.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.607 1.163 . . . . 0.0 109.83 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -73.21 139.05 45.98 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.33 167.56 40.31 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.13 144.12 9.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.068 1.747 . . . . 0.0 107.432 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.419 ' HB ' HG23 ' A' ' 31' ' ' THR . 59.0 t -136.8 158.32 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -145.42 155.45 43.15 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.566 1.546 . . . . 0.0 108.115 173.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.489 HD11 HG21 ' A' ' 46' ' ' VAL . 39.5 mt -140.98 112.93 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.99 108.92 19.84 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.458 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -95.35 116.99 29.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -73.31 141.16 47.14 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 121.001 1.728 . . . . 0.0 106.542 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.12 -81.27 0.22 Allowed Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -158.89 -60.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -78.61 38.84 0.33 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 130.096 3.359 . . . . 0.0 111.445 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.0 151.29 17.03 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.13 0.871 . . . . 0.0 110.994 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.6 152.09 53.34 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 120.994 1.13 . . . . 0.0 111.529 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -110.5 101.6 10.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.4 tt -88.91 88.94 7.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.0 m -85.71 174.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.561 1.944 . . . . 0.0 110.785 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -119.23 166.72 12.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.367 0.985 . . . . 0.0 113.368 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.419 HG23 ' HB ' ' A' ' 16' ' ' VAL . 13.2 t -168.44 171.89 8.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.407 2.283 . . . . 0.0 108.212 174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.666 ' HE1' HM73 ' A' ' 123' ' ' FMN . 83.1 m95 -121.34 141.71 50.68 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.084 1.754 . . . . 0.0 110.192 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -50.69 -31.25 15.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.795 0.838 . . . . 0.0 111.376 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 t -59.31 -8.66 1.79 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.095 1.758 . . . . 0.0 113.682 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -118.56 -13.21 9.69 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.722 1.209 . . . . 0.0 110.623 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.543 HD22 HG22 ' A' ' 46' ' ' VAL . 27.8 mt -91.1 168.62 11.5 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 120.64 -1.288 . . . . 0.0 111.901 -173.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.91 37.61 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 172.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.46 134.05 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.28 179.07 4.53 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.897 1.679 . . . . 0.0 107.337 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 35.0 t0 -75.83 -179.21 4.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.274 0.629 . . . . 0.0 110.31 173.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.437 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 58.6 28.85 63.16 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.419 -1.425 . . . . 0.0 110.303 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 p30 53.82 13.23 0.5 Allowed 'General case' 0 C--N 1.345 0.39 0 C-N-CA 130.106 3.362 . . . . 0.0 114.684 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -74.01 128.05 34.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.082 0.401 . . . . 0.0 110.301 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mm -119.07 158.83 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -143.5 142.72 25.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 O-C-N 120.397 -1.439 . . . . 0.0 107.732 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.543 HG22 HD22 ' A' ' 36' ' ' LEU . 58.2 t -124.38 126.15 25.53 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 128.623 2.769 . . . . 0.0 106.522 -173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -72.9 108.4 2.57 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.453 1.436 . . . . 0.0 108.934 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.87 111.59 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.7 -21.48 5.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.35 0.976 . . . . 0.0 112.097 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.58 41.3 0.47 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-O 117.854 -1.526 . . . . 0.0 110.044 -174.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB2' HG23 ' A' ' 48' ' ' VAL . 8.7 mtt -109.75 71.74 0.77 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.271 1.429 . . . . 0.0 108.203 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -67.04 -64.13 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 130.239 3.416 . . . . 0.0 112.794 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -51.66 -41.04 61.07 Favored 'General case' 0 C--O 1.217 -0.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.258 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.8 m -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.358 1.463 . . . . 0.0 111.509 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.95 -48.97 79.62 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.714 1.206 . . . . 0.0 108.838 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.83 94.88 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -66.0 -41.86 90.52 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 124.014 0.926 . . . . 0.0 109.316 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.34 -47.96 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.39 -28.3 28.69 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.505 -0.747 . . . . 0.0 112.322 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -45.96 17.57 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -150.79 138.97 20.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.051 0.842 . . . . 0.0 110.174 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -74.62 -18.52 60.54 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.362 -0.836 . . . . 0.0 111.984 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.79 118.15 6.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.804 1.241 . . . . 0.0 113.935 -174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 20' ' ' THR . 9.2 m -139.31 152.72 23.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 123.084 1.421 . . . . 0.0 112.762 173.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.7 tt -111.74 148.78 32.75 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.0 ttt -140.47 123.44 16.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 8.0 p -108.79 128.15 54.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.03 167.68 10.93 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 120.408 1.458 . . . . 0.0 109.208 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.91 178.82 46.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 173.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.8 t -151.89 155.18 37.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.6 mtt-85 -98.4 -8.4 26.99 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.284 0.634 . . . . 0.0 111.182 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -72.39 -7.66 50.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.872 -1.061 . . . . 0.0 112.535 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.98 135.77 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 174.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.01 130.36 35.44 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.24 -137.54 5.29 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -90.76 -58.39 2.5 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.575 0.75 . . . . 0.0 109.142 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.91 102.61 5.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 118.794 -1.162 . . . . 0.0 108.532 -174.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.21 -168.27 0.12 Allowed Glycine 0 CA--C 1.54 1.642 0 O-C-N 120.647 -1.283 . . . . 0.0 111.086 -174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.37 90.78 0.58 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 N-CA-C 106.462 -2.169 . . . . 0.0 106.462 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.41 0.71 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-O 117.748 -1.585 . . . . 0.0 109.599 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -105.99 168.87 8.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.399 1.099 . . . . 0.0 110.091 174.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.43 -166.14 35.31 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-O 121.266 0.37 . . . . 0.0 113.646 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -142.69 152.39 42.34 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.497 1.119 . . . . 0.0 110.009 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.0 tp -101.22 131.12 47.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.502 ' CG2' HG13 ' A' ' 115' ' ' VAL . 5.3 mt -133.55 150.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -124.25 138.23 54.42 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.687 1.995 . . . . 0.0 106.268 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.45 -167.17 26.71 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -121.14 142.1 50.19 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.448 1.899 . . . . 0.0 108.682 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.06 160.99 16.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.913 1.233 . . . . 0.0 110.935 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.11 120.44 3.33 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.266 1.027 . . . . 0.0 109.448 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.413 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 3.4 m-85 -74.13 128.7 36.21 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -120.56 141.12 50.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.782 2.433 . . . . 0.0 109.632 173.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -121.21 29.53 7.25 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.658 1.983 . . . . 0.0 107.262 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.77 165.98 33.03 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.646 2.378 . . . . 0.0 108.663 -173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.7 178.97 46.34 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.499 1.523 . . . . 0.0 113.643 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.73 -20.43 68.81 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.545 2.163 . . . . 0.0 111.11 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.32 -55.58 20.29 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.52 1.528 . . . . 0.0 108.595 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.435 ' CD1' HD11 ' A' ' 101' ' ' ILE . 33.1 t80 -61.34 -31.35 71.22 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 116.924 -1.512 . . . . 0.0 110.521 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.22 -48.39 65.3 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 121.515 1.962 . . . . 0.0 110.516 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.11 -35.99 60.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.854 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.436 HD13 ' HB1' ' A' ' 107' ' ' ALA 0.25 1.3 pp -93.68 -20.95 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 173.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.66 93.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 121.544 1.974 . . . . 0.0 111.695 -173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.464 0.0 OUTLIER -51.35 -18.02 0.89 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.988 1.715 . . . . 0.0 114.744 173.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -174.74 0.21 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -129.22 10.59 5.82 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 119.022 -2.299 . . . . 0.0 113.003 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -139.66 8.82 2.39 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.495 0.718 . . . . 0.0 112.587 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 101' ' ' ILE . . . -79.36 151.25 31.09 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.231 0.923 . . . . 0.0 111.356 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -120.65 -21.34 6.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.216 2.207 . . . . 0.0 111.657 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.784 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.78 161.63 11.16 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.659 1.584 . . . . 0.0 109.482 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.41 103.69 15.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.43 94.68 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.7 t -79.19 131.59 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.211 1.804 . . . . 0.0 106.59 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -118.99 138.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.7 m -114.64 101.39 9.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.502 HG13 ' CG2' ' A' ' 85' ' ' ILE . 59.7 t -60.15 153.77 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.639 0.733 . . . . 0.0 109.352 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.91 -40.83 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.6 m -151.03 128.06 11.1 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 120.857 -1.152 . . . . 0.0 110.924 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.4 138.81 49.54 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.589 2.356 . . . . 0.0 109.117 173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -142.01 140.97 32.81 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.86 1.664 . . . . 0.0 110.762 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.56 133.8 47.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -152.84 -58.55 0.14 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.252 1.224 0 CA-C-O 115.216 -2.326 . . . . 0.0 115.687 -172.936 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 1.407 ' C10' ' N1 ' ' A' ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtm . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.79 157.31 8.03 Favored Pre-proline 0 C--O 1.242 0.704 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.47 160.32 48.44 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.606 2.204 . . . . 0.0 111.329 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.65 -47.53 90.45 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.83 -42.11 62.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.22 1.408 . . . . 0.0 111.99 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.569 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 34.7 t80 -51.12 -56.62 11.79 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.555 0.616 . . . . 0.0 111.493 173.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -59.17 -48.52 81.3 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.316 0.646 . . . . 0.0 110.578 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -55.79 -40.5 72.76 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.935 0.789 . . . . 0.0 111.976 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.89 -44.05 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.021 0.828 . . . . 0.0 108.884 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 25.4 mt -56.71 -43.89 81.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.087 0.858 . . . . 0.0 112.437 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -51.69 -27.08 10.61 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -99.11 171.63 7.89 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 122.295 1.045 . . . . 0.0 111.205 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -73.45 131.67 42.08 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.1 168.57 41.67 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.2 t -101.01 149.88 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.4 t -131.81 157.09 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.95 152.44 42.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mt -138.79 116.31 11.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.91 109.23 20.06 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -89.35 114.88 26.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 -176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.38 118.54 16.47 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.71 -74.65 0.11 Allowed Glycine 0 C--N 1.333 0.403 0 CA-C-N 118.236 0.471 . . . . 0.0 112.91 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -158.23 -48.24 0.06 Allowed 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -173.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -78.18 38.48 0.29 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.523 1.529 . . . . 0.0 110.792 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 152.47 6.59 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 105.851 -2.9 . . . . 0.0 105.851 -172.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 10.1 Cg_endo -51.19 147.76 19.91 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 122.233 3.016 . . . . 0.0 106.875 173.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -119.71 101.26 7.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.533 -172.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.4 tp -78.13 88.57 4.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.302 1.041 . . . . 0.0 111.208 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -77.48 171.71 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.942 1.297 . . . . 0.0 110.401 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -122.12 166.32 14.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.628 1.104 . . . . 0.0 113.516 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -168.52 175.01 6.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.561 2.344 . . . . 0.0 108.473 174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.44 ' HE1' HM73 ' A' ' 123' ' ' FMN . 92.9 m95 -120.67 141.68 50.16 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.327 2.251 . . . . 0.0 109.463 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -55.21 -31.42 61.43 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.77 0.714 . . . . 0.0 110.598 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -59.24 -8.81 1.79 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.99 2.116 . . . . 0.0 113.876 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -118.13 -7.05 10.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.594 1.158 . . . . 0.0 109.576 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.429 HD22 HG22 ' A' ' 46' ' ' VAL . 28.9 mt -97.18 171.41 8.47 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.747 -1.221 . . . . 0.0 112.01 -173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.537 ' HE2' HD11 ' A' ' 39' ' ' LEU . 15.9 ptmt -133.64 123.15 24.54 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 172.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.502 HG21 HD13 ' A' ' 10' ' ' LEU . 58.8 t -101.7 139.5 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.537 HD11 ' HE2' ' A' ' 37' ' ' LYS . 3.2 mp -121.66 178.52 4.81 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -76.55 -178.3 4.62 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.14 67.38 Favored Glycine 0 CA--C 1.524 0.614 0 O-C-N 120.511 -1.368 . . . . 0.0 109.812 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 53.79 13.0 0.47 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 130.337 3.455 . . . . 0.0 115.602 -174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -73.6 140.03 45.94 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.673 -173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 mt -130.59 161.4 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.87 145.63 20.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG22 HD22 ' A' ' 36' ' ' LEU . 60.5 t -122.24 130.04 24.85 Favored Pre-proline 0 N--CA 1.444 -0.729 0 C-N-CA 128.31 2.644 . . . . 0.0 106.548 -174.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.49 108.69 2.74 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.223 2.615 . . . . 0.0 109.087 174.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.725 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.58 111.66 21.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 121.879 -0.513 . . . . 0.0 109.958 173.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.57 -21.31 5.82 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.954 1.74 . . . . 0.0 111.93 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.06 39.97 0.38 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-N 118.89 1.345 . . . . 0.0 110.353 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.529 ' HB2' HG23 ' A' ' 48' ' ' VAL . 31.2 mtt -109.23 50.16 0.79 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.472 1.509 . . . . 0.0 107.052 173.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.47 -50.06 35.34 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 117.445 -1.264 . . . . 0.0 113.484 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -52.27 -41.57 62.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 121.272 1.851 . . . . 0.0 108.611 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 3.1 m -58.77 -38.4 78.41 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.71 0.804 . . . . 0.0 110.811 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -57.1 -48.18 79.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.682 1.583 . . . . 0.0 110.065 173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.89 -42.1 98.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 119.788 -0.148 . . . . 0.0 111.122 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 9.5 m-20 -61.22 -41.27 96.56 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 123.826 0.85 . . . . 0.0 110.052 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.9 -47.97 88.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.843 1.201 . . . . 0.0 109.361 173.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.92 -25.92 45.32 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.042 -1.036 . . . . 0.0 112.154 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . 1.3 mmm-85 -78.09 -45.03 24.55 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 173.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -151.25 140.82 21.64 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.234 1.014 . . . . 0.0 109.884 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -70.33 -19.41 63.07 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.873 -1.142 . . . . 0.0 111.94 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.3 mmp_? -60.8 120.77 10.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.18 1.392 . . . . 0.0 113.639 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 20' ' ' THR . 15.2 m -139.06 155.91 27.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 123.001 1.382 . . . . 0.0 112.185 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.9 tp -111.11 151.95 27.53 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 172.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.02 132.79 25.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 p -128.47 128.07 43.68 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -116.98 167.2 11.35 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.81 1.186 . . . . 0.0 110.781 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 178.5 42.42 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -150.32 170.79 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.732 -0.864 . . . . 0.0 109.076 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -98.66 -8.79 25.68 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.362 1.865 . . . . 0.0 110.888 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -91.58 -10.74 39.43 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.4 137.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.86 131.45 36.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.214 1.005 . . . . 0.0 109.798 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.22 -140.99 6.81 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.5 mtp-105 -83.99 -58.48 2.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.53 102.92 8.14 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.3 -168.72 2.27 Favored Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.201 -0.937 . . . . 0.0 112.6 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.5 59.53 6.76 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.867 2.378 . . . . 0.0 110.789 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.44 121.32 1.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -113.95 169.07 9.27 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.91 1.355 . . . . 0.0 110.181 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 176.57 44.35 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 123.463 0.554 . . . . 0.0 112.889 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -126.39 144.6 50.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.718 1.607 . . . . 0.0 110.197 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.54 128.39 46.61 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 128.253 2.621 . . . . 0.0 104.442 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 mt -138.41 153.83 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -173.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 -119.84 148.16 43.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.89 1.676 . . . . 0.0 107.52 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.77 -171.38 31.89 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.1 m -120.85 144.38 48.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.376 2.27 . . . . 0.0 107.179 174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.93 161.05 16.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.778 1.172 . . . . 0.0 111.405 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.22 114.92 2.54 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.174 0.99 . . . . 0.0 109.966 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -73.94 129.45 37.91 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.67 141.57 51.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 129.119 2.967 . . . . 0.0 108.606 174.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 p -118.28 30.36 7.27 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.774 1.629 . . . . 0.0 107.552 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -158.81 163.82 36.34 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.209 1.804 . . . . 0.0 109.328 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.38 178.74 46.87 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.116 1.817 . . . . 0.0 113.782 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.88 -13.86 37.36 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.707 2.938 . . . . 0.0 112.653 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -68.59 -63.38 1.07 Allowed 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -61.23 -31.31 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.967 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -68.62 -55.54 11.18 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.689 1.131 . . . . 0.0 109.42 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.462 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.53 -27.12 68.38 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.857 -1.152 . . . . 0.0 112.178 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.362 1.0 OUTLIER -86.25 -18.18 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.881 1.218 . . . . 0.0 111.567 173.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.33 -27.67 2.69 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.961 2.104 . . . . 0.0 111.675 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -49.26 -35.79 18.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.271 1.028 . . . . 0.0 111.764 173.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -77.94 178.05 7.77 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.89 -0.98 1.44 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 118.529 -2.607 . . . . 0.0 111.568 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.5 p-90 -97.01 8.38 44.61 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.979 0.912 . . . . 0.0 110.682 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.72 149.41 22.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.821 0.737 . . . . 0.0 109.515 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 ttt-85 -117.71 -11.22 10.41 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.244 1.818 . . . . 0.0 110.936 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.28 161.7 12.3 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 110.0 -174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.15 104.57 14.33 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.512 2.725 . . . . 0.0 106.174 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -82.32 96.96 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.08 131.65 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.378 1.871 . . . . 0.0 107.11 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.11 139.76 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.9 m -118.9 101.44 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.2 t -60.28 160.98 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.613 1.565 . . . . 0.0 109.472 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.22 -57.14 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 m -141.06 122.84 15.31 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.17 -174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.96 146.99 42.66 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 128.054 2.542 . . . . 0.0 111.337 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -143.91 152.13 40.72 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.563 1.545 . . . . 0.0 108.894 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -81.05 137.31 36.03 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.6 p -138.69 -58.49 0.62 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -173.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--O 1.251 1.168 0 C-N-CA 123.594 0.757 . . . . 0.0 111.182 -173.52 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.44 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mmt . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.9 mt -62.9 157.24 61.84 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 118.47 -0.776 . . . . 0.0 108.922 171.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.61 160.17 50.77 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.974 1.782 . . . . 0.0 111.756 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.09 -39.26 96.86 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -52.85 -38.82 61.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.931 1.692 . . . . 0.0 112.072 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.501 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 32.6 t80 -51.14 -51.89 49.16 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.487 1.039 . . . . 0.0 110.962 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -60.1 -48.39 81.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.338 0.655 . . . . 0.0 110.73 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -54.97 -37.22 66.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.642 1.11 . . . . 0.0 112.638 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -69.09 -45.01 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.364 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 38' ' ' VAL . 34.2 mt -57.21 -44.09 83.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.397 0.999 . . . . 0.0 112.018 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -51.85 -18.93 1.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -107.71 158.41 17.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.556 1.071 . . . . 0.0 110.788 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -77.0 147.69 36.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 169.47 168.54 31.57 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.4 t -77.18 149.05 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.24 161.98 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 127.343 2.257 . . . . 0.0 105.021 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.43 157.17 43.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.371 1.068 . . . . 0.0 109.139 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -139.39 120.13 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.91 108.77 19.73 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 173.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.485 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.8 m -90.6 113.45 25.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -73.2 131.71 42.32 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.93 -79.14 0.17 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 122.514 1.064 . . . . 0.0 111.131 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -158.32 -48.59 0.06 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 113.647 -1.277 . . . . 0.0 109.003 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.61 37.74 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.773 1.229 . . . . 0.0 112.053 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.28 152.12 5.76 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 25.6 Cg_endo -59.23 148.02 88.02 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 121.043 2.421 . . . . 0.0 108.481 177.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' CD2' ' HZ1' ' A' ' 53' ' ' LYS . 70.2 t60 -117.04 101.45 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.622 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 13.2 tp -75.02 88.64 2.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.832 0.853 . . . . 0.0 111.531 -175.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.9 m -78.1 169.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 124.395 1.078 . . . . 0.0 109.834 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -119.85 166.34 13.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.023 0.929 . . . . 0.0 112.243 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -168.52 176.05 5.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.453 2.301 . . . . 0.0 107.879 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.516 ' HE1' HM73 ' A' ' 123' ' ' FMN . 84.6 m95 -121.28 141.62 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.517 1.527 . . . . 0.0 110.76 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -50.86 -29.96 13.26 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 119.077 0.853 . . . . 0.0 111.154 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -55.13 -19.89 8.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.669 2.388 . . . . 0.0 112.58 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -118.13 -4.23 11.01 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.144 1.378 . . . . 0.0 109.619 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.468 HD22 HG22 ' A' ' 46' ' ' VAL . 6.3 mt -98.88 167.15 10.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.94 -1.1 . . . . 0.0 111.016 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.65 140.49 42.79 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.61 HG21 HD13 ' A' ' 10' ' ' LEU . 85.4 t -101.9 149.51 6.65 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.8 mt -122.24 178.82 4.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.638 2.775 . . . . 0.0 106.244 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -76.03 -179.04 4.69 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.33 31.01 72.48 Favored Glycine 0 CA--C 1.528 0.844 0 O-C-N 120.237 -1.539 . . . . 0.0 110.715 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.5 p30 54.08 13.06 0.53 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.765 3.226 . . . . 0.0 115.257 -173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -73.49 142.32 46.78 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.059 0.845 . . . . 0.0 109.547 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.41 166.41 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.408 ' CG1' ' HB1' ' A' ' 110' ' ' ALA . 16.9 t -147.97 145.07 18.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 O-C-N 120.793 -1.192 . . . . 0.0 108.644 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG22 HD22 ' A' ' 36' ' ' LEU . 60.9 t -123.58 136.07 26.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 108.585 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.77 121.28 6.2 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 124.269 3.312 . . . . 0.0 110.582 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.558 HG23 ' HB2' ' A' ' 51' ' ' MET . 7.7 p -85.48 111.94 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 119.52 1.055 . . . . 0.0 112.764 173.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.31 -20.81 5.76 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.774 1.654 . . . . 0.0 111.64 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.54 30.0 0.23 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-N 119.459 1.63 . . . . 0.0 112.292 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.558 ' HB2' HG23 ' A' ' 48' ' ' VAL . 37.2 mtt -99.4 61.96 1.21 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.103 1.452 . . . . 0.0 107.825 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -71.15 -60.89 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.029 0.932 . . . . 0.0 112.951 -174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.426 ' HZ1' ' CD2' ' A' ' 27' ' ' HIS . 4.0 ttpm? -52.09 -41.77 62.68 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.138 174.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 57' ' ' ASN . 2.0 m -61.62 -38.55 88.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 118.852 0.751 . . . . 0.0 111.641 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 36.9 tt0 -59.08 -44.74 91.93 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.927 1.239 . . . . 0.0 109.792 173.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.04 93.25 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.536 -0.268 . . . . 0.0 111.234 173.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 8.8 m-20 -62.61 -41.39 98.96 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 124.175 0.99 . . . . 0.0 109.473 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.78 -48.17 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 108.708 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.93 29.82 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.377 -0.827 . . . . 0.0 112.616 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -45.39 19.06 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -151.04 138.95 19.92 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.747 1.219 . . . . 0.0 109.417 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -73.1 -19.79 61.08 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.03 -1.044 . . . . 0.0 112.009 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.1 mmp_? -60.88 119.97 9.25 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.268 1.427 . . . . 0.0 114.265 -174.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 89' ' ' ALA . 16.1 m -139.64 156.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 123.108 1.432 . . . . 0.0 112.8 173.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 15.4 tp -110.81 151.19 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 102.718 -3.067 . . . . 0.0 102.718 172.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.5 ttt -142.4 140.89 32.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.0 p -129.68 130.66 45.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.3 pt? -116.68 163.62 15.85 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.11 179.53 44.47 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 174.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.2 t -147.62 163.65 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -9.01 25.09 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.508 0.723 . . . . 0.0 109.221 173.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -81.1 -7.7 59.61 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.009 -0.996 . . . . 0.0 113.165 -174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.99 137.07 56.72 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 131.08 36.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.38 -141.48 6.15 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 173.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp-105 -81.57 -58.98 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.582 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.46 102.64 9.8 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.388 -175.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 49.51 -168.71 0.2 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.236 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.3 87.52 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 N-CA-C 107.557 -1.747 . . . . 0.0 107.557 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 121.25 0.7 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-O 117.734 -1.592 . . . . 0.0 109.16 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -115.52 -179.85 3.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.252 1.026 . . . . 0.0 108.963 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.32 -155.81 20.97 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 117.819 -1.545 . . . . 0.0 110.063 -173.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -151.2 157.49 42.71 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.306 1.442 . . . . 0.0 109.629 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.1 131.12 47.18 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 129.239 3.015 . . . . 0.0 104.811 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 115' ' ' VAL . 4.8 mt -136.95 152.31 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -119.61 140.77 50.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.4 1.88 . . . . 0.0 107.078 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.51 -171.15 30.4 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.415 0.531 . . . . 0.0 112.047 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -121.12 149.16 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.815 2.046 . . . . 0.0 108.289 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -107.29 165.13 11.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.633 1.173 . . . . 0.0 110.402 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.14 121.69 0.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 109.394 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 37.9 m-85 -76.45 150.73 36.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.766 -1.209 . . . . 0.0 114.191 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.315 0.0 OUTLIER -140.89 139.02 34.32 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 173.254 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 p -122.11 29.47 7.02 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 129.741 3.216 . . . . 0.0 102.582 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 92' ' ' ARG 0.288 8.9 t70 -158.43 160.21 36.57 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 130.353 3.461 . . . . 0.0 114.004 -172.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.97 178.41 47.54 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 125.007 1.289 . . . . 0.0 115.768 172.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.04 -16.28 53.36 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.093 2.529 . . . . 0.0 110.085 173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -64.76 -66.7 0.51 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.14 -31.2 70.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.289 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -68.4 -59.43 3.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HB3' ' HD2' ' A' ' 37' ' ' LYS 0.258 . . -61.7 -19.41 62.34 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.862 -1.148 . . . . 0.0 113.39 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.339 1.2 pp -91.95 -18.08 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.326 1.421 . . . . 0.0 110.785 172.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.73 2.73 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.021 2.128 . . . . 0.0 112.747 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -50.48 -37.92 41.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.177 1.391 . . . . 0.0 112.157 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -75.55 177.9 6.39 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.64 -0.78 1.34 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 118.777 -2.452 . . . . 0.0 111.632 174.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -93.34 8.24 41.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.373 0.669 . . . . 0.0 109.697 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.84 129.69 36.87 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.2 1.0 . . . . 0.0 108.63 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -99.03 -16.0 18.85 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.466 0.706 . . . . 0.0 111.347 174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -168.39 161.78 12.08 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.757 1.623 . . . . 0.0 108.95 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB1' ' CG1' ' A' ' 45' ' ' VAL . . . -100.8 110.42 22.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.755 2.822 . . . . 0.0 109.469 175.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.7 tp -81.15 94.54 6.66 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.26 131.12 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.1 mm -117.44 142.44 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 m -120.39 101.55 7.86 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 173.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.451 HG13 ' CG2' ' A' ' 85' ' ' ILE . 25.0 t -60.22 156.96 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.026 1.33 . . . . 0.0 109.352 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.26 -49.44 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.8 m -151.25 140.79 21.61 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 120.887 -1.133 . . . . 0.0 111.741 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.12 139.49 49.28 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 128.154 2.582 . . . . 0.0 108.528 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -142.09 163.18 33.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.783 2.033 . . . . 0.0 109.694 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -90.97 142.4 27.82 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 121.206 -0.934 . . . . 0.0 109.89 -175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.17 -58.0 1.07 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.939 2.496 . . . . 0.0 110.92 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.6 pt? . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.294 1.437 . . . . 0.0 110.032 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.516 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.632 ' C ' HD12 ' A' ' 2' ' ' LEU . 4.9 mpp? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 1' ' ' MET . 8.4 mp -135.77 157.82 75.35 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.472 1.109 . . . . 0.0 108.264 -168.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.16 155.81 69.06 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.78 2.32 . . . . 0.0 111.142 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.94 -38.81 93.25 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.16 -38.97 63.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.839 1.256 . . . . 0.0 111.184 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -51.44 -54.23 28.92 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.823 1.192 . . . . 0.0 110.743 173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -56.71 -48.27 78.08 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.27 1.028 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -58.6 -35.23 72.12 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.895 -0.574 . . . . 0.0 112.363 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 68' ' ' LEU . 88.2 t -69.16 -43.5 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.909 1.231 . . . . 0.0 109.369 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -56.05 -43.24 77.68 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.219 1.372 . . . . 0.0 112.176 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -51.99 -21.35 3.02 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.099 0.863 . . . . 0.0 113.284 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -110.83 174.03 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.744 1.618 . . . . 0.0 110.965 -177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -73.35 129.4 37.93 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.43 164.28 34.41 Favored Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.5 145.52 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.1 t -130.57 164.94 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.83 160.45 43.56 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 107.952 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 46' ' ' VAL . 90.4 mt -138.74 119.49 15.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.41 108.9 19.61 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 173.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.573 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.7 m -93.89 114.48 26.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 115.407 -2.235 . . . . 0.0 108.586 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -73.26 129.4 37.96 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 122.836 2.562 . . . . 0.0 107.958 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.85 -76.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 124.609 1.099 . . . . 0.0 110.892 173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -158.66 -48.71 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.71 2.004 . . . . 0.0 108.465 -173.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.77 38.06 0.31 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.295 1.438 . . . . 0.0 111.268 -174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.36 152.33 5.96 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 22.3 Cg_endo -56.2 147.74 64.07 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 CA-C-N 122.25 3.025 . . . . 0.0 107.386 174.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.471 ' CG ' ' HE2' ' A' ' 53' ' ' LYS . 70.0 t60 -111.24 101.42 9.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.343 -172.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.02 88.71 3.54 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.565 1.546 . . . . 0.0 111.649 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.8 m -87.93 168.86 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.861 1.264 . . . . 0.0 110.113 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -119.14 166.66 12.65 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.267 1.394 . . . . 0.0 114.203 -174.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -168.42 171.62 8.95 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.529 1.932 . . . . 0.0 109.636 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.528 ' HE1' HM73 ' A' ' 123' ' ' FMN . 89.9 m95 -121.17 141.84 50.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.444 2.297 . . . . 0.0 110.738 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -53.75 -31.17 47.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.341 0.656 . . . . 0.0 112.412 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -59.38 -12.47 5.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.911 1.684 . . . . 0.0 112.97 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -117.92 -2.78 11.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.392 -1.443 . . . . 0.0 109.805 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 46' ' ' VAL . 10.3 mt -99.48 166.38 11.19 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.076 -1.015 . . . . 0.0 110.17 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -136.77 128.88 29.6 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.52 141.4 18.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.911 1.684 . . . . 0.0 107.581 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.94 -177.9 3.7 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.041 1.736 . . . . 0.0 108.385 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.51 175.21 5.72 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.687 1.195 . . . . 0.0 108.432 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.27 28.19 13.14 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.275 1.893 . . . . 0.0 111.053 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.533 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.335 0.1 OUTLIER 53.27 25.24 4.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.016 2.126 . . . . 0.0 114.537 -178.5 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -73.66 126.71 30.93 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 173.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -114.97 164.89 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.16 144.19 18.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 O-C-N 120.346 -1.471 . . . . 0.0 108.579 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.587 HG22 HD22 ' A' ' 36' ' ' LEU . 58.8 t -130.78 137.46 30.83 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.998 1.719 . . . . 0.0 108.611 -176.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.49 112.32 2.71 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 124.139 3.226 . . . . 0.0 111.663 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -85.4 112.45 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.28 -20.96 5.37 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.657 1.123 . . . . 0.0 113.051 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.86 39.67 0.39 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.775 -1.569 . . . . 0.0 111.293 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 6.3 mtt -112.11 71.48 0.74 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -63.82 -53.79 45.28 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.46 -0.775 . . . . 0.0 111.952 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' HE2' ' CG ' ' A' ' 27' ' ' HIS . 3.9 ttpm? -51.93 -41.43 62.02 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.322 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -62.39 -39.36 92.97 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.03 1.286 . . . . 0.0 111.507 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 34.6 tt0 -55.98 -50.62 70.34 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.22 1.373 . . . . 0.0 109.482 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.2 97.88 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -67.64 -41.73 83.41 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.547 1.139 . . . . 0.0 109.156 -173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.53 -48.07 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.735 1.152 . . . . 0.0 108.047 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.72 31.14 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HE ' ' HB3' ' A' ' 60' ' ' ARG . 5.7 mmm180 -84.05 -46.9 11.5 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.651 1.114 . . . . 0.0 113.872 173.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -151.13 140.88 21.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.03 0.919 . . . . 0.0 111.567 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.78 -23.48 55.92 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.247 -0.908 . . . . 0.0 113.015 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.38 122.43 15.13 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.798 1.181 . . . . 0.0 110.339 -173.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 20' ' ' THR . 22.7 m -139.22 155.97 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 123.43 1.586 . . . . 0.0 111.453 174.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 12.8 tp -106.85 154.51 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 173.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.3 ttt -138.85 137.35 36.49 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 173.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.2 p -131.15 129.12 41.37 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -116.38 173.29 6.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.604 1.093 . . . . 0.0 111.831 174.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.17 178.52 45.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.9 t -151.07 165.59 33.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.054 0.93 . . . . 0.0 109.418 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -98.74 -20.72 16.76 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.344 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -91.76 -6.2 52.27 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.114 1.366 . . . . 0.0 113.904 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.8 t -122.62 131.45 73.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -78.86 131.5 36.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.415 1.086 . . . . 0.0 109.079 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.17 -141.5 11.47 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -85.89 -58.86 2.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.63 102.84 11.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.337 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.48 -178.5 0.66 Allowed Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.452 1.025 . . . . 0.0 113.987 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 85.0 Cg_endo -78.13 81.66 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.311 2.007 . . . . 0.0 109.828 175.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.72 103.79 0.17 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 t -98.68 169.23 9.64 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.739 1.269 . . . . 0.0 110.372 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.6 161.86 30.04 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.663 1.125 . . . . 0.0 111.741 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -134.73 145.44 48.46 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.503 1.921 . . . . 0.0 109.28 -173.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.3 tp -101.01 131.53 46.85 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 128.525 2.73 . . . . 0.0 107.728 173.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 mt -140.36 152.4 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -132.99 148.34 52.27 Favored 'General case' 0 C--O 1.239 0.514 0 O-C-N 121.154 -0.966 . . . . 0.0 108.703 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.43 -168.17 36.16 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 118.847 0.749 . . . . 0.0 112.251 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -118.99 134.53 55.13 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.566 1.147 . . . . 0.0 108.867 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.67 158.76 15.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.556 1.142 . . . . 0.0 108.86 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -158.98 120.75 3.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.678 1.191 . . . . 0.0 108.297 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 29.8 m-85 -74.34 139.65 44.29 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.405 -0.809 . . . . 0.0 112.695 174.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -140.85 141.4 34.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.01 1.324 . . . . 0.0 109.929 173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.1 p -120.67 41.1 3.35 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -159.32 159.55 34.06 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 129.478 3.111 . . . . 0.0 111.013 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.21 178.66 47.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.712 1.625 . . . . 0.0 114.003 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.77 -8.86 20.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.25 2.633 . . . . 0.0 111.059 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -65.53 0.66 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.941 2.497 . . . . 0.0 107.083 173.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -61.28 -31.77 71.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.283 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -72.01 -48.85 41.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.935 0.789 . . . . 0.0 110.527 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.5 67.83 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.55 -1.344 . . . . 0.0 112.568 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.4 pp -90.33 -18.14 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.107 0.867 . . . . 0.0 112.021 173.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.63 -27.95 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.201 1.8 . . . . 0.0 111.685 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -50.56 -22.85 2.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -81.3 178.86 8.13 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 119.554 1.07 . . . . 0.0 110.732 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -135.63 20.44 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 119.904 -1.748 . . . . 0.0 110.025 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -132.45 10.48 4.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.675 1.59 . . . . 0.0 111.284 -174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.0 150.26 32.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.712 -0.618 . . . . 0.0 111.141 -175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -120.74 -21.91 6.49 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 129.139 2.975 . . . . 0.0 112.362 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.33 161.74 1.44 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.779 2.031 . . . . 0.0 110.01 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.89 112.36 24.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 173.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.2 94.62 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 t -78.78 131.29 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.5 mm -121.15 129.13 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.1 m -110.15 90.81 3.42 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 2' ' ' LEU . 94.0 t -61.17 159.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 173.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.37 -56.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 104.0 -2.592 . . . . 0.0 104.0 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.6 m -148.58 141.05 24.29 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.454 0.57 . . . . 0.0 112.115 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.01 143.74 46.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.544 3.138 . . . . 0.0 106.79 173.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.0 145.62 39.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.701 1.6 . . . . 0.0 108.016 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.2 140.05 37.8 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -129.42 -58.41 1.12 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.252 1.227 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.063 -173.499 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.528 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.24 154.26 71.53 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 119.127 0.876 . . . . 0.0 108.877 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.06 164.65 34.99 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.443 2.095 . . . . 0.0 110.879 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.29 -47.12 92.37 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 173.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.326 9.0 m -53.08 -38.56 62.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.648 1.179 . . . . 0.0 113.092 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -51.52 -58.56 5.96 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.0 1.273 . . . . 0.0 108.497 172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -55.24 -48.25 74.21 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 117.536 -1.221 . . . . 0.0 111.856 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -53.99 -40.89 67.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.924 1.238 . . . . 0.0 111.009 178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.7 t -68.85 -43.61 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 120.933 -1.105 . . . . 0.0 108.854 175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.77 -36.35 72.02 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.257 1.389 . . . . 0.0 111.359 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -33.42 42.45 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 118.451 -2.655 . . . . 0.0 113.022 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -98.92 158.77 15.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 122.204 1.002 . . . . 0.0 110.928 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.29 141.13 41.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.44 175.09 47.41 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.5 t -86.13 144.76 8.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 125.143 1.377 . . . . 0.0 107.585 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.76 159.27 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.62 152.1 38.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.387 1.475 . . . . 0.0 107.289 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 46' ' ' VAL . 6.9 mt -138.99 117.94 13.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.5 19.61 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.555 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -89.03 110.83 21.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -73.95 141.81 45.92 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 122.11 2.232 . . . . 0.0 107.204 173.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.25 -81.8 0.26 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -159.63 -61.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -81.55 38.72 0.51 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.189 2.196 . . . . 0.0 110.165 173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.57 151.58 23.52 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.04 -1.037 . . . . 0.0 113.761 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.88 158.32 46.52 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.269 1.979 . . . . 0.0 112.918 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.32 101.86 7.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.107 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 10.9 tp -74.01 88.8 1.9 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.19 0.904 . . . . 0.0 110.666 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.86 170.97 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.986 1.315 . . . . 0.0 110.352 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.41 165.21 14.62 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.868 1.267 . . . . 0.0 111.172 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -168.41 172.31 8.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.7 2.0 . . . . 0.0 107.978 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.619 ' HE1' HM73 ' A' ' 123' ' ' FMN . 80.6 m95 -121.22 141.66 50.66 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.319 1.448 . . . . 0.0 110.235 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -51.2 -28.32 11.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.4 0.68 . . . . 0.0 111.104 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.41 -14.87 8.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.859 2.464 . . . . 0.0 111.751 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -118.13 -5.21 10.94 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.995 1.718 . . . . 0.0 109.686 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 46' ' ' VAL . 31.6 mt -97.32 171.64 8.29 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 120.332 -1.48 . . . . 0.0 112.882 -173.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 10.4 ptmt -136.08 135.87 39.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.55 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.4 mt -121.24 -178.18 3.71 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.073 1.749 . . . . 0.0 107.491 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -75.55 176.98 7.09 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.79 0.836 . . . . 0.0 109.264 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.02 30.25 69.74 Favored Glycine 0 CA--C 1.525 0.698 0 O-C-N 120.475 -1.391 . . . . 0.0 110.831 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 p30 53.84 12.88 0.46 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 130.864 3.665 . . . . 0.0 114.868 -173.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -74.8 122.44 23.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.9 mm -114.02 155.57 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 112' ' ' VAL . 41.0 t -137.46 140.54 41.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -174.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 18' ' ' ILE . 58.7 t -122.22 138.99 29.78 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 127.476 2.31 . . . . 0.0 108.778 -173.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.5 108.02 1.45 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.677 1.585 . . . . 0.0 109.589 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.729 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.87 111.81 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 172.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.35 -21.59 5.12 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 118.677 -1.068 . . . . 0.0 113.133 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 41.38 0.34 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.559 ' HB2' HG23 ' A' ' 48' ' ' VAL . 8.6 mtt -108.78 71.23 0.77 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 173.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -64.03 -63.11 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 129.817 3.247 . . . . 0.0 112.666 -173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -51.8 -40.75 60.94 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 121.665 -0.647 . . . . 0.0 109.351 173.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.2 m -62.92 -38.86 92.66 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.496 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -58.45 -50.42 73.78 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 120.611 1.55 . . . . 0.0 109.683 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.29 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 122.201 -0.312 . . . . 0.0 111.375 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -62.73 -41.8 99.35 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.044 -1.455 . . . . 0.0 110.336 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -63.69 -47.98 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 120.192 1.36 . . . . 0.0 108.542 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.93 -23.63 13.55 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 173.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -87.44 -46.55 9.52 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.25 -1.531 . . . . 0.0 114.127 173.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -151.26 137.11 18.08 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.532 1.133 . . . . 0.0 112.656 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -22.48 54.34 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.67 126.57 27.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.697 1.589 . . . . 0.0 111.017 -173.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.6 m -139.07 144.06 30.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.38 1.086 . . . . 0.0 111.941 173.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.7 tp -91.75 150.36 21.14 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 16.8 ttt -139.17 120.8 15.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.7 p -108.82 127.97 54.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 pp -116.95 163.27 16.46 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 119.641 1.109 . . . . 0.0 109.229 173.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.05 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.5 t -158.1 166.91 31.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -99.02 -9.37 24.03 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -9.42 59.04 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.967 -1.016 . . . . 0.0 111.888 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.12 141.57 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.93 131.08 36.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.866 0.867 . . . . 0.0 110.437 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.38 5.9 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 125.575 1.56 . . . . 0.0 111.253 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.3 mmt-85 -84.08 -58.76 2.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.45 102.58 9.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.8 -168.07 0.16 Allowed Glycine 0 CA--C 1.543 1.813 0 O-C-N 120.47 -1.394 . . . . 0.0 112.18 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.49 89.73 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 108.014 -1.571 . . . . 0.0 108.014 173.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.74 121.32 0.7 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-O 117.231 -1.872 . . . . 0.0 109.391 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.08 169.75 9.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.624 1.712 . . . . 0.0 110.906 175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.62 -176.18 43.65 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 123.381 0.515 . . . . 0.0 112.576 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.4 145.68 49.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.127 2.171 . . . . 0.0 109.348 -174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.0 131.03 47.07 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.0 159.51 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -125.92 149.29 48.84 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.653 1.581 . . . . 0.0 107.782 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.84 -176.22 36.33 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 123.76 0.695 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.1 m -120.35 129.12 53.83 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.944 1.697 . . . . 0.0 108.102 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.23 160.23 14.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.871 1.668 . . . . 0.0 112.288 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.14 120.91 3.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.82 1.248 . . . . 0.0 108.678 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.71 144.48 39.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -140.84 138.28 33.87 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.148 1.379 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.3 p -120.87 40.93 3.42 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -159.17 157.18 30.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 128.754 2.821 . . . . 0.0 111.317 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.77 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.899 1.238 . . . . 0.0 114.538 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.79 -8.67 22.05 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.329 2.686 . . . . 0.0 110.687 173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' CD ' ' HZ3' ' A' ' 37' ' ' LYS . 24.7 mm-40 -70.72 -63.18 1.14 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.747 1.619 . . . . 0.0 108.15 173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.13 -31.81 71.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.436 -0.793 . . . . 0.0 111.245 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -73.45 -48.43 33.68 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.915 0.779 . . . . 0.0 111.346 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.78 -25.16 66.33 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.003 -1.685 . . . . 0.0 112.12 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.377 1.2 pp -89.51 -18.22 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 119.855 1.207 . . . . 0.0 110.844 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.7 -27.52 2.95 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.048 2.539 . . . . 0.0 110.687 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.9 ptt-85 -49.02 -37.21 19.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.073 0.949 . . . . 0.0 110.543 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -80.62 178.0 8.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.44 -0.56 1.39 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 117.979 -2.95 . . . . 0.0 111.864 173.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -87.56 8.33 25.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.914 1.286 . . . . 0.0 111.127 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.64 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.914 1.286 . . . . 0.0 111.962 -173.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 -21.97 6.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 128.47 2.708 . . . . 0.0 111.119 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -177.27 162.03 1.89 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.203 1.801 . . . . 0.0 110.445 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.42 104.6 14.71 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 172.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.69 94.02 5.01 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.099 1.759 . . . . 0.0 107.079 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 45' ' ' VAL . 48.7 t -80.0 127.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.39 128.97 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.6 m -100.15 100.5 11.35 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.4 158.46 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.984 0.897 . . . . 0.0 109.304 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.57 -56.88 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.1 m -140.92 124.78 17.09 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 119.215 -0.421 . . . . 0.0 111.432 -174.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.5 149.57 41.07 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.36 2.664 . . . . 0.0 111.176 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -141.68 144.66 34.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.134 1.774 . . . . 0.0 108.232 173.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -74.01 140.51 45.5 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -136.86 -77.61 0.41 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.255 1.364 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 -173.244 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.619 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.09 153.46 34.98 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.82 164.73 31.36 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.238 2.625 . . . . 0.0 111.877 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.92 96.58 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -55.7 -39.5 71.12 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.232 1.413 . . . . 0.0 110.446 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -51.06 -57.09 9.56 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.974 0.806 . . . . 0.0 110.017 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -58.83 -48.7 80.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.049 -0.5 . . . . 0.0 109.834 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -59.21 -41.16 87.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.08 -39.49 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.634 1.106 . . . . 0.0 109.107 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -58.55 -44.92 89.82 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.837 1.198 . . . . 0.0 111.251 173.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -51.99 -21.31 2.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -106.91 178.47 4.55 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 125.495 1.518 . . . . 0.0 110.983 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -73.55 129.43 37.96 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.15 167.16 33.81 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.01 146.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 173.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 t -130.52 159.8 42.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HB1' HD11 ' A' ' 28' ' ' LEU . . . -144.54 160.01 41.84 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.612 1.165 . . . . 0.0 108.999 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 80.3 mt -139.24 120.44 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -93.14 108.44 20.04 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 173.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.58 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.2 m -89.84 116.35 27.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 116.873 -1.536 . . . . 0.0 107.048 -173.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -73.42 135.81 44.23 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 121.582 1.992 . . . . 0.0 106.394 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.66 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -159.2 -59.33 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 15.9 p-10 -78.83 39.21 0.35 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.35 2.66 . . . . 0.0 111.429 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.34 151.47 21.01 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.238 0.923 . . . . 0.0 111.053 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.08 149.08 89.59 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 CA-C-N 118.335 1.068 . . . . 0.0 109.986 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.428 ' CD2' ' HE3' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -115.43 99.71 7.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.633 1.573 . . . . 0.0 110.641 -173.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD11 ' HB1' ' A' ' 17' ' ' ALA . 8.1 tp -82.13 103.54 11.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.129 0.972 . . . . 0.0 110.406 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.15 168.65 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.675 1.59 . . . . 0.0 110.868 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 10.0 m120 -126.63 164.13 21.94 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -168.41 172.46 8.32 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.248 1.819 . . . . 0.0 110.242 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.457 ' NE1' HM73 ' A' ' 123' ' ' FMN . 96.2 m95 -121.37 141.77 50.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.913 2.485 . . . . 0.0 108.809 -178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.87 -30.38 45.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.57 0.623 . . . . 0.0 111.695 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -57.72 -13.72 4.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.576 1.95 . . . . 0.0 113.145 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -118.3 -2.47 11.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.793 1.237 . . . . 0.0 110.194 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 46' ' ' VAL . 17.4 mt -101.07 168.1 9.81 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.589 1.086 . . . . 0.0 111.82 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -136.87 128.76 29.18 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -101.3 142.95 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.0 mt -121.06 -178.61 3.8 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.39 1.876 . . . . 0.0 106.183 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -73.71 -178.81 3.31 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.77 29.18 66.84 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 120.392 -1.443 . . . . 0.0 110.423 -176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 p30 54.1 13.2 0.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 129.209 3.004 . . . . 0.0 115.155 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -73.18 141.73 47.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.361 0.982 . . . . 0.0 110.58 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.87 154.94 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.36 143.98 24.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 36' ' ' LEU . 61.9 t -126.94 134.38 26.05 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 126.649 1.98 . . . . 0.0 107.419 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.18 118.03 4.83 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.875 2.383 . . . . 0.0 107.651 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 109' ' ' ALA . 2.6 p -79.34 111.5 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 119.348 0.976 . . . . 0.0 108.999 173.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.94 -21.68 9.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.24 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.66 18.87 0.3 Allowed Glycine 0 C--N 1.345 1.077 0 CA-C-N 120.467 2.134 . . . . 0.0 114.386 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.433 ' HB2' HG23 ' A' ' 48' ' ' VAL . 29.9 mtt -97.96 52.24 1.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.77 1.285 . . . . 0.0 108.176 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -64.0 -51.55 63.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.368 0.667 . . . . 0.0 111.6 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HE3' ' CD2' ' A' ' 27' ' ' HIS 0.285 17.5 ttpp -52.19 -41.16 62.42 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 120.325 -1.484 . . . . 0.0 110.839 173.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 57' ' ' ASN 0.27 1.6 m -60.35 -38.42 83.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.143 1.338 . . . . 0.0 113.026 173.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -55.39 -45.14 76.63 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.826 1.25 . . . . 0.0 107.829 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.31 81.07 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.958 -0.464 . . . . 0.0 111.647 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 54' ' ' THR . 3.8 m120 -59.6 -41.73 90.98 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 117.367 -1.301 . . . . 0.0 109.904 178.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.33 -48.24 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 120.122 1.328 . . . . 0.0 108.917 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.68 -25.98 12.49 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -46.44 10.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 173.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -151.5 134.08 15.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.991 1.268 . . . . 0.0 111.072 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -19.77 57.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.449 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.61 130.63 46.8 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.274 1.397 . . . . 0.0 110.92 -177.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.8 m -142.32 155.86 18.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 123.797 1.76 . . . . 0.0 112.99 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.9 tp -101.17 151.16 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.6 ttt -139.24 141.48 37.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 p -129.7 140.69 51.06 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -116.91 163.97 15.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 173.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.93 178.66 46.61 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.2 t -151.24 169.36 22.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -98.87 -18.36 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.55 1.54 . . . . 0.0 108.964 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -91.81 -1.46 57.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 117.073 -1.442 . . . . 0.0 113.938 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.8 t -130.99 127.03 60.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.32 131.42 36.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.023 0.929 . . . . 0.0 109.149 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.97 -141.12 6.46 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -79.17 -59.02 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.733 1.613 . . . . 0.0 109.434 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.65 102.99 14.06 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.5 -169.4 2.21 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.84 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 69.7 Cg_endo -77.86 69.39 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.456 2.104 . . . . 0.0 110.412 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.49 108.37 0.32 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -101.88 169.57 8.7 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.06 172.55 45.48 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.457 1.031 . . . . 0.0 114.472 -174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.09 151.25 51.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.215 1.406 . . . . 0.0 110.248 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -100.9 131.5 46.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 128.838 2.855 . . . . 0.0 104.464 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 68' ' ' LEU . 12.8 mt -135.59 153.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.1 mtt-85 -132.97 135.78 45.7 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.58 -168.61 36.22 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.805 1.184 . . . . 0.0 112.182 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 m -121.23 148.21 44.58 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.729 0.812 . . . . 0.0 109.285 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -104.2 162.18 13.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.905 1.682 . . . . 0.0 110.669 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.3 113.07 2.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.536 1.134 . . . . 0.0 109.64 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 111' ' ' LEU . 8.5 m-85 -74.17 134.24 42.78 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -141.14 141.06 34.19 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.5 0.72 . . . . 0.0 111.287 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.1 p -116.58 41.1 2.75 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.55 154.14 26.16 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 127.588 2.355 . . . . 0.0 110.466 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.1 178.67 47.3 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.854 1.692 . . . . 0.0 114.146 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.94 -9.42 19.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.709 2.939 . . . . 0.0 111.491 173.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -67.34 -64.8 0.78 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.402 1.481 . . . . 0.0 107.253 173.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -61.54 -31.4 71.43 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.485 1.114 . . . . 0.0 111.486 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.71 -56.07 9.32 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 119.304 0.956 . . . . 0.0 109.234 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.6 -27.66 68.8 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.966 -1.084 . . . . 0.0 112.195 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.334 1.1 pp -85.89 -18.17 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.754 1.161 . . . . 0.0 111.869 173.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.68 -27.97 3.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.663 1.585 . . . . 0.0 112.062 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -50.53 -21.89 1.71 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.486 1.114 . . . . 0.0 113.827 173.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -80.91 178.66 8.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.706 1.139 . . . . 0.0 110.702 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -133.6 11.12 4.06 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.077 -1.639 . . . . 0.0 111.517 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -138.1 8.99 2.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.848 1.259 . . . . 0.0 112.968 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 151.84 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.307 1.043 . . . . 0.0 111.116 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -111.72 -21.93 11.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.392 1.077 . . . . 0.0 110.342 174.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 48' ' ' VAL . . . -178.19 161.96 1.52 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 127.718 2.407 . . . . 0.0 109.206 -173.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.43 105.97 18.05 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 91' ' ' PHE . 7.7 tp -79.63 92.82 5.4 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 173.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.6 t -83.35 129.76 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.092 1.357 . . . . 0.0 107.666 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.404 HD12 HG21 ' A' ' 64' ' ' VAL . 36.6 mm -117.28 133.7 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 19.1 m -112.02 97.28 6.56 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.53 161.26 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 125.464 1.506 . . . . 0.0 110.361 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.69 -55.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 173.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.2 m -151.54 141.46 22.02 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.832 -1.167 . . . . 0.0 112.476 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.1 138.74 48.34 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.938 2.895 . . . . 0.0 106.599 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -140.08 137.42 34.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.185 1.794 . . . . 0.0 107.749 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -77.15 141.16 40.28 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.6 p -129.64 -58.62 1.1 Allowed 'General case' 0 C--O 1.236 0.372 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.739 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.457 HM73 ' NE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' C ' HD12 ' A' ' 2' ' ' LEU . 4.9 mpp? . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.5 HD13 ' CB ' ' A' ' 42' ' ' ASN . 8.1 mp -130.68 154.2 81.72 Favored Pre-proline 0 N--CA 1.465 0.302 0 C-N-CA 124.764 1.225 . . . . 0.0 108.748 -171.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.09 154.63 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.713 2.275 . . . . 0.0 110.049 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.79 92.87 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -49.58 -38.57 31.9 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.682 1.593 . . . . 0.0 112.21 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -50.53 -54.75 20.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.226 1.375 . . . . 0.0 109.729 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -61.09 -48.54 81.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.516 1.126 . . . . 0.0 109.117 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -60.75 -34.14 74.0 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.1 t -72.71 -42.54 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.65 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.82 -39.75 82.13 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 120.437 1.471 . . . . 0.0 112.596 173.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -51.88 -24.99 7.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.965 0.802 . . . . 0.0 112.546 173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -99.85 159.2 15.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.865 0.866 . . . . 0.0 109.402 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.56 146.12 45.01 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.335 -0.853 . . . . 0.0 109.078 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -179.27 171.23 43.1 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.551 HG23 HH12 ' A' ' 71' ' ' ARG . 6.6 t -101.63 148.53 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.532 HG22 ' HA ' ' A' ' 68' ' ' LEU . 6.0 t -124.61 158.44 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 128.544 2.738 . . . . 0.0 104.771 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 28' ' ' LEU . . . -139.58 153.61 47.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 46' ' ' VAL . 7.4 mt -139.2 116.82 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.0 108.43 19.58 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.536 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -89.35 109.22 20.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 116.035 -1.935 . . . . 0.0 106.662 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -73.74 141.74 46.31 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 122.015 2.189 . . . . 0.0 107.754 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.52 -59.04 0.16 Allowed Glycine 0 C--O 1.223 -0.562 0 C-N-CA 123.56 0.6 . . . . 0.0 111.807 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HB3' HH21 ' A' ' 60' ' ' ARG . 4.2 tm-20 168.51 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 129.491 3.117 . . . . 0.0 107.856 -177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.7 46.98 0.7 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 123.819 1.771 . . . . 0.0 110.173 177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.8 150.96 5.47 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.478 1.99 . . . . 0.0 111.36 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.37 162.44 38.34 Favored 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 120.463 0.775 . . . . 0.0 110.693 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -120.94 101.75 7.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 118.569 -0.729 . . . . 0.0 109.443 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 17' ' ' ALA . 10.0 tp -74.05 88.79 1.91 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.308 0.504 . . . . 0.0 110.541 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.39 169.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.719 1.208 . . . . 0.0 110.297 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -120.79 167.94 11.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.757 1.223 . . . . 0.0 111.333 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.25 170.23 10.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.549 1.94 . . . . 0.0 108.089 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.471 ' HE1' HM73 ' A' ' 123' ' ' FMN . 78.5 m95 -116.78 141.63 47.96 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.637 1.975 . . . . 0.0 109.338 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -55.17 -30.7 60.4 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -51.16 -21.05 1.76 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.174 2.589 . . . . 0.0 113.401 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -118.17 -4.33 10.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.207 1.403 . . . . 0.0 112.208 -173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 HG22 ' A' ' 46' ' ' VAL . 53.5 mt -97.08 166.83 11.4 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.036 1.289 . . . . 0.0 112.024 -174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -136.52 132.45 35.28 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -101.41 142.58 15.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 105.061 -2.199 . . . . 0.0 105.061 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.22 179.18 4.49 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.411 1.484 . . . . 0.0 108.274 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -70.33 174.81 5.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.194 0.998 . . . . 0.0 109.797 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.29 33.99 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.742 1.639 . . . . 0.0 110.928 -173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.5 ' CB ' HD13 ' A' ' 2' ' ' LEU 0.277 0.1 OUTLIER 53.49 19.87 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.893 2.077 . . . . 0.0 114.694 -176.833 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -74.69 135.79 41.87 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 mm -124.92 161.12 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.5 t -144.64 145.46 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 O-C-N 120.674 -1.266 . . . . 0.0 108.379 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 HD22 ' A' ' 36' ' ' LEU . 59.3 t -129.21 137.53 31.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.605 2.762 . . . . 0.0 107.126 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -83.34 108.47 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.898 2.398 . . . . 0.0 111.066 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.85 111.87 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 124.62 1.168 . . . . 0.0 108.853 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.94 -21.83 4.81 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.555 1.074 . . . . 0.0 112.605 173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.71 41.13 0.43 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 118.089 -1.395 . . . . 0.0 110.135 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.491 ' HB2' HG23 ' A' ' 48' ' ' VAL . 18.4 mtt -108.65 71.48 0.79 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.149 1.379 . . . . 0.0 107.532 174.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -64.21 -65.33 0.69 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 130.284 3.433 . . . . 0.0 114.444 -173.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -51.7 -40.29 59.86 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 119.245 0.93 . . . . 0.0 108.602 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -63.14 -39.58 95.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.209 -0.9 . . . . 0.0 112.984 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 22.2 tt0 -58.59 -51.04 71.59 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 120.654 1.57 . . . . 0.0 109.623 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.59 -48.02 83.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.503 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -61.02 -41.97 97.57 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 116.197 -1.858 . . . . 0.0 111.311 -173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -48.09 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 120.248 1.385 . . . . 0.0 108.845 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.26 54.15 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.066 -0.969 . . . . 0.0 113.234 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.441 HH21 ' HB3' ' A' ' 23' ' ' GLU . 14.4 mtp180 -87.51 -46.91 9.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.027 1.285 . . . . 0.0 113.675 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -142.56 128.93 20.03 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 122.291 1.044 . . . . 0.0 111.802 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -18.86 58.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.65 126.48 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.389 1.45 . . . . 0.0 111.176 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.3 m -138.81 141.47 36.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 122.997 1.38 . . . . 0.0 112.584 173.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 3.5 tp -89.59 154.24 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 15.1 ttt -140.25 141.23 35.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.0 p -124.97 135.88 53.21 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.532 ' HA ' HG22 ' A' ' 16' ' ' VAL . 1.7 pp -116.47 164.64 14.27 Favored 'General case' 0 CA--C 1.509 -0.606 0 O-C-N 121.364 -0.835 . . . . 0.0 109.007 173.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.67 178.78 41.94 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 38.5 t -147.29 174.11 11.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.945 1.298 . . . . 0.0 108.948 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.551 HH12 HG23 ' A' ' 15' ' ' VAL . 69.6 mtt85 -117.01 -8.03 11.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.425 2.29 . . . . 0.0 109.797 174.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 mmpm? -91.64 -11.08 38.08 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 119.482 -2.011 . . . . 0.0 115.304 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.37 133.1 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.21 131.48 36.21 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.29 1.036 . . . . 0.0 111.403 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.89 -141.19 6.95 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.463 HH22 ' CD ' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -85.9 -59.23 2.36 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.212 1.405 . . . . 0.0 107.607 176.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.49 102.95 6.24 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.82 -168.94 1.83 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-O 121.608 0.56 . . . . 0.0 112.964 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 62.4 Cg_endo -78.0 58.98 6.76 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.612 2.208 . . . . 0.0 110.87 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.55 120.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 t -113.72 168.95 9.35 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 117.777 0.789 . . . . 0.0 110.222 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.7 -176.72 40.23 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 124.703 1.144 . . . . 0.0 113.2 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.76 153.6 45.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.576 1.15 . . . . 0.0 109.662 -173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.52 129.53 47.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.8 mp -139.98 161.46 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 108.602 -173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.417 HH22 ' CD ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -139.15 151.06 46.33 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.605 -1.31 . . . . 0.0 107.905 173.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.13 -174.94 33.62 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.053 0.835 . . . . 0.0 111.782 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -115.93 129.34 56.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.245 1.418 . . . . 0.0 108.161 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.01 14.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.017 1.327 . . . . 0.0 112.162 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.01 120.68 3.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.767 1.227 . . . . 0.0 108.926 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.2 m-85 -76.73 140.58 40.87 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -140.8 139.24 34.51 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.672 1.189 . . . . 0.0 111.249 173.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -121.21 39.84 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 103.236 -2.875 . . . . 0.0 103.236 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.253 7.5 t70 -158.87 150.19 20.5 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 128.951 2.9 . . . . 0.0 111.55 -172.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.04 179.03 47.33 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.35 0.976 . . . . 0.0 114.183 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.42 -9.54 13.42 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.046 3.164 . . . . 0.0 112.179 173.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -67.66 -67.61 0.45 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.584 1.953 . . . . 0.0 106.943 173.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -61.45 -31.62 71.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.813 0.845 . . . . 0.0 111.925 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -68.71 -54.07 18.33 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.57 -32.56 72.66 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.099 -1.001 . . . . 0.0 112.567 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.403 1.1 pp -79.08 -17.84 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 119.017 0.826 . . . . 0.0 112.612 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.1 -27.69 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.063 1.345 . . . . 0.0 111.367 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -45.67 -27.95 0.9 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.822 1.249 . . . . 0.0 112.975 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -81.06 178.88 8.14 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 124.306 1.042 . . . . 0.0 110.689 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -140.48 21.04 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 119.812 -1.805 . . . . 0.0 111.002 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -136.97 8.77 3.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.246 1.418 . . . . 0.0 111.117 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.22 25.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.68 -0.637 . . . . 0.0 110.664 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.75 -21.05 8.01 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.173 2.189 . . . . 0.0 111.282 174.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.785 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.58 161.57 11.56 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.948 1.299 . . . . 0.0 109.772 -174.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.88 104.38 14.63 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.73 93.64 4.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -78.91 131.44 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.05 128.28 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 24.7 m -99.21 90.43 4.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 2' ' ' LEU . 77.7 t -60.6 159.38 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 175.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.4 t -118.66 -57.1 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.0 m -148.93 141.09 23.96 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.209 0.459 . . . . 0.0 112.038 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.91 138.88 53.89 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.306 3.042 . . . . 0.0 109.485 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.417 ' CD ' HH22 ' A' ' 86' ' ' ARG . 17.7 pm0 -140.68 151.31 44.46 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.779 0.832 . . . . 0.0 110.874 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' HH22 ' A' ' 76' ' ' ARG . 0.0 OUTLIER -65.77 138.12 57.72 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 125.036 1.334 . . . . 0.0 109.944 -175.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -138.45 -81.31 0.32 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.432 0.458 . . . . 0.0 110.836 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.456 ' C ' HH21 ' A' ' 76' ' ' ARG . 2.1 pp . . . . . 0 C--O 1.242 0.665 0 C-N-CA 123.955 0.902 . . . . 0.0 110.43 -174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.471 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' C ' HD12 ' A' ' 2' ' ' LEU . 5.1 mpp? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.569 HD11 ' CG1' ' A' ' 115' ' ' VAL . 9.5 mp -128.11 152.18 77.25 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 124.547 1.139 . . . . 0.0 108.197 -173.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.47 156.28 58.48 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.291 1.994 . . . . 0.0 110.321 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.83 -38.77 92.89 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.49 -38.68 55.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.838 1.655 . . . . 0.0 112.234 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -50.79 -54.23 25.31 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.337 1.426 . . . . 0.0 109.401 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.86 -48.58 76.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.515 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -60.26 -33.78 72.79 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.346 0.975 . . . . 0.0 112.482 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.05 -41.03 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.484 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -39.77 85.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.88 1.218 . . . . 0.0 112.047 173.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.72 -24.85 6.32 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.975 1.261 . . . . 0.0 112.433 173.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -101.48 158.6 15.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.94 0.791 . . . . 0.0 109.287 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -74.22 148.68 41.36 Favored 'General case' 0 C--O 1.243 0.741 0 O-C-N 121.074 -1.016 . . . . 0.0 109.818 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -178.19 168.23 39.37 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 122.852 0.263 . . . . 0.0 112.724 -174.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -101.08 144.53 12.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.33 159.98 42.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 127.752 2.421 . . . . 0.0 105.607 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.16 157.32 45.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.32 1.048 . . . . 0.0 109.531 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.7 118.7 12.35 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 125.232 1.413 . . . . 0.0 107.71 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.92 108.78 19.74 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.3 m -88.79 109.42 20.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -73.53 141.23 46.73 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.42 -81.63 0.22 Allowed Glycine 0 C--O 1.221 -0.714 0 N-CA-C 106.007 -2.837 . . . . 0.0 106.007 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -170.69 -59.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -78.92 52.12 1.21 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 123.497 1.618 . . . . 0.0 110.201 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.57 144.94 3.93 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.83 2.157 . . . . 0.0 111.551 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.92 161.29 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.362 1.374 . . . . 0.0 109.983 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.12 97.46 5.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.976 1.71 . . . . 0.0 107.462 -173.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 11.0 tp -83.55 88.55 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.8 0.727 . . . . 0.0 109.322 -178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.23 169.04 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.013 0.925 . . . . 0.0 110.293 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -118.81 167.61 11.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.235 1.414 . . . . 0.0 112.856 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 t -168.35 174.61 6.89 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.627 1.971 . . . . 0.0 108.021 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.451 ' NE1' HM73 ' A' ' 123' ' ' FMN . 83.4 m95 -120.56 141.99 49.77 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 127.702 2.401 . . . . 0.0 109.463 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -53.88 -30.75 47.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.334 0.97 . . . . 0.0 109.737 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -52.15 -21.16 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.535 2.334 . . . . 0.0 112.671 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.7 m-30 -118.12 -5.12 10.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.921 1.688 . . . . 0.0 112.108 -173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 69.7 mt -87.8 159.22 18.52 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.506 1.503 . . . . 0.0 111.588 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 100' ' ' ALA 0.25 0.0 OUTLIER -136.36 131.85 34.79 Favored 'General case' 0 C--N 1.338 0.097 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.802 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -101.18 147.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.57 178.89 4.64 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.397 1.879 . . . . 0.0 107.725 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -71.28 175.86 5.03 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.107 0.963 . . . . 0.0 110.47 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 56.87 28.43 57.57 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.333 1.444 . . . . 0.0 111.476 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.518 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.272 0.1 OUTLIER 53.72 20.73 2.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.415 1.886 . . . . 0.0 114.375 -175.239 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -73.97 126.31 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.152 1.381 . . . . 0.0 107.373 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.66 159.17 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 -176.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -146.0 144.28 20.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 120.536 -1.353 . . . . 0.0 109.262 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.92 136.54 28.59 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.925 2.09 . . . . 0.0 107.534 -173.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.69 108.32 1.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.455 2.104 . . . . 0.0 109.039 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.49 111.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.19 -21.33 10.11 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.338 1.447 . . . . 0.0 113.255 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.92 0.31 Allowed Glycine 0 C--N 1.339 0.729 0 CA-C-N 119.305 1.553 . . . . 0.0 115.09 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -97.89 67.94 1.99 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 123.394 1.568 . . . . 0.0 108.353 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -64.21 -48.79 74.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.193 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.255 81.8 tttt -52.04 -36.29 49.87 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.794 1.633 . . . . 0.0 110.674 173.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -64.86 -39.51 93.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 120.429 1.468 . . . . 0.0 110.705 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 91' ' ' PHE . 32.3 tt0 -55.08 -50.73 68.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.507 1.503 . . . . 0.0 110.631 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.23 -49.1 79.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.131 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -58.52 -41.99 86.72 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 115.781 -2.057 . . . . 0.0 111.45 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.16 -48.36 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 119.874 1.216 . . . . 0.0 109.116 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.59 -28.94 66.05 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 118.267 -0.873 . . . . 0.0 113.277 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -87.44 -47.06 9.07 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.662 1.119 . . . . 0.0 112.48 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -140.04 132.31 28.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.65 1.18 . . . . 0.0 112.325 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -75.97 -22.52 55.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.452 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.51 129.65 42.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.896 1.225 . . . . 0.0 112.47 -173.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 20' ' ' THR . 10.4 m -139.29 139.4 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 122.837 1.303 . . . . 0.0 112.336 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 20.2 tp -92.98 153.7 18.59 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 172.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.6 ttt -140.03 141.37 36.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -123.17 130.62 53.0 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 pp -115.35 166.19 12.14 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 119.617 1.098 . . . . 0.0 108.38 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.63 179.11 41.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 173.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.443 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 47.2 t -147.18 168.67 21.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.687 1.595 . . . . 0.0 108.157 174.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -116.42 -9.41 11.48 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.014 1.326 . . . . 0.0 109.87 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmpm? -92.38 -11.67 34.3 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 173.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.8 t -118.44 134.19 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 118.5 20.66 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.941 0.791 . . . . 0.0 112.33 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 81' ' ' THR . . . -121.5 -127.26 3.37 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.91 1.243 . . . . 0.0 111.704 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -91.68 -58.7 2.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -74.62 102.63 4.64 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 109.875 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.55 -167.9 0.4 Allowed Glycine 0 CA--C 1.537 1.452 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.27 62.85 5.25 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.72 121.88 1.39 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 129.73 3.538 . . . . 0.0 106.83 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.415 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 3.5 t -109.98 176.82 4.92 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.132 0.966 . . . . 0.0 110.699 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.52 177.41 44.38 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 124.839 1.209 . . . . 0.0 112.158 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -138.4 154.65 48.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.149 0.979 . . . . 0.0 108.369 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.27 129.3 47.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.46 154.04 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 119' ' ' GLU . 36.7 mtm180 -135.89 141.64 44.61 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.882 1.273 . . . . 0.0 108.618 -176.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -169.81 34.94 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.412 0.53 . . . . 0.0 112.238 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.8 m -121.11 151.1 40.27 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.959 1.303 . . . . 0.0 109.074 173.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.32 163.64 13.45 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.625 1.17 . . . . 0.0 113.017 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.59 121.19 3.28 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.103 1.361 . . . . 0.0 109.377 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 55' ' ' GLU . 3.5 m-85 -77.55 149.07 34.93 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.231 -0.918 . . . . 0.0 111.989 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -141.03 134.42 29.78 Favored 'General case' 0 CA--C 1.523 -0.068 0 C-N-CA 125.339 1.456 . . . . 0.0 107.709 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.0 p -120.42 20.17 11.93 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.597 173.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.75 150.1 20.65 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 127.698 2.399 . . . . 0.0 109.583 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.59 -177.83 45.45 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.917 1.246 . . . . 0.0 112.507 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.26 -14.27 19.26 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.133 3.222 . . . . 0.0 113.524 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.3 -63.72 1.01 Allowed 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.101 -0.999 . . . . 0.0 108.978 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -61.64 -31.62 71.73 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.448 1.499 . . . . 0.0 111.079 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -69.12 -49.66 55.01 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.438 0.695 . . . . 0.0 109.636 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -61.13 -35.39 76.94 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.146 -0.971 . . . . 0.0 111.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.402 0.8 OUTLIER -79.02 -17.89 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.533 -0.746 . . . . 0.0 112.736 173.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.2 -27.58 2.5 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.691 1.996 . . . . 0.0 112.22 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -47.65 -36.38 10.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.305 1.042 . . . . 0.0 111.205 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -80.89 177.95 8.72 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.308 0.958 . . . . 0.0 108.537 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -141.14 -0.6 1.44 Allowed 'General case' 0 C--O 1.222 -0.393 0 O-C-N 119.18 -2.2 . . . . 0.0 112.262 -176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -106.3 8.87 32.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.032 1.733 . . . . 0.0 110.873 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -82.41 145.75 29.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.389 -0.819 . . . . 0.0 110.869 -174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -121.29 -13.71 8.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.864 2.866 . . . . 0.0 111.913 -174.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -173.78 161.71 3.89 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.143 2.177 . . . . 0.0 109.536 177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.17 101.97 11.42 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.386 2.275 . . . . 0.0 105.012 173.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.07 95.91 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.672 1.589 . . . . 0.0 106.764 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.98 131.67 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.16 128.49 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.6 m -98.92 88.46 4.0 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.796 -2.668 . . . . 0.0 103.796 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.569 ' CG1' HD11 ' A' ' 2' ' ' LEU . 86.4 t -61.03 156.13 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.827 175.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.49 -55.46 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.5 m -148.5 141.25 24.59 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.666 0.666 . . . . 0.0 112.32 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.35 138.73 51.59 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 128.919 2.887 . . . . 0.0 107.886 173.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 86' ' ' ARG . 3.3 pm0 -140.1 138.68 35.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 110.609 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.1 138.58 58.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 111.928 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -143.39 -80.51 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.259 0.624 . . . . 0.0 112.299 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.142 0 C-N-CA 126.432 1.893 . . . . 0.0 114.892 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.451 HM73 ' NE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' C ' HD22 ' A' ' 2' ' ' LEU . 66.2 mtt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 42' ' ' ASN . 4.4 mm? -136.16 153.26 76.54 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.156 1.382 . . . . 0.0 108.691 -172.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.12 164.34 35.68 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.813 2.342 . . . . 0.0 110.329 173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.86 -47.56 89.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.367 5.0 m -50.3 -38.11 39.79 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.255 1.822 . . . . 0.0 113.635 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -50.65 -51.97 44.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.095 1.316 . . . . 0.0 110.649 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -63.55 -48.35 77.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.035 0.934 . . . . 0.0 110.13 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.71 -38.09 66.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.427 1.012 . . . . 0.0 111.757 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.8 t -72.86 -43.77 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.083 -1.011 . . . . 0.0 109.629 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.65 -35.06 75.28 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.202 1.364 . . . . 0.0 112.32 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -51.84 -27.09 11.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.025 0.93 . . . . 0.0 112.133 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -99.37 159.2 15.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.468 1.107 . . . . 0.0 108.114 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -73.92 153.34 39.86 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 122.077 0.941 . . . . 0.0 109.151 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.97 174.52 45.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 125.611 1.577 . . . . 0.0 109.422 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.4 t -100.92 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.74 160.93 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.22 154.69 44.1 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.0 mt -138.84 116.17 11.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -174.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 26' ' ' PRO . . . -88.56 108.86 19.64 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -94.36 123.05 37.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 116.971 -1.49 . . . . 0.0 108.134 -174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -72.91 119.55 17.31 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 121.242 1.837 . . . . 0.0 106.579 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.29 -81.65 0.23 Allowed Glycine 0 C--N 1.341 0.861 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.136 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -158.63 -60.7 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -78.82 41.03 0.41 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.113 2.565 . . . . 0.0 110.479 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.63 152.24 9.47 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 106.57 -2.612 . . . . 0.0 106.57 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.572 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 18.8 Cg_endo -54.25 148.05 42.81 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 CA-C-N 120.791 2.295 . . . . 0.0 107.973 173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -103.3 101.3 11.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.195 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.3 tp -76.22 88.53 3.08 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.168 0.587 . . . . 0.0 110.425 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.7 m -83.24 170.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.887 1.675 . . . . 0.0 110.069 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.13 166.1 13.35 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.09 1.314 . . . . 0.0 113.793 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.0 t -168.32 176.19 6.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.374 2.27 . . . . 0.0 108.054 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.458 ' HE1' HM73 ' A' ' 123' ' ' FMN . 82.2 m95 -118.95 141.81 48.34 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.659 1.983 . . . . 0.0 109.721 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -53.07 -31.56 42.37 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.372 0.669 . . . . 0.0 110.016 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -60.76 -11.79 8.66 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.903 3.281 . . . . 0.0 112.108 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -118.68 -6.36 10.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.023 1.329 . . . . 0.0 111.58 -177.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.4 HD22 HG22 ' A' ' 46' ' ' VAL . 22.6 mt -95.05 160.11 14.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 120.089 1.313 . . . . 0.0 112.084 -173.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 141.61 44.64 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.28 150.95 5.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -122.0 179.21 4.59 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 128.461 2.704 . . . . 0.0 107.103 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -70.97 -179.91 2.47 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.26 28.21 26.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.479 1.514 . . . . 0.0 111.245 -173.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.6 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.342 0.1 OUTLIER 53.39 24.59 4.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.891 2.076 . . . . 0.0 114.32 -175.817 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -73.45 151.26 41.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mt -131.29 164.38 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -144.43 140.93 24.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 36' ' ' LEU . 59.8 t -123.0 124.86 26.44 Favored Pre-proline 0 N--CA 1.443 -0.788 0 C-N-CA 127.483 2.313 . . . . 0.0 105.4 -176.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.87 108.52 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.116 1.878 . . . . 0.0 109.008 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.833 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.83 111.61 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -21.24 6.85 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 112.077 173.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.3 40.89 0.31 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 119.095 1.448 . . . . 0.0 110.697 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.496 ' HB2' HG23 ' A' ' 48' ' ' VAL . 28.7 mtt -106.56 57.5 0.65 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.799 1.239 . . . . 0.0 108.598 173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.53 -49.81 37.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.627 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -52.17 -41.3 62.48 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.821 1.646 . . . . 0.0 110.854 173.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 m -61.1 -38.91 88.0 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.514 174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -57.53 -49.51 76.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 121.04 1.746 . . . . 0.0 110.413 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.62 97.08 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -61.88 -41.94 98.46 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.567 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.36 -48.15 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.746 1.157 . . . . 0.0 109.32 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -28.14 53.18 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.387 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.5 mtp85 -85.56 -46.31 10.94 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.102 0.864 . . . . 0.0 112.726 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.46 129.21 15.2 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.161 0.984 . . . . 0.0 110.962 -173.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -73.92 -17.75 60.98 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.53 123.19 16.04 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 20' ' ' THR . 11.9 m -138.82 141.05 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 123.082 1.42 . . . . 0.0 110.52 173.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 7.0 tt -107.32 148.48 28.96 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 102.091 -3.299 . . . . 0.0 102.091 172.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 17.4 ttt -141.66 121.06 13.17 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -108.93 128.36 54.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 168.52 10.01 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.042 1.292 . . . . 0.0 107.847 173.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.64 -169.22 31.8 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -147.01 175.47 10.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.409 1.099 . . . . 0.0 108.707 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -113.87 -7.94 13.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.676 2.391 . . . . 0.0 109.317 173.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 mmpm? -91.46 -10.95 39.03 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 119.601 -1.937 . . . . 0.0 115.007 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.76 136.49 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.57 131.49 36.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.479 1.112 . . . . 0.0 111.104 -175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.44 -140.98 6.34 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 124.703 1.144 . . . . 0.0 110.886 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.27 -58.99 2.53 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.564 1.546 . . . . 0.0 107.731 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.95 102.84 8.51 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.072 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.24 -168.6 2.26 Favored Glycine 0 CA--C 1.538 1.499 0 O-C-N 121.754 -0.591 . . . . 0.0 112.655 176.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 77.9 Cg_endo -75.52 59.74 5.61 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.815 2.344 . . . . 0.0 110.993 174.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.25 121.11 1.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 108.138 -1.985 . . . . 0.0 108.138 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 t -113.47 169.88 8.64 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.477 1.138 . . . . 0.0 110.334 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.2 -177.36 45.15 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 123.602 0.62 . . . . 0.0 113.283 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -136.8 152.67 50.56 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.862 1.265 . . . . 0.0 109.502 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tt -101.39 131.27 47.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.648 2.379 . . . . 0.0 104.58 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -136.06 158.33 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 43.7 mtt85 -129.86 150.79 51.0 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.644 1.178 . . . . 0.0 109.453 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.89 -174.59 40.9 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.455 1.026 . . . . 0.0 111.693 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -106.03 137.35 44.1 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.4 161.93 13.33 Favored 'General case' 0 CA--C 1.526 0.053 0 CA-C-N 118.787 0.722 . . . . 0.0 111.181 174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.2 119.24 3.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.148 0.979 . . . . 0.0 109.833 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -74.17 131.52 41.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.2 141.46 50.65 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.83 2.852 . . . . 0.0 109.572 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -121.14 27.07 8.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.384 1.873 . . . . 0.0 107.425 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -158.81 163.95 36.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 128.11 2.564 . . . . 0.0 107.797 -173.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.48 178.35 46.82 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.072 1.796 . . . . 0.0 113.077 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.41 -22.91 58.95 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.167 2.578 . . . . 0.0 112.007 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -64.29 -59.31 4.55 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 173.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -61.56 -31.31 71.34 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 117.094 -1.431 . . . . 0.0 112.402 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -68.47 -53.99 19.83 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.957 1.708 . . . . 0.0 108.227 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.32 -28.51 69.26 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.909 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.299 1.4 pp -93.67 -19.9 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 117.764 -1.113 . . . . 0.0 112.87 173.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.94 -35.21 70.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.533 1.969 . . . . 0.0 110.406 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.285 2.2 ptm180 -51.07 -18.18 0.78 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.947 2.099 . . . . 0.0 113.815 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -67.88 -171.2 0.2 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -132.13 4.17 4.07 Favored 'General case' 0 C--N 1.343 0.325 0 O-C-N 118.597 -2.564 . . . . 0.0 113.786 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 23.3 p-90 -131.05 8.84 4.8 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.811 0.844 . . . . 0.0 111.704 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.86 140.61 38.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.498 -0.751 . . . . 0.0 109.062 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.21 -10.59 8.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.348 1.459 . . . . 0.0 111.418 178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.833 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.0 161.85 10.77 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.79 2.436 . . . . 0.0 108.201 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.43 107.63 18.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.802 2.041 . . . . 0.0 106.6 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 tt -84.49 96.34 9.09 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 103.786 -2.672 . . . . 0.0 103.786 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.9 t -79.29 131.72 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 125.672 1.589 . . . . 0.0 107.516 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.06 128.86 75.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.4 m -106.09 92.19 4.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 2' ' ' LEU . 14.3 t -61.08 157.42 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.888 1.275 . . . . 0.0 110.723 176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.52 -56.27 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.9 m -151.29 141.66 22.43 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.37 155.2 29.99 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 128.538 2.735 . . . . 0.0 112.295 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -141.07 140.95 34.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.815 2.046 . . . . 0.0 108.208 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -76.56 140.77 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.1 p -138.7 -79.49 0.34 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.307 0.643 . . . . 0.0 111.5 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.242 0.697 0 CA-C-O 116.825 -1.559 . . . . 0.0 112.169 -174.182 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.458 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 118' ' ' ALA . 67.0 mt -133.18 167.36 23.34 Favored Pre-proline 0 N--CA 1.466 0.368 0 C-N-CA 124.609 1.163 . . . . 0.0 110.05 -169.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.77 152.39 42.48 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.846 2.364 . . . . 0.0 111.939 173.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.84 -39.18 93.54 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -51.35 -40.27 58.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.624 1.57 . . . . 0.0 111.89 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -51.28 -56.08 14.85 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.251 0.932 . . . . 0.0 110.611 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -56.06 -48.27 76.35 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.126 0.97 . . . . 0.0 110.454 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -55.41 -35.04 64.95 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.697 0.681 . . . . 0.0 112.565 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.6 t -69.06 -46.59 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.113 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' HG ' HG21 ' A' ' 38' ' ' VAL . 4.0 mm? -54.48 -41.32 69.42 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.169 1.35 . . . . 0.0 112.879 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -51.55 -18.71 1.19 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -119.94 158.69 26.2 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.367 0.985 . . . . 0.0 108.781 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -80.61 149.28 29.93 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.543 -1.348 . . . . 0.0 110.39 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.4 169.63 42.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 126.705 2.098 . . . . 0.0 110.194 174.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.1 151.04 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -136.98 159.58 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 127.574 2.349 . . . . 0.0 105.749 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.72 40.85 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.241 1.416 . . . . 0.0 109.419 174.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.589 HD11 HG21 ' A' ' 46' ' ' VAL . 9.8 mt -145.32 115.82 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.98 108.82 19.78 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.435 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -95.91 108.82 21.23 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -79.56 141.33 36.71 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 122.002 2.183 . . . . 0.0 106.168 173.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 -81.49 0.22 Allowed Glycine 0 C--O 1.224 -0.486 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 173.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -159.06 -61.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.4 45.73 0.68 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.131 1.772 . . . . 0.0 110.123 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 151.62 6.74 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.953 1.263 . . . . 0.0 112.685 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.19 157.72 53.37 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.212 1.275 . . . . 0.0 110.878 -175.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -121.46 102.03 8.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.087 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.6 tt -87.35 88.71 7.76 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -175.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.58 173.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.762 2.025 . . . . 0.0 110.676 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -119.63 165.62 14.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.584 1.154 . . . . 0.0 111.574 173.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 178.43 4.85 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.247 2.219 . . . . 0.0 108.052 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -121.36 141.79 50.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.811 2.044 . . . . 0.0 110.685 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -51.52 -30.98 22.29 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.509 1.049 . . . . 0.0 110.799 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.48 -13.08 4.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.948 2.899 . . . . 0.0 112.008 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -118.14 -1.16 11.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.13 1.372 . . . . 0.0 110.48 -174.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.613 HD22 HG22 ' A' ' 46' ' ' VAL . 27.6 mt -102.4 168.92 9.01 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.599 -1.313 . . . . 0.0 112.762 -173.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 125.3 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 172.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.422 HG21 ' HG ' ' A' ' 10' ' ' LEU . 35.3 t -101.69 148.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.9 mt -121.58 -177.11 3.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.944 2.098 . . . . 0.0 107.973 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 36.2 t0 -71.44 177.99 3.68 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' H ' ' CG ' ' A' ' 40' ' ' ASP . . . 49.37 28.15 8.96 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 126.098 1.809 . . . . 0.0 110.443 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.3 0.5 OUTLIER 53.23 28.27 6.96 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.373 2.269 . . . . 0.0 114.304 179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -73.62 144.63 45.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 173.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 mt -128.79 159.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 t -143.05 141.76 26.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.613 HG22 HD22 ' A' ' 36' ' ' LEU . 57.7 t -122.79 140.39 33.11 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.302 2.641 . . . . 0.0 106.066 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.43 110.97 2.02 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.795 2.33 . . . . 0.0 108.61 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.754 ' CG1' ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.3 112.22 21.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.25 -21.77 5.44 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.081 -1.012 . . . . 0.0 112.148 173.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.78 41.31 0.35 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.344 1.572 . . . . 0.0 109.958 -175.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 48' ' ' VAL . 22.0 mtt -105.71 71.13 0.9 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.677 1.191 . . . . 0.0 108.498 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -64.39 -65.57 0.66 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 130.048 3.339 . . . . 0.0 114.558 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -51.72 -41.27 61.39 Favored 'General case' 0 C--O 1.223 -0.304 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 174.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -63.47 -38.69 92.11 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.66 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 91' ' ' PHE . 35.4 tt0 -56.29 -51.22 68.98 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.242 1.383 . . . . 0.0 109.489 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.53 93.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.175 0.59 . . . . 0.0 112.158 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -65.34 -41.93 93.41 Favored 'General case' 0 C--O 1.225 -0.237 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.576 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.8 -48.06 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.23 -28.82 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.157 -0.925 . . . . 0.0 112.819 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -86.81 -46.3 10.09 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.598 -1.191 . . . . 0.0 112.087 173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -149.05 140.78 23.56 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.749 1.159 . . . . 0.0 110.255 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -13.27 62.24 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -173.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 63' ' ' ARG . 8.8 mmp_? -49.88 114.16 1.01 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.754 2.422 . . . . 0.0 115.934 -173.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 20' ' ' THR . 7.7 m -141.7 146.32 23.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 CA-C-O 123.905 1.812 . . . . 0.0 114.797 173.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 4.0 tt -111.46 148.78 32.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 101.623 -3.473 . . . . 0.0 101.623 172.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 21.4 ttt -141.05 140.98 34.33 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -121.6 128.21 51.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 175.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -117.19 169.73 9.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 120.227 -1.546 . . . . 0.0 108.112 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.86 -176.22 38.85 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.441 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 24.8 t -148.65 164.14 35.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.709 0.804 . . . . 0.0 110.364 174.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -98.35 -8.68 26.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.748 1.619 . . . . 0.0 109.447 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -91.39 -9.89 43.12 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 116.891 -1.528 . . . . 0.0 114.725 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -131.45 138.86 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 131.07 36.28 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.502 0.721 . . . . 0.0 110.753 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.25 -140.43 9.26 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 124.907 1.241 . . . . 0.0 111.765 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -90.68 -58.6 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 103.29 -2.855 . . . . 0.0 103.29 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 103.06 9.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.08 -168.67 3.91 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 121.38 -0.825 . . . . 0.0 113.129 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.28 58.82 6.81 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.658 2.238 . . . . 0.0 111.132 175.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.46 120.99 1.07 Allowed Glycine 0 C--O 1.226 -0.396 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -114.45 169.17 9.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.733 1.266 . . . . 0.0 110.105 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.54 178.21 41.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-O 121.725 0.625 . . . . 0.0 112.261 177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.71 149.1 49.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.383 1.473 . . . . 0.0 108.473 -173.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tt -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 173.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mm -131.35 156.53 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 -173.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -135.59 146.01 47.51 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.285 1.434 . . . . 0.0 108.686 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.19 -165.54 34.46 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.942 0.782 . . . . 0.0 112.183 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.5 m -115.88 147.54 40.97 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.057 1.343 . . . . 0.0 108.045 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.99 164.35 12.89 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.794 1.637 . . . . 0.0 111.873 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.94 120.95 2.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.394 1.078 . . . . 0.0 108.853 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.614 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 63.8 m-85 -76.24 138.7 40.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -140.63 141.35 35.11 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.094 0.958 . . . . 0.0 110.112 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.3 p -117.2 39.64 3.21 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -159.07 156.13 28.63 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 128.115 2.566 . . . . 0.0 111.567 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.15 178.54 47.26 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 126.292 1.901 . . . . 0.0 114.391 173.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.71 -17.26 58.07 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.347 2.698 . . . . 0.0 111.584 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -63.77 1.13 Allowed 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.151 1.78 . . . . 0.0 107.488 173.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -61.45 -31.26 71.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.03 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -68.62 -49.08 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.555 1.07 . . . . 0.0 109.074 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.96 78.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.218 -0.926 . . . . 0.0 111.404 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.345 0.9 OUTLIER -82.58 -18.41 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.55 173.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.01 -27.96 3.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.826 1.651 . . . . 0.0 112.133 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -51.17 -35.9 38.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.72 0.808 . . . . 0.0 111.78 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.26 177.84 8.53 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -141.37 -1.11 1.36 Allowed 'General case' 0 C--O 1.222 -0.387 0 O-C-N 119.144 -2.222 . . . . 0.0 113.18 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -98.26 8.76 44.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.449 1.1 . . . . 0.0 110.271 173.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -81.37 150.8 28.26 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.524 -0.735 . . . . 0.0 111.03 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -120.88 -21.28 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.168 2.987 . . . . 0.0 111.024 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . . . -171.5 161.77 6.37 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.736 2.014 . . . . 0.0 109.114 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.99 108.38 19.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.5 93.89 5.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.2 t -79.04 131.43 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 83.3 mt -120.9 128.68 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 25.1 m -106.2 92.09 3.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.04 155.48 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.848 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.05 -41.79 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 125.521 1.528 . . . . 0.0 107.275 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.5 m -151.26 141.0 21.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.838 1.199 . . . . 0.0 113.618 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 2' ' ' LEU . . . -115.5 140.13 49.43 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 129.948 3.299 . . . . 0.0 110.626 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -139.3 136.31 34.73 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.013 1.725 . . . . 0.0 109.291 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -75.91 140.82 42.33 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -137.23 -77.57 0.4 Allowed 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.256 1.397 0 C-N-CA 125.359 1.464 . . . . 0.0 114.37 -173.539 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.6 ' C ' HD12 ' A' ' 2' ' ' LEU . 19.0 mmt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 42' ' ' ASN . 7.4 mp -139.6 157.31 70.42 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 124.372 1.069 . . . . 0.0 108.877 -171.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.43 159.39 51.63 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.677 2.251 . . . . 0.0 111.832 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.16 -38.77 93.6 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 173.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -48.5 -43.14 34.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.065 1.746 . . . . 0.0 111.427 175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.34 -55.45 18.35 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 119.352 0.978 . . . . 0.0 111.247 174.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -56.7 -48.52 77.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -59.21 -33.62 71.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.759 0.709 . . . . 0.0 112.835 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -68.76 -41.93 82.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -59.6 -38.4 81.12 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.33 1.423 . . . . 0.0 112.493 173.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 -18.9 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.177 1.353 . . . . 0.0 112.63 173.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -113.73 159.05 20.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.414 1.086 . . . . 0.0 108.754 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -73.72 148.36 42.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.924 -1.11 . . . . 0.0 108.794 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -165.35 171.25 40.59 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 126.801 2.143 . . . . 0.0 110.079 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.42 150.71 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.7 t -139.82 160.46 26.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.974 2.109 . . . . 0.0 106.041 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 157.05 44.14 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.512 1.125 . . . . 0.0 108.46 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 HG21 ' A' ' 46' ' ' VAL . 23.0 mt -139.4 115.72 9.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -176.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.04 108.56 19.65 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 174.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -91.36 114.3 26.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 116.308 -1.806 . . . . 0.0 106.649 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.41 141.5 46.95 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 121.845 2.111 . . . . 0.0 108.47 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.28 -81.05 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -158.82 -56.98 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 20.0 p-10 -78.87 38.34 0.33 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.668 2.787 . . . . 0.0 111.517 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.37 151.67 6.48 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.416 -176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.92 148.9 58.53 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 CA-C-N 118.028 0.914 . . . . 0.0 111.449 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -101.88 101.39 11.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.84 88.64 3.44 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.663 0.665 . . . . 0.0 110.071 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.3 m -80.31 170.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 125.15 1.38 . . . . 0.0 110.046 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -119.36 165.91 13.72 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 0.989 . . . . 0.0 112.523 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -168.29 176.22 6.03 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 108.548 175.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.16 141.53 50.74 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.433 1.893 . . . . 0.0 110.611 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.26 -31.06 52.65 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.111 0.869 . . . . 0.0 109.706 173.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -59.95 -13.33 10.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 128.765 2.826 . . . . 0.0 111.413 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -119.23 -2.94 10.6 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.622 1.569 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 46' ' ' VAL . 42.5 mt -90.18 164.78 14.3 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.477 1.489 . . . . 0.0 112.229 -173.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.461 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -134.98 132.2 38.08 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 173.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.5 t -101.17 145.74 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.48 179.13 4.54 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.333 1.853 . . . . 0.0 108.101 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -70.44 175.24 4.9 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.347 1.059 . . . . 0.0 109.474 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.09 28.42 33.38 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.721 1.629 . . . . 0.0 111.105 -173.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.61 ' HB2' HD13 ' A' ' 2' ' ' LEU 0.28 0.1 OUTLIER 53.41 23.11 3.17 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.86 2.064 . . . . 0.0 114.102 -177.029 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -73.58 129.08 37.22 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 mm -118.0 150.91 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 t -139.51 147.08 24.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 O-C-N 120.837 -1.164 . . . . 0.0 108.843 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 18' ' ' ILE . 58.7 t -126.65 135.73 27.69 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 126.188 1.795 . . . . 0.0 107.869 -173.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -77.0 108.36 2.63 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.022 1.815 . . . . 0.0 108.457 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.877 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.57 111.52 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.52 -21.35 6.9 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 112.256 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.75 41.38 0.32 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 117.46 -1.745 . . . . 0.0 109.901 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.503 ' HB2' HG23 ' A' ' 48' ' ' VAL . 20.1 mtt -109.12 59.82 0.6 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.654 1.181 . . . . 0.0 109.225 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -71.48 -49.65 39.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.994 -174.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HZ1' ' CG ' ' A' ' 24' ' ' ASP . 55.0 tttp -51.99 -41.44 62.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 121.044 1.747 . . . . 0.0 109.296 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 m -60.73 -39.47 88.77 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.151 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.93 -48.28 80.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 121.248 1.84 . . . . 0.0 110.782 173.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.68 99.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.099 0.159 . . . . 0.0 111.253 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -62.88 -41.87 99.56 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 117.241 -1.361 . . . . 0.0 110.379 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.7 -48.24 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 120.409 1.459 . . . . 0.0 109.132 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.49 -28.17 59.06 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -46.42 15.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -151.34 128.61 11.24 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 123.986 0.914 . . . . 0.0 109.204 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -15.39 60.05 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.799 -1.188 . . . . 0.0 113.969 -174.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.495 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.64 130.69 47.07 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.641 1.11 . . . . 0.0 111.575 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 20' ' ' THR . 11.7 m -139.35 156.13 26.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 123.392 1.567 . . . . 0.0 111.895 173.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.7 tp -108.93 149.87 28.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 173.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.3 ttt -140.01 123.02 16.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -109.02 127.99 54.57 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 174.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.97 172.4 7.29 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.421 1.464 . . . . 0.0 109.559 173.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.44 -166.16 27.03 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.0 t -146.65 159.94 42.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.83 0.852 . . . . 0.0 109.467 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -98.69 -15.47 19.37 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.145 0.978 . . . . 0.0 108.994 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.03 -7.01 50.01 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 116.323 -1.799 . . . . 0.0 115.388 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.5 t -131.02 129.69 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 121.767 2.076 . . . . 0.0 106.14 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.3 131.42 36.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.907 0.883 . . . . 0.0 110.631 -174.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.71 -140.98 7.18 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -78.98 -59.11 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.877 1.271 . . . . 0.0 108.855 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -88.25 103.12 15.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.716 0.77 . . . . 0.0 109.907 -174.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.51 -172.01 3.97 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.952 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 54.0 Cg_endo -80.54 58.87 7.21 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.208 1.939 . . . . 0.0 110.571 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.69 109.83 0.43 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.0 t -99.32 169.65 9.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.498 0.649 . . . . 0.0 110.375 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.97 169.91 40.87 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -125.0 157.33 36.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.84 1.256 . . . . 0.0 110.386 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -100.89 130.54 46.91 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mt -134.77 153.01 34.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -130.76 140.38 50.31 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.805 1.642 . . . . 0.0 107.342 -174.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.68 36.82 Favored Glycine 0 CA--C 1.522 0.52 0 CA-C-N 118.691 0.678 . . . . 0.0 111.718 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.7 m -121.4 150.99 40.69 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.869 0.868 . . . . 0.0 110.163 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.13 162.33 14.36 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.167 1.387 . . . . 0.0 112.288 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.02 121.19 3.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.643 1.177 . . . . 0.0 109.289 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -74.18 138.54 43.85 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.193 0.997 . . . . 0.0 110.771 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -135.56 123.34 22.45 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 126.448 1.899 . . . . 0.0 115.399 176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -121.72 32.94 5.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.177 2.991 . . . . 0.0 103.924 172.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -158.64 151.76 22.6 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 130.488 3.515 . . . . 0.0 110.141 -172.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.92 178.55 47.59 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.543 1.068 . . . . 0.0 113.37 173.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.82 -9.09 23.46 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.945 2.43 . . . . 0.0 111.17 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -61.32 -60.86 3.07 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -61.56 -31.48 71.52 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 125.071 1.482 . . . . 0.0 111.138 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.46 -48.56 64.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.741 1.155 . . . . 0.0 109.357 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.461 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -59.58 -41.22 89.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.421 -178.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.281 1.2 pp -79.82 -18.75 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 119.251 -0.98 . . . . 0.0 113.556 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.91 -28.84 53.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.841 1.655 . . . . 0.0 113.745 -174.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.259 0.6 OUTLIER -52.08 -38.58 57.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.124 173.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -66.05 177.88 1.26 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 173.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 -1.12 1.5 Allowed 'General case' 0 C--O 1.222 -0.385 0 O-C-N 118.308 -2.745 . . . . 0.0 113.378 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -110.32 8.35 23.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.503 0.721 . . . . 0.0 109.903 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.14 138.83 33.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.82 -8.36 9.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.025 1.73 . . . . 0.0 110.917 -174.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.877 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.24 161.75 10.29 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.324 2.649 . . . . 0.0 108.506 176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.85 105.14 15.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.774 2.429 . . . . 0.0 104.72 173.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.4 90.84 5.63 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.7 t -79.48 131.34 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.6 mt -120.22 128.23 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 26.9 m -99.34 88.47 3.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 103.622 -2.732 . . . . 0.0 103.622 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 2' ' ' LEU . 25.0 t -60.71 157.29 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.037 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.79 -56.99 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.5 m -148.32 141.38 24.92 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.5 149.84 30.78 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.261 2.624 . . . . 0.0 108.534 173.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -139.55 133.14 30.38 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.31 1.844 . . . . 0.0 107.487 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -68.8 137.75 54.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -136.99 -58.23 0.72 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 77' ' ' ASN . 2.3 pp . . . . . 0 C--O 1.247 0.937 0 C-N-CA 124.23 1.012 . . . . 0.0 113.323 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' C ' HD12 ' A' ' 2' ' ' LEU . 4.4 mpp? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 1' ' ' MET . 7.2 mp -142.73 156.75 62.7 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.24 159.63 52.37 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.607 2.205 . . . . 0.0 111.818 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.75 95.38 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -53.26 -38.72 63.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 110.482 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -50.61 -56.01 13.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.496 1.043 . . . . 0.0 110.228 173.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -59.34 -48.56 81.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.372 0.669 . . . . 0.0 109.534 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -56.69 -41.05 76.67 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -70.08 -41.22 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 117.865 -1.064 . . . . 0.0 109.841 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.28 -42.84 78.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 120.307 1.412 . . . . 0.0 111.85 173.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -52.02 -18.92 1.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -116.08 175.02 5.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 126.373 1.869 . . . . 0.0 111.666 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -73.26 132.5 43.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.79 166.24 39.25 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 106.747 -2.541 . . . . 0.0 106.747 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.83 147.81 7.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 t -128.02 159.34 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -145.51 154.81 42.61 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 125.386 1.474 . . . . 0.0 107.183 174.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.09 114.03 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.774 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.98 108.38 19.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 173.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.475 ' HA ' HG12 ' A' ' 64' ' ' VAL . 5.1 m -88.68 116.17 26.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -73.3 138.18 45.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.4 -81.57 0.22 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -159.79 -60.74 0.07 Allowed 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -78.94 52.53 1.26 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.657 2.383 . . . . 0.0 110.043 177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.43 150.41 5.73 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.017 1.77 . . . . 0.0 111.735 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HB2' ' HB1' ' A' ' 19' ' ' ALA . 36.5 Cg_endo -66.94 150.16 82.97 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 CA-C-N 118.241 1.02 . . . . 0.0 111.321 174.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -103.19 101.82 11.79 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.8 tt -87.4 88.88 7.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.5 m -76.1 169.34 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.117 1.767 . . . . 0.0 110.6 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 9.7 m120 -119.28 166.91 12.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.647 1.179 . . . . 0.0 113.079 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -168.68 174.25 6.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.315 2.246 . . . . 0.0 109.025 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.488 ' HE1' HM73 ' A' ' 123' ' ' FMN . 89.0 m95 -120.67 141.57 50.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.294 2.238 . . . . 0.0 110.218 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -54.63 -31.21 56.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.255 0.48 . . . . 0.0 112.03 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.5 t -59.72 -8.97 2.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.521 1.528 . . . . 0.0 113.343 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.13 -1.77 11.33 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.644 1.178 . . . . 0.0 109.845 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.66 169.62 8.35 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.701 -1.249 . . . . 0.0 113.133 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' NZ ' HD21 ' A' ' 39' ' ' LEU . 2.0 pttt -136.48 141.55 43.51 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.9 t -99.38 146.81 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.407 HD21 ' NZ ' ' A' ' 37' ' ' LYS . 22.7 mt -121.68 -174.08 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.968 2.907 . . . . 0.0 111.825 -177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.37 158.89 6.76 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 128.122 2.569 . . . . 0.0 111.067 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.09 35.82 42.32 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.055 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' HB2' HD13 ' A' ' 2' ' ' LEU . 0.2 OUTLIER 54.05 22.73 3.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.253 1.821 . . . . 0.0 114.347 -175.125 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -74.16 158.01 34.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.791 1.636 . . . . 0.0 108.084 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -140.77 170.23 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 -175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.8 t -144.89 140.06 23.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.767 1.227 . . . . 0.0 108.132 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.92 133.85 24.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 128.578 2.751 . . . . 0.0 106.885 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.37 108.43 2.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.874 2.383 . . . . 0.0 109.88 174.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.786 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.86 111.76 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 173.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.21 -21.34 6.29 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.6 1.571 . . . . 0.0 112.816 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.86 41.56 0.27 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.512 ' HB2' HG23 ' A' ' 48' ' ' VAL . 17.6 mtt -107.83 71.38 0.81 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.611 1.565 . . . . 0.0 107.728 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -67.21 -63.91 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 129.895 3.278 . . . . 0.0 113.278 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -51.74 -40.67 60.65 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -60.19 -40.85 91.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.306 -1.33 . . . . 0.0 112.252 175.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -58.19 -48.78 79.24 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 121.606 2.003 . . . . 0.0 110.32 173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.16 95.69 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -65.1 -41.63 94.77 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-O 116.989 -1.481 . . . . 0.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.76 -48.25 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 120.3 1.409 . . . . 0.0 108.503 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -25.7 59.9 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 174.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -82.25 -44.92 15.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 173.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -151.15 136.24 17.48 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.438 1.495 . . . . 0.0 108.791 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -21.85 63.76 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.162 -0.961 . . . . 0.0 112.256 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.9 mmt85 -61.05 128.88 38.58 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 124.68 1.192 . . . . 0.0 114.115 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 20' ' ' THR . 6.3 m -139.52 154.99 25.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 122.749 1.262 . . . . 0.0 110.139 172.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.774 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 9.3 tt -111.66 150.97 29.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 103.058 -2.941 . . . . 0.0 103.058 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 13.7 ttt -139.01 135.52 34.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.554 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 18.5 p -121.05 128.45 52.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.97 165.95 12.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 109.083 173.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.11 178.11 42.5 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -159.8 170.31 21.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.974 0.892 . . . . 0.0 108.901 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -99.27 -9.32 23.76 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.873 2.069 . . . . 0.0 110.325 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -91.85 -11.26 36.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.54 136.73 56.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -78.92 131.42 36.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.526 0.73 . . . . 0.0 109.847 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.32 -141.1 7.31 Favored Glycine 0 N--CA 1.451 -0.353 0 O-C-N 124.222 0.951 . . . . 0.0 110.933 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 mmm-85 -81.67 -58.82 2.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.47 102.9 13.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.615 0.721 . . . . 0.0 109.625 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.73 -168.94 3.44 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.617 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 57.9 Cg_endo -78.52 59.43 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.578 2.185 . . . . 0.0 110.914 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.09 121.08 1.09 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.578 -2.209 . . . . 0.0 107.578 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -110.09 169.31 8.81 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 118.029 0.914 . . . . 0.0 109.836 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.73 177.87 35.16 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 123.962 0.791 . . . . 0.0 113.441 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -136.48 141.5 43.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.23 1.412 . . . . 0.0 109.348 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -101.18 130.68 47.32 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 127.174 2.189 . . . . 0.0 106.271 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.4 mt -141.32 150.99 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.812 -0.555 . . . . 0.0 109.762 -173.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -128.03 148.82 50.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.81 2.044 . . . . 0.0 109.967 173.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.4 -168.09 34.06 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.355 1.455 . . . . 0.0 110.458 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.7 m -121.0 149.04 43.28 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.351 1.46 . . . . 0.0 108.838 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.02 163.56 13.71 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.763 1.225 . . . . 0.0 112.191 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.16 121.5 3.52 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.795 1.638 . . . . 0.0 108.749 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -73.68 143.91 46.03 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -133.36 134.53 43.87 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 126.414 1.886 . . . . 0.0 107.537 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.8 p -121.22 28.77 7.64 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 108.695 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -158.78 155.79 28.58 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.714 2.006 . . . . 0.0 110.036 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.19 -174.8 44.1 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 124.384 0.992 . . . . 0.0 115.263 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.35 -10.77 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.713 2.942 . . . . 0.0 112.735 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.81 -62.67 1.31 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.235 1.814 . . . . 0.0 106.86 173.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.41 -31.37 71.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.751 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.67 -48.86 62.88 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.566 1.075 . . . . 0.0 109.558 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.16 66.96 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.389 -0.819 . . . . 0.0 111.661 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.333 1.2 pp -93.2 -18.45 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 173.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.42 -28.48 13.0 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.093 1.757 . . . . 0.0 112.988 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -51.43 -25.86 7.05 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.005 0.922 . . . . 0.0 112.893 173.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -81.11 178.61 8.3 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.029 0.831 . . . . 0.0 109.56 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -139.04 20.79 2.63 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.01 -1.681 . . . . 0.0 110.741 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 19.2 p-90 -131.95 8.55 4.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.267 1.427 . . . . 0.0 111.055 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.62 21.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.608 -0.682 . . . . 0.0 111.071 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 -21.16 6.46 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 128.595 2.758 . . . . 0.0 111.663 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.786 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.2 161.86 10.41 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.213 1.805 . . . . 0.0 109.456 -177.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.9 100.69 10.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.651 1.98 . . . . 0.0 105.686 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 tt -79.12 98.95 6.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.1 131.77 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.01 1.724 . . . . 0.0 107.508 176.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 70.0 mt -118.51 128.52 75.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.3 m -100.91 93.75 5.68 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.98 154.75 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.5 t -118.71 -49.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.4 m -151.22 141.01 21.86 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 120.249 1.386 . . . . 0.0 112.129 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.3 150.58 39.24 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.987 2.915 . . . . 0.0 109.413 173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.8 148.9 44.37 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.626 1.97 . . . . 0.0 107.3 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -85.84 134.72 33.9 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.3 p -130.27 -78.8 0.54 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -173.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.244 0.807 0 CA-C-O 116.056 -1.926 . . . . 0.0 112.717 -173.797 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.488 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.76 157.39 83.86 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.509 -0.757 . . . . 0.0 109.18 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.96 161.76 44.42 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.328 2.018 . . . . 0.0 113.047 -174.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.22 -42.55 98.71 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -54.42 -42.09 70.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.86 1.264 . . . . 0.0 111.092 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.561 ' CZ ' HD11 ' A' ' 10' ' ' LEU . 32.4 t80 -51.36 -53.39 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.392 0.677 . . . . 0.0 111.691 173.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.18 -48.53 81.1 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.243 0.617 . . . . 0.0 110.992 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.75 -37.47 68.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.923 0.783 . . . . 0.0 111.833 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.12 -44.09 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.164 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD11 ' CZ ' ' A' ' 6' ' ' PHE . 16.7 mt -57.48 -42.51 82.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.674 1.125 . . . . 0.0 112.32 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -51.65 -18.57 1.22 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -117.44 158.94 23.62 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.636 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -74.09 147.21 42.98 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -170.18 167.22 40.36 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 127.529 2.49 . . . . 0.0 109.012 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.7 t -83.42 150.96 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.95 159.87 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.256 2.222 . . . . 0.0 105.487 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.48 157.05 45.16 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.065 0.946 . . . . 0.0 109.724 173.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.69 108.39 4.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -88.95 108.41 19.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.464 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -96.38 109.41 21.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -74.27 141.09 45.35 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 121.38 1.9 . . . . 0.0 106.818 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.53 -81.91 0.23 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -166.16 -57.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.67 53.17 1.29 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.441 2.696 . . . . 0.0 109.113 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 141.42 2.31 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.008 1.766 . . . . 0.0 112.038 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 158.89 55.21 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -120.69 101.82 7.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.7 tt -84.83 88.61 7.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.8 m -82.79 175.58 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.842 2.057 . . . . 0.0 109.982 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -118.84 166.69 12.5 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.083 0.856 . . . . 0.0 112.103 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -168.3 175.8 6.25 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.241 2.217 . . . . 0.0 107.611 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -121.43 141.52 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.995 1.718 . . . . 0.0 110.647 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -53.97 -30.88 48.85 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.124 0.874 . . . . 0.0 109.204 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 t -58.74 -13.93 7.31 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.149 2.979 . . . . 0.0 111.875 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -118.88 -4.75 10.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.777 1.631 . . . . 0.0 111.8 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -93.41 165.8 12.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.32 1.418 . . . . 0.0 113.034 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.0 138.56 42.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 10' ' ' LEU . 86.7 t -101.69 150.7 5.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -122.12 178.98 4.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.811 2.844 . . . . 0.0 107.102 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -76.02 -179.05 4.69 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 60.55 31.3 74.27 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.243 -1.535 . . . . 0.0 110.732 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 p30 54.08 12.99 0.52 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 130.095 3.358 . . . . 0.0 115.056 -173.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -73.58 143.22 46.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.877 0.762 . . . . 0.0 109.627 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mt -129.3 163.28 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -142.86 140.88 27.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -118.93 127.74 26.35 Favored Pre-proline 0 N--CA 1.445 -0.707 0 C-N-CA 127.44 2.296 . . . . 0.0 104.829 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.01 108.3 2.43 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 107.798 -1.654 . . . . 0.0 107.798 173.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.809 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.65 111.63 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 173.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.58 -21.69 6.03 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.32 0.962 . . . . 0.0 112.67 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.65 41.59 0.33 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-O 118.099 -1.39 . . . . 0.0 110.0 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 48' ' ' VAL . 21.4 mtt -106.57 71.39 0.86 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.96 1.304 . . . . 0.0 108.28 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -67.45 -65.78 0.64 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 129.99 3.316 . . . . 0.0 113.682 -173.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -51.85 -40.89 61.31 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.863 1.21 . . . . 0.0 109.764 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 m -60.92 -39.08 88.03 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.787 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.5 -48.38 81.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.812 1.642 . . . . 0.0 110.86 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.82 99.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.407 0.283 . . . . 0.0 111.24 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -63.41 -41.64 98.74 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 117.444 -1.265 . . . . 0.0 110.446 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -63.86 -48.23 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 120.11 1.323 . . . . 0.0 108.963 174.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.83 -24.65 37.7 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.456 -0.777 . . . . 0.0 112.567 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -85.09 -42.5 14.75 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 115.581 1.696 . . . . 0.0 115.581 173.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -150.95 139.48 20.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.662 1.185 . . . . 0.0 109.115 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -75.17 -18.03 60.27 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.211 -0.931 . . . . 0.0 112.312 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 mmp_? -60.8 119.76 8.81 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.357 1.463 . . . . 0.0 114.492 -173.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 89' ' ' ALA . 20.4 m -139.23 146.23 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 123.112 1.434 . . . . 0.0 112.588 173.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 3.7 tt -111.67 149.2 31.91 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 172.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.9 ttt -141.15 141.12 34.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 p -125.45 128.08 47.5 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -117.2 173.39 6.7 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.713 1.597 . . . . 0.0 107.923 172.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.01 -171.27 34.59 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.424 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 23.4 t -146.85 157.38 43.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.65 0.78 . . . . 0.0 109.351 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -98.54 -17.43 18.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.493 1.517 . . . . 0.0 108.847 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -91.98 -4.43 54.59 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 116.687 -1.625 . . . . 0.0 114.864 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.7 t -129.49 130.2 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 121.711 2.051 . . . . 0.0 105.775 -173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.04 131.41 36.26 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.092 0.957 . . . . 0.0 111.173 -173.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.48 -141.07 6.36 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -81.92 -58.96 2.75 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.363 1.465 . . . . 0.0 108.323 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.414 HD21 HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -81.87 102.96 11.2 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 121.468 0.651 . . . . 0.0 109.523 -179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.18 -169.11 2.89 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.198 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 60.2 Cg_endo -79.04 58.85 7.13 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.204 1.936 . . . . 0.0 110.692 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.73 120.66 1.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.7 t -114.66 169.45 9.06 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.187 0.994 . . . . 0.0 110.433 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.73 45.33 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.78 0.705 . . . . 0.0 113.64 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -132.99 152.76 51.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.016 1.326 . . . . 0.0 109.353 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -101.03 130.9 47.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.328 -2.842 . . . . 0.0 103.328 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.04 154.46 36.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtt-85 -131.24 135.04 47.02 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.21 -169.11 28.39 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-N 118.765 0.711 . . . . 0.0 112.356 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 m -121.02 146.43 46.71 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.028 2.131 . . . . 0.0 108.287 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -111.24 163.71 13.65 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.566 1.075 . . . . 0.0 112.94 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.95 120.98 3.1 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.235 1.014 . . . . 0.0 110.331 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -75.86 141.06 42.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -140.74 135.88 31.99 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.035 1.334 . . . . 0.0 111.0 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.2 p -120.81 36.67 4.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.669 -2.715 . . . . 0.0 103.669 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.72 154.94 27.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.847 2.859 . . . . 0.0 111.165 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.07 178.39 47.41 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.484 1.516 . . . . 0.0 113.556 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -65.73 -11.78 32.22 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.193 2.595 . . . . 0.0 112.242 175.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.04 -60.27 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -61.58 -31.43 71.48 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.318 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.85 -49.77 55.55 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.683 1.129 . . . . 0.0 109.611 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.05 76.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.309 -0.869 . . . . 0.0 111.489 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.331 1.2 pp -82.5 -18.36 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 119.061 0.846 . . . . 0.0 112.159 174.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.16 -28.07 4.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.514 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.58 -30.03 19.44 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.164 1.386 . . . . 0.0 112.256 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -80.67 178.32 8.43 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 173.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.39 -0.54 1.4 Allowed 'General case' 0 C--O 1.22 -0.455 0 O-C-N 118.172 -2.83 . . . . 0.0 112.631 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -96.09 8.2 44.38 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.73 23.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.24 1.016 . . . . 0.0 109.402 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.6 ttp85 -121.13 -14.08 8.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.443 1.897 . . . . 0.0 111.717 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.809 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -168.56 161.61 11.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.041 1.736 . . . . 0.0 110.176 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.78 104.69 16.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 tp -82.74 91.34 7.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.18 131.16 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.792 1.637 . . . . 0.0 106.673 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -121.71 135.61 61.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.0 m -114.12 101.36 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.01 160.57 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.335 1.454 . . . . 0.0 110.088 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.4 t -121.51 -59.88 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 m -142.9 140.49 31.21 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.85 145.65 41.93 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.853 2.861 . . . . 0.0 108.168 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -139.21 130.18 26.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.243 1.817 . . . . 0.0 106.684 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -74.04 139.59 44.8 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.0 p -129.65 -58.31 1.1 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.414 HD13 HD21 ' A' ' 77' ' ' ASN . 2.6 pp . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.926 0.89 . . . . 0.0 111.437 -173.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmt . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.93 160.91 42.84 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 119.969 1.258 . . . . 0.0 109.171 170.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.77 158.63 32.18 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.504 2.136 . . . . 0.0 113.54 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.11 -49.31 79.86 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -53.64 -41.26 66.56 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.235 1.014 . . . . 0.0 111.283 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.26 -60.4 3.15 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.62 0.768 . . . . 0.0 109.482 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -52.28 -48.23 65.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 118.396 -0.812 . . . . 0.0 111.386 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 27.7 mm-40 -54.88 -38.36 67.44 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.743 1.156 . . . . 0.0 112.66 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.87 -45.5 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 119.802 1.183 . . . . 0.0 109.135 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.09 -42.28 80.41 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.664 1.12 . . . . 0.0 112.073 177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 8' ' ' GLU . 25.4 mtmm -51.65 -18.65 1.24 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -112.99 158.65 20.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.816 1.189 . . . . 0.0 109.874 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.12 148.83 41.44 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.975 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . 177.41 170.8 40.21 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 123.22 0.438 . . . . 0.0 112.058 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.9 t -92.72 149.12 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -132.15 163.51 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 127.556 2.342 . . . . 0.0 105.298 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.53 153.18 40.82 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 124.851 1.26 . . . . 0.0 109.15 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -138.38 109.79 5.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -89.45 109.22 20.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 126.134 1.773 . . . . 0.0 109.886 174.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 54' ' ' THR . 4.7 m -97.3 107.96 20.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -175.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 98.76 9.01 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.34 -59.89 0.18 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 120.824 1.647 . . . . 0.0 113.503 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -158.36 -60.79 0.08 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.008 1.404 . . . . 0.0 113.845 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -79.28 39.08 0.38 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.878 1.672 . . . . 0.0 111.777 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.94 151.47 12.36 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 -173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.76 148.06 93.9 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 CA-C-N 120.751 2.275 . . . . 0.0 109.037 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.488 ' CE1' ' HZ3' ' A' ' 53' ' ' LYS . 40.4 t60 -121.43 101.67 7.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -173.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -90.48 88.7 7.26 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.5 m -77.34 173.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 110.638 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -119.81 168.48 11.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.445 1.02 . . . . 0.0 113.003 174.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.4 t -168.42 172.61 8.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.813 2.445 . . . . 0.0 108.183 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' HE1' HM73 ' A' ' 123' ' ' FMN . 85.5 m95 -120.91 141.75 50.35 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.887 2.075 . . . . 0.0 109.989 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -52.09 -30.53 26.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.685 0.675 . . . . 0.0 110.478 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 t -50.24 -21.31 1.31 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.663 2.385 . . . . 0.0 113.565 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.4 -6.71 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.379 1.071 . . . . 0.0 111.572 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.2 mt -91.46 171.3 9.29 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 120.448 -1.408 . . . . 0.0 111.781 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.727 ' HE2' HD11 ' A' ' 39' ' ' LEU . 13.6 ptmt -134.08 119.93 19.54 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 172.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.55 131.44 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.727 HD11 ' HE2' ' A' ' 37' ' ' LYS . 2.7 mp -121.43 178.14 4.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -76.97 -178.0 4.71 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.9 29.61 75.31 Favored Glycine 0 C--O 1.223 -0.591 0 O-C-N 120.473 -1.392 . . . . 0.0 109.663 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 54.0 12.87 0.49 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 130.631 3.572 . . . . 0.0 115.483 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -79.37 128.84 33.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.205 1.366 . . . . 0.0 110.137 -174.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.4 mm -124.34 155.43 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 t -145.24 142.46 22.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -121.78 132.8 24.16 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 126.993 2.117 . . . . 0.0 106.873 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.89 108.57 2.56 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.537 2.158 . . . . 0.0 108.666 173.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.53 111.76 21.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -114.45 -20.85 5.7 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.378 1.942 . . . . 0.0 112.281 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.18 40.99 0.45 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 119.047 1.423 . . . . 0.0 109.958 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.509 ' HB2' HG23 ' A' ' 48' ' ' VAL . 25.4 mtt -113.8 53.47 0.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.042 1.337 . . . . 0.0 108.515 174.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.46 91.2 m-70 -71.88 -48.18 47.58 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.488 ' HZ3' ' CE1' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -51.91 -38.28 55.71 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.76 1.618 . . . . 0.0 108.933 172.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.412 HG23 ' OG1' ' A' ' 20' ' ' THR . 48.0 m -64.41 -38.8 92.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.404 1.481 . . . . 0.0 110.291 173.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.21 -47.68 74.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.799 1.636 . . . . 0.0 109.391 173.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.38 89.36 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.803 0.441 . . . . 0.0 110.803 174.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -57.07 -41.47 78.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.744 -1.122 . . . . 0.0 113.369 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -67.08 -48.28 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 120.249 1.386 . . . . 0.0 109.211 175.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.36 -26.16 39.42 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 119.1 -0.476 . . . . 0.0 112.041 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.21 -47.19 13.74 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 173.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -152.28 141.67 21.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.433 1.015 . . . . 0.0 108.773 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.358 -1.464 . . . . 0.0 113.718 -178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -51.94 115.6 1.76 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.667 1.987 . . . . 0.0 114.722 -172.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.54 143.43 32.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 123.669 1.7 . . . . 0.0 112.723 173.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 2.8 tt -111.35 148.48 32.9 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 101.364 -3.569 . . . . 0.0 101.364 172.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 22.0 ttt -142.36 129.09 20.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 p -111.29 128.25 55.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 pp -117.01 166.88 11.67 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 120.548 -1.345 . . . . 0.0 108.578 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.9 -174.83 37.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.452 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 45.2 t -146.57 157.56 43.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.634 1.174 . . . . 0.0 107.898 174.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -98.86 -8.45 25.71 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.591 1.156 . . . . 0.0 110.05 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -91.46 -7.13 51.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 116.942 -1.504 . . . . 0.0 113.962 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.23 136.03 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 121.083 1.765 . . . . 0.0 106.243 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . . . -79.24 131.37 36.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.884 0.874 . . . . 0.0 111.086 -175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.44 -140.88 6.51 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 125.219 1.39 . . . . 0.0 110.516 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -84.48 -59.05 2.49 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.01 102.98 9.58 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.98 -168.79 1.96 Allowed Glycine 0 CA--C 1.537 1.461 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.584 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 74' ' ' ALA . 70.5 Cg_endo -76.3 65.9 7.15 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.35 2.033 . . . . 0.0 110.37 174.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.97 121.1 1.05 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 t -116.54 169.53 9.26 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.371 1.086 . . . . 0.0 109.846 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.64 -177.76 45.87 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-O 121.418 0.454 . . . . 0.0 113.381 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -131.58 147.01 52.49 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.416 1.086 . . . . 0.0 110.39 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -100.88 129.66 46.78 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 103.003 -2.962 . . . . 0.0 103.003 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.3 mt -141.2 157.05 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -132.75 149.12 52.32 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.172 1.789 . . . . 0.0 109.753 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.99 -174.14 37.95 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.505 1.526 . . . . 0.0 110.548 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -114.14 143.15 45.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.118 1.767 . . . . 0.0 106.828 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.81 163.36 13.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.188 1.395 . . . . 0.0 111.962 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.42 121.11 3.33 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.882 0.873 . . . . 0.0 109.764 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.03 138.13 43.87 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 141.48 35.0 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.121 0.968 . . . . 0.0 109.863 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -116.07 35.17 4.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.33 154.66 25.49 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 128.112 2.565 . . . . 0.0 110.742 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.47 178.67 46.76 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.642 2.067 . . . . 0.0 113.893 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -61.13 -17.92 55.14 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 124.028 3.152 . . . . 0.0 112.538 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -65.61 0.65 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.243 1.817 . . . . 0.0 107.617 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.18 -31.2 70.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.192 0.997 . . . . 0.0 111.391 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.6 -57.76 5.27 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.757 0.708 . . . . 0.0 109.138 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.456 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . . . -61.65 -25.42 67.37 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.916 -1.115 . . . . 0.0 113.058 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.346 1.3 pp -87.43 -18.11 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 119.733 1.151 . . . . 0.0 111.919 173.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.48 -27.93 3.0 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.408 1.483 . . . . 0.0 111.685 174.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -49.05 -21.47 0.71 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.641 1.176 . . . . 0.0 113.949 173.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.54 178.75 8.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.669 1.122 . . . . 0.0 110.611 175.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -130.29 11.61 5.44 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.099 -1.625 . . . . 0.0 111.234 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -132.26 9.0 4.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.226 1.41 . . . . 0.0 111.202 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.94 145.21 34.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.619 -0.676 . . . . 0.0 109.874 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.44 -21.05 6.98 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 127.951 2.5 . . . . 0.0 110.621 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.764 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.12 161.96 10.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.391 1.876 . . . . 0.0 109.137 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.59 107.9 18.93 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 tp -78.89 93.92 5.12 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.2 t -78.98 130.88 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.37 129.49 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.1 m -112.14 99.03 7.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.5 t -60.99 161.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 127.069 2.147 . . . . 0.0 110.15 177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.0 t -120.98 -51.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -150.93 141.04 22.15 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.154 -0.966 . . . . 0.0 111.246 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.91 146.34 43.02 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.693 3.197 . . . . 0.0 108.765 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -138.82 142.65 38.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.521 1.928 . . . . 0.0 107.599 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -81.16 133.51 35.47 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 p -135.21 -68.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.24 0.561 0 CA-C-O 117.358 -1.306 . . . . 0.0 110.221 178.092 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.498 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.5 mtm . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.431 ' CD1' ' H ' ' A' ' 2' ' ' LEU . 5.2 mp -60.04 156.21 39.03 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.339 1.856 . . . . 0.0 109.593 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.88 158.7 56.14 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.735 2.29 . . . . 0.0 111.442 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.99 -40.86 95.99 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -53.16 -38.96 63.22 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.6 1.56 . . . . 0.0 111.263 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -50.99 -56.26 13.33 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.653 1.115 . . . . 0.0 111.088 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -61.77 -48.96 78.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -61.01 -33.58 73.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.51 -41.85 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.392 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.12 -38.63 83.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.236 1.38 . . . . 0.0 111.811 173.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.74 -19.11 1.47 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.298 1.408 . . . . 0.0 114.345 172.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -106.4 158.93 16.53 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 119.717 1.144 . . . . 0.0 107.966 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -73.86 148.63 42.16 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 121.328 -0.858 . . . . 0.0 109.346 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 70' ' ' SER . . . -176.23 177.13 47.84 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 124.8 1.191 . . . . 0.0 112.534 -174.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.9 t -100.75 145.82 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -129.82 163.82 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 126.738 2.015 . . . . 0.0 106.059 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.44 159.9 42.79 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.305 1.442 . . . . 0.0 110.001 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.44 HD11 HG21 ' A' ' 46' ' ' VAL . 88.3 mt -140.34 117.32 9.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -89.08 108.35 19.54 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 104.886 -2.264 . . . . 0.0 104.886 173.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.627 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -94.03 110.57 22.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 115.546 -2.169 . . . . 0.0 106.806 -173.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -73.8 141.71 46.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.271 2.305 . . . . 0.0 107.721 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.7 -81.35 0.23 Allowed Glycine 0 C--O 1.224 -0.472 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 173.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.45 -61.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -79.73 44.49 0.64 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.24 2.216 . . . . 0.0 109.968 174.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.96 151.49 5.95 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.263 1.887 . . . . 0.0 113.719 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.19 153.93 56.85 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 121.357 1.371 . . . . 0.0 111.414 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -121.37 101.97 7.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.542 -175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 7.5 tt -86.13 88.73 7.65 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.04 169.14 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.082 1.753 . . . . 0.0 110.625 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -121.54 167.62 12.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.528 1.131 . . . . 0.0 112.29 173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.43 170.32 9.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.983 2.113 . . . . 0.0 108.364 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.461 ' HE1' HM73 ' A' ' 123' ' ' FMN . 84.2 m95 -116.48 141.67 47.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.745 1.618 . . . . 0.0 111.265 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -56.18 -31.77 63.72 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.997 0.919 . . . . 0.0 110.834 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 t -60.57 -8.39 2.8 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.387 1.475 . . . . 0.0 113.613 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -117.92 -7.24 10.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.095 1.316 . . . . 0.0 109.099 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 mt -98.24 162.19 13.32 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.151 -1.593 . . . . 0.0 112.29 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.15 140.52 41.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.409 -1.432 . . . . 0.0 108.916 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.9 t -101.8 144.27 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 78.0 mt -120.91 179.06 4.48 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.324 1.85 . . . . 0.0 107.126 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -70.53 177.27 3.54 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.254 0.549 . . . . 0.0 110.429 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.47 28.45 59.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -173.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 p30 53.64 13.72 0.53 Allowed 'General case' 0 C--N 1.343 0.285 0 C-N-CA 128.559 2.743 . . . . 0.0 114.848 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -73.21 109.33 6.65 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.487 1.04 . . . . 0.0 110.328 -173.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.07 161.15 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 175.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.97 134.83 21.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.44 HG21 HD11 ' A' ' 18' ' ' ILE . 60.6 t -121.04 135.39 24.81 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 127.127 2.171 . . . . 0.0 107.277 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.94 108.88 2.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.53 2.153 . . . . 0.0 110.458 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.742 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.4 111.91 21.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.13 -21.34 7.42 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.979 1.752 . . . . 0.0 112.676 173.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.41 41.31 0.28 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.188 1.494 . . . . 0.0 109.945 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.471 ' HB2' HG23 ' A' ' 48' ' ' VAL . 14.3 mtt -109.32 66.98 0.64 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.156 0.982 . . . . 0.0 109.77 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . 0.322 41.3 m-70 -71.47 -48.64 47.91 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -51.7 -40.95 61.06 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 121.799 2.09 . . . . 0.0 109.418 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.1 m -62.59 -41.29 98.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 127.002 2.121 . . . . 0.0 110.495 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -56.28 -50.82 70.28 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 121.027 1.74 . . . . 0.0 110.611 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.33 94.13 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.237 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -66.3 -42.02 88.94 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.679 -1.629 . . . . 0.0 109.845 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.93 -48.19 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 120.177 1.353 . . . . 0.0 109.032 176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.97 57.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.487 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -87.06 -46.02 10.19 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.926 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -145.15 132.31 20.45 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.275 1.036 . . . . 0.0 112.169 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.1 -21.59 56.51 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.454 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.46 122.13 14.42 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.499 1.045 . . . . 0.0 111.353 -173.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.2 m -138.85 155.94 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 123.379 1.561 . . . . 0.0 111.503 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 tt -111.13 149.95 30.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 20.8 ttt -138.95 140.87 38.4 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 p -123.72 128.6 49.84 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -116.93 167.78 10.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.218 1.827 . . . . 0.0 107.172 172.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.13 -175.0 38.12 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.434 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 44.5 t -148.14 157.38 43.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -99.28 -8.72 24.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.312 0.505 . . . . 0.0 109.923 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -90.71 3.11 55.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 117.89 -1.052 . . . . 0.0 113.087 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.0 t -130.92 133.61 62.79 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.05 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 173.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 130.32 35.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 118.879 0.763 . . . . 0.0 110.217 -174.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.28 -140.62 5.95 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.975 1.75 . . . . 0.0 109.318 173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -88.51 -58.3 2.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.15 102.68 5.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.184 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.95 -168.26 0.16 Allowed Glycine 0 CA--C 1.539 1.573 0 O-C-N 120.794 -1.191 . . . . 0.0 111.087 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.53 91.07 0.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 N-CA-C 106.501 -2.153 . . . . 0.0 106.501 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.95 121.4 0.71 Allowed Glycine 0 N--CA 1.442 -0.947 0 CA-C-O 117.723 -1.598 . . . . 0.0 109.827 173.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -109.31 168.97 9.0 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.341 1.071 . . . . 0.0 109.715 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.4 -176.97 44.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 121.062 0.257 . . . . 0.0 112.896 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -131.42 151.94 51.09 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.422 1.089 . . . . 0.0 109.958 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -100.86 131.25 46.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.422 ' CG2' HG13 ' A' ' 115' ' ' VAL . 6.0 mt -139.08 156.57 27.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -173.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -132.2 150.23 52.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.997 1.319 . . . . 0.0 108.088 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.61 -172.13 40.17 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.5 m -106.28 131.93 52.93 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.26 1.024 . . . . 0.0 108.432 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB2' HG11 ' A' ' 64' ' ' VAL . . . -89.0 163.51 15.5 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.67 120.88 3.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.873 0.869 . . . . 0.0 110.045 174.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -74.26 130.61 40.04 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 173.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -132.16 130.7 41.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.5 p -120.85 33.47 5.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 125.17 1.388 . . . . 0.0 107.677 173.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -158.82 161.96 36.96 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 128.635 2.774 . . . . 0.0 109.276 -173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.4 -179.95 46.52 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 125.19 1.376 . . . . 0.0 115.104 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.94 -19.15 64.89 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.536 2.157 . . . . 0.0 110.773 173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.86 -63.02 1.18 Allowed 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.817 0.847 . . . . 0.0 109.338 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -61.39 -31.17 71.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.346 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -68.26 -48.78 64.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.721 1.146 . . . . 0.0 110.481 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -30.69 69.73 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.782 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.3 pp -93.29 -19.31 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.74 85.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.809 1.64 . . . . 0.0 112.188 -173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.551 0.0 OUTLIER -51.54 -18.36 1.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 173.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.34 179.54 0.97 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.87 1.214 . . . . 0.0 108.242 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -128.55 12.39 6.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 119.601 -1.937 . . . . 0.0 112.14 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -135.91 10.47 3.34 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.882 1.273 . . . . 0.0 111.212 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.92 145.33 34.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.439 -0.788 . . . . 0.0 110.985 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.23 -21.38 6.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.002 2.521 . . . . 0.0 111.902 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.742 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -176.4 161.85 2.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.611 1.964 . . . . 0.0 109.431 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.61 110.66 23.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 tt -85.98 95.11 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 103.306 -2.849 . . . . 0.0 103.306 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.5 t -90.55 131.01 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.174 1.39 . . . . 0.0 107.806 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 64' ' ' VAL . 42.6 mm -114.14 137.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.4 m -113.96 93.22 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.422 HG13 ' CG2' ' A' ' 85' ' ' ILE . 60.8 t -61.45 160.32 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.29 1.436 . . . . 0.0 111.072 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -125.97 -57.26 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.5 m -140.9 127.22 19.79 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.131 0.423 . . . . 0.0 111.944 -174.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -118.08 139.34 51.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.75 3.22 . . . . 0.0 110.637 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -142.24 139.55 32.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.482 1.513 . . . . 0.0 110.668 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -72.87 135.26 45.12 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -174.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.3 p -143.21 -58.6 0.42 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.253 1.261 0 CA-C-O 115.753 -2.07 . . . . 0.0 113.929 -173.481 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.461 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' C ' HD22 ' A' ' 2' ' ' LEU . 75.8 mmm . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.642 HD21 HG11 ' A' ' 115' ' ' VAL . 3.6 mm? -136.19 157.43 75.65 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 124.997 1.319 . . . . 0.0 108.664 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.15 162.25 42.25 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.539 2.159 . . . . 0.0 110.683 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.21 -38.85 93.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -50.73 -40.43 54.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.125 1.77 . . . . 0.0 112.016 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.3 -56.41 13.16 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.8 1.182 . . . . 0.0 109.989 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -59.14 -48.45 81.55 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 110.201 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.83 -40.28 75.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.764 0.711 . . . . 0.0 112.624 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.2 t -68.9 -40.78 81.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.861 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.79 -45.68 85.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.377 1.444 . . . . 0.0 111.501 173.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -51.91 -20.62 2.4 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -105.95 161.66 14.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.407 1.083 . . . . 0.0 110.156 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.55 139.57 45.72 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.45 174.46 47.0 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.8 143.2 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -174.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.3 164.76 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -151.83 158.95 43.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.759 1.224 . . . . 0.0 109.162 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 46' ' ' VAL . 89.5 mt -142.63 119.94 6.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 124.768 1.227 . . . . 0.0 107.947 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . . . -94.05 108.42 20.25 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.568 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.8 m -89.95 121.3 31.93 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 116.194 -1.86 . . . . 0.0 106.386 -173.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -73.47 137.23 44.38 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 122.062 2.21 . . . . 0.0 108.689 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.08 -81.21 0.22 Allowed Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -158.84 -61.51 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -79.35 39.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.203 3.001 . . . . 0.0 111.511 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.87 151.13 13.36 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.64 150.02 56.13 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 CA-C-N 118.177 0.989 . . . . 0.0 111.208 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -99.51 101.59 12.88 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 6.5 tt -84.86 88.97 7.45 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -173.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.99 168.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.37 1.468 . . . . 0.0 110.254 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -120.34 167.7 12.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.411 1.084 . . . . 0.0 112.216 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -168.44 172.11 8.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.86 2.064 . . . . 0.0 108.195 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.498 ' HE1' HM73 ' A' ' 123' ' ' FMN . 86.2 m95 -120.86 141.65 50.39 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.894 1.678 . . . . 0.0 110.385 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -51.11 -31.26 18.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.095 0.958 . . . . 0.0 111.905 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -57.74 -14.51 5.85 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.205 1.802 . . . . 0.0 112.733 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.21 -3.55 11.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.711 1.204 . . . . 0.0 110.214 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.489 HD22 HG22 ' A' ' 46' ' ' VAL . 20.4 mt -95.21 163.52 13.24 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 120.51 -1.369 . . . . 0.0 112.759 -173.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.427 ' HE3' ' CB ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -136.63 140.72 43.0 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 172.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.2 t -101.55 151.78 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.26 1.424 . . . . 0.0 109.58 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.42 HD11 ' CD ' ' A' ' 97' ' ' GLU . 25.0 mt -121.55 178.33 4.86 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.553 1.941 . . . . 0.0 109.436 173.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -76.21 177.1 7.47 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.31 1.444 . . . . 0.0 107.903 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.25 29.34 59.92 Favored Glycine 0 CA--C 1.526 0.754 0 O-C-N 120.598 -1.313 . . . . 0.0 110.721 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB2' HD23 ' A' ' 2' ' ' LEU 0.321 0.0 OUTLIER 53.44 15.35 0.69 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 130.233 3.413 . . . . 0.0 115.091 -175.744 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -73.86 145.57 44.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.3 mm -127.98 168.66 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.7 t -146.38 142.74 21.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.013 -1.055 . . . . 0.0 108.883 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 36' ' ' LEU . 61.2 t -126.34 135.49 27.25 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 126.842 2.057 . . . . 0.0 107.769 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.82 108.53 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.743 2.296 . . . . 0.0 109.448 173.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.9 HG13 ' HB3' ' A' ' 109' ' ' ALA . 2.4 p -85.61 111.39 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.24 -21.36 6.63 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.759 1.647 . . . . 0.0 112.241 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.23 41.4 0.31 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 117.746 -1.586 . . . . 0.0 109.552 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.513 ' HB2' HG23 ' A' ' 48' ' ' VAL . 20.2 mtt -109.74 57.63 0.61 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.014 1.326 . . . . 0.0 107.909 173.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -71.58 -48.82 45.79 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.056 1.342 . . . . 0.0 113.42 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.98 -41.4 62.12 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.721 1.6 . . . . 0.0 108.87 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.9 m -59.98 -40.47 89.23 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.76 1.624 . . . . 0.0 110.369 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -57.92 -49.02 78.17 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 121.152 1.796 . . . . 0.0 110.988 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.66 98.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.819 0.343 . . . . 0.0 111.311 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -63.19 -41.59 99.2 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.009 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -61.55 -48.24 89.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 120.452 1.478 . . . . 0.0 109.286 174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.74 -29.28 59.28 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.634 -0.667 . . . . 0.0 112.423 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.7 mmm-85 -78.46 -46.46 19.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -151.26 129.53 11.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.781 1.233 . . . . 0.0 109.764 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.25 -23.23 62.87 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.492 -0.755 . . . . 0.0 112.487 174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -61.28 124.09 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.947 0.899 . . . . 0.0 112.027 -177.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 20' ' ' THR . 6.9 m -138.88 155.37 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 123.76 1.743 . . . . 0.0 110.253 173.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 4.5 tt -107.49 150.36 26.9 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 173.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 19.4 ttt -139.29 141.93 37.73 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 4.6 p -125.2 128.52 48.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 116.159 -1.877 . . . . 0.0 106.046 173.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.494 HD12 HD11 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -116.42 160.22 20.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 122.087 2.222 . . . . 0.0 106.345 173.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.13 -172.22 45.15 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -150.07 168.37 24.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 80' ' ' GLY . 21.4 mmm180 -98.92 -8.8 25.01 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.611 0.764 . . . . 0.0 109.844 173.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -79.33 -6.19 56.2 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.448 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.43 140.3 49.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.0 121.06 24.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.37 -130.11 3.88 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 125.158 1.361 . . . . 0.0 110.107 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.34 -63.64 1.23 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.302 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -84.03 102.63 12.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.863 -174.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.96 -168.45 0.93 Allowed Glycine 0 CA--C 1.542 1.78 0 O-C-N 120.99 -1.069 . . . . 0.0 112.194 -174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.03 91.43 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.838 2.359 . . . . 0.0 108.997 173.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 71' ' ' ARG . . . 178.81 122.02 0.74 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 117.336 -1.813 . . . . 0.0 110.445 176.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 t -123.72 171.68 9.42 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 118.815 1.307 . . . . 0.0 110.026 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.23 -157.58 28.35 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.783 1.183 . . . . 0.0 112.579 -173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -148.42 154.87 40.49 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.931 1.293 . . . . 0.0 109.811 -174.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.41 131.21 47.62 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 128.916 2.886 . . . . 0.0 104.56 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.494 HD11 HD12 ' A' ' 68' ' ' LEU . 2.9 mp -138.63 163.6 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.802 1.241 . . . . 0.0 108.579 -173.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -134.37 151.09 51.0 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.204 1.402 . . . . 0.0 109.123 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.65 -175.6 40.07 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.175 0.893 . . . . 0.0 111.715 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 m -113.93 128.8 56.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.41 1.084 . . . . 0.0 109.888 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.66 17.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.319 1.447 . . . . 0.0 111.465 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.04 120.44 2.27 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.02 1.328 . . . . 0.0 109.481 173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -77.13 142.69 39.61 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.568 -0.707 . . . . 0.0 109.634 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 140.92 34.24 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.354 1.061 . . . . 0.0 109.714 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 p -121.25 35.94 4.75 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.457 1.903 . . . . 0.0 106.221 173.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -159.35 157.54 30.58 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.502 2.321 . . . . 0.0 110.091 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.71 178.25 46.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 127.951 2.691 . . . . 0.0 113.089 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.28 -8.95 22.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.187 2.591 . . . . 0.0 112.634 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.42 ' CD ' HD11 ' A' ' 39' ' ' LEU . 7.6 mm-40 -65.98 -56.34 12.16 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -61.4 -31.89 71.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.781 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -72.59 -48.61 38.39 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.539 0.685 . . . . 0.0 110.043 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' ' HE3' ' A' ' 37' ' ' LYS . . . -58.9 -27.45 65.24 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.061 -1.024 . . . . 0.0 111.712 177.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.323 1.7 pp -93.26 -18.39 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.963 173.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.33 -28.4 4.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.585 1.954 . . . . 0.0 112.656 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -50.99 -22.88 2.52 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.768 1.227 . . . . 0.0 113.293 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -80.71 178.64 8.23 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.619 1.099 . . . . 0.0 110.312 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -128.51 3.83 5.6 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 120.149 -1.595 . . . . 0.0 111.23 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -135.68 8.28 3.31 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 111.54 -174.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.55 142.4 34.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.034 0.834 . . . . 0.0 109.112 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.61 -10.76 8.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.044 1.337 . . . . 0.0 111.829 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.9 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -169.49 161.91 9.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.187 2.595 . . . . 0.0 108.332 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.76 107.07 16.94 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.114 2.166 . . . . 0.0 106.588 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.1 tp -82.12 98.56 8.74 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.426 1.891 . . . . 0.0 107.594 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.8 t -83.96 127.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.699 1.6 . . . . 0.0 107.373 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.74 129.06 72.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 119.367 0.985 . . . . 0.0 108.488 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 m -99.11 87.91 3.81 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.642 HG11 HD21 ' A' ' 2' ' ' LEU . 71.1 t -60.66 153.57 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.991 0.916 . . . . 0.0 109.967 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.0 t -126.7 -59.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.4 m -149.58 141.22 23.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.528 0.604 . . . . 0.0 112.452 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.58 159.52 25.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 127.953 2.501 . . . . 0.0 112.448 174.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -140.87 145.25 35.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.259 2.224 . . . . 0.0 108.458 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -76.19 134.78 39.8 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.4 p -133.69 -58.79 0.87 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.47 0.577 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.463 HD13 ' H ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.712 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.498 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' C ' HD12 ' A' ' 2' ' ' LEU . 87.0 mmm . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 121.159 0.504 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 1' ' ' MET . 6.8 mp -141.38 155.6 67.51 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.52 163.61 38.43 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.903 2.402 . . . . 0.0 112.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.4 97.59 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 173.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.305 2.9 m -51.82 -38.11 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 126.966 2.107 . . . . 0.0 112.822 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -50.85 -49.11 59.67 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.519 1.054 . . . . 0.0 110.202 173.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -63.27 -48.19 79.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.775 1.23 . . . . 0.0 111.352 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.47 -41.48 63.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.562 0.619 . . . . 0.0 111.067 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.43 -45.55 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.119 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.5 mt -52.5 -28.37 20.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.576 1.08 . . . . 0.0 112.754 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 mmpm? -51.72 -18.51 1.24 Allowed 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.904 -1.747 . . . . 0.0 112.646 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -114.84 160.38 19.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.38 1.872 . . . . 0.0 109.719 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -74.36 156.54 36.96 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 166.3 35.11 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.476 -0.868 . . . . 0.0 113.64 -173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -81.97 141.36 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 31' ' ' THR . 12.7 t -133.92 160.55 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.94 155.9 40.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.714 1.205 . . . . 0.0 108.467 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.95 119.97 15.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . . . -88.87 108.73 19.69 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.511 ' HA ' HG12 ' A' ' 64' ' ' VAL . 4.9 m -90.76 113.24 25.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -73.72 141.55 46.36 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 122.045 2.202 . . . . 0.0 108.037 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 -81.21 0.32 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 173.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -162.54 -48.97 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.671 0.788 . . . . 0.0 108.938 173.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.68 39.24 0.34 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.389 2.276 . . . . 0.0 110.657 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.27 151.16 6.03 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.911 1.719 . . . . 0.0 111.303 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.31 161.02 45.6 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.017 1.145 . . . . 0.0 111.411 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -112.77 101.75 9.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.242 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 tp -74.04 88.69 1.91 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 174.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -74.13 168.73 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.916 0.886 . . . . 0.0 109.408 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -119.1 165.1 14.57 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.616 1.166 . . . . 0.0 111.669 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.405 HG23 ' HB ' ' A' ' 16' ' ' VAL . 15.4 t -168.69 175.7 5.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.952 2.101 . . . . 0.0 108.068 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.644 ' HE1' HM73 ' A' ' 123' ' ' FMN . 82.7 m95 -120.41 142.0 49.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.492 2.317 . . . . 0.0 109.852 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -51.94 -30.3 24.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.301 -0.856 . . . . 0.0 110.402 174.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 t -50.47 -20.37 1.12 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.052 2.941 . . . . 0.0 113.295 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.5 m-30 -118.12 -12.75 9.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.775 -1.203 . . . . 0.0 110.539 -173.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.14 158.35 15.5 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 120.583 -1.323 . . . . 0.0 112.872 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.9 140.96 42.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 120.892 -1.13 . . . . 0.0 109.501 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -100.86 144.09 13.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.519 -2.401 . . . . 0.0 104.519 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.4 mt -121.19 -179.09 3.94 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.84 2.056 . . . . 0.0 107.806 175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.52 169.83 4.5 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.246 0.618 . . . . 0.0 111.382 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 55.89 28.41 52.86 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.911 1.719 . . . . 0.0 111.354 -174.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.318 0.2 OUTLIER 53.37 27.54 6.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.06 1.744 . . . . 0.0 113.11 -175.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -73.41 150.97 41.34 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 mt -132.76 158.01 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -141.35 135.8 31.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.08 130.73 24.68 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 128.743 2.817 . . . . 0.0 106.526 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.6 108.74 2.72 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.569 2.179 . . . . 0.0 110.023 173.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.725 ' CG1' ' HB3' ' A' ' 109' ' ' ALA . 2.5 p -85.56 111.84 21.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.5 -21.6 5.06 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.519 1.056 . . . . 0.0 112.422 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.02 41.26 0.34 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 119.285 1.543 . . . . 0.0 109.266 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.469 ' HB2' HG23 ' A' ' 48' ' ' VAL . 21.4 mtt -109.78 70.62 0.73 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.582 1.153 . . . . 0.0 108.125 174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -71.44 -55.96 6.89 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.985 2.114 . . . . 0.0 114.876 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -51.92 -41.35 61.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 121.341 1.882 . . . . 0.0 108.469 173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -63.17 -38.77 92.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.248 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -56.79 -50.64 71.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.076 1.307 . . . . 0.0 110.134 174.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.44 98.79 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.899 0.48 . . . . 0.0 111.547 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -64.01 -41.61 97.4 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.689 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.22 -48.05 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 120.051 1.296 . . . . 0.0 108.27 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.02 -22.12 25.39 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.2 mmm-85 -86.92 -44.38 11.69 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -150.95 140.81 21.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.31 1.444 . . . . 0.0 109.13 -174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 -18.05 59.7 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.028 -1.045 . . . . 0.0 112.221 175.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -59.32 117.47 4.85 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.353 1.061 . . . . 0.0 113.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 20' ' ' THR . 13.1 m -138.93 153.39 24.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 124.055 1.883 . . . . 0.0 112.549 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 13.6 tp -111.01 151.16 28.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 173.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 ttt -139.24 134.29 32.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.5 p -126.58 127.87 45.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -117.11 164.21 15.1 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.651 1.114 . . . . 0.0 108.966 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.08 178.26 42.99 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -150.7 -178.41 6.55 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -113.24 -9.34 13.46 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.116 0.966 . . . . 0.0 110.504 173.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -86.1 -4.49 59.18 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.96 138.71 52.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.31 130.6 35.61 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.594 0.634 . . . . 0.0 109.827 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.51 -132.24 4.12 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 124.573 1.082 . . . . 0.0 111.953 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -91.43 -58.84 2.31 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.56 102.57 7.99 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 48.83 -167.98 0.16 Allowed Glycine 0 CA--C 1.542 1.719 0 O-C-N 120.53 -1.356 . . . . 0.0 111.798 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.55 90.65 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.619 -2.108 . . . . 0.0 106.619 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.58 121.64 0.71 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.959 -2.056 . . . . 0.0 107.959 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -117.78 169.89 9.23 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 119.396 1.598 . . . . 0.0 109.544 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.29 179.48 43.85 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 123.798 0.713 . . . . 0.0 112.081 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -132.53 149.32 52.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.265 1.026 . . . . 0.0 109.75 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -97.24 130.11 44.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 102.435 -3.172 . . . . 0.0 102.435 173.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.8 mt -136.46 152.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -130.48 140.81 50.51 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 125.205 1.402 . . . . 0.0 107.247 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.3 -176.48 42.72 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 119.141 0.882 . . . . 0.0 112.799 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 m -103.98 143.67 32.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.91 164.4 12.44 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 120.058 1.299 . . . . 0.0 111.214 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.15 121.25 2.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.308 1.043 . . . . 0.0 109.15 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.84 143.27 45.97 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.9 141.76 38.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.993 1.317 . . . . 0.0 111.51 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 p -114.76 25.87 10.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.826 2.05 . . . . 0.0 106.863 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -158.59 165.08 35.33 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.705 2.402 . . . . 0.0 109.725 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.15 178.61 45.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 127.165 2.316 . . . . 0.0 113.173 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.55 -24.11 77.56 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.672 2.248 . . . . 0.0 111.154 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -62.3 -56.54 17.43 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 124.531 1.132 . . . . 0.0 109.017 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' A' ' 101' ' ' ILE . 37.3 t80 -61.34 -31.37 71.24 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.72 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -68.02 -48.17 66.44 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 121.608 2.004 . . . . 0.0 110.622 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.16 -38.78 41.22 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.419 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' A' ' 98' ' ' PHE . 1.2 pp -93.67 -20.7 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.15 92.94 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 121.351 1.887 . . . . 0.0 112.453 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.505 0.0 OUTLIER -51.96 -21.92 3.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 173.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -73.05 178.97 4.01 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 172.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -133.92 7.88 3.77 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 118.393 -2.692 . . . . 0.0 114.388 -176.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -121.53 8.57 10.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.742 0.701 . . . . 0.0 111.796 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -85.42 150.78 24.47 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.459 -0.776 . . . . 0.0 110.622 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -115.52 -19.17 10.74 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.686 1.994 . . . . 0.0 110.397 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . . . -168.2 161.49 12.35 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 122.581 1.182 . . . . 0.0 109.383 -173.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.52 106.9 18.96 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -83.39 95.09 8.12 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 102.068 -3.308 . . . . 0.0 102.068 173.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.9 t -81.95 131.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 126.389 1.876 . . . . 0.0 106.567 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.32 128.53 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 29.2 m -104.12 91.98 4.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.84 157.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.305 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.04 -53.26 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.3 m -151.34 141.58 22.31 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.505 1.048 . . . . 0.0 113.235 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.01 144.7 39.71 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 128.451 2.7 . . . . 0.0 108.836 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -139.05 136.46 35.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.945 2.098 . . . . 0.0 106.944 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -78.92 139.16 38.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 p -141.21 -59.1 0.49 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.252 1.186 0 CA-C-O 115.444 -2.217 . . . . 0.0 114.019 -173.334 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' FMN . . . . . 0.644 HM73 ' HE1' ' A' ' 32' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_